Citrus Sinensis ID: 022309
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 299 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.792 | 0.519 | 0.726 | 5e-99 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.959 | 0.693 | 0.573 | 2e-92 | |
| Q9LQQ8 | 423 | Probable serine/threonine | no | no | 0.799 | 0.565 | 0.683 | 4e-92 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.775 | 0.544 | 0.604 | 4e-76 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.775 | 0.544 | 0.587 | 2e-73 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.792 | 0.609 | 0.558 | 3e-71 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.772 | 0.560 | 0.557 | 1e-70 | |
| Q06548 | 410 | Protein kinase APK1A, chl | no | no | 0.769 | 0.560 | 0.551 | 1e-68 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.943 | 0.572 | 0.481 | 6e-68 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.909 | 0.555 | 0.493 | 9e-68 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 360 bits (925), Expect = 5e-99, Method: Compositional matrix adjust.
Identities = 173/238 (72%), Positives = 197/238 (82%), Gaps = 1/238 (0%)
Query: 60 NTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVE 119
+TF +R+L AAT NF FLG+GGFG VYKG+L TGQVVAVKQLD G QG +EFLVE
Sbjct: 72 HTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVE 131
Query: 120 VLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIA 179
VLMLSL+ HPNLV+LIGYCA+G QRLLVYE+MPLGSLEDHL L P+ + LDWN RMKIA
Sbjct: 132 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIA 191
Query: 180 AGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVM 239
AGAA+GLE+LH+KA+PPVIYRD K+ NILL +GFHPKLSDFGLAK GPTGDKSHVSTRVM
Sbjct: 192 AGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVM 251
Query: 240 GTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH-ERMLVDWVTLFF 296
GT+GYCAPEYA TG+LT KSD++SFGVV LELITGR A+D H E+ LV W F
Sbjct: 252 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLF 309
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 339 bits (869), Expect = 2e-92, Method: Compositional matrix adjust.
Identities = 176/307 (57%), Positives = 212/307 (69%), Gaps = 20/307 (6%)
Query: 4 NC-PCFGWRKKKTKPKINE------------DKDSPGPSRIDTVERQETPARRNTLDDTL 50
NC CF + +KK P+ ++ D + P TV Q N +D
Sbjct: 2 NCFSCFYFHEKKKVPRDSDNSYRRNGEVTGRDNNKTHPENPKTVNEQ------NKNNDED 55
Query: 51 SAHENKNKENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF 110
N TF++R+L AT NF+ +G+GGFG VYKGKL +TG +VAVKQLD G
Sbjct: 56 KEVTNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGL 115
Query: 111 QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPL 170
QG KEF+VEVLMLSL+ H +LV+LIGYCA+G QRLLVYEYM GSLEDHLL LTP+ PL
Sbjct: 116 QGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPL 175
Query: 171 DWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230
DW+TR++IA GAA GLEYLH+KA+PPVIYRDLKA NILL F+ KLSDFGLAK GP GD
Sbjct: 176 DWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGD 235
Query: 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ-GHERMLV 289
K HVS+RVMGT+GYCAPEY TG+LT KSD++SFGVVLLELITGR +D ++ E+ LV
Sbjct: 236 KQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLV 295
Query: 290 DWVTLFF 296
W F
Sbjct: 296 TWAQPVF 302
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 338 bits (866), Expect = 4e-92, Method: Compositional matrix adjust.
Identities = 164/240 (68%), Positives = 192/240 (80%), Gaps = 1/240 (0%)
Query: 58 KENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFL 117
K TFT+++L AT NF+ FLG+GGFG V+KG + + QVVA+KQLD G QG +EF+
Sbjct: 87 KAQTFTFQELAEATGNFRSDCFLGEGGFGKVFKGTIEKLDQVVAIKQLDRNGVQGIREFV 146
Query: 118 VEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMK 177
VEVL LSL HPNLV LIG+CAEG QRLLVYEYMP GSLEDHL L KPLDWNTRMK
Sbjct: 147 VEVLTLSLADHPNLVKLIGFCAEGDQRLLVYEYMPQGSLEDHLHVLPSGKKPLDWNTRMK 206
Query: 178 IAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTR 237
IAAGAARGLEYLH++ PPVIYRDLK NILLG+ + PKLSDFGLAK GP+GDK+HVSTR
Sbjct: 207 IAAGAARGLEYLHDRMTPPVIYRDLKCSNILLGEDYQPKLSDFGLAKVGPSGDKTHVSTR 266
Query: 238 VMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH-ERMLVDWVTLFF 296
VMGT+GYCAP+YA TG+LT KSDI+SFGVVLLELITGR A+D+++ ++ LV W F
Sbjct: 267 VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDNTKTRKDQNLVGWARPLF 326
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 285 bits (728), Expect = 4e-76, Method: Compositional matrix adjust.
Identities = 148/245 (60%), Positives = 176/245 (71%), Gaps = 13/245 (5%)
Query: 62 FTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAET---------GQVVAVKQLDDTGFQG 112
FT+ +L AT NF+ N LG+GGFG V+KG + +T G VVAVKQL GFQG
Sbjct: 74 FTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKPEGFQG 133
Query: 113 EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDW 172
KE+L EV L + HPNLV L+GYCAEG RLLVYE+MP GSLE+HL +PL W
Sbjct: 134 HKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLF--RRGAQPLTW 191
Query: 173 NTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKS 232
RMK+A GAA+GL +LH +A VIYRD KA NILL F+ KLSDFGLAK GPTGD +
Sbjct: 192 AIRMKVAVGAAKGLTFLH-EAKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGDNT 250
Query: 233 HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ-GHERMLVDW 291
HVST+V+GTHGY APEY TG+LTAKSD++SFGVVLLELI+GR AMD+S G+E LVDW
Sbjct: 251 HVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNEYSLVDW 310
Query: 292 VTLFF 296
T +
Sbjct: 311 ATPYL 315
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 276 bits (705), Expect = 2e-73, Method: Compositional matrix adjust.
Identities = 144/245 (58%), Positives = 175/245 (71%), Gaps = 13/245 (5%)
Query: 62 FTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAET---------GQVVAVKQLDDTGFQG 112
FT+ +L AT NF+ + LG+GGFG V+KG + T G VVAVK+L G+QG
Sbjct: 71 FTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKLKTEGYQG 130
Query: 113 EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDW 172
KE+L EV L + HPNLV L+GYC EG RLLVYE+MP GSLE+HL +PL W
Sbjct: 131 HKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLF--RRGAQPLTW 188
Query: 173 NTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKS 232
RMK+A GAA+GL +LH+ A VIYRD KA NILL F+ KLSDFGLAK GPTGDK+
Sbjct: 189 AIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGDKT 247
Query: 233 HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ-GHERMLVDW 291
HVST+VMGTHGY APEY TG+LTAKSD++SFGVVLLEL++GR A+D S+ G E+ LVDW
Sbjct: 248 HVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQSLVDW 307
Query: 292 VTLFF 296
T +
Sbjct: 308 ATPYL 312
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 268 bits (686), Expect = 3e-71, Method: Compositional matrix adjust.
Identities = 139/249 (55%), Positives = 174/249 (69%), Gaps = 12/249 (4%)
Query: 54 ENKNKENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAE---------TGQVVAVKQ 104
+N N +N F+ +L +AT NF+ + +G+GGFG V+KG + E TG V+AVK+
Sbjct: 49 QNANLKN-FSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKR 107
Query: 105 LDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLT 164
L+ GFQG +E+L E+ L + HPNLV LIGYC E RLLVYE+M GSLE+HL
Sbjct: 108 LNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRG 167
Query: 165 PEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224
+PL WNTR+++A GAARGL +LHN A P VIYRD KA NILL ++ KLSDFGLA+
Sbjct: 168 TFYQPLSWNTRVRMALGAARGLAFLHN-AQPQVIYRDFKASNILLDSNYNAKLSDFGLAR 226
Query: 225 FGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG- 283
GP GD SHVSTRVMGT GY APEY TG L+ KSD++SFGVVLLEL++GR A+D +Q
Sbjct: 227 DGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPV 286
Query: 284 HERMLVDWV 292
E LVDW
Sbjct: 287 GEHNLVDWA 295
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 266 bits (680), Expect = 1e-70, Method: Compositional matrix adjust.
Identities = 135/242 (55%), Positives = 173/242 (71%), Gaps = 11/242 (4%)
Query: 61 TFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAE---------TGQVVAVKQLDDTGFQ 111
+FT+ +L AAT NF+ + LG+GGFG+V+KG + E TG V+AVK+L+ G+Q
Sbjct: 56 SFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGWQ 115
Query: 112 GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLD 171
G +E+L EV L HPNLV LIGYC E RLLVYE+MP GSLE+HL +PL
Sbjct: 116 GHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLS 175
Query: 172 WNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231
W R+K+A GAA+GL +LHN A+ VIYRD K NILL ++ KLSDFGLAK GPTGDK
Sbjct: 176 WTLRLKVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDK 234
Query: 232 SHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ-GHERMLVD 290
SHVSTR+MGT+GY APEY TG LT KSD++S+GVVLLE+++GR A+D ++ E+ LV+
Sbjct: 235 SHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLVE 294
Query: 291 WV 292
W
Sbjct: 295 WA 296
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 259 bits (663), Expect = 1e-68, Method: Compositional matrix adjust.
Identities = 133/241 (55%), Positives = 170/241 (70%), Gaps = 11/241 (4%)
Query: 61 TFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAE---------TGQVVAVKQLDDTGFQ 111
+F++ +L +AT NF+ + LG+GGFG V+KG + E TG V+AVK+L+ G+Q
Sbjct: 55 SFSFAELKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPGTGLVIAVKKLNQDGWQ 114
Query: 112 GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLD 171
G +E+L EV L H +LV LIGYC E RLLVYE+MP GSLE+HL +PL
Sbjct: 115 GHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGLYFQPLS 174
Query: 172 WNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231
W R+K+A GAA+GL +LH+ ++ VIYRD K NILL ++ KLSDFGLAK GP GDK
Sbjct: 175 WKLRLKVALGAAKGLAFLHS-SETRVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPIGDK 233
Query: 232 SHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ-GHERMLVD 290
SHVSTRVMGTHGY APEY TG LT KSD++SFGVVLLEL++GR A+D ++ ER LV+
Sbjct: 234 SHVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPSGERNLVE 293
Query: 291 W 291
W
Sbjct: 294 W 294
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 257 bits (657), Expect = 6e-68, Method: Compositional matrix adjust.
Identities = 144/299 (48%), Positives = 184/299 (61%), Gaps = 17/299 (5%)
Query: 4 NCPCFGWRKKKTKPKINEDKDSPGPSRIDTVERQETPARRNTLDDTLSAHENKNKENTFT 63
NC K K N D+ S T E+ + + + L+ + K FT
Sbjct: 76 NCTVTTMESKSANEKSN-DQPVGQVSSTTTTSNAESSSSTPVISEELNISSHLRK---FT 131
Query: 64 YRQLVAATDNFKDTNFLGQGGFGAVYKGKLAE---------TGQVVAVKQLDDTGFQGEK 114
+ L +T NF+ + LG+GGFG V+KG + E TG VAVK L+ G QG K
Sbjct: 132 FNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHK 191
Query: 115 EFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNT 174
E+L E+ L + HPNLV L+GYC E QRLLVYE+MP GSLE+HL + PL W+
Sbjct: 192 EWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSI 248
Query: 175 RMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHV 234
RMKIA GAA+GL +LH +A PVIYRD K NILL ++ KLSDFGLAK P K+HV
Sbjct: 249 RMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHV 308
Query: 235 STRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH-ERMLVDWV 292
STRVMGT+GY APEY TG LT+KSD++SFGVVLLE++TGR +MD ++ + E LV+W
Sbjct: 309 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 367
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 257 bits (656), Expect = 9e-68, Method: Compositional matrix adjust.
Identities = 143/290 (49%), Positives = 185/290 (63%), Gaps = 18/290 (6%)
Query: 15 TKPKINEDKDSP-GP-SRIDTVERQETPARRNTLDDTLSAHENKNKENTFTYRQLVAATD 72
++ I + D P GP S T E+ + + L+ + + K F++ L AT
Sbjct: 78 SQSAIVQSNDQPVGPVSSTTTTSNAESSLSTPIISEELNIYSHLKK---FSFIDLKLATR 134
Query: 73 NFKDTNFLGQGGFGAVYKGKLAE---------TGQVVAVKQLDDTGFQGEKEFLVEVLML 123
NF+ + LG+GGFG V+KG + E TG VAVK L+ G QG KE+L E+ L
Sbjct: 135 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINYL 194
Query: 124 SLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAA 183
+ HPNLV L+GYC E QRLLVYE+MP GSLE+HL + PL W+ RMKIA GAA
Sbjct: 195 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAA 251
Query: 184 RGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG 243
+GL +LH +A PVIYRD K NILL ++ KLSDFGLAK P K+HVSTRVMGT+G
Sbjct: 252 KGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYG 311
Query: 244 YCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH-ERMLVDWV 292
Y APEY TG LT+KSD++SFGVVLLE++TGR +MD ++ + E LV+W
Sbjct: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 361
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 299 | ||||||
| 357508335 | 425 | Protein kinase family protein [Medicago | 0.949 | 0.668 | 0.635 | 1e-107 | |
| 242087721 | 474 | hypothetical protein SORBIDRAFT_09g01850 | 0.969 | 0.611 | 0.629 | 1e-102 | |
| 242087719 | 474 | hypothetical protein SORBIDRAFT_09g01849 | 0.969 | 0.611 | 0.629 | 1e-101 | |
| 224075521 | 456 | serine/threonine protein kinase PBS1 [Po | 0.926 | 0.607 | 0.654 | 1e-101 | |
| 255543659 | 438 | receptor serine-threonine protein kinase | 0.929 | 0.634 | 0.610 | 1e-101 | |
| 356571603 | 414 | PREDICTED: serine/threonine-protein kina | 0.976 | 0.705 | 0.620 | 1e-100 | |
| 413949526 | 474 | putative protein kinase superfamily prot | 0.969 | 0.611 | 0.626 | 1e-100 | |
| 255568155 | 375 | receptor serine-threonine protein kinase | 0.963 | 0.768 | 0.640 | 1e-100 | |
| 255547614 | 461 | receptor serine-threonine protein kinase | 0.973 | 0.631 | 0.611 | 1e-100 | |
| 356560452 | 424 | PREDICTED: serine/threonine-protein kina | 0.979 | 0.691 | 0.602 | 1e-100 |
| >gi|357508335|ref|XP_003624456.1| Protein kinase family protein [Medicago truncatula] gi|355499471|gb|AES80674.1| Protein kinase family protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 393 bits (1010), Expect = e-107, Method: Compositional matrix adjust.
Identities = 195/307 (63%), Positives = 227/307 (73%), Gaps = 23/307 (7%)
Query: 5 CPCFGWRKKKTKPKINEDKDS----------PGPSRIDTV-----ERQETPARRNTLDDT 49
CPCFG RKK ED+ + G S +D + R E NT
Sbjct: 4 CPCFGSRKKGKGKNDQEDEKNLKSVGSTVSVSGRSLVDIIWFDTERRSEATTAENT---- 59
Query: 50 LSAHENKNKENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG 109
+ NK FT+R+L AT NF+D F+GQGGFG VYKGKL TGQ VAVK+LD TG
Sbjct: 60 ----DISNKAQIFTFRELATATKNFRDETFIGQGGFGTVYKGKLGSTGQAVAVKRLDTTG 115
Query: 110 FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKP 169
FQGEKEFLVEVLMLSL+ HPNLV +IGYCAEG QRLLVYEYMP+GSLE HL L P+ +P
Sbjct: 116 FQGEKEFLVEVLMLSLLHHPNLVSMIGYCAEGDQRLLVYEYMPMGSLESHLHDLLPDNEP 175
Query: 170 LDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229
LDWNTRM+IA GAARGL YLH++A+P VIYRDLK+ NILL +GF+PKLSDFGLAKFGPTG
Sbjct: 176 LDWNTRMRIAVGAARGLNYLHHEAEPSVIYRDLKSSNILLDEGFYPKLSDFGLAKFGPTG 235
Query: 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLV 289
D+S+V+TRVMGTHGYCAPEYATTGKLT +SDI+SFGVVLLELITGR A D+++ H++ LV
Sbjct: 236 DQSYVATRVMGTHGYCAPEYATTGKLTMRSDIYSFGVVLLELITGRRAYDETRAHDKHLV 295
Query: 290 DWVTLFF 296
DW F
Sbjct: 296 DWARPLF 302
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|242087721|ref|XP_002439693.1| hypothetical protein SORBIDRAFT_09g018500 [Sorghum bicolor] gi|241944978|gb|EES18123.1| hypothetical protein SORBIDRAFT_09g018500 [Sorghum bicolor] | Back alignment and taxonomy information |
|---|
Score = 376 bits (966), Expect = e-102, Method: Compositional matrix adjust.
Identities = 187/297 (62%), Positives = 225/297 (75%), Gaps = 7/297 (2%)
Query: 6 PCFGWRKKKTKPKINEDKDSPGPSRIDTVERQETPAR--RNTLDDTLSAHENKNKE---N 60
PCFG + K+ KD R+ VE ++ A+ ++ D + + N+ +
Sbjct: 5 PCFGSAGEGAAKKVGARKDGSSDRRVTRVESDKSKAQGGPDSKKDAVILRDENNQHIAAH 64
Query: 61 TFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEV 120
TFT+R+L AAT NF+ LG+GGFG VYKG+L E GQVVAVKQLD G QG +EFLVEV
Sbjct: 65 TFTFRELAAATKNFRQDCLLGEGGFGRVYKGRL-ENGQVVAVKQLDRNGLQGNREFLVEV 123
Query: 121 LMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAA 180
LMLSL+ H NLV+LIGYCA+G QRLLVYE+MPLGSLEDHL + PE +PLDWNTRMKIAA
Sbjct: 124 LMLSLLHHDNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDIPPEKEPLDWNTRMKIAA 183
Query: 181 GAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMG 240
GAA+GLEYLH+KA PPVIYRD K+ NILLG+GFHPKLSDFGLAK GP GDK+HVSTRVMG
Sbjct: 184 GAAKGLEYLHDKASPPVIYRDFKSSNILLGEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 243
Query: 241 THGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH-ERMLVDWVTLFF 296
T+GYCAPEYA TG+LT KSD++SFGVV LELITGR A+D+++ H E+ LV W F
Sbjct: 244 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDNTKPHGEQNLVAWARPLF 300
|
Source: Sorghum bicolor Species: Sorghum bicolor Genus: Sorghum Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|242087719|ref|XP_002439692.1| hypothetical protein SORBIDRAFT_09g018490 [Sorghum bicolor] gi|241944977|gb|EES18122.1| hypothetical protein SORBIDRAFT_09g018490 [Sorghum bicolor] | Back alignment and taxonomy information |
|---|
Score = 375 bits (964), Expect = e-101, Method: Compositional matrix adjust.
Identities = 187/297 (62%), Positives = 224/297 (75%), Gaps = 7/297 (2%)
Query: 6 PCFGWRKKKTKPKINEDKDSPGPSRIDTVERQETPARR--NTLDDTLSAHENKNKE---N 60
PCFG + K+ KD R+ VE ++ A ++ D + + N+ +
Sbjct: 5 PCFGSAGEGAAKKVGARKDGSSDRRVTRVESDKSKAHGGPDSKKDAVILRDGSNQHIAAH 64
Query: 61 TFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEV 120
TFT+R+L AAT NF+ LG+GGFG VYKG+L E GQVVAVKQLD G QG +EFLVEV
Sbjct: 65 TFTFRELAAATKNFRQDCLLGEGGFGRVYKGRL-ENGQVVAVKQLDRNGLQGNREFLVEV 123
Query: 121 LMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAA 180
LMLSL+ H NLV+LIGYCA+G QRLLVYE+MPLGSLEDHL + PE +PLDWNTRMKIAA
Sbjct: 124 LMLSLLHHDNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDIPPEKEPLDWNTRMKIAA 183
Query: 181 GAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMG 240
GAA+GLEYLH+KA PPVIYRD K+ NILLG+GFHPKLSDFGLAK GP GDK+HVSTRVMG
Sbjct: 184 GAAKGLEYLHDKASPPVIYRDFKSSNILLGEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 243
Query: 241 THGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH-ERMLVDWVTLFF 296
T+GYCAPEYA TG+LT KSD++SFGVV LELITGR A+D+++ H E+ LV W F
Sbjct: 244 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDNTKPHGEQNLVAWARPLF 300
|
Source: Sorghum bicolor Species: Sorghum bicolor Genus: Sorghum Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224075521|ref|XP_002304664.1| serine/threonine protein kinase PBS1 [Populus trichocarpa] gi|222842096|gb|EEE79643.1| serine/threonine protein kinase PBS1 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 375 bits (964), Expect = e-101, Method: Compositional matrix adjust.
Identities = 191/292 (65%), Positives = 222/292 (76%), Gaps = 15/292 (5%)
Query: 13 KKTKPKI--NEDKDSPGPSRIDT-----VERQETPARRNTLDDTLSAHENKNKENTFTYR 65
K+T P + N K S G R + ++E P+ ++ ++AH FT+R
Sbjct: 25 KQTLPPVSSNISKLSSGADRFKSRSNGEQSKRELPSPKDAPGVNIAAH-------IFTFR 77
Query: 66 QLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSL 125
+L AAT NF+ FLG+GGFG VYKG+L TGQVVAVKQLD G QG +EFLVEVLMLSL
Sbjct: 78 ELAAATKNFRPECFLGEGGFGRVYKGRLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSL 137
Query: 126 MRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARG 185
+ HPNLV+LIGYCA+G QRLLVYE+MPLGSLEDHL L PE +PLDWNTRMKIAAGAARG
Sbjct: 138 LHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPEKEPLDWNTRMKIAAGAARG 197
Query: 186 LEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYC 245
LEYLH+KA PPVIYRD K+ NILL +GFHPKLSDFGLAK GPTGDKSHVSTRVMGT+GYC
Sbjct: 198 LEYLHDKASPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYC 257
Query: 246 APEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH-ERMLVDWVTLFF 296
APEYA TG+LT KSD++SFGVV LELITGR A+D S+ H E+ LV W F
Sbjct: 258 APEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSSRPHGEQNLVTWTRPLF 309
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255543659|ref|XP_002512892.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223547903|gb|EEF49395.1| receptor serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 374 bits (961), Expect = e-101, Method: Compositional matrix adjust.
Identities = 191/313 (61%), Positives = 227/313 (72%), Gaps = 35/313 (11%)
Query: 4 NCPCFGWRKKKTKPKINEDKDSPGPS-------------------------RIDTVERQE 38
+CPCFG +K K+ D + PS ++ R E
Sbjct: 3 HCPCFGMLNRK---KLKHDIINKEPSYESRAGSGSKSKPSSASRSKSSSVSKVTADLRPE 59
Query: 39 TPARRNTLDDTLSAHENKNKENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQ 98
P R+ ++ + N TFTY +L AT+NF T+ +G+GGFGAVYKGKL TGQ
Sbjct: 60 PPVPRH------RSNASSNVAPTFTYEELAIATNNFSPTSLIGRGGFGAVYKGKLESTGQ 113
Query: 99 VVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLED 158
VVAVKQLD +G QGEKEFLVEVLML+LM HPNLV+LIG+CAEG QRLL+YEY+P+GSLED
Sbjct: 114 VVAVKQLDLSGIQGEKEFLVEVLMLTLMHHPNLVNLIGFCAEGEQRLLIYEYLPMGSLED 173
Query: 159 HLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLS 218
HL + P+M+PLDWNTRMKIAAGAA+GL+YLHN A+PPVIYRDLKA NILL +GFHPKLS
Sbjct: 174 HLFDVPPDMEPLDWNTRMKIAAGAAKGLDYLHN-ANPPVIYRDLKASNILLDEGFHPKLS 232
Query: 219 DFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAM 278
DFGLAKFGPTGD SHVSTRVMGT+GYCAPEYA+TG+LT K+DI+SFGVVLLELITG A+
Sbjct: 233 DFGLAKFGPTGDNSHVSTRVMGTYGYCAPEYASTGRLTMKTDIYSFGVVLLELITGHRAI 292
Query: 279 DDSQGHERMLVDW 291
DD G L+ W
Sbjct: 293 DDINGRHMHLIHW 305
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356571603|ref|XP_003553966.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 372 bits (955), Expect = e-100, Method: Compositional matrix adjust.
Identities = 185/298 (62%), Positives = 223/298 (74%), Gaps = 6/298 (2%)
Query: 1 MSPNCPCFGWRKKKTKPKINEDKDSPGPSR--IDTVERQETPARRNTLDDTLSAHENKNK 58
M +CPCFG KTK K + ++ +R +D E ++ S+H K
Sbjct: 1 MMGSCPCFGLWSWKTKGKTVKAQEEQNKNRKSLDVSETSSGLGPEENPTESDSSH----K 56
Query: 59 ENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV 118
FT+R+L AT NF+D F+GQGGFG VYKG + + QVVAVK+LD TG QGEKEFLV
Sbjct: 57 AQIFTFRELATATKNFRDETFIGQGGFGTVYKGTIGKINQVVAVKRLDTTGVQGEKEFLV 116
Query: 119 EVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKI 178
EVLMLSL+RH NLV++IGYCAEG QRLLVYEYM LGSLE HL ++P+ +PLDWNTRM I
Sbjct: 117 EVLMLSLLRHSNLVNMIGYCAEGDQRLLVYEYMALGSLESHLHDVSPDEEPLDWNTRMMI 176
Query: 179 AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRV 238
A GAA+GL YLH++A P VIYRDLK+ NILL +GFHPKLSDFGLAKFGPTG++S+V+TRV
Sbjct: 177 AFGAAKGLNYLHHEAKPSVIYRDLKSSNILLDEGFHPKLSDFGLAKFGPTGEQSYVATRV 236
Query: 239 MGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVDWVTLFF 296
MGT GYCAPEYAT+GKLT +SDI+SFGVVLLELITGR A DD+ G E+ LV+W F
Sbjct: 237 MGTQGYCAPEYATSGKLTMRSDIYSFGVVLLELITGRRAYDDNGGPEKHLVEWARPMF 294
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|413949526|gb|AFW82175.1| putative protein kinase superfamily protein [Zea mays] | Back alignment and taxonomy information |
|---|
Score = 370 bits (951), Expect = e-100, Method: Compositional matrix adjust.
Identities = 186/297 (62%), Positives = 224/297 (75%), Gaps = 7/297 (2%)
Query: 6 PCFGWRKKKTKPKINEDKDSPGPSRIDTVERQETPARR--NTLDDTLSAHENKNKE---N 60
PCFG + + KD R+ VE ++ + ++ D + E N+ +
Sbjct: 5 PCFGSAGEGAAKEGGARKDGTSDLRVTRVESDKSKPQGGLDSKKDAVILREGNNQHIAAH 64
Query: 61 TFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEV 120
TFT+R+L AAT NF+ LG+GGFG VYKG+L E GQVVAVKQLD G QG +EFLVEV
Sbjct: 65 TFTFRELAAATKNFRQDCLLGEGGFGRVYKGRL-ENGQVVAVKQLDRNGLQGNREFLVEV 123
Query: 121 LMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAA 180
LMLSL+ H NLV+LIGYCA+G QRLLVYE+MPLGSLEDHL + P+ +PLDWNTRMKIAA
Sbjct: 124 LMLSLLHHDNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDIPPDKEPLDWNTRMKIAA 183
Query: 181 GAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMG 240
GAA+GLEYLH+KA PPVIYRD K+ NILLG+GFHPKLSDFGLAK GP GDK+HVSTRVMG
Sbjct: 184 GAAKGLEYLHDKASPPVIYRDFKSSNILLGEGFHPKLSDFGLAKLGPVGDKTHVSTRVMG 243
Query: 241 THGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH-ERMLVDWVTLFF 296
T+GYCAPEYA TG+LTAKSD++SFGVV LELITGR A+D+++ H E+ LV W F
Sbjct: 244 TYGYCAPEYAMTGQLTAKSDVYSFGVVFLELITGRKAIDNTKPHGEQNLVAWARPLF 300
|
Source: Zea mays Species: Zea mays Genus: Zea Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255568155|ref|XP_002525053.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223535634|gb|EEF37300.1| receptor serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 370 bits (951), Expect = e-100, Method: Compositional matrix adjust.
Identities = 187/292 (64%), Positives = 217/292 (74%), Gaps = 4/292 (1%)
Query: 6 PCFGWRKKKTKPKINEDKDSPGPSRIDTVERQETPARRNTLDDTLSAHENKNKENTFTYR 65
PC G K K+ + D PS D + + T D S H +TFT+R
Sbjct: 5 PCAGKSSNDAKKKLKKRPDDQIPSSSDKTKPSLALDVKETSKDGGSDH---IAAHTFTFR 61
Query: 66 QLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSL 125
+L AAT NF+ LG+GGFG VYKG+L T QVVA+KQLD G QG +EFLVEVLMLSL
Sbjct: 62 ELAAATKNFRADCLLGEGGFGRVYKGRLESTSQVVAIKQLDRNGLQGNREFLVEVLMLSL 121
Query: 126 MRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARG 185
+ HPNLV+LIGYCA+G QRLLVYEYMPLGSLEDHL L P+ K LDWNTRMKIAAGAA+G
Sbjct: 122 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWNTRMKIAAGAAKG 181
Query: 186 LEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYC 245
LEYLH+KA+PPVIYRDLK NILLG+G+HPKLSDFGLAK GP GDK+HVSTRVMGT+GYC
Sbjct: 182 LEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 241
Query: 246 APEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH-ERMLVDWVTLFF 296
APEYA TG+LT KSD++SFGVVLLE+ITGR A+D+S+ E LV W F
Sbjct: 242 APEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSRAAGEHNLVAWARPLF 293
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255547614|ref|XP_002514864.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223545915|gb|EEF47418.1| receptor serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 370 bits (950), Expect = e-100, Method: Compositional matrix adjust.
Identities = 187/306 (61%), Positives = 228/306 (74%), Gaps = 15/306 (4%)
Query: 6 PCFGWRKKKT--KPKINEDKDSPGPSRIDTVERQETPARR-NTLDDTLSAHENKNKEN-- 60
PCF R+++T K ++D+ P+ + + + A R + + S E + ++
Sbjct: 5 PCFDSREEETLNPQKESDDRKQSLPTESSNISKLSSGADRLRSRSNGRSKRELPSPKDGP 64
Query: 61 ---------TFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ 111
TFT+R+L AAT NF+ +F+G+GGFG VYKG L TGQVVAVKQLD G Q
Sbjct: 65 VPGVNIAAQTFTFRELAAATKNFRQESFIGEGGFGRVYKGLLETTGQVVAVKQLDRNGLQ 124
Query: 112 GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLD 171
G +EFLVEVLMLSL+ HPNLV+LIGYCA+G QRLLVYE+MPLGSLEDHL L P +PLD
Sbjct: 125 GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPAKEPLD 184
Query: 172 WNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231
WNTRM+IAAGAA+GLEYLH+KA+PPVIYRD K+ NILL +GFHPKLSDFGLAK GPTGDK
Sbjct: 185 WNTRMRIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDK 244
Query: 232 SHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH-ERMLVD 290
SHVSTRVMGT+GYCAPEYA TG+LT KSD++SFGVV LELITGR A+D ++ H E+ LV
Sbjct: 245 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVT 304
Query: 291 WVTLFF 296
W F
Sbjct: 305 WARPLF 310
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356560452|ref|XP_003548506.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 369 bits (948), Expect = e-100, Method: Compositional matrix adjust.
Identities = 182/302 (60%), Positives = 222/302 (73%), Gaps = 9/302 (2%)
Query: 4 NCPCFGWRKKKTKPK----INEDKDSPGPSRIDTVERQETPARRNTL-----DDTLSAHE 54
+CPCFG R KT+ K ++D+ + +D T ++ L+
Sbjct: 3 SCPCFGLRSWKTRVKSGVKAHQDEQNKNRKSLDNNSNNNINNVSETSSGLGPEENLTESG 62
Query: 55 NKNKENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEK 114
+ K FT+R+L AT NF+D F+GQGGFG VYKG + + QVVAVK+LD TG QGEK
Sbjct: 63 SSYKPQIFTFRELATATKNFRDETFIGQGGFGIVYKGTIGKINQVVAVKRLDTTGVQGEK 122
Query: 115 EFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNT 174
EFLVEVLMLSL+RH NLV++IGYCAEG QRLLVYEYM LGSLE HL ++P+ +PLDWNT
Sbjct: 123 EFLVEVLMLSLLRHSNLVNMIGYCAEGDQRLLVYEYMALGSLESHLHDVSPDEEPLDWNT 182
Query: 175 RMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHV 234
RM IA GAA+GL YLH++A P VIYRDLK+ NILL +GFHPKLSDFGLAKFGPTG++S+V
Sbjct: 183 RMMIACGAAKGLNYLHHEAKPSVIYRDLKSSNILLDEGFHPKLSDFGLAKFGPTGEQSYV 242
Query: 235 STRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVDWVTL 294
+TRVMGT GYCAPEYAT+GKLT +SDI+SFGVVLLELITGR A DD+ G + LV+W
Sbjct: 243 ATRVMGTQGYCAPEYATSGKLTIRSDIYSFGVVLLELITGRRAYDDNSGPVKHLVEWARP 302
Query: 295 FF 296
F
Sbjct: 303 MF 304
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 299 | ||||||
| TAIR|locus:2183018 | 513 | AT5G18610 [Arabidopsis thalian | 0.989 | 0.576 | 0.611 | 3.9e-92 | |
| TAIR|locus:2179857 | 456 | PBS1 "avrPphB susceptible 1" [ | 0.792 | 0.519 | 0.726 | 3.5e-91 | |
| TAIR|locus:2151191 | 378 | CDL1 "CDG1-like 1" [Arabidopsi | 0.973 | 0.769 | 0.606 | 8.3e-90 | |
| TAIR|locus:2098580 | 414 | AT3G07070 [Arabidopsis thalian | 0.979 | 0.707 | 0.581 | 8.9e-86 | |
| TAIR|locus:2034344 | 381 | ASG5 "ALTERED SEED GERMINATION | 0.765 | 0.601 | 0.703 | 1.4e-85 | |
| TAIR|locus:2091980 | 432 | CDG1 "CONSTITUTIVE DIFFERENTIA | 0.963 | 0.666 | 0.586 | 1.3e-84 | |
| TAIR|locus:2085720 | 386 | AT3G20530 [Arabidopsis thalian | 0.956 | 0.740 | 0.575 | 3.4e-84 | |
| TAIR|locus:2087263 | 363 | AT3G24790 [Arabidopsis thalian | 0.869 | 0.716 | 0.627 | 3.4e-84 | |
| TAIR|locus:2014604 | 381 | AT1G76370 [Arabidopsis thalian | 0.949 | 0.745 | 0.570 | 1.5e-81 | |
| TAIR|locus:2056613 | 424 | AT2G28590 [Arabidopsis thalian | 0.799 | 0.563 | 0.658 | 2e-81 |
| TAIR|locus:2183018 AT5G18610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 918 (328.2 bits), Expect = 3.9e-92, P = 3.9e-92
Identities = 187/306 (61%), Positives = 223/306 (72%)
Query: 1 MSPNCPCFGWRKKK--TKPKINED---KD-SPGPSR---IDTVERQETPARRNTLDDTLS 51
MS PCFG K +K + ++ KD S S +D + + P ++ L
Sbjct: 1 MSGCLPCFGSSAKDAASKDSVKKELSAKDGSVTQSHHISLDKSKSRRGPEQKKELTAPKE 60
Query: 52 AHENKNKENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ 111
TFT+R+L AAT NF+ LG+GGFG VYKG+L TGQ+VAVKQLD G Q
Sbjct: 61 GPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLETTGQIVAVKQLDRNGLQ 120
Query: 112 GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLD 171
G +EFLVEVLMLSL+ HPNLV+LIGYCA+G QRLLVYEYMPLGSLEDHL L P+ +PLD
Sbjct: 121 GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKEPLD 180
Query: 172 WNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231
W+TRM IAAGAA+GLEYLH+KA+PPVIYRDLK+ NILLG G+HPKLSDFGLAK GP GDK
Sbjct: 181 WSTRMTIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLGDGYHPKLSDFGLAKLGPVGDK 240
Query: 232 SHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH-ERMLVD 290
+HVSTRVMGT+GYCAPEYA TG+LT KSD++SFGVV LELITGR A+D+++ E LV
Sbjct: 241 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNARAPGEHNLVA 300
Query: 291 WVTLFF 296
W F
Sbjct: 301 WARPLF 306
|
|
| TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 909 (325.0 bits), Expect = 3.5e-91, P = 3.5e-91
Identities = 173/238 (72%), Positives = 197/238 (82%)
Query: 60 NTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVE 119
+TF +R+L AAT NF FLG+GGFG VYKG+L TGQVVAVKQLD G QG +EFLVE
Sbjct: 72 HTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVE 131
Query: 120 VLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIA 179
VLMLSL+ HPNLV+LIGYCA+G QRLLVYE+MPLGSLEDHL L P+ + LDWN RMKIA
Sbjct: 132 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIA 191
Query: 180 AGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVM 239
AGAA+GLE+LH+KA+PPVIYRD K+ NILL +GFHPKLSDFGLAK GPTGDKSHVSTRVM
Sbjct: 192 AGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVM 251
Query: 240 GTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH-ERMLVDWVTLFF 296
GT+GYCAPEYA TG+LT KSD++SFGVV LELITGR A+D H E+ LV W F
Sbjct: 252 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLF 309
|
|
| TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 896 (320.5 bits), Expect = 8.3e-90, P = 8.3e-90
Identities = 177/292 (60%), Positives = 210/292 (71%)
Query: 6 PCFGWRKKKTKPKINEDKDSPGPSRIDTVERQETPARRNTLDDTLSAHENKNKENTFTYR 65
PC G + K + N D S +V E +++L ++ S + TFT+
Sbjct: 5 PCSGKSSGRNKTRRNGDHKLDRKSSDCSVSTSEKSRAKSSLSESKSKGSDHIVAQTFTFS 64
Query: 66 QLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSL 125
+L AT NF+ +G+GGFG VYKG LA T Q A+KQLD G QG +EFLVEVLMLSL
Sbjct: 65 ELATATRNFRKECLIGEGGFGRVYKGYLASTSQTAAIKQLDHNGLQGNREFLVEVLMLSL 124
Query: 126 MRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARG 185
+ HPNLV+LIGYCA+G QRLLVYEYMPLGSLEDHL ++P +PLDWNTRMKIAAGAA+G
Sbjct: 125 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDISPGKQPLDWNTRMKIAAGAAKG 184
Query: 186 LEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYC 245
LEYLH+K PPVIYRDLK NILL + PKLSDFGLAK GP GDKSHVSTRVMGT+GYC
Sbjct: 185 LEYLHDKTMPPVIYRDLKCSNILLDDDYFPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 244
Query: 246 APEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH-ERMLVDWVTLFF 296
APEYA TG+LT KSD++SFGVVLLE+ITGR A+D S+ E+ LV W F
Sbjct: 245 APEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDSSRSTGEQNLVAWARPLF 296
|
|
| TAIR|locus:2098580 AT3G07070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 858 (307.1 bits), Expect = 8.9e-86, P = 8.9e-86
Identities = 175/301 (58%), Positives = 214/301 (71%)
Query: 4 NC-PCFGWRKKKTKPKINEDK-----DSPGPSRIDT-VERQETPARRNTLDDTLSAHENK 56
NC CF + +KK P+ +++ + G T E +T +N +D N
Sbjct: 2 NCFSCFYFHEKKKVPRDSDNSYRRNGEVTGRDNNKTHPENPKTVNEQNKNNDEDKEVTNN 61
Query: 57 NKENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEF 116
TF++R+L AT NF+ +G+GGFG VYKGKL +TG +VAVKQLD G QG KEF
Sbjct: 62 IAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGNKEF 121
Query: 117 LVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRM 176
+VEVLMLSL+ H +LV+LIGYCA+G QRLLVYEYM GSLEDHLL LTP+ PLDW+TR+
Sbjct: 122 IVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWDTRI 181
Query: 177 KIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVST 236
+IA GAA GLEYLH+KA+PPVIYRDLKA NILL F+ KLSDFGLAK GP GDK HVS+
Sbjct: 182 RIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQHVSS 241
Query: 237 RVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH-ERMLVDWVTLF 295
RVMGT+GYCAPEY TG+LT KSD++SFGVVLLELITGR +D ++ E+ LV W
Sbjct: 242 RVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWAQPV 301
Query: 296 F 296
F
Sbjct: 302 F 302
|
|
| TAIR|locus:2034344 ASG5 "ALTERED SEED GERMINATION 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 856 (306.4 bits), Expect = 1.4e-85, P = 1.4e-85
Identities = 164/233 (70%), Positives = 191/233 (81%)
Query: 61 TFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEV 120
+FT+++L AAT NF++ N LG+GGFG VYKG+L ++GQVVA+KQL+ G QG +EF+VEV
Sbjct: 65 SFTFKELAAATRNFREVNLLGEGGFGRVYKGRL-DSGQVVAIKQLNPDGLQGNREFIVEV 123
Query: 121 LMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAA 180
LMLSL+ HPNLV LIGYC G QRLLVYEYMP+GSLEDHL L +PL WNTRMKIA
Sbjct: 124 LMLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQEPLSWNTRMKIAV 183
Query: 181 GAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMG 240
GAARG+EYLH A+PPVIYRDLK+ NILL K F PKLSDFGLAK GP GD++HVSTRVMG
Sbjct: 184 GAARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKLSDFGLAKLGPVGDRTHVSTRVMG 243
Query: 241 THGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMD--DSQGHERMLVDW 291
T+GYCAPEYA +GKLT KSDI+ FGVVLLELITGR A+D QG E+ LV W
Sbjct: 244 TYGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKAIDLGQKQG-EQNLVTW 295
|
|
| TAIR|locus:2091980 CDG1 "CONSTITUTIVE DIFFERENTIAL GROWTH 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 847 (303.2 bits), Expect = 1.3e-84, P = 1.3e-84
Identities = 177/302 (58%), Positives = 214/302 (70%)
Query: 4 NCPCFGWRKKKTKPKINEDKDSPGPSRIDTVERQETPARR-----NTLDDTLSAHENKNK 58
+C CF +KTK K DK R T PA ++ T+ ++ +
Sbjct: 3 SCLCFR-PSRKTKLK---DKSHKRSIRNQTSSSSAQPAGTAKEVDSSSSQTVVQDSSRYR 58
Query: 59 ENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV 118
F+YR+L AT++F++ + +G+GGFG VYKG+L+ TGQ +AVK LD +G QG+KEFLV
Sbjct: 59 CQIFSYRELAIATNSFRNESLIGRGGFGTVYKGRLS-TGQNIAVKMLDQSGIQGDKEFLV 117
Query: 119 EVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKI 178
EVLMLSL+ H NLVHL GYCAEG QRL+VYEYMPLGS+EDHL L+ + LDW TRMKI
Sbjct: 118 EVLMLSLLHHRNLVHLFGYCAEGDQRLVVYEYMPLGSVEDHLYDLSEGQEALDWKTRMKI 177
Query: 179 AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRV 238
A GAA+GL +LHN+A PPVIYRDLK NILL + PKLSDFGLAKFGP+ D SHVSTRV
Sbjct: 178 ALGAAKGLAFLHNEAQPPVIYRDLKTSNILLDHDYKPKLSDFGLAKFGPSDDMSHVSTRV 237
Query: 239 MGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPA-MDDSQ--GHE-RMLVDWVTL 294
MGTHGYCAPEYA TGKLT KSDI+SFGVVLLELI+GR A M S+ G++ R LV W
Sbjct: 238 MGTHGYCAPEYANTGKLTLKSDIYSFGVVLLELISGRKALMPSSECVGNQSRYLVHWARP 297
Query: 295 FF 296
F
Sbjct: 298 LF 299
|
|
| TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 843 (301.8 bits), Expect = 3.4e-84, P = 3.4e-84
Identities = 167/290 (57%), Positives = 211/290 (72%)
Query: 11 RKKKTKPKINEDKDSPGP-SRIDTVERQETPARRNTLDDTLSAHENKN-KENTFTYRQLV 68
R+ ++ I + D+ + D + + +RR + + ++ N + FT+R+L
Sbjct: 17 RRSSSRQSIKDCIDAKNNITTFDNISFKTDSSRRRYISEEIAKLGKGNISAHIFTFRELC 76
Query: 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRH 128
AT NF N LG+GGFG VYKG++ QVVAVKQLD G+QG +EFLVEV+MLSL+ H
Sbjct: 77 VATKNFNPDNQLGEGGFGRVYKGQIETPEQVVAVKQLDRNGYQGNREFLVEVMMLSLLHH 136
Query: 129 PNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTP-EMKPLDWNTRMKIAAGAARGLE 187
NLV+L+GYCA+G QR+LVYEYM GSLEDHLL L + KPLDW+TRMK+AAGAARGLE
Sbjct: 137 QNLVNLVGYCADGDQRILVYEYMQNGSLEDHLLELARNKKKPLDWDTRMKVAAGAARGLE 196
Query: 188 YLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAP 247
YLH ADPPVIYRD KA NILL + F+PKLSDFGLAK GPTG ++HVSTRVMGT+GYCAP
Sbjct: 197 YLHETADPPVIYRDFKASNILLDEEFNPKLSDFGLAKVGPTGGETHVSTRVMGTYGYCAP 256
Query: 248 EYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG-HERMLVDWVTLFF 296
EYA TG+LT KSD++SFGVV LE+ITGR +D ++ E+ LV W + F
Sbjct: 257 EYALTGQLTVKSDVYSFGVVFLEMITGRRVIDTTKPTEEQNLVTWASPLF 306
|
|
| TAIR|locus:2087263 AT3G24790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 843 (301.8 bits), Expect = 3.4e-84, P = 3.4e-84
Identities = 167/266 (62%), Positives = 198/266 (74%)
Query: 36 RQETPARRNTLDDTLSAHENKNKENT----FTYRQLVAATDNFKDTNFLGQGGFGAVYKG 91
+Q +R T + ++ + N N FT+R+L AT NF+ +G+GGFG VYKG
Sbjct: 6 KQPNSPKRTT-GEVVAKNANGPSNNMGARIFTFRELATATKNFRQECLIGEGGFGRVYKG 64
Query: 92 KLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYM 151
KL QVVAVKQLD G QG++EFLVEVLMLSL+ H NLV+LIGYCA+G QRLLVYEYM
Sbjct: 65 KLENPAQVVAVKQLDRNGLQGQREFLVEVLMLSLLHHRNLVNLIGYCADGDQRLLVYEYM 124
Query: 152 PLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK 211
PLGSLEDHLL L P KPLDWNTR+KIA GAA+G+EYLH++ADPPVIYRDLK+ NILL
Sbjct: 125 PLGSLEDHLLDLEPGQKPLDWNTRIKIALGAAKGIEYLHDEADPPVIYRDLKSSNILLDP 184
Query: 212 GFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLEL 271
+ KLSDFGLAK GP GD HVS+RVMGT+GYCAPEY TG LT KSD++SFGVVLLEL
Sbjct: 185 EYVAKLSDFGLAKLGPVGDTLHVSSRVMGTYGYCAPEYQRTGYLTNKSDVYSFGVVLLEL 244
Query: 272 ITGRPAMDDSQ-GHERMLVDWVTLFF 296
I+GR +D + HE+ LV W F
Sbjct: 245 ISGRRVIDTMRPSHEQNLVTWALPIF 270
|
|
| TAIR|locus:2014604 AT1G76370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 818 (293.0 bits), Expect = 1.5e-81, P = 1.5e-81
Identities = 166/291 (57%), Positives = 213/291 (73%)
Query: 7 CFGWRKKKTKP-KINED--KDSPGPSRIDT-VERQETPARRNTL-DDTLSAHENKNKENT 61
CF +T +IN D D + + T ++ + T ++ L + +++ + +
Sbjct: 3 CFSCLNTQTNDMRINIDTLSDLTDYASVATKIDPRGTGSKSGILVNGKVNSPKPGGGARS 62
Query: 62 FTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVL 121
FT+++L AAT NF++ N +G+GGFG+VYKG+L ++GQVVA+KQL+ G QG +EF+VEV
Sbjct: 63 FTFKELAAATKNFREGNIIGKGGFGSVYKGRL-DSGQVVAIKQLNPDGHQGNQEFIVEVC 121
Query: 122 MLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAG 181
MLS+ HPNLV LIGYC G QRLLVYEYMP+GSLEDHL L P+ PL W TRMKIA G
Sbjct: 122 MLSVFHHPNLVTLIGYCTSGAQRLLVYEYMPMGSLEDHLFDLEPDQTPLSWYTRMKIAVG 181
Query: 182 AARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGT 241
AARG+EYLH K P VIYRDLK+ NILL K F KLSDFGLAK GP G+++HVSTRVMGT
Sbjct: 182 AARGIEYLHCKISPSVIYRDLKSANILLDKEFSVKLSDFGLAKVGPVGNRTHVSTRVMGT 241
Query: 242 HGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH-ERMLVDW 291
+GYCAPEYA +G+LT KSDI+SFGVVLLELI+GR A+D S+ + E+ LV W
Sbjct: 242 YGYCAPEYAMSGRLTIKSDIYSFGVVLLELISGRKAIDLSKPNGEQYLVAW 292
|
|
| TAIR|locus:2056613 AT2G28590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 817 (292.7 bits), Expect = 2.0e-81, P = 2.0e-81
Identities = 158/240 (65%), Positives = 187/240 (77%)
Query: 58 KENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFL 117
K TFT+ +L +T NFK FLG+GGFG VYKG + + QVVA+KQLD G QG +EF+
Sbjct: 82 KAQTFTFEELSVSTGNFKSDCFLGEGGFGKVYKGFIEKINQVVAIKQLDRNGAQGIREFV 141
Query: 118 VEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMK 177
VEVL LSL HPNLV LIG+CAEG QRLLVYEYMPLGSL++HL L PL WNTRMK
Sbjct: 142 VEVLTLSLADHPNLVKLIGFCAEGVQRLLVYEYMPLGSLDNHLHDLPSGKNPLAWNTRMK 201
Query: 178 IAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTR 237
IAAGAARGLEYLH+ PPVIYRDLK NIL+ +G+H KLSDFGLAK GP G ++HVSTR
Sbjct: 202 IAAGAARGLEYLHDTMKPPVIYRDLKCSNILIDEGYHAKLSDFGLAKVGPRGSETHVSTR 261
Query: 238 VMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG-HERMLVDWVTLFF 296
VMGT+GYCAP+YA TG+LT KSD++SFGVVLLELITGR A D+++ + + LV+W F
Sbjct: 262 VMGTYGYCAPDYALTGQLTFKSDVYSFGVVLLELITGRKAYDNTRTRNHQSLVEWANPLF 321
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | Sb09g018500.1 | hypothetical protein (475 aa) | |||||||||
(Sorghum bicolor) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 299 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-57 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-54 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-54 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-54 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-52 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-52 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-50 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-43 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-43 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-37 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-34 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-33 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-33 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-33 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-32 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-31 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-30 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-30 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-29 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-29 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-28 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-27 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-27 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-26 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-26 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-25 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-25 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-25 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-25 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-25 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-25 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-25 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-25 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-25 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-25 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-24 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-24 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-24 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-24 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-23 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-23 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-23 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-23 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-22 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-22 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-22 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-22 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-22 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-22 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-22 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-21 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-21 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-21 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-21 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-21 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-21 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-21 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-21 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-20 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-20 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-20 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-20 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-19 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-19 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-19 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-19 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-19 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-18 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-18 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-18 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-17 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-17 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-17 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-16 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-15 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-14 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-14 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-13 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-13 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-11 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-04 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 7e-57
Identities = 73/195 (37%), Positives = 101/195 (51%), Gaps = 11/195 (5%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLD-DTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYC 138
LG+GGFG VY + +TG+ VA+K + + +E L E+ +L + HPN+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 139 AEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVI 198
+ LV EY GSL+D L L + ++I GLEYLH+ +I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDL---LKENEGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 199 YRDLKAGNILLGKG-FHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE-YATTGKLT 256
+RDLK NILL KL+DFGL+K + ++GT Y APE G +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 257 AKSDIFSFGVVLLEL 271
KSDI+S GV+L EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 1e-54
Identities = 81/202 (40%), Positives = 109/202 (53%), Gaps = 17/202 (8%)
Query: 80 LGQGGFGAVYKGKL----AETGQVVAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVHL 134
LG+G FG VYKG L VAVK L +D Q +EFL E ++ + HPN+V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 135 IGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKAD 194
+G C E ++V EYMP G L D+L K L + + A ARG+EYL +K
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLESK-- 122
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG---YCAPEYAT 251
I+RDL A N L+G+ K+SDFGL++ D +V G + APE
Sbjct: 123 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY----YKVKGGKLPIRWMAPESLK 177
Query: 252 TGKLTAKSDIFSFGVVLLELIT 273
GK T+KSD++SFGV+L E+ T
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 3e-54
Identities = 80/200 (40%), Positives = 105/200 (52%), Gaps = 12/200 (6%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQL--DDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGY 137
LG G FG VYK K TG++VAVK L + ++ E+ +L + HPN+V LI
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 138 CAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPV 197
+ LV EY G L D+L PL + KIA RGLEYLH+ +
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLS----RGGPLSEDEAKKIALQILRGLEYLHSNG---I 119
Query: 198 IYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE-YATTGKLT 256
I+RDLK NILL + K++DFGLAK S ++T V GT Y APE
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177
Query: 257 AKSDIFSFGVVLLELITGRP 276
K D++S GV+L EL+TG+P
Sbjct: 178 PKVDVWSLGVILYELLTGKP 197
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 5e-54
Identities = 79/202 (39%), Positives = 107/202 (52%), Gaps = 18/202 (8%)
Query: 80 LGQGGFGAVYKGKL----AETGQVVAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVHL 134
LG+G FG VYKGKL + VAVK L +D Q +EFL E ++ + HPN+V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 135 IGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKAD 194
+G C E +V EYM G L +L P++ D + A ARG+EYL +K
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSD---LLSFALQIARGMEYLESK-- 121
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG---YCAPEYAT 251
I+RDL A N L+G+ K+SDFGL++ R G + APE
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLY----DDDYYRKRGGKLPIRWMAPESLK 176
Query: 252 TGKLTAKSDIFSFGVVLLELIT 273
GK T+KSD++SFGV+L E+ T
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 3e-52
Identities = 71/216 (32%), Positives = 106/216 (49%), Gaps = 11/216 (5%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE-FLVEVLMLSLMRHPNLV 132
++ LG+G FG VY + +TG++VA+K + + ++E L E+ +L ++HPN+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 133 HLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK 192
L + + LV EY G L D L + L + LEYLH+K
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLK----KRGRLSEDEARFYLRQILSALEYLHSK 116
Query: 193 ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATT 252
+++RDLK NILL + H KL+DFGLA+ ++T V GT Y APE
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMAPEVLLG 170
Query: 253 GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288
DI+S GV+L EL+TG+P +
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELF 206
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 5e-52
Identities = 79/208 (37%), Positives = 108/208 (51%), Gaps = 22/208 (10%)
Query: 80 LGQGGFGAVYKGKL---AETGQVVAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVHLI 135
LG+G FG VYKGKL VAVK L +D + K+FL E ++ + HPN+V L+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 136 GYCAEGTQRLLVYEYMPLGSLEDHL-----LGLTPEMKPLDWNTRMKIAAGAARGLEYLH 190
G C E LV EYM G L D+L + +PE L + A A+G+EYL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 191 NKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG-----YC 245
+K ++RDL A N L+G+ K+SDFGL++ D T G +
Sbjct: 123 SK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY-----YRKKTGGKLPIRWM 174
Query: 246 APEYATTGKLTAKSDIFSFGVVLLELIT 273
APE G T+KSD++SFGV+L E+ T
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 2e-50
Identities = 75/205 (36%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 80 LGQGGFGAVYKGKL----AETGQVVAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVHL 134
LG+G FG VYKG L T VAVK L + + +EFL E ++ + HPN+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 135 IGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKAD 194
+G C +G +V EYMP G L D L L +++A A+G+EYL +K
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGY-----CAPEY 249
++RDL A N L+ + K+SDFGL++ D G APE
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSR-----DIYEDDYYRKRGGGKLPIKWMAPES 175
Query: 250 ATTGKLTAKSDIFSFGVVLLELITG 274
GK T+KSD++SFGV+L E+ T
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 3e-43
Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 15/210 (7%)
Query: 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE--KEFLVEVLMLSLMRHPN 130
+ LG+G FG+VY +TG+++AVK ++ +G E + E+ +LS ++HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 131 LVHLIGYC--AEGTQRLLVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRMKIAAGAARGL 186
+V G E + EY+ GSL L G PE + TR + GL
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY-TRQIL-----EGL 114
Query: 187 EYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCA 246
YLH+ +++RD+K NIL+ KL+DFG AK + + V GT + A
Sbjct: 115 AYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171
Query: 247 PEYATTGKLTAKSDIFSFGVVLLELITGRP 276
PE + +DI+S G ++E+ TG+P
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 5e-43
Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 9/214 (4%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVH 133
F+ +G+GGFG VYK + TG+ VA+K + + +++ + E+ +L +HPN+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 134 LIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA 193
G + + +V E+ GSL+D L + L + + +GLEYLH+
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 194 DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTG 253
+I+RD+KA NILL KL DFGL+ + ++GT + APE
Sbjct: 119 ---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAPEVINGK 172
Query: 254 KLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
K+DI+S G+ +EL G+P + + +
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPYSELPPMKAL 206
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 6e-37
Identities = 73/208 (35%), Positives = 106/208 (50%), Gaps = 15/208 (7%)
Query: 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE--KEFLVEVLMLSLMRHPN 130
N++ + +G+G FG VYKG ETG VA+KQ+ + E K + E+ +L ++HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRMKIAAGAARGLEY 188
+V IG ++ EY GSL + G PE + ++ +GL Y
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQV------LQGLAY 114
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE 248
LH + VI+RD+KA NIL K KL+DFG+A D S V+GT + APE
Sbjct: 115 LHEQG---VIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPE 169
Query: 249 YATTGKLTAKSDIFSFGVVLLELITGRP 276
+ SDI+S G ++EL+TG P
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 5e-34
Identities = 71/215 (33%), Positives = 104/215 (48%), Gaps = 17/215 (7%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLA----ETGQVVAVKQLD-DTGFQGEKEFLVEVLMLSLM 126
+ K LG+G FG V + TG+ VAVK L+ Q +F E+ +L +
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL 63
Query: 127 RHPNLVHLIGYCAEGTQR--LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAAR 184
H N+V G C + R L+ EY+P GSL D+L + ++ + ++ +
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ---INLKRLLLFSSQICK 120
Query: 185 GLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVST--RVMGTH 242
G++YL ++ I+RDL A NIL+ K+SDFGLAK P +
Sbjct: 121 GMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177
Query: 243 GYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRP 276
Y APE T K ++ SD++SFGV L EL T G P
Sbjct: 178 WY-APECLRTSKFSSASDVWSFGVTLYELFTYGDP 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-33
Identities = 68/207 (32%), Positives = 109/207 (52%), Gaps = 20/207 (9%)
Query: 80 LGQGGFGAVYKG---KLAETGQV-VAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVHL 134
LG G FG VYKG E ++ VA+K L ++T + KE L E +++ + HP++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 135 IGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKP---LDWNTRMKIAAGAARGLEYLHN 191
+G C +Q L+ + MPLG L D++ + L+W ++ A+G+ YL
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLEE 127
Query: 192 KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYAT 251
K +++RDL A N+L+ H K++DFGLAK +K + + + A E
Sbjct: 128 KR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 252 TGKLTAKSDIFSFGVVLLELIT--GRP 276
T KSD++S+GV + EL+T +P
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-33
Identities = 76/212 (35%), Positives = 102/212 (48%), Gaps = 36/212 (16%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV----------EVLMLSLMRHP 129
LG+G FG V + +TG++ A+K L +K+ ++ E +LS + HP
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVL-------KKKKIIKRKEVEHTLTERNILSRINHP 53
Query: 130 NLVHLIGYCAEGTQR--LLVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRMK-IAAGAAR 184
+V L + A T+ LV EY P G L HL G E R + AA
Sbjct: 54 FIVKL--HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSE-------ERARFYAAEIVL 104
Query: 185 GLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGY 244
LEYLH+ +IYRDLK NILL H KL+DFGLAK + S +T GT Y
Sbjct: 105 ALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC-GTPEY 159
Query: 245 CAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
APE D +S GV+L E++TG+P
Sbjct: 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-33
Identities = 72/212 (33%), Positives = 113/212 (53%), Gaps = 25/212 (11%)
Query: 80 LGQGGFGAVYKGKL-----AETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVH 133
LG+G FG VYKG+L + VA+K L + + ++EF E ++S ++HPN+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 134 LIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPE------------MKPLDWNTRMKIAAG 181
L+G C + +++EY+ G L + L+ +P LD + + IA
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 182 AARGLEYL--HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVM 239
A G+EYL H+ ++RDL A N L+G+G K+SDFGL++ + D V ++ +
Sbjct: 133 IAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL 187
Query: 240 GTHGYCAPEYATTGKLTAKSDIFSFGVVLLEL 271
+ PE GK T +SDI+SFGVVL E+
Sbjct: 188 LPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 4e-33
Identities = 66/207 (31%), Positives = 99/207 (47%), Gaps = 13/207 (6%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVK--QLDDTGFQGEKEFLVEVLMLSLMRHP 129
+ + LGQG G VYK + TG++ A+K +D + K+ L E+ L P
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESP 59
Query: 130 NLVHLIG-YCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEY 188
+V G + EG + V EYM GSL D LL ++ IA +GL+Y
Sbjct: 60 YVVKCYGAFYKEGEISI-VLEYMDGGSLAD-LLKKVGKIPE---PVLAYIARQILKGLDY 114
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE 248
LH K +I+RD+K N+L+ K++DFG++K +T V GT Y +PE
Sbjct: 115 LHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-NTFV-GTVTYMSPE 170
Query: 249 YATTGKLTAKSDIFSFGVVLLELITGR 275
+ +DI+S G+ LLE G+
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-32
Identities = 71/213 (33%), Positives = 106/213 (49%), Gaps = 12/213 (5%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE-FLVEVLMLSLMRHPNLVHLIGYC 138
+G+G FG VYKG L + VAVK T K FL E +L HPN+V LIG C
Sbjct: 3 IGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 139 AEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVI 198
+ +V E +P GSL L + ++++ AA G+EYL +K I
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTV---KKLLQMSLDAAAGMEYLESKN---CI 115
Query: 199 YRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAK 258
+RDL A N L+G+ K+SDFG+++ G + + APE G+ T++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 259 SDIFSFGVVLLELITG----RPAMDDSQGHERM 287
SD++S+G++L E + P M + Q ER+
Sbjct: 176 SDVWSYGILLWETFSLGDTPYPGMSNQQTRERI 208
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 7e-32
Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLV-EVLMLSLMRHPN 130
++ +G+G FG VY + G++ +K++D + + E+E + EV +L + HPN
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLL------GLTPEMKPLDWNTRMKIAAGAAR 184
++ E + +V EY G L + PE + LDW ++ +A
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA----- 115
Query: 185 GLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK-FGPTGDKSHVSTRVMGTHG 243
L+YLH++ +++RD+K NI L KL DFG++K T D + T V GT
Sbjct: 116 -LKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA--KTVV-GTPY 168
Query: 244 YCAPEYATTGKLTAKSDIFSFGVVLLELITGRPA 277
Y +PE KSDI+S G VL EL T +
Sbjct: 169 YLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-31
Identities = 78/219 (35%), Positives = 108/219 (49%), Gaps = 36/219 (16%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA 139
LG G FG V+ G T +V AVK L G + FL E ++ +RH LV L C+
Sbjct: 14 LGAGQFGEVWMGTWNGTTKV-AVKTLKP-GTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 140 EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIY 199
E +V EYM GSL D L + E K L + +AA A G+ YL ++ I+
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLK--SGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIH 126
Query: 200 RDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYC------------AP 247
RDL A NIL+G+ K++DFGLA R++ Y AP
Sbjct: 127 RDLAARNILVGENLVCKIADFGLA-------------RLIEDDEYTAREGAKFPIKWTAP 173
Query: 248 EYATTGKLTAKSDIFSFGVVLLELIT-GR---PAMDDSQ 282
E A G+ T KSD++SFG++L E++T GR P M + +
Sbjct: 174 EAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE 212
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-31
Identities = 72/200 (36%), Positives = 102/200 (51%), Gaps = 20/200 (10%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA 139
+G+G FG V G GQ VAVK L D + FL E +++ +RHPNLV L+G
Sbjct: 14 IGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGVVL 70
Query: 140 EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIY 199
+G +V EYM GSL D+L + + ++ A G+EYL K ++
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYL--RSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVH 125
Query: 200 RDLKAGNILLGKGFHPKLSDFGLAK---FGPTGDKSHVSTRVMGTHGYCAPEYATTGKLT 256
RDL A N+L+ + K+SDFGLAK G K V + APE K +
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTAPEALREKKFS 177
Query: 257 AKSDIFSFGVVLLELIT-GR 275
KSD++SFG++L E+ + GR
Sbjct: 178 TKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-30
Identities = 68/210 (32%), Positives = 98/210 (46%), Gaps = 19/210 (9%)
Query: 80 LGQGGFGAVYKGKLA-----ETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVH 133
LG+G FG V+ G+ ++VAVK L +T K+F E +L+ +H N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 134 LIGYCAEGTQRLLVYEYMPLGSLEDHL----------LGLTPEMKPLDWNTRMKIAAGAA 183
G C EG ++V+EYM G L L M L + ++IA A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 184 RGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG 243
G+ YL A ++RDL N L+G K+ DFG+++ T D V M
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 244 YCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
+ PE K T +SD++SFGVVL E+ T
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 76/224 (33%), Positives = 112/224 (50%), Gaps = 21/224 (9%)
Query: 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV----EVLMLSLMRH 128
+++ LG+G FG VY + + VA+K L + + + + E+ +L+ + H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLA-KKLESKSKEVERFLREIQILASLNH 56
Query: 129 P-NLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLE 187
P N+V L + + LV EY+ GSLED LL PL + + I A LE
Sbjct: 57 PPNIVKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALE 115
Query: 188 YLHNKADPPVIYRDLKAGNILLGK-GFHPKLSDFGLAK-FGPTGDKSHV---STRVMGTH 242
YLH+K +I+RD+K NILL + G KL DFGLAK G S + + +GT
Sbjct: 116 YLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 243 GYCAPEYAT---TGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283
GY APE ++ SDI+S G+ L EL+TG P + +
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216
|
Length = 384 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-30
Identities = 73/202 (36%), Positives = 108/202 (53%), Gaps = 20/202 (9%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLD-DTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYC 138
LG+G +G+VYK ETGQVVA+K + + Q E + E+ +L P +V G
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ---EIIKEISILKQCDSPYIVKYYGSY 67
Query: 139 AEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAA---GAARGLEYLHNKADP 195
+ T +V EY GS+ D ++ +T K L T +IAA +GLEYLH+
Sbjct: 68 FKNTDLWIVMEYCGAGSVSD-IMKITN--KTL---TEEEIAAILYQTLKGLEYLHSNK-- 119
Query: 196 PVIYRDLKAGNILLGKGFHPKLSDFGLA-KFGPTGDKSHVSTRVMGTHGYCAPEYATTGK 254
I+RD+KAGNILL + KL+DFG++ + T K + V+GT + APE
Sbjct: 120 -KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT---VIGTPFWMAPEVIQEIG 175
Query: 255 LTAKSDIFSFGVVLLELITGRP 276
K+DI+S G+ +E+ G+P
Sbjct: 176 YNNKADIWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 9e-30
Identities = 70/241 (29%), Positives = 99/241 (41%), Gaps = 47/241 (19%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV------------E 119
D+FK +G+G F V K ET + A+K LD K L+ E
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILD-------KRQLIKEKKVKYVKIEKE 53
Query: 120 VLMLSLMRHPNLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKI 178
VL L HP ++ L Y + + L V EY P G L ++ + LD
Sbjct: 54 VLTR-LNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIR----KYGSLDEKCTRFY 107
Query: 179 AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRV 238
AA LEYLH+K +I+RDLK NILL K H K++DFG AK +
Sbjct: 108 AAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGD 164
Query: 239 M------------------GTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDD 280
GT Y +PE SD+++ G ++ +++TG+P
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224
Query: 281 S 281
S
Sbjct: 225 S 225
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-29
Identities = 70/209 (33%), Positives = 107/209 (51%), Gaps = 15/209 (7%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPN 130
+ +K+ +G+G G VYK TG+ VA+K++ Q ++ + E+L++ +HPN
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAA---RGLE 187
+V G + +V EYM GSL D + + N IA +GLE
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDII-----TQNFVRMNEPQ-IAYVCREVLQGLE 130
Query: 188 YLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAP 247
YLH++ VI+RD+K+ NILL K KL+DFG A T +KS ++ V GT + AP
Sbjct: 131 YLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL-TKEKSKRNSVV-GTPYWMAP 185
Query: 248 EYATTGKLTAKSDIFSFGVVLLELITGRP 276
E K DI+S G++ +E+ G P
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 8e-29
Identities = 69/211 (32%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV-EVLMLSLMRHPNLV 132
F +G+G FG VYK T QVVA+K +D + E E + E+ LS R P +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 133 HLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK 192
G +G++ ++ EY GS D L + LD I GLEYLH +
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 193 ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTR---VMGTHGYCAPEY 249
I+RD+KA NILL + KL+DFG++ G + ++ +GT + APE
Sbjct: 118 G---KIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEV 169
Query: 250 ATTGKLTAKSDIFSFGVVLLELITGRPAMDD 280
K+DI+S G+ +EL G P + D
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-28
Identities = 76/202 (37%), Positives = 108/202 (53%), Gaps = 15/202 (7%)
Query: 80 LGQGGFGAV----YKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLI 135
LG+G FG+V Y TG+VVAVK+L + + ++F E+ +L ++H N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 136 GYC-AEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA 193
G C + G + L LV EY+P GSL D+L + LD + A+ +G+EYL +K
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYLGSKR 128
Query: 194 DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG--YCAPEYAT 251
++RDL NIL+ K+ DFGL K P DK + R G + APE T
Sbjct: 129 ---YVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESPIFWYAPESLT 184
Query: 252 TGKLTAKSDIFSFGVVLLELIT 273
K + SD++SFGVVL EL T
Sbjct: 185 ESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-28
Identities = 70/205 (34%), Positives = 102/205 (49%), Gaps = 25/205 (12%)
Query: 80 LGQGGFGAVYKGKLAETGQV---VAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVHLI 135
LG G FG+V KG VAVK L + G+KEFL E +++ + HP +V LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 136 GYCAEGTQRLLVYEYMPLGSLEDHLL--GLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA 193
G C +G +LV E PLG L +L P + ++ A G+ YL +K
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLESKH 115
Query: 194 DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG-----YCAPE 248
++RDL A N+LL K+SDFG+++ G + +T T G + APE
Sbjct: 116 ---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYAPE 168
Query: 249 YATTGKLTAKSDIFSFGVVLLELIT 273
GK ++KSD++S+GV L E +
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-27
Identities = 71/210 (33%), Positives = 107/210 (50%), Gaps = 18/210 (8%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA 139
LG G FG V++G T V AVK L G K+FL E ++ +RHP L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPV-AVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 140 EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL--HNKADPPV 197
+V E M GSL ++L G + L + +AA A G+ YL N
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASGMAYLEAQN-----Y 124
Query: 198 IYRDLKAGNILLGKGFHPKLSDFGLAK-FGPTGDKSHVSTRVMGTHGYCAPEYATTGKLT 256
I+RDL A N+L+G+ K++DFGLA+ ++ + + APE A + +
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEAALYNRFS 182
Query: 257 AKSDIFSFGVVLLELIT-GR---PAMDDSQ 282
KSD++SFG++L E++T GR P M +++
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMPYPGMTNAE 212
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-27
Identities = 66/209 (31%), Positives = 96/209 (45%), Gaps = 8/209 (3%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV-EVLMLSLMRHPN 130
D+++ +G G VY + VA+K++D Q + L EV +S HPN
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLH 190
+V G + LV Y+ GSL D + P LD + +GLEYLH
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPR-GGLDEAIIATVLKEVLKGLEYLH 119
Query: 191 NKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK--FGPTGDKSHVSTRVMGTHGYCAPE 248
+ I+RD+KAGNILLG+ K++DFG++ V +GT + APE
Sbjct: 120 SNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 249 YATTGK-LTAKSDIFSFGVVLLELITGRP 276
K+DI+SFG+ +EL TG
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAA 205
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 69/218 (31%), Positives = 106/218 (48%), Gaps = 41/218 (18%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE-----FLVEVLMLSLMRHPNLVHL 134
+G+G +G VYK + +TG++VA+K++ + EKE + E+ +L +RHPN+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR---MENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 135 IGYCAE--GTQRLLVYEYMPLGSLEDH-LLGLTPEMKPLDWNTRMKIAAGAAR------- 184
+V+EYM DH L GL LD + +K +
Sbjct: 64 KEIVTSKGKGSIYMVFEYM------DHDLTGL------LD-SPEVKFTESQIKCYMKQLL 110
Query: 185 -GLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG 243
GL+YLH+ +++RD+K NIL+ KL+DFGLA+ T S T + T
Sbjct: 111 EGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVITLW 166
Query: 244 YCAPEY---ATTGKLTAKSDIFSFGVVLLELITGRPAM 278
Y PE AT + + D++S G +L EL G+P
Sbjct: 167 YRPPELLLGAT--RYGPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-27
Identities = 68/196 (34%), Positives = 105/196 (53%), Gaps = 12/196 (6%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQL--DDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGY 137
LG G FG V++G +V A+K L DD Q + F EV L +RH +L+ L
Sbjct: 14 LGSGYFGEVWEGLWKNRVRV-AIKILKSDDLLKQQD--FQKEVQALKRLRHKHLISLFAV 70
Query: 138 CAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPV 197
C+ G ++ E M GSL L +PE + L + + +A A G+ YL +
Sbjct: 71 CSVGEPVYIITELMEKGSLL-AFLR-SPEGQVLPVASLIDMACQVAEGMAYLEEQN---S 125
Query: 198 IYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTA 257
I+RDL A NIL+G+ K++DFGLA+ + ++S+ + + APE A+ G +
Sbjct: 126 IHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKWTAPEAASHGTFST 183
Query: 258 KSDIFSFGVVLLELIT 273
KSD++SFG++L E+ T
Sbjct: 184 KSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 9e-27
Identities = 70/216 (32%), Positives = 103/216 (47%), Gaps = 26/216 (12%)
Query: 79 FLGQGGFGAVYKGKLAETGQVVAVKQ--LDDTGFQGE---KEFLVEVLMLSLMRHPNLVH 133
LG G FG+VY+G + G AVK+ L D G G+ K+ E+ +LS ++HPN+V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 134 LIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA 193
+G E + E +P GSL L +P+ +I GLEYLH++
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL----GLEYLHDRN 122
Query: 194 DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVM-----GTHGYCAPE 248
++RD+K NIL+ KL+DFG+AK V G+ + APE
Sbjct: 123 ---TVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPYWMAPE 171
Query: 249 Y-ATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283
A G +DI+S G +LE+ TG+P +G
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG 207
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-26
Identities = 68/213 (31%), Positives = 102/213 (47%), Gaps = 29/213 (13%)
Query: 80 LGQGGFGAVYKGKLA--ETGQV---VAVKQLDDTGFQGEK-EFLVEVLMLSLMRHPNLVH 133
LGQG FG VY+G G+ VA+K +++ E+ EFL E ++ ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 134 LIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMK------PLDWNTRMKIAAGAARGLE 187
L+G + G L+V E M G L+ +L PE + P +++AA A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 188 YLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK-------FGPTGDKSHVSTRVMG 240
YL K ++RDL A N ++ + K+ DFG+ + + G K + R M
Sbjct: 134 YLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG-KGLLPVRWM- 188
Query: 241 THGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
APE G T KSD++SFGVVL E+ T
Sbjct: 189 -----APESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-26
Identities = 70/206 (33%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 80 LGQGGFGAVYKGK-LAETGQV--VAVKQLDDTGFQG-EKEFLVEVLMLSLMRHPNLVHLI 135
LG G FG V +G+ G+V VAVK L +FL E ++ + H NL+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 136 GYCAEGTQRL-LVYEYMPLGSLED--HLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK 192
G T L +V E PLGSL D L + + ++IA G + YL +K
Sbjct: 63 GVVL--THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANG----MRYLESK 116
Query: 193 ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTH-----GYCAP 247
I+RDL A NILL K+ DFGL + P + +V M H +CAP
Sbjct: 117 R---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV----MEEHLKVPFAWCAP 169
Query: 248 EYATTGKLTAKSDIFSFGVVLLELIT 273
E T + SD++ FGV L E+ T
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 6e-26
Identities = 70/214 (32%), Positives = 110/214 (51%), Gaps = 11/214 (5%)
Query: 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGY 137
+ LG G +G VY+G + VAVK L + + E EFL E ++ ++HPNLV L+G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 70
Query: 138 CAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPV 197
C ++ E+M G+L D+L + ++ + +A + +EYL K
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKKN---F 125
Query: 198 IYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTA 257
I+RDL A N L+G+ K++DFGL++ TGD + APE K +
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 258 KSDIFSFGVVLLELIT----GRPAMDDSQGHERM 287
KSD+++FGV+L E+ T P +D SQ +E +
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 218
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 65/209 (31%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV-----EVLMLSLMRHPNLV 132
N +G G FG VY +TG+++AVK++ Q + E+ +L L++HPNLV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIR---IQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 133 HLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK 192
G + + EY G+LE+ L + LD + GL YLH+
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEE----LLEHGRILDEHVIRVYTLQLLEGLAYLHSH 118
Query: 193 ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK-FGPTGDKSHVSTRVM-GTHGYCAPEYA 250
+++RD+K NI L KL DFG A + + GT Y APE
Sbjct: 119 G---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 251 TTGKLTAK---SDIFSFGVVLLELITGRP 276
T GK +DI+S G V+LE+ TG+
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 66/208 (31%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLD-DTGFQGEKEFLV-EVLMLSLMRHPNLVHLI 135
+G+G FG V K + G+++ K++D + EK+ LV EV +L ++HPN+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 136 GYCAEGTQRLL--VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA 193
+ + + L V EY G L + E K ++ +I L HN++
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 194 DPP--VIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD---KSHVSTRVMGTHGYCAPE 248
DP V++RDLK NI L + KL DFGLAK K++V GT Y +PE
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-----GTPYYMSPE 180
Query: 249 YATTGKLTAKSDIFSFGVVLLELITGRP 276
KSDI+S G ++ EL P
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALSP 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 69/217 (31%), Positives = 104/217 (47%), Gaps = 18/217 (8%)
Query: 75 KDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHL 134
K+ N + +G GA YKGK + G VK+++D E + ++HPN+V L
Sbjct: 693 KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIA----DMGKLQHPNIVKL 748
Query: 135 IGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKAD 194
IG C L++EY+ +L + L L+ W R KIA G A+ L +LH +
Sbjct: 749 IGLCRSEKGAYLIHEYIEGKNLSEVLRNLS-------WERRRKIAIGIAKALRFLHCRCS 801
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGK 254
P V+ +L I++ P L L T K +S+ Y APE T
Sbjct: 802 PAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYVAPETRETKD 854
Query: 255 LTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVDW 291
+T KSDI+ FG++L+EL+TG+ D G +V+W
Sbjct: 855 ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEW 891
|
Length = 968 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-25
Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 22/204 (10%)
Query: 80 LGQGGFGAVYKGKLAETGQ---VVAVKQLDDTGFQGEK-EFLVEVLMLSLMRHPNLVHLI 135
+G G FG V +G+L G+ VA+K L ++ +FL E ++ HPN++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 136 GYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADP 195
G + +++ EYM GSL+ L + + + G A G++YL ++
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQL---VGMLRGIASGMKYL---SEM 125
Query: 196 PVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG------YCAPEY 249
++RDL A NIL+ K+SDFGL++ D T T G + APE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRR--LEDSEATYT----TKGGKIPIRWTAPEA 179
Query: 250 ATTGKLTAKSDIFSFGVVLLELIT 273
K T+ SD++SFG+V+ E+++
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 2e-25
Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMRHPNLVHLIG 136
+ +G +G V+ K TG + A+K + + + L E +LS + P +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 137 YCAEGTQRL-LVYEYMP---LGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK 192
Y +G + L LV EY+P L SL +++ G E + A LEYLH+
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENV-GSLDE------DVARIYIAEIVLALEYLHSN 112
Query: 193 ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVS------TRVMGTHGYCA 246
+I+RDLK NIL+ H KL+DFGL+K G + +++ R++GT Y A
Sbjct: 113 G---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 247 PEYATTGKLTAKSDIFSFGVVLLELITGRP 276
PE + D +S G +L E + G P
Sbjct: 170 PEVILGQGHSKTVDWWSLGCILYEFLVGIP 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 71/213 (33%), Positives = 103/213 (48%), Gaps = 25/213 (11%)
Query: 80 LGQGGFGAVYKGKLAETGQV--------VAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNL 131
LG+G FG V+ LAE + VAVK L + ++F E +L++++H ++
Sbjct: 13 LGEGAFGKVF---LAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI 69
Query: 132 VHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMK-----------PLDWNTRMKIAA 180
V G C EG L+V+EYM G L L P+ K L + IA+
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 181 GAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMG 240
A G+ YL A ++RDL N L+G+G K+ DFG+++ + D V R M
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 241 THGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
+ PE K T +SDI+SFGVVL E+ T
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 75/216 (34%), Positives = 105/216 (48%), Gaps = 23/216 (10%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE---FLVEVLMLSLMR 127
D ++ LG G FG VYK + ETG A K + + E+E F+VE+ +LS +
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQ---IESEEELEDFMVEIDILSECK 60
Query: 128 HPNLVHLI-GYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGL 186
HPN+V L Y E +L+ E+ G+L+ +L L + L + L
Sbjct: 61 HPNIVGLYEAYFYENKLWILI-EFCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEAL 116
Query: 187 EYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL-AKFGPTGDKSHVSTRVMGTHGYC 245
+LH+ VI+RDLKAGNILL KL+DFG+ AK T K +GT +
Sbjct: 117 NFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWM 170
Query: 246 APEYAT--TGKLTA---KSDIFSFGVVLLELITGRP 276
APE T K K+DI+S G+ L+EL P
Sbjct: 171 APEVVACETFKDNPYDYKADIWSLGITLIELAQMEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 68/201 (33%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIG 136
LG+GGFG V ++ TG++ A K+LD +GE+ L E +L + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 137 YCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKI-AAGAARGLEYLHNKAD 194
Y E L LV M G L+ H+ + P R AA GLE+LH +
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP---EARAIFYAAQIICGLEHLHQRR- 115
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGK 254
++YRDLK N+LL + ++SD GLA G K GT GY APE
Sbjct: 116 --IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEV 170
Query: 255 LTAKSDIFSFGVVLLELITGR 275
D F+ G L E+I GR
Sbjct: 171 YDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 10/214 (4%)
Query: 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPN 130
+F+ N +G+G FG V+K +V A+KQ+D + +E + E +L+ +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLH 190
++ + + +V EY G L L +PL + + GL +LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLK--MQRGRPLPEDQVWRFFIQILLGLAHLH 118
Query: 191 NKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYA 250
+K +++RD+K+ N+ L + K+ D G+AK D ++ + ++GT Y +PE
Sbjct: 119 SKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELC 173
Query: 251 TTGKLTAKSDIFSFGVVLLELITGRPAMD-DSQG 283
KSD+++ GVVL E TG+ D ++QG
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG 207
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-25
Identities = 68/212 (32%), Positives = 107/212 (50%), Gaps = 21/212 (9%)
Query: 80 LGQGGFGAVYKGKL----AETGQVVAVKQLDD-TGFQGEKEFLVEVLMLSLMRHPNLVHL 134
LG+ FG +YKG L + Q+VA+K L D Q EF E +++ + HPN+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 135 IGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPE-------------MKPLDWNTRMKIAAG 181
+G + +++EY+ G L + L+ +P LD + IA
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 182 AARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGT 241
A G+EYL + +++DL A NIL+G+ H K+SD GL++ + D V + +
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 242 HGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
+ PE GK ++ SDI+SFGVVL E+ +
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-25
Identities = 73/202 (36%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 80 LGQGGFGAV----YKGKLAETGQVVAVKQLD-DTGFQGEKEFLVEVLMLSLMRHPNLVHL 134
LG+G FG V Y TG++VAVK L + G Q + E+ +L + H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 135 IGYCAEGTQR--LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK 192
G C+E + L+ EY+PLGSL D+L P+ K L+ + A G+ YLH++
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHK-LNLAQLLLFAQQICEGMAYLHSQ 126
Query: 193 ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH-VSTRVMGTHGYCAPEYAT 251
I+RDL A N+LL K+ DFGLAK P G + + V + A E
Sbjct: 127 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 252 TGKLTAKSDIFSFGVVLLELIT 273
K + SD++SFGV L EL+T
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-25
Identities = 71/209 (33%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLD-DTGFQ--GEKEFLV---EVLMLSLMRHPNL 131
LG+G +G VY G L GQ++AVKQ++ DT EKE+ EV +L ++H N+
Sbjct: 6 EVLGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 132 VHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN 191
V +G C + + E++P GS+ L P +P+ +I G A YLHN
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLHN 120
Query: 192 KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK----FGPTGDKSHVSTRVMGTHGYCAP 247
V++RD+K N++L KL DFG A+ G G S++ + GT + AP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 248 EYATTGKLTAKSDIFSFGVVLLELITGRP 276
E KSDI+S G + E+ TG+P
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 8e-25
Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 9/209 (4%)
Query: 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLV-EVLMLSLMRHPN 130
+FK LG+G +G+VYK K Q A+K++D Q E+E V E+ +L+ + HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLH 190
++ +G + +V EY P G L + + K + +I RGL+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 191 NKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYA 250
+ +++RDLK+ NILL K+ D G++K K +++ +GT Y APE
Sbjct: 121 ---EQKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEVW 173
Query: 251 TTGKLTAKSDIFSFGVVLLELITGRPAMD 279
+ KSDI+S G +L E+ T P +
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 9e-25
Identities = 76/220 (34%), Positives = 106/220 (48%), Gaps = 31/220 (14%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNL 131
+ K LG G FG V+ G VA+K L G + FL E ++ ++HP L
Sbjct: 6 ETLKLVKKLGAGQFGEVWMG-YYNGHTKVAIKSLKQ-GSMSPEAFLAEANLMKQLQHPRL 63
Query: 132 VHLIGYCAEGTQR--LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL 189
V L A TQ ++ EYM GSL D L TPE L N + +AA A G+ ++
Sbjct: 64 VRLY---AVVTQEPIYIITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIAEGMAFI 118
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF-------GPTGDKSHVSTRVMGTH 242
K I+RDL+A NIL+ + K++DFGLA+ G K +
Sbjct: 119 ERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK------- 168
Query: 243 GYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GR---PAM 278
+ APE G T KSD++SFG++L E++T GR P M
Sbjct: 169 -WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 9e-25
Identities = 69/214 (32%), Positives = 97/214 (45%), Gaps = 15/214 (7%)
Query: 70 ATDNFKDTNFLGQGGFGAVYKGKLA-----ETGQVVAVKQL-DDTGFQGEKEFLVEVLML 123
D+ LG G FG VY+G VAVK L + Q E +FL+E L++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 124 SLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMK---PLDWNTRMKIAA 180
S H N+V LIG E R ++ E M G L+ L P + L + A
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 181 GAARGLEYLHNKADPPVIYRDLKAGNILL---GKGFHPKLSDFGLAKFGPTGDKSHVSTR 237
A+G +YL I+RD+ A N LL G G K++DFG+A+ R
Sbjct: 124 DVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 238 VMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLEL 271
M + PE G T+K+D++SFGV+L E+
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 80/210 (38%), Positives = 106/210 (50%), Gaps = 21/210 (10%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG-EK--EFLVEVLMLSLMRHPN 130
F D +G G FGAVY + T +VVA+K++ +G Q EK + + EV L +RHPN
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 131 LVHLIG-YCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL 189
+ G Y E T LV EY LGS D L KPL I GA +GL YL
Sbjct: 77 TIEYKGCYLREHTA-WLVMEYC-LGSASDI---LEVHKKPLQEVEIAAICHGALQGLAYL 131
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEY 249
H+ I+RD+KAGNILL + KL+DFG A S ++ V GT + APE
Sbjct: 132 HSHE---RIHRDIKAGNILLTEPGTVKLADFGSASL-----VSPANSFV-GTPYWMAPEV 182
Query: 250 ATT---GKLTAKSDIFSFGVVLLELITGRP 276
G+ K D++S G+ +EL +P
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 3e-24
Identities = 70/213 (32%), Positives = 107/213 (50%), Gaps = 11/213 (5%)
Query: 79 FLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYC 138
LG+G FG V+KG L + V +D + + +FL E +L HPN+V LIG C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 139 AEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVI 198
TQR +Y M L D L L + L +K A AA G+ YL +K I
Sbjct: 62 ---TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CI 115
Query: 199 YRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAK 258
+RDL A N L+G+ K+SDFG+++ G S + + + APE G+ +++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK-WTAPEALNYGRYSSE 174
Query: 259 SDIFSFGVVLLEL----ITGRPAMDDSQGHERM 287
SD++S+G++L E + P M + Q E++
Sbjct: 175 SDVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 3e-24
Identities = 77/212 (36%), Positives = 107/212 (50%), Gaps = 21/212 (9%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMRHPN 130
F + +G G FGAVY + T +VVAVK++ +G Q ++ + EV L ++HPN
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 131 LVHLIG-YCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL 189
+ G Y E T LV EY LGS D L KPL I GA +GL YL
Sbjct: 83 TIEYKGCYLKEHTA-WLVMEYC-LGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYL 137
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEY 249
H+ +I+RD+KAGNILL + KL+DFG A KS + +GT + APE
Sbjct: 138 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPEV 188
Query: 250 ATT---GKLTAKSDIFSFGVVLLELITGRPAM 278
G+ K D++S G+ +EL +P +
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 3e-24
Identities = 69/217 (31%), Positives = 106/217 (48%), Gaps = 23/217 (10%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEK-EFLVEVLMLSLMRHPNLVHLIGYC 138
+G+G FG V+ G+L VAVK +T K +FL E +L HPN+V LIG C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 139 AEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVI 198
TQ+ +Y M L D L L E L +++ AA G+EYL +K I
Sbjct: 63 ---TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 199 YRDLKAGNILLGKGFHPKLSDFGLAK------FGPTGDKSHVSTRVMGTHGYCAPEYATT 252
+RDL A N L+ + K+SDFG+++ + TG + + + APE
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK------WTAPEALNY 170
Query: 253 GKLTAKSDIFSFGVVLLELIT----GRPAMDDSQGHE 285
G+ +++SD++SFG++L E + + + Q E
Sbjct: 171 GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE 207
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 3e-24
Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 10/207 (4%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA 139
+G G FG V+ G E +V A+K + + G E++F+ E ++ + HP LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKV-AIKTIRE-GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 140 EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIY 199
E + LV+E+M G L D+ L + T + + G+ YL + VI+
Sbjct: 70 ERSPICLVFEFMEHGCLSDY---LRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 200 RDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKS 259
RDL A N L+G+ K+SDFG+ +F D+ ST + +PE + K ++KS
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182
Query: 260 DIFSFGVVLLELIT-GRPAMDDSQGHE 285
D++SFGV++ E+ + G+ ++ E
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYENRSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 4e-24
Identities = 68/212 (32%), Positives = 103/212 (48%), Gaps = 27/212 (12%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQL---DDTGFQGEKEFLVEVLMLSLMRHPNLVHLIG 136
+G G +G VYK + TG++VA+K + F + E+ ML RHPN+V G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDF---EIIQQEISMLKECRHPNIVAYFG 67
Query: 137 YCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIA---AGAARGLEYLHNKA 193
+ +V EY GSL+D + +T PL + ++IA +GL YLH
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQD-IYQVTRG--PL---SELQIAYVCRETLKGLAYLHETG 121
Query: 194 DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTR--VMGTHGYCAPEYA- 250
I+RD+K NILL + KL+DFG++ + ++ R +GT + APE A
Sbjct: 122 ---KIHRDIKGANILLTEDGDVKLADFGVS----AQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 251 --TTGKLTAKSDIFSFGVVLLELITGRPAMDD 280
G K DI++ G+ +EL +P M D
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMFD 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 5e-24
Identities = 79/223 (35%), Positives = 116/223 (52%), Gaps = 29/223 (13%)
Query: 65 RQLVAATD-NFKDTNF--LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV-EV 120
R +V+ D K T F +GQG G VY TGQ VA+KQ++ Q +KE ++ E+
Sbjct: 9 RTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEI 67
Query: 121 LMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAA 180
L++ +HPN+V+ + G + +V EY+ GSL D + T M
Sbjct: 68 LVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----------ETCMDEGQ 116
Query: 181 GAA------RGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL-AKFGPTGDKSH 233
AA + LE+LH+ VI+RD+K+ NILLG KL+DFG A+ P ++S
Sbjct: 117 IAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSK 171
Query: 234 VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
ST V GT + APE T K DI+S G++ +E++ G P
Sbjct: 172 RSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 5e-24
Identities = 72/219 (32%), Positives = 107/219 (48%), Gaps = 15/219 (6%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLD-DTGFQGEKEFLVEVLMLSLMRH---P 129
++ +G+G +GAVY+GK TG+VVA+K ++ DT + EV +LS +R P
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 130 NLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL 189
N+ G +G + ++ EY GS+ + + P+ I L+Y+
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM-----KAGPIAEKYISVIIREVLVALKYI 117
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEY 249
H VI+RD+KA NIL+ + KL DFG+A S ST V GT + APE
Sbjct: 118 HKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN-SSKRSTFV-GTPYWMAPEV 172
Query: 250 ATTGKL-TAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
T GK K+DI+S G+ + E+ TG P D M
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM 211
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 8e-24
Identities = 66/200 (33%), Positives = 104/200 (52%), Gaps = 19/200 (9%)
Query: 80 LGQGGFGAVYKGKLAETGQV-VAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYC 138
LG G FG V+ GK G++ VA+K + + G E +F+ E ++ + HPNLV L G C
Sbjct: 12 LGSGQFGVVHLGKW--RGKIDVAIKMIRE-GAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 139 AEGTQRLLVYEYMPLGSLEDHLLGLTPEMKP-LDWNTRMKIAAGAARGLEYLHNKADPPV 197
+ +V EYM G L ++L E K L + + + +EYL +
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYL----RERKGKLGTEWLLDMCSDVCEAMEYLESNG---F 121
Query: 198 IYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTH---GYCAPEYATTGK 254
I+RDL A N L+G+ K+SDFGLA++ D + S+ GT + PE +
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSS--QGTKFPVKWAPPEVFDYSR 177
Query: 255 LTAKSDIFSFGVVLLELITG 274
++KSD++SFGV++ E+ +
Sbjct: 178 FSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 1e-23
Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 23/216 (10%)
Query: 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV--EVLMLSLMRHPN 130
++ +G+G FG V+ + ++V +KQ+ ++ E +L L+ HPN
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLL----GLTPEMKPLDWNTRMKIAAGAARGL 186
++ E ++V EY P G+L +++ L E L + ++ +A L
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------L 114
Query: 187 EYLHNKADPPVIYRDLKAGNILLGKGFHP---KLSDFGLAKFGPTGDKSHVSTRVMGTHG 243
++H K +++RDLK NILL K H K+ DFG++K KS T V+GT
Sbjct: 115 HHVHTKL---ILHRDLKTQNILLDK--HKMVVKIGDFGISKI--LSSKSKAYT-VVGTPC 166
Query: 244 YCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMD 279
Y +PE KSDI++ G VL EL + + A +
Sbjct: 167 YISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 2e-23
Identities = 74/214 (34%), Positives = 111/214 (51%), Gaps = 20/214 (9%)
Query: 78 NFLGQGGFGAVYKGKLAETGQV---VAVKQLDD-TGFQGEKEFLVEVLMLSLMRHPNLVH 133
+G+G FG VY G L ++ AVK L+ T + ++FL E +++ HPN++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 134 LIGYC--AEGTQRLLVYEYMPLGSLEDHLLGLT--PEMKPLDWNTRMKIAAGAARGLEYL 189
L+G C +EG+ L+V YM G L + + T P +K L + A+G+EYL
Sbjct: 61 LLGICLPSEGSP-LVVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGMEYL 114
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK--FGPTGDKSHVSTRVMGTHGYCAP 247
+K ++RDL A N +L + F K++DFGLA+ + H T + A
Sbjct: 115 ASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 248 EYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDD 280
E T K T KSD++SFGV+L EL+T G P D
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 2e-23
Identities = 72/227 (31%), Positives = 100/227 (44%), Gaps = 41/227 (18%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV----------EVL 121
D+F+ LG G FG V + +G+ A+K L K +V E
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILS-------KAKIVKLKQVEHVLNEKR 53
Query: 122 MLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRMKIA 179
+L +RHP LV+L G + + LV EY+P G L HL G PE A
Sbjct: 54 ILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPE------PVARFYA 107
Query: 180 AGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVM 239
A LEYLH+ ++YRDLK N+LL + K++DFG AK V R
Sbjct: 108 AQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTY 156
Query: 240 ---GTHGYCAPEYATTGKLTAKS-DIFSFGVVLLELITGRPAMDDSQ 282
GT Y APE K K+ D ++ G+++ E++ G P D
Sbjct: 157 TLCGTPEYLAPE-IILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 2e-23
Identities = 71/216 (32%), Positives = 97/216 (44%), Gaps = 32/216 (14%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE-KEFLVEVLMLSLMRHPN 130
D+ + LG G G V K TG+++AVK + + K+ L E+ +L P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHL---LGLTPEMKPLDWNTRMKIAAGAARGLE 187
+V G + EYM GSL+ L G PE + L KIA +GL
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPE-RILG-----KIAVAVLKGLT 114
Query: 188 YLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVM-------- 239
YLH K +I+RD+K NIL+ KL DFG VS +++
Sbjct: 115 YLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKTFV 160
Query: 240 GTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGR 275
GT Y APE + KSDI+S G+ L+EL TGR
Sbjct: 161 GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (241), Expect = 3e-23
Identities = 67/211 (31%), Positives = 108/211 (51%), Gaps = 34/211 (16%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQL----DDTGFQGEKEFLVEVLMLSLMRHPNLVHLI 135
LG+G +G VYK + +TG++VA+K++ ++ G L E+ +L ++HPN+V L+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIP--STALREISLLKELKHPNIVKLL 64
Query: 136 GYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRM--KIAAGAARGLEYLHNKA 193
+ LV+EY + L+ +L + +P + + I RGL Y H+
Sbjct: 65 DVIHTERKLYLVFEYCDM-DLKKYL-----DKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 194 DPPVIYRDLKAGNILLGKGFHPKLSDFGLAK-FGPTGDKSHVSTRVMGTHGYCAPE---- 248
+++RDLK NIL+ + KL+DFGLA+ FG + V+ T Y APE
Sbjct: 119 ---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVV-TLWYRAPEILLG 172
Query: 249 ---YATTGKLTAKSDIFSFGVVLLELITGRP 276
Y+T DI+S G + E+ITG+P
Sbjct: 173 SKHYSTA------VDIWSVGCIFAEMITGKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 4e-23
Identities = 75/212 (35%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMRHPN 130
F D +G G FGAVY + T +VVA+K++ +G Q ++ + EV L ++HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 131 LVHLIG-YCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL 189
+ G Y E T LV EY LGS D L KPL I GA +GL YL
Sbjct: 87 SIEYKGCYLREHTA-WLVMEYC-LGSASDL---LEVHKKPLQEVEIAAITHGALQGLAYL 141
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEY 249
H+ +I+RD+KAGNILL + KL+DFG A + +GT + APE
Sbjct: 142 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPEV 192
Query: 250 ATT---GKLTAKSDIFSFGVVLLELITGRPAM 278
G+ K D++S G+ +EL +P +
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 5e-23
Identities = 69/199 (34%), Positives = 107/199 (53%), Gaps = 20/199 (10%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLD-DTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYC 138
+G+G FGAV +G+ TGQ VAVK + D Q FL E +++ + H NLV L+G
Sbjct: 14 IGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 139 AEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVI 198
+ V E M G+L + L + + ++ + A G+EYL +K ++
Sbjct: 69 LHNGLYI-VMELMSKGNLVNFLRTRGRALVSVI--QLLQFSLDVAEGMEYLESKK---LV 122
Query: 199 YRDLKAGNILLGKGFHPKLSDFGLAKFGPTG-DKSHVSTRVMGTHGYCAPEYATTGKLTA 257
+RDL A NIL+ + K+SDFGLA+ G G D S + + + APE K ++
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSS 176
Query: 258 KSDIFSFGVVLLELIT-GR 275
KSD++S+GV+L E+ + GR
Sbjct: 177 KSDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 6e-23
Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 80 LGQGGFGAVYKGKLAE---TGQVVAVKQLDDTGFQGE--KEFLVEVLMLSLMRHPNLVHL 134
LG+G FG+V +G+L++ + VAVK + +EFL E + HPN++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 135 IGYCAEGTQR------LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRM--KIAAGAARGL 186
IG C E + +++ +M G L LL P + K A G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 187 EYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD---KSHVSTRVMGTHG 243
EYL N+ I+RDL A N +L + ++DFGL+K +GD + ++ +
Sbjct: 127 EYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV---K 180
Query: 244 YCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
+ A E T+KSD+++FGV + E+ T
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 9e-23
Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQL----DDTGFQGEKEFLVEVLMLSLMRHP 129
++ +G+G +G VYK + TG++VA+K++ + G K L E+ +L + HP
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIP--KTALREIKLLKELNHP 58
Query: 130 NLVHLIGYCAEGTQRLLVYEYMP---LGSLEDHLLGLTPE-MKPLDWNTRMKIAAGAARG 185
N++ L+ LV+E+M ++D GL +K + +G
Sbjct: 59 NIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQL--------LQG 110
Query: 186 LEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK-FGPTGD--KSHVSTRVMGTH 242
L + H+ +++RDLK N+L+ KL+DFGLA+ FG +V TR
Sbjct: 111 LAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR----- 162
Query: 243 GYCAPEYATTGKL-TAKSDIFSFGVVLLELITGRP 276
Y APE K + DI+S G + EL++ RP
Sbjct: 163 WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 9e-23
Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 27/218 (12%)
Query: 80 LGQGGFGAVYKGKL-----AETGQVVAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVH 133
+GQG FG V++ + E +VAVK L ++ + +F E +++ HPN+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 134 LIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPE----------------MKPLDWNT--R 175
L+G CA G L++EYM G L + L +P + PL + +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 176 MKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVS 235
+ IA A G+ YL ++ ++RDL N L+G+ K++DFGL++ + D S
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 236 TRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
+ PE + T +SD++++GVVL E+ +
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-22
Identities = 73/224 (32%), Positives = 102/224 (45%), Gaps = 20/224 (8%)
Query: 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLML-SLMRH 128
T F+ +G+G +G VYK + +TGQ+VA+K +D E+E E +L H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNH 62
Query: 129 PNLVHLIG------YCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGA 182
PN+ G Q LV E GS+ D + GL + K L I
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122
Query: 183 ARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL-AKFGPTGDKSHVSTRVMGT 241
RGL YLH VI+RD+K NILL K KL DFG+ A+ T + + GT
Sbjct: 123 LRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI---GT 176
Query: 242 HGYCAPE-----YATTGKLTAKSDIFSFGVVLLELITGRPAMDD 280
+ APE A+SD++S G+ +EL G+P + D
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-22
Identities = 77/215 (35%), Positives = 107/215 (49%), Gaps = 27/215 (12%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMRHPN 130
F D +G G FGAVY + +VVA+K++ +G Q ++ + EV L +RHPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 131 LVHLIG-YCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAA---GAARGL 186
+ G Y E T LV EY LGS D L KPL ++IAA GA +GL
Sbjct: 77 TIQYRGCYLREHTA-WLVMEYC-LGSASDLL---EVHKKPLQ---EVEIAAVTHGALQGL 128
Query: 187 EYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCA 246
YLH+ +I+RD+KAGNILL + KL DFG A + +GT + A
Sbjct: 129 AYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMA 179
Query: 247 PEYATT---GKLTAKSDIFSFGVVLLELITGRPAM 278
PE G+ K D++S G+ +EL +P +
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-22
Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 80 LGQGGFGAVYKGK---LAETGQ--VVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHL 134
LG+G FG V+ + L+ T +VAVK L D K+F E +L+ ++H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 135 IGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEM------KPLDWNTRM------KIAAGA 182
G C +G ++V+EYM G L L P+ +P + IA+
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 183 ARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTH 242
A G+ YL A ++RDL N L+G K+ DFG+++ + D V M
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 243 GYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
+ PE K T +SD++SFGV+L E+ T
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 2e-22
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 27/218 (12%)
Query: 80 LGQGGFGAVY-------KGKLAETGQ---------VVAVKQLDDTGFQGEK-EFLVEVLM 122
LG+G FG V+ + + +VAVK L + +FL EV +
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 123 LSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEM-------KPLDWNTR 175
LS + PN+ L+G C ++ EYM G L L E K L ++T
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 176 MKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVS 235
+ +A A G+ YL + ++RDL N L+GK + K++DFG+++ + D V
Sbjct: 133 LYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 236 TRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
R + A E GK T KSD+++FGV L E++T
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 2e-22
Identities = 72/217 (33%), Positives = 113/217 (52%), Gaps = 17/217 (7%)
Query: 65 RQLVAATDNFKD-TNF--LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV-EV 120
R +V+ D K T F +GQG G VY TGQ VA++Q++ Q +KE ++ E+
Sbjct: 10 RSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEI 68
Query: 121 LMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAA 180
L++ ++PN+V+ + G + +V EY+ GSL D + +D +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCR 123
Query: 181 GAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL-AKFGPTGDKSHVSTRVM 239
+ LE+LH+ VI+RD+K+ NILLG KL+DFG A+ P K + ++
Sbjct: 124 ECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMV 177
Query: 240 GTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
GT + APE T K DI+S G++ +E+I G P
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 3e-22
Identities = 76/215 (35%), Positives = 111/215 (51%), Gaps = 19/215 (8%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA 139
LG G FG V+ G +V AVK L G + FL E ++ +RH LV L +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKV-AVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 140 EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIY 199
E +V EYM GSL D L E + L + +AA A G+ Y+ I+
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLK--DGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIH 125
Query: 200 RDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTH---GYCAPEYATTGKLT 256
RDL++ NIL+G G K++DFGLA+ D + + + G + APE A G+ T
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARL--IEDNEYTARQ--GAKFPIKWTAPEAALYGRFT 181
Query: 257 AKSDIFSFGVVLLELIT-GR---PAMDDSQGHERM 287
KSD++SFG++L EL+T GR P M++ + E++
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 3e-22
Identities = 63/212 (29%), Positives = 108/212 (50%), Gaps = 17/212 (8%)
Query: 80 LGQGGFGAVYKGKLAETG---QVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHL 134
+G G FG V +G+L G VA+K L +G+ + ++FL E ++ HPN++HL
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLK-SGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 135 IGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKAD 194
G + +++ E+M G+L+ L + + + + G A G++YL ++
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYL---SE 124
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTH---GYCAPEYAT 251
++RDL A NIL+ K+SDFGL++F T +G + APE
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 252 TGKLTAKSDIFSFGVVLLELIT--GRPAMDDS 281
K T+ SD++S+G+V+ E+++ RP D S
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-22
Identities = 75/206 (36%), Positives = 106/206 (51%), Gaps = 19/206 (9%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA 139
LGQG FG V+ G T +V A+K L G + FL E ++ +RH LV L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRV-AIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 140 EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIY 199
E +V EYM GSL D L G + L + +AA A G+ Y+ ++
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERMN---YVH 125
Query: 200 RDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTH---GYCAPEYATTGKLT 256
RDL+A NIL+G+ K++DFGLA+ D + + + G + APE A G+ T
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQ--GAKFPIKWTAPEAALYGRFT 181
Query: 257 AKSDIFSFGVVLLELIT-GR---PAM 278
KSD++SFG++L EL T GR P M
Sbjct: 182 IKSDVWSFGILLTELTTKGRVPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 5e-22
Identities = 71/214 (33%), Positives = 113/214 (52%), Gaps = 22/214 (10%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQVV----AVKQLDDT-GFQGEKEFLVEVLMLSLMRH 128
K LG G FG VYKG G+ V A+K L++T G + EF+ E L+++ M H
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 68
Query: 129 PNLVHLIGYCAEGTQRLLVYEYMPLGSL----EDHLLGLTPEMKPLDWNTRMKIAAGAAR 184
P+LV L+G C T + LV + MP G L +H + ++ L+W ++ A+
Sbjct: 69 PHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLL-LNWCVQI------AK 120
Query: 185 GLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGY 244
G+ YL + +++RDL A N+L+ H K++DFGLA+ +K + + +
Sbjct: 121 GMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 177
Query: 245 CAPEYATTGKLTAKSDIFSFGVVLLELIT--GRP 276
A E K T +SD++S+GV + EL+T G+P
Sbjct: 178 MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 5e-22
Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQV----VAVKQLDD-TGFQGEKEFLVEVLMLSL 125
+ LG G FG V+KG G VA+K + D +G Q +E +L +
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65
Query: 126 MRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKP---LDWNTRMKIAAGA 182
+ H +V L+G C G LV + PLGSL DH+ + P L+W ++
Sbjct: 66 LDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------ 118
Query: 183 ARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTH 242
A+G+ YL +++R+L A NILL +++DFG+A DK + +
Sbjct: 119 AKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI 175
Query: 243 GYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
+ A E G+ T +SD++S+GV + E+++
Sbjct: 176 KWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 5e-22
Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 24/214 (11%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQ-LDDTGFQGEKEFLVEVLMLSLMRHPN 130
+ + + LG+G G+V K +L TG + A+K D +K+ L E+ + + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 131 LVHLIGYCAEGTQRLL--VYEYMPLGSLED------HLLGLTPEMKPLDWNTRMKIAAGA 182
+V G + + + EY GSL+ G E K L KIA
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGE-KVLG-----KIAESV 114
Query: 183 ARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA-KFGPTGDKSHVSTRVMGT 241
+GL YLH++ +I+RD+K NILL + KL DFG++ + + + GT
Sbjct: 115 LKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GT 166
Query: 242 HGYCAPEYATTGKLTAKSDIFSFGVVLLELITGR 275
Y APE + SD++S G+ LLE+ R
Sbjct: 167 SFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 6e-22
Identities = 68/227 (29%), Positives = 109/227 (48%), Gaps = 39/227 (17%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQ--LDDTGFQGE--KEFLVEVL-----MLSLMRHPN 130
+G G FG+VY G A +G+++AVKQ L + K +++ L +L ++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRMKIAAGAARGLEY 188
+V +G + + EY+P GS+ L G E L N +I +GL Y
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE--TLVRNFVRQI----LKGLNY 121
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG----- 243
LHN+ +I+RD+K NIL+ K+SDFG++K K ++ T+G
Sbjct: 122 LHNRG---IIHRDIKGANILVDNKGGIKISDFGISK------KLEANSLSTKTNGARPSL 172
Query: 244 -----YCAPEYATTGKLTAKSDIFSFGVVLLELITGR---PAMDDSQ 282
+ APE T K+DI+S G +++E++TG+ P Q
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 6e-22
Identities = 68/216 (31%), Positives = 104/216 (48%), Gaps = 25/216 (11%)
Query: 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQL----DDTGFQGEKEFL-VEVLMLSLMR 127
N++ LGQG FG VY +TG+ +AVKQ+ D + E L E+ +L ++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 128 HPNLVHLIGYCAEGTQRLLVY-EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGL 186
H +V G C + L ++ EYMP GS++D L L K G+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL----KAYGALTETVTRKYTRQILEGV 117
Query: 187 EYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK------FGPTGDKSHVSTRVMG 240
EYLH+ +++RD+K NIL + KL DFG +K TG KS V G
Sbjct: 118 EYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-----VTG 169
Query: 241 THGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
T + +PE + K+D++S G ++E++T +P
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 6e-22
Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGY 137
+G+G G V+K K ETG+ VA+K++ +G + L E+ L +HP +V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 138 CAEGTQRLLVYEYMP------LGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN 191
G+ +LV EYMP L E L ++K RM + +G+ Y+H
Sbjct: 68 FPHGSGFVLVMEYMPSDLSEVLRDEERPL--PEAQVKSY---MRMLL-----KGVAYMHA 117
Query: 192 KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE--Y 249
+++RDLK N+L+ K++DFGLA+ + S +V T Y APE Y
Sbjct: 118 NG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLY 173
Query: 250 ATTGKLTAKSDIFSFGVVLLELITGRP 276
K D+++ G + EL+ G P
Sbjct: 174 GAR-KYDPGVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 7e-22
Identities = 69/219 (31%), Positives = 104/219 (47%), Gaps = 43/219 (19%)
Query: 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE-----FLVEVLMLSLMRHPNLV 132
LG+G + VYK + ETG++VA+K++ + K+ L E+ +L ++HPN++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 133 HLIGYCAEGTQRLLVYEYMPLGSLE----DHLLGLTP-EMKPLDWNTRMKIAAGAARGLE 187
L+ + LV+E+M LE D + LTP ++K T RGLE
Sbjct: 66 GLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMT--------LRGLE 116
Query: 188 YLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK-FGPTGDK--SHVSTRVMGTHGY 244
YLH+ +++RDLK N+L+ KL+DFGLA+ FG K V TR Y
Sbjct: 117 YLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW-----Y 168
Query: 245 CAPE-------YATTGKLTAKSDIFSFGVVLLELITGRP 276
APE Y D++S G + EL+ P
Sbjct: 169 RAPELLFGARHYGVG------VDMWSVGCIFAELLLRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 92.5 bits (229), Expect = 9e-22
Identities = 74/217 (34%), Positives = 115/217 (52%), Gaps = 17/217 (7%)
Query: 65 RQLVAATDNFKD-TNF--LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV-EV 120
R +V+ D K T F +GQG G VY TGQ VA+KQ++ Q +KE ++ E+
Sbjct: 9 RSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEI 67
Query: 121 LMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAA 180
L++ ++PN+V+ + G + +V EY+ GSL D + +D +
Sbjct: 68 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCR 122
Query: 181 GAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL-AKFGPTGDKSHVSTRVM 239
+ L++LH+ VI+RD+K+ NILLG KL+DFG A+ P ++S ST V
Sbjct: 123 ECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV- 176
Query: 240 GTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
GT + APE T K DI+S G++ +E++ G P
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-21
Identities = 81/227 (35%), Positives = 116/227 (51%), Gaps = 28/227 (12%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRH---PNLVH 133
+G+GGFG VY + A+TG++ A+K LD QGE L E +MLSL+ P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV- 60
Query: 134 LIGYCAEGTQRL-LVYEYMPLGSLEDHLL--GLTPEMKPLDWNTRMKI-AAGAARGLEYL 189
+ Y +L + + M G L HL G+ E M+ AA GLE++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE-------AEMRFYAAEIILGLEHM 113
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA-KFGPTGDKSHVSTRVMGTHGYCAPE 248
HN+ V+YRDLK NILL + H ++SD GLA F + K H S +GTHGY APE
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF--SKKKPHAS---VGTHGYMAPE 165
Query: 249 YATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVDWVTL 294
G + +D FS G +L +L+ G + ++ +D +TL
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-21
Identities = 68/206 (33%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQL--DDTGFQGEKEF-LVEVLMLSLM-RHPNLVHLI 135
LG+G FG V +L T ++ AVK L D + E + E +L+L +HP L L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 136 GYCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKAD 194
C + RL V EY+ G L H+ D AA GL++LH +
Sbjct: 63 S-CFQTKDRLFFVMEYVNGGDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFLHERG- 116
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVM-GTHGYCAPEYATTG 253
+IYRDLK N+LL H K++DFG+ K G G V+T GT Y APE +
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---VTTSTFCGTPDYIAPEILSYQ 171
Query: 254 KLTAKSDIFSFGVVLLELITGRPAMD 279
D ++ GV+L E++ G+ +
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-21
Identities = 72/202 (35%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEF---LVEVLMLSLM-RHPNLVHLI 135
LG+G FG V+ +L T Q A+K L + + +VE +LSL HP L HL
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL- 61
Query: 136 GYCAEGTQRLL--VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA 193
YC T+ L V EY+ G L H+ D AA GL++LH+K
Sbjct: 62 -YCTFQTKENLFFVMEYLNGGDLMFHI----QSCHKFDLPRATFYAAEIICGLQFLHSKG 116
Query: 194 DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTG 253
++YRDLK NILL H K++DFG+ K GD + GT Y APE
Sbjct: 117 ---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAPEILLGQ 171
Query: 254 KLTAKSDIFSFGVVLLELITGR 275
K D +SFGV+L E++ G+
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-21
Identities = 67/199 (33%), Positives = 107/199 (53%), Gaps = 14/199 (7%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV-EVLMLSLMRHPNLVHLIGYC 138
+GQG G V+ TGQ VA+KQ++ Q +KE ++ E+L++ +++PN+V+ +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 139 AEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVI 198
G + +V EY+ GSL D + +D + + LE+LH VI
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETC-----MDEAQIAAVCRECLQALEFLHANQ---VI 137
Query: 199 YRDLKAGNILLGKGFHPKLSDFGL-AKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTA 257
+RD+K+ N+LLG KL+DFG A+ P ++S ST V GT + APE T
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGP 194
Query: 258 KSDIFSFGVVLLELITGRP 276
K DI+S G++ +E++ G P
Sbjct: 195 KVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-21
Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 32/218 (14%)
Query: 80 LGQGGFGAVYKGKLAETG-----QVVAVKQLDDTGFQGE-KEFLVEVLMLSLM-RHPNLV 132
LG+G FG V K + VAVK L D + + + + E+ M+ ++ +H N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 133 HLIGYCAEGTQRLLVYEYMPLGSLEDHL------------LGLTPEMKPLDWNTRMKIAA 180
+L+G C + +V EY G+L D L P + L + A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 181 GAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMG 240
ARG+E+L +K I+RDL A N+L+ + K++DFGLA+ D H+
Sbjct: 140 QVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLAR-----DIHHIDYYRKT 191
Query: 241 THG-----YCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
T+G + APE T +SD++SFGV+L E+ T
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-21
Identities = 68/211 (32%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 80 LGQGGFGAVYKGKLAETGQV--------VAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNL 131
LG+G FG V+ LAE + VAVK L D K+F E +L+ ++H ++
Sbjct: 13 LGEGAFGKVF---LAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 132 VHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTP------EMKP---LDWNTRMKIAAGA 182
V G C EG ++V+EYM G L L P E L + + IA
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 183 ARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTH 242
A G+ YL A ++RDL N L+G+ K+ DFG+++ + D V M
Sbjct: 130 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 243 GYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
+ PE K T +SD++S GVVL E+ T
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-21
Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 80 LGQGGFGAVYKGKL-----AETGQVVAVKQLDDTG-FQGEKEFLVEVLMLSLMRHPNLVH 133
LG+ FG VYKG L E Q VA+K L D +EF E +M S ++HPN+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 134 LIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPE---------------MKPLDWNTRMKI 178
L+G + +++ Y L + L+ +P ++P D+ + I
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF---VHI 129
Query: 179 AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRV 238
A G+E+L + V+++DL N+L+ + K+SD GL + D +
Sbjct: 130 VTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 239 MGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
+ + +PE GK + SDI+S+GVVL E+ +
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 5e-21
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE--KEFLVEVLMLSLMRHPNLVHLIGY 137
+G+G +G V K + TG++VA+K+ ++ + K L EV +L +RH N+V+L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 138 CAEGTQRLLVYEYMP---LGSLEDHLLGLTPE-MKPLDWNTRMKIAAGAARGLEYLHNKA 193
+ LV+EY+ L LE GL P+ ++ W + + Y H+
Sbjct: 69 FRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL--------LQAIAYCHSHN 120
Query: 194 DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE----Y 249
+I+RD+K NIL+ + KL DFG A+ S ++ V T Y APE
Sbjct: 121 ---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLVGD 176
Query: 250 ATTGKLTAKSDIFSFGVVLLELITGRP 276
GK D+++ G ++ EL+ G P
Sbjct: 177 TNYGK---PVDVWAIGCIMAELLDGEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 6e-21
Identities = 61/228 (26%), Positives = 94/228 (41%), Gaps = 18/228 (7%)
Query: 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQL---DDTGFQGEKEFLVEVLMLSLMRHP 129
+F+ +G+G FG V + +T ++ A+K + + L E +L + HP
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 130 NLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL 189
LV+L + LV + + G L HL + LEYL
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLS----QKVKFSEEQVKFWICEIVLALEYL 116
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEY 249
H+K +I+RD+K NILL + H ++DF +A +T GT GY APE
Sbjct: 117 HSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTPGYMAPEV 170
Query: 250 ATTGKLTAKSDIFSFGVVLLELITG-RPAMDDSQGHERMLVDWVTLFF 296
+ D +S GV E + G RP +GH R + D +
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKRPY----RGHSRTIRDQIRAKQ 214
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 7e-21
Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 28/212 (13%)
Query: 80 LGQGGFGAVYKGK---LAETGQVVAVKQLDDTGFQGEK-EFLVEVLMLSLMRHPNLVHLI 135
+G G FG V G+ +VV VK+L + E+ FL EV + HPN++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVV-VKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 136 GYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPL-DWNTRMKIAAGAARGLEYLHNKAD 194
G C E LLV E+ PLG L+++L + + + ++A A GL +LH +AD
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH-QAD 120
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLA------KFGPTGDKSHVSTRVMGTHGYCAPE 248
I+ DL N L K+ D+GLA + T D V R + APE
Sbjct: 121 --FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR------WLAPE 172
Query: 249 YAT-------TGKLTAKSDIFSFGVVLLELIT 273
T KS+I+S GV + EL T
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 7e-21
Identities = 71/211 (33%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 78 NFLGQGGFGAVYKGKL------AETGQVVAVKQLDDTGFQGEK-EFLVEVLMLSLMRHPN 130
NFLG G FG VY+G VAVK L EK EFL E ++S HPN
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKP---LDWNTRMKIAAGAARGLE 187
+V L+G C + ++ E M G L +L E L + I A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 188 YLHNKADPPVIYRDLKAGNILLG-KGFHP----KLSDFGLAKFGPTGDKSHVSTRVMGTH 242
YL I+RDL A N L+ KG+ K+ DFGLA+ D +
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 243 GYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
+ APE GK T +SD++SFGV++ E++T
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 8e-21
Identities = 68/204 (33%), Positives = 101/204 (49%), Gaps = 11/204 (5%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV-EVLMLSLMRHPNLV 132
F +G+G FG V+KG T +VVA+K +D + E E + E+ +LS P +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 133 HLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK 192
G + T+ ++ EY+ GS D L E PLD I +GL+YLH++
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHSE 120
Query: 193 ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATT 252
I+RD+KA N+LL + KL+DFG+A G D +GT + APE
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 253 GKLTAKSDIFSFGVVLLELITGRP 276
+K+DI+S G+ +EL G P
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 9e-21
Identities = 69/208 (33%), Positives = 102/208 (49%), Gaps = 11/208 (5%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV-EVLMLSLMRHPNLV 132
F +G+G FG VYKG T +VVA+K +D + E E + E+ +LS P +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 133 HLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK 192
G +GT+ ++ EY+ GS D L + PL+ I +GL+YLH++
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHSE 120
Query: 193 ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATT 252
I+RD+KA N+LL + KL+DFG+A G D +GT + APE
Sbjct: 121 RK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 253 GKLTAKSDIFSFGVVLLELITGRPAMDD 280
K+DI+S G+ +EL G P D
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 9e-21
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 15/212 (7%)
Query: 73 NFKDTNFLGQGGFGAVYKGKL-----AETGQVVAVKQLDDTGFQG-EKEFLVEVLMLSLM 126
N ++ LG+G FG V+ K +V VK L T + + EF E+ M +
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 127 RHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEM-----KPLDWNTRMKIAAG 181
H N+V L+G C E ++ EY LG L+ L + PL ++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 182 AARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGT 241
A G+++L N ++RDL A N L+ K+S L+K + + ++
Sbjct: 126 IALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 242 HGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
+ APE + KSD++SFGV++ E+ T
Sbjct: 183 R-WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 9e-21
Identities = 77/225 (34%), Positives = 116/225 (51%), Gaps = 24/225 (10%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPN--LVHL 134
+G+GGFG VY + A+TG++ A+K LD QGE L E +MLSL+ + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 135 IGYCAEGTQRL-LVYEYMPLGSLEDHLL--GLTPEMKPLDWNTRMKIAAGAARGLEYLHN 191
+ Y +L + + M G L HL G+ E + + T + + GLE++HN
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL------GLEHMHN 115
Query: 192 KADPPVIYRDLKAGNILLGKGFHPKLSDFGLA-KFGPTGDKSHVSTRVMGTHGYCAPEYA 250
+ V+YRDLK NILL + H ++SD GLA F + K H S +GTHGY APE
Sbjct: 116 RF---VVYRDLKPANILLDEHGHVRISDLGLACDF--SKKKPHAS---VGTHGYMAPEVL 167
Query: 251 TTGK-LTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVDWVTL 294
G + +D FS G +L +L+ G + ++ +D +TL
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 9e-21
Identities = 66/204 (32%), Positives = 102/204 (50%), Gaps = 20/204 (9%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE--KEFLVEVLMLSLMRHPNLVHLIGY 137
+G+G +G V K K ETGQ+VA+K+ ++ K + E+ ML +RH NLV+LI
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 138 CAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKP--LDWNTRMKIAAGAARGLEYLHNKADP 195
+ LV+E++ DH + E P LD + K RG+E+ H+
Sbjct: 69 FRRKKRLYLVFEFV------DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN-- 120
Query: 196 PVIYRDLKAGNILLGKGFHPKLSDFGLAKF--GPTGDKSHVSTRVMGTHGYCAPEYATTG 253
+I+RD+K NIL+ + KL DFG A+ P V T + T Y APE
Sbjct: 121 -IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP----GEVYTDYVATRWYRAPELLVGD 175
Query: 254 KLTAKS-DIFSFGVVLLELITGRP 276
++ DI++ G ++ E++TG P
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTGEP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-20
Identities = 68/208 (32%), Positives = 101/208 (48%), Gaps = 11/208 (5%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV-EVLMLSLMRHPNLV 132
F +G+G FG V+KG T QVVA+K +D + E E + E+ +LS P +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 133 HLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK 192
G +GT+ ++ EY+ GS D L P D + +GL+YLH++
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLL-----RAGPFDEFQIATMLKEILKGLDYLHSE 120
Query: 193 ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATT 252
I+RD+KA N+LL + KL+DFG+A G D +GT + APE
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQ 175
Query: 253 GKLTAKSDIFSFGVVLLELITGRPAMDD 280
+K+DI+S G+ +EL G P D
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-20
Identities = 69/214 (32%), Positives = 103/214 (48%), Gaps = 40/214 (18%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQL----DDTGFQGEKEFLVEVLMLSLMRHPNLVHLI 135
+G+G +G V+K + ETGQ+VA+K+ DD +K L E+ ML ++HPNLV+LI
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP--VIKKIALREIRMLKQLKHPNLVNLI 66
Query: 136 GYCAEGTQRLLVYEYMP---LGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK 192
+ LV+EY L LE + + + + KI + + + H
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVLNELEKN-------PRGVPEHLIKKIIWQTLQAVNFCHKH 119
Query: 193 ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF--GPTGDKS-HVSTRVMGTHGYCAPE- 248
I+RD+K NIL+ K KL DFG A+ GP D + +V+TR Y APE
Sbjct: 120 N---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPEL 171
Query: 249 ------YATTGKLTAKSDIFSFGVVLLELITGRP 276
Y D+++ G V EL+TG+P
Sbjct: 172 LVGDTQYGPP------VDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-20
Identities = 71/207 (34%), Positives = 98/207 (47%), Gaps = 27/207 (13%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQL--------DDTGFQGEKEFLVEVLMLSLM-RHPN 130
LG+G FG V +L T + A+K L DD + +VE +L+L HP
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDV-----ECTMVERRVLALAWEHPF 57
Query: 131 LVHLIGYCAEGTQRLL--VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEY 188
L HL +C T+ L V EY+ G L H+ D AA GL++
Sbjct: 58 LTHL--FCTFQTKEHLFFVMEYLNGGDLMFHI----QSSGRFDEARARFYAAEIICGLQF 111
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE 248
LH K +IYRDLK N+LL K H K++DFG+ K G+ ++ GT Y APE
Sbjct: 112 LHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPE 166
Query: 249 YATTGKLTAKSDIFSFGVVLLELITGR 275
K D +SFGV+L E++ G+
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-20
Identities = 68/213 (31%), Positives = 105/213 (49%), Gaps = 29/213 (13%)
Query: 80 LGQGGFGAVYKGKLA-----ETGQVVAVKQLDDTGFQGEK-EFLVEVLMLSLMRHPNLVH 133
LGQG FG VY+G E VA+K +++ E+ EFL E ++ ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 134 LIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMK------PLDWNTRMKIAAGAARGLE 187
L+G ++G L++ E M G L+ +L L PEM+ P +++A A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 188 YLH-NKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK------FGPTGDKSHVSTRVMG 240
YL+ NK ++RDL A N ++ + F K+ DFG+ + + G K + R M
Sbjct: 134 YLNANK----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM- 188
Query: 241 THGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
+PE G T SD++SFGVVL E+ T
Sbjct: 189 -----SPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 5e-20
Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 29/220 (13%)
Query: 80 LGQGGFGAVYKGKLAETG-----QVVAVKQLDDTGFQGE-KEFLVEVLMLSLMRHPNLVH 133
LG+G FG V K VAVK L + E ++ L E +L + HP+++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 134 LIGYCAEGTQRLLVYEYMPLGSLEDHL----------LGL----------TPEMKPLDWN 173
L G C++ LL+ EY GSL L LG P+ + L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 174 TRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233
+ A +RG++YL A+ +++RDL A N+L+ +G K+SDFGL++ D
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 234 VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
++ + A E T +SD++SFGV+L E++T
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 5e-20
Identities = 66/206 (32%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 80 LGQGGFGAVYKGK---LAETGQV--VAVKQLDDTGFQGEKEFLVEVL--MLSLMRHPNLV 132
LG G FG V + L+++ V VAVK L T E+E L+ L M L H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 133 HLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK 192
+L+G C G L++ EY G L + L L + + A+G+ +L +K
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF--LTLEDLLSFSYQVAKGMAFLASK 160
Query: 193 ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG-----YCAP 247
I+RDL A N+LL G K+ DFGLA+ D + S V+ + + AP
Sbjct: 161 N---CIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNARLPVKWMAP 212
Query: 248 EYATTGKLTAKSDIFSFGVVLLELIT 273
E T +SD++S+G++L E+ +
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-20
Identities = 68/218 (31%), Positives = 111/218 (50%), Gaps = 28/218 (12%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETG--QVVAVKQLDDTGFQGE-KEFLVEVLML-SLMRHP 129
F+D +G+G FG V K ++ + G A+K++ + + + ++F E+ +L L HP
Sbjct: 11 FQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 68
Query: 130 NLVHLIGYCAEGTQRLLVYEYMPLGSLEDHL-----LGLTPEM-------KPLDWNTRMK 177
N+++L+G C L EY P G+L D L L P L +
Sbjct: 69 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128
Query: 178 IAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTR 237
AA ARG++YL K I+RDL A NIL+G+ + K++DFGL++ G + +V +
Sbjct: 129 FAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-K 180
Query: 238 VMGTHG--YCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
MG + A E T SD++S+GV+L E+++
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 7e-20
Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 20/216 (9%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQL---------DDTGFQGEKEFL-VEVLMLSLMRHP 129
+G+G +G VY TG+++AVKQ+ D+ + + L E+ L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 130 NLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL 189
N+V +G+ + EY+P GS+ L + L ++ GL YL
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV----LEGLAYL 124
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEY 249
H+K +++RDLKA N+L+ K+SDFG++K + + + G+ + APE
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 250 ATTGK--LTAKSDIFSFGVVLLELITG-RPAMDDSQ 282
+ +AK DI+S G V+LE+ G RP D+
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 9e-20
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 26/217 (11%)
Query: 80 LGQGGFGAVY------------KGKLAETGQ--VVAVKQL-DDTGFQGEKEFLVEVLMLS 124
LG+G FG V+ +G GQ +VAVK L D +FL E+ ++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 125 LMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHL--------LGLTPEMKPLDWNTRM 176
+++PN++ L+G C ++ EYM G L L + + +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 177 KIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVST 236
+A A G++YL A ++RDL N L+G + K++DFG+++ +GD +
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 237 RVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
R + + A E GK T SD+++FGV L E+ T
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 9e-20
Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 30/217 (13%)
Query: 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE-----FLVEVLMLSLMR 127
F+ N +G+G +G VY+ + +G++VA+K++ E++ L E+ +L +R
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR---MDNERDGIPISSLREITLLLNLR 64
Query: 128 HPNLVHL----IGYCAEGTQRLLVYEY--MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAG 181
HPN+V L +G + LV EY L SL D++ P + +
Sbjct: 65 HPNIVELKEVVVGKHLDSI--FLVMEYCEQDLASLLDNM------PTPFSESQVKCLMLQ 116
Query: 182 AARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGT 241
RGL+YLH +I+RDLK N+LL K++DFGLA+ G + T + T
Sbjct: 117 LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVVT 171
Query: 242 HGYCAPE--YATTGKLTAKSDIFSFGVVLLELITGRP 276
Y APE T TA D+++ G +L EL+ +P
Sbjct: 172 LWYRAPELLLGCTTYTTA-IDMWAVGCILAELLAHKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-19
Identities = 56/213 (26%), Positives = 104/213 (48%), Gaps = 16/213 (7%)
Query: 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQL----DDTGFQGE--KEFLVEVLMLSLM 126
+ LG G F + Y+ + +TG ++AVKQ+ + + Q E + E+ +++ +
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 127 RHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGL 186
HP+++ ++G E + L E+M GS+ HLL + + RGL
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVS-HLLS---KYGAFKEAVIINYTEQLLRGL 116
Query: 187 EYLHNKADPPVIYRDLKAGNILL-GKGFHPKLSDFGLA-KFGPTGDKS-HVSTRVMGTHG 243
YLH + +I+RD+K N+L+ G +++DFG A + G + +++GT
Sbjct: 117 SYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173
Query: 244 YCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
+ APE + D++S G V++E+ T +P
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-19
Identities = 65/208 (31%), Positives = 100/208 (48%), Gaps = 19/208 (9%)
Query: 80 LGQGGFGAVYKGKLAETGQV--VAVKQLD-DTGFQGEKE-FLVEVLMLSLMRHPNLVHLI 135
LG+G FG+V +G+L + + VAVK + + E E FL E + + HPN++ LI
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 136 GYCAEGTQR------LLVYEYMPLGSLEDHL----LGLTPEMKPLDWNTRMKIAAGAARG 185
G C + + +++ +M G L L LG P+ P +K A G
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPT--QMLVKFMTDIASG 124
Query: 186 LEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYC 245
+EYL +K+ I+RDL A N +L + + ++DFGL+K GD +
Sbjct: 125 MEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 246 APEYATTGKLTAKSDIFSFGVVLLELIT 273
A E T KSD++SFGV + E+ T
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-19
Identities = 64/217 (29%), Positives = 110/217 (50%), Gaps = 28/217 (12%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE-F----LVEVLMLSLM 126
D ++ N + +G +G VY+ + +TG++VA+K+L + EKE F L E+ +L +
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK---MEKEKEGFPITSLREINILLKL 61
Query: 127 RHPNLVHL--IGYCAEGTQRLLVYEYMP--LGSLEDHLLG--LTPEMKPLDWNTRMKIAA 180
+HPN+V + + + + +V EY+ L SL + + L E+K L M
Sbjct: 62 QHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCL-----ML--- 113
Query: 181 GAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMG 240
G+ +LH+ +++RDLK N+LL K+ DFGLA+ G T+++
Sbjct: 114 QLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVV 168
Query: 241 THGYCAPE-YATTGKLTAKSDIFSFGVVLLELITGRP 276
T Y APE + + D++S G + EL+T +P
Sbjct: 169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-19
Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPN 130
D + LG+G +G VY + T +A+K++ + + + E+ + S ++H N
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAA--RGLEY 188
+V +G +E + E +P GSL L + PL N + I GL+Y
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSAL---LRSKWGPLKDNEQTIIFYTKQILEGLKY 123
Query: 189 LHNKADPPVIYRDLKAGNILLG--KGFHPKLSDFG----LAKFGPTGDKSHVSTRVMGTH 242
LH D +++RD+K N+L+ G K+SDFG LA P + GT
Sbjct: 124 LH---DNQIVHRDIKGDNVLVNTYSGV-VKISDFGTSKRLAGINP------CTETFTGTL 173
Query: 243 GYCAPEYATTGK--LTAKSDIFSFGVVLLELITGRP 276
Y APE G A +DI+S G ++E+ TG+P
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKP 209
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-19
Identities = 68/225 (30%), Positives = 109/225 (48%), Gaps = 36/225 (16%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVV--AVKQL-------DDTGFQGEKEFLVEVLM 122
++ K + +G+G FG V + + + G + A+K L D F GE E L +
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCK--- 58
Query: 123 LSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHL-----LGLTPEM-------KPL 170
L HPN+++L+G C + EY P G+L D L L P L
Sbjct: 59 --LGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTL 116
Query: 171 DWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230
++ A+ A G++YL K I+RDL A N+L+G+ K++DFGL++ G+
Sbjct: 117 TSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR----GE 169
Query: 231 KSHVSTRVMGTHG--YCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
+ +V + MG + A E T KSD++SFGV+L E+++
Sbjct: 170 EVYVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-19
Identities = 71/209 (33%), Positives = 114/209 (54%), Gaps = 27/209 (12%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIG-YC 138
LG G FG VYK K ETG + A K ++ + ++++VE+ +L+ HP +V L+G +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 139 AEGTQRLLVYEYMPLGSLEDHLL----GLT-PEMKPLDWNTRMKIAAGAARGLEYLHNKA 193
+G +++ E+ P G+++ +L GLT P+++ + R + A L+YLH+
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVI---CRQMLEA-----LQYLHSMK 130
Query: 194 DPPVIYRDLKAGNILLGKGFHPKLSDFGL-AKFGPTGDKSHVSTRVMGTHGYCAPEYAT- 251
+I+RDLKAGN+LL KL+DFG+ AK T + +GT + APE
Sbjct: 131 ---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR---RDSFIGTPYWMAPEVVMC 184
Query: 252 -TGKLTA---KSDIFSFGVVLLELITGRP 276
T K T K+DI+S G+ L+E+ P
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-19
Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 15/223 (6%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLD-DTGFQGEKEFLVEVLMLSLMRHPNLVHLIG-Y 137
LG G G+V K K TG V+A K + K+ L E+ ++ R P +V G +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 138 CAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPV 197
E + E+M GSL+ + + P+ KIA GL YL+N +
Sbjct: 73 LNEN-NICMCMEFMDCGSLD----RIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--I 125
Query: 198 IYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK-SHVSTRVMGTHGYCAPEYATTGKLT 256
++RD+K NIL+ KL DFG+ +G+ + ++ +GT Y +PE GK T
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGV-----SGELINSIADTFVGTSTYMSPERIQGGKYT 180
Query: 257 AKSDIFSFGVVLLELITGRPAMDDSQGHERMLVDWVTLFFCMH 299
KSD++S G+ ++EL G+ S + D + + +
Sbjct: 181 VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ 223
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-19
Identities = 69/212 (32%), Positives = 104/212 (49%), Gaps = 27/212 (12%)
Query: 80 LGQGGFGAVYKGKL-----AETGQVVAVKQLDDTGFQGEK-EFLVEVLMLSLMRHPNLVH 133
LGQG FG VY+G E VAVK ++++ E+ EFL E ++ ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 134 LIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMK------PLDWNTRMKIAAGAARGLE 187
L+G ++G L+V E M G L+ +L L PE + P +++AA A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 188 YLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK------FGPTGDKSHVSTRVMGT 241
YL+ K ++RDL A N ++ F K+ DFG+ + + G K + R M
Sbjct: 134 YLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 188
Query: 242 HGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
APE G T SD++SFGVVL E+ +
Sbjct: 189 ----APESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-19
Identities = 69/219 (31%), Positives = 106/219 (48%), Gaps = 36/219 (16%)
Query: 78 NFLGQGGFGAVYKGKLAETG--QVVAVKQL-------DDTGFQGEKEFLVEVLMLSLMRH 128
+ +G+G FG V K ++ + G A+K++ D F GE E L + L H
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK-----LGHH 55
Query: 129 PNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHL-----LGLTPEM-------KPLDWNTRM 176
PN+++L+G C L EY P G+L D L L P L +
Sbjct: 56 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 177 KIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVST 236
AA ARG++YL K I+RDL A NIL+G+ + K++DFGL++ G + +V
Sbjct: 116 HFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK- 167
Query: 237 RVMGTHG--YCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
+ MG + A E T SD++S+GV+L E+++
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 4e-19
Identities = 70/207 (33%), Positives = 92/207 (44%), Gaps = 27/207 (13%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLD-----DTGFQGEKEFLVEVLMLSLMRHPNLVHL 134
LG GGFG V K+ + A+K + +TG Q + E +L HP +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ--EHIFSEKEILEECNHPFIVKL 58
Query: 135 IGYCAEGTQRLLVY---EYMPLGSLEDHL--LGLTPEMKPLDWNTRMKIAAGAARGLEYL 189
Y ++ +Y EY G L L GL E + R A EYL
Sbjct: 59 --YRTFKDKKY-IYMLMEYCLGGELWTILRDRGLFDE-----YTARF-YIACVVLAFEYL 109
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEY 249
HN+ +IYRDLK N+LL + KL DFG AK +G K+ GT Y APE
Sbjct: 110 HNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEI 163
Query: 250 ATTGKLTAKSDIFSFGVVLLELITGRP 276
D +S G++L EL+TGRP
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 4e-19
Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 18/208 (8%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQ----VVAVKQLDD-TGFQGEKEFLVEVLMLSLMRH 128
FK LG G FG VYKG G+ VA+K+L + T + KE L E +++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 129 PNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKP---LDWNTRMKIAAGAARG 185
P++ L+G C T +L + + MP G L D++ + L+W ++ A+G
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 121
Query: 186 LEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYC 245
+ YL + +++RDL A N+L+ H K++DFGLAK +K + + +
Sbjct: 122 MNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 246 APEYATTGKLTAKSDIFSFGVVLLELIT 273
A E T +SD++S+GV + EL+T
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 4e-19
Identities = 67/224 (29%), Positives = 110/224 (49%), Gaps = 32/224 (14%)
Query: 80 LGQGGFGAVYKGKLAETGQ---VVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHL 134
+G G FG V++G L G+ VA+K L G+ + ++FL E ++ H N++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLK-PGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 135 IGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKAD 194
G + +++ EYM G+L+ +L E ++ G A G++YL +D
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYL---SD 125
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAK---------FGPTGDKSHVSTRVMGTHGYC 245
++RDL A NIL+ K+SDFGL++ + +G K + +
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR--------WT 177
Query: 246 APEYATTGKLTAKSDIFSFGVVLLELIT--GRPAMDDSQGHERM 287
APE K T+ SD++SFG+V+ E+++ RP D S HE M
Sbjct: 178 APEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVM 220
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-19
Identities = 74/204 (36%), Positives = 105/204 (51%), Gaps = 15/204 (7%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA 139
LGQG FG V+ G T +V A+K L G + FL E ++ +RH LV L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKV-AIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 140 EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIY 199
E +V E+M GSL D L + K L + +AA A G+ Y+ I+
Sbjct: 72 E-EPIYIVTEFMGKGSLLDFLK--EGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIH 125
Query: 200 RDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTR-VMGTHGYCAPEYATTGKLTAK 258
RDL+A NIL+G K++DFGLA+ D + + + + APE A G+ T K
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 259 SDIFSFGVVLLELIT-GR---PAM 278
SD++SFG++L EL+T GR P M
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 7e-19
Identities = 53/183 (28%), Positives = 93/183 (50%), Gaps = 11/183 (6%)
Query: 99 VVAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLE 157
+VAVK L +D +FL E+ ++S ++ PN++ L+ C ++ EYM G L
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 158 DHLLGLTPEMKPLD-------WNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLG 210
L P+ ++T + +A A G++YL + ++RDL N L+G
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVG 164
Query: 211 KGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLE 270
K + K++DFG+++ +GD + R + + + E GK T SD+++FGV L E
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224
Query: 271 LIT 273
++T
Sbjct: 225 ILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 8e-19
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 21/200 (10%)
Query: 80 LGQGGFGAVYKGKLAETGQV-VAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYC 138
LG G FG V GK GQ VA+K + + G E EF+ E ++ + H LV L G C
Sbjct: 12 LGTGQFGVVKYGKW--RGQYDVAIKMIKE-GSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 139 AEGTQRLLVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPP 196
+ +V EYM G L ++L G + L +++ G+ YL +K
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-----LEMCKDVCEGMAYLESKQ--- 120
Query: 197 VIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTH---GYCAPEYATTG 253
I+RDL A N L+ K+SDFGL+++ D + S+ +G+ + PE
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLLYS 176
Query: 254 KLTAKSDIFSFGVVLLELIT 273
K ++KSD+++FGV++ E+ +
Sbjct: 177 KFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 8e-19
Identities = 56/196 (28%), Positives = 90/196 (45%), Gaps = 19/196 (9%)
Query: 95 ETGQVVAVKQLDDTGFQGEKE---FLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL-VYEY 150
TG VA+K L + E + F E + + + HPN+V L+ L V+EY
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL- 209
+P +L + L L ++ L HN+ +++RDLK NI++
Sbjct: 61 VPGRTLREVL----AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVS 113
Query: 210 --GKGFHPKLSDFGLAKFGP-TGDKSHV----STRVMGTHGYCAPEYATTGKLTAKSDIF 262
G H K+ DFG+ P D +T V+GT YCAPE +T SD++
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 263 SFGVVLLELITGRPAM 278
++G++ LE +TG+ +
Sbjct: 174 AWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 8e-19
Identities = 66/217 (30%), Positives = 104/217 (47%), Gaps = 25/217 (11%)
Query: 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQL--DDTGFQGEKE---FLVEVLMLSLMR 127
N++ LG+G FG VY A+TG+ +AVKQ+ D + KE E+ +L +R
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 128 HPNLVHLIGYCAEGTQRLL--VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARG 185
H +V G + ++ L EYMP GS++D L L N + +G
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQG 118
Query: 186 LEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK------FGPTGDKSHVSTRVM 239
+ YLH+ +++RD+K NIL + KL DFG +K TG KS V
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-----VT 170
Query: 240 GTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
GT + +PE + K+D++S ++E++T +P
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 9e-19
Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 23/201 (11%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA 139
LG G FG V+ GK +V A+K +++ G E++F+ E ++ + HP LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKV-AIKAINE-GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 140 EGTQRLLVYEYMPLGSLEDHLLG----LTPEMKPLDWNTRMKIAAGAARGLEYLHNKADP 195
+ +V E+M G L ++L L+ +M + + G+EYL +
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDM-------LLSMCQDVCEGMEYLERNS-- 120
Query: 196 PVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTH---GYCAPEYATT 252
I+RDL A N L+ K+SDFG+ ++ D + S+ G + PE
Sbjct: 121 -FIHRDLAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSS--SGAKFPVKWSPPEVFNF 175
Query: 253 GKLTAKSDIFSFGVVLLELIT 273
K ++KSD++SFGV++ E+ T
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 9e-19
Identities = 68/200 (34%), Positives = 100/200 (50%), Gaps = 20/200 (10%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYC 138
+G+G FG V G G VAVK + +D Q FL E +++ +RH NLV L+G
Sbjct: 14 IGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 68
Query: 139 AEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPV 197
E L +V EYM GSL D+L + L + +K + +EYL
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEANN---F 123
Query: 198 IYRDLKAGNILLGKGFHPKLSDFGLAK-FGPTGDKSHVSTRVMGTHGYCAPEYATTGKLT 256
++RDL A N+L+ + K+SDFGL K T D + + + APE K +
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFS 177
Query: 257 AKSDIFSFGVVLLELIT-GR 275
KSD++SFG++L E+ + GR
Sbjct: 178 TKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-18
Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQ----VVAVKQL-DDTGFQGEKEFLVEVLMLSLMRH 128
K LG G FG VYKG G+ VA+K L ++T + KE L E +++ +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68
Query: 129 PNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLL---GLTPEMKPLDWNTRMKIAAGAARG 185
P + L+G C T +L V + MP G L D++ L+W ++ A+G
Sbjct: 69 PYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKG 121
Query: 186 LEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYC 245
+ YL + +++RDL A N+L+ H K++DFGLA+ + + + +
Sbjct: 122 MSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM 178
Query: 246 APEYATTGKLTAKSDIFSFGVVLLELIT 273
A E + T +SD++S+GV + EL+T
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-18
Identities = 56/199 (28%), Positives = 85/199 (42%), Gaps = 17/199 (8%)
Query: 82 QGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEF----LVEVLMLSLMRHPNLVHLIGY 137
+G FG+VY K TG A+K L + + + +M+ P + L
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 138 CAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPV 197
LV EY+ G + L P DW + A G+E LH + +
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTLGG--LPEDWAK--QYIAEVVLGVEDLHQRG---I 118
Query: 198 IYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTA 257
I+RD+K N+L+ + H KL+DFGL++ G + + +GT Y APE
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVGDDK 172
Query: 258 KSDIFSFGVVLLELITGRP 276
SD +S G V+ E + G P
Sbjct: 173 MSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-18
Identities = 66/223 (29%), Positives = 108/223 (48%), Gaps = 18/223 (8%)
Query: 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLV-EVLMLSLMRHPN 130
++ +G+G FG +Y K + +K++D T EKE EV++L+ M+HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLG----LTPEMKPLDWNTRMKIAAGAARGL 186
+V E + +V EY G L + L E + L W ++ + GL
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GL 114
Query: 187 EYLHNKADPPVIYRDLKAGNILLGK-GFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYC 245
+++H D +++RD+K+ NI L K G KL DFG+A+ D ++ +GT Y
Sbjct: 115 KHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR--QLNDSMELAYTCVGTPYYL 169
Query: 246 APEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288
+PE K+DI+S G VL EL T + + + H+ +L
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-18
Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 17/208 (8%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLD--DTGFQGEKEFLVEVLMLSLMRHPNLVHLIGY 137
LG+G FG + E +V K+++ + ++ L E+++LSL++HPN++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 138 CAEGTQRLLVYEYMPLGSLEDHLL----GLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA 193
+ L+ EY G+L D ++ L E L + ++ A + Y+H KA
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA------VSYIH-KA 120
Query: 194 DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTG 253
+++RD+K NI L K KL DFG++K + + S T V+GT Y +PE
Sbjct: 121 G--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGS-EYSMAET-VVGTPYYMSPELCQGV 176
Query: 254 KLTAKSDIFSFGVVLLELITGRPAMDDS 281
K KSDI++ G VL EL+T + D +
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKRTFDAT 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 3e-18
Identities = 70/234 (29%), Positives = 95/234 (40%), Gaps = 35/234 (14%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEF---LVEVLMLSLMRH 128
+FK LG+G G V+ +L TG++ A+K LD + L E +L+ + H
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 129 PNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEY 188
P L L T LV +Y P G L LL P K L AA LEY
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQRQP-GKCLSEEVARFYAAEVLLALEY 118
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK--------------FGPTGDKSH- 233
LH ++YRDLK NILL + H LSDF L+K G +
Sbjct: 119 LHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 234 ---------VSTRVM---GTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGR 275
S R GT Y APE + + D ++ G++L E++ G
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-18
Identities = 63/233 (27%), Positives = 108/233 (46%), Gaps = 27/233 (11%)
Query: 65 RQLVAATD---NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV-EV 120
+ +V D + +G+G G V TG+ VAVK++D Q +E L EV
Sbjct: 9 QLVVDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEV 67
Query: 121 LMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRM---K 177
+++ +HPN+V + G + +V E++ G+L D + +TRM +
Sbjct: 68 VIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVT-----------HTRMNEEQ 116
Query: 178 IAA---GAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHV 234
IA + L +LH + VI+RD+K+ +ILL KLSDFG +
Sbjct: 117 IATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPR 171
Query: 235 STRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
++GT + APE + + DI+S G++++E++ G P + + M
Sbjct: 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-18
Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 21/200 (10%)
Query: 80 LGQGGFGAVYKG--KLAETGQVVAVKQL--DDTGFQGEKEFLVEVLMLSLMRHPNLVHLI 135
LG G FG V KG K+ ++ + VAVK L D+ + E L E ++ + +P +V +I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 136 GYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADP 195
G C E +LV E LG L L + K + ++ + G++YL +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFL----QKNKHVTEKNITELVHQVSMGMKYLE---ET 114
Query: 196 PVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG-----YCAPEYA 250
++RDL A N+LL + K+SDFGL+K D+++ + THG + APE
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAK---THGKWPVKWYAPECM 170
Query: 251 TTGKLTAKSDIFSFGVVLLE 270
K ++KSD++SFGV++ E
Sbjct: 171 NYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-18
Identities = 69/217 (31%), Positives = 103/217 (47%), Gaps = 25/217 (11%)
Query: 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQL--DDTGFQGEKE---FLVEVLMLSLMR 127
N++ LGQG FG VY A+TG+ +AVKQ+ D + KE E+ +L +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 128 HPNLVHLIGYCAEGTQRLL--VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARG 185
H +V G + +R L E+MP GS++D L L N K G
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEG 118
Query: 186 LEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK------FGPTGDKSHVSTRVM 239
+ YLH+ +++RD+K NIL + KL DFG +K TG KS V
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-----VT 170
Query: 240 GTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
GT + +PE + K+DI+S G ++E++T +P
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-18
Identities = 69/220 (31%), Positives = 114/220 (51%), Gaps = 13/220 (5%)
Query: 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV-EVLMLSLMRHPNL 131
NFK LG+G + VYKG+ TG++VA+K++ +G + E+ ++ ++H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 132 VHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN 191
V L + +LV+EYM L+ + + LD NT +G+ + H
Sbjct: 61 VRLHDVIHTENKLMLVFEYMD-KDLKKY-MDTHGVRGALDPNTVKSFTYQLLKGIAFCH- 117
Query: 192 KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK-FG-PTGDKSHVSTRVMGTHGYCAPEY 249
+ V++RDLK N+L+ K KL+DFGLA+ FG P + S V+ T Y AP+
Sbjct: 118 --ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV---NTFSNEVV-TLWYRAPDV 171
Query: 250 ATTGKLTAKS-DIFSFGVVLLELITGRPAMDDSQGHERML 288
+ + S DI+S G ++ E+ITGRP + +++L
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL 211
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-18
Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 29/208 (13%)
Query: 80 LGQGGFGAVYKGKLAETGQ---VVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHL 134
+G G FG V G+L G+ VA+K L G+ + ++FL E ++ HPN++HL
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLK-AGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 135 IGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKAD 194
G + ++V EYM GSL+ L + + ++ G A G++YL +D
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---GIASGMKYL---SD 124
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDFGL---------AKFGPTGDKSHVSTRVMGTHGYC 245
++RDL A NIL+ K+SDFGL A + G K + +
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR--------WT 176
Query: 246 APEYATTGKLTAKSDIFSFGVVLLELIT 273
APE K T+ SD++S+G+V+ E+++
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 6e-18
Identities = 63/204 (30%), Positives = 98/204 (48%), Gaps = 11/204 (5%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVLMLSLMRHPNLVHLIG 136
LG+GGFG V ++ TG++ A K+LD + GEK L+E +L + P +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 137 YCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPP 196
T LV M G L+ H+ + + L+ + +A G+ +LH+
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSMD--- 115
Query: 197 VIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLT 256
++YRD+K N+LL + +LSD GLA G T+ GT+GY APE +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPYS 172
Query: 257 AKSDIFSFGVVLLELITGRPAMDD 280
D F+ G + E++ GR D
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-18
Identities = 68/218 (31%), Positives = 106/218 (48%), Gaps = 18/218 (8%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNL 131
++ K LG G FG V+ G + +V AVK L G + FL E ++ ++H L
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLK-PGTMSVQAFLEEANLMKTLQHDKL 63
Query: 132 VHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN 191
V L + ++ EYM GSL D L + E + + +A A G+ Y+
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLK--SDEGGKVLLPKLIDFSAQIAEGMAYIER 121
Query: 192 KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTH---GYCAPE 248
K I+RDL+A N+L+ + K++DFGLA+ D + + G + APE
Sbjct: 122 KN---YIHRDLRAANVLVSESLMCKIADFGLARV--IEDNEYTARE--GAKFPIKWTAPE 174
Query: 249 YATTGKLTAKSDIFSFGVVLLELIT-GR---PAMDDSQ 282
G T KSD++SFG++L E++T G+ P M +S
Sbjct: 175 AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 9e-18
Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 50/219 (22%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEF--------LVEVLML-SLMRHPN 130
LG G FG+VY + ETG++VA+K++ +K+F L EV L L HPN
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGL--TPEMKPLDWNTRMKIAAGAARGLEY 188
+V L E + V+EYM E +L L + KP + I +GL +
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK----SHVSTRVMGTHGY 244
+H +RDLK N+L+ K++DFGLA+ + +VSTR Y
Sbjct: 115 IHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTR-----WY 164
Query: 245 CAPE-------YATTGKLTAKSDIFSFGVVLLELITGRP 276
APE Y ++ DI++ G ++ EL T RP
Sbjct: 165 RAPEILLRSTSY------SSPVDIWALGCIMAELYTLRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 9e-18
Identities = 65/218 (29%), Positives = 106/218 (48%), Gaps = 24/218 (11%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV---EVLMLSLMRH 128
++F+ +G G +G VYK + TG++ A+K + + ++F V E++M+ +H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKH 65
Query: 129 PNLVHLIGYCAEGTQRLLVYEYMPLGSLED--HLLGLTPEMKPLDWNTRMKIAAGAARGL 186
N+V G + + E+ GSL+D H+ G PL + ++ +GL
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG------PLSESQIAYVSRETLQGL 119
Query: 187 EYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL-AKFGPTGDKSHVSTRVMGTHGYC 245
YLH+K ++RD+K NILL H KL+DFG+ A+ T K +GT +
Sbjct: 120 YYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAK---RKSFIGTPYWM 173
Query: 246 APEYATT---GKLTAKSDIFSFGVVLLELITGRPAMDD 280
APE A G DI++ G+ +EL +P M D
Sbjct: 174 APEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-17
Identities = 69/200 (34%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLD-DTGFQGE--KEFLVEVLMLSLMR-HPNLVHLI 135
LG+G FG V +L E+G++ AVK L D Q + + + E +LSL R HP L L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 136 GYCAEGTQRLL-VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKAD 194
C + RL V E++ G L H+ + + D AA L +LH+K
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDLMFHI----QKSRRFDEARARFYAAEITSALMFLHDKG- 116
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGK 254
+IYRDLK N+LL H KL+DFG+ K G K+ ++ GT Y APE
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEILQEML 172
Query: 255 LTAKSDIFSFGVVLLELITG 274
D ++ GV+L E++ G
Sbjct: 173 YGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-17
Identities = 54/190 (28%), Positives = 90/190 (47%), Gaps = 19/190 (10%)
Query: 99 VVAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLE 157
+VAVK L D +FL EV +LS ++ PN++ L+G C + ++ EYM G L
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 158 D-----HLLGLTPEMKPLD----------WNTRMKIAAGAARGLEYLHNKADPPVIYRDL 202
HL +++ + +A A G++YL + ++RDL
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDL 164
Query: 203 KAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIF 262
N L+G+ K++DFG+++ GD + R + + A E GK T SD++
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVW 224
Query: 263 SFGVVLLELI 272
+FGV L E++
Sbjct: 225 AFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-17
Identities = 77/230 (33%), Positives = 111/230 (48%), Gaps = 26/230 (11%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQL--DDTGFQGEKE-FLVEVLMLSLM-RHPNLVHLI 135
LG+G FG V +L G+ AVK L D + E +VE +L+L +P L HL
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL- 61
Query: 136 GYCAEGTQRLL--VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA 193
YC T+ L V E++ G L H+ + D AA GL++LH+K
Sbjct: 62 -YCTFQTKEHLFFVMEFLNGGDLMFHI----QDKGRFDLYRATFYAAEIVCGLQFLHSKG 116
Query: 194 DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTG 253
+IYRDLK N++L + H K++DFG+ K GD ++ GT Y APE
Sbjct: 117 ---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEILQGL 171
Query: 254 KLTAKSDIFSFGVVLLELITGRPAM---DDSQGHERMLVD------WVTL 294
K T D +SFGV+L E++ G+ D+ + E + VD W+T
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITK 221
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-17
Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 15/212 (7%)
Query: 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQL--DDTGFQGEKE---FLVEVLMLSLMR 127
N++ LGQG FG VY +TG+ +A KQ+ D + KE E+ +L ++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 128 HPNLVHLIGYCAEGTQRLLV--YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARG 185
H +V G + ++ L EYMP GS++D L L + K G
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTRKYTRQILEG 118
Query: 186 LEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTR-VMGTHGY 244
+ YLH+ +++RD+K NIL + KL DFG +K T S R V GT +
Sbjct: 119 MSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 245 CAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
+PE + K+D++S G ++E++T +P
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-17
Identities = 68/220 (30%), Positives = 102/220 (46%), Gaps = 21/220 (9%)
Query: 65 RQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLM-- 122
++ A ++ ++ +G G G VYK + +TG V+AVKQ+ TG KE +LM
Sbjct: 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG---NKEENKRILMDL 64
Query: 123 -LSLMRH--PNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIA 179
+ L H P +V GY + + E M + D LL P+ + K+
Sbjct: 65 DVVLKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRI--QGPIPEDILGKMT 120
Query: 180 AGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVM 239
+ L YL K VI+RD+K NILL + KL DFG++ K+ TR
Sbjct: 121 VAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGR-LVDSKAK--TRSA 175
Query: 240 GTHGYCAPEYAT----TGKLTAKSDIFSFGVVLLELITGR 275
G Y APE K ++D++S G+ L+EL TG+
Sbjct: 176 GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-17
Identities = 66/211 (31%), Positives = 92/211 (43%), Gaps = 32/211 (15%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFL-----VEVLM--------LSLM 126
LG+G FG V + +TG++ A+K L +K + VE LM +
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKAL-------KKGDIIARDEVESLMCEKRIFETANSE 59
Query: 127 RHPNLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARG 185
RHP LV+L C + + V EY G L H+ + AA G
Sbjct: 60 RHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHI-----HTDVFSEPRAVFYAACVVLG 113
Query: 186 LEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYC 245
L+YLH ++YRDLK N+LL K++DFGL K G G ST GT +
Sbjct: 114 LQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG-MGFGDRTST-FCGTPEFL 168
Query: 246 APEYATTGKLTAKSDIFSFGVVLLELITGRP 276
APE T T D + GV++ E++ G
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVGES 199
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 2e-17
Identities = 65/249 (26%), Positives = 96/249 (38%), Gaps = 91/249 (36%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMRHPN 130
++ +G G +G V TG+ VA+K++ + F K L E+ +L +RH N
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-FDDLIDAKRILREIKLLRHLRHEN 60
Query: 131 LVHLIG-------------YCAEGTQRLLVYEYMP--LGSL--------EDH-------L 160
++ L+ Y +V E M L + +DH +
Sbjct: 61 IIGLLDILRPPSPEDFNDVY--------IVTELMETDLHKVIKSPQPLTDDHIQYFLYQI 112
Query: 161 LGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDF 220
L RGL+YLH A+ VI+RDLK NIL+ K+ DF
Sbjct: 113 L----------------------RGLKYLH-SAN--VIHRDLKPSNILVNSNCDLKICDF 147
Query: 221 GLAKFGPTGDKS------HVSTRVMGTHGYCAPE-------YATTGKLTAKSDIFSFGVV 267
GLA+ + +V TR Y APE Y T DI+S G +
Sbjct: 148 GLARGVDPDEDEKGFLTEYVVTRW-----YRAPELLLSSSRY------TKAIDIWSVGCI 196
Query: 268 LLELITGRP 276
EL+T +P
Sbjct: 197 FAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-17
Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 80 LGQGGFGAV----YKGKLAETGQVVAVKQLD-DTGFQGEKEFLVEVLMLSLMRHPNLVHL 134
LG+G FG V Y + TG+ VAVK L ++G + E+ +L + H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 135 IGYCAEGTQR--LLVYEYMPLGSLEDHLLGLTPEMK-PLDWNTRMKIAAGAARGLEYLHN 191
G C E L+ E++P GSL+++L P K ++ ++K A +G++YL +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL----PRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 192 KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTR--VMGTHGYCAPEY 249
+ ++RDL A N+L+ K+ DFGL K T DK + + + + + APE
Sbjct: 128 RQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIET-DKEYYTVKDDLDSPVFWYAPEC 183
Query: 250 ATTGKLTAKSDIFSFGVVLLELIT 273
K SD++SFGV L EL+T
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-17
Identities = 69/227 (30%), Positives = 107/227 (47%), Gaps = 39/227 (17%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE-FLV----EVLMLSLM 126
D F +G+G +G VYK + +TG++VA+K++ EKE F + E+ +L +
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVR---LDNEKEGFPITAIREIKILRQL 63
Query: 127 RHPNLVHLIGYCAEGTQRL----------LVYEYMPLGSLEDH-LLGLTPEMKPLDWN-- 173
H N+V+L + L LV+EYM DH L+GL E + ++
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM------DHDLMGLL-ESGLVHFSED 116
Query: 174 ---TRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230
+ MK GL Y H K ++RD+K NILL KL+DFGLA+ + +
Sbjct: 117 HIKSFMK---QLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170
Query: 231 KSHVSTRVMGTHGYCAPEYAT-TGKLTAKSDIFSFGVVLLELITGRP 276
+ +V+ T Y PE + D++S G +L EL T +P
Sbjct: 171 SRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-17
Identities = 75/245 (30%), Positives = 113/245 (46%), Gaps = 61/245 (24%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE-F----LVEVLMLSLM 126
++ +GQG FG V+K + +T Q+VA+K++ + EKE F L E+ +L L+
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVL---MENEKEGFPITALREIKILQLL 68
Query: 127 RHPNLVHLIGYC-AEGTQR-------LLVYEYMPLGSLEDHLLGLT---------PEMKP 169
+H N+V+LI C + T LV+E+ E L GL E+K
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEF-----CEHDLAGLLSNKNVKFTLSEIK- 122
Query: 170 LDWNTRMKIAAGAARGLEYLH-NKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK-FG- 226
MK+ GL Y+H NK +++RD+KA NIL+ K KL+DFGLA+ F
Sbjct: 123 ----KVMKMLLN---GLYYIHRNK----ILHRDMKAANILITKDGILKLADFGLARAFSL 171
Query: 227 PTGDKSHVSTRVMGTHGYCAPE-------YATTGKLTAKSDIFSFGVVLLELITGRPAMD 279
K + T + T Y PE Y D++ G ++ E+ T P M
Sbjct: 172 SKNSKPNRYTNRVVTLWYRPPELLLGERDYGP------PIDMWGAGCIMAEMWTRSPIM- 224
Query: 280 DSQGH 284
QG+
Sbjct: 225 --QGN 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-17
Identities = 71/212 (33%), Positives = 104/212 (49%), Gaps = 18/212 (8%)
Query: 76 DTNFL---GQGGFGAVYKGKLAETGQVVAVKQLD-DTGFQGE--KEFLVEVLMLSLMRHP 129
D NFL G+G FG V + T ++ A+K L D Q + + +VE +L+L P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 130 NLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEY 188
+ + C + RL V EY+ G L H+ + +P + AA A GL +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEP----HAVFYAAEIAIGLFF 116
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVM-GTHGYCAP 247
LH+K +IYRDLK N++L H K++DFG+ K G K +TR GT Y AP
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK---TTRTFCGTPDYIAP 170
Query: 248 EYATTGKLTAKSDIFSFGVVLLELITGRPAMD 279
E D ++FGV+L E++ G+P D
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-17
Identities = 67/217 (30%), Positives = 101/217 (46%), Gaps = 26/217 (11%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE-KEFL--VEVLMLSLMRH 128
++ KD +G+G FG V K +G ++AVK++ T + E K L ++V+M S
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRS-SDC 62
Query: 129 PNLVHLIGYCAEGTQRLLVYEYMPLGSLE-------DHLLGLTPEMKPLDWNTRMKIAAG 181
P +V G + E M + SL+ + L + PE KIA
Sbjct: 63 PYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPE------EILGKIAVA 115
Query: 182 AARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGT 241
+ L YL K + +I+RD+K NILL + + KL DFG++ G D S TR G
Sbjct: 116 TVKALNYL--KEELKIIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVD-SIAKTRDAGC 170
Query: 242 HGYCAPEYATTGKLTA---KSDIFSFGVVLLELITGR 275
Y APE +SD++S G+ L E+ TG+
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-17
Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA 139
LG G FG VYK + ETG + A K +D + ++++VE+ +L+ HPN+V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 140 EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIY 199
++ E+ G+++ +L L +PL + L YLH + +I+
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLH---ENKIIH 126
Query: 200 RDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYAT--TGK--- 254
RDLKAGNIL KL+DFG++ + S +GT + APE T K
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRP 184
Query: 255 LTAKSDIFSFGVVLLELITGRP 276
K+D++S G+ L+E+ P
Sbjct: 185 YDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 6e-17
Identities = 73/252 (28%), Positives = 108/252 (42%), Gaps = 53/252 (21%)
Query: 68 VAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEF-----LVEVLM 122
+ +++ LG+G FG VYK + +TG+VVA+K++ EK+ L E+ +
Sbjct: 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKIL---MHNEKDGFPITALREIKI 60
Query: 123 LSLMRHPNLVHLIGYCAE-----GTQRLLVYEYMPL------GSLEDHLLGLTPE----- 166
L ++HPN+V LI E +R VY P G LE+ + LT
Sbjct: 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCY 120
Query: 167 MKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF- 225
M L G+ YLH +++RD+KA NIL+ K++DFGLA+
Sbjct: 121 MLQL------------LEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPY 165
Query: 226 --------GPTGDKSHVSTRVMGTHGYCAPEY-ATTGKLTAKSDIFSFGVVLLELITGRP 276
G G + T ++ T Y PE + T DI+ G V E+ T RP
Sbjct: 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRP 225
Query: 277 ----AMDDSQGH 284
D Q H
Sbjct: 226 ILQGKSDIDQLH 237
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 6e-17
Identities = 68/224 (30%), Positives = 98/224 (43%), Gaps = 35/224 (15%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---------QGEKEFLVEVLM 122
D+ + +G G FG V+ + + A+K + EK L EV
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-- 58
Query: 123 LSLMRHPNLVHLIGYCAEGTQRLL--VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAA 180
HP ++ L + E QR L + EY+P G L +L +T + A+
Sbjct: 59 ----SHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRN----SGRFSNSTGLFYAS 108
Query: 181 GAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVM- 239
LEYLH+K ++YRDLK NILL K H KL+DFG AK K T +
Sbjct: 109 EIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK------KLRDRTWTLC 159
Query: 240 GTHGYCAPE-YATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282
GT Y APE + G A D ++ G+++ E++ G P D
Sbjct: 160 GTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 6e-17
Identities = 65/236 (27%), Positives = 104/236 (44%), Gaps = 65/236 (27%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQ----LDDTGFQGEKEFLVEVLML---SLM 126
+++ +G+G +G VYK + TG+ VA+K+ L + G + + L +L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG--------IPLSTLREIALL 52
Query: 127 R------HPNLVHLIGYCA-----EGTQRLLVYEYMP--LGSLEDHL--LGLTPE----- 166
+ HPN+V L+ C + LV+E++ L + GL PE
Sbjct: 53 KQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDL 112
Query: 167 MKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226
M+ L RG+++LH+ +++RDLK NIL+ K++DFGLA+
Sbjct: 113 MRQL------------LRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR-- 155
Query: 227 PTGDKSHVSTRVMGTHGYCAPE------YATTGKLTAKSDIFSFGVVLLELITGRP 276
T V+ T Y APE YAT D++S G + EL RP
Sbjct: 156 -IYSFEMALTSVVVTLWYRAPEVLLQSSYATP------VDMWSVGCIFAELFRRRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-17
Identities = 75/224 (33%), Positives = 110/224 (49%), Gaps = 23/224 (10%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLD---DTGFQGEKEFLVEVLMLSLMR 127
TD ++ +G+G +G VYK + G + AVK LD D + E E+ + + SL
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI---LQSLPN 77
Query: 128 HPNLVHLIG--YCAE---GTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGA 182
HPN+V G Y A+ G Q LV E GS+ + + GL + LD I GA
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 183 ARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL-AKFGPTGDKSHVSTRVMGT 241
GL++LHN +I+RD+K NILL KL DFG+ A+ T + + S +GT
Sbjct: 138 LLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS---VGT 191
Query: 242 HGYCAPEYATTGK-----LTAKSDIFSFGVVLLELITGRPAMDD 280
+ APE + A+ D++S G+ +EL G P + D
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 9e-17
Identities = 65/209 (31%), Positives = 93/209 (44%), Gaps = 28/209 (13%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDT------GFQG---EKEFLVEVLMLSLMRHPN 130
LG+GGFG V ++ TG++ A K+L+ G++G EK L +V H
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-------HSR 53
Query: 131 LVHLIGYCAE-GTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL 189
+ + Y + T LV M G L H+ + E A GLE+L
Sbjct: 54 FIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA---KFGPTGDKSHVSTRVMGTHGYCA 246
H + +IYRDLK N+LL + ++SD GLA K G + K + GT G+ A
Sbjct: 114 HQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----GTPGFMA 165
Query: 247 PEYATTGKLTAKSDIFSFGVVLLELITGR 275
PE + D F+ GV L E+I R
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-16
Identities = 61/204 (29%), Positives = 109/204 (53%), Gaps = 18/204 (8%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQL----DDTGFQGEKEFLVEVLMLSLMRHPNLVHLI 135
+G+G +G VYKG+ +TGQ+VA+K++ ++ G + E+ +L ++HPN+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA--IREISLLKELQHPNIVCLQ 65
Query: 136 GYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADP 195
+ ++ L++E++ + L+ +L L P+ + +D +G+ + H++
Sbjct: 66 DVLMQESRLYLIFEFLSM-DLKKYLDSL-PKGQYMDAELVKSYLYQILQGILFCHSRR-- 121
Query: 196 PVIYRDLKAGNILLGKGFHPKLSDFGLAK-FG-PTGDKSHVSTRVMGTHGYCAPEYATTG 253
V++RDLK N+L+ KL+DFGLA+ FG P V T + T Y APE
Sbjct: 122 -VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV----RVYTHEVVTLWYRAPEVLLGS 176
Query: 254 -KLTAKSDIFSFGVVLLELITGRP 276
+ + DI+S G + E+ T +P
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-16
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEK--EFLVEVLMLSLMRHPNLVHLIGY 137
+G+G FG K E G+ +K+++ + ++ E EV +LS M+HPN+V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 138 CAEGTQRLLVYEYMPLGSLEDHLLG----LTPEMKPLDWNTRMKIAAGAARGLEYLHNKA 193
E +V +Y G L + L PE + LDW ++ +A L+++H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVH--- 118
Query: 194 DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTG 253
D +++RD+K+ NI L K KL DFG+A+ ++ +GT Y +PE
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSPEICENR 176
Query: 254 KLTAKSDIFSFGVVLLELITGRPAMD 279
KSDI++ G VL E+ T + A +
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 73/249 (29%), Positives = 110/249 (44%), Gaps = 72/249 (28%)
Query: 64 YRQLVAAT-----DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KE 115
YRQ + T D +++ + +G G +G V +TG+ VA+K+L FQ K
Sbjct: 2 YRQELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP-FQSAIHAKR 60
Query: 116 FLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLED--------HLLGLTPEM 167
E+ +L M H N++ L+ + P SLED HL+G
Sbjct: 61 TYRELRLLKHMDHENVIGLLDV------------FTPASSLEDFQDVYLVTHLMGA---- 104
Query: 168 KPLDWNTRMK-----------IAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPK 216
D N +K + RGL+Y+H+ A +I+RDLK NI + + K
Sbjct: 105 ---DLNNIVKCQKLSDDHIQFLVYQILRGLKYIHS-AG--IIHRDLKPSNIAVNEDCELK 158
Query: 217 LSDFGLAKFGPTGDK--SHVSTRVMGTHGYCAPE-------YATTGKLTAKSDIFSFGVV 267
+ DFGLA+ T D+ +V+TR Y APE Y T DI+S G +
Sbjct: 159 ILDFGLAR--HTDDEMTGYVATR-----WYRAPEIMLNWMHYNQT------VDIWSVGCI 205
Query: 268 LLELITGRP 276
+ EL+TG+
Sbjct: 206 MAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-16
Identities = 69/206 (33%), Positives = 98/206 (47%), Gaps = 13/206 (6%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVLMLSLMRHPN 130
F+ LG+GGFG V ++ TG++ A K+L+ + GE L E +L +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 131 LVHLIGYCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL 189
+V L Y E L LV M G L+ H+ + D + AA GLE L
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDL 118
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEY 249
H + ++YRDLK NILL H ++SD GLA P G+ + RV GT GY APE
Sbjct: 119 HRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPEV 172
Query: 250 ATTGKLTAKSDIFSFGVVLLELITGR 275
+ T D + G ++ E+I G+
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-16
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 32/212 (15%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQ----LDDTGFQGEKEFLVEVLMLSLMRHPNLVHLI 135
LG+G +G+VYK TG +A+K+ LD++ F ++E+ +L P +V
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQ---IIMELDILHKAVSPYIVDFY 65
Query: 136 G-YCAEGTQRLLVY---EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN 191
G + EG VY EYM GSL D L + + + +I +GL++L
Sbjct: 66 GAFFIEGA----VYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFL-- 118
Query: 192 KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD--KSHVSTRVMGTHGYCAPEY 249
K + +I+RD+K N+L+ KL DFG+ +G+ S T + G Y APE
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGV-----SGNLVASLAKTNI-GCQSYMAPER 172
Query: 250 ATTGKLTA------KSDIFSFGVVLLELITGR 275
+G +SD++S G+ +LE+ GR
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-16
Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLD-DTGFQGEKEFLV-EVLMLSLMRHPN 130
NF+ +G+G +G VYK + TG+VVA+K++ DT +G + E+ +L + HPN
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLH 190
+V L+ + LV+E++ L+ + PL +GL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPL--PLIKSYLFQLLQGLAFCH 117
Query: 191 NKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK-FG-PTGDKSHVSTRVMGTHGYCAPE 248
+ V++RDLK N+L+ KL+DFGLA+ FG P +H T Y APE
Sbjct: 118 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPE 170
Query: 249 YATTGKLTAKS-DIFSFGVVLLELITGR 275
K + + DI+S G + E++T R
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-16
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 8/204 (3%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQL---DDTGFQGEKEFLVEVLMLSLMR 127
NFK +G+G F VYK G+VVA+K++ + + ++ L E+ +L +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 128 HPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLE 187
HPN++ + E + +V E G L + + + + T K LE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 188 YLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAP 247
++H+K +++RD+K N+ + KL D GL +F K+ + ++GT Y +P
Sbjct: 121 HMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSP 175
Query: 248 EYATTGKLTAKSDIFSFGVVLLEL 271
E KSDI+S G +L E+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-16
Identities = 67/202 (33%), Positives = 91/202 (45%), Gaps = 15/202 (7%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQL-DDTGFQGEKE--FLVEVLMLSLMR-HPNLVHLI 135
LG+G FG V +L T +V A+K L D Q + + E +L+L HP L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 136 GYCAEGTQRLL-VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKAD 194
C + RL V EY+ G L + + D AA L +LH
Sbjct: 63 C-CFQTKDRLFFVMEYVNGGDLMFQI----QRSRKFDEPRSRFYAAEVTLALMFLHRHG- 116
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGK 254
VIYRDLK NILL H KL+DFG+ K G +T GT Y APE +
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQELE 172
Query: 255 LTAKSDIFSFGVVLLELITGRP 276
D ++ GV++ E++ G+P
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQP 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-16
Identities = 70/210 (33%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVLMLSLMRHPN 130
F+ LG+GGFG V ++ TG++ A K+L+ + GE L E +L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 131 LVHLIGYCAEGTQRL-LVYEYMPLGSLEDHLLGLT----PEMKPLDWNTRMKIAAGAARG 185
+V L Y E L LV M G L+ H+ + E + + + AA G
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFY------AAEICCG 114
Query: 186 LEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYC 245
LE LH + ++YRDLK NILL H ++SD GLA P G + RV GT GY
Sbjct: 115 LEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYM 168
Query: 246 APEYATTGKLTAKSDIFSFGVVLLELITGR 275
APE + T D ++ G +L E+I G+
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 5e-16
Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 35/212 (16%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE-----FLVEVLMLSLMRHPNLVHL 134
+G+G +G VYK + TG++VA+K++ + E E + E+ +L + HPN+V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIR---LETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 135 IGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAA---GAARGLEYLHN 191
+ + LV+E++ L L+ ++ + PL I + +G+ Y H+
Sbjct: 64 LDVVHSENKLYLVFEFLDL-DLKKYM-----DSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 192 KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK-FGPTGDKSHVSTRVMGTHG-----YC 245
V++RDLK N+L+ + KL+DFGLA+ FG V R TH Y
Sbjct: 118 HR---VLHRDLKPQNLLIDREGALKLADFGLARAFG-------VPVRTY-THEVVTLWYR 166
Query: 246 APEYATTGKLTAKS-DIFSFGVVLLELITGRP 276
APE + + DI+S G + E++ RP
Sbjct: 167 APEILLGSRQYSTPVDIWSIGCIFAEMVNRRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-16
Identities = 70/206 (33%), Positives = 97/206 (47%), Gaps = 13/206 (6%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVLMLSLMRHPN 130
F+ LG+GGFG V ++ TG++ A K+L+ + GE L E +L +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 131 LVHLIGYCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL 189
+V L Y E L LV M G L+ H+ + D + AA GLE L
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDL 118
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEY 249
+ ++YRDLK NILL H ++SD GLA P G+ V RV GT GY APE
Sbjct: 119 QRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMAPEV 172
Query: 250 ATTGKLTAKSDIFSFGVVLLELITGR 275
K T D + G ++ E+I G+
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 9e-16
Identities = 69/202 (34%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE---FLVE-VLMLSLMRHPNLVHLI 135
+G+G FG V K G+ AVK L +KE + E ++L ++HP LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 136 GYCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKAD 194
Y + +L V +Y+ G L HL E + R AA A L YLH+
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHL---QRERSFPEPRARF-YAAEIASALGYLHSLN- 116
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGK 254
+IYRDLK NILL H L+DFGL K G K+ ++ GT Y APE
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQP 172
Query: 255 LTAKSDIFSFGVVLLELITGRP 276
D + G VL E++ G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 61/225 (27%), Positives = 105/225 (46%), Gaps = 36/225 (16%)
Query: 80 LGQGGFGAVYKGKL-------AETGQVVAVKQLDDTGFQGEKEFLV-EVLMLSLM-RHPN 130
LG+G FG V + + + VAVK L D + L+ E+ ++ L+ +H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTP------------EMKPLDWNTRMKI 178
+++L+G C + ++ EY G+L + L P + L + +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 179 AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRV 238
A ARG+EYL ++ I+RDL A N+L+ + K++DFGLA+ +
Sbjct: 140 AYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLAR-----GVHDIDYYK 191
Query: 239 MGTHG-----YCAPEYATTGKLTAKSDIFSFGVVLLELIT--GRP 276
++G + APE T +SD++SFG+++ E+ T G P
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 69/207 (33%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVLMLSLMRHPN 130
F+ LG+GGFG V ++ TG++ A K+L+ + GE L E +L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 131 LVHLIGYCAEGTQRL-LVYEYMPLGSLEDHLLGL-TPEMKPLDWNTRMKIAAGAARGLEY 188
+V+L Y E L LV M G L+ H+ + P + + AA GLE
Sbjct: 62 VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEE---ERALFYAAEILCGLED 117
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE 248
LH + +YRDLK NILL H ++SD GLA P G+ + RV GT GY APE
Sbjct: 118 LHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAPE 171
Query: 249 YATTGKLTAKSDIFSFGVVLLELITGR 275
+ T D + G ++ E+I G+
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-15
Identities = 73/212 (34%), Positives = 103/212 (48%), Gaps = 32/212 (15%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRH---PNLVHLIG 136
LG+G +G V K + TG ++AVK++ T E++ L+ L +S MR P V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDIS-MRSVDCPYTVTFYG 67
Query: 137 YC-AEGTQRLLVYEYMPL--GSLED-----HLLGLT-PEMKPLDWNTRMKIAAGAARGLE 187
EG V+ M + SL+ + GLT PE + KIA + LE
Sbjct: 68 ALFREGD----VWICMEVMDTSLDKFYKKVYDKGLTIPE------DILGKIAVSIVKALE 117
Query: 188 YLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAP 247
YLH+K VI+RD+K N+L+ + KL DFG++ G D S T G Y AP
Sbjct: 118 YLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVD-SVAKTIDAGCKPYMAP 172
Query: 248 EY---ATTGK-LTAKSDIFSFGVVLLELITGR 275
E K KSD++S G+ ++EL TGR
Sbjct: 173 ERINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 38/226 (16%)
Query: 80 LGQGGFGAVY--------KGKLAETGQVVAVKQLDDTGFQGEKEFLV-EVLMLSLM-RHP 129
LG+G FG V K K E VAVK L D + + LV E+ M+ ++ +H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEA-VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 81
Query: 130 NLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTP-EM-----------KPLDWNTRMK 177
N+++L+G C + ++ EY G+L ++L P M + + + +
Sbjct: 82 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141
Query: 178 IAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTR 237
ARG+EYL A I+RDL A N+L+ + K++DFGLA+ D +++
Sbjct: 142 CTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DVNNIDYY 193
Query: 238 VMGTHG-----YCAPEYATTGKLTAKSDIFSFGVVLLELIT--GRP 276
T+G + APE T +SD++SFGV++ E+ T G P
Sbjct: 194 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 15/212 (7%)
Query: 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLD-DTGFQGE--KEFLVEVLMLSLMRHP 129
+F LG+G FG V + T ++ A+K L D Q + + +VE +L+L P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 130 NLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEY 188
+ + C + RL V EY+ G L H+ + +P + AA + GL +
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP----QAVFYAAEISVGLFF 116
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVM-GTHGYCAP 247
LH + +IYRDLK N++L H K++DFG+ K V+TR GT Y AP
Sbjct: 117 LHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAP 170
Query: 248 EYATTGKLTAKSDIFSFGVVLLELITGRPAMD 279
E D +++GV+L E++ G+P D
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-15
Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG---EKEFLVEVLMLSLMR 127
T+ + D +G G FG V + TGQ VA+K++ F K E+ +L +R
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKP-FSTPVLAKRTYRELKLLKHLR 67
Query: 128 HPNLVHLIG-YCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGL 186
H N++ L + + V E + G+ LL +PL+ RGL
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELL--GTDLHRLL----TSRPLEKQFIQYFLYQILRGL 121
Query: 187 EYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCA 246
+Y+H+ V++RDLK NIL+ + K+ DFGLA+ +VSTR Y A
Sbjct: 122 KYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRA 173
Query: 247 PEYATT-GKLTAKSDIFSFGVVLLELITGRP 276
PE T K + DI+S G + E++ G+P
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 69/224 (30%), Positives = 98/224 (43%), Gaps = 23/224 (10%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE---FLVEVLMLSLMRHPNLVHLIG 136
+GQGG+G V+ K +TG++VA+K++ + E L E +L+ + LV L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 137 YCAEGTQRL-LVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA 193
Y + + L L EY+P G L LG+ E + M A A L Y+H
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIH--- 124
Query: 194 DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTG 253
RDLK N L+ H KL+DFGL+K T S V+G+ Y APE
Sbjct: 125 ------RDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAPEVLRGK 173
Query: 254 KLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM--LVDWVTLF 295
D +S G +L E + G P S +E L W
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL 217
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-15
Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 19/210 (9%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA 139
LG G FG V+ + +V AVK + G + FL E ++ ++H LV L
Sbjct: 14 LGAGQFGEVWMATYNKHTKV-AVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 140 EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIY 199
+ ++ E+M GSL D L +PL + +A A G+ ++ + I+
Sbjct: 72 K-EPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN---YIH 125
Query: 200 RDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTH---GYCAPEYATTGKLT 256
RDL+A NIL+ K++DFGLA+ D + + G + APE G T
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARV--IEDNEYTARE--GAKFPIKWTAPEAINFGSFT 181
Query: 257 AKSDIFSFGVVLLELIT-GR---PAMDDSQ 282
KSD++SFG++L+E++T GR P M + +
Sbjct: 182 IKSDVWSFGILLMEIVTYGRIPYPGMSNPE 211
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 2e-15
Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 22/220 (10%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLML-SLMRHPNLV 132
F+ +G G +G VYKG+ +TGQ+ A+K +D TG + E+E E+ ML H N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIA 66
Query: 133 HLIGYCAEGT------QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGL 186
G + Q LV E+ GS+ D + +W I RGL
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGL 124
Query: 187 EYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL-AKFGPTGDKSHVSTRVMGTHGYC 245
+LH VI+RD+K N+LL + KL DFG+ A+ T + + +GT +
Sbjct: 125 SHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGTPYWM 178
Query: 246 APEYATT-----GKLTAKSDIFSFGVVLLELITGRPAMDD 280
APE KSD++S G+ +E+ G P + D
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-15
Identities = 66/209 (31%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 80 LGQGGFGAVYKGKLAE---TGQVVAVKQLDDTGFQGE--KEFLVEVLMLSLMRHPNLVHL 134
LG+G FG+V + +L + Q VAVK L F +EFL E + HPN++ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 135 IGYC--AEGTQRL----LVYEYMPLGSLEDHLL----GLTPEMKPLDWNTRMKIAAGAAR 184
IG + RL ++ +M G L LL G P PL T ++ A
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPL--QTLVRFMIDIAS 124
Query: 185 GLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGY 244
G+EYL +K I+RDL A N +L + ++DFGL+K +GD +
Sbjct: 125 GMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 245 CAPEYATTGKLTAKSDIFSFGVVLLELIT 273
A E T SD+++FGV + E++T
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-15
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 19/199 (9%)
Query: 80 LGQGGFGAVYKG--KLAETGQVVAVKQLDDTGFQGEK----EFLVEVLMLSLMRHPNLVH 133
LG G FG V KG K+ + VA+K L + + EK E + E ++ + +P +V
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKN---ENEKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 134 LIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA 193
+IG C E +LV E G L L G E+ + +++ + G++YL K
Sbjct: 60 MIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITV---SNVVELMHQVSMGMKYLEGKN 115
Query: 194 DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTH--GYCAPEYAT 251
++RDL A N+LL + K+SDFGL+K D S+ R G + APE
Sbjct: 116 ---FVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPECIN 171
Query: 252 TGKLTAKSDIFSFGVVLLE 270
K +++SD++S+G+ + E
Sbjct: 172 FRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-15
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 34/209 (16%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA 139
+G+G G V TG+ VAVK++D Q + EV+++ H N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 140 EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMK------IAAGAARGLEYLHNKA 193
G + +V E++ G+L D + +TRM + R L YLHN+
Sbjct: 90 VGDELWVVMEFLEGGALTDIVT-----------HTRMNEEQIATVCLSVLRALSYLHNQG 138
Query: 194 DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRV------MGTHGYCAP 247
VI+RD+K+ +ILL KLSDFG + VS V +GT + AP
Sbjct: 139 ---VIHRDIKSDSILLTSDGRIKLSDFGFC--------AQVSKEVPKRKSLVGTPYWMAP 187
Query: 248 EYATTGKLTAKSDIFSFGVVLLELITGRP 276
E + + DI+S G++++E+I G P
Sbjct: 188 EVISRLPYGTEVDIWSLGIMVIEMIDGEP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 4e-15
Identities = 72/261 (27%), Positives = 104/261 (39%), Gaps = 57/261 (21%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQL---------DDTGFQGEKEFLVEVLM 122
D+F+ +G+G FG V+ + +TGQV A+K L + E++ L +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-- 58
Query: 123 LSLMRHPNLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRMKIA 179
P +V L Y + + L LV EYMP G L + L + PE + R IA
Sbjct: 59 ----DSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE----ET-ARFYIA 108
Query: 180 AGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKS------- 232
L+ +H I+RD+K NIL+ H KL+DFGL K
Sbjct: 109 ELVL-ALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDS 164
Query: 233 ---------------HVSTRVM-----GTHGYCAPEYATTGKLTAKSDIFSFGVVLLELI 272
H RV GT Y APE + D +S GV+L E++
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
Query: 273 TGRP--AMDDSQGHERMLVDW 291
G P D Q +++W
Sbjct: 225 YGFPPFYSDTLQETYNKIINW 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-15
Identities = 72/214 (33%), Positives = 99/214 (46%), Gaps = 15/214 (7%)
Query: 79 FLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEF---LVEVLMLSLMRHPNLVHLI 135
LG+G FG V + TG+ A+K L + E + E +L RHP L L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL- 60
Query: 136 GYCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKAD 194
Y + RL V EY G L HL + E + R A LEYLH++
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARF-YGAEIVSALEYLHSRD- 115
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGK 254
V+YRD+K N++L K H K++DFGL K G + D + + T GT Y APE
Sbjct: 116 --VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKT-FCGTPEYLAPEVLEDND 171
Query: 255 LTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288
D + GVV+ E++ GR +Q HER+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLF 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 5e-15
Identities = 69/207 (33%), Positives = 103/207 (49%), Gaps = 28/207 (13%)
Query: 80 LGQGGFGAVY---KGKLAETGQVVAVKQL--------DDTGFQGEKEFLVEVLMLSLMRH 128
LGQG FG V+ K + GQ+ A+K L D + E++ L EV H
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------NH 57
Query: 129 PNLVHL-IGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLE 187
P +V L + EG + L+ +++ G L L+ E+ + + + +A A L+
Sbjct: 58 PFIVKLHYAFQTEG-KLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYLAE-LALALD 112
Query: 188 YLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAP 247
+LH+ +IYRDLK NILL + H KL+DFGL+K +K S GT Y AP
Sbjct: 113 HLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAP 167
Query: 248 EYATTGKLTAKSDIFSFGVVLLELITG 274
E T +D +SFGV++ E++TG
Sbjct: 168 EVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 5e-15
Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 14/198 (7%)
Query: 80 LGQGGFGAVYKG--KLAETGQV-VAVK--QLDDTGFQGEKEFLVEVLMLSLMRHPNLVHL 134
+G+G FG VY+G E ++ VAVK + + EK FL E ++ HP++V L
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQFDHPHIVKL 72
Query: 135 IGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKAD 194
IG E +V E PLG L + L LD + + + + L YL +K
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSY---LQVNKYSLDLASLILYSYQLSTALAYLESKR- 127
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGK 254
++RD+ A N+L+ KL DFGL+++ S + + APE +
Sbjct: 128 --FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK-WMAPESINFRR 184
Query: 255 LTAKSDIFSFGVVLLELI 272
T+ SD++ FGV + E++
Sbjct: 185 FTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 6e-15
Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 80 LGQGGFGAVYKGKLAETGQ-VVAVKQ-----LDDTGFQGEKEFLVEVLMLSL------MR 127
LG G FG VYK + GQ ++A+K+ + E++ + ++ + +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 128 HPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLD----WNTRMKIAAGAA 183
HPN+V E + +V + + L +H L + + WN +++
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA-- 125
Query: 184 RGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG 243
L YLH + +++RDL NI+LG+ ++DFGLAK +S + T V+GT
Sbjct: 126 --LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKL-TSVVGTIL 178
Query: 244 YCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
Y PE K+D+++FG +L ++ T +P
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQP 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 9e-15
Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV--EVLMLSLMRHPNLVHLIGY 137
+G G +G VYK + TG++ AVK + G+ L+ E+ M+ +H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 138 CAEGTQRLLVYEYMPLGSLED--HLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADP 195
+ + EY GSL+D H+ G E++ + + R + +GL YLH+K
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVTGPLSELQ-IAYVCRETL-----QGLAYLHSKGK- 127
Query: 196 PVIYRDLKAGNILLGKGFHPKLSDFGL-AKFGPTGDKSHVSTRVMGTHGYCAPEYAT--- 251
++RD+K NILL KL+DFG+ AK T K +GT + APE A
Sbjct: 128 --MHRDIKGANILLTDNGDVKLADFGVAAKITATIAK---RKSFIGTPYWMAPEVAAVEK 182
Query: 252 TGKLTAKSDIFSFGVVLLELITGRPAMDD 280
G DI++ G+ +EL +P M D
Sbjct: 183 NGGYNQLCDIWAVGITAIELAELQPPMFD 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 9e-15
Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLD-DTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYC 138
LG G G VYK T +++AVK + D + +K+ + E+ +L P ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 139 AEGTQRLLVYEYMPLGSLE------DHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK 192
+ + E+M GSL+ +H+LG +IA +GL YL +
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPEHVLG--------------RIAVAVVKGLTYLWSL 114
Query: 193 ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATT 252
+++RD+K N+L+ KL DFG++ T + ++ +GT+ Y APE +
Sbjct: 115 K---ILHRDVKPSNMLVNTRGQVKLCDFGVS----TQLVNSIAKTYVGTNAYMAPERISG 167
Query: 253 GKLTAKSDIFSFGVVLLELITGR---PAMDDSQG 283
+ SD++S G+ +EL GR P + +QG
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQG 201
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-14
Identities = 67/220 (30%), Positives = 102/220 (46%), Gaps = 22/220 (10%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLML-SLMRHPNLV 132
F+ +G G +G VYKG+ +TGQ+ A+K +D T + E+E +E+ ML H N+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIA 76
Query: 133 HLIGYCAEGT------QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGL 186
G + + Q LV E+ GS+ D + DW I RGL
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGL 134
Query: 187 EYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL-AKFGPTGDKSHVSTRVMGTHGYC 245
+LH VI+RD+K N+LL + KL DFG+ A+ T + + +GT +
Sbjct: 135 AHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGTPYWM 188
Query: 246 APEYATT-----GKLTAKSDIFSFGVVLLELITGRPAMDD 280
APE +SDI+S G+ +E+ G P + D
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-14
Identities = 64/208 (30%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLD-DTGFQGEKEFLV-EVLMLSLMR---HPNLVHL 134
+G G +G VYK + +G VA+K + T G V EV +L + HPN+V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 135 IGYCA-----EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL 189
+ CA T+ LV+E++ L +L + P P + T + RGL++L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAE--TIKDLMRQFLRGLDFL 124
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVS-TRVMGTHGYCAPE 248
H +++RDLK NIL+ G KL+DFGLA+ ++ T V+ T Y APE
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVTLWYRAPE 177
Query: 249 YATTGKLTAKSDIFSFGVVLLELITGRP 276
D++S G + E+ +P
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFRRKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 68/228 (29%), Positives = 108/228 (47%), Gaps = 42/228 (18%)
Query: 80 LGQGGFGAVYKGKLAETGQV----------VAVKQL-DDTGFQGEKEFLVEVLMLSLM-R 127
LG+G FG V +AE + VAVK L D + + + E+ M+ ++ +
Sbjct: 26 LGEGCFGQVV---MAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 128 HPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTR------------ 175
H N+++L+G C + ++ EY G+L ++L P +N
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 176 MKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVS 235
+ A ARG+EYL +K I+RDL A N+L+ + K++DFGLA+ D H+
Sbjct: 143 VSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHID 194
Query: 236 TRVMGTHG-----YCAPEYATTGKLTAKSDIFSFGVVLLELIT--GRP 276
T+G + APE T +SD++SFGV+L E+ T G P
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 80 LGQGGFGAVYKGKLAETGQ-------VVAVKQLDDTGFQGEKEFLV-EVLMLSLM-RHPN 130
LG+G FG V + + VAVK L D + LV E+ M+ ++ +H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTP------------EMKPLDWNTRMKI 178
+++L+G C + ++ EY G+L ++L P + L + +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 179 AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRV 238
A ARG+EYL A I+RDL A N+L+ + K++DFGLA+ D +T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 239 MGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
+ APE T +SD++SFGV+L E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-14
Identities = 54/198 (27%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA 139
+G+G G V + +G+ VAVK +D Q + EV+++ +H N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 140 EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIY 199
G + ++ E++ G+L D + + + L+ + + L YLH++ VI+
Sbjct: 89 VGEELWVLMEFLQGGALTD----IVSQTR-LNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 200 RDLKAGNILLGKGFHPKLSDFGL-AKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAK 258
RD+K+ +ILL KLSDFG A+ K ++GT + APE + +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK---SLVGTPYWMAPEVISRTPYGTE 197
Query: 259 SDIFSFGVVLLELITGRP 276
DI+S G++++E++ G P
Sbjct: 198 VDIWSLGIMVIEMVDGEP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 72/214 (33%), Positives = 100/214 (46%), Gaps = 15/214 (7%)
Query: 79 FLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEF---LVEVLMLSLMRHPNLVHLI 135
LG+G FG V + +G+ A+K L + E L E +L RHP L L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60
Query: 136 GYCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKAD 194
Y + RL V EY+ G L HL + E + TR A L+YLH+
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHL---SRERVFSEDRTRF-YGAEIVSALDYLHSGK- 115
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGK 254
++YRDLK N++L K H K++DFGL K G T D + + T GT Y APE
Sbjct: 116 --IVYRDLKLENLMLDKDGHIKITDFGLCKEGIT-DAATMKT-FCGTPEYLAPEVLEDND 171
Query: 255 LTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288
D + GVV+ E++ GR + Q HE++
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLF 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-14
Identities = 72/212 (33%), Positives = 97/212 (45%), Gaps = 15/212 (7%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEF---LVEVLMLSLMRHPNLVHLIG 136
LG+G FG V + TG+ A+K L + E L E +L RHP L L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL-K 61
Query: 137 YCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADP 195
Y + RL V EY G L HL + E + R A L YLH+
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARF-YGAEIVSALGYLHSCD-- 115
Query: 196 PVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKL 255
V+YRDLK N++L K H K++DFGL K G + D + + T GT Y APE
Sbjct: 116 -VVYRDLKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKT-FCGTPEYLAPEVLEDNDY 172
Query: 256 TAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
D + GVV+ E++ GR +Q HE++
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKL 203
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-14
Identities = 66/225 (29%), Positives = 104/225 (46%), Gaps = 24/225 (10%)
Query: 64 YRQLVAAT-----DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KE 115
YRQ V T D ++D +G G +G V TG VA+K+L FQ E K
Sbjct: 2 YRQEVNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRP-FQSELFAKR 60
Query: 116 FLVEVLMLSLMRHPNLVHLIG-YCAEGTQRLL--VYEYMPLGSLEDHLLGLTPEMKPLDW 172
E+ +L M+H N++ L+ + + + Y MP + LG + + L
Sbjct: 61 AYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTD---LGKLMKHEKLSE 117
Query: 173 NTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKS 232
+ + +GL+Y+H +I+RDLK GN+ + + K+ DFGLA+ +
Sbjct: 118 DRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTG 174
Query: 233 HVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRP 276
+V TR Y APE T DI+S G ++ E++TG+P
Sbjct: 175 YVVTR-----WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP 214
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-14
Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA 139
+G+G G V + +G++VAVK++D Q + EV+++ +H N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 140 EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMK------IAAGAARGLEYLHNKA 193
G + +V E++ G+L D + +TRM + + L LH +
Sbjct: 88 VGDELWVVMEFLEGGALTDIVT-----------HTRMNEEQIAAVCLAVLKALSVLHAQG 136
Query: 194 DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTG 253
VI+RD+K+ +ILL KLSDFG + ++GT + APE +
Sbjct: 137 ---VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPELISRL 191
Query: 254 KLTAKSDIFSFGVVLLELITGRP 276
+ DI+S G++++E++ G P
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-14
Identities = 66/205 (32%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVK--QLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGY 137
+G+G +G V+K K ET ++VA+K +LDD L E+ +L ++H N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 138 CAEGTQRLLVYEY--MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADP 195
+ LV+EY L D G +D +GL + H+
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNG------DIDPEIVKSFMFQLLKGLAFCHSHN-- 119
Query: 196 PVIYRDLKAGNILLGKGFHPKLSDFGLAK-FG-PTGDKSHVSTRVMGTHGYCAPEYATTG 253
V++RDLK N+L+ K KL+DFGLA+ FG P S V+ T Y P+
Sbjct: 120 -VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA---EVV-TLWYRPPDVLFGA 174
Query: 254 KLTAKS-DIFSFGVVLLELIT-GRP 276
KL + S D++S G + EL GRP
Sbjct: 175 KLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 5e-14
Identities = 67/212 (31%), Positives = 98/212 (46%), Gaps = 32/212 (15%)
Query: 80 LGQGGFGAVYKGKL---AETGQVVAVK----------QLDDTGFQGEKEFLVEVLMLSLM 126
LG+GG+G V++ + A+TG++ A+K Q D + E+ L V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV------ 57
Query: 127 RHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLL--GLTPEMKPLDWNTRMKIAAGAAR 184
+HP +V LI G + L+ EY+ G L HL G+ E +T + +
Sbjct: 58 KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFME------DTACFYLSEISL 111
Query: 185 GLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGY 244
LE+LH + +IYRDLK NILL H KL+DFGL K V+ GT Y
Sbjct: 112 ALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEY 166
Query: 245 CAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
APE D +S G ++ +++TG P
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGAP 198
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 6e-14
Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 35/223 (15%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQL--DDTGFQG-EKEFLVEVLMLSLMRHPNLVHLIG 136
+G+GG G VY + VA+K++ D + +K FL E + + + HP +V +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 137 YCAEGTQRLLVYEYMPL--GSLEDHLLGLTPEM----KPLDWNTRMK----IAAGAARGL 186
C++G VY MP G LL + K L T + I +
Sbjct: 70 ICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 187 EYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF-------------GPTGDKSH 233
EY+H+K V++RDLK NILLG + D+G A F
Sbjct: 127 EYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 234 VST---RVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
T +++GT Y APE + +DI++ GV+L +++T
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-14
Identities = 67/215 (31%), Positives = 97/215 (45%), Gaps = 38/215 (17%)
Query: 80 LGQGGFGAVYKGKL---AETGQVVAVKQLD-DTGFQGEKEFLVEVLMLSLMRHPNLVHLI 135
+G G FG V G++ QVV VK+L Q + +FL E ++H NL+ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVV-VKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 136 GYCAEGTQRLLVYEYMPLGSLEDHLLG------LTPEMKPLDWNTRMKIAAGAARGLEYL 189
G C E T LLV E+ PLG L+ +L +TP+ L ++A A GL +L
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ-----RMACEIALGLLHL 116
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA------KFGPTGDKSHVSTRVMGTHG 243
H I+ DL N LL K+ D+GL+ + T D+ V R
Sbjct: 117 HKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR------ 167
Query: 244 YCAPEYA--TTGKL-----TAKSDIFSFGVVLLEL 271
+ APE G L T +S+++S GV + EL
Sbjct: 168 WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 8e-14
Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 18/200 (9%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLD-DTGFQGEKEFLVEVLMLSLMRHPNLVHLI-GY 137
+G+G FG + + Q A+K++ ++ E ++L+ M+HPN+V +
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 138 CAEGTQRLLVYEYMPLGSL----EDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA 193
A+G +V EY G L + L PE L W +M + G++++H K
Sbjct: 68 EADG-HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEKR 120
Query: 194 DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTG 253
V++RD+K+ NI L + KL DFG A+ T ++ T V GT Y PE
Sbjct: 121 ---VLHRDIKSKNIFLTQNGKVKLGDFGSARL-LTSPGAYACTYV-GTPYYVPPEIWENM 175
Query: 254 KLTAKSDIFSFGVVLLELIT 273
KSDI+S G +L EL T
Sbjct: 176 PYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-13
Identities = 71/214 (33%), Positives = 96/214 (44%), Gaps = 14/214 (6%)
Query: 79 FLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEF---LVEVLMLSLMRHPNLVHLI 135
LG+G FG V K TG+ A+K L + E L E +L RHP L L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL- 60
Query: 136 GYCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKAD 194
Y + RL V EY G L HL + + A L+YLH ++
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLH--SE 114
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGK 254
V+YRDLK N++L K H K++DFGL K G D + + T GT Y APE
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEYLAPEVLEDND 172
Query: 255 LTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288
D + GVV+ E++ GR + Q HE++
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLF 205
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 68/224 (30%), Positives = 104/224 (46%), Gaps = 23/224 (10%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLD---DTGFQGEKEFLVEVLMLSLMR 127
+D ++ +G+G +G V+K + G AVK LD D + E E+ + + +L
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNI---LKALSD 73
Query: 128 HPNLVHLIGY-----CAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGA 182
HPN+V G G Q LV E GS+ D + G + ++ I A
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 183 ARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL-AKFGPTGDKSHVSTRVMGT 241
GL++LH I+RD+K NILL KL DFG+ A+ T + + S +GT
Sbjct: 134 LMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS---VGT 187
Query: 242 HGYCAPEY-ATTGKL----TAKSDIFSFGVVLLELITGRPAMDD 280
+ APE A +L A+ D++S G+ +EL G P + D
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD 231
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 70/226 (30%), Positives = 103/226 (45%), Gaps = 24/226 (10%)
Query: 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE---FLVEVLMLSLMRHP 129
+F+ LG G FG V K TG+ A+K L K+ E +L + HP
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 130 NLVHLIGYCAEGTQRLLVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRMKI-AAGAARGL 186
+V+++ + + + E++ G L HL G P N K A
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFP-------NDVAKFYHAELVLAF 131
Query: 187 EYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCA 246
EYLH+K +IYRDLK N+LL H K++DFG AK P D++ + GT Y A
Sbjct: 132 EYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--DRTFT---LCGTPEYLA 183
Query: 247 PEYATTGKLTAKSDIFSFGVVLLELITGRPAM-DDS--QGHERMLV 289
PE + D ++ GV+L E I G P DD+ + +E++L
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA 229
|
Length = 329 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 76 DTNFL---GQGGFGAVYKGKLAETGQVVAVKQLD-DTGFQGE--KEFLVEVLMLSLMRHP 129
D NFL G+G FG V + T ++ A+K L D Q + + +VE +L+L P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 130 NLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEY 188
+ + C + RL V EY+ G L + + +P + AA A GL +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEP----HAVFYAAEIAIGLFF 116
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVM-GTHGYCAP 247
LH+K +IYRDLK N++L H K++DFG+ K V+T+ GT Y AP
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPDYIAP 170
Query: 248 EYATTGKLTAKSDIFSFGVVLLELITGRPAMD 279
E D ++FGV+L E++ G+ +
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 72/217 (33%), Positives = 100/217 (46%), Gaps = 18/217 (8%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE---FLVEV-LMLSLMRHPNLVHLI 135
+G+G FG V K G AVK L +KE + E ++L ++HP LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 136 GYCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKAD 194
Y + ++L V +Y+ G L HL E L+ R AA A + YLH+
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHL---QRERCFLEPRARF-YAAEVASAIGYLHSLN- 116
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGK 254
+IYRDLK NILL H L+DFGL K G + ++ GT Y APE
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCKEGV--EPEETTSTFCGTPEYLAPEVLRKEP 172
Query: 255 LTAKSDIFSFGVVLLELITGRP---AMDDSQGHERML 288
D + G VL E++ G P + D SQ ++ +L
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-13
Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 8/202 (3%)
Query: 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQL---DDTGFQGEKEFLVEVLMLSLMRHP 129
NF+ +G+G F VY+ G VA+K++ D + + + E+ +L + HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 130 NLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL 189
N++ E + +V E G L + + + + T K LE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEY 249
H++ V++RD+K N+ + KL D GL +F + K+ + ++GT Y +PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPER 177
Query: 250 ATTGKLTAKSDIFSFGVVLLEL 271
KSDI+S G +L E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 66/234 (28%), Positives = 106/234 (45%), Gaps = 36/234 (15%)
Query: 78 NFLGQGGFGAVYKGKLAETGQVVAVKQL----DDTGFQGEKEFLVEVLMLSLMRHPNLVH 133
N +G G G VYK TG++ A+K + +DT ++ E+ +L + HPN+V
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTV---RRQICREIEILRDVNHPNVVK 136
Query: 134 LIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA 193
+ ++ E+M GSLE + + + A G+ YLH +
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADV--------ARQILSGIAYLHRRH 188
Query: 194 DPPVIYRDLKAGNILLGKGFHPKLSDFGLAK-FGPTGDKSHVSTRVMGTHGYCAPEYATT 252
+++RD+K N+L+ + K++DFG+++ T D + S +GT Y +PE T
Sbjct: 189 ---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---VGTIAYMSPERINT 242
Query: 253 ----GKLTAKS-DIFSFGVVLLELITGR-PAMDDSQGHERMLVDWVTLF--FCM 298
G + DI+S GV +LE GR P QG DW +L CM
Sbjct: 243 DLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG------DWASLMCAICM 290
|
Length = 353 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-13
Identities = 67/207 (32%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDD---------TGFQGEKEFLVEVLMLSLMRHPN 130
+G+G FG VY+ + +T ++ A+K L GE+ LV L+ P
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLL---DESPF 57
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLL--GLTPEMKPLDWNTRMKIAAGAARGLEY 188
+V L + LV +YM G L HL G E + + + +A LE+
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLA------LEH 111
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE 248
LH K D ++YRDLK NILL H L DFGL+K T +K+ + GT Y APE
Sbjct: 112 LH-KYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPE 166
Query: 249 YATTGK-LTAKSDIFSFGVVLLELITG 274
K T D +S GV++ E+ G
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-13
Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 35/225 (15%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF----QGEKEFLVEVLMLSLMR 127
++F+ + G +GAVY + ET Q A+K+++ Q ++ F VE +L+
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAE 59
Query: 128 HPNLVHLIGYCAEGTQRLL--VYEYMPLG---SLEDHLLGLTPEMKPLDWNTRMKIAAGA 182
+P +V + +C+ T+R L V EY+ G +L ++ L +M RM A
Sbjct: 60 NPFVVSM--FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDM------ARMYFAE-T 110
Query: 183 ARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG-------------PTG 229
LEYLHN +++RDLK N+L+ H KL+DFGL+K G
Sbjct: 111 VLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD 167
Query: 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITG 274
+ + +V GT Y APE D ++ G++L E + G
Sbjct: 168 TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 61/226 (26%), Positives = 103/226 (45%), Gaps = 43/226 (19%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEF-----LVEVLMLSLM 126
+++ +++G+G +G V TG VA+K++ + F E + L E+ +L
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI--SPF--EHQTFCQRTLREIKILRRF 60
Query: 127 RHPNLVHLIG-YCAEGTQRL----LVYEYMP--LGSL-------EDHLLGLTPEMKPLDW 172
+H N++ ++ + +V E M L L DH+ ++
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQI----- 115
Query: 173 NTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG-PTGDK 231
RGL+Y+H+ A+ V++RDLK N+LL K+ DFGLA+ P D
Sbjct: 116 ----------LRGLKYIHS-AN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162
Query: 232 SHVSTRVMGTHGYCAPEYATTGKLTAKS-DIFSFGVVLLELITGRP 276
+ T + T Y APE K K+ DI+S G +L E+++ RP
Sbjct: 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 70/212 (33%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE---FLVEV-LMLSLMRHPNLVHLI 135
+G+G FG V K G+ AVK L KE + E ++L ++HP LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 136 GYCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKI-AAGAARGLEYLHNKA 193
Y + T++L V +++ G L HL +P R + AA A L YLH+
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP-----RARFYAAEIASALGYLHSIN 116
Query: 194 DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTG 253
++YRDLK NILL H L+DFGL K G +S +T GT Y APE
Sbjct: 117 ---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCGTPEYLAPEVIRKQ 171
Query: 254 KLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285
D + G VL E++ G P E
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-13
Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEF--LVEV-LMLSLMRHPNLVHLIG 136
+G+G F V K + +TG+ A+K + F+ ++ L E+ + L HPN++ LI
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKH-FKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 137 YCAE-GTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKAD 194
+ T RL LV+E M + +L + + G +PL + L+++H
Sbjct: 66 VLFDRKTGRLALVFELMDM-NLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRNG- 120
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE-YATTG 253
+ +RD+K NIL+ K KL+DFG + T + T Y APE T G
Sbjct: 121 --IFHRDIKPENILI-KDDILKLADFGSCR---GIYSKPPYTEYISTRWYRAPECLLTDG 174
Query: 254 KLTAKSDIFSFGVVLLELITGRP 276
K DI++ G V E+++ P
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFP 197
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-13
Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 42/219 (19%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE---FLVEVLMLSLMRHPNLVHLIG 136
+G+G +G V TG+ VA+K+++D F+ + L E+ +L L+RHP++V +
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 137 YCAEGTQR-----LLVYEYMP------LGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARG 185
++R +V+E M + + +D LTPE + R
Sbjct: 67 IMLPPSRREFKDIYVVFELMESDLHQVIKANDD----LTPEHHQFFLYQLL-------RA 115
Query: 186 LEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK--FGPTGDK----SHVSTRVM 239
L+Y+H V +RDLK NIL K+ DFGLA+ F T +V+TR
Sbjct: 116 LKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR-- 170
Query: 240 GTHGYCAPEYATT--GKLTAKSDIFSFGVVLLELITGRP 276
Y APE + K T DI+S G + E++TG+P
Sbjct: 171 ---WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 6e-13
Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 46/219 (21%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMRHPNLVHLIG 136
+G+G +G V K +ET + VA+K++ + F K L E+ +L + H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA-FDNRIDAKRTLREIKLLRHLDHENVIAIKD 71
Query: 137 YCAEGTQR------LLVYEYM------------PLGSLEDHLLGLTPEMKPLDWNTRMKI 178
R +VYE M L +DH ++
Sbjct: 72 -IMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLS--DDHCQYFLYQL----------- 117
Query: 179 AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRV 238
RGL+Y+H+ A+ V++RDLK N+LL K+ DFGLA+ T +K T
Sbjct: 118 ----LRGLKYIHS-AN--VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEY 168
Query: 239 MGTHGYCAPE-YATTGKLTAKSDIFSFGVVLLELITGRP 276
+ T Y APE + T D++S G + EL+ +P
Sbjct: 169 VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-13
Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 8/202 (3%)
Query: 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQL---DDTGFQGEKEFLVEVLMLSLMRHP 129
NF+ +G+G F VY+ + VA+K++ + + ++ + E+ +L + HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 130 NLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL 189
N++ + E + +V E G L + + + + T K +E++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEY 249
H++ V++RD+K N+ + KL D GL +F + K+ + ++GT Y +PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPER 177
Query: 250 ATTGKLTAKSDIFSFGVVLLEL 271
KSDI+S G +L E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 9e-13
Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 20/212 (9%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEF----LVEVLMLSLMR 127
+ F+ +G+G +G V K + ET ++VA+K+ D+ + +E L E+ ML ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLK 58
Query: 128 HPNLVHLIGYCAEGTQRLLVYEYMP---LGSLEDHLLGLTPEMKPLDWNTRMKIAAGAAR 184
N+V L + LV+EY+ L LE+ G+ PE K+ + +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE----------KVRSYIYQ 108
Query: 185 GLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGY 244
++ +H +++RD+K N+L+ KL DFG A+ G ++ T + T Y
Sbjct: 109 LIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWY 167
Query: 245 CAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
+PE D++S G +L EL G+P
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGELSDGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 48/227 (21%)
Query: 79 FLGQGGFGAVYKGKLAE--TGQVVAVKQLDDTGFQGEKEFLV--------EVLMLSLMRH 128
+G+G +G VYK K G+ A+K+ F+G+KE E+ +L ++H
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKK-----FKGDKEQYTGISQSACREIALLRELKH 61
Query: 129 PNLVHLIGYCAEGTQRL--LVYEYMPLGSLEDHLLGL-----TPEMKPLDWNTRMKIAAG 181
N+V L+ E + L+++Y E L + + + + +
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 182 AARGLEYLHNKADPPVIYRDLKAGNILL-GKGFHP---KLSDFGLAKF--GP-----TGD 230
G+ YLH+ V++RDLK NIL+ G+G K+ D GLA+ P D
Sbjct: 117 ILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173
Query: 231 KSHVSTRVMGTHGYCAPEYATTGK-LTAKSDIFSFGVVLLELITGRP 276
V+ T Y APE + T DI++ G + EL+T P
Sbjct: 174 P------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 1e-12
Identities = 70/227 (30%), Positives = 106/227 (46%), Gaps = 56/227 (24%)
Query: 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ----GEKEFLVEVLMLSLMR-HPNLV 132
LG+G +G V+K T +VVA+K++ D F+ ++ F E++ L + HPN+V
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFD-AFRNATDAQRTFR-EIMFLQELGDHPNIV 70
Query: 133 HLIG-YCAEGTQRL-LVYEYMPL--------GSLED-H-------LLGLTPEMKPLDWNT 174
L+ AE + + LV+EYM LED H LL
Sbjct: 71 KLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLL------------- 117
Query: 175 RMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF---GPTGDK 231
+ L+Y+H+ VI+RDLK NILL KL+DFGLA+ +
Sbjct: 118 ---------KALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE 165
Query: 232 SHVSTRVMGTHGYCAPE--YATTGKLTAKSDIFSFGVVLLELITGRP 276
+ V T + T Y APE +T + T D++S G +L E++ G+P
Sbjct: 166 NPVLTDYVATRWYRAPEILLGST-RYTKGVDMWSVGCILGEMLLGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 51/140 (36%), Positives = 70/140 (50%), Gaps = 19/140 (13%)
Query: 149 EYMPLGSLEDHLL---GLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAG 205
E+M GSL D +L G PE N KI+ RGL YL K +++RD+K
Sbjct: 79 EHMDGGSL-DQVLKKAGRIPE------NILGKISIAVLRGLTYLREKHK--IMHRDVKPS 129
Query: 206 NILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFG 265
NIL+ KL DFG++ G D S ++ V GT Y +PE T +SDI+S G
Sbjct: 130 NILVNSRGEIKLCDFGVS--GQLID-SMANSFV-GTRSYMSPERLQGTHYTVQSDIWSLG 185
Query: 266 VVLLELITGR---PAMDDSQ 282
+ L+E+ GR P D +
Sbjct: 186 LSLVEMAIGRYPIPPPDAKE 205
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 80 LGQGGFGAVYKGK-LAETGQVVAVK----QLDDTGFQGEKEFLVEVL-MLSLMRHPNLVH 133
+G+G +G V+K + L G+ VA+K Q + G V VL L HPN+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 134 LIGYCA-----EGTQRLLVYEYMPLGSLEDHLLGLTPEMKP---LDWNTRMKIAAGAARG 185
L C T+ LV+E++ D L + P + T + RG
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV------DQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 122
Query: 186 LEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYC 245
L++LH+ V++RDLK NIL+ KL+DFGLA+ T V+ T Y
Sbjct: 123 LDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYR 176
Query: 246 APEYATTGKLTAKSDIFSFGVVLLELITGRP 276
APE D++S G + E+ +P
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 3e-12
Identities = 64/227 (28%), Positives = 108/227 (47%), Gaps = 21/227 (9%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEK-EFLVEVLMLSLMRHPN 130
D+++ LG+G + VYKGK G++VA+K + +G + E +L ++H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLG---SLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLE 187
+V L LV+EY+ ++ H GL PE N ++ + RGL
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPE------NVKLFLFQ-LLRGLS 117
Query: 188 YLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAP 247
Y+H + +++RDLK N+L+ KL+DFGLA+ SH + + T Y P
Sbjct: 118 YIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV--PSHTYSNEVVTLWYRPP 172
Query: 248 EYAT-TGKLTAKSDIFSFGVVLLELITGR---PAMDDSQGH-ERMLV 289
+ + + + D++ G + +E+I G P M D Q ER+ +
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFL 219
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-12
Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 24/215 (11%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQL----DDTGFQGEKEFLVEVLMLSLMR 127
D ++ +G+G +G VYK + T + +A+K++ +D G + E+ +L M+
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTA--IREISLLKEMQ 59
Query: 128 HPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRM--KIAAGAARG 185
H N+V L + LV+EY+ L L+ H + +P+ N R+ RG
Sbjct: 60 HGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKH-MDSSPDFAK---NPRLIKTYLYQILRG 114
Query: 186 LEYLHNKADPPVIYRDLKAGNILLGKGFHP-KLSDFGLAK-FG-PTGDKSHVSTRVMGTH 242
+ Y H+ V++RDLK N+L+ + + KL+DFGLA+ FG P +H T
Sbjct: 115 IAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TL 167
Query: 243 GYCAPEYATTGK-LTAKSDIFSFGVVLLELITGRP 276
Y APE + + DI+S G + E++ +P
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKP 202
|
Length = 294 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-12
Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 19/211 (9%)
Query: 80 LGQGGFGAVYKGKLAETGQ---VVAVKQLDDTGFQGEKE-FLVEVLMLSLMRHPNLVHLI 135
LG G FG + +G L + VA+ L ++ FL E L L H N+V L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 136 GYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADP 195
G G ++V EYM G+L+ L L M + G A G++YL ++
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSF---LRKHEGQLVAGQLMGMLPGLASGMKYL---SEM 126
Query: 196 PVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG---YCAPEYATT 252
+++ L A +L+ K+S F + DKS M + APE
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQ----EDKSEAIYTTMSGKSPVLWAAPEAIQY 182
Query: 253 GKLTAKSDIFSFGVVLLELIT--GRPAMDDS 281
++ SD++SFG+V+ E+++ RP D S
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERPYWDMS 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 6e-12
Identities = 69/234 (29%), Positives = 108/234 (46%), Gaps = 44/234 (18%)
Query: 64 YRQLVAAT-----DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG---EKE 115
YRQ + T + +++ + +G G +G+V +TG VAVK+L FQ K
Sbjct: 4 YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKR 62
Query: 116 FLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLED--------HLLG----- 162
E+ +L M+H N++ L+ + P SLE+ HL+G
Sbjct: 63 TYRELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNN 110
Query: 163 LTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL 222
+ K D + + I RGL+Y+H+ AD +I+RDLK N+ + + K+ DFGL
Sbjct: 111 IVKCQKLTDDHVQFLIYQ-ILRGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGL 166
Query: 223 AKFGPTGDKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGR 275
A+ +V+TR Y APE DI+S G ++ EL+TGR
Sbjct: 167 ARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 7e-12
Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 47/218 (21%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEK----EFLVEVLMLSLMRHPNLV--H 133
LG+G + VYKG+ TGQ+VA+K++ + E+ + E +L ++H N+V H
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIR---LEHEEGAPFTAIREASLLKDLKHANIVTLH 69
Query: 134 LIGYCAEGTQRLL--VYEYM--PLGS-LEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEY 188
I + T++ L V+EY+ L ++D GL+ N R+ + RGL Y
Sbjct: 70 DIIH----TKKTLTLVFEYLDTDLKQYMDDCGGGLSMH------NVRLFLFQ-LLRGLAY 118
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL--AKFGPTGDKSHVSTRVMGTHGYCA 246
H + V++RDLK N+L+ + KL+DFGL AK P+ S+ V+ T Y
Sbjct: 119 CHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN---EVV-TLWYRP 171
Query: 247 P-------EYATTGKLTAKSDIFSFGVVLLELITGRPA 277
P EY+T+ D++ G + E+ TGRP
Sbjct: 172 PDVLLGSTEYSTS------LDMWGVGCIFYEMATGRPL 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 64/213 (30%), Positives = 95/213 (44%), Gaps = 31/213 (14%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQL------DDTGF---QGEKEFLVEVLMLSLMRHPN 130
+G+G + V +L +T ++ A+K + DD Q EK + HP
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA-----SNHPF 57
Query: 131 LVHLIGYCAEGTQRLL-VYEYMPLGSLEDHLLGLT--PEMKPLDWNTRMKIAAGAARGLE 187
LV L C + RL V EY+ G L H+ PE ++ + +A L
Sbjct: 58 LVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA------LN 110
Query: 188 YLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG-PTGDKSHVSTRVMGTHGYCA 246
YLH + +IYRDLK N+LL H KL+D+G+ K G GD ++ GT Y A
Sbjct: 111 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIA 164
Query: 247 PEYATTGKLTAKSDIFSFGVVLLELITGRPAMD 279
PE D ++ GV++ E++ GR D
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-11
Identities = 44/150 (29%), Positives = 63/150 (42%), Gaps = 18/150 (12%)
Query: 129 PNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGL--TPEMKPLDWNTRMKIAAGAARGL 186
PN+V L Y LV ++ G L H+ PE W M +A L
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA------L 98
Query: 187 EYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFG-LAKFGPTGDKSHVSTRVMGTHGYC 245
+ LH + ++ RDL NILL H +L+ F ++ + D V YC
Sbjct: 99 DALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YC 149
Query: 246 APEYATTGKLTAKSDIFSFGVVLLELITGR 275
APE + T D +S G +L EL+TG+
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 27/211 (12%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQL------DDTGF---QGEKEFLVEVLMLSLMRHPN 130
+G+G + V +L +T ++ A+K + DD Q EK + + HP
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKH-----VFETASNHPF 57
Query: 131 LVHLIGYCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL 189
LV L C + RL V E++ G L H+ + K + + R +A + L +L
Sbjct: 58 LVGLHS-CFQTESRLFFVIEFVSGGDLMFHM---QRQRKLPEEHARF-YSAEISLALNFL 112
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG-PTGDKSHVSTRVMGTHGYCAPE 248
H + +IYRDLK N+LL H KL+D+G+ K G GD ++ GT Y APE
Sbjct: 113 HERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---TTSTFCGTPNYIAPE 166
Query: 249 YATTGKLTAKSDIFSFGVVLLELITGRPAMD 279
D ++ GV++ E++ GR D
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 77/264 (29%), Positives = 109/264 (41%), Gaps = 47/264 (17%)
Query: 40 PARRN--TLDDTLSAHENKNKENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETG 97
PA R +D+ LS +E ++ +L ++F +G+G FG V + +
Sbjct: 13 PALRKNKNIDNFLSRYEKAAEK----ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSK 68
Query: 98 QVVAVKQLD--------DTGFQGEKEFLVEVLMLSLMRHPN---LVHLIGYCAEGTQRLL 146
QV A+K L D+ F E+ +M H N +V L + A + L
Sbjct: 69 QVYAMKLLSKFEMIKRSDSAFFWEER--------DIMAHANSEWIVQL--HYAFQDDKYL 118
Query: 147 --VYEYMPLGSLEDHLLGLTPEMK-PLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLK 203
V EYMP G L + L P W R A L+ +H+ I+RD+K
Sbjct: 119 YMVMEYMPGGDL----VNLMSNYDIPEKW-ARFYTAE-VVLALDAIHSMG---FIHRDVK 169
Query: 204 AGNILLGKGFHPKLSDFGLA-KFGPTGDKSHVSTRVMGTHGYCAPEY----ATTGKLTAK 258
N+LL K H KL+DFG K G T V GT Y +PE G +
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMDANG-MVRCDTAV-GTPDYISPEVLKSQGGDGYYGRE 227
Query: 259 SDIFSFGVVLLELITGR-PAMDDS 281
D +S GV L E++ G P DS
Sbjct: 228 CDWWSVGVFLYEMLVGDTPFYADS 251
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 19/229 (8%)
Query: 47 DDTLSAHENKNKENTFTYRQL---VAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVK 103
DD+ S ++ + + +Q V A+ + L G G V+ V +K
Sbjct: 38 DDSASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLK 97
Query: 104 QLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGL 163
G +G L+E ++L + HP+++ + G +V + D L
Sbjct: 98 ----IGQKGTT--LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS----SDLYTYL 147
Query: 164 TPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA 223
T +PL + + I GL YLH + +I+RD+K NI + + D G A
Sbjct: 148 TKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAA 204
Query: 224 KFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELI 272
+F P + + + GT APE K +K+DI+S G+VL E++
Sbjct: 205 QF-PVVAPAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 11/205 (5%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLD-DTGFQGEKEFLVEVLMLSLMRHPN 130
D+F+ + LG G G V K + +G ++A K + + + + E+ +L P
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLH 190
+V G + + E+M GSL+ L E K + K++ RGL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KEAKRIPEEILGKVSIAVLRGLAYLR 120
Query: 191 NKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYA 250
K +++RD+K NIL+ KL DFG++ G D ++ +GT Y +PE
Sbjct: 121 EKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERL 174
Query: 251 TTGKLTAKSDIFSFGVVLLELITGR 275
+ +SDI+S G+ L+EL GR
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 78 NFLGQGGFGAVYKGKLAETG----QVVAVKQLDDTGFQGEKE-FLVEVLMLSLMRHPNLV 132
+ L +G FG ++ G L + + V VK + D + + L E +L + H N++
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 133 HLIGYCAEGTQRLLV-YEYMPLGSLEDHLLG--LTPEMKPLDWNTR--MKIAAGAARGLE 187
++ C E + V Y YM G+L+ L L P +T+ + +A A G+
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 188 YLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK------FGPTGDKSHVSTRVMGT 241
YLH + VI++D+ A N ++ + K++D L++ + GD + + M
Sbjct: 132 YLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWM-- 186
Query: 242 HGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
A E + ++ SD++SFGV+L EL+T
Sbjct: 187 ----ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 66/212 (31%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQL------DDTGF---QGEKEFLVEVLMLSLMRHPN 130
+G+G + V +L + Q+ A+K + DD Q EK + +P
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQA-----SSNPF 57
Query: 131 LVHLIGYCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL 189
LV L C + T RL LV EY+ G L H+ + K + + R AA L +L
Sbjct: 58 LVGLHS-CFQTTSRLFLVIEYVNGGDLMFHM---QRQRKLPEEHARF-YAAEICIALNFL 112
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK--FGPTGDKSHVSTRVMGTHGYCAP 247
H + +IYRDLK N+LL H KL+D+G+ K GP GD ++ GT Y AP
Sbjct: 113 HERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GD---TTSTFCGTPNYIAP 165
Query: 248 EYATTGKLTAKSDIFSFGVVLLELITGRPAMD 279
E + D ++ GV++ E++ GR D
Sbjct: 166 EILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 30/221 (13%)
Query: 73 NFKDTNFLGQGGFGAVYKGKLAET--GQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMR 127
++ LGQG +G V + AET + VA+K++ + F + K L E+ +L R
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNV-FSKKILAKRALRELKLLRHFR 59
Query: 128 -HPNLVHLI--------GYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKI 178
H N+ L + +Y Y L +E L + +PL
Sbjct: 60 GHKNITCLYDMDIVFPGNFNE-------LYLYEEL--MEADLHQIIRSGQPLTDAHFQSF 110
Query: 179 AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK-FGPT-GDKSHVST 236
GL+Y+H+ A+ V++RDLK GN+L+ K+ DFGLA+ F G+ + T
Sbjct: 111 IYQILCGLKYIHS-AN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167
Query: 237 RVMGTHGYCAPEYATTGKLTAKS-DIFSFGVVLLELITGRP 276
+ T Y APE + + K+ D++S G +L EL+ +P
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-11
Identities = 65/222 (29%), Positives = 91/222 (40%), Gaps = 38/222 (17%)
Query: 73 NFKDTNFLGQGGFGAVY---KGKLAETGQVVAVKQLDD-TGFQGEK---EFLVEVLMLSL 125
NF+ LG G +G V+ K + G++ A+K L T Q K E +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 126 MRH-PNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAAR 184
+R P LV L T+ L+ +Y+ G L HL R R
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY------------QREHFTESEVR 108
Query: 185 --------GLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK--FGPTGDKSHV 234
L++LH +IYRD+K NILL H L+DFGL+K ++++
Sbjct: 109 VYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY- 164
Query: 235 STRVMGTHGYCAPEYATTGKLTAKS--DIFSFGVVLLELITG 274
GT Y APE G D +S GV+ EL+TG
Sbjct: 165 --SFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-11
Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 27/221 (12%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVK----QLDDTGFQGEKEFLVEV-LMLSLM 126
D ++ +G+G +G VYK + TG++VA+K ++D+ G L E+ L+ L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQMLS 58
Query: 127 RHPNLVHLIGYCAEGTQR-------LLVYEYMP--LGSLEDHLLGLTPEMKPLDWNTRMK 177
+V L+ E + LV+EY+ L D +PL T
Sbjct: 59 ESIYIVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPG--RPLPAKTIKS 114
Query: 178 IAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK-GFHPKLSDFGLAKFGPTGDKSHVST 236
+G+ + H V++RDLK N+L+ K K++D GL + KS+ T
Sbjct: 115 FMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--T 169
Query: 237 RVMGTHGYCAPEYATTGKLTAKS-DIFSFGVVLLELITGRP 276
+ T Y APE + DI+S G + E+ +P
Sbjct: 170 HEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP 210
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 64/205 (31%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEV-LMLSLMRHPNLVHLI 135
+G+G FG V + + AVK L + EK + E ++L ++HP LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61
Query: 136 GYCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKI-AAGAARGLEYLHNKA 193
+ + +L V +Y+ G L HL ++P R + AA A L YLH+
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-----RARFYAAEIASALGYLHSLN 116
Query: 194 DPPVIYRDLKAGNILLGKGFHPKLSDFGLAK--FGPTGDKSHVSTRVMGTHGYCAPEYAT 251
++YRDLK NILL H L+DFGL K G ++ GT Y APE
Sbjct: 117 ---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG----TTSTFCGTPEYLAPEVLH 169
Query: 252 TGKLTAKSDIFSFGVVLLELITGRP 276
D + G VL E++ G P
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 15/212 (7%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEK-EFLVEVLMLSLMRHPNLVHLIGYC 138
LG+G + VYKG+ T +VA+K++ +G + EV +L ++H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 139 AEGTQRLLVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPP 196
LV+EY+ L+ +L G + M N ++ + RGL Y H +
Sbjct: 74 HTEKSLTLVFEYLD-KDLKQYLDDCGNSINMH----NVKLFLFQ-LLRGLNYCHRRK--- 124
Query: 197 VIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYAT-TGKL 255
V++RDLK N+L+ + KL+DFGLA+ K++ + V T Y P+ +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDY 182
Query: 256 TAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
+ + D++ G + E+ TGRP S E++
Sbjct: 183 STQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-11
Identities = 64/210 (30%), Positives = 91/210 (43%), Gaps = 14/210 (6%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEF---LVEVLMLSLMRHPNLVHLIG 136
+G+G FG V + + +T ++ A+K + E L E +L+ + P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 137 YCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADP 195
+ + ++L LV ++ G L HL E + R A LE LH
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHL---QREGRFDLSRARFYTAE-LLCALENLHKFN-- 113
Query: 196 PVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKL 255
VIYRDLK NILL H L DFGL K + GT Y APE
Sbjct: 114 -VIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPEYLAPELLLGHGY 170
Query: 256 TAKSDIFSFGVVLLELITGRPAMDDSQGHE 285
T D ++ GV+L E++TG P D +E
Sbjct: 171 TKAVDWWTLGVLLYEMLTGLPPFYDENVNE 200
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 5e-11
Identities = 59/218 (27%), Positives = 87/218 (39%), Gaps = 13/218 (5%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--------QGEKEFLVEVLMLSLMR-HPN 130
LG G G V K G+ AVK +D G Q E L+ S+++ H +
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99
Query: 131 LVHLIGYCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL 189
E + LV +Y G L + + + + + ++
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHV 159
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEY 249
H+K +I+RD+K+ NILL KL DFG +K V GT Y APE
Sbjct: 160 HSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEI 216
Query: 250 ATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
+ K+D+FS GV+L EL+T + D E M
Sbjct: 217 WRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM 254
|
Length = 496 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-11
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 11/210 (5%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEK-EFLVEVLMLSLMRHPNLVHLIGYC 138
LG+G + V+KG+ T +VA+K++ +G + EV +L ++H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 139 AEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVI 198
LV+EY+ L+ +L M + M RGL Y H + ++
Sbjct: 73 HTERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFM---FQLLRGLSYCHKRK---IL 125
Query: 199 YRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYAT-TGKLTA 257
+RDLK N+L+ + KL+DFGLA+ K++ + V T Y P+ + + +
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEYST 183
Query: 258 KSDIFSFGVVLLELITGRPAMDDSQGHERM 287
D++ G +L E+ TGRP S E +
Sbjct: 184 PIDMWGVGCILYEMATGRPMFPGSTVKEEL 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 6e-11
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLD-DTGFQGEKEFLVEVLMLSLMRHPN 130
D+F+ + LG G G V+K +G ++A K + + + + E+ +L P
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRMKIAAGAARGLEY 188
+V G + + E+M GSL+ L G PE K++ +GL Y
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE------QILGKVSIAVIKGLTY 118
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE 248
L K +++RD+K NIL+ KL DFG++ G D ++ +GT Y +PE
Sbjct: 119 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPE 172
Query: 249 YATTGKLTAKSDIFSFGVVLLELITGR 275
+ +SDI+S G+ L+E+ GR
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 8e-11
Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 80 LGQGGFGAVY--KGKLAETGQVVAVKQLDDTGFQGEKEFL---VEVLMLSLMRHPNLVHL 134
LG+G FG VY K K A + + V + G E + E +LS + HP +V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 135 IGYCAEGTQRLLVYEYMPLGSLEDHLLGLT------PEMKPLDWNTRMKIAAGAARGLEY 188
E ++ EY L+ L L E + +W ++ + G+ Y
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GVHY 121
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE 248
+H + +++RDLKA NI L K+ DFG+++ ++T GT Y +PE
Sbjct: 122 MHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGTPYYMSPE 175
Query: 249 YATTGKLTAKSDIFSFGVVLLEL 271
+KSDI+S G +L E+
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 9e-11
Identities = 62/214 (28%), Positives = 92/214 (42%), Gaps = 18/214 (8%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE---FLVEVLMLSLMRH 128
+F + +G+G FG V + TG + A+K + + ++ F E +LS+
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 129 PNLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLE 187
P + L Y + L LV EY P G L L L D + A +
Sbjct: 61 PWIPQLQ-YAFQDKDNLYLVMEYQPGGDL---LSLLNRYEDQFDEDMAQFYLAELVLAIH 116
Query: 188 YLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAP 247
+H ++RD+K N+L+ + H KL+DFG A T +K S +GT Y AP
Sbjct: 117 SVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAA-RLTANKMVNSKLPVGTPDYIAP 172
Query: 248 EYATTGKLTAKS------DIFSFGVVLLELITGR 275
E TT K D +S GV+ E+I GR
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-10
Identities = 53/216 (24%), Positives = 102/216 (47%), Gaps = 36/216 (16%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLD--DTGFQGEKEFLVEVLMLSLMRHPNLVH---- 133
+G+G +G V + G+ +K+L+ + + K E +LS ++HPN+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 134 ----------LIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAA 183
++G+C G Y L + LL PE + ++W ++ +A
Sbjct: 68 WEGEDGLLYIVMGFCEGGDL------YHKLKEQKGKLL---PENQVVEWFVQIAMA---- 114
Query: 184 RGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG 243
L+YLH K +++RDLK N+ L + K+ D G+A+ ++ +++ ++GT
Sbjct: 115 --LQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPY 167
Query: 244 YCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMD 279
Y +PE + KSD+++ G + E+ T + A +
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 56/232 (24%), Positives = 89/232 (38%), Gaps = 47/232 (20%)
Query: 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE--------------FLVEVLML 123
LG+G +G V K TG++VA+K++ + L E+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 124 SLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMK------ 177
+ ++H N++ L+ EG LV + M L+ K +D R+
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLK----------KVVDRKIRLTESQVKC 123
Query: 178 IAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK-------FGPTGD 230
I GL LH ++RDL NI + K++DFGLA+
Sbjct: 124 ILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 231 KSHVSTRVMGTHG-----YCAPEYAT-TGKLTAKSDIFSFGVVLLELITGRP 276
+ R T Y APE K D++S G + EL+TG+P
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
|
Length = 335 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 27/239 (11%)
Query: 51 SAHENKNKENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQ-LDDTG 109
+A E++++E + ++K N +G G FG VY+ +T + VA+K+ L D
Sbjct: 45 NAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ 104
Query: 110 FQGEKEFLVEVLMLSLMRHPNLVHLIGY----CAEGTQRLL----VYEYMPLGSLEDHLL 161
++ E+L++ + H N++ L Y C + ++ + V E++P ++ ++
Sbjct: 105 YKNR-----ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMK 158
Query: 162 GLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHP-KLSDF 220
L + R L Y+H+K + +RDLK N+L+ H KL DF
Sbjct: 159 HYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215
Query: 221 GLAKFGPTGDKS--HVSTRVMGTHGYCAPEYAT-TGKLTAKSDIFSFGVVLLELITGRP 276
G AK G +S ++ +R Y APE T D++S G ++ E+I G P
Sbjct: 216 GSAKNLLAGQRSVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYP 269
|
Length = 440 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 45/148 (30%), Positives = 68/148 (45%), Gaps = 14/148 (9%)
Query: 82 QGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMRHPNLVHLIGYC 138
+G FG VY G+ ++ AVK + + + E L+L + P +VHL
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 139 AEGTQRLLVYEYMPLGSLED--HLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPP 196
LV EY+ G ++ H+ G D +K + A L+YLH
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGY------FDEEMAVKYISEVALALDYLHRHG--- 124
Query: 197 VIYRDLKAGNILLGKGFHPKLSDFGLAK 224
+I+RDLK N+L+ H KL+DFGL+K
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 65/222 (29%), Positives = 102/222 (45%), Gaps = 20/222 (9%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEK-EFLVEVLMLSLMRHPNLVHLIGYC 138
LG+G + VYKG GQ+VA+K + +G + E +L ++H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 139 AEGTQRLLVYEYMPLG---SLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADP 195
V+EYM + H GL P +N R+ + RGL Y+H +
Sbjct: 73 HTKETLTFVFEYMHTDLAQYMIQHPGGLHP------YNVRLFMFQ-LLRGLAYIHGQH-- 123
Query: 196 PVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKL 255
+++RDLK N+L+ KL+DFGLA+ +++ S V T Y P+ G
Sbjct: 124 -ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD-VLLGAT 179
Query: 256 TAKS--DIFSFGVVLLELITGRPAMDD-SQGHERMLVDWVTL 294
S DI+ G + +E++ G+PA S E++ W L
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVL 221
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEK-EFLVEVLMLSLMRHPNLVHLIGYC 138
LG+G + V+KG+ T +VA+K++ +G + EV +L ++H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 139 AEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKI-AAGAARGLEYLHNKADPPV 197
LV+EY L+ L + + +KI RGL Y H + V
Sbjct: 74 HTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---V 125
Query: 198 IYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYAT-TGKLT 256
++RDLK N+L+ + KL+DFGLA+ K++ + V T Y P+ + + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYS 183
Query: 257 AKSDIFSFGVVLLELITGRP 276
+ D++ G + E+ +GRP
Sbjct: 184 TQIDMWGVGCIFFEMASGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-10
Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 33/212 (15%)
Query: 80 LGQGGFGAVYKGKLAETGQVVA---VKQLD-DTGFQGEKEFLVEVLMLSLMRHPNLVHLI 135
+G G FG V ++ T VA VK+L + + + EFL + +++HPN++ +
Sbjct: 3 IGNGWFGKVLLSEIY-TDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 136 GYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADP 195
G C E LLV+EY LG L+ +L + ++A A G+ ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN-- 119
Query: 196 PVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP---------TGDKSHVSTRVMGTHGYCA 246
++ DL N L K+ D+G+ GP T D V R + A
Sbjct: 120 -FLHSDLALRNCFLTSDLTVKVGDYGI---GPSRYKEDYIETEDDKCVPLR------WLA 169
Query: 247 PEYAT-------TGKLTAKSDIFSFGVVLLEL 271
PE T + T S++++ GV L EL
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 6e-10
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVLMLSLMRHPNLVH--- 133
+G G FG V+ G+ VA+K++ + FQ K E+ ML +H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNV-FQNLVSCKRVFRELKMLCFFKHDNVLSALD 66
Query: 134 -----LIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEY 188
I E +Y L + H + ++P+ PL + RGL+Y
Sbjct: 67 ILQPPHIDPFEE------IYVVTELMQSDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKY 118
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE 248
LH+ +++RD+K GN+L+ K+ DFGLA+ + H++ V+ T Y APE
Sbjct: 119 LHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYYRAPE 174
Query: 249 YATTGK-LTAKSDIFSFGVVLLELITGR 275
+ T+ DI+S G + EL+ R
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 7e-10
Identities = 58/212 (27%), Positives = 87/212 (41%), Gaps = 35/212 (16%)
Query: 80 LGQGGFGAVYKGKLAETGQV----------VAVKQLDDTGFQGEKEFLVEVLMLSLMRHP 129
LGQG F +YKG L + V +K L F ++S + H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLSHK 61
Query: 130 NLVHLIGYC-AEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEY 188
+LV L G C + +V EY+ G L D L L W ++ +A A L Y
Sbjct: 62 HLVKLYGVCVRDENI--MVEEYVKFGPL-DVFLHREKNNVSLHW--KLDVAKQLASALHY 116
Query: 189 LHNKADPPVIYRDLKAGNILLGK-----GFHP--KLSDFGLAKFGPTGDKSHVSTRVMGT 241
L +K +++ ++ NIL+ + G+ P KLSD G+ + R+
Sbjct: 117 LEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI--- 168
Query: 242 HGYCAPEY--ATTGKLTAKSDIFSFGVVLLEL 271
+ APE LT +D +SFG LLE+
Sbjct: 169 -PWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-10
Identities = 59/232 (25%), Positives = 95/232 (40%), Gaps = 28/232 (12%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVH 133
+ D LG G G V+ ++ + VAVK++ T Q K L E+ ++ + H N+V
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 134 LIGYCAEGTQRL--------------LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIA 179
+ L +V EYM + L E PL
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM------ETDLANVLEQGPLSEEHARLFM 120
Query: 180 AGAARGLEYLHNKADPPVIYRDLKAGNILLG-KGFHPKLSDFGLAKFGPTGDKSHVSTRV 238
RGL+Y+H+ V++RDLK N+ + + K+ DFGLA+ SH
Sbjct: 121 YQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDP-HYSHKGYLS 176
Query: 239 MG--THGYCAPEYA-TTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
G T Y +P + T D+++ G + E++TG+P + E+M
Sbjct: 177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM 228
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-09
Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 22/204 (10%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMRHPNLVHLIG 136
+G G +G+V TG+ VA+K+L FQ E K E+ +L M+H N++ L+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRP-FQSEIFAKRAYRELTLLKHMQHENVIGLLD 81
Query: 137 YCAEGTQRLLVYEY---MPLGSLE-DHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK 192
++ MP + ++G PL + + GL+Y+H+
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGH-----PLSEDKVQYLVYQMLCGLKYIHSA 136
Query: 193 ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATT 252
+I+RDLK GN+ + + K+ DFGLA+ +V TR Y APE
Sbjct: 137 G---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILN 188
Query: 253 G-KLTAKSDIFSFGVVLLELITGR 275
DI+S G ++ E++TG+
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 72/252 (28%), Positives = 113/252 (44%), Gaps = 38/252 (15%)
Query: 40 PA-RRN-TLDDTLSAHENKNKENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETG 97
PA R+N +D+ L+ +E ++ R+L +++ +G+G FG V + +
Sbjct: 13 PALRKNKNIDNFLNRYEKIVRK----IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQ 68
Query: 98 QVVAVKQLD--------DTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL--V 147
+V A+K L D+ F F E +++ P +V L +CA + L V
Sbjct: 69 KVYAMKLLSKFEMIKRSDSAF-----FWEERDIMAFANSPWVVQL--FCAFQDDKYLYMV 121
Query: 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNI 207
EYMP G L + + K + T A L+ +H+ +I+RD+K N+
Sbjct: 122 MEYMPGGDLVNLMSNYDVPEKWAKFYT-----AEVVLALDAIHSMG---LIHRDVKPDNM 173
Query: 208 LLGKGFHPKLSDFGLA-KFGPTGDKSHVSTRVMGTHGYCAPEYATT----GKLTAKSDIF 262
LL K H KL+DFG K TG T V GT Y +PE + G + D +
Sbjct: 174 LLDKHGHLKLADFGTCMKMDETG-MVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWW 231
Query: 263 SFGVVLLELITG 274
S GV L E++ G
Sbjct: 232 SVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 66/237 (27%), Positives = 100/237 (42%), Gaps = 31/237 (13%)
Query: 53 HENKNKENTFTYRQLVAATDNFKDTNF---LGQGGFG----AVYKGKLAETGQVVAVKQL 105
+K K++ T ++D NF LG G FG A YK E VA+K+
Sbjct: 8 QLHKKKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKN---EDFPPVAIKRF 64
Query: 106 DDTGFQGEKEF---LVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLG 162
+ + +K+ E +L+ + HP V+L G + + LV E++ G L
Sbjct: 65 EKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-- 122
Query: 163 LTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL 222
K + AA EYL + ++YRDLK N+LL K K++DFG
Sbjct: 123 --RRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGF 177
Query: 223 AKFGPTGDKSHVSTR---VMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
AK V TR + GT Y APE +D ++ G+ + E++ G P
Sbjct: 178 AKV--------VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-09
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 32/213 (15%)
Query: 80 LGQGGFGAVYKGKLAETGQV-------VAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLV 132
LGQG F ++KG E G V +K LD + + F M+S + H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 133 HLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK 192
G C G + ++V EY+ GSL D L + + W ++++A A L +L +K
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSL-DTYLKKNKNLINISW--KLEVAKQLAWALHFLEDK 119
Query: 193 ADPPVIYRDLKAGNILLGK------GFHP--KLSDFGLAKFGPTGDKSHVSTRVMGTH-- 242
+ + ++ A N+LL + G P KLSD G++ T V + +
Sbjct: 120 G---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS---IT-----VLPKEILLERI 168
Query: 243 GYCAPEYATTGK-LTAKSDIFSFGVVLLELITG 274
+ PE + L+ +D +SFG L E+ +G
Sbjct: 169 PWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 74/282 (26%), Positives = 113/282 (40%), Gaps = 79/282 (28%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---------QGEKEFLVEVLM 122
D+F+ +G+G FG V + +TG + A+K+L + + E++ L E
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-- 58
Query: 123 LSLMRHPNLVHLIGYCA-EGTQRL-LVYEYMPLGSLEDHLLG---LTPEMKPLDWNTRMK 177
+P +V L Y + + L L+ EY+P G + L+ T E TR
Sbjct: 59 ----DNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE------TRFY 106
Query: 178 IAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG-DKSHVST 236
IA ++ +H I+RD+K N+LL H KLSDFGL TG KSH +
Sbjct: 107 IAE-TILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLC----TGLKKSHRTE 158
Query: 237 ----------------------------------RVM-----GTHGYCAPEYATTGKLTA 257
R + GT Y APE
Sbjct: 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNK 218
Query: 258 KSDIFSFGVVLLELITGRPAM--DDSQGHERMLVDWV-TLFF 296
+ D +S GV++ E++ G P D+ Q R +++W TL F
Sbjct: 219 ECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQF 260
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-09
Identities = 59/233 (25%), Positives = 103/233 (44%), Gaps = 42/233 (18%)
Query: 64 YRQLVAAT-----DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG---EKE 115
YRQ + T + +++ +G G +G+V Q VAVK+L FQ +
Sbjct: 2 YRQELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRP-FQSLIHARR 60
Query: 116 FLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLED-HLLGLTPEMKPLDWNT 174
E+ +L M+H N++ L+ + P S+E+ + + L + D N
Sbjct: 61 TYRELRLLKHMKHENVIGLLDV------------FTPATSIENFNEVYLVTNLMGADLNN 108
Query: 175 RMKIAAGA-----------ARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA 223
+K + RGL+Y+H+ +I+RDLK N+ + + ++ DFGLA
Sbjct: 109 IVKCQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLA 165
Query: 224 KFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKS-DIFSFGVVLLELITGR 275
+ +V+TR Y APE ++ DI+S G ++ EL+ G+
Sbjct: 166 RQADDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 6e-09
Identities = 56/228 (24%), Positives = 100/228 (43%), Gaps = 15/228 (6%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDD--TGFQGEKEFLVEVLMLSLMRHP 129
+K +G G +G V +G+ VA+K++ K L E+ +L +H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 130 NLVHLIG-YCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEY 188
N++ + G VY M L +E L + +PL RGL+Y
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDL--MESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKY 122
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH--VSTRVMGTHGYCA 246
+H+ A+ VI+RDLK N+L+ + ++ DFG+A+ + H T + T Y A
Sbjct: 123 IHS-AN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179
Query: 247 PEYA-TTGKLTAKSDIFSFGVVLLELITGRPAM---DDSQGHERMLVD 290
PE + + T D++S G + E++ GR + + ++++
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYVHQLKLILS 226
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 8e-09
Identities = 55/218 (25%), Positives = 82/218 (37%), Gaps = 44/218 (20%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQ--LDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGY 137
+ K K T +VAVK+ LD + K E++ ++HPN++ +
Sbjct: 10 FEDLMIVHLAKHK--PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 138 CAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIA---AGAARGLEYLHNKAD 194
++ +V M GS ED L PE P + IA L+Y+H+K
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-----ELAIAFILKDVLNALDYIHSKG- 121
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDF----GLAKFG---------PTGDKSHV---STRV 238
I+R +KA +ILL LS + K G P ++ S V
Sbjct: 122 --FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179
Query: 239 M--GTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITG 274
+ GY KSDI+S G+ EL G
Sbjct: 180 LQQNLQGY-----------NEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 9e-09
Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 30/223 (13%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEK--EFLVEVLMLSLMRHPNLVHLIG- 136
+G G FG V+ K T + K + G + + + ++EV ++ ++H N+V I
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 137 YCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADP 195
+ + Q+L ++ E+ G L ++ ++ + + I L Y HN D
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140
Query: 196 P----VIYRDLKAGNILLGKGFH-----------------PKLSDFGLAKFGPTGDKSHV 234
P V++RDLK NI L G K+ DFGL+K +H
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH- 199
Query: 235 STRVMGTHGYCAPEYA--TTGKLTAKSDIFSFGVVLLELITGR 275
+GT Y +PE T KSD+++ G ++ EL +G+
Sbjct: 200 --SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 70/283 (24%), Positives = 109/283 (38%), Gaps = 72/283 (25%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---------QGEKEFLVEVLM 122
++F +G+G FG V + +TG++ A+K L + + E++ L E
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE--- 57
Query: 123 LSLMRHPNLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAG 181
P +V L Y + Q L L+ E++P G L L+ + + TR +A
Sbjct: 58 ---SDSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV---TRFYMAE- 109
Query: 182 AARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL------------------- 222
+E +H I+RD+K NIL+ +G H KLSDFGL
Sbjct: 110 CVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQG 166
Query: 223 --AKFGPTGDKSHV-------------------STRVM-----GTHGYCAPEYATTGKLT 256
K S + R+M GT Y APE
Sbjct: 167 KSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226
Query: 257 AKSDIFSFGVVLLELITGRPAMDDSQGHE--RMLVDWV-TLFF 296
+ D +S G ++ E + G P HE R +++W TL+F
Sbjct: 227 QECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYF 269
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 61/233 (26%), Positives = 96/233 (41%), Gaps = 28/233 (12%)
Query: 55 NKNKENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLD-------- 106
N+ K+ R L ++++ +G+G FG V + T +V A+K L
Sbjct: 26 NRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRS 85
Query: 107 DTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGL-TP 165
D+ F F E +++ P +V L + +V EYMP G L + + P
Sbjct: 86 DSAF-----FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP 140
Query: 166 EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225
E + + +A A + ++H RD+K N+LL K H KL+DFG
Sbjct: 141 EKWARFYTAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMK 191
Query: 226 GPTGDKSHVSTRVMGTHGYCAPEYATT----GKLTAKSDIFSFGVVLLELITG 274
T V GT Y +PE + G + D +S GV L E++ G
Sbjct: 192 MNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 61/219 (27%), Positives = 94/219 (42%), Gaps = 33/219 (15%)
Query: 73 NFKDTNFLGQGGFGAVY---KGKLAETGQVVAVKQLDDTGF-QGEK---EFLVEVLMLSL 125
NF+ LG G +G V+ K +TG++ A+K L Q K E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 126 MRHPNLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAAR 184
+R + + Y + +L L+ +Y+ G + HL R + R
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY------------QRDNFSEDEVR 108
Query: 185 --------GLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVST 236
LE+LH ++YRD+K NILL H L+DFGL+K + +K +
Sbjct: 109 FYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS 165
Query: 237 RVMGTHGYCAPEYATTGKLTAKS-DIFSFGVVLLELITG 274
GT Y APE K+ D +S G+++ EL+TG
Sbjct: 166 -FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 64/212 (30%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 73 NFKDTNFLGQGGFGAVY---KGKLAETGQVVAVKQLDD-TGFQGEK---EFLVEVLMLSL 125
NF+ LG G +G V+ K ++G++ A+K L T Q K E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 126 MRH-PNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAAR 184
+R P LV L T+ L+ +Y+ G L HL + + +
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLS----QRERFKEQEVQIYSGEIVL 116
Query: 185 GLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGY 244
LE+LH +IYRD+K NILL H L+DFGL+K D+ + GT Y
Sbjct: 117 ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEY 172
Query: 245 CAPEYATTGKLTAKS--DIFSFGVVLLELITG 274
AP+ G D +S GV++ EL+TG
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 21/210 (10%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMRHPN 130
+++ +G G G V TGQ VA+K+L FQ K E++++ L+ H N
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRP-FQNVTHAKRAYRELVLMKLVNHKN 76
Query: 131 LVHLIGYCAEGTQRLL-----VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARG 185
++ L+ Q+ L VY M L D L +M LD + G
Sbjct: 77 IIGLLN--VFTPQKSLEEFQDVYLVM---ELMDANLCQVIQMD-LDHERMSYLLYQMLCG 130
Query: 186 LEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYC 245
+++LH+ +I+RDLK NI++ K+ DFGLA+ T S + T + T Y
Sbjct: 131 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 184
Query: 246 APEYATTGKLTAKSDIFSFGVVLLELITGR 275
APE DI+S G ++ E+I G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 60/206 (29%), Positives = 87/206 (42%), Gaps = 21/206 (10%)
Query: 87 AVYKGKLAETGQVVAVK--QLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQR 144
+VY + TG +V V+ L++ + K EV++ RHPN++ G+
Sbjct: 15 SVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL 74
Query: 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKA 204
++ +M GS L PE + I GA RGL YLH I+R++KA
Sbjct: 75 WVISPFMAYGSANSLLKTYFPE--GMSEALIGNILFGALRGLNYLHQNG---YIHRNIKA 129
Query: 205 GNILLGKGFHPKLSDFG-LAKFGPTGDKSHV-------STRVMGTHGYCAPEYATTG--K 254
+IL+ LS L G K+ V ST V+ + +PE
Sbjct: 130 SHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVL---PWLSPELLRQDLYG 186
Query: 255 LTAKSDIFSFGVVLLELITGR-PAMD 279
KSDI+S G+ EL TGR P D
Sbjct: 187 YNVKSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 4/98 (4%)
Query: 186 LEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYC 245
L+ +H++ +++RDLK+ NI L KL DFG +K V++ GT Y
Sbjct: 182 LDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238
Query: 246 APEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQ 282
APE + + K+D++S GV+L EL+T RP SQ
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ 276
|
Length = 478 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 69/263 (26%), Positives = 99/263 (37%), Gaps = 75/263 (28%)
Query: 80 LGQGGFGAV--------YKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVL--MLSLMRHP 129
LG G FG V K T VAVK L + E + L+ L ++ + H
Sbjct: 15 LGHGAFGKVVEASAFGIDKKSSCNT---VAVKMLKEGATASEHKALMSELKILIHIGNHL 71
Query: 130 NLVHLIGYCAEGTQRLLV-YEYMPLGSLEDHLL----GLTP--EMKPLDW---------- 172
N+V+L+G C + L+V E+ G+L + L +P E P
Sbjct: 72 NVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQS 131
Query: 173 NTRMKIAAGAARGLEYLHNK-----ADPP------------------------------- 196
+I AG A L +PP
Sbjct: 132 RVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLA 191
Query: 197 ---VIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHV---STRVMGTHGYCAPEYA 250
I+RDL A NILL + K+ DFGLA+ D +V S R+ + APE
Sbjct: 192 SRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGSARL--PLKWMAPESI 248
Query: 251 TTGKLTAKSDIFSFGVVLLELIT 273
T +SD++SFGV+L E+ +
Sbjct: 249 FDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 60/224 (26%), Positives = 91/224 (40%), Gaps = 41/224 (18%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDD---------TGFQGEKEFLVE--- 119
++F+ +G+G FG V KL +V A+K L+ F+ E++ LV
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 120 ----VLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTR 175
L + NL ++ Y G L L ED L PE +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTL------LSKFEDRL----PEDMARFYLAE 110
Query: 176 MKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVS 235
M IA + L Y+H RD+K NIL+ H +L+DFG + D + S
Sbjct: 111 MVIAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQS 160
Query: 236 TRVMGTHGYCAPEYATT-----GKLTAKSDIFSFGVVLLELITG 274
+ +GT Y +PE GK + D +S GV + E++ G
Sbjct: 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 5e-07
Identities = 36/114 (31%), Positives = 63/114 (55%), Gaps = 11/114 (9%)
Query: 164 TPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA 223
T + PLD + ++ ++ A+G+++L +K I+RD+ A N+LL G K+ DFGLA
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLA 259
Query: 224 KFGPTGDKSHVSTRVMGTH----GYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
+ D ++V V G + APE T +SD++S+G++L E+ +
Sbjct: 260 R-DIMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 7e-07
Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 17/98 (17%)
Query: 183 ARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK-------FGPTGDKSHVS 235
ARG+E+L ++ I+RDL A NILL + K+ DFGLA+ + GD + +
Sbjct: 183 ARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD-ARLP 238
Query: 236 TRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
+ M APE T +SD++SFGV+L E+ +
Sbjct: 239 LKWM------APESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 7e-07
Identities = 41/163 (25%), Positives = 75/163 (46%), Gaps = 17/163 (10%)
Query: 119 EVLMLSLMRHPNLVHLIGYCAEGTQRL----LVYEYMPLGSLEDHLLGLTPEMKPLDWNT 174
E+ L + N++ + G+ + L L+ EY G L + L + K L + T
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD----KEKDLSFKT 123
Query: 175 RMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHV 234
++ +A +GL L+ + P Y++L + + L+ + + K+ GL K + +V
Sbjct: 124 KLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNV 181
Query: 235 STRVMGTHGYCAPEYATT--GKLTAKSDIFSFGVVLLELITGR 275
+ V Y + + + T K DI+S GVVL E+ TG+
Sbjct: 182 NFMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 8e-07
Identities = 63/224 (28%), Positives = 95/224 (42%), Gaps = 41/224 (18%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLD--------DTG-FQGEKEFLVE--- 119
D+F+ +G+G FG V K+ TGQV A+K L+ +T F+ E++ LV
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 120 ----VLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTR 175
L + NL ++ Y G L L ED L PE +
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTL------LSKFEDRL----PEDMARFYLAE 110
Query: 176 MKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVS 235
M +A + L Y+H RD+K N+LL K H +L+DFG + D + S
Sbjct: 111 MVLAIDSVHQLGYVH---------RDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQS 160
Query: 236 TRVMGTHGYCAPEYAT-----TGKLTAKSDIFSFGVVLLELITG 274
+GT Y +PE G+ + D +S GV + E++ G
Sbjct: 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 8e-07
Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 27/224 (12%)
Query: 59 ENTFT----YRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE- 113
++TFT Y+QL +G G G V G VAVK+L FQ +
Sbjct: 14 DSTFTVLKRYQQLKP----------IGSGAQGIVCAAFDTVLGINVAVKKLSRP-FQNQT 62
Query: 114 --KEFLVEVLMLSLMRHPNLVHLIG-YCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPL 170
K E+++L + H N++ L+ + + + Y+ + L D L M+ L
Sbjct: 63 HAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM-ELMDANLCQVIHME-L 120
Query: 171 DWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230
D + G+++LH+ +I+RDLK NI++ K+ DFGLA+ T
Sbjct: 121 DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAC 174
Query: 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITG 274
+ + T + T Y APE DI+S G ++ EL+ G
Sbjct: 175 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 40/130 (30%), Positives = 51/130 (39%), Gaps = 21/130 (16%)
Query: 167 MKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA-KF 225
PL + I L YLH + +I+RD+K NI L + + L DFG A K
Sbjct: 179 SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKL 235
Query: 226 GPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285
D GT +PE AK+DI+S G+VL E
Sbjct: 236 DAHPDTPQCYGWS-GTLETNSPELLALDPYCAKTDIWSAGLVLFE--------------- 279
Query: 286 RMLVDWVTLF 295
M V VTLF
Sbjct: 280 -MSVKNVTLF 288
|
Length = 392 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 65/279 (23%), Positives = 99/279 (35%), Gaps = 83/279 (29%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---------QGEKEFLVEV---- 120
F +G G FG V + +T + A+K L + E++ L E
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 121 ---LMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHL--LGLTPEMKPLDWNTR 175
L S NL V +Y+P G + L LG+ E R
Sbjct: 63 VVKLYYSFQDKDNL-------------YFVMDYIPGGDMMSLLIRLGIFEEDL-----AR 104
Query: 176 MKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL---------AKFG 226
IA +E +H I+RD+K NIL+ + H KL+DFGL +K+
Sbjct: 105 FYIAE-LTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160
Query: 227 PTGDKSHVS---------------------------TRVM-----GTHGYCAPEYATTGK 254
GD R + GT Y APE
Sbjct: 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG 220
Query: 255 LTAKSDIFSFGVVLLELITGRPA-MDDSQGHERM-LVDW 291
T D +S GV+L E++ G+P + D+ ++ +++W
Sbjct: 221 YTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 13/96 (13%)
Query: 183 ARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTH 242
ARG+E+L +K ++RDL A N+LL +G K+ DFGLA+ D H S V
Sbjct: 247 ARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLAR-----DIMHDSNYVSKGS 298
Query: 243 GYC-----APEYATTGKLTAKSDIFSFGVVLLELIT 273
+ APE T SD++S+G++L E+ +
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 58/224 (25%), Positives = 90/224 (40%), Gaps = 41/224 (18%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDD---------TGFQGEKEFLVE--- 119
D+F+ +G+G FG V K+ T ++ A+K L+ F+ E+ LV
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 120 ----VLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTR 175
L + L ++ Y G L L ED L PE +
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTL------LSKFEDRL----PEDMARFYIAE 110
Query: 176 MKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVS 235
M +A + L Y+H RD+K N+LL H +L+DFG + D + S
Sbjct: 111 MVLAIHSIHQLHYVH---------RDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQS 160
Query: 236 TRVMGTHGYCAPEYATT-----GKLTAKSDIFSFGVVLLELITG 274
+ +GT Y +PE GK + D +S GV + E++ G
Sbjct: 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 52/180 (28%), Positives = 85/180 (47%), Gaps = 20/180 (11%)
Query: 100 VAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDH 159
V +K LD + F ++S + H +L + G C G++ ++V E++ G L D
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DV 105
Query: 160 LLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNIL-----LGKGFH 214
L P+ W ++ +A A L YL +K +++ ++ A NIL L +G
Sbjct: 106 CLRKEKGRVPVAW--KITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTS 160
Query: 215 P--KLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLEL 271
P KLSD G++ F + V R+ + APE G L+ +D +SFG LLE+
Sbjct: 161 PFIKLSDPGVS-FTALSREERVE-RI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 59/215 (27%), Positives = 91/215 (42%), Gaps = 27/215 (12%)
Query: 80 LGQGGFGAVYKG--KLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGY 137
+G+G +G VYK K + + A+KQ++ TG E+ +L ++HPN++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA--CREIALLRELKHPNVIALQKV 66
Query: 138 CAEGTQR----LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRM--KIAAGAARGLEYLHN 191
+ R L Y L + KP+ M + G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 192 KADPPVIYRDLKAGNIL-LGKG---FHPKLSDFGLAK-----FGPTGDKSHVSTRVMGTH 242
V++RDLK NIL +G+G K++D G A+ P D V T
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV----TF 179
Query: 243 GYCAPEYATTGKLTAKS-DIFSFGVVLLELITGRP 276
Y APE + K+ DI++ G + EL+T P
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 68/274 (24%), Positives = 108/274 (39%), Gaps = 66/274 (24%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQL--------DDTG-FQGEKEFLVEVLM 122
++F+ +G+G FG V + +TG V A+K L + G + E++ LVE
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 123 LSLMRHPNLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHLLG---LTPEMKPLDWNTRMKI 178
L +++ + Y + L L+ E++P G + L+ LT E T+ I
Sbjct: 61 LWVVK-------MFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEE------ETQFYI 107
Query: 179 AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA--------------- 223
A ++ +H I+RD+K N+LL H KLSDFGL
Sbjct: 108 AE-TVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNL 163
Query: 224 --------KFGPTGDKSHVST----------RVMGTHGYCAPEYATTGKLTAKSDIFSFG 265
F K T +GT Y APE D +S G
Sbjct: 164 NHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLG 223
Query: 266 VVLLELITGRPAM--DDSQGHERMLVDWV-TLFF 296
V++ E++ G P + Q + +++W TL F
Sbjct: 224 VIMYEMLIGYPPFCSETPQETYKKVMNWKETLIF 257
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 11/95 (11%)
Query: 183 ARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTH 242
A+G+ +L +K I+RDL A NILL G K+ DFGLA+ D ++V V G
Sbjct: 224 AKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR-DIRNDSNYV---VKGNA 276
Query: 243 ----GYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
+ APE T +SD++S+G++L E+ +
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 58/215 (26%), Positives = 91/215 (42%), Gaps = 27/215 (12%)
Query: 80 LGQGGFGAVYKGKL--AETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHL--- 134
+G+G +G VYK K + + A+KQ++ TG E+ +L ++HPN++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQKV 66
Query: 135 -IGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRM--KIAAGAARGLEYLHN 191
+ + L Y L + KP+ M + G+ YLH
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 192 KADPPVIYRDLKAGNIL-LGKG---FHPKLSDFGLAK-----FGPTGDKSHVSTRVMGTH 242
V++RDLK NIL +G+G K++D G A+ P D V T
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV----TF 179
Query: 243 GYCAPEYATTGKLTAKS-DIFSFGVVLLELITGRP 276
Y APE + K+ DI++ G + EL+T P
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 64/274 (23%), Positives = 106/274 (38%), Gaps = 66/274 (24%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---------QGEKEFLVEVLM 122
D+F+ +G+G FG V + +TG + A+K L + E++ LVE
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 123 LSLMRHPNLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHLLG---LTPEMKPLDWNTRMKI 178
+++ + Y + + L L+ E++P G + L+ L+ E + +
Sbjct: 61 AWVVK-------MFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQF-YIAETVL 112
Query: 179 AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA--------------- 223
A A L ++H RD+K N+LL H KLSDFGL
Sbjct: 113 AIDAIHQLGFIH---------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNL 163
Query: 224 KFGPTGD------------------KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFG 265
P D + ++ +GT Y APE D +S G
Sbjct: 164 THNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLG 223
Query: 266 VVLLELITGRPAM--DDSQGHERMLVDWV-TLFF 296
V++ E++ G P + Q R +++W TL F
Sbjct: 224 VIMYEMLIGYPPFCSETPQETYRKVMNWKETLVF 257
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 40/135 (29%), Positives = 65/135 (48%), Gaps = 21/135 (15%)
Query: 140 EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIY 199
E T+R + P S D L+G + ++ A G+E+L +K ++
Sbjct: 222 ERTRRDTLINESPALSYMD-LVGFSYQV---------------ANGMEFLASKN---CVH 262
Query: 200 RDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVST-RVMGTHGYCAPEYATTGKLTAK 258
RDL A N+L+ +G K+ DFGLA+ D +++S + APE T
Sbjct: 263 RDLAARNVLICEGKLVKICDFGLAR-DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTL 321
Query: 259 SDIFSFGVVLLELIT 273
SD++SFG++L E+ T
Sbjct: 322 SDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 35/111 (31%), Positives = 50/111 (45%), Gaps = 10/111 (9%)
Query: 176 MKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPK---LSDFGLAKFGPTGDKS 232
+ I R ++YLH +I+RD+KA NI + HP L DFG A F P +
Sbjct: 185 LAIERSVLRAIQYLHENR---IIHRDIKAENIFIN---HPGDVCLGDFGAACF-PVDINA 237
Query: 233 HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283
+ GT APE DI+S G+VL E+ T ++ + G
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDG 288
|
Length = 391 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 7e-06
Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 72 DNFKDTNFLGQGGFGAVYKGK---LAETGQV--VAVKQLDDTGFQGEKEFLV-EVLMLS- 124
DN + LG G FG V + L + V VAVK L + E+E L+ E+ +LS
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 125 LMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHL 160
L +H N+V+L+G C G L++ EY G L + L
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 7e-06
Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 13/203 (6%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMRHPN 130
+++ +G G G V A + VA+K+L FQ + K E++++ + H N
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKN 77
Query: 131 LVHLIG-YCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL 189
++ L+ + + + Y+ + L D L +M+ LD + G+++L
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVM-ELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHL 135
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEY 249
H+ +I+RDLK NI++ K+ DFGLA+ T S + T + T Y APE
Sbjct: 136 HSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEV 189
Query: 250 ATTGKLTAKSDIFSFGVVLLELI 272
DI+S G ++ E++
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 9e-06
Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 17/98 (17%)
Query: 183 ARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK-------FGPTGDKSHVS 235
A+G+E+L A I+RDL A NILL + K+ DFGLA+ + GD + +
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD-ARLP 244
Query: 236 TRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
+ M APE T +SD++SFGV+L E+ +
Sbjct: 245 LKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 58/259 (22%), Positives = 96/259 (37%), Gaps = 71/259 (27%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---------QGEKEFLVEVLMLS 124
F LG G FG V + +T + A+K L + E++ L E
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA---- 58
Query: 125 LMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRMKIAAGA 182
+ +V L + V +Y+P G + L +G+ PE + + A +
Sbjct: 59 --DNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVES 116
Query: 183 ARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL---------AKFGPTGD--- 230
+ ++H RD+K NIL+ + H KL+DFGL +K+ +GD
Sbjct: 117 VHKMGFIH---------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVR 167
Query: 231 ------------------------------KSH---VSTRVMGTHGYCAPEYATTGKLTA 257
+ H ++ ++GT Y APE T
Sbjct: 168 QDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 227
Query: 258 KSDIFSFGVVLLELITGRP 276
D +S GV+L E++ G+P
Sbjct: 228 LCDWWSVGVILYEMLVGQP 246
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 11/205 (5%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMRHPN 130
+++ +G G G V A + VA+K+L FQ + K E++++ + H N
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKN 84
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLH 190
++ L+ + + L D L +M+ LD + G+++LH
Sbjct: 85 IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLH 143
Query: 191 NKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYA 250
+ +I+RDLK NI++ K+ DFGLA+ T S + T + T Y APE
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 251 TTGKLTAKSDIFSFGVVLLELITGR 275
DI+S G ++ E+I G
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 31/88 (35%), Positives = 44/88 (50%), Gaps = 7/88 (7%)
Query: 80 LGQGGFGAVYKGKL-----AETGQVVAVKQLDDTGFQGEKEFLVEVL--MLSLMRHPNLV 132
LG G FG V + +++ VAVK L T EK+ L+ L M L H N+V
Sbjct: 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104
Query: 133 HLIGYCAEGTQRLLVYEYMPLGSLEDHL 160
+L+G C +G ++ EY G L D+L
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYL 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 5e-05
Identities = 32/88 (36%), Positives = 45/88 (51%), Gaps = 7/88 (7%)
Query: 80 LGQGGFGAV-----YKGKLAETGQVVAVKQLDDTGFQGEKEFLV-EVLMLS-LMRHPNLV 132
LG G FG V Y ++ VAVK L + E+E L+ E+ +LS L H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIV 102
Query: 133 HLIGYCAEGTQRLLVYEYMPLGSLEDHL 160
+L+G C G L++ EY G L + L
Sbjct: 103 NLLGACTVGGPTLVITEYCCYGDLLNFL 130
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 42/173 (24%), Positives = 72/173 (41%), Gaps = 40/173 (23%)
Query: 119 EVLMLSLMRHPNLVHL------IGYCAEGTQR--LLVYEYMPLGSLEDHLLGLTPEMKPL 170
E+L L + H N++ + TQ+ +Y +M + + + +PL
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD-------WKDRPL 265
Query: 171 DWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA------- 223
TR I +EY+H+K +I+RD+K NI L L DFG A
Sbjct: 266 LKQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER 321
Query: 224 ---KFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
+G G + S ++ GYC +DI+S G++LL++++
Sbjct: 322 EAFDYGWVGTVATNSPEILAGDGYCE-----------ITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 32/88 (36%), Positives = 45/88 (51%), Gaps = 7/88 (7%)
Query: 80 LGQGGFGAVYKGK---LAETGQV--VAVKQLDDTGFQGEKEFLVEVL--MLSLMRHPNLV 132
LG G FG V +G L+ + V VAVK L T EK+ L+ L M L H N+V
Sbjct: 45 LGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIV 104
Query: 133 HLIGYCAEGTQRLLVYEYMPLGSLEDHL 160
+L+G C + ++ EY G L ++L
Sbjct: 105 NLLGACTKSGPIYIITEYCFYGDLVNYL 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 31/111 (27%), Positives = 50/111 (45%), Gaps = 9/111 (8%)
Query: 163 LTPEMKPLDWNTRMKIAAGAAR---GLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSD 219
L ++PL ++ A A + ++Y+H + +I+RD+K N+L+ L D
Sbjct: 250 LGARLRPLG---LAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGD 303
Query: 220 FGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLE 270
FG A F + + GT APE T DI+S G+V+ E
Sbjct: 304 FGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 4e-04
Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 48/220 (21%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLML---------------S 124
LG+G +Y G L +D G+ EKE V + +L S
Sbjct: 3 LGRGTRTQIYAGILNYK------DDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETAS 56
Query: 125 LMR---HPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAG 181
+MR H ++V L G C + ++V E++ G L+ L + + L + K+A
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD---LFMHRKSDVLTTPWKFKVAKQ 113
Query: 182 AARGLEYLHNKADPPVIYRDLKAGNILLGK-------GFHPKLSDFGLAKFGPTG--DKS 232
A L YL +K +++ ++ NILL + G KLSD G+ P +
Sbjct: 114 LASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI----PITVLSRQ 166
Query: 233 HVSTRVMGTHGYCAPEYATTGK-LTAKSDIFSFGVVLLEL 271
R+ + APE K L+ +D +SFG L E+
Sbjct: 167 ECVERI----PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 7e-04
Identities = 56/253 (22%), Positives = 92/253 (36%), Gaps = 71/253 (28%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---------QGEKEFLVEVLMLSLMRHPN 130
LG G FG V +T + A+K L + E++ L E +
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA------DNEW 62
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRMKIAAGAARGLEY 188
+V L + V +Y+P G + L + + PE+ + + +A + + +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL---------AKFGPTGD--------- 230
+H RD+K NIL+ H KL+DFGL +K+ G
Sbjct: 123 IH---------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP 173
Query: 231 ------------------------KSH---VSTRVMGTHGYCAPEYATTGKLTAKSDIFS 263
K H ++ ++GT Y APE T D +S
Sbjct: 174 SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233
Query: 264 FGVVLLELITGRP 276
GV+L E++ G+P
Sbjct: 234 VGVILFEMLVGQP 246
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 299 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.98 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.89 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.83 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.82 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.8 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.78 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.77 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.77 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.72 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.6 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.58 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.57 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.57 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.56 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.51 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.48 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.48 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.4 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.39 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.37 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.23 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.21 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.2 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.18 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.07 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.96 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.88 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.88 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.87 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.84 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.68 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.67 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.64 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.61 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.55 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.54 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.52 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.52 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.44 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.43 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.34 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.3 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.25 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.21 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.19 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.1 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.04 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.95 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.8 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.73 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.69 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.69 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.63 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.6 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.59 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.57 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.55 | |
| PLN02236 | 344 | choline kinase | 97.35 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.35 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.35 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.1 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.08 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.07 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.92 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.6 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.58 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.41 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.3 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.2 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.02 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 95.85 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.76 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 95.54 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.42 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-53 Score=361.47 Aligned_cols=207 Identities=30% Similarity=0.501 Sum_probs=186.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
..+|...+.||.|+||+||+|+++.++..||||.+.+... ...+.+..|+.+|+.++|||||.+++++..+++.|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 4679999999999999999999999999999999987743 33466889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCC------CceEEccccc
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKG------FHPKLSDFGL 222 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~------~~~kl~Dfg~ 222 (299)
|||+||+|.+++. ..+.+++..+..++.||+.||++||+++ |+||||||.|||++.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~----~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIR----RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 9999999999995 4468999999999999999999999999 9999999999999765 5689999999
Q ss_pred cccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 223 AKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 223 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
|+.... .....+.+|+|.|||||++..+.|+.|+|+||+|+++|+|++|.+||...+..|-+
T Consensus 162 AR~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~ 223 (429)
T KOG0595|consen 162 ARFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELL 223 (429)
T ss_pred hhhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHH
Confidence 997653 33456689999999999999999999999999999999999999999977766544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-52 Score=348.59 Aligned_cols=205 Identities=32% Similarity=0.471 Sum_probs=186.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH---HHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.++|+++++||+|+||+||+++.+.+++.||+|++++...... +....|..+|..++||.||+++..|++...+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4679999999999999999999999999999999987654443 4578899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
+||+.||.|...|. +...+++..+..++.+|+.||.|||++| |+||||||+|||++.+|+++|+||||++...
T Consensus 104 ld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999994 5678999999999999999999999999 9999999999999999999999999998532
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
. ......+++||+.|||||++.+..|+..+|.||||+++||||+|.+||...+..
T Consensus 177 ~--~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~ 231 (357)
T KOG0598|consen 177 K--DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK 231 (357)
T ss_pred c--CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH
Confidence 2 223345589999999999999999999999999999999999999999988743
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-51 Score=348.01 Aligned_cols=211 Identities=28% Similarity=0.447 Sum_probs=184.1
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc-------HHHHHHHHHHHhhcCCCcceeeeeEEecCC
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG-------EKEFLVEVLMLSLMRHPNLVHLIGYCAEGT 142 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 142 (299)
..+.|.+.+.||+|+||.|-+|..+.|++.||||++.+..... ...+.+|+++|++++|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 5678999999999999999999999999999999997643322 234679999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCC---CceEEcc
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKG---FHPKLSD 219 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~---~~~kl~D 219 (299)
+.||||||++||+|.+.+. ..+.+.+.....++.||+.|+.|||++| |+||||||+|||++.+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecc
Confidence 9999999999999999995 4567888888999999999999999999 9999999999999876 6799999
Q ss_pred ccccccCCCCCCcccccccccCccccCcccccCCC---CCcccceehhHHHHHHHHhCCCCCCCCchhhhhhHH
Q 022309 220 FGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGK---LTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVD 290 (299)
Q Consensus 220 fg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~ 290 (299)
||+|+... ......+.+|||.|.|||++.+.. +..++|||||||+||.+|+|.+||.+.-.+..+..+
T Consensus 323 FGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ 393 (475)
T KOG0615|consen 323 FGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ 393 (475)
T ss_pred cchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHH
Confidence 99999743 345567789999999999997764 344789999999999999999999877665534333
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-51 Score=359.74 Aligned_cols=207 Identities=31% Similarity=0.521 Sum_probs=188.5
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
.+|...++||+|+|+.||.+++..+|+.||+|++.+... ...+.+.+|+++.+.++|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 569999999999999999999999999999999976432 33467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
|+|..++|..++. ..++++|.+++.+++||+.||.|||+++ |+|||||..|+|++++.+|||+|||||.....
T Consensus 98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999994 6689999999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
+. ....+.+|||.|.|||++.....+..+||||+||+||.||+|+|||+..+..+..
T Consensus 171 ~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety 227 (592)
T KOG0575|consen 171 DG--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY 227 (592)
T ss_pred cc--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH
Confidence 32 2344578999999999999999999999999999999999999999998766654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-52 Score=338.58 Aligned_cols=209 Identities=27% Similarity=0.400 Sum_probs=184.1
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeee-EEecCCe-eEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIG-YCAEGTQ-RLLV 147 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~-~~~~~~~-~~lv 147 (299)
.+|+++++||.|+||+||++.+..+|+.+|.|.++-... ...++...|+.+|++|+|||||++++ .+.++.. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 458999999999999999999999999999999874332 23467899999999999999999998 4544444 8999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA-DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~-~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
||+|++|+|..++...+...+.+++.++|.++.|++.||..+|++- ..-|+||||||.||+++.+|.+||+||||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999999888888899999999999999999999999831 012999999999999999999999999999975
Q ss_pred CCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
.. ......+.+|||.||+||.+.+.+|+.++||||+||++|||..-.+||.+.+
T Consensus 179 ~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n 232 (375)
T KOG0591|consen 179 SS--KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN 232 (375)
T ss_pred cc--hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc
Confidence 43 3344556899999999999999999999999999999999999999998874
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-50 Score=325.73 Aligned_cols=201 Identities=31% Similarity=0.435 Sum_probs=185.4
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH---HHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++++.||.|+||+|.+++.+.++..||+|++.+...... +-...|..+|+.+.||.++++++.+.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 569999999999999999999999999999999987665544 34667999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+.||.|.+++. ..+++++..++.++.||+.||+|||+++ |++|||||+|||+|++|.+||+|||.|+...
T Consensus 124 eyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~- 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS- 195 (355)
T ss_pred eccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec-
Confidence 9999999999994 5678999999999999999999999999 9999999999999999999999999998632
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
....+.+|||.|+|||++...+|+.++|.|||||++|||+.|.+||.+.++.
T Consensus 196 ----~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~ 247 (355)
T KOG0616|consen 196 ----GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI 247 (355)
T ss_pred ----CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH
Confidence 2355689999999999999999999999999999999999999999998873
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=333.11 Aligned_cols=199 Identities=31% Similarity=0.443 Sum_probs=179.8
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC-cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCe-eEEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG-FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQ-RLLVYE 149 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~-~~lv~e 149 (299)
++.+.+..||+|..|+||+++++.|++.+|+|++.... ....+++.+|+.+++.++||+||.+|++|..+.. ..|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 45777889999999999999999999999999995432 2334778999999999999999999999999884 999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN-KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+||+|.+++. ..+.+++.....++.+|++||.|||. ++ |+||||||+||||+..|.+||||||.+.....
T Consensus 159 YMDgGSLd~~~k----~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 159 YMDGGSLDDILK----RVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred hcCCCCHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 999999999995 44779999999999999999999996 77 99999999999999999999999999975432
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCC
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDS 281 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 281 (299)
....+++||..|||||.+.+..|+.++||||||++++||.+|+.||...
T Consensus 232 ----S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 232 ----SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred ----hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 2456688999999999999999999999999999999999999999876
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-49 Score=344.53 Aligned_cols=216 Identities=26% Similarity=0.403 Sum_probs=189.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH---HHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
..++|+++..||+|+||.||+|+-+.||+.||+|+++++..... +-+..|-.+|...++|+||++|..|++..++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 35789999999999999999999999999999999988754433 456789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
||||++||++..+|. ....+++..+..++.+++.|++.||+.| ++||||||+|+|||..|++||+||||+.-.
T Consensus 219 iMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence 999999999999994 6688999999999999999999999999 999999999999999999999999998421
Q ss_pred CC----------------------CCCcc-----------------------cccccccCccccCcccccCCCCCcccce
Q 022309 227 PT----------------------GDKSH-----------------------VSTRVMGTHGYCAPEYATTGKLTAKSDI 261 (299)
Q Consensus 227 ~~----------------------~~~~~-----------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Di 261 (299)
.. .+... .....+|||.|+|||++.+..|+..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 00 00000 0011369999999999999999999999
Q ss_pred ehhHHHHHHHHhCCCCCCCCchhhhh--hHHHH
Q 022309 262 FSFGVVLLELITGRPAMDDSQGHERM--LVDWV 292 (299)
Q Consensus 262 wslG~il~elltg~~pf~~~~~~~~~--~~~~~ 292 (299)
||||||+||||.|.|||..+++.+.. +..|.
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr 404 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR 404 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999999999999999999988765 66665
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=341.43 Aligned_cols=208 Identities=31% Similarity=0.461 Sum_probs=184.9
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH---HHHHHHHHHHhhc-CCCcceeeeeEEecCCee
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQR 144 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 144 (299)
....+|.+++.||+|+|++|++|+...+++.||||++.+.-...+ +.+..|-.+|.+| .||.|++++..|.++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 345679999999999999999999999999999999976543333 4467788888888 899999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
|+|+||+++|+|.++|. ..+.+++..++.++.||+.||+|||++| ||||||||+|||++++++++|+|||.|+
T Consensus 150 YFvLe~A~nGdll~~i~----K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIK----KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred EEEEEecCCCcHHHHHH----HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence 99999999999999995 5588999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCc---------cc--ccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 225 FGPTGDKS---------HV--STRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 225 ~~~~~~~~---------~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
........ .. ...++||..|.+||++.....++.+|||+||||+|+|+.|.|||...++
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne 292 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE 292 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH
Confidence 75433222 11 2458999999999999999999999999999999999999999988764
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-49 Score=321.06 Aligned_cols=208 Identities=27% Similarity=0.387 Sum_probs=183.0
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
+.|+.+.++|+|+||+||+|+++.||+.||||++..+.. .-.+-..+|+.+|++++|+|+|.++++|.....+++|||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 468889999999999999999999999999999965432 223557899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
||+. ++.+-+.. ....++...+..++.|++.|+.|+|+++ ++||||||+||||+.+|.+||||||.|+....
T Consensus 82 ~~dh-TvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCDH-TVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecch-HHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 9986 55555543 4467899999999999999999999999 99999999999999999999999999987653
Q ss_pred CCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhhhhh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 288 (299)
....++.++.|..|+|||++.+ -.|++++||||+||++.||++|++.|.+.++-+++.
T Consensus 154 -pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy 212 (396)
T KOG0593|consen 154 -PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLY 212 (396)
T ss_pred -CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHH
Confidence 2334566789999999999988 579999999999999999999999999998877763
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=336.33 Aligned_cols=211 Identities=28% Similarity=0.421 Sum_probs=186.0
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecC--Cee
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEG--TQR 144 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~ 144 (299)
...+.|+.++.||+|.||.||+|++..+|+.||+|+++..... ...-..+|+.+|++++||||+++.+...+. ..+
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 3456689999999999999999999999999999999865433 235678999999999999999999998776 689
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
|||||||+. +|..++.. ..-.|++.++..++.||+.||+|||++| |+|||||.+|||||++|.+||+|||||+
T Consensus 194 YlVFeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLAR 266 (560)
T ss_pred EEEEecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEecccccee
Confidence 999999985 88888852 3457999999999999999999999999 9999999999999999999999999999
Q ss_pred cCCCCCCcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 225 FGPTGDKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
++...... ..+..+-|+.|.|||++.|. .|+.++|+||.||||.||++|++.|.+.++.+++
T Consensus 267 ~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl 329 (560)
T KOG0600|consen 267 FYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQL 329 (560)
T ss_pred eccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHH
Confidence 77554433 34556689999999999886 5999999999999999999999999999988876
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=306.41 Aligned_cols=210 Identities=28% Similarity=0.439 Sum_probs=186.7
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
++|...++||+|.||.||+|++..+|+.||||+++.....+ .....+|++.|+.++|+||+.++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46888999999999999999999999999999998664443 3567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|++ .+|...+. .....++..++..++.+++.||+|||++. |+||||||.|+||+.+|.+||+|||+|+.+...
T Consensus 82 fm~-tdLe~vIk---d~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMP-TDLEVVIK---DKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred ecc-ccHHHHhc---ccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 997 59999986 46678999999999999999999999999 999999999999999999999999999986554
Q ss_pred CCcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhhhhhHH
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVD 290 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~ 290 (299)
+.... ..+-|..|.|||++.|. .|+..+||||.|||+.||+-|.|-|.+.++-+++-..
T Consensus 155 ~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~I 214 (318)
T KOG0659|consen 155 NRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKI 214 (318)
T ss_pred Ccccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHH
Confidence 43322 23678899999998775 5999999999999999999999999999988876544
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=340.05 Aligned_cols=201 Identities=34% Similarity=0.486 Sum_probs=185.1
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+..... .+.+.+|+++++.++||||+.++++|+....+|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57889999999999999999999999999999998765443 2568999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+.| +|..++. ....++++++..++.|++.||.|||+.+ |+|||+||.|||++.+|.+|+||||+|+.. .
T Consensus 82 ~a~g-~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m--~ 151 (808)
T KOG0597|consen 82 YAVG-DLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAM--S 151 (808)
T ss_pred hhhh-hHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhc--c
Confidence 9986 9999994 6688999999999999999999999999 999999999999999999999999999864 3
Q ss_pred CCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
.+........|||.|||||++.+++|+..+|+|||||++|||++|.|||...+
T Consensus 152 ~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s 204 (808)
T KOG0597|consen 152 TNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS 204 (808)
T ss_pred cCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH
Confidence 35556677889999999999999999999999999999999999999998765
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=333.78 Aligned_cols=207 Identities=31% Similarity=0.459 Sum_probs=183.7
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC----c-ccHHHHHHHHHHHhhcC-CCcceeeeeEEecCC
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG----F-QGEKEFLVEVLMLSLMR-HPNLVHLIGYCAEGT 142 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~-~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~ 142 (299)
...++|.+.+.||+|+||+|++|.+..+++.||+|++.+.. . ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34568999999999999999999999999999999876642 2 22355678999999998 999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCC-CceEEcccc
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKG-FHPKLSDFG 221 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~-~~~kl~Dfg 221 (299)
.+++||||+.||+|.+++. ...++.+.++..+++|++.|++|||++| |+||||||+|||++.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~----~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIV----NKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccc
Confidence 9999999999999999995 3578999999999999999999999999 9999999999999999 999999999
Q ss_pred ccccCCCCCCcccccccccCccccCcccccCCC-CC-cccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 222 LAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGK-LT-AKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 222 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
++.... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||++.+..
T Consensus 167 ~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~ 229 (370)
T KOG0583|consen 167 LSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP 229 (370)
T ss_pred cccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH
Confidence 998653 2334455678999999999999977 75 7899999999999999999999996543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=327.14 Aligned_cols=237 Identities=62% Similarity=1.033 Sum_probs=202.9
Q ss_pred CCCCccHHHHHHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeE
Q 022309 58 KENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGY 137 (299)
Q Consensus 58 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 137 (299)
....+++.++..++++|.....||+|+||.||+|.... +..||||.+.........+|..|+.++..++|||+|+++++
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 34568899999999999999999999999999999864 48999998876543314569999999999999999999999
Q ss_pred EecCC-eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceE
Q 022309 138 CAEGT-QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPK 216 (299)
Q Consensus 138 ~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~k 216 (299)
|.+.+ ..++|+||+..|+|.+.|...... +++|....+|+.+++.||+|||....++|+||||||+|||+|+++++|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 99988 599999999999999999753222 889999999999999999999998888999999999999999999999
Q ss_pred EccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCc-hhhhhhHHHHhhh
Q 022309 217 LSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ-GHERMLVDWVTLF 295 (299)
Q Consensus 217 l~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~~~~~~~ 295 (299)
|+|||+|+..+.. .........||..|+|||.+.....+.++|||||||++.||+||+.|.+... ..+..+.+|+.+.
T Consensus 218 lsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 218 LSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred ccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 9999999765431 1111111169999999999988889999999999999999999999988765 3445599999777
Q ss_pred hcC
Q 022309 296 FCM 298 (299)
Q Consensus 296 ~~~ 298 (299)
+.+
T Consensus 297 ~~~ 299 (361)
T KOG1187|consen 297 LEE 299 (361)
T ss_pred HHC
Confidence 654
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=335.77 Aligned_cols=209 Identities=31% Similarity=0.480 Sum_probs=185.9
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH---HHHHHHHHHHhhc-CCCcceeeeeEEecCCee
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQR 144 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 144 (299)
...++|.++++||+|+||+|+++..+.+++.||||++++...-.. +....|..+++.. +||.++.++.+|+..+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 345789999999999999999999999999999999998765443 4567788888877 599999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
|+||||+.||++..+. ....+++..+..++..|+.||+|||.+| |++||||.+|||+|..|.+||+|||+++
T Consensus 445 ~fvmey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 9999999999954433 4478999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 225 FGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
..... .....+++|||.|+|||++.+..|+.++|.|||||+|||||.|..||.+.+++|.+
T Consensus 517 e~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F 577 (694)
T KOG0694|consen 517 EGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF 577 (694)
T ss_pred ccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 64322 23566799999999999999999999999999999999999999999988876653
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=319.19 Aligned_cols=203 Identities=41% Similarity=0.626 Sum_probs=176.4
Q ss_pred CCCCCceecccCceEEEEEEECCCCcE-EEEEEcCCCCcccH--HHHHHHHHHHhhcCCCcceeeeeEEecCC-eeEEEE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQV-VAVKQLDDTGFQGE--KEFLVEVLMLSLMRHPNLVHLIGYCAEGT-QRLLVY 148 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~-vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~~lv~ 148 (299)
...+.+.||+|+||+||+|.+. |.. ||+|.+........ +.|.+|+.+|++++|||||++++++.+.. ..+|||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 3455566999999999999995 455 99999987654443 58999999999999999999999999887 789999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC-ceEEccccccccCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF-HPKLSDFGLAKFGP 227 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~-~~kl~Dfg~a~~~~ 227 (299)
||+++|+|.+++... ....++...++.++.||+.||.|||+++. ||||||||+|||++.++ ++||+|||+++...
T Consensus 120 Ey~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred EeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 999999999999743 45789999999999999999999999863 89999999999999997 99999999998643
Q ss_pred CCCCcccccccccCccccCccccc--CCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYAT--TGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
... .......||+.|||||++. ...|+.++||||||+++|||+||+.||.+...
T Consensus 196 ~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 196 ISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred ccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 221 2223367999999999999 56899999999999999999999999999987
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=324.22 Aligned_cols=209 Identities=28% Similarity=0.392 Sum_probs=185.4
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH-HHHHHHHHHHhhcC-CCcceeeeeEEecCC-eeE
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE-KEFLVEVLMLSLMR-HPNLVHLIGYCAEGT-QRL 145 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~-~~~ 145 (299)
...++|.++++||.|+||.||+|+...+++.||||.+++.....+ ..-++|+..|++++ ||||+++.+++.+.+ .++
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 345789999999999999999999999999999999986654433 34578999999998 999999999998888 899
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
+|||||+ .+|.+++.. +.+.+++..+..|+.||++||+|+|.+| ++|||+||+|||+..+..+||+|||+|+.
T Consensus 87 fVfE~Md-~NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeHHhhh-hhHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence 9999997 599999974 4689999999999999999999999999 99999999999999888999999999986
Q ss_pred CCCCCCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 226 GPTGDKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
.. ....++.++.|..|+|||++.. ..|+.+.||||+|||++|+.+-+|.|.+.++-+++
T Consensus 160 v~---SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi 219 (538)
T KOG0661|consen 160 VR---SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQI 219 (538)
T ss_pred cc---cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHH
Confidence 43 2234556788999999998755 46899999999999999999999999999887775
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-46 Score=305.82 Aligned_cols=210 Identities=27% Similarity=0.393 Sum_probs=182.7
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEecC--Cee
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAEG--TQR 144 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~ 144 (299)
...+.|+.+..|++|+||.||+|+++.|++.||+|.++...... .....+|+.+|.+++|||||.+-++.... +..
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 34567999999999999999999999999999999997553221 24568999999999999999999987543 468
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
|||||||+. +|..++... .+++...++..+..|++.|++|||.+. |+||||||+|+|++..|.+||+|||+|+
T Consensus 153 y~VMe~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR 225 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAR 225 (419)
T ss_pred eeeHHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhh
Confidence 999999974 899999753 378999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCcccccccccCccccCcccccCCC-CCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 225 FGPTGDKSHVSTRVMGTHGYCAPEYATTGK-LTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
.+... ....+..+-|..|.|||++.+.+ |+.+.||||+|||+.||+++.|.|.+.++-+++
T Consensus 226 ~ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl 287 (419)
T KOG0663|consen 226 EYGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQL 287 (419)
T ss_pred hhcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHH
Confidence 75433 23345567899999999998864 999999999999999999999999999887765
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=315.06 Aligned_cols=204 Identities=25% Similarity=0.406 Sum_probs=187.9
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHH---HHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE---FLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
...+|++.+.||+|.||.|-+|.....|+.||||.|++....++++ +.+|++++..|+||||+.+|++|...+...|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 3457999999999999999999999999999999999888777765 5789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
||||..+|.|++++. ..+.+++.++..+++||..|+.|+|.++ ++|||||.+|||+|.++++||.|||++.++
T Consensus 131 vMEYaS~GeLYDYiS----er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 131 VMEYASGGELYDYIS----ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEEecCCccHHHHHH----HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhh
Confidence 999999999999994 5678999999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCcccccccccCccccCcccccCCCC-CcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATTGKL-TAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
.. .....+++|+|.|.+||++.+.+| ++.+|.|||||+||.|+.|..||++.+.
T Consensus 204 ~~---~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh 258 (668)
T KOG0611|consen 204 AD---KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH 258 (668)
T ss_pred cc---ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH
Confidence 43 334567899999999999999887 5789999999999999999999998764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=324.53 Aligned_cols=204 Identities=30% Similarity=0.463 Sum_probs=186.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
...|....+||+|+-|.||.|....+++.||||++.......++-+..|+.+++..+|+|||.+++.|..++.+|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 45689999999999999999999999999999999988777788899999999999999999999999998999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
++||+|.+.+.. ..+++.++..+++++++||+|||.+| |+|||||.+|||++.+|.+||+|||++.......
T Consensus 352 m~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 352 MEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred cCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 999999999943 55899999999999999999999999 9999999999999999999999999987543322
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
....+.+|||+|||||++....|+++.||||||++++||+-|+|||-..++-
T Consensus 424 --~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl 475 (550)
T KOG0578|consen 424 --SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 475 (550)
T ss_pred --CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH
Confidence 2445578999999999999999999999999999999999999999876653
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=325.83 Aligned_cols=208 Identities=30% Similarity=0.458 Sum_probs=184.9
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC---cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG---FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
..|++++.||.|+-|.|.+|++..||+.+|||++.+.. ......+.+|+.+++.+.||||+++|+++.+...+|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45899999999999999999999999999999997652 223467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||++||.|++++. ..+++++.++..++.||+.|+.|+|..+ |+||||||+|+|++..+++||+|||+|....
T Consensus 92 Eyv~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~- 163 (786)
T KOG0588|consen 92 EYVPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV- 163 (786)
T ss_pred EecCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc-
Confidence 9999999999994 6689999999999999999999999999 9999999999999999999999999997633
Q ss_pred CCCcccccccccCccccCcccccCCCC-CcccceehhHHHHHHHHhCCCCCCCCchhhhhhHH
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKL-TAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVD 290 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~ 290 (299)
......+.||+|.|++||++.|.+| +.++||||.|||||.||||..||++.+ -..++..
T Consensus 164 --~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-ir~LLlK 223 (786)
T KOG0588|consen 164 --PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-IRVLLLK 223 (786)
T ss_pred --CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-HHHHHHH
Confidence 2334556789999999999999987 578999999999999999999999554 3334433
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=321.55 Aligned_cols=207 Identities=25% Similarity=0.369 Sum_probs=179.2
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc---cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++++.||+|+||+||+|.+..+++.||+|++.+.... ....+..|+.++..++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4689999999999999999999999999999999754221 2245778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||++|++|.+++. ....+++.++..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999995 3467899999999999999999999999 99999999999999999999999999864321
Q ss_pred CCCc---------------------------------ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCC
Q 022309 229 GDKS---------------------------------HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGR 275 (299)
Q Consensus 229 ~~~~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 275 (299)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1100 0012357999999999999999999999999999999999999
Q ss_pred CCCCCCchhh
Q 022309 276 PAMDDSQGHE 285 (299)
Q Consensus 276 ~pf~~~~~~~ 285 (299)
+||...+..+
T Consensus 234 ~Pf~~~~~~~ 243 (363)
T cd05628 234 PPFCSETPQE 243 (363)
T ss_pred CCCCCCCHHH
Confidence 9998776544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=307.90 Aligned_cols=216 Identities=28% Similarity=0.420 Sum_probs=189.6
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH-HHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE-KEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
..+.|++.++||.|..++||+|+...+++.||||++........ +.+.+|+..++.++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 34679999999999999999999999999999999987665554 78999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC-C
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG-P 227 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~-~ 227 (299)
.+|.+|++.+++..... ..+++..+..|+++++.||.|||.+| .+|||||+.||||+.+|.|||+|||.+-.. .
T Consensus 104 pfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 99999999999976443 55999999999999999999999999 999999999999999999999999986443 2
Q ss_pred CCCCcccc-cccccCccccCcccccC--CCCCcccceehhHHHHHHHHhCCCCCCCCchhhhhhHH
Q 022309 228 TGDKSHVS-TRVMGTHGYCAPEYATT--GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVD 290 (299)
Q Consensus 228 ~~~~~~~~-~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~ 290 (299)
.+...... ..++|+++|||||++.. ..|+.|+||||||++..||.+|..||....+...++..
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t 244 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT 244 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 22222222 55789999999999644 46999999999999999999999999999887766544
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=301.41 Aligned_cols=214 Identities=26% Similarity=0.377 Sum_probs=183.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCc-ceeeeeEEecCC-----
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPN-LVHLIGYCAEGT----- 142 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~----- 142 (299)
...|+.+++||+|+||+||+|+...+|+.||+|+++..... -.....+|+.+++.++|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34577788999999999999999999999999999765432 2356789999999999999 999999998777
Q ss_pred -eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccc
Q 022309 143 -QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFG 221 (299)
Q Consensus 143 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg 221 (299)
.+++||||++ -+|..++.........++...+..++.||+.||+|||+++ |+||||||.||+|+++|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 7899999997 5999999764433356778899999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhhhhhHH
Q 022309 222 LAKFGPTGDKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVD 290 (299)
Q Consensus 222 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~ 290 (299)
+|+....+.. .....++|..|+|||++.+. .|+...||||+|||++||+++.+.|.+.++.+++.-.
T Consensus 166 lAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~I 233 (323)
T KOG0594|consen 166 LARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRI 233 (323)
T ss_pred hHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHH
Confidence 9985443322 24456789999999999887 6999999999999999999999999999886665433
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=308.62 Aligned_cols=204 Identities=34% Similarity=0.524 Sum_probs=173.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCC--eeEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT--QRLLVY 148 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--~~~lv~ 148 (299)
..+|...+.||+|+||+||++.+..+|+..|+|.+........+.+.+|+.+|+.++|||||++++...... .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 345888899999999999999999889999999987653333566899999999999999999999754444 689999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC-CCceEEccccccccCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK-GFHPKLSDFGLAKFGP 227 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~-~~~~kl~Dfg~a~~~~ 227 (299)
||+++|+|.+++.... ..+++..+..+.+|+++||.|||++| |+|+||||+|||++. ++.+||+|||++....
T Consensus 96 Ey~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999996422 27999999999999999999999999 999999999999999 7999999999997543
Q ss_pred C-CCCcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCC
Q 022309 228 T-GDKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDD 280 (299)
Q Consensus 228 ~-~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~ 280 (299)
. ...........||+.|||||++... ...+++|||||||++.||+||.+||..
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 2 1122223357799999999999853 344599999999999999999999987
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=320.08 Aligned_cols=206 Identities=26% Similarity=0.325 Sum_probs=177.7
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc---cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
.|++++.||+|+||+||+|.+..+++.||+|++...... ....+..|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588999999999999999999999999999999754322 23467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|++|++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 82 ~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLI----RMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999985 3456889999999999999999999999 999999999999999999999999997532100
Q ss_pred CC---------------------------------------------cccccccccCccccCcccccCCCCCcccceehh
Q 022309 230 DK---------------------------------------------SHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSF 264 (299)
Q Consensus 230 ~~---------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 264 (299)
.. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 000123569999999999988889999999999
Q ss_pred HHHHHHHHhCCCCCCCCchhh
Q 022309 265 GVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 265 G~il~elltg~~pf~~~~~~~ 285 (299)
||++|||++|.+||...+..+
T Consensus 235 G~il~elltG~~Pf~~~~~~~ 255 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTE 255 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHH
Confidence 999999999999998776544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=320.80 Aligned_cols=207 Identities=27% Similarity=0.398 Sum_probs=177.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++++.||+|+||.||+|.+..+++.||+|++.+... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 468999999999999999999999999999999865322 12245778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||++|++|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999985 3467889999999999999999999999 99999999999999999999999999853211
Q ss_pred CCCc---------------------------------------------ccccccccCccccCcccccCCCCCcccceeh
Q 022309 229 GDKS---------------------------------------------HVSTRVMGTHGYCAPEYATTGKLTAKSDIFS 263 (299)
Q Consensus 229 ~~~~---------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Diws 263 (299)
.... ......+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 0001246999999999999889999999999
Q ss_pred hHHHHHHHHhCCCCCCCCchhh
Q 022309 264 FGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 264 lG~il~elltg~~pf~~~~~~~ 285 (299)
|||++|||++|.+||...+..+
T Consensus 234 lGvil~elltG~~Pf~~~~~~~ 255 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHE 255 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHH
Confidence 9999999999999998776544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=319.77 Aligned_cols=206 Identities=26% Similarity=0.341 Sum_probs=177.2
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
+|++++.||+|+||.||+|.+..+++.||+|++.+... .....+.+|+.+++.++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 58899999999999999999999999999999875432 123467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 82 ~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLI----RMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999985 3356889999999999999999999999 999999999999999999999999997422100
Q ss_pred C---------------------------------------------CcccccccccCccccCcccccCCCCCcccceehh
Q 022309 230 D---------------------------------------------KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSF 264 (299)
Q Consensus 230 ~---------------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 264 (299)
. ........+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 0000123468999999999999899999999999
Q ss_pred HHHHHHHHhCCCCCCCCchhh
Q 022309 265 GVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 265 G~il~elltg~~pf~~~~~~~ 285 (299)
||++|||++|.+||...+..+
T Consensus 235 Gvil~elltG~~Pf~~~~~~~ 255 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLE 255 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHH
Confidence 999999999999998776544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=318.11 Aligned_cols=207 Identities=26% Similarity=0.402 Sum_probs=178.7
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++++.||+|+||+||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 469999999999999999999999999999999975422 22245778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+.|++|.+++. ....+++.++..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLM----KKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999985 3356899999999999999999999999 99999999999999999999999999864321
Q ss_pred CCCc------------------------------------ccccccccCccccCcccccCCCCCcccceehhHHHHHHHH
Q 022309 229 GDKS------------------------------------HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELI 272 (299)
Q Consensus 229 ~~~~------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell 272 (299)
.... ......+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 0111246999999999999889999999999999999999
Q ss_pred hCCCCCCCCchhh
Q 022309 273 TGRPAMDDSQGHE 285 (299)
Q Consensus 273 tg~~pf~~~~~~~ 285 (299)
+|.+||...+..+
T Consensus 234 ~G~~Pf~~~~~~~ 246 (364)
T cd05599 234 VGYPPFCSDNPQE 246 (364)
T ss_pred cCCCCCCCCCHHH
Confidence 9999998776543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=319.47 Aligned_cols=207 Identities=25% Similarity=0.345 Sum_probs=178.0
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++++.||+|+||.||+|.+..+++.||+|++.+... .....+.+|+.+++.++||||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 369999999999999999999999999999999865322 22355778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+++++|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||+|.....
T Consensus 81 E~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLI----RLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 9999999999995 3456889999999999999999999999 99999999999999999999999999742210
Q ss_pred CC-----------------------------------------CcccccccccCccccCcccccCCCCCcccceehhHHH
Q 022309 229 GD-----------------------------------------KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVV 267 (299)
Q Consensus 229 ~~-----------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~i 267 (299)
.. .........||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 0000113469999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCchhh
Q 022309 268 LLELITGRPAMDDSQGHE 285 (299)
Q Consensus 268 l~elltg~~pf~~~~~~~ 285 (299)
+|+|++|.+||...+..+
T Consensus 234 lyell~G~~Pf~~~~~~~ 251 (376)
T cd05598 234 LYEMLVGQPPFLADTPAE 251 (376)
T ss_pred eeehhhCCCCCCCCCHHH
Confidence 999999999998877544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=302.09 Aligned_cols=207 Identities=29% Similarity=0.437 Sum_probs=176.7
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCC-----eeEEE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT-----QRLLV 147 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-----~~~lv 147 (299)
.|.-.+++|.|+||.||+|...++++.||||++-... .--.+|+.+|+.++|||||++..+|.... +..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 3677899999999999999999999999999885432 23356899999999999999998884322 44699
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCC-CceEEccccccccC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKG-FHPKLSDFGLAKFG 226 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~-~~~kl~Dfg~a~~~ 226 (299)
|||++ .+|.+.+.........++...+.-+..||+.||.|||+.+ |+||||||.|+|||.+ |.+||||||+|+..
T Consensus 101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 99997 6999999765556788899999999999999999999999 9999999999999976 99999999999876
Q ss_pred CCCCCcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhhhhhHH
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVD 290 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~ 290 (299)
..+..+ .++..|..|+|||++.+. .|+.+.||||.||++.||+-|.+.|.+.+..+++...
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eI 238 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEI 238 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHH
Confidence 544433 345678899999999886 5999999999999999999999999998887776543
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=312.01 Aligned_cols=202 Identities=30% Similarity=0.424 Sum_probs=179.5
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++++.||+|+||.||+|.+..+++.||+|++.+... .....+..|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 368999999999999999999999999999999875422 22356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||++|++|.+++. ....+++.++..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999994 3457899999999999999999999999 99999999999999999999999999975322
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
......|++.|+|||++.+..++.++|||||||++|||++|.+||...+..+
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~ 205 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH
Confidence 2234568999999999998899999999999999999999999998776544
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=312.64 Aligned_cols=207 Identities=31% Similarity=0.436 Sum_probs=185.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH-HHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE-KEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
..|+.+++||+|+||.||+|.+..+++.||+|++......++ +++.+|+.+|..++++||.++|+.|..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 457888999999999999999999999999999987665554 6789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+.||++.+.+. ....+.+.++..++++++.||.|||+++ .+|||||+.|||+..+|.+||+|||.+......
T Consensus 93 ~~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~- 164 (467)
T KOG0201|consen 93 CGGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNT- 164 (467)
T ss_pred hcCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeech-
Confidence 99999999994 4445588888999999999999999999 999999999999999999999999999754332
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
.....+++|||.|||||++....|+.++||||||++.+||++|.||+.+..+...+
T Consensus 165 -~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl 220 (467)
T KOG0201|consen 165 -VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL 220 (467)
T ss_pred -hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE
Confidence 22336689999999999999889999999999999999999999999988875443
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=311.19 Aligned_cols=201 Identities=30% Similarity=0.438 Sum_probs=178.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 3569999999999999999999999999999999865422 2235678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||+.+++|.+++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 97 ~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 97 LEFVVGGELFTHLR----KAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EcCCCCChHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 99999999999985 3456889999999999999999999999 9999999999999999999999999997542
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
.. .....|++.|+|||++.+..++.++|||||||++|+|++|.+||...+.
T Consensus 170 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 220 (329)
T PTZ00263 170 DR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220 (329)
T ss_pred CC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH
Confidence 21 1235689999999999998899999999999999999999999987654
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=306.04 Aligned_cols=207 Identities=29% Similarity=0.429 Sum_probs=174.4
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--------------cHHHHHHHHHHHhhcCCCcceeee
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--------------GEKEFLVEVLMLSLMRHPNLVHLI 135 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~h~nIv~~~ 135 (299)
..+.|++++.||+|.||.|-+|++..+++.||||++.+.... ..+...+|+.+++++.|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 357799999999999999999999999999999999653221 124788999999999999999999
Q ss_pred eEEecC--CeeEEEEEecCCCCHHHHhcccCCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCC
Q 022309 136 GYCAEG--TQRLLVYEYMPLGSLEDHLLGLTPEMKP-LDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKG 212 (299)
Q Consensus 136 ~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~-~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~ 212 (299)
++..+. +.+|||+|||..|.+...- ...+ +++.+++.+++.++.||+|||.+| |+||||||+|+|++.+
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 998654 5789999999988875433 3344 999999999999999999999999 9999999999999999
Q ss_pred CceEEccccccccCCCCC---CcccccccccCccccCcccccCCC----CCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 213 FHPKLSDFGLAKFGPTGD---KSHVSTRVMGTHGYCAPEYATTGK----LTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 213 ~~~kl~Dfg~a~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
|++||+|||.+.....+. ........+|||.|+|||++.+.. .+.+.||||+||+||.|+.|..||.+...-
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 999999999997653321 122233467999999999987632 456899999999999999999999877543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=307.46 Aligned_cols=201 Identities=29% Similarity=0.396 Sum_probs=178.0
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 468999999999999999999999999999999865322 22356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+.+++|.+++. ....+++..+..++.|++.||+|||+++ ++||||||+|||++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999985 3457899999999999999999999999 99999999999999999999999999975422
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
. .....|++.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 154 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~ 204 (291)
T cd05612 154 R-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF 204 (291)
T ss_pred C-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 1 12346899999999999888999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=311.21 Aligned_cols=208 Identities=38% Similarity=0.521 Sum_probs=177.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.+.++.++.||+|.||.||.|.+.. ...||+|.++.. ....++|.+|+.++++|+|+|||++++++..+..++|||||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 3446667889999999999999954 346999998765 34557889999999999999999999999998889999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
++.|+|.++|.. .....+...+.+.++.|||+|++||++++ +|||||..+||||+++..+||+|||||+.... +
T Consensus 283 m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d-~ 356 (468)
T KOG0197|consen 283 MPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGD-D 356 (468)
T ss_pred cccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCC-C
Confidence 999999999975 34577889999999999999999999999 99999999999999999999999999994322 2
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHER 286 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~ 286 (299)
.........-...|.|||++....++.+||||||||+||||+| |+.||...+..+.
T Consensus 357 ~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev 413 (468)
T KOG0197|consen 357 EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV 413 (468)
T ss_pred ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH
Confidence 2222222223457999999999999999999999999999999 8999988876654
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=314.45 Aligned_cols=206 Identities=24% Similarity=0.332 Sum_probs=177.5
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeE
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 145 (299)
...++|++.+.||+|+||.||+|.+..+++.||+|++.+... .....+.+|+.+++.++||||+++++++.++...+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 345789999999999999999999999999999999864321 22345778999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
+||||+++++|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++..
T Consensus 120 lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence 99999999999999842 35789999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCcccccccccCccccCcccccCCC----CCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 226 GPTGDKSHVSTRVMGTHGYCAPEYATTGK----LTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+.
T Consensus 192 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~ 252 (370)
T cd05621 192 MDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL 252 (370)
T ss_pred cccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH
Confidence 432111 1123457999999999986643 78899999999999999999999987664
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=309.80 Aligned_cols=208 Identities=31% Similarity=0.439 Sum_probs=187.2
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH---HHHHHHHHHHhhcC-CCcceeeeeEEecCCeeE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMR-HPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~ 145 (299)
....|++.+.||.|.||.||+|+.+.+|+.+|+|.+.+...... ..+.+|+.+|+.+. |||||.++++|.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 45679999999999999999999999999999999987665443 58999999999998 999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCC----CceEEcccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKG----FHPKLSDFG 221 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~----~~~kl~Dfg 221 (299)
+|||++.||.|.+.+... .+++..+..++.|++.++.|||+.| |+||||||+|+|+... +.++++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999643 3999999999999999999999999 9999999999999543 579999999
Q ss_pred ccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhhhh
Q 022309 222 LAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288 (299)
Q Consensus 222 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 288 (299)
++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||...+..+..+
T Consensus 185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~ 248 (382)
T KOG0032|consen 185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL 248 (382)
T ss_pred CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH
Confidence 9987654 334556789999999999999999999999999999999999999999988665544
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=308.13 Aligned_cols=198 Identities=31% Similarity=0.394 Sum_probs=172.9
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCcc---cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCC
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLG 154 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~ 154 (299)
+.||+|+||.||+|.+..+++.||+|++++.... ....+.+|+.+++.++||||+++++++...+..++||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999999999999999998754221 2245778999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCccc
Q 022309 155 SLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHV 234 (299)
Q Consensus 155 ~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~ 234 (299)
+|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~ 151 (323)
T cd05571 81 ELFFHLS----RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GAT 151 (323)
T ss_pred cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCc
Confidence 9999884 3467899999999999999999999999 999999999999999999999999998743211 112
Q ss_pred ccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 235 STRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 235 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
.....|++.|+|||++.+..++.++|||||||++|||++|..||...+..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~ 201 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 201 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH
Confidence 23456999999999999989999999999999999999999999876644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=294.34 Aligned_cols=213 Identities=32% Similarity=0.418 Sum_probs=185.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH---HHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.+.|++++.||+|.-|+||++....++..+|+|++.+...... .....|..||..++||.++.+|..|+.+...+++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 3458888999999999999999999999999999987655443 3466789999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
||||.||+|..+++. ...+.+++..+..++.+++-||+|||-.| ||.|||||+||||.++|++.|+||.|+....
T Consensus 156 meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 999999999998875 34577999999999999999999999999 9999999999999999999999998874210
Q ss_pred C---------------------------------CCC---------------------cccccccccCccccCcccccCC
Q 022309 228 T---------------------------------GDK---------------------SHVSTRVMGTHGYCAPEYATTG 253 (299)
Q Consensus 228 ~---------------------------------~~~---------------------~~~~~~~~g~~~y~aPE~~~~~ 253 (299)
. ... ......++||..|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 000 0111236799999999999999
Q ss_pred CCCcccceehhHHHHHHHHhCCCCCCCCchhhhhh
Q 022309 254 KLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288 (299)
Q Consensus 254 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 288 (299)
..+.++|+|+|||++||||.|..||.+.+.++++.
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~ 345 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR 345 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHH
Confidence 99999999999999999999999999999887754
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=314.75 Aligned_cols=211 Identities=30% Similarity=0.481 Sum_probs=180.5
Q ss_pred HHHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEecCCee
Q 022309 67 LVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQR 144 (299)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 144 (299)
.....+...+.+.||+|.||+||+|.+-.+ ||||++....... .+.|..|+.++++-+|-||+-+.+++..+..
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred cccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 334445577889999999999999998543 9999997655443 3789999999999999999999999999877
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
.||+.||+|-+|+.++.. ....|...+.+.|++|+++|+.|||.++ |+|||||..|||+.+++.|||+||||+.
T Consensus 463 AIiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred eeeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 999999999999999974 4477899999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCcccccccccCccccCcccccCC---CCCcccceehhHHHHHHHHhCCCCCCCCchhhhhh
Q 022309 225 FGPTGDKSHVSTRVMGTHGYCAPEYATTG---KLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 288 (299)
.-.............|...|||||++..+ +|+..+||||||+++|||+||..||. .+..++++
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIi 602 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQII 602 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheE
Confidence 54443333444445688899999998654 68999999999999999999999999 55555544
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=315.74 Aligned_cols=206 Identities=27% Similarity=0.402 Sum_probs=179.5
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcC-C-----CcceeeeeEEecCCe
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMR-H-----PNLVHLIGYCAEGTQ 143 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~nIv~~~~~~~~~~~ 143 (299)
...+|++++.||+|+||.|.+|.+..|++.||||+++....- -.....|+.+|..++ | -|||+++++|...++
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 344799999999999999999999999999999999765322 234566899999886 3 489999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCC--CceEEcccc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKG--FHPKLSDFG 221 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~--~~~kl~Dfg 221 (299)
+|||+|.+. .+|.+++.. ....+++...++.++.||+.||..||..+ |||+||||+|||+... ..+||+|||
T Consensus 263 lciVfELL~-~NLYellK~--n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 263 LCIVFELLS-TNLYELLKN--NKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred eeeeehhhh-hhHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecc
Confidence 999999995 699999986 45577999999999999999999999999 9999999999999654 379999999
Q ss_pred ccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 222 LAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 222 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
+|..... .. ..++.+..|+|||++.|.+|+.+.||||||||++||++|.|.|.+.++.+++
T Consensus 337 SSc~~~q----~v-ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl 397 (586)
T KOG0667|consen 337 SSCFESQ----RV-YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQL 397 (586)
T ss_pred cccccCC----cc-eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHH
Confidence 9986422 12 2567888999999999999999999999999999999999999999987775
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=313.80 Aligned_cols=207 Identities=25% Similarity=0.381 Sum_probs=178.8
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++++.||+|+||.||+|.+..+++.||+|++..... .....+..|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 468899999999999999999999999999999865321 22356778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||++|++|.+++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999999984 3467899999999999999999999999 99999999999999999999999999864321
Q ss_pred CCC---------------------------------cccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCC
Q 022309 229 GDK---------------------------------SHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGR 275 (299)
Q Consensus 229 ~~~---------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 275 (299)
... .......+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 100 00112346999999999999999999999999999999999999
Q ss_pred CCCCCCchhh
Q 022309 276 PAMDDSQGHE 285 (299)
Q Consensus 276 ~pf~~~~~~~ 285 (299)
+||...+..+
T Consensus 234 ~Pf~~~~~~~ 243 (360)
T cd05627 234 PPFCSETPQE 243 (360)
T ss_pred CCCCCCCHHH
Confidence 9998776544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=310.30 Aligned_cols=201 Identities=27% Similarity=0.402 Sum_probs=176.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCC-cEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETG-QVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 356999999999999999999876554 6899998864322 223567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
||||+.+++|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++...
T Consensus 109 v~Ey~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 999999999999995 3457899999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.
T Consensus 182 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 233 (340)
T PTZ00426 182 DT-----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233 (340)
T ss_pred CC-----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH
Confidence 22 12245699999999999888899999999999999999999999987654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=298.63 Aligned_cols=202 Identities=32% Similarity=0.459 Sum_probs=176.0
Q ss_pred CCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc---cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
|+..+.||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.++|+||+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 77889999999999999999999999999998754322 234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+.+++|.+.+... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999998887532 2346899999999999999999999999 9999999999999999999999999997643221
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
......|++.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 206 (285)
T cd05631 157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206 (285)
T ss_pred ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence 12234689999999999999999999999999999999999999986553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=311.32 Aligned_cols=209 Identities=25% Similarity=0.328 Sum_probs=178.9
Q ss_pred HHHHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCC
Q 022309 66 QLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT 142 (299)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 142 (299)
......++|++.+.||+|+||.||+|.+..+++.||+|++.+... .....+.+|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 344456789999999999999999999999999999999864321 22345778999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccc
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL 222 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~ 222 (299)
..++||||++|++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999843 45788999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccCccccCcccccCCC----CCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 223 AKFGPTGDKSHVSTRVMGTHGYCAPEYATTGK----LTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 223 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
+....... ........||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+.
T Consensus 189 a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 252 (371)
T cd05622 189 CMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (371)
T ss_pred eeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH
Confidence 97543221 11223456999999999986543 78899999999999999999999987664
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=302.87 Aligned_cols=197 Identities=31% Similarity=0.410 Sum_probs=172.1
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEcCCCC---cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCCCH
Q 022309 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTG---FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSL 156 (299)
Q Consensus 80 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L 156 (299)
||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999999999999999986532 12235677899999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCccccc
Q 022309 157 EDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVST 236 (299)
Q Consensus 157 ~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 236 (299)
.+++. ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~ 151 (312)
T cd05585 81 FHHLQ----REGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTN 151 (312)
T ss_pred HHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccc
Confidence 99985 3456899999999999999999999999 9999999999999999999999999997532211 1223
Q ss_pred ccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 237 RVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 237 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
...||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~ 200 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE 200 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH
Confidence 4569999999999999899999999999999999999999998765443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=295.17 Aligned_cols=210 Identities=29% Similarity=0.409 Sum_probs=181.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCC--CcccHHHHHHHHHHHhhcCCCcceeeeeEEec-----CC
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDT--GFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAE-----GT 142 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-----~~ 142 (299)
....|..++.||+|+||.|..|.+..+|+.||||++... .....+...+|+.+|+.++|+||+.+++.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 345677789999999999999999999999999999743 23344678999999999999999999999854 34
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccc
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL 222 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~ 222 (299)
..|+|+|+| +.+|...+. ....++...+..++.|++.||.|+|+.+ |+||||||+|++++.+..+||+|||+
T Consensus 100 DvYiV~elM-etDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHH-hhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence 679999999 468999884 4455999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 223 AKFGPTGDKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 223 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
|+...........+..+.|..|.|||++.. ..|+...||||+|||+.|||+|++.|.+.+..+++
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql 237 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQL 237 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHH
Confidence 987543333334456788999999998744 57999999999999999999999999999887665
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=303.94 Aligned_cols=198 Identities=30% Similarity=0.414 Sum_probs=172.8
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCC
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLG 154 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~ 154 (299)
+.||+|+||.||++.+..+++.||+|++.+... .....+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999975422 22356788999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCccc
Q 022309 155 SLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHV 234 (299)
Q Consensus 155 ~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~ 234 (299)
+|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 151 (328)
T cd05593 81 ELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AAT 151 (328)
T ss_pred CHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccc
Confidence 9998884 3457899999999999999999999999 999999999999999999999999998753221 112
Q ss_pred ccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 235 STRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 235 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~ 201 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 201 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH
Confidence 23456999999999999889999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=303.78 Aligned_cols=199 Identities=30% Similarity=0.399 Sum_probs=172.5
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCcc---cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCC
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLG 154 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~ 154 (299)
+.||+|+||.||++.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++...+..++||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999999999999999998754221 2245678999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCccc
Q 022309 155 SLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHV 234 (299)
Q Consensus 155 ~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~ 234 (299)
+|..++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++....... ..
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 151 (323)
T cd05595 81 ELFFHLS----RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--AT 151 (323)
T ss_pred cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cc
Confidence 9998884 3457899999999999999999999999 9999999999999999999999999987432211 11
Q ss_pred ccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 235 STRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 235 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||...+..+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~ 202 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 202 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 223568999999999998899999999999999999999999998766443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=282.38 Aligned_cols=207 Identities=32% Similarity=0.481 Sum_probs=185.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc---cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.++|++.+.||+|-||.||+|+.+.++-.||+|++-++... -+..+.+|+++.+.|+||||+++|++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 46799999999999999999999999999999999765422 246789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
+||...|+|...|.. .....+++..++.++.|++.||.|+|.++ |+||||||+|+|++..+.+||+|||-+-..+
T Consensus 101 lEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999999964 24467899999999999999999999999 9999999999999999999999999986532
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
.....+.+||..|.+||...+..++..+|+|++|++.||++.|.+||...+..+.
T Consensus 176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et 230 (281)
T KOG0580|consen 176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET 230 (281)
T ss_pred ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH
Confidence 3334567899999999999999999999999999999999999999998885544
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=309.22 Aligned_cols=207 Identities=30% Similarity=0.401 Sum_probs=180.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++++.||+|+||+||+|.+..+++.||+|++..... .....+..|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 469999999999999999999999999999999875422 23356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+.+++|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999999953 367899999999999999999999999 99999999999999999999999999975433
Q ss_pred CC---------------------------CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCC
Q 022309 229 GD---------------------------KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDS 281 (299)
Q Consensus 229 ~~---------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 281 (299)
.. .........||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 22 001122356899999999999999999999999999999999999999887
Q ss_pred chhh
Q 022309 282 QGHE 285 (299)
Q Consensus 282 ~~~~ 285 (299)
+..+
T Consensus 234 ~~~~ 237 (350)
T cd05573 234 TLQE 237 (350)
T ss_pred CHHH
Confidence 6543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=301.89 Aligned_cols=204 Identities=31% Similarity=0.452 Sum_probs=175.1
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCC-cceeeeeEEecCCeeEEEE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHP-NLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~-nIv~~~~~~~~~~~~~lv~ 148 (299)
+|++++.||+|+||.||+|.+..+++.||+|++.+... .....+..|+.++..+.|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 48889999999999999999999999999999875422 2235577888899888764 6888999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+++++|.+++. ....+++.++..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999884 3356889999999999999999999999 99999999999999999999999999864322
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.. .......|++.|+|||++.+..++.++|||||||++|+|++|.+||...+..+
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~ 208 (324)
T cd05587 154 GG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208 (324)
T ss_pred CC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 11 12234568999999999999899999999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=308.14 Aligned_cols=206 Identities=25% Similarity=0.308 Sum_probs=176.8
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
..++|++.+.||+|+||.||+|.+..+++.||+|++.+... .....+..|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 34679999999999999999999999999999999864321 223457789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
||||++||+|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++...
T Consensus 121 v~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 9999999999998843 45788999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCCcccccccccCccccCcccccCC----CCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATTG----KLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|.+||...+..
T Consensus 193 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~ 253 (370)
T cd05596 193 DANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253 (370)
T ss_pred cCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH
Confidence 32211 122345699999999998653 3788999999999999999999999876653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=296.77 Aligned_cols=207 Identities=27% Similarity=0.385 Sum_probs=176.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
.++|++.+.||+|+||.||+|.+..+++.||+|+++..... ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 35799999999999999999999999999999998754322 23467789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+.+ +|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 84 YLDS-DLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CCCc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 9975 89988853 2345788999999999999999999999 999999999999999999999999999753322
Q ss_pred CCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
.. ......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~ 212 (288)
T cd07871 157 TK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE 212 (288)
T ss_pred Cc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 11 1223467899999998865 5689999999999999999999999987765443
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=301.45 Aligned_cols=203 Identities=29% Similarity=0.408 Sum_probs=174.4
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc---cHHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEEEE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
+|++++.||+|+||.||+|.+..+++.||+|++.+.... ....+..|..++..+ .|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 488899999999999999999999999999998754322 223456677777766 5899999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+++++|.+.+. ....+++.++..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999999884 3356889999999999999999999999 99999999999999999999999999974322
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
.. .......||+.|+|||++.+..++.++|||||||++|||++|..||...+..
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~ 207 (323)
T cd05616 154 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 207 (323)
T ss_pred CC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH
Confidence 11 1223456899999999999999999999999999999999999999877654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=316.66 Aligned_cols=209 Identities=23% Similarity=0.250 Sum_probs=181.7
Q ss_pred CCCCCceecccCceEEEEEEECCC-CcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEec
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAET-GQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYM 151 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 151 (299)
.|.+.+.||+|++|.||+|....+ ++.||+|.+..........+..|+.+++.++||||+++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 489999999999999999998777 7889999876554444456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCC
Q 022309 152 PLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231 (299)
Q Consensus 152 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~ 231 (299)
+|++|.+++........++++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988643344567899999999999999999999999 99999999999999999999999999986543322
Q ss_pred cccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 232 SHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~ 277 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR 277 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 22334467999999999999889999999999999999999999999876543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=289.08 Aligned_cols=205 Identities=27% Similarity=0.402 Sum_probs=180.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
..+.|++-+.||+|.|+.|+++.+..+|+.+|+|.+..... .+-+++.+|+.+.+.++||||+++.+.+.+....|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 45678899999999999999999999999999998864332 3457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC---CCceEEccccccc
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK---GFHPKLSDFGLAK 224 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~---~~~~kl~Dfg~a~ 224 (299)
+|++.|++|..-|. ....+++..+...++||++||.|+|.++ |+|||+||.|+++.. ..-+||+|||+|.
T Consensus 89 Fe~m~G~dl~~eIV----~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 89 FDLVTGGELFEDIV----AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EecccchHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEE
Confidence 99999999987774 2356788999999999999999999999 999999999999953 4569999999998
Q ss_pred cCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 225 FGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
... ....-...+|||.|||||++...+|+.++|||+.||+||-||.|.+||.+.+.+
T Consensus 162 ~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~ 218 (355)
T KOG0033|consen 162 EVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 218 (355)
T ss_pred EeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH
Confidence 654 222334467999999999999999999999999999999999999999986644
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=306.05 Aligned_cols=209 Identities=30% Similarity=0.399 Sum_probs=187.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEecCCe-eEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQ-RLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~-~~lv 147 (299)
.++|..++.+|+|+||.+++++++.+++.|++|.+....... ......|+.+++++.|||||.+++.|.+++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 367999999999999999999999999999999997654433 3467889999999999999999999998888 8999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|+|++||++.+.+...+ ...+++..+..++.|++.|+.|||+++ |+|||||+.|||+++++.|+|+|||+|+...
T Consensus 83 m~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcC
Confidence 99999999999997533 467899999999999999999999998 9999999999999999999999999999754
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
... ....+++||+.|+.||++.+.+|+.++|||||||++|||++-+++|...+-.+-
T Consensus 158 ~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L 214 (426)
T KOG0589|consen 158 PED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL 214 (426)
T ss_pred Cch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH
Confidence 432 345567899999999999999999999999999999999999999998875443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=303.29 Aligned_cols=212 Identities=29% Similarity=0.421 Sum_probs=173.2
Q ss_pred hcCCCCCceecccCceEEEEEEE-----CCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhc-CCCcceeeeeEEecCC-
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKL-----AETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGT- 142 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~- 142 (299)
.++|++.+.||+|+||.||+|.+ ..+++.||+|++...... ....+.+|+.++..+ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46799999999999999999975 234568999998754322 235688999999999 8999999999887644
Q ss_pred eeEEEEEecCCCCHHHHhcccCCC--------------------------------------------------------
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTPE-------------------------------------------------------- 166 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~-------------------------------------------------------- 166 (299)
.++++|||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 578999999999999998642110
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcccccccccCccc
Q 022309 167 --MKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGY 244 (299)
Q Consensus 167 --~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y 244 (299)
..++++.++..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||+++...............+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 235788899999999999999999999 999999999999999999999999999754322221122233466789
Q ss_pred cCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 245 CAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 245 ~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
+|||++.+..++.++|||||||++|||++ |..||......+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~ 284 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE 284 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH
Confidence 99999988889999999999999999997 999998765443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=300.93 Aligned_cols=201 Identities=29% Similarity=0.455 Sum_probs=172.2
Q ss_pred CCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHH---hhcCCCcceeeeeEEecCCeeEEE
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLML---SLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l---~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
|++++.||+|+||.||+|.+..+++.||+|++++... ...+.+..|+.++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 6788999999999999999999999999999975421 1224566666554 456899999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||+++++|...+. ...+++.+++.++.||+.||+|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 81 ~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 99999999998873 256899999999999999999999999 9999999999999999999999999986432
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
... .......|++.|+|||.+.+..++.++|||||||++|+|++|..||...+..
T Consensus 153 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~ 207 (324)
T cd05589 153 GFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE 207 (324)
T ss_pred CCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH
Confidence 211 1223457999999999999989999999999999999999999999876643
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=295.89 Aligned_cols=206 Identities=25% Similarity=0.353 Sum_probs=176.9
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 4699999999999999999999999999999998754322 23567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+.++.+..+.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 999876655442 3356899999999999999999999999 999999999999999999999999999764322
Q ss_pred CCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.. .......|++.|+|||++.+..++.++|||||||++|+|++|.+||...+..+
T Consensus 154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~ 208 (287)
T cd07848 154 SN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID 208 (287)
T ss_pred cc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 21 12223568999999999988889999999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=299.31 Aligned_cols=198 Identities=33% Similarity=0.499 Sum_probs=169.2
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhh-cCCCcceeeeeEEecCCeeEEEEEecCC
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSL-MRHPNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~-l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
+.||+|+||.||+|.+..+++.||+|+++.... ...+.+..|..++.. .+||||+++++++..++..++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999875421 222345566666654 4899999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcc
Q 022309 154 GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233 (299)
Q Consensus 154 ~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~ 233 (299)
++|.+++. ....+++.++..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++....... .
T Consensus 81 g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~ 151 (316)
T cd05592 81 GDLMFHIQ----SSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G 151 (316)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence 99999885 3356899999999999999999999999 9999999999999999999999999997532222 2
Q ss_pred cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 234 VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~ 202 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED 202 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH
Confidence 223456899999999999889999999999999999999999999876653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=302.07 Aligned_cols=206 Identities=24% Similarity=0.273 Sum_probs=176.2
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++.+.||+|+||.||++++..+++.||+|++.+... .....+..|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 479999999999999999999999999999999865321 12244778899999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+.||+|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999963 2356889999999999999999999999 99999999999999999999999999975432
Q ss_pred CCCcccccccccCccccCcccccC-----CCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATT-----GKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
... .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~ 214 (331)
T cd05624 155 DGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (331)
T ss_pred CCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH
Confidence 211 11223569999999999865 45788999999999999999999999876543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=296.64 Aligned_cols=204 Identities=26% Similarity=0.377 Sum_probs=174.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 46799999999999999999999999999999998754322 23457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+. ++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 688887753 3356889999999999999999999999 999999999999999999999999998743221
Q ss_pred CCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
. .......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.....
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 209 (303)
T cd07869 157 S--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD 209 (303)
T ss_pred C--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 1 12233468899999998865 4578899999999999999999999987644
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=301.00 Aligned_cols=206 Identities=26% Similarity=0.299 Sum_probs=175.7
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++++.||+|+||.||++++..+++.||+|++.+... ...+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 469999999999999999999999999999999864221 22345788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+.|++|.+++.. ....+++.++..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999853 2356899999999999999999999999 99999999999999999999999999865332
Q ss_pred CCCcccccccccCccccCcccccC-----CCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATT-----GKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
... .......|++.|+|||++.. ..++.++|||||||++|+|++|..||...+..
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~ 214 (331)
T cd05597 155 DGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (331)
T ss_pred CCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH
Confidence 211 11122468999999999863 45788999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=302.04 Aligned_cols=198 Identities=32% Similarity=0.406 Sum_probs=171.5
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCcc---cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCC
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLG 154 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~ 154 (299)
+.||+|+||.||++.+..+++.||+|++.+.... ....+..|+.++..++||||+++++++...+..++||||+.++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999999999999999999754222 2245678899999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcc
Q 022309 155 SLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN-KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233 (299)
Q Consensus 155 ~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~ 233 (299)
+|.+++. ....+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.++|+|||++....... .
T Consensus 81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~ 151 (325)
T cd05594 81 ELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--A 151 (325)
T ss_pred cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--c
Confidence 9998884 34578999999999999999999997 78 9999999999999999999999999987432211 1
Q ss_pred cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 234 VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
......|++.|+|||++.+..++.++|||||||++|+|++|..||...+.+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~ 202 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 202 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH
Confidence 122356999999999998889999999999999999999999999876654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=298.95 Aligned_cols=199 Identities=31% Similarity=0.455 Sum_probs=171.1
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEEEEEecCC
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
+.||+|+||.||+|.+..+++.||+|++.+... .....+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999999999999999999875422 2224566788888765 799999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcc
Q 022309 154 GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233 (299)
Q Consensus 154 ~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~ 233 (299)
++|...+. ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~ 151 (321)
T cd05591 81 GDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--V 151 (321)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--c
Confidence 99998884 3456889999999999999999999999 9999999999999999999999999987532211 1
Q ss_pred cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 234 VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
......|++.|+|||++.+..++.++|||||||++|+|++|.+||...+..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~ 203 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD 203 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH
Confidence 2234568999999999998899999999999999999999999998776543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=303.61 Aligned_cols=206 Identities=27% Similarity=0.356 Sum_probs=177.7
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++.+.||+|+||.||+|.+..+++.||+|+++.... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 468999999999999999999999999999999975432 22355788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 99999999999963 2357899999999999999999999999 99999999999999999999999999976433
Q ss_pred CCCcccccccccCccccCccccc------CCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYAT------TGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
.... ......||+.|+|||++. +..++.++|||||||++|+|++|..||...+..
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~ 215 (330)
T cd05601 155 NKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA 215 (330)
T ss_pred CCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH
Confidence 2221 222346899999999986 456788999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=298.06 Aligned_cols=199 Identities=31% Similarity=0.461 Sum_probs=170.7
Q ss_pred CceecccCceEEEEEEEC---CCCcEEEEEEcCCCCc----ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 77 TNFLGQGGFGAVYKGKLA---ETGQVVAVKQLDDTGF----QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
++.||+|+||.||+++.. .+++.||+|++..... .....+..|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 367999999999999874 4688999999875321 223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+.+++|.+++. ....+.+..+..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 81 YLSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 999999999984 3456788999999999999999999999 999999999999999999999999998743221
Q ss_pred CCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
. .......|++.|+|||++.+..++.++|||||||++|||++|.+||...+..
T Consensus 154 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~ 206 (323)
T cd05584 154 G--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK 206 (323)
T ss_pred C--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH
Confidence 1 1223356899999999998888999999999999999999999999876643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=298.34 Aligned_cols=199 Identities=31% Similarity=0.472 Sum_probs=170.9
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEEEEEecCC
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
+.||+|+||.||+|++..+++.||+|++.+... .....+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999875321 2234566788888765 799999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcc
Q 022309 154 GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233 (299)
Q Consensus 154 ~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~ 233 (299)
++|.+++. ....+++..+..++.|++.||+|||+++ ++||||||+|||++.++.++|+|||++...... ..
T Consensus 81 g~L~~~i~----~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~ 151 (320)
T cd05590 81 GDLMFHIQ----KSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GK 151 (320)
T ss_pred chHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CC
Confidence 99999884 3357899999999999999999999999 999999999999999999999999998743211 11
Q ss_pred cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 234 VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
......|++.|+|||++.+..++.++|||||||++|+|++|..||...+..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~ 203 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD 203 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH
Confidence 2234568999999999998889999999999999999999999998776543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=299.18 Aligned_cols=207 Identities=25% Similarity=0.281 Sum_probs=175.8
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++.+.||+|+||.||++.+..+++.||+|++.+... .....+..|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468999999999999999999999999999999864321 12244778899999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+.+|+|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999953 2356899999999999999999999999 99999999999999999999999999864322
Q ss_pred CCCcccccccccCccccCccccc-----CCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYAT-----TGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.. ........||+.|+|||++. ...++.++|||||||++|||++|..||...+..+
T Consensus 155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~ 215 (332)
T cd05623 155 DG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215 (332)
T ss_pred CC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH
Confidence 11 11222356999999999985 3457889999999999999999999998766433
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=297.85 Aligned_cols=203 Identities=29% Similarity=0.429 Sum_probs=173.9
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcC-CCcceeeeeEEecCCeeEEEE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMR-HPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~ 148 (299)
+|+..+.||+|+||.||+|.+..+++.||+|++.+... ...+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 37788999999999999999999999999999875322 22245677888888775 577888999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||++|++|.+++. ....+++.++..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 Ey~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999884 3456899999999999999999999999 99999999999999999999999999874322
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~ 207 (323)
T cd05615 154 DG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED 207 (323)
T ss_pred CC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 11 1223356899999999999888999999999999999999999999877643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=297.90 Aligned_cols=194 Identities=27% Similarity=0.415 Sum_probs=169.1
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCcc---cHHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEEEEEecCC
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
+.||+|+||.||+|.+..+++.||+|++++.... ....+..|..++..+ +||||+++++++.+.+..++||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999754322 224577889999888 799999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcc
Q 022309 154 GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233 (299)
Q Consensus 154 ~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~ 233 (299)
++|.+++. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++...... ..
T Consensus 81 g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~ 151 (329)
T cd05588 81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GD 151 (329)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CC
Confidence 99998884 3467999999999999999999999999 999999999999999999999999998642111 11
Q ss_pred cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCC
Q 022309 234 VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDD 280 (299)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 280 (299)
......||+.|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 22345789999999999998999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=297.21 Aligned_cols=202 Identities=28% Similarity=0.379 Sum_probs=178.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
.++|++++.||+|+||.||++.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 4679999999999999999999999999999999875432 223568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK-ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
|+++++|.+++. ....+++..+..++.|++.||.|||+. + |+||||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 84 HMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred cCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 999999999985 335688999999999999999999985 6 99999999999999999999999999875422
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
. ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 157 ~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~ 207 (331)
T cd06649 157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA 207 (331)
T ss_pred c----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 1 12234689999999999988899999999999999999999999976654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=297.35 Aligned_cols=198 Identities=32% Similarity=0.440 Sum_probs=168.7
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCcc---cHHHHHHHHH-HHhhcCCCcceeeeeEEecCCeeEEEEEecCC
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVL-MLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
+.||+|+||+||+|.+..+++.||+|++.+.... ....+..|.. +++.++||||+++++.+.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999999999999999998653221 2233444544 56778999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcc
Q 022309 154 GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233 (299)
Q Consensus 154 ~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~ 233 (299)
++|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~ 151 (323)
T cd05575 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SK 151 (323)
T ss_pred CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CC
Confidence 99999884 3457899999999999999999999999 999999999999999999999999998743221 11
Q ss_pred cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 234 VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
......|++.|+|||++.+..++.++|||||||++|+|++|.+||...+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~ 202 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA 202 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH
Confidence 223456899999999999989999999999999999999999999876643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=297.52 Aligned_cols=199 Identities=31% Similarity=0.417 Sum_probs=168.5
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHH-HHHhhcCCCcceeeeeEEecCCeeEEEEEecCC
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEV-LMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
+.||+|+||.||+|++..+++.||+|++.+... .....+..|. .+++.++||||+++++++...+..++||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 469999999999999999999999999865321 1223344444 456778999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcc
Q 022309 154 GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233 (299)
Q Consensus 154 ~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~ 233 (299)
++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 ~~L~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~ 151 (325)
T cd05602 81 GELFYHLQ----RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NG 151 (325)
T ss_pred CcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CC
Confidence 99999884 3456888999999999999999999999 999999999999999999999999998743221 11
Q ss_pred cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 234 VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
......|++.|+|||++.+..++.++|||||||++|+|++|.+||...+..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 203 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH
Confidence 2334569999999999999899999999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=296.26 Aligned_cols=198 Identities=33% Similarity=0.496 Sum_probs=169.8
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhh-cCCCcceeeeeEEecCCeeEEEEEecCC
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSL-MRHPNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~-l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
+.||+|+||.||+|.+..+++.||+|++++... ........|..++.. ++||||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999999999999999975421 223456667777765 4899999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcc
Q 022309 154 GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233 (299)
Q Consensus 154 ~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~ 233 (299)
++|.+++. ....+++.++..++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++....... .
T Consensus 81 g~L~~~i~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05620 81 GDLMFHIQ----DKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--N 151 (316)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--C
Confidence 99999884 3356889999999999999999999999 9999999999999999999999999987432211 1
Q ss_pred cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 234 VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
......|++.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~ 202 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED 202 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 223456899999999999999999999999999999999999999876643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=298.36 Aligned_cols=199 Identities=32% Similarity=0.419 Sum_probs=169.2
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHH-HHhhcCCCcceeeeeEEecCCeeEEEEEecCC
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVL-MLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
+.||+|+||.||+|.+..+++.||+|++.+... .....+..|.. +++.++||||+++++.+..++..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999999999999999999865321 12234455544 56778999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcc
Q 022309 154 GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233 (299)
Q Consensus 154 ~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~ 233 (299)
++|...+. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~ 151 (325)
T cd05604 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SD 151 (325)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CC
Confidence 99998884 4467899999999999999999999999 999999999999999999999999998743211 11
Q ss_pred cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 234 VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
......|++.|+|||++.+..++.++|||||||++|+|++|.+||...+..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~ 203 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE 203 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH
Confidence 2234568999999999999899999999999999999999999998766443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=299.12 Aligned_cols=203 Identities=29% Similarity=0.445 Sum_probs=171.4
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC--cccHHHHHHHHHHHhhcCCCcceeeeeEEecC-----CeeE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG--FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG-----TQRL 145 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-----~~~~ 145 (299)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5889999999999999999999999999999987432 22335688999999999999999999987543 2479
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
+||||+. ++|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 81 lv~e~~~-~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 68998884 3456899999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCc-ccccccccCccccCcccccC--CCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 226 GPTGDKS-HVSTRVMGTHGYCAPEYATT--GKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 226 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
....... .......|++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~ 213 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 213 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh
Confidence 3222111 11233568999999999866 5789999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=296.81 Aligned_cols=197 Identities=31% Similarity=0.436 Sum_probs=168.0
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHH-HHHhhcCCCcceeeeeEEecCCeeEEEEEecCC
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEV-LMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
+.||+|+||.||+|++..+++.||+|++.+... .....+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999865322 1223445554 467888999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcc
Q 022309 154 GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233 (299)
Q Consensus 154 ~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~ 233 (299)
++|...+. ....+++.++..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++....... .
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 151 (321)
T cd05603 81 GELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--E 151 (321)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--C
Confidence 99998884 3456889999999999999999999999 9999999999999999999999999987432211 1
Q ss_pred cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 234 VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
......|++.|+|||++.+..++.++|||||||++|+|++|.+||...+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 201 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV 201 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH
Confidence 22345689999999999888899999999999999999999999987764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=294.73 Aligned_cols=198 Identities=34% Similarity=0.513 Sum_probs=169.8
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhh-cCCCcceeeeeEEecCCeeEEEEEecCC
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSL-MRHPNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~-l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
+.||+|+||.||+|.+..+++.||+|+++.... ........|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999875421 223445667777765 5999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcc
Q 022309 154 GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233 (299)
Q Consensus 154 ~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~ 233 (299)
++|.+++. ....+++.++..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++....... .
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05619 81 GDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--A 151 (316)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--C
Confidence 99999984 3356889999999999999999999999 9999999999999999999999999987432211 1
Q ss_pred cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 234 VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~ 202 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE 202 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH
Confidence 223456899999999999889999999999999999999999999876643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=289.82 Aligned_cols=198 Identities=30% Similarity=0.414 Sum_probs=171.9
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEcCCCCccc---HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCCCH
Q 022309 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG---EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSL 156 (299)
Q Consensus 80 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L 156 (299)
||+|+||+||++.+..+++.||+|.+....... .+.+..|+.+++.++||||+++.+++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999999999999999987543222 24567899999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCccccc
Q 022309 157 EDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVST 236 (299)
Q Consensus 157 ~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 236 (299)
.+.+.........+++..++.++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 9887544344567899999999999999999999999 99999999999999999999999999975433221 122
Q ss_pred ccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 237 RVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 237 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
...|++.|+|||.+.+..++.++|||||||++|+|++|..||...+
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 3568999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=296.37 Aligned_cols=193 Identities=28% Similarity=0.432 Sum_probs=167.7
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCcc---cHHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEEEEEecCC
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
+.||+|+||.||+|.+..+++.||+|++.+.... ....+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999764322 224567788888766 899999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcc
Q 022309 154 GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233 (299)
Q Consensus 154 ~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~ 233 (299)
++|..++. ....+++..++.++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~ 151 (329)
T cd05618 81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--D 151 (329)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--C
Confidence 99998884 3457899999999999999999999999 9999999999999999999999999987432111 1
Q ss_pred cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCC
Q 022309 234 VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMD 279 (299)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 279 (299)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 2234568999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=311.76 Aligned_cols=211 Identities=27% Similarity=0.323 Sum_probs=180.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCC------
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT------ 142 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~------ 142 (299)
.++|++.+.||+|+||+||+|.+..+++.||+|++...... ....+.+|+.++..++|+||+++++.+....
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 46899999999999999999999999999999998755332 2356788999999999999999988764332
Q ss_pred --eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccc
Q 022309 143 --QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDF 220 (299)
Q Consensus 143 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Df 220 (299)
..++||||+.+|+|.+++.........+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEec
Confidence 367999999999999998654444567999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 221 GLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 221 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
|+++...............||+.|+|||++.+..++.++|||||||++|||++|..||...+..
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~ 251 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME 251 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 9997644332222334467999999999999989999999999999999999999999876543
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=297.77 Aligned_cols=207 Identities=30% Similarity=0.419 Sum_probs=185.8
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH--HHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE--KEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
.-|.+.+.||+|.|.+|-+|++.-+|+.||||++.+...... ..+.+|+..++.++|||||++|++......+|+|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 458888999999999999999999999999999988765443 468899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEe-cCCCceEEccccccccCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL-GKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv-~~~~~~kl~Dfg~a~~~~~ 228 (299)
.-++|+|.++|.. ....+.+..+..++.||+.|+.|+|+.+ +|||||||+||.+ .+-|-+||.|||++..+.+
T Consensus 98 LGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999999999974 5578999999999999999999999999 9999999999976 5678999999999976655
Q ss_pred CCCcccccccccCccccCcccccCCCCC-cccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLT-AKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
+.+ ..+.+|++.|.|||++.+..|+ +++||||||||||.|++|++||+..++.|.+
T Consensus 172 G~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL 228 (864)
T KOG4717|consen 172 GKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL 228 (864)
T ss_pred cch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh
Confidence 433 4557899999999999999887 5689999999999999999999988887764
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=295.29 Aligned_cols=194 Identities=28% Similarity=0.415 Sum_probs=169.0
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCccc---HHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEEEEEecCC
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG---EKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
+.||+|+||.||+|.+..+++.||+|++.+..... ...+..|+.++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999997643222 24577888888877 699999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcc
Q 022309 154 GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233 (299)
Q Consensus 154 ~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~ 233 (299)
++|...+. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++....... .
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~ 151 (327)
T cd05617 81 GDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--D 151 (327)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--C
Confidence 99998884 3357899999999999999999999999 9999999999999999999999999987422111 1
Q ss_pred cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCC
Q 022309 234 VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDD 280 (299)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 280 (299)
......|++.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 22345799999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=302.61 Aligned_cols=190 Identities=33% Similarity=0.529 Sum_probs=169.8
Q ss_pred CCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCCC
Q 022309 76 DTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGS 155 (299)
Q Consensus 76 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~ 155 (299)
-++.||+|+.|.||+|+. .++.||||+++.- -..+++-|++|+||||+.+.++|.....++||||||..|.
T Consensus 128 ELeWlGSGaQGAVF~Grl--~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL--HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhccCcccceeeeec--cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 367899999999999998 5789999987532 2447888999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcccc
Q 022309 156 LEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVS 235 (299)
Q Consensus 156 L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~ 235 (299)
|.++| +..+++.......|..+|+.|+.|||.+. |||||||.-||||+.+..|||+|||.++.... . ...
T Consensus 199 L~~VL----ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~--~-STk 268 (904)
T KOG4721|consen 199 LYEVL----KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSD--K-STK 268 (904)
T ss_pred HHHHH----hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhh--h-hhh
Confidence 99999 46678999999999999999999999999 99999999999999999999999999975321 2 233
Q ss_pred cccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 236 TRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 236 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
-.++||..|||||++.+.+++.|+|||||||+|||||||+.||.+-+..
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss 317 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS 317 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh
Confidence 4578999999999999999999999999999999999999999887643
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=288.48 Aligned_cols=203 Identities=31% Similarity=0.449 Sum_probs=176.3
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc---HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG---EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
+|++.+.||+|+||.||++.+..+++.||+|++....... ...+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4888999999999999999999899999999987543222 2456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+.+++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999888532 2356899999999999999999999999 999999999999999999999999999754322
Q ss_pred CCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
. ......|++.|+|||++.+..++.++||||+||++|+|++|..||...+.
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~ 206 (285)
T cd05605 156 E---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206 (285)
T ss_pred C---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch
Confidence 1 11234689999999999888899999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=301.58 Aligned_cols=196 Identities=23% Similarity=0.280 Sum_probs=171.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
..+|++++.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+++.++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 4679999999999999999999999999999996532 3467899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+. ++|..++. ....+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.++|+|||+|.......
T Consensus 165 ~~-~~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 165 YK-TDLYCYLA----AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred CC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 85 68888884 3356889999999999999999999999 9999999999999999999999999996532211
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCC
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDS 281 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 281 (299)
........||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 237 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~ 286 (391)
T PHA03212 237 -ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK 286 (391)
T ss_pred -ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCc
Confidence 11223457999999999999889999999999999999999999887543
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=295.95 Aligned_cols=201 Identities=28% Similarity=0.388 Sum_probs=171.3
Q ss_pred CCCCCceecccCceEEEEEEEC---CCCcEEEEEEcCCCCc----ccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCee
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLA---ETGQVVAVKQLDDTGF----QGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQR 144 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 144 (299)
+|++++.||+|+||.||+++.. .+++.||+|++.+... ...+.+..|+.+++.+ +||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4889999999999999998874 4789999999865322 1224577899999998 589999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
++||||+.+++|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 99999999999999984 3456899999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCC
Q 022309 225 FGPTGDKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDS 281 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~ 281 (299)
........ ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus 154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred cccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 54322211 22235699999999998765 4788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=290.16 Aligned_cols=204 Identities=31% Similarity=0.464 Sum_probs=184.8
Q ss_pred CCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCC
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
|.++++||+|+||.||+|.++.+|..+|||.+... .+.+++.+|+.++.+++.|++|++|+.|.....+|||||||-.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 67789999999999999999999999999998765 4567899999999999999999999999998999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcc
Q 022309 154 GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233 (299)
Q Consensus 154 ~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~ 233 (299)
|+..+.+. .+.+++++.++..+++..+.||+|||... -+|||||..|||++.+|..||.|||.|.... +.-.
T Consensus 113 GSiSDI~R---~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLT--DTMA 184 (502)
T KOG0574|consen 113 GSISDIMR---ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLT--DTMA 184 (502)
T ss_pred CcHHHHHH---HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhh--hhHH
Confidence 99999986 35688999999999999999999999988 8999999999999999999999999997532 2333
Q ss_pred cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 234 VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
...++.|||.|||||++..-.|+.++||||||++..||..|+|||.+..+...+
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI 238 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI 238 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee
Confidence 445688999999999999999999999999999999999999999987765543
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=293.01 Aligned_cols=198 Identities=31% Similarity=0.476 Sum_probs=170.7
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEEEEEecCC
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
+.||+|+||+||+|.+..+++.||+|++++... .....+..|..+++.+ +||||+++++++.+.+..++||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999975422 2234567788888877 799999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcc
Q 022309 154 GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233 (299)
Q Consensus 154 ~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~ 233 (299)
++|.+.+. ....+++.++..++.|++.||+|||+++ ++||||||+||++++++.++|+|||++....... .
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 151 (318)
T cd05570 81 GDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--V 151 (318)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--C
Confidence 99999884 3357899999999999999999999999 9999999999999999999999999986422211 1
Q ss_pred cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 234 VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
......|++.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~ 202 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED 202 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH
Confidence 223356899999999999999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=323.33 Aligned_cols=213 Identities=27% Similarity=0.326 Sum_probs=185.4
Q ss_pred HHHHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC---cccHHHHHHHHHHHhhcCCCcceeeeeEEecCC
Q 022309 66 QLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG---FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT 142 (299)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 142 (299)
......++|.++++||+|+||.|.+++++.+++.||+|++.+.. ..+..-|..|-.++..-+.+-|+.+..+|.++.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 34445688999999999999999999999999999999998732 233466888999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccc
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL 222 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~ 222 (299)
++|+||+|++||+|..++. ...++++.-+++++..|+.||+-||+.| +|||||||+|||+|..|++||+|||.
T Consensus 149 ~LYlVMdY~pGGDlltLlS----k~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLS----KFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred ceEEEEecccCchHHHHHh----hcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence 9999999999999999994 3447999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccCccccCcccccC-----CCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 223 AKFGPTGDKSHVSTRVMGTHGYCAPEYATT-----GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 223 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
+-.... +........+|||.|.+||++.. +.|++.+|.||+||++||||.|..||+..+-.++
T Consensus 222 Clkm~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveT 289 (1317)
T KOG0612|consen 222 CLKMDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVET 289 (1317)
T ss_pred HHhcCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHH
Confidence 854332 22233445689999999999832 4689999999999999999999999988775554
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=278.45 Aligned_cols=209 Identities=26% Similarity=0.393 Sum_probs=175.9
Q ss_pred cHHHHHHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhc-CCCcceeeeeEEecC
Q 022309 63 TYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEG 141 (299)
Q Consensus 63 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 141 (299)
++.+....++ +.||+|+++.|-.+....++..||||++.+...-....+.+|++++..+ .|+||++++++|+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3555544443 5799999999999999999999999999988666678899999999998 699999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC---ceEEc
Q 022309 142 TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF---HPKLS 218 (299)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~---~~kl~ 218 (299)
..+|+|||.+.||+|...|. ....+++.++..+...|+.||.+||.+| |.|||+||+|||-.... -+|||
T Consensus 149 ~~FYLVfEKm~GGplLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQ----KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred ceEEEEEecccCchHHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeee
Confidence 99999999999999999995 4567999999999999999999999999 99999999999986543 48999
Q ss_pred cccccccCCCCCCc-----ccccccccCccccCccccc---C--CCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 219 DFGLAKFGPTGDKS-----HVSTRVMGTHGYCAPEYAT---T--GKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 219 Dfg~a~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~---~--~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
||.++.-......- ....+.+|+..|||||+.. + ..|+.++|.||||+|+|.||+|++||.+.-+
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 99887532211111 1123467999999999762 2 2589999999999999999999999976654
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=286.81 Aligned_cols=205 Identities=28% Similarity=0.415 Sum_probs=169.5
Q ss_pred cCCCCCceecccCceEEEEEEECC-CCcEEEEEEcCCCCccc--HHHHHHHHHHHhhc---CCCcceeeeeEEe-----c
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAE-TGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLM---RHPNLVHLIGYCA-----E 140 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l---~h~nIv~~~~~~~-----~ 140 (299)
++|++++.||+|+||.||+|.+.. ++..||+|.++...... ...+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 369999999999999999999854 46889999886543222 24556677776655 6999999999885 3
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccc
Q 022309 141 GTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDF 220 (299)
Q Consensus 141 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Df 220 (299)
....++|||++. ++|.+++... ....+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999996 5899988642 2345889999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 221 GLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 221 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
|++...... .......|++.|+|||++.+..++.++|||||||++|||++|.+||...+..+
T Consensus 155 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~ 216 (290)
T cd07862 155 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 216 (290)
T ss_pred cceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH
Confidence 999754322 22234568999999999988889999999999999999999999998876544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=295.53 Aligned_cols=199 Identities=30% Similarity=0.414 Sum_probs=171.8
Q ss_pred CceecccCceEEEEEEE---CCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEec
Q 022309 77 TNFLGQGGFGAVYKGKL---AETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYM 151 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 151 (299)
++.||+|+||.||++.+ ..+++.||+|++...... ....+..|+.+++.++||||+++++++.+++..++||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 36799999999999886 357899999999754322 2345678999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCC
Q 022309 152 PLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231 (299)
Q Consensus 152 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~ 231 (299)
.+++|.+++. ....+++.+++.++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 152 (318)
T cd05582 81 RGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE- 152 (318)
T ss_pred CCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-
Confidence 9999999984 3456899999999999999999999999 9999999999999999999999999987543221
Q ss_pred cccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 232 SHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
.......|++.|+|||.+.+..++.++|||||||++|+|++|..||...+..
T Consensus 153 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~ 204 (318)
T cd05582 153 -KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK 204 (318)
T ss_pred -CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH
Confidence 1223456899999999998888999999999999999999999999876643
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=292.81 Aligned_cols=202 Identities=26% Similarity=0.373 Sum_probs=177.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
.++|++.+.||+|+||.||+|.+..++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 4679999999999999999999999999999998875422 223568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK-ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
|+.+++|.+++. ....+++..+..++.|++.||.|||+. + ++||||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 84 HMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred cCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 999999999985 335688999999999999999999974 6 99999999999999999999999999875322
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
. ......|++.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 157 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 207 (333)
T cd06650 157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA 207 (333)
T ss_pred h----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch
Confidence 1 12234688999999999888899999999999999999999999976554
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=288.35 Aligned_cols=211 Identities=27% Similarity=0.463 Sum_probs=173.6
Q ss_pred hcCCCCCceecccCceEEEEEEECC----------------CCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCccee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAE----------------TGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVH 133 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~ 133 (299)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+...... ....+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3579999999999999999998532 3447999998764322 2356889999999999999999
Q ss_pred eeeEEecCCeeEEEEEecCCCCHHHHhcccC---------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 022309 134 LIGYCAEGTQRLLVYEYMPLGSLEDHLLGLT---------------PEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVI 198 (299)
Q Consensus 134 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~ 198 (299)
+++++.+.+..++||||+.+++|.+++.... .....+++.+++.++.|++.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999885321 11134677889999999999999999999 99
Q ss_pred ecCCCCCCEEecCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh--CCC
Q 022309 199 YRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT--GRP 276 (299)
Q Consensus 199 H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt--g~~ 276 (299)
||||||+|||++.++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999975433322222233446788999999988889999999999999999987 567
Q ss_pred CCCCCchh
Q 022309 277 AMDDSQGH 284 (299)
Q Consensus 277 pf~~~~~~ 284 (299)
||...+..
T Consensus 241 p~~~~~~~ 248 (304)
T cd05096 241 PYGELTDE 248 (304)
T ss_pred CCCcCCHH
Confidence 88765543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=302.54 Aligned_cols=205 Identities=26% Similarity=0.394 Sum_probs=170.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecC--------C
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG--------T 142 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--------~ 142 (299)
..+|++++.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467999999999999999999999999999999885432 2345799999999999999999876432 2
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC-ceEEcccc
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF-HPKLSDFG 221 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~-~~kl~Dfg 221 (299)
.+++||||+. ++|.+++.........+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 4679999997 4787777543345567899999999999999999999999 99999999999998664 79999999
Q ss_pred ccccCCCCCCcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 222 LAKFGPTGDKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 222 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
+|+...... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||...+..+.
T Consensus 217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 279 (440)
T PTZ00036 217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ 279 (440)
T ss_pred cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 997543222 12235689999999988664 689999999999999999999999988765544
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=296.88 Aligned_cols=213 Identities=29% Similarity=0.447 Sum_probs=175.1
Q ss_pred hhcCCCCCceecccCceEEEEEEECCC-----CcEEEEEEcCCCCcc-cHHHHHHHHHHHhhc-CCCcceeeeeEEecCC
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAET-----GQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGT 142 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~ 142 (299)
..++|++.+.||+|+||.||+|.+..+ +..||+|.++..... ....+.+|+.+++.+ +|+||+++++++....
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 345799999999999999999986433 357999999754322 235678899999999 8999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCC---------------------------------------------------------
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTP--------------------------------------------------------- 165 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------- 165 (299)
..++||||+.+|+|.+++.....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 99999999999999998853210
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCccccc
Q 022309 166 ---------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVST 236 (299)
Q Consensus 166 ---------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 236 (299)
...++++.+++.++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++.............
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 1135788899999999999999999999 9999999999999999999999999997543222211222
Q ss_pred ccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 237 RVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 237 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
...++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~ 322 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS 322 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH
Confidence 2335667999999988889999999999999999997 999998765443
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=282.15 Aligned_cols=205 Identities=30% Similarity=0.411 Sum_probs=183.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHH---HHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE---FLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.++|..+++||+|.||+|.+++.+.+++.||+|++++.......+ -..|-.+|...+||.+..+...|+..+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467889999999999999999999999999999998876555443 46688999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||..||.|.-.| ...+.+++..+..+-..|+.||.|||+++ ||.||||.+|.|++++|++||.|||+++...
T Consensus 247 MeyanGGeLf~HL----srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 247 MEYANGGELFFHL----SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEccCceEeeeh----hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence 9999999998888 35677899999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
. ......+++|||.|+|||++....|+..+|.|.+||++|||++|+.||...+.+
T Consensus 320 ~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~ 374 (516)
T KOG0690|consen 320 K--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE 374 (516)
T ss_pred c--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh
Confidence 2 223345689999999999999999999999999999999999999999987743
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=289.08 Aligned_cols=197 Identities=27% Similarity=0.395 Sum_probs=166.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
++|+.++.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 4577889999999999999999999999999998654322 235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+++++|.+. ....+..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 154 ~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 154 MDGGSLEGT--------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 999988643 23457788899999999999999999 9999999999999999999999999997543221
Q ss_pred CcccccccccCccccCcccccC-----CCCCcccceehhHHHHHHHHhCCCCCCCC
Q 022309 231 KSHVSTRVMGTHGYCAPEYATT-----GKLTAKSDIFSFGVVLLELITGRPAMDDS 281 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~ 281 (299)
.......|+..|+|||.+.. ...+.++|||||||++|||++|..||...
T Consensus 223 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 276 (353)
T PLN00034 223 --DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276 (353)
T ss_pred --ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 11223468999999998743 23456899999999999999999999743
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=311.81 Aligned_cols=214 Identities=34% Similarity=0.547 Sum_probs=183.1
Q ss_pred hcCCCCCceecccCceEEEEEEEC-----CCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLA-----ETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQR 144 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 144 (299)
..+-...+.||+|.||+||+|... .....||||.++..... ..++|.+|+.+++.++|||||+++++|.+++.+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 345666789999999999999863 23457999999877655 568999999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPE----------MKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFH 214 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~----------~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~ 214 (299)
+||+|||..|+|.++|...... ..+++..+.+.|+.||+.|++||-++. +|||||..+|.||+++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 9999999999999999743211 234889999999999999999999999 999999999999999999
Q ss_pred eEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhhhh
Q 022309 215 PKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHERM 287 (299)
Q Consensus 215 ~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~ 287 (299)
|||+|||+++.....+.........-..+|||||.|..++++.+|||||+||+|||+++ |..||.+..++|.+
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI 715 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI 715 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence 99999999985433333333323344678999999999999999999999999999999 99999998877653
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=314.57 Aligned_cols=210 Identities=25% Similarity=0.402 Sum_probs=177.7
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc---HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG---EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++.++||+|+||.||+|.+..+++.||+|++....... .+.+.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999999999999999997543222 356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccc
Q 022309 149 EYMPLGSLEDHLLGLTP-------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFG 221 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg 221 (299)
||++|++|.+++..... .....+...++.++.|++.||+|||+++ |+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998853211 1234566788999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCC----------------cccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 222 LAKFGPTGDK----------------SHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 222 ~a~~~~~~~~----------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
++........ ........||+.|+|||.+.+..++.++|||||||++|||+||.+||...+..
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9975421110 01112346999999999999999999999999999999999999999775543
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=293.53 Aligned_cols=201 Identities=26% Similarity=0.329 Sum_probs=171.7
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEecCC-----
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT----- 142 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~----- 142 (299)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 45789999999999999999999999999999999865422 23356788999999999999999999986543
Q ss_pred -eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccc
Q 022309 143 -QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFG 221 (299)
Q Consensus 143 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg 221 (299)
..++||||+.+ +|.+.+. ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence 46899999975 6666653 34788899999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 222 LAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 222 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 169 ~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~ 227 (359)
T cd07876 169 LARTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH 227 (359)
T ss_pred Ccccccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 9975321 1122335689999999999998999999999999999999999999987764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=270.27 Aligned_cols=212 Identities=28% Similarity=0.372 Sum_probs=180.8
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecC-----Ce
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG-----TQ 143 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-----~~ 143 (299)
...++|++.+.||+|||+-||+++...+++.||+|++......+.+...+|+...++++|||+++++++...+ ..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 3467899999999999999999999999999999999887767778899999999999999999999876433 34
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA 223 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a 223 (299)
.||+++|...|+|.+.+.........+++.+++.|+.++++||++||+. .+++.||||||.|||+++.+.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999999987766667899999999999999999999997 478999999999999999999999999999
Q ss_pred ccCCCCCCcccc-------cccccCccccCcccccC---CCCCcccceehhHHHHHHHHhCCCCCCCC
Q 022309 224 KFGPTGDKSHVS-------TRVMGTHGYCAPEYATT---GKLTAKSDIFSFGVVLLELITGRPAMDDS 281 (299)
Q Consensus 224 ~~~~~~~~~~~~-------~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~ 281 (299)
......-..... .....|..|.|||++.- ...+.++|||||||+||+|+.|..||+..
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~ 244 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI 244 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH
Confidence 754322111110 11346788999998843 45788999999999999999999999643
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=294.45 Aligned_cols=211 Identities=29% Similarity=0.429 Sum_probs=174.6
Q ss_pred hcCCCCCceecccCceEEEEEEE-----CCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKL-----AETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQ 143 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 143 (299)
.++|++.+.||+|+||.||+|.+ ..++..||+|+++.... ...+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45799999999999999999974 34567899999875432 2345688999999999 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCC----------------------------------------------------------
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTP---------------------------------------------------------- 165 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~---------------------------------------------------------- 165 (299)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999854211
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCc
Q 022309 166 -------------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKS 232 (299)
Q Consensus 166 -------------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~ 232 (299)
....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1125788899999999999999999999 999999999999999999999999999754332221
Q ss_pred ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 233 HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 233 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||.....+
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~ 323 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD 323 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch
Confidence 12222335667999999998899999999999999999998 89999776543
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=274.08 Aligned_cols=204 Identities=30% Similarity=0.435 Sum_probs=178.1
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc----H----HHHHHHHHHHhhc-CCCcceeeeeEEec
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG----E----KEFLVEVLMLSLM-RHPNLVHLIGYCAE 140 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~----~~~~~E~~~l~~l-~h~nIv~~~~~~~~ 140 (299)
.-..|.-.+.||.|..++|.++.++.++..+|+|++....... . ++..+|+.+|+++ .||+|+++.++|+.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456888899999999999999999999999999986432211 1 4457799999987 69999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccc
Q 022309 141 GTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDF 220 (299)
Q Consensus 141 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Df 220 (299)
+..+++|+|.+..|.|.|+|. ..-.+++.....|++|+++|+.|||.++ |+||||||+|||++++.+++|+||
T Consensus 95 ~sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cchhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence 999999999999999999994 5567899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccCccccCcccccC------CCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 221 GLAKFGPTGDKSHVSTRVMGTHGYCAPEYATT------GKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 221 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
|.|.....+.+ ....+|||+|+|||.+.- ..|+..+|+||+|||+|.||.|.+||.+...
T Consensus 168 GFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ 233 (411)
T KOG0599|consen 168 GFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ 233 (411)
T ss_pred ceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH
Confidence 99987655443 345789999999998733 3588899999999999999999999987653
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=294.15 Aligned_cols=204 Identities=26% Similarity=0.401 Sum_probs=173.3
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEecCC-----eeE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT-----QRL 145 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-----~~~ 145 (299)
+|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 47889999999999999999999999999999865322 22356788999999999999999999998776 789
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
+||||+. ++|.+.+. ....+++..+..++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 57888773 3467899999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 226 GPTGDKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
...... .......+++.|+|||.+.+. .++.++|||||||++|||++|.+||...+..+
T Consensus 153 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 212 (372)
T cd07853 153 EEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212 (372)
T ss_pred cccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH
Confidence 432221 122234578899999998774 47899999999999999999999998776543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=286.24 Aligned_cols=205 Identities=25% Similarity=0.392 Sum_probs=174.1
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
++|++.+.||+|+||.||+|.+..+++.||+|.++..... ....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 5799999999999999999999999999999998754322 234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+.+ +|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 975 88887753 2345788999999999999999999999 9999999999999999999999999997532221
Q ss_pred CcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
. ......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+..+
T Consensus 159 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 212 (309)
T cd07872 159 K--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED 212 (309)
T ss_pred c--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 1 1223457889999998865 458899999999999999999999998776543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=302.08 Aligned_cols=203 Identities=23% Similarity=0.336 Sum_probs=167.5
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCC------CcceeeeeEEecC-
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRH------PNLVHLIGYCAEG- 141 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~nIv~~~~~~~~~- 141 (299)
...++|++++.||+|+||+||+|.+..+++.||||+++... ........|+.+++.++| .+++++++++...
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 34578999999999999999999999999999999986432 222345567777666654 5688999988654
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEecCCC-------
Q 022309 142 TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN-KADPPVIYRDLKAGNILLGKGF------- 213 (299)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~dikp~Nilv~~~~------- 213 (299)
..+++||+++ |++|.+++. ....+++.++..++.||+.||+|||+ .+ |+||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIM----KHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred ceEEEEEecc-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccc
Confidence 4678999987 778998884 33578999999999999999999998 58 99999999999998765
Q ss_pred ---------ceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 214 ---------HPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 214 ---------~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
.+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|++||...+..
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred ccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 49999999886321 1223457999999999999999999999999999999999999999877654
Q ss_pred h
Q 022309 285 E 285 (299)
Q Consensus 285 ~ 285 (299)
+
T Consensus 352 ~ 352 (467)
T PTZ00284 352 E 352 (467)
T ss_pred H
Confidence 3
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=293.05 Aligned_cols=197 Identities=29% Similarity=0.391 Sum_probs=165.2
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEcCCCCcccH---HHHHHHHHHHhhc---CCCcceeeeeEEecCCeeEEEEEecCC
Q 022309 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLM---RHPNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 80 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
||+|+||+||+|.+..+++.||+|++.+...... .....|..++... +||||+++++.+.+.+..++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999999999999999865322221 2344566666554 799999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcc
Q 022309 154 GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233 (299)
Q Consensus 154 ~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~ 233 (299)
++|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++....... .
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~ 151 (330)
T cd05586 81 GELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--K 151 (330)
T ss_pred ChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--C
Confidence 99999884 3467899999999999999999999999 9999999999999999999999999987432211 1
Q ss_pred cccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 234 VSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~ 204 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ 204 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH
Confidence 22345699999999998654 47899999999999999999999998766443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=314.65 Aligned_cols=219 Identities=23% Similarity=0.393 Sum_probs=179.6
Q ss_pred HHHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEec--CC
Q 022309 67 LVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAE--GT 142 (299)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~ 142 (299)
.....++|++++.||+|+||+||+|.+..+++.||+|++...... ....+..|+.+++.++||||++++++|.+ ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 344567899999999999999999999999999999998754332 23568899999999999999999998854 35
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEecCCCCCCEEecC-------
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKAD----PPVIYRDLKAGNILLGK------- 211 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~----~~i~H~dikp~Nilv~~------- 211 (299)
.++|||||+.+++|.++|.........+++..++.|+.||+.||+|||+.+. .+|+||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 6899999999999999996544445679999999999999999999998431 23999999999999964
Q ss_pred ----------CCceEEccccccccCCCCCCcccccccccCccccCcccccC--CCCCcccceehhHHHHHHHHhCCCCCC
Q 022309 212 ----------GFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATT--GKLTAKSDIFSFGVVLLELITGRPAMD 279 (299)
Q Consensus 212 ----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~ 279 (299)
.+.+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||+||+|++|..||.
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred ccccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 245899999999754322 12234569999999999854 358899999999999999999999998
Q ss_pred CCchhhhhh
Q 022309 280 DSQGHERML 288 (299)
Q Consensus 280 ~~~~~~~~~ 288 (299)
..+....++
T Consensus 245 ~~~~~~qli 253 (1021)
T PTZ00266 245 KANNFSQLI 253 (1021)
T ss_pred cCCcHHHHH
Confidence 766544443
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=279.51 Aligned_cols=195 Identities=32% Similarity=0.494 Sum_probs=168.1
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEcCCCCcc---cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCCCH
Q 022309 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSL 156 (299)
Q Consensus 80 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L 156 (299)
||+|+||.||++.+..+++.||+|.+...... ....+..|+.+++.++||||+++++.+.++...++||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999998643222 234456799999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCccccc
Q 022309 157 EDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVST 236 (299)
Q Consensus 157 ~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 236 (299)
.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~ 152 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TIT 152 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eee
Confidence 9888532 2345888999999999999999999999 9999999999999999999999999987543221 122
Q ss_pred ccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 237 RVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 237 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
...|++.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence 3468899999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=300.46 Aligned_cols=204 Identities=32% Similarity=0.450 Sum_probs=175.0
Q ss_pred CCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCC------eeEE
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT------QRLL 146 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~------~~~l 146 (299)
|..-+.||+|+||.||+|+++.+|+.||||.+++.... ..+...+|++++++++|||||++++.-.+.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 55668899999999999999999999999999875433 3466789999999999999999998865443 5689
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEec--CCC--ceEEccccc
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLG--KGF--HPKLSDFGL 222 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~--~~~--~~kl~Dfg~ 222 (299)
|||||.||+|...+..- .+...+++.+.+.++..+..||.|||.+| |+||||||.||++- .+| ..||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999653 35578999999999999999999999999 99999999999983 323 479999999
Q ss_pred cccCCCCCCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 223 AKFGPTGDKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 223 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
|+.... .....+.+||+.|.+||+... ..|+..+|.|||||++|++.||..||-...+.
T Consensus 171 Arel~d---~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 171 ARELDD---NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred cccCCC---CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 986433 235667889999999999984 78999999999999999999999999655544
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=282.21 Aligned_cols=206 Identities=29% Similarity=0.448 Sum_probs=181.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
..+|++++.||+|++|.||+|.+..+++.|++|.+..........+.+|+.+++.++||||+++++.+..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 46799999999999999999999999999999999776555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+.+++|.+++.. ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999999842 45788999999999999999999999 9999999999999999999999999987533221
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
. ......+++.|+|||.+.+..++.++|||||||++|+|++|.+||...+....
T Consensus 171 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~ 224 (296)
T cd06654 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224 (296)
T ss_pred c--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh
Confidence 1 12234588899999999888889999999999999999999999987765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=280.45 Aligned_cols=204 Identities=29% Similarity=0.442 Sum_probs=169.0
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhc---CCCcceeeeeEEec-----CC
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLM---RHPNLVHLIGYCAE-----GT 142 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l---~h~nIv~~~~~~~~-----~~ 142 (299)
+|++++.||+|+||.||+|.+..+++.||+|.++...... ...+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5889999999999999999999999999999987543222 23456677766654 79999999998754 24
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccc
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL 222 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~ 222 (299)
..+++||++. ++|.+++... ....+++.++..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence 5789999997 4888888542 2245899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 223 AKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 223 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
+....... ......|++.|+|||++.+..++.++|||||||++|+|++|.+||...+..+
T Consensus 155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~ 214 (288)
T cd07863 155 ARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD 214 (288)
T ss_pred cccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH
Confidence 97543211 1223467899999999988889999999999999999999999997765543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=272.11 Aligned_cols=201 Identities=27% Similarity=0.331 Sum_probs=170.5
Q ss_pred hhcCCCCC-ceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhh-cCCCcceeeeeEEec----CCe
Q 022309 70 ATDNFKDT-NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSL-MRHPNLVHLIGYCAE----GTQ 143 (299)
Q Consensus 70 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~~~~~~~~----~~~ 143 (299)
.+++|.+. ++||-|-.|.|..|.++.|++.+|+|++... ....+|+++.-. ..|||||.++++|.+ ..+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45566665 5899999999999999999999999988644 445667665433 479999999998843 456
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC---CCceEEccc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK---GFHPKLSDF 220 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~---~~~~kl~Df 220 (299)
+.+|||.++||.|++.+... ....+++.++..|+.||+.|+.|||+.+ |.||||||+|+|... +..+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccc
Confidence 78999999999999999763 4467999999999999999999999999 999999999999964 457999999
Q ss_pred cccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 221 GLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 221 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
|+|+... ......+.+-||+|.|||++...+|+..+|+||+||++|.||+|.|||+...+
T Consensus 209 GFAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg 268 (400)
T KOG0604|consen 209 GFAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_pred ccccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC
Confidence 9998532 22334456789999999999999999999999999999999999999987654
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=275.89 Aligned_cols=207 Identities=29% Similarity=0.425 Sum_probs=177.4
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-----cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-----GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
++|++.+.||+|++|.||.|.+..+++.||+|.+...... ....+.+|+.+++.++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4689999999999999999999999999999988654321 12467889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
|+|++++++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++...
T Consensus 82 v~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLK----AYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999999999885 3356889999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCCccc-ccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 227 PTGDKSHV-STRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 227 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
........ .....++..|+|||.+.+..++.++||||||+++|+|++|..||...+..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 214 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA 214 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH
Confidence 32211111 123457889999999998889999999999999999999999997765443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=279.84 Aligned_cols=201 Identities=31% Similarity=0.464 Sum_probs=174.6
Q ss_pred CCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc---HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG---EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
|++.+.||+|+||.||++.+..+++.||+|.+....... ...+..|+.+++.++|+||+++++.+.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 778899999999999999999999999999986543222 24567899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+.|++|.+++... ....+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 9999999988532 2346889999999999999999999999 9999999999999999999999999987543221
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
. .....|++.|+|||.+.+..++.++||||||+++|+|++|.+||....
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 157 T---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred c---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 1 123468999999999998889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=279.45 Aligned_cols=202 Identities=31% Similarity=0.443 Sum_probs=175.3
Q ss_pred CCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc---HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG---EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
|+..+.||+|+||+||+|.+..+++.||+|.+....... ...+.+|+.+++.++|+||+++.+.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 677889999999999999999999999999986543222 24567899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+.+++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 9999999888532 2346899999999999999999999999 9999999999999999999999999986532221
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
......|++.|+|||.+.+..++.++|+|||||++|+|++|..||.....
T Consensus 157 ---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~ 206 (285)
T cd05632 157 ---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206 (285)
T ss_pred ---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 12234689999999999888899999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=278.29 Aligned_cols=207 Identities=27% Similarity=0.404 Sum_probs=174.0
Q ss_pred hcCCCCCceecccCceEEEEEEEC---CCCcEEEEEEcCCCCccc-HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLA---ETGQVVAVKQLDDTGFQG-EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
.++|++.+.||+|+||.||+|.+. ..+..||+|.++...... ...+.+|+.+++.++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356899999999999999999864 345689999987653322 3568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
||||+.+++|.+++.. ....+++.+++.++.|++.||+|||+++ ++||||||+||+++.++.++|+|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 9999999999999853 2356899999999999999999999999 999999999999999999999999987643
Q ss_pred CCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
..... .......++..|+|||.+.+..++.++|||||||++|||++ |.+||...+..
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~ 215 (266)
T cd05064 158 KSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ 215 (266)
T ss_pred cccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence 22111 11112335678999999988899999999999999999875 99999876544
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=284.73 Aligned_cols=207 Identities=30% Similarity=0.485 Sum_probs=173.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcE----EEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQV----VAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 145 (299)
..+|++.+.||+|+||.||+|.+..+++. ||+|.+..... .....+..|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 35699999999999999999998666554 89999875432 2346788899999999999999999998765 567
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
++++++.+|+|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++..
T Consensus 85 ~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccc
Confidence 99999999999999863 2345788999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 226 GPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
..............++..|+|||.+.+..++.++||||||+++|||++ |..||.+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~ 218 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 218 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 543322222222334668999999988899999999999999999998 99999876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=276.92 Aligned_cols=204 Identities=29% Similarity=0.386 Sum_probs=176.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++.+..+...++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35799999999999999999999999999999998765444456678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+.+++|.+++. ...++++.++..++.|++.||+|||+.+ |+||||+|+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 99999999884 3357899999999999999999999999 9999999999999999999999999997543211
Q ss_pred CcccccccccCccccCccccc---CCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 231 KSHVSTRVMGTHGYCAPEYAT---TGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
.......|++.|+|||.+. ...++.++|+|||||++|+|++|..||...++
T Consensus 161 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~ 214 (267)
T cd06646 161 --AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred --cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccch
Confidence 1122345888999999874 34477899999999999999999999965543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=305.46 Aligned_cols=209 Identities=27% Similarity=0.347 Sum_probs=174.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcC-CCcceeeeeE-Ee---cC---
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMR-HPNLVHLIGY-CA---EG--- 141 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~-~~---~~--- 141 (299)
...++++.+.|.+|||+.||+|.+...+..||+|++-.........+.+|+.++++|. |+|||.++|. .. ..
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 3456888899999999999999998888999999886665555577899999999996 9999999993 21 11
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccc
Q 022309 142 TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFG 221 (299)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg 221 (299)
-.++|+||||.||.|.+++.... ...|++.++++|+.|+++|+++||.. .+||+|||||-+||||+.+|..||||||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence 23579999999999999997533 24499999999999999999999998 5999999999999999999999999999
Q ss_pred ccccCCCCCCccccc-------ccccCccccCcccc---cCCCCCcccceehhHHHHHHHHhCCCCCCCC
Q 022309 222 LAKFGPTGDKSHVST-------RVMGTHGYCAPEYA---TTGKLTAKSDIFSFGVVLLELITGRPAMDDS 281 (299)
Q Consensus 222 ~a~~~~~~~~~~~~~-------~~~g~~~y~aPE~~---~~~~~~~~~DiwslG~il~elltg~~pf~~~ 281 (299)
.|.-........... ...-|+.|+|||++ .+.+.+.|+|||||||+||-|+....||++.
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 996432221111110 12368999999976 6678999999999999999999999999887
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=292.56 Aligned_cols=200 Identities=25% Similarity=0.257 Sum_probs=172.8
Q ss_pred hhcCCCCCceecccCceEEEEEEEC--CCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLA--ETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
...+|++++.||+|+||.||+|... .++..||+|.+... ....+|+.+++.++||||+++++++......+++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 4567999999999999999999764 35678999987643 3456799999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
||++. ++|.+++. ....+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++....
T Consensus 165 ~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 165 MPKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred ehhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 99985 68888883 4467899999999999999999999999 9999999999999999999999999997544
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
............||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 3332222334679999999999998899999999999999999999999997654
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=279.57 Aligned_cols=211 Identities=33% Similarity=0.513 Sum_probs=177.5
Q ss_pred cCCCCCceecccCceEEEEEEECC-----CCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAE-----TGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 145 (299)
++|.+.+.||+|+||.||+|.+.. +++.||+|.+...... ..+.+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 458889999999999999998743 3578999998765443 3467899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCce
Q 022309 146 LVYEYMPLGSLEDHLLGLT----------PEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHP 215 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~ 215 (299)
+||||+++++|.+++.... .....+++.++..++.|++.||.|||+++ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999996432 12345788999999999999999999999 9999999999999999999
Q ss_pred EEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 216 KLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 216 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
+|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+..+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~ 232 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE 232 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999975322221112223345778999999999899999999999999999999 999997766543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=278.92 Aligned_cols=210 Identities=34% Similarity=0.566 Sum_probs=176.7
Q ss_pred cCCCCCceecccCceEEEEEEECCCC-----cEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETG-----QVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 145 (299)
++|++++.||+|+||.||+|.....+ ..|++|.+...... ....+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 46899999999999999999876554 67999988754322 2356889999999999999999999999888999
Q ss_pred EEEEecCCCCHHHHhcccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC
Q 022309 146 LVYEYMPLGSLEDHLLGLTPE------------MKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF 213 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~ 213 (299)
++|||+++++|.+++...... ...+++.+++.++.|++.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 999999999999998643211 145788999999999999999999999 99999999999999999
Q ss_pred ceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 214 HPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 214 ~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
.++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||...+..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~ 233 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ 233 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 999999999975433322222333456788999999988889999999999999999998 99999876654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=287.64 Aligned_cols=200 Identities=25% Similarity=0.371 Sum_probs=171.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEecC------
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG------ 141 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------ 141 (299)
..++|++++.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 45789999999999999999999999999999999875432 2235577899999999999999999987543
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccc
Q 022309 142 TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFG 221 (299)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg 221 (299)
...+++++++ +++|.+++. ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3468999987 789988873 256899999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 222 LAKFGPTGDKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 222 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
++...... .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 221 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY 221 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 99754221 223468999999999876 4688999999999999999999999977654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=278.07 Aligned_cols=203 Identities=29% Similarity=0.416 Sum_probs=176.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEec
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYM 151 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 151 (299)
++|++.+.||+|+||.||+|.+..+++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46888999999999999999999999999999987654444456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCC
Q 022309 152 PLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231 (299)
Q Consensus 152 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~ 231 (299)
.+++|.+++. ....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 89 ~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd06645 89 GGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT-- 159 (267)
T ss_pred CCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc--
Confidence 9999999884 3457899999999999999999999999 999999999999999999999999998654321
Q ss_pred cccccccccCccccCccccc---CCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 232 SHVSTRVMGTHGYCAPEYAT---TGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
........|++.|+|||.+. ...++.++|+|||||++|+|++|.+||....+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~ 214 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc
Confidence 11123346899999999874 44588899999999999999999999876554
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=290.14 Aligned_cols=203 Identities=25% Similarity=0.317 Sum_probs=172.8
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEecC------
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG------ 141 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------ 141 (299)
..++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 45789999999999999999999999999999999875432 2335678899999999999999999987543
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccc
Q 022309 142 TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFG 221 (299)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg 221 (299)
...++||||+.+ +|.+.+. ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.++|+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence 356999999964 7777763 34788899999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 222 LAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 222 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
++...... .......|++.|+|||++.+..++.++|||||||++|+|++|..||...+..+
T Consensus 172 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 232 (364)
T cd07875 172 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID 232 (364)
T ss_pred CccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 99753221 12233568999999999999999999999999999999999999998766533
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=278.58 Aligned_cols=193 Identities=21% Similarity=0.329 Sum_probs=166.4
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCccc---HHHHHHHHHHHhhcCCCcceeeeeEEec----CCeeEEEEEe
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG---EKEFLVEVLMLSLMRHPNLVHLIGYCAE----GTQRLLVYEY 150 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~~~----~~~~~lv~e~ 150 (299)
..||+|++|.||+|.. +|+.||+|.++...... .+.+.+|+.+++.++||||+++++++.+ ....++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999998 78999999997654333 2567799999999999999999999876 3467899999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK-ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
+++|+|.+++. ....+++...+.++.|++.||.|||+. + ++||||||+||++++++.+||+|||++......
T Consensus 104 ~~~g~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 104 CTRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred CCCCcHHHHHh----hCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 99999999995 335688899999999999999999984 7 889999999999999999999999999753221
Q ss_pred CCcccccccccCccccCcccccC--CCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATT--GKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
.....|+..|+|||++.+ ..++.++|||||||++|||++|..||...+..
T Consensus 177 -----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~ 228 (283)
T PHA02988 177 -----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK 228 (283)
T ss_pred -----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH
Confidence 122457889999999976 67899999999999999999999999877643
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=281.72 Aligned_cols=206 Identities=29% Similarity=0.445 Sum_probs=181.1
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
...+|++++.||+|++|.||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++.+..+...++|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 34679999999999999999999999999999999976655556778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+++++|.+++.. ..+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 97 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 97 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred ccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 9999999999842 45788999999999999999999999 999999999999999999999999998754322
Q ss_pred CCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.. ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+...
T Consensus 169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~ 222 (297)
T cd06656 169 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 222 (297)
T ss_pred cc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch
Confidence 21 1223458889999999988889999999999999999999999997765533
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=283.81 Aligned_cols=208 Identities=30% Similarity=0.448 Sum_probs=182.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHH---HHHHHHHHhhc-CCCcceeeeeEEecCCeeEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE---FLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~l 146 (299)
..+|..+.+||+|+||.|.+|..+.+.+.||||++++....+..+ -..|..+|+.. +-|.++++..+|+.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 356899999999999999999999999999999998765444333 34577788776 45788999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
||||+.||+|--.+. +.+.+.+..+..++.+|+.||-+||++| |+.||||.+|||++..|++||.|||+++..
T Consensus 428 VMEyvnGGDLMyhiQ----Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQ----QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEEecCchhhhHHH----HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 999999999988884 5577888999999999999999999999 999999999999999999999999999854
Q ss_pred CCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
..+. ....+++|||.|+|||++..++|+.++|.||+||+|||||.|.+||++.++++.+
T Consensus 501 i~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF 559 (683)
T KOG0696|consen 501 IFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF 559 (683)
T ss_pred ccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 3322 2345689999999999999999999999999999999999999999999877654
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=275.41 Aligned_cols=206 Identities=23% Similarity=0.368 Sum_probs=178.0
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++.+.||+|+||.||+|++..+++.||+|.+..... .....+.+|+.+++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 579999999999999999999999999999998764322 22346788999999999999999999999989999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+.+++|.+++.........+++.+++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999988654444466889999999999999999999999 99999999999999999999999999876432
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
.. .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~ 210 (267)
T cd08228 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc
Confidence 21 11223458889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=278.91 Aligned_cols=211 Identities=30% Similarity=0.474 Sum_probs=177.3
Q ss_pred hcCCCCCceecccCceEEEEEEE-----CCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKL-----AETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 145 (299)
..+|.+.+.||+|+||.||++.+ ..++..+|+|.+..........+.+|+.+++.++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 35688999999999999999985 2345679999987665444567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceE
Q 022309 146 LVYEYMPLGSLEDHLLGLT---------PEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPK 216 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~k 216 (299)
+||||+.+++|.+++.... .....+++.+++.++.|++.||+|||+++ ++||||||+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999986422 12235899999999999999999999999 99999999999999999999
Q ss_pred EccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 217 LSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 217 l~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |.+||...+..
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~ 229 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 229 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999975432222222223345778999999988889999999999999999998 99999876544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=291.02 Aligned_cols=211 Identities=27% Similarity=0.379 Sum_probs=174.6
Q ss_pred hhcCCCCCceecccCceEEEEEEECCC-----CcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcC-CCcceeeeeEEecCC
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAET-----GQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMR-HPNLVHLIGYCAEGT 142 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~ 142 (299)
..++|++++.||+|+||.||+|.+... +..||+|++...... ..+.+.+|+.+++.+. ||||+++++++.+..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 356899999999999999999987432 347999999754332 2357889999999996 999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCC---------------------------------------------------------
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTP--------------------------------------------------------- 165 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------- 165 (299)
..++||||+++|+|.+++.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999998853210
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEec
Q 022309 166 -----------------------------------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLG 210 (299)
Q Consensus 166 -----------------------------------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~ 210 (299)
....+++.+++.++.|++.||+|||+.+ ++||||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 0134778889999999999999999999 99999999999999
Q ss_pred CCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCch
Q 022309 211 KGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQG 283 (299)
Q Consensus 211 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 283 (299)
.++.++|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~ 345 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV 345 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence 999999999999975433222222223446778999999988889999999999999999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=295.95 Aligned_cols=199 Identities=36% Similarity=0.521 Sum_probs=175.8
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc---cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
.|.-++.||.|+||.||.|++..+.+.||||++.-++.. ...++.+|+..|+.++|||++.+.++|..+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 366678999999999999999999999999999754433 33689999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
||- |+-.|++.. ..+++.+.++..|+.+.++||+|||+++ .||||||..|||+++.|.|||+|||.|....
T Consensus 107 YCl-GSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-- 177 (948)
T KOG0577|consen 107 YCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA-- 177 (948)
T ss_pred HHh-ccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC--
Confidence 995 688888864 3478999999999999999999999999 9999999999999999999999999997532
Q ss_pred CCcccccccccCccccCcccc---cCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYA---TTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~---~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
...+++|||+|||||++ ..+.|+-++|||||||+..||.-.+||+...+..
T Consensus 178 ----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM 231 (948)
T KOG0577|consen 178 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 231 (948)
T ss_pred ----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH
Confidence 33457899999999987 4457999999999999999999999997665543
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=277.86 Aligned_cols=205 Identities=29% Similarity=0.441 Sum_probs=176.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.+.|++++.||.|+||.||+|.+..+++.|++|.+..........+.+|+.+++.++||||+++++.+..+..+++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 46799999999999999999999999999999999766545556788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+++++|..++.. ....+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 91 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~- 163 (292)
T cd06644 91 CPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT- 163 (292)
T ss_pred CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc-
Confidence 999999887753 2356899999999999999999999999 999999999999999999999999998643211
Q ss_pred CcccccccccCccccCccccc-----CCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 231 KSHVSTRVMGTHGYCAPEYAT-----TGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
........+++.|+|||.+. ...++.++|+|||||++|+|++|.+||...+.
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 220 (292)
T cd06644 164 -LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 220 (292)
T ss_pred -ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH
Confidence 11122345888999999884 33467889999999999999999999977653
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=279.19 Aligned_cols=206 Identities=28% Similarity=0.453 Sum_probs=181.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
..+|++.+.||.|++|.||+|.+..+++.|++|.+..........+.+|+.+++.++||||+++++++......++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 35699999999999999999999999999999999766555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+.+++|.+++.. ..+++.++..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 98 LAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred cCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 999999998842 45899999999999999999999999 9999999999999999999999999987543221
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
. ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+..+.
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~ 223 (296)
T cd06655 170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223 (296)
T ss_pred c--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 1 12234588899999999888899999999999999999999999988776444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=289.38 Aligned_cols=202 Identities=25% Similarity=0.307 Sum_probs=172.2
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecC------
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEG------ 141 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------ 141 (299)
..++|++++.||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 457899999999999999999999999999999998754322 235677899999999999999999988543
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccc
Q 022309 142 TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFG 221 (299)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg 221 (299)
...++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 246899999975 6777663 34788999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 222 LAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 222 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
++..... ........|++.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 165 ~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 224 (355)
T cd07874 165 LARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI 224 (355)
T ss_pred ccccCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9975322 11223356899999999999889999999999999999999999999876643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=278.59 Aligned_cols=200 Identities=32% Similarity=0.464 Sum_probs=177.4
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++.+.||+|++|.||++.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 468999999999999999999999999999999865432 22356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLR----KSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999999985 3367899999999999999999999999 99999999999999999999999999976432
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
. .....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+.
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 203 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP 203 (290)
T ss_pred C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2 2234688999999999888889999999999999999999999987663
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=280.07 Aligned_cols=200 Identities=28% Similarity=0.365 Sum_probs=175.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
++|++.+.||+|+||.||++.+..++..+|+|.+...... ....+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3689999999999999999999999999999988754322 235688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN-KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
+++++|.+++. ....+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 81 MDGGSLDQVLK----KAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred cCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 99999999995 33668999999999999999999997 57 999999999999999999999999998653221
Q ss_pred CCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+
T Consensus 154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 202 (308)
T cd06615 154 ----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD 202 (308)
T ss_pred ----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc
Confidence 1223468899999999988889999999999999999999999997554
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=275.83 Aligned_cols=205 Identities=28% Similarity=0.435 Sum_probs=176.2
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecC
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMP 152 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 152 (299)
.|++.+.||+|+||.||+|.+..++..+++|.+..........+.+|+.+++.++||||+++++.+..+...++|+||+.
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 37888999999999999999999999999999876554445678889999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCc
Q 022309 153 LGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKS 232 (299)
Q Consensus 153 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~ 232 (299)
+++|..++.. ...++++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...... .
T Consensus 86 ~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~ 157 (282)
T cd06643 86 GGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--I 157 (282)
T ss_pred CCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc--c
Confidence 9999888753 3357899999999999999999999999 999999999999999999999999998653221 1
Q ss_pred ccccccccCccccCccccc-----CCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 233 HVSTRVMGTHGYCAPEYAT-----TGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 233 ~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.......+++.|+|||++. +..++.++|||||||++|+|++|.+||...+..+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~ 215 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR 215 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH
Confidence 1222346888999999873 3457789999999999999999999998766443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=272.12 Aligned_cols=205 Identities=25% Similarity=0.337 Sum_probs=178.1
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC-cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEec
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG-FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYM 151 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 151 (299)
+|++.+.||+|+||.||++.+..+++.||+|.++... ....+.+..|+.+++.++|+||+++++.+.+++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4888999999999999999999999999999986433 233467788999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCC
Q 022309 152 PLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231 (299)
Q Consensus 152 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~ 231 (299)
++++|.+++... ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 154 (255)
T cd08219 81 DGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG- 154 (255)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc-
Confidence 999999988532 2356789999999999999999999999 9999999999999999999999999997543221
Q ss_pred cccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 232 SHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
.......|++.|+|||++.+..++.++|+||||+++|+|++|.+||...+..
T Consensus 155 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~ 206 (255)
T cd08219 155 -AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK 206 (255)
T ss_pred -cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH
Confidence 1223356888999999998888999999999999999999999999876643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=276.51 Aligned_cols=199 Identities=39% Similarity=0.600 Sum_probs=175.9
Q ss_pred CCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHH--HHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEec
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEK--EFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYM 151 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 151 (299)
|++++.||+|+||+||++++..+++.||+|++......... ...+|+.+++.++||||+++++++.+....++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 67789999999999999999999999999999877544332 3456999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCC
Q 022309 152 PLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231 (299)
Q Consensus 152 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~ 231 (299)
.+++|.+++. ....+++.+++.++.|+++||++||+.+ ++|+||||+||++++++.++|+|||.+... ...
T Consensus 81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL--SEN 151 (260)
T ss_dssp TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES--TST
T ss_pred cccccccccc----cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc--ccc
Confidence 9999999995 3467899999999999999999999999 999999999999999999999999999743 112
Q ss_pred cccccccccCccccCccccc-CCCCCcccceehhHHHHHHHHhCCCCCCCC
Q 022309 232 SHVSTRVMGTHGYCAPEYAT-TGKLTAKSDIFSFGVVLLELITGRPAMDDS 281 (299)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~ 281 (299)
........++..|+|||++. +..++.++|+||||+++|+|++|..||...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 22333456899999999998 778999999999999999999999999987
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=276.22 Aligned_cols=212 Identities=29% Similarity=0.470 Sum_probs=174.4
Q ss_pred hhcCCCCCceecccCceEEEEEEEC-----CCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCe
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLA-----ETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQ 143 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 143 (299)
..++|++.+.||+|+||.||+|.+. .++..||+|.+..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567999999999999999999864 2356799998865432 233568899999999999999999999999899
Q ss_pred eEEEEEecCCCCHHHHhcccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEE
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPE------MKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKL 217 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl 217 (299)
.++||||+.+++|.+++...... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 99999999999999998642211 234577889999999999999999999 999999999999999999999
Q ss_pred ccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 218 SDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 218 ~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||...+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~ 228 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE 228 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999875432222111222345678999999988889999999999999999999 78999776543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=277.70 Aligned_cols=206 Identities=31% Similarity=0.420 Sum_probs=178.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|++++.||+|++|.||+|.+..++..+|+|.+........+.+..|+.+++.++||||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 35699999999999999999999889999999998765544556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+++++|.+++.. ....+++.+++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 999999998853 2356899999999999999999999999 9999999999999999999999999986532211
Q ss_pred CcccccccccCccccCccccc-----CCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 231 KSHVSTRVMGTHGYCAPEYAT-----TGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
.......+++.|+|||.+. ...++.++|+||||+++|+|++|.+||...+..
T Consensus 158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~ 214 (280)
T cd06611 158 --QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM 214 (280)
T ss_pred --cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH
Confidence 1222346888999999874 344678999999999999999999999876543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=279.37 Aligned_cols=205 Identities=27% Similarity=0.405 Sum_probs=174.4
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.++||||+++++++..+...++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 5699999999999999999999999999999998754322 234677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+. ++|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 589888853 2356889999999999999999999999 9999999999999999999999999997532221
Q ss_pred CcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
. ......+++.|+|||.+.+. .++.++|||||||++|+|++|.+||...+..+
T Consensus 159 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~ 212 (301)
T cd07873 159 K--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212 (301)
T ss_pred C--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 1 11223578899999988654 57889999999999999999999998776543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=271.69 Aligned_cols=208 Identities=30% Similarity=0.405 Sum_probs=181.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|++.+.||+|+||.||+|.+..+++.+++|.+........+.+.+|+.+++.++||||+++++.+.+....+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 36799999999999999999999989999999999766555567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+.+++|.+++.. ....+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 82 CGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 999999998853 2257899999999999999999999999 9999999999999999999999999987533211
Q ss_pred CcccccccccCccccCcccccCC---CCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTG---KLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||...+..+.
T Consensus 156 --~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~ 212 (262)
T cd06613 156 --AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA 212 (262)
T ss_pred --hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 112234678889999998776 788899999999999999999999987764443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=270.86 Aligned_cols=200 Identities=31% Similarity=0.464 Sum_probs=168.2
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCCCH
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSL 156 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L 156 (299)
+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++......++||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 469999999999999998999999998865432 2235688999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCccccc
Q 022309 157 EDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVST 236 (299)
Q Consensus 157 ~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 236 (299)
.+++.. ....+++.+++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999853 2346889999999999999999999999 9999999999999999999999999987533211111111
Q ss_pred ccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCch
Q 022309 237 RVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQG 283 (299)
Q Consensus 237 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 283 (299)
....+..|+|||.+.+..++.++||||||+++|+|++ |.+||.....
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~ 202 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN 202 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH
Confidence 1123456999999988889999999999999999998 8999976554
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=274.63 Aligned_cols=195 Identities=26% Similarity=0.379 Sum_probs=170.9
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
++|++++.||+|+||.||+|.+..+++.||+|.+..... .....+..|+.+++.++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 358889999999999999999999999999999865432 2335688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 9999986542 4678889999999999999999999 999999999999999999999999999754221
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCC
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDS 281 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 281 (299)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence 122346889999999999888999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=295.80 Aligned_cols=199 Identities=30% Similarity=0.464 Sum_probs=176.7
Q ss_pred eecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCCCHHH
Q 022309 79 FLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLED 158 (299)
Q Consensus 79 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~ 158 (299)
+||+|.||+||.|++..++..+|||.+........+-+-.|+.+.+.++|.|||++++.+.+++++-|.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999999999999999987766666778889999999999999999999999999999999999999999
Q ss_pred HhcccCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC-CCceEEccccccccCCCCCCcccc
Q 022309 159 HLLGLTPEMKPL--DWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK-GFHPKLSDFGLAKFGPTGDKSHVS 235 (299)
Q Consensus 159 ~l~~~~~~~~~~--~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~-~~~~kl~Dfg~a~~~~~~~~~~~~ 235 (299)
++. ..-+|+ .+.++-.+..||++||.|||.+. |||||||-+||||+. .|.+||+|||.++.... .....
T Consensus 662 LLr---skWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~T 733 (1226)
T KOG4279|consen 662 LLR---SKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCT 733 (1226)
T ss_pred HHH---hccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCccc
Confidence 996 355777 78899999999999999999998 999999999999974 68999999999976432 23344
Q ss_pred cccccCccccCcccccCC--CCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 236 TRVMGTHGYCAPEYATTG--KLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 236 ~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.++.||..|||||++..+ .|++++|||||||++.||.||+|||.......
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq 785 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ 785 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh
Confidence 567899999999999765 48999999999999999999999997665543
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=283.53 Aligned_cols=210 Identities=30% Similarity=0.431 Sum_probs=171.8
Q ss_pred hcCCCCCceecccCceEEEEEEEC-----CCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhc-CCCcceeeeeEEec-CC
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLA-----ETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLM-RHPNLVHLIGYCAE-GT 142 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~-~~ 142 (299)
.++|++.+.||+|+||.||+|... .+++.||+|+++..... ....+..|+.++..+ +|+||+++++++.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 457999999999999999999753 34578999998754322 235677899999999 89999999998764 45
Q ss_pred eeEEEEEecCCCCHHHHhcccCCC--------------------------------------------------------
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTPE-------------------------------------------------------- 166 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~-------------------------------------------------------- 166 (299)
..+++|||+++++|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 678999999999999998532110
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcccccccccCcccc
Q 022309 167 -MKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYC 245 (299)
Q Consensus 167 -~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~ 245 (299)
..++++..+..++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++................++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 136789999999999999999999999 9999999999999999999999999997643322222222334567899
Q ss_pred CcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCch
Q 022309 246 APEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQG 283 (299)
Q Consensus 246 aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 283 (299)
|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~ 281 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI 281 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 9999999999999999999999999998 9999976544
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=271.46 Aligned_cols=205 Identities=28% Similarity=0.483 Sum_probs=176.0
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH---------HHHHHHHHHHhhcCCCcceeeeeEEecCCe
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---------KEFLVEVLMLSLMRHPNLVHLIGYCAEGTQ 143 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---------~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 143 (299)
+|.+...||+|++|.||+|.+..+++.||+|.+........ +.+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 47889999999999999999988899999998865433221 457789999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA 223 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a 223 (299)
.+++|||+.+++|.+++. ....+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLN----NYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHH----hccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCC
Confidence 999999999999999994 3356889999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCC----cccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 224 KFGPTGDK----SHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 224 ~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
........ ........|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 218 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL 218 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH
Confidence 75432111 11112345788999999998888999999999999999999999999876543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=298.21 Aligned_cols=210 Identities=27% Similarity=0.404 Sum_probs=186.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.+.|+|+..||.|+||.||+|.++.++-..|.|+|........+++..|+.||..++||+||++++.|..++.+||+.|+
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 45689999999999999999999999888899999766656668899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
|.||-...++.. -..++++.++..+++|++.||.|||+++ |+|||||..|||++-+|.++|.|||.+-.. ..
T Consensus 111 C~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn--~~ 182 (1187)
T KOG0579|consen 111 CGGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKN--KS 182 (1187)
T ss_pred cCCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccc--hh
Confidence 999999888864 4578999999999999999999999999 999999999999999999999999987421 11
Q ss_pred CcccccccccCccccCcccc-----cCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhhhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYA-----TTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~-----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 288 (299)
.......++|||+|||||+. ...+|+.++||||||++|.||..+.||....++...++
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVll 245 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL 245 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHH
Confidence 22334568899999999975 55689999999999999999999999999888776654
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=270.71 Aligned_cols=206 Identities=26% Similarity=0.400 Sum_probs=179.0
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++.+.||+|++|.||+|.+..+++.||+|.++.... ...+.+.+|+.+++.++|+||+++++.+..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 579999999999999999999998999999998864322 22457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+++++|.+++.........+++.+++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998654444566899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence 211 1223458889999999988889999999999999999999999996554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=275.34 Aligned_cols=209 Identities=33% Similarity=0.523 Sum_probs=173.9
Q ss_pred cCCCCCceecccCceEEEEEEE----CCCCcEEEEEEcCCCCccc-HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKL----AETGQVVAVKQLDDTGFQG-EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
+.|++.+.||+|+||.||+|.. ..++..|++|.+....... ...+.+|+.+++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4688899999999999999985 3456789999987543322 3568889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC
Q 022309 147 VYEYMPLGSLEDHLLGLTP-------------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF 213 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~ 213 (299)
||||+.+++|.+++..... ....+++.++..++.|++.||+|||+++ ++||||||+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999842110 1234788899999999999999999999 99999999999999999
Q ss_pred ceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCch
Q 022309 214 HPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQG 283 (299)
Q Consensus 214 ~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 283 (299)
.++|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |.+||...+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN 232 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999975433222222233345677999999988889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=273.52 Aligned_cols=207 Identities=24% Similarity=0.369 Sum_probs=178.8
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc---cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++.+.||+|++|.||+|.+..+++.+++|.+...... ....+..|+.+++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688899999999999999999889999999988653322 2357888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
|++.+++|.+++.........+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988644344567899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.....
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 211 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 221 12234688899999999888899999999999999999999999975543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=269.61 Aligned_cols=204 Identities=27% Similarity=0.387 Sum_probs=177.9
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC--cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG--FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
+|++.+.||+|++|.||+|.+..+++.|++|.+.... ......+..|+.+++.++||||+++++.+.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999999999999999986432 23346788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+++++|.+++... ....+++.+++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999999998642 2357889999999999999999999999 9999999999999999999999999987543321
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 206 (256)
T cd08529 156 --NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ 206 (256)
T ss_pred --chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 112234588899999999888899999999999999999999999987663
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=273.67 Aligned_cols=206 Identities=29% Similarity=0.449 Sum_probs=171.2
Q ss_pred cCCCCCceecccCceEEEEEEECCCCc----EEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQ----VVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
++|++++.||+|+||.||+|.+..+++ .+++|.+...... ...++..|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 468899999999999999999877766 4777777543222 22567778888999999999999998864 45788
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
++|++.+++|.+++.. ....+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999963 2356899999999999999999999999 999999999999999999999999999765
Q ss_pred CCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
.............++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 218 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 43332222333456778999999988889999999999999999998 99999876543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=273.70 Aligned_cols=206 Identities=29% Similarity=0.422 Sum_probs=175.8
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
++|++.+.||+|++|.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 468999999999999999999998999999998864432 223567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+++++|..++. ....+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999988877763 3356899999999999999999999999 999999999999999999999999999764332
Q ss_pred CCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
.. ......++..|+|||.+.+ ..++.++||||||+++|+|++|.+||...+..+.
T Consensus 154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~ 209 (286)
T cd07847 154 GD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ 209 (286)
T ss_pred cc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 21 1223457788999999866 4578899999999999999999999987765443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=278.99 Aligned_cols=200 Identities=27% Similarity=0.367 Sum_probs=162.3
Q ss_pred CceecccCceEEEEEEEC--CCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEec--CCeeEEEEEecC
Q 022309 77 TNFLGQGGFGAVYKGKLA--ETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAE--GTQRLLVYEYMP 152 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~lv~e~~~ 152 (299)
.++||+|+||+||+|.+. .+++.||+|.+..... ...+.+|+.+++.++||||+++++++.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999975 4678999999875432 3457789999999999999999998854 456789999985
Q ss_pred CCCHHHHhcccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEe----cCCCceEEcccccc
Q 022309 153 LGSLEDHLLGLT-----PEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL----GKGFHPKLSDFGLA 223 (299)
Q Consensus 153 ~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv----~~~~~~kl~Dfg~a 223 (299)
++|.+++.... .....+++..+..++.||+.||+|||+++ |+||||||+|||+ +..+.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58888775321 12235889999999999999999999999 9999999999999 45678999999999
Q ss_pred ccCCCCCCc-ccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 224 KFGPTGDKS-HVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 224 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
......... .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...+
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 764322111 122345689999999998764 58899999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=270.45 Aligned_cols=208 Identities=28% Similarity=0.437 Sum_probs=175.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCC---CcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAET---GQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
.++|++.+.||+|+||.||+|.+..+ ...||+|.+...... ....+.+|+.+++.++||||+++++++......++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 35699999999999999999998644 457999988754332 23568889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
+||++.+++|.+++.. ....+++.+++.++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999999863 2347899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
.............+++.|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~ 215 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ 215 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH
Confidence 42222222222335678999999988889999999999999999998 99999765533
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=271.16 Aligned_cols=206 Identities=30% Similarity=0.395 Sum_probs=173.2
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-----ccHHHHHHHHHHHhhcCCCcceeeeeEEecC--Cee
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-----QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG--TQR 144 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~ 144 (299)
++|++.+.||+|+||.||.|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 468999999999999999999999999999998853221 1124678899999999999999999998663 467
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
+++|||+++++|.+++. ....+++..+..++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 89999999999999985 3345788999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCc-ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 225 FGPTGDKS-HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 225 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
........ .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 215 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM 215 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH
Confidence 53221111 1122345888999999998888999999999999999999999999765433
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=291.35 Aligned_cols=196 Identities=24% Similarity=0.292 Sum_probs=169.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
...|.+.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+++.++|+||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3479999999999999999999999999999996432 3456899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+. ++|.+++.. ....+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.......
T Consensus 242 ~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 95 688888753 2347899999999999999999999999 9999999999999999999999999997643322
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCC
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMD 279 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 279 (299)
.........||+.|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 2222234569999999999999899999999999999999999876543
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=275.62 Aligned_cols=211 Identities=30% Similarity=0.497 Sum_probs=177.5
Q ss_pred cCCCCCceecccCceEEEEEEEC-----CCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLA-----ETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+........+.+.+|+.+++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45888899999999999999853 3456799999876655555678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCc
Q 022309 147 VYEYMPLGSLEDHLLGLTP------------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFH 214 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~ 214 (299)
||||+++++|.+++..... ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999864221 1234789999999999999999999999 999999999999999999
Q ss_pred eEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 215 PKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 215 ~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 233 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 233 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999975433222222223456788999999988889999999999999999999 999997766543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=272.82 Aligned_cols=202 Identities=33% Similarity=0.435 Sum_probs=177.9
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC-cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG-FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
++|++.+.||.|++|.||+|.+..+++.||+|.+.... ......+.+|+.+++.++|+||+++++.+.++...++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46889999999999999999999999999999987553 23335688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+.+++|.+++.. .++++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999852 37899999999999999999999999 9999999999999999999999999997643321
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
.......+++.|+|||.+.+..++.++||||||+++|+|++|.+||...+.
T Consensus 153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~ 203 (274)
T cd06609 153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP 203 (274)
T ss_pred --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch
Confidence 122234678899999999888899999999999999999999999976554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=273.68 Aligned_cols=211 Identities=29% Similarity=0.444 Sum_probs=176.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCC-----CcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAET-----GQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQR 144 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 144 (299)
.++|++.+.||+|+||.||+|.+... +..||+|.+..... .....+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 46799999999999999999988643 47899999865432 2335688899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTP------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLS 218 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~ 218 (299)
++||||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999864322 1234788899999999999999999999 9999999999999999999999
Q ss_pred cccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 219 DFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 219 Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
|||++................++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 228 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE 228 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH
Confidence 9999875433222222223346778999999988889999999999999999998 99999766543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=273.07 Aligned_cols=205 Identities=27% Similarity=0.409 Sum_probs=173.5
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
+|++++.||+|++|.||+|.+..+++.||+|.+...... ....+.+|+.+++.++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 488899999999999999999999999999998654322 235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+. ++|.+++.... ....+++.+++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 58888875432 2356899999999999999999999999 9999999999999999999999999987543221
Q ss_pred CcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
.......+++.|+|||.+.+. .++.++|||||||++|+|++|.+||...+..
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~ 208 (285)
T cd07861 156 --RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI 208 (285)
T ss_pred --ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 112233568889999987654 5788999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=287.15 Aligned_cols=202 Identities=30% Similarity=0.429 Sum_probs=182.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH--HHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE--KEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
...|.+...||+|.|+.|.+|++..++..||||.+.++..... ..+.+|+.++..++|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 4669999999999999999999999999999999987754443 45889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+.+|.+.+++. ......+..+..++.|+..|++|||+++ |+|||||++|||++.+.++||+|||++.++.
T Consensus 135 eya~~ge~~~yl~----~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~- 206 (596)
T KOG0586|consen 135 EYASGGELFDYLV----KHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD- 206 (596)
T ss_pred EeccCchhHHHHH----hcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec-
Confidence 9999999999995 4456677899999999999999999999 9999999999999999999999999998764
Q ss_pred CCCcccccccccCccccCcccccCCCC-CcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKL-TAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
......+++|++.|.|||++.+..| ++.+|+||+|+++|.|+.|..||++.+
T Consensus 207 --~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~ 259 (596)
T KOG0586|consen 207 --YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN 259 (596)
T ss_pred --ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc
Confidence 3344556899999999999988876 578999999999999999999998654
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=274.86 Aligned_cols=216 Identities=29% Similarity=0.392 Sum_probs=178.9
Q ss_pred HHHHHHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhc-CCCcceeeeeEEe---
Q 022309 64 YRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLM-RHPNLVHLIGYCA--- 139 (299)
Q Consensus 64 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~--- 139 (299)
+.......++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+..|+.+++.+ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3444456788999999999999999999999999999999876532 2235677899999998 7999999999873
Q ss_pred --cCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEE
Q 022309 140 --EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKL 217 (299)
Q Consensus 140 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl 217 (299)
.+...++||||+++++|.+++.........+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence 445789999999999999988643334467889999999999999999999999 999999999999999999999
Q ss_pred ccccccccCCCCCCcccccccccCccccCcccccC-----CCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 218 SDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATT-----GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 218 ~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
+|||++....... .......|++.|+|||.+.. ..++.++|||||||++|+|++|..||...+..+
T Consensus 166 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~ 236 (286)
T cd06638 166 VDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR 236 (286)
T ss_pred ccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH
Confidence 9999987543221 11223468899999998753 447889999999999999999999998766533
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=291.93 Aligned_cols=203 Identities=26% Similarity=0.430 Sum_probs=175.6
Q ss_pred CceecccCceEEEEEEECCCCcEEEEEEcCCCC----cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCe--eEEEEEe
Q 022309 77 TNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG----FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQ--RLLVYEY 150 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~--~~lv~e~ 150 (299)
..+||+|+|-+||+|.+..+|..||.-.++... ....+.|..|+.+|+.|+||||+++|+.|.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 468999999999999999999999987665322 1223679999999999999999999999977665 7899999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC-CCceEEccccccccCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK-GFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~-~~~~kl~Dfg~a~~~~~~ 229 (299)
+..|+|..++. ..+..+...+..|++||+.||.|||++ +|||+|||||.+||||+. .|.|||+|+|||.....
T Consensus 125 ~TSGtLr~Y~k----k~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~- 198 (632)
T KOG0584|consen 125 FTSGTLREYRK----KHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK- 198 (632)
T ss_pred ccCCcHHHHHH----HhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc-
Confidence 99999999995 456788889999999999999999998 699999999999999975 58999999999986432
Q ss_pred CCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhhhhH
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLV 289 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 289 (299)
.....++|||.|||||+.. ..|+..+||||||.++.||.|+..||..-....++.-
T Consensus 199 ---s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYK 254 (632)
T KOG0584|consen 199 ---SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYK 254 (632)
T ss_pred ---cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHH
Confidence 2233478999999999986 7899999999999999999999999988877766543
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=269.65 Aligned_cols=209 Identities=32% Similarity=0.461 Sum_probs=171.1
Q ss_pred CCCCceecccCceEEEEEEECCC---CcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCCe-----
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAET---GQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQ----- 143 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~----- 143 (299)
|++.+.||+|+||.||+|....+ +..||+|.++..... ....+..|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 57789999999999999987543 478999998754322 23568899999999999999999998865544
Q ss_pred -eEEEEEecCCCCHHHHhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccc
Q 022309 144 -RLLVYEYMPLGSLEDHLLGLT--PEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDF 220 (299)
Q Consensus 144 -~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Df 220 (299)
.++++||+++++|..++.... .....+++..++.++.|++.||.|||+.+ ++||||||+||++++++.++|+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999999885321 22346899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 221 GLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 221 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
|+++...............++..|+|||.+.+..++.++|||||||++|||++ |.+||.+.+..+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~ 223 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE 223 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99976433322111122234668999999988889999999999999999999 899997766543
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=267.28 Aligned_cols=206 Identities=27% Similarity=0.408 Sum_probs=179.3
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC--cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG--FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
+|++++.||.|+||.||.+++..+++.+++|.+.... ......+.+|+.+++.++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5889999999999999999999999999999886543 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+++++|.+++.... ...+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999996421 356889999999999999999999999 9999999999999999999999999997643322
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
. ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+
T Consensus 156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~ 208 (256)
T cd08221 156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN 208 (256)
T ss_pred c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 1 2233568899999999988888999999999999999999999998765433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=281.45 Aligned_cols=196 Identities=25% Similarity=0.362 Sum_probs=168.3
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
....+|++++.||+|+||.||+|.+..+++.||+|+.... ....|+.+++.++||||+++++++......++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 3446799999999999999999999999999999975433 2356899999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
|++. ++|.+++.. ...++++.+++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 137 e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 137 PHYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 9995 588888753 3467899999999999999999999999 99999999999999999999999999975322
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCC-CCCCC
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGR-PAMDD 280 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~-~pf~~ 280 (299)
. .......||+.|+|||++.+..++.++|||||||++|||+++. ++|..
T Consensus 210 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 210 A---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred C---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence 1 1122356899999999999989999999999999999999864 44544
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=272.48 Aligned_cols=206 Identities=29% Similarity=0.457 Sum_probs=171.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCc----EEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQ----VVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 145 (299)
.++|++++.||+|+||+||+|.+..+++ .||+|.+...... ....+.+|+.++..+.||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 3568999999999999999999876666 4899988754332 345688899999999999999999998764 568
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
++++++++|+|.+++.. ....+++.+++.++.|++.||+|||+++ ++||||||+||++++++.++|+|||++..
T Consensus 85 l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence 99999999999999853 2356899999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCch
Q 022309 226 GPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQG 283 (299)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 283 (299)
..............+++.|+|||.+.+..++.++|||||||++|||++ |.+||.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 217 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA 217 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 543222211222235678999999988889999999999999999998 8999976543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=272.89 Aligned_cols=210 Identities=32% Similarity=0.500 Sum_probs=175.8
Q ss_pred cCCCCCceecccCceEEEEEEEC-----CCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLA-----ETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
.+|.+.++||+|+||.||++... .++..+++|.+..........+.+|+.+++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 56888999999999999999743 3566899999876655556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCce
Q 022309 147 VYEYMPLGSLEDHLLGLTP-----------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHP 215 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~ 215 (299)
+|||+.+++|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999864321 1135788999999999999999999999 9999999999999999999
Q ss_pred EEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 216 KLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 216 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
+|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 231 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT 231 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH
Confidence 9999999875432221111222345678999999988889999999999999999998 99999765543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=271.76 Aligned_cols=207 Identities=33% Similarity=0.503 Sum_probs=179.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
..+|++.+.||.|+||.||+|.+.. +..+++|.+..........+..|+.+++.++||||+++++++.+....++||||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 4568999999999999999999977 889999999876655567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+++++|.+++... ....+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 84 MEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred cccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 9999999999642 2356889999999999999999999999 9999999999999999999999999997543221
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
. ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+
T Consensus 159 ~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~ 212 (261)
T cd05148 159 Y--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE 212 (261)
T ss_pred c--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 1 1112335678999999988889999999999999999998 899998766443
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=289.37 Aligned_cols=209 Identities=34% Similarity=0.465 Sum_probs=174.7
Q ss_pred HHhhcCCCCCceecccCceEEEEEEECCCCc---E-EEEEEcCCCC---cccHHHHHHHHHHHhhcCCCcceeeeeEEec
Q 022309 68 VAATDNFKDTNFLGQGGFGAVYKGKLAETGQ---V-VAVKQLDDTG---FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAE 140 (299)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~-vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 140 (299)
....++-.+.++||+|+||.||+|.....+. . ||+|..+... .....++.+|++++++++|||||++||+...
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 3344556667899999999999999865422 3 8999887522 2334689999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccc
Q 022309 141 GTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDF 220 (299)
Q Consensus 141 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Df 220 (299)
...+++|||+|+||+|.++|.. ....++..+...++.+.+.||+|||+++ ++||||..+|+|++.++.+||+||
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcc
Confidence 9999999999999999999964 2236899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 221 GLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 221 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
|+++..... ........-...|+|||.+....|+.++|||||||++||+++ |..||.+....
T Consensus 307 GLs~~~~~~--~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~ 369 (474)
T KOG0194|consen 307 GLSRAGSQY--VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY 369 (474)
T ss_pred ccccCCcce--eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH
Confidence 999854311 111111124568999999999999999999999999999999 88899888754
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=270.03 Aligned_cols=206 Identities=30% Similarity=0.472 Sum_probs=175.8
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEec
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYM 151 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 151 (299)
..|.+.+.||+|++|.||+|.+..+++.||+|.+.... .....+.+|+.+++.++||||+++++++..++..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45888899999999999999999899999999987543 33467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCC
Q 022309 152 PLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231 (299)
Q Consensus 152 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~ 231 (299)
++++|.+++... ....+++..++.++.|+++||+|||+++ ++||||||+||++++++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999998542 2346888999999999999999999999 99999999999999999999999999976433211
Q ss_pred cccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 232 SHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
. ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+.+
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 212 (263)
T cd05052 160 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 212 (263)
T ss_pred e-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 1 1111234567999999988889999999999999999998 99999776543
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=276.81 Aligned_cols=210 Identities=33% Similarity=0.432 Sum_probs=179.5
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc---cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++.+.||+|++|.||+|.+..+++.||+|.+...... ....+..|+.+++.++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 3688999999999999999999999999999999765433 2356888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+.+++|.+++... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999999998532 2357899999999999999999999999 99999999999999999999999999864322
Q ss_pred CCCc---------------------------ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCC
Q 022309 229 GDKS---------------------------HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDS 281 (299)
Q Consensus 229 ~~~~---------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 281 (299)
.... .......|+..|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1110 0111245788999999998888999999999999999999999999877
Q ss_pred chhhh
Q 022309 282 QGHER 286 (299)
Q Consensus 282 ~~~~~ 286 (299)
+..+.
T Consensus 236 ~~~~~ 240 (316)
T cd05574 236 NRDET 240 (316)
T ss_pred chHHH
Confidence 65543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=268.59 Aligned_cols=207 Identities=28% Similarity=0.407 Sum_probs=174.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-----cHHHHHHHHHHHhhcCCCcceeeeeEEec--CCee
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-----GEKEFLVEVLMLSLMRHPNLVHLIGYCAE--GTQR 144 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~ 144 (299)
.+|++.+.||+|+||.||+|.+..++..|++|.+...... ....+.+|+.+++.++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3689999999999999999999999999999988643221 12457889999999999999999998865 3567
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
++++||+++++|.+++. ....+++..++.++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLK----AYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 89999999999999985 3345889999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCC-cccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 225 FGPTGDK-SHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 225 ~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
....... ........++..|+|||.+.+..++.++|+|||||++|+|++|.+||...+..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~ 216 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA 216 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH
Confidence 5322111 111123457889999999988889999999999999999999999998765443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=247.70 Aligned_cols=207 Identities=26% Similarity=0.373 Sum_probs=178.6
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
+|.-.++||+|.||+||+|++..+++.||+|.++..... -.....+|+-+++.++|+|||+++++...+...-+|+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 466678999999999999999999999999998754322 236789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
|+ .+|..+... -.+.++.+.+..++.|++.||.++|+++ ++|||+||.|.+|+.+|.+||.|||+++-...+
T Consensus 83 cd-qdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgip- 154 (292)
T KOG0662|consen 83 CD-QDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIP- 154 (292)
T ss_pred hh-HHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCc-
Confidence 96 588887753 3467899999999999999999999999 999999999999999999999999999864332
Q ss_pred CcccccccccCccccCcccccCCC-CCcccceehhHHHHHHHHh-CCCCCCCCchhhhhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGK-LTAKSDIFSFGVVLLELIT-GRPAMDDSQGHERML 288 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~ 288 (299)
.......+-|..|.+|.++.+.+ |+...|+||.|||+.|+.. |+|.|.+.+.++++.
T Consensus 155 -vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlk 213 (292)
T KOG0662|consen 155 -VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213 (292)
T ss_pred -eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHH
Confidence 22233345788999999998875 8999999999999999987 788899988877764
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=273.81 Aligned_cols=212 Identities=31% Similarity=0.441 Sum_probs=176.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCC-----CcEEEEEEcCCCCcc-cHHHHHHHHHHHhhc-CCCcceeeeeEEecCC
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAET-----GQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGT 142 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~ 142 (299)
..++|++.+.||+|+||.||++..... ...+|+|.+...... ....+.+|+.+++.+ +|+||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 346799999999999999999987643 378999998754322 235678899999999 8999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEec
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLT------------PEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLG 210 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~ 210 (299)
..+++|||+.+++|.+++.... .....+++..++.++.|++.||+|||+.+ |+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 9999999999999999985421 23456889999999999999999999999 99999999999999
Q ss_pred CCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 211 KGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 211 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 999999999999976433222222222334567999999988889999999999999999998 99999776543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=274.92 Aligned_cols=206 Identities=27% Similarity=0.420 Sum_probs=175.7
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++.+.||+|+||.||++.+..+++.|++|.+..... .....+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 368899999999999999999999999999999875532 22346778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||++|++|.+++. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++....
T Consensus 81 e~~~g~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLK----NIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 9999999999995 3356899999999999999999999999 99999999999999999999999999864211
Q ss_pred CCCc-------------ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 229 GDKS-------------HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 229 ~~~~-------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
.... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~ 222 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 222 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 1000 0111235778899999998888999999999999999999999999866543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=267.52 Aligned_cols=204 Identities=28% Similarity=0.461 Sum_probs=172.9
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEec
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYM 151 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 151 (299)
++|++.+.||+|+||.||++... ++..+|+|.+.... .....+.+|+.+++.++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 46888999999999999999875 45679999886543 33467888999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCC
Q 022309 152 PLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231 (299)
Q Consensus 152 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~ 231 (299)
++++|.+++.. ....+++..++.++.|++.||+|||+++ ++||||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 82 ENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 99999998853 2245889999999999999999999999 99999999999999999999999999875422211
Q ss_pred cccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 232 SHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
. ......++..|+|||.+.+..++.++|+||||+++|+|++ |.+||...+..
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~ 208 (256)
T cd05114 156 T-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY 208 (256)
T ss_pred e-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 1 1112235567999999988889999999999999999999 89999876644
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=277.07 Aligned_cols=205 Identities=21% Similarity=0.275 Sum_probs=169.3
Q ss_pred CCceeccc--CceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEec
Q 022309 76 DTNFLGQG--GFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYM 151 (299)
Q Consensus 76 ~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 151 (299)
++++||+| +|++||++.+..+++.||+|.+....... ...+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 78999999999999999999997653322 245778999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCC
Q 022309 152 PLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231 (299)
Q Consensus 152 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~ 231 (299)
++++|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+||+++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999998542 2245889999999999999999999999 99999999999999999999999987543211111
Q ss_pred c-----ccccccccCccccCcccccC--CCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 232 S-----HVSTRVMGTHGYCAPEYATT--GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 232 ~-----~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
. .......++..|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 217 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 217 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH
Confidence 0 01112346778999999876 458899999999999999999999998655433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=271.65 Aligned_cols=203 Identities=28% Similarity=0.411 Sum_probs=172.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
.++|++.+.||+|++|.||+|.+..+++.||+|.+...... ....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 36799999999999999999999989999999998654322 22456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+.+ +|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~-~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 84 YLDT-DLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 9975 89998853 2346889999999999999999999999 999999999999999999999999998643221
Q ss_pred CCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
.. ......++..|+|||.+.+ ..++.++||||+|+++|+|++|.+||...+
T Consensus 157 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 157 SK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred Cc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 11 1122346788999998865 457889999999999999999999997665
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=269.45 Aligned_cols=206 Identities=32% Similarity=0.449 Sum_probs=173.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhc-CCCcceeeeeEEecC------Ce
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEG------TQ 143 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~------~~ 143 (299)
.+.|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+..|+.+++.+ +||||+++++.+... ..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 466888999999999999999999999999999986543 3446788899999888 799999999998653 45
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA 223 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a 223 (299)
.+++|||+.+++|.+++... ....+++..+..++.|++.||+|||+++ ++|+||+|+||++++++.++|+|||++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 78999999999999998642 2356889999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCCcccccccccCccccCccccc-----CCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 224 KFGPTGDKSHVSTRVMGTHGYCAPEYAT-----TGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
....... .......|++.|+|||++. +..++.++|||||||++|+|++|..||...+..
T Consensus 159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~ 222 (272)
T cd06637 159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 222 (272)
T ss_pred eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 7542211 1223356889999999985 335788999999999999999999999765543
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=273.57 Aligned_cols=210 Identities=29% Similarity=0.431 Sum_probs=173.5
Q ss_pred cCCCCCceecccCceEEEEEEECCC-----CcEEEEEEcCCCCccc-HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAET-----GQVVAVKQLDDTGFQG-EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 145 (299)
.+|++.+.||+|+||.||+|.+..+ +..||+|.+....... ...+.+|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 3478889999999999999987543 5789999997543222 356788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC
Q 022309 146 LVYEYMPLGSLEDHLLGLT------------PEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF 213 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~ 213 (299)
+++||+.+++|.+++.... .....+++..++.++.|++.||+|||+++ ++||||||+||+++.++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999984211 11245788899999999999999999999 99999999999999999
Q ss_pred ceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 214 HPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 214 ~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |.+||...+..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 233 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 233 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 999999999875433322222223446778999999988889999999999999999998 88899776543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=275.93 Aligned_cols=202 Identities=28% Similarity=0.393 Sum_probs=175.4
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecC
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMP 152 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 152 (299)
.|.....||+|+||.||++.+..++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 35556789999999999999998999999999876544445678899999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCc
Q 022309 153 LGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKS 232 (299)
Q Consensus 153 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~ 232 (299)
+++|.+++.. ..+++.+++.++.|++.||+|||+++ ++||||||+||++++++.++|+|||++.......
T Consensus 103 ~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-- 172 (292)
T cd06658 103 GGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-- 172 (292)
T ss_pred CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--
Confidence 9999998842 45889999999999999999999999 9999999999999999999999999987533221
Q ss_pred ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 233 HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 233 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
.......|++.|+|||.+.+..++.++|+||||+++|||++|..||...+..
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~ 224 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL 224 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 1122345888999999998888999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=274.72 Aligned_cols=207 Identities=30% Similarity=0.482 Sum_probs=170.4
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcE--EEEEEcCCCCc-ccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQV--VAVKQLDDTGF-QGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv 147 (299)
++|++.+.||+|+||.||+|.+..++.. +++|.+..... .....+.+|+.++..+ +||||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 5689999999999999999998777754 57777654322 2335678899999999 899999999999999999999
Q ss_pred EEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCce
Q 022309 148 YEYMPLGSLEDHLLGLTP------------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHP 215 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~ 215 (299)
|||+++++|.+++..... ....+++.+++.++.|++.||+|||+++ ++||||||+||+++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999864211 1235789999999999999999999999 9999999999999999999
Q ss_pred EEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 216 KLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 216 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
+|+|||++...... .......++..|+|||.+.+..++.++|||||||++|+|+| |.+||...+..
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 230 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 230 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH
Confidence 99999998632111 01111224567999999988889999999999999999998 99999766543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=303.94 Aligned_cols=214 Identities=35% Similarity=0.523 Sum_probs=178.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCC-C----cEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAET-G----QVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQR 144 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 144 (299)
.+.-+..+.||+|.||.||.|....- + ..||+|.+++... .+..+|.+|+.+++.++|||||++++++.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 44566778999999999999987532 2 3499999876543 3447899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTP---EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFG 221 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg 221 (299)
+|++|||+||+|..+|...+. ....++....+.++.||++|+.||++++ +|||||..+|+|++....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999975321 1456889999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhhhh
Q 022309 222 LAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHERM 287 (299)
Q Consensus 222 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~ 287 (299)
+|+.....+.........-...|||||.+....++.++|||||||++||++| |..||.+.++.+.+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~ 914 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL 914 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH
Confidence 9984333222222222223458999999999999999999999999999999 89999988865543
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=279.00 Aligned_cols=203 Identities=33% Similarity=0.460 Sum_probs=180.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.+.|+.-++||+|+||.|+-++.+.||+.||.|.+.+... ..+.....|..+|.+++.+.||.+-.+|...+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 4678889999999999999999999999999998865432 2335578899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
+..|+||+|.-.|.+.. ...+++..++.++.+|+-||++||+.+ ||.||+||+|||+|+.|+++|+|+|||...+
T Consensus 264 LtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 99999999988886543 268999999999999999999999999 9999999999999999999999999998655
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCC
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDS 281 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 281 (299)
.+... ...+||.+|||||++.+..|+...|.|||||++|||+.|+.||...
T Consensus 339 ~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 339 EGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred CCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 43322 2237999999999999999999999999999999999999999654
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=270.70 Aligned_cols=212 Identities=32% Similarity=0.454 Sum_probs=174.4
Q ss_pred hcCCCCCceecccCceEEEEEEECC-----CCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAE-----TGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQR 144 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 144 (299)
.++|++.+.||+|++|.||+|.+.. ++..|++|.+...... ....+.+|+.+++.++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 3568999999999999999999976 6788999988754333 235688999999999999999999999988899
Q ss_pred EEEEEecCCCCHHHHhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC---ceEEc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTP---EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF---HPKLS 218 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~---~~kl~ 218 (299)
++||||+.|++|.+++..... ....+++.+++.++.|++.||+|||+++ ++||||||+||+++.++ .++|+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999864321 1235889999999999999999999999 99999999999998654 59999
Q ss_pred cccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 219 DFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 219 Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
|||++.................+..|+|||++.+..++.++|||||||++|+|++ |..||...+..+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~ 229 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE 229 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999975422111111112233567999999988889999999999999999997 999998765443
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=265.69 Aligned_cols=203 Identities=38% Similarity=0.550 Sum_probs=175.1
Q ss_pred ceecccCceEEEEEEECCC---CcEEEEEEcCCCCccc-HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCC
Q 022309 78 NFLGQGGFGAVYKGKLAET---GQVVAVKQLDDTGFQG-EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
+.||+|+||.||+|.+... +..|++|.+....... ...+.+|+.+++.++|+||+++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4699999999999999765 8899999997654433 56788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 154 GSLEDHLLGLTPE-----MKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 154 ~~L~~~l~~~~~~-----~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
++|.+++...... ...+++.+++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999643211 377899999999999999999999999 99999999999999999999999999986544
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCch
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQG 283 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 283 (299)
...........+++.|+|||.+....++.++||||||+++|+|++ |..||...+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 213 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH
Confidence 332222333457889999999988889999999999999999999 6999987754
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=268.10 Aligned_cols=206 Identities=30% Similarity=0.446 Sum_probs=174.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|+++++||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.+++.++|+||+++++.+.+.+..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 457999999999999999999875 56679999886543 2356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+.+++|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 83 MAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 9999999998642 2356788899999999999999999999 9999999999999999999999999997643221
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
. .......++..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 158 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~ 211 (261)
T cd05072 158 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS 211 (261)
T ss_pred e-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH
Confidence 1 11122335678999999988889999999999999999998 99999766543
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=267.23 Aligned_cols=204 Identities=29% Similarity=0.458 Sum_probs=172.0
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEec
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYM 151 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 151 (299)
.+|++.+.||+|+||.||+|.+. ++..+|+|.+.... .....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 45889999999999999999886 46689999886543 23456888999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCC
Q 022309 152 PLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231 (299)
Q Consensus 152 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~ 231 (299)
++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 82 ANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 99999999853 2246889999999999999999999999 99999999999999999999999999875432111
Q ss_pred cccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 232 SHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
. ......++..|+|||.+.+..++.++||||||+++|+|++ |.+||...+..
T Consensus 156 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 208 (256)
T cd05059 156 T-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS 208 (256)
T ss_pred c-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH
Confidence 1 1111123457999999988889999999999999999999 89999766543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=265.61 Aligned_cols=206 Identities=24% Similarity=0.338 Sum_probs=175.8
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEec-CCeeEEEEE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAE-GTQRLLVYE 149 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~~~~lv~e 149 (299)
.|++.+.||+|++|.||++.+..+++.||+|.+..... ...+.+.+|+.+++.++|+|++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 48899999999999999999998999999999865432 233567889999999999999999998764 446789999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+++++|.+++... ....+++.+++.++.|++.||++||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 99999999998642 2356899999999999999999999999 999999999999999999999999999754322
Q ss_pred CCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
. .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+...
T Consensus 156 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~ 209 (257)
T cd08223 156 C--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS 209 (257)
T ss_pred C--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 1 12233568889999999988889999999999999999999999998766433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=266.48 Aligned_cols=205 Identities=33% Similarity=0.453 Sum_probs=180.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|++.+.||+|+||.||+|....++..|++|.+..... .+.+.+|+.+++.++||||+++++.+.++...++++|+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3679999999999999999999988899999999875532 56789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+.+++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 80 CGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred CCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 999999999853 3367899999999999999999999999 9999999999999999999999999997643322
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
. ......++..|+|||.+.+..++.++||||||+++|+|++|.+||...+...
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~ 206 (256)
T cd06612 154 A--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR 206 (256)
T ss_pred c--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh
Confidence 1 2223457889999999988889999999999999999999999998765443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=270.51 Aligned_cols=203 Identities=34% Similarity=0.463 Sum_probs=168.8
Q ss_pred cCC-CCCceecccCceEEEEEE----ECCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecC--Ce
Q 022309 72 DNF-KDTNFLGQGGFGAVYKGK----LAETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG--TQ 143 (299)
Q Consensus 72 ~~y-~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~ 143 (299)
++| ++++.||+|+||+||++. ...++..||+|.+..... .....+.+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 345 889999999999998865 345678999999876532 2346788999999999999999999987653 45
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA 223 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a 223 (299)
.+++|||+++++|.+++.. ..+++.+++.++.|++.||.|||+++ ++||||||+||++++++.++|+|||++
T Consensus 83 ~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~ 154 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLA 154 (283)
T ss_pred EEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccc
Confidence 7899999999999999843 45899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCccc-ccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 224 KFGPTGDKSHV-STRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 224 ~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
........... .....++..|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 214 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPP 214 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCc
Confidence 76433222111 112235667999999988889999999999999999999999986544
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=272.69 Aligned_cols=211 Identities=28% Similarity=0.406 Sum_probs=175.7
Q ss_pred hhcCCCCCceecccCceEEEEEEE-----CCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhc-CCCcceeeeeEEecCC
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKL-----AETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGT 142 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~ 142 (299)
..++|.+.+.||+|+||.||+|.+ ..++..||+|.++..... ..+.+.+|+.+++.+ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 345799999999999999999975 334568999988754322 235688999999999 7999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccc
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL 222 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~ 222 (299)
..+++|||+.+++|.+++... ....+++.++..++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999998532 2234899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 223 AKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 223 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
+................+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~ 251 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS 251 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH
Confidence 975433222112222345678999999988889999999999999999998 999997766543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=272.02 Aligned_cols=210 Identities=30% Similarity=0.457 Sum_probs=176.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCC----------------cEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCccee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETG----------------QVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVH 133 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~ 133 (299)
.++|++++.||+|+||.||+|.+..++ ..||+|.+...... ..+.+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 357999999999999999999876543 45899998765433 3467889999999999999999
Q ss_pred eeeEEecCCeeEEEEEecCCCCHHHHhcccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 022309 134 LIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTP-------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGN 206 (299)
Q Consensus 134 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~N 206 (299)
+++++..++..+++||++.+++|.+++..... ....+++..++.++.|++.||+|||+++ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999864321 1236899999999999999999999999 9999999999
Q ss_pred EEecCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh--CCCCCCCCch
Q 022309 207 ILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT--GRPAMDDSQG 283 (299)
Q Consensus 207 ilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt--g~~pf~~~~~ 283 (299)
|+++.++.++|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 9999999999999999875433322222334456778999999988889999999999999999998 7788876554
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=271.52 Aligned_cols=209 Identities=30% Similarity=0.431 Sum_probs=172.6
Q ss_pred CCCCCceecccCceEEEEEEECC-----CCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAE-----TGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
+|++.+.||+|+||.||+|.+.. ....+++|.+...... ....+..|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47889999999999999998743 2357899988754332 23568889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 022309 147 VYEYMPLGSLEDHLLGLT--------------------PEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGN 206 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~N 206 (299)
++||+.+++|.+++.... ....++++.+++.++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999885321 11245788999999999999999999999 9999999999
Q ss_pred EEecCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 207 ILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 207 ilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
|++++++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 9999999999999999975432222111222345678999999988889999999999999999998 99999766543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=266.12 Aligned_cols=206 Identities=32% Similarity=0.467 Sum_probs=174.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|++.+.||+|++|.||+|.+. +++.||+|.++... ...+.+.+|+.+++.++||||+++++++...+..+++||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 456999999999999999999875 45789999987653 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+.+++|.+++.... ...+++.++..++.|++.||.+||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999986421 246889999999999999999999999 9999999999999999999999999997653211
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
.. .......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 211 (261)
T cd05068 158 YE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA 211 (261)
T ss_pred cc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 11 1111123457999999988889999999999999999999 99999876543
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=272.61 Aligned_cols=211 Identities=27% Similarity=0.468 Sum_probs=172.9
Q ss_pred hcCCCCCceecccCceEEEEEEECC----------------CCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCccee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAE----------------TGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVH 133 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~ 133 (299)
.++|++.+.||+|+||.||++.+.. ++..+|+|.+...... ....+.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 3579999999999999999986432 3457999998754322 3357889999999999999999
Q ss_pred eeeEEecCCeeEEEEEecCCCCHHHHhcccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 022309 134 LIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPE-------MKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGN 206 (299)
Q Consensus 134 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~N 206 (299)
+++++..++..+++|||+.+++|.+++...... ...+++.++..++.|++.||+|||+++ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 999999999999999999999999998643211 124677899999999999999999999 9999999999
Q ss_pred EEecCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh--CCCCCCCCchh
Q 022309 207 ILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT--GRPAMDDSQGH 284 (299)
Q Consensus 207 ilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt--g~~pf~~~~~~ 284 (299)
|+++.++.++|+|||++................+++.|++||...+..++.++|+|||||++|||++ |..||...+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999875432222112222334678999999888889999999999999999998 78899766543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=270.68 Aligned_cols=205 Identities=26% Similarity=0.383 Sum_probs=172.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc-HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG-EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
.++|++++.||+|+||.||+|.+..+++.||+|.+....... ...+.+|+.+++.++|+||+++++++..+...++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 467999999999999999999999999999999986543222 2467789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+. ++|.+++.. ....+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 996 677777642 2345788889999999999999999999 999999999999999999999999998753221
Q ss_pred CCcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
.. ......+++.|+|||.+.+. .++.++||||||+++|+|++|.+||...+..
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~ 210 (291)
T cd07870 157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV 210 (291)
T ss_pred CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH
Confidence 11 12233578899999998654 5788999999999999999999999876654
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=275.28 Aligned_cols=201 Identities=26% Similarity=0.385 Sum_probs=174.5
Q ss_pred CCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCC
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
|.....||+|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++.+..++..++++||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 44456799999999999999889999999998765444556788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcc
Q 022309 154 GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233 (299)
Q Consensus 154 ~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~ 233 (299)
++|.+++. ...+++.+++.++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++....... .
T Consensus 103 ~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~ 172 (297)
T cd06659 103 GALTDIVS-----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--P 172 (297)
T ss_pred CCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--c
Confidence 99998773 256889999999999999999999999 9999999999999999999999999986432221 1
Q ss_pred cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 234 VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
......|+..|+|||.+.+..++.++||||||+++|+|++|..||...+..
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 223 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV 223 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 122356889999999998888999999999999999999999999766543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=270.64 Aligned_cols=203 Identities=29% Similarity=0.453 Sum_probs=175.4
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
+|++.+.||+|++|.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 48899999999999999999998999999999876542 2246788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+ +++|.+++.. ...++++.+++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 9999999853 2367899999999999999999999999 9999999999999999999999999997643322
Q ss_pred CcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
. .......++..|+|||.+.+. .++.++||||||+++|+|++|.+||...+.
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~ 206 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND 206 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH
Confidence 1 112234688899999998654 468899999999999999999988876654
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=269.57 Aligned_cols=202 Identities=32% Similarity=0.458 Sum_probs=176.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
..|+.++.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++.+.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 458888999999999999999998999999999875432 3346688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+.+++|.+++.. .++++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999998842 46889999999999999999999999 9999999999999999999999999997543222
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
.......++..|+|||.+.+..++.++|+||||+++|+|++|.+||...+.
T Consensus 156 --~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 206 (277)
T cd06640 156 --IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP 206 (277)
T ss_pred --cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcCh
Confidence 112234578889999999888899999999999999999999999976554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=271.96 Aligned_cols=202 Identities=25% Similarity=0.336 Sum_probs=170.1
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
+|++.+.||+|+||.||+|.+..+|+.||+|.++..... ....+.+|+.+++.++||||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 588899999999999999999999999999998654222 235677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+. ++|.+++.. ....+++..++.++.||++||.|||+++ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 97 588887753 2356899999999999999999999999 9999999999999999999999999997543221
Q ss_pred CcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
. ......+++.|+|||.+.+. .++.++|||||||++|+|++|..||...+.
T Consensus 154 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~ 205 (284)
T cd07839 154 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 205 (284)
T ss_pred C--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC
Confidence 1 12234578899999988664 478899999999999999999888654443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=269.06 Aligned_cols=203 Identities=30% Similarity=0.426 Sum_probs=169.4
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-ccHHHHHHHHHH-HhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLVEVLM-LSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+..|... ++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 468999999999999999999999999999999876532 223455556654 566799999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK-ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
|++ ++|.+++.........+++.+++.++.|++.||+|||++ + ++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 688888765433446789999999999999999999987 8 99999999999999999999999999975422
Q ss_pred CCCcccccccccCccccCcccccC----CCCCcccceehhHHHHHHHHhCCCCCCCC
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATT----GKLTAKSDIFSFGVVLLELITGRPAMDDS 281 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~ 281 (299)
. .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...
T Consensus 157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (283)
T cd06617 157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW 210 (283)
T ss_pred c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence 1 11122457888999998865 44688999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=265.98 Aligned_cols=209 Identities=28% Similarity=0.408 Sum_probs=175.2
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC-----cccHHHHHHHHHHHhhcCCCcceeeeeEEecC--Cee
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG-----FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG--TQR 144 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~ 144 (299)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46899999999999999999999999999999875321 11224678899999999999999999998664 467
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
++++||+.+++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 89999999999999984 3355889999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCC-cccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 225 FGPTGDK-SHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 225 ~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
....... ........++..|+|||.+.+..++.++|+|||||++|+|++|.+||...+..+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 218 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI 218 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH
Confidence 5422111 11112345888999999998888899999999999999999999999876554443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=272.23 Aligned_cols=208 Identities=29% Similarity=0.467 Sum_probs=171.1
Q ss_pred cCCCCCceecccCceEEEEEEECCCCc--EEEEEEcCCCC-cccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQ--VVAVKQLDDTG-FQGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv 147 (299)
++|++.+.||+|+||.||+|....++. .+++|.++... ....+.+..|+.+++++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999999877665 46888776422 22335688899999988 799999999999998999999
Q ss_pred EEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCce
Q 022309 148 YEYMPLGSLEDHLLGLTP------------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHP 215 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~ 215 (299)
+||+++++|.+++..... ....+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999854211 1135888999999999999999999999 9999999999999999999
Q ss_pred EEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 216 KLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 216 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
+|+|||++...... ........+..|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~ 226 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE 226 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 99999998632111 11111123456999999988889999999999999999998 999998766543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=274.44 Aligned_cols=211 Identities=30% Similarity=0.417 Sum_probs=173.0
Q ss_pred hcCCCCCceecccCceEEEEEEECC-------CCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhc-CCCcceeeeeEEecC
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAE-------TGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEG 141 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 141 (299)
.++|.+.+.||+|+||.||+|.+.. +...+|+|.+..... .....+..|+.+++.+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3569999999999999999998643 235699999875432 2335678899999998 799999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEe
Q 022309 142 TQRLLVYEYMPLGSLEDHLLGLTP------------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL 209 (299)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv 209 (299)
+..++||||+.+++|.+++..... ....+++.+++.++.|++.||+|||+++ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999964321 1235788999999999999999999999 9999999999999
Q ss_pred cCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 210 GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 210 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
+.++.++|+|||++................+++.|+|||.+.+..++.++|+|||||++|+|++ |..||...+.+
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 9999999999999875432211111112234568999999988889999999999999999998 88999766543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=281.98 Aligned_cols=197 Identities=31% Similarity=0.440 Sum_probs=174.0
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCCC
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGS 155 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~ 155 (299)
++||+|.||+||-|+++.+|+.||||+|.+... ..+..+..|+.+|..+.||.||.+--.|+..+..+.|||.+.|.-
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 689999999999999999999999999986543 344678999999999999999999999999999999999997655
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCC---CceEEccccccccCCCCCCc
Q 022309 156 LEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKG---FHPKLSDFGLAKFGPTGDKS 232 (299)
Q Consensus 156 L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~---~~~kl~Dfg~a~~~~~~~~~ 232 (299)
|.-+|. .....+++.....++.||+.||.|||.++ |+|.||||+|||+... ..+||||||.|+.... .
T Consensus 650 LEMILS---sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---k 720 (888)
T KOG4236|consen 650 LEMILS---SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---K 720 (888)
T ss_pred HHHHHH---hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecch---h
Confidence 544443 35578999999999999999999999999 9999999999999654 4799999999997532 3
Q ss_pred ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 233 HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 233 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
.....++|||.|+|||++.++.|...-||||+|||+|.-|+|..||...++
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd 771 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED 771 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc
Confidence 345568899999999999999999999999999999999999999987665
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=270.89 Aligned_cols=212 Identities=30% Similarity=0.463 Sum_probs=173.3
Q ss_pred hhcCCCCCceecccCceEEEEEEECC-----CCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCe
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAE-----TGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQ 143 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 143 (299)
..++|++.+.||+|+||.||+|.... .+..||+|.+..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 35679999999999999999997642 345799998865432 223467889999999999999999999999899
Q ss_pred eEEEEEecCCCCHHHHhcccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEE
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTP------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKL 217 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl 217 (299)
.++||||+.+++|.+++..... .....+...+..++.|++.||.|||+++ ++||||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999964221 1234567788999999999999999999 999999999999999999999
Q ss_pred ccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 218 SDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 218 ~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
+|||+++...............++..|+|||.+.+..++.++|+|||||++|||++ |.+||...+.+
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~ 228 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 228 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999875432222222222345677999999988889999999999999999999 78999766543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=266.87 Aligned_cols=207 Identities=30% Similarity=0.432 Sum_probs=167.9
Q ss_pred CCCCceecccCceEEEEEEECCCCc--EEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEecC------Ce
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQ--VVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG------TQ 143 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------~~ 143 (299)
+.+.+.||+|+||.||+|.+..++. .+|+|.++.... ...+.+.+|+.+++.++||||+++++.+... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999877665 589998875432 2235688899999999999999999976432 24
Q ss_pred eEEEEEecCCCCHHHHhccc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccc
Q 022309 144 RLLVYEYMPLGSLEDHLLGL--TPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFG 221 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg 221 (299)
.+++|||+.+++|.+++... ......+++..+..++.|++.||+|||+++ |+||||||+||++++++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999987421 123345889999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCch
Q 022309 222 LAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQG 283 (299)
Q Consensus 222 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 283 (299)
++................+++.|++||.+.+..++.++||||||+++|+|++ |.+||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 220 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN 220 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9976433222111122345678999999988889999999999999999999 8999976543
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=273.91 Aligned_cols=201 Identities=27% Similarity=0.357 Sum_probs=162.0
Q ss_pred CceecccCceEEEEEEECC--CCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEe--cCCeeEEEEEecC
Q 022309 77 TNFLGQGGFGAVYKGKLAE--TGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA--EGTQRLLVYEYMP 152 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~--~~~~~~lv~e~~~ 152 (299)
..+||+|+||.||+|.... ++..||+|.+.... ....+.+|+.+++.++||||+++++++. .+...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3579999999999999754 56789999987543 2345778999999999999999999884 3557789999986
Q ss_pred CCCHHHHhcccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEe----cCCCceEEcccccc
Q 022309 153 LGSLEDHLLGLT-----PEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL----GKGFHPKLSDFGLA 223 (299)
Q Consensus 153 ~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv----~~~~~~kl~Dfg~a 223 (299)
++|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+||++ +.++.++|+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 57877764211 12245889999999999999999999999 9999999999999 56679999999999
Q ss_pred ccCCCCCCc-ccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 224 KFGPTGDKS-HVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 224 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
+........ .......||+.|+|||++.+. .++.++|||||||++|||+||.+||...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~ 221 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccc
Confidence 764332211 112235688999999998764 578999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=267.60 Aligned_cols=204 Identities=25% Similarity=0.435 Sum_probs=174.8
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc------cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ------GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
+|+..+.||+|++|.||+|.+..+++.||+|++...... ....+..|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 488889999999999999999999999999998643311 23568889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC-ceEEcccccccc
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF-HPKLSDFGLAKF 225 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~-~~kl~Dfg~a~~ 225 (299)
|+||+.+++|.+++. ...++++..++.++.|++.||.|||+++ ++|+||+|+||+++.++ .++|+|||++..
T Consensus 81 v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999985 3357889999999999999999999999 99999999999998765 599999999876
Q ss_pred CCCCCCc--ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 226 GPTGDKS--HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 226 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
....... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 213 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH 213 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 4332111 112234578899999999888899999999999999999999999976543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=268.07 Aligned_cols=207 Identities=29% Similarity=0.485 Sum_probs=172.9
Q ss_pred cCCCCCceecccCceEEEEEEECCCCc---EEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQ---VVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
..|++.+.||+|+||.||+|.+..+++ .||+|.+..... .....+..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 458889999999999999999876664 599999875432 2345788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||+.+++|.+++.. ....+++.+++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence 999999999999853 2356889999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCCcccccccc---cCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 228 TGDKSHVSTRVM---GTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 228 ~~~~~~~~~~~~---g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
............ .+..|+|||.+.+..++.++|||||||++|||++ |..||...+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~ 218 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 218 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH
Confidence 322111111111 2357999999988889999999999999999887 99999776543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=271.25 Aligned_cols=204 Identities=30% Similarity=0.459 Sum_probs=178.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|++++.||+|+||.||++.+..++..|++|.+........+.+..|+.+++.++||||+++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 36799999999999999999999888999999998755445556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+++++|.+++.. ..+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999999842 45788999999999999999999999 9999999999999999999999999886543222
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
. ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..
T Consensus 170 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~ 221 (293)
T cd06647 170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221 (293)
T ss_pred c--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh
Confidence 1 122345888999999998888899999999999999999999999766543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=266.08 Aligned_cols=205 Identities=30% Similarity=0.399 Sum_probs=166.0
Q ss_pred ceecccCceEEEEEEEC--CCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCC
Q 022309 78 NFLGQGGFGAVYKGKLA--ETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLG 154 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~ 154 (299)
+.||+|+||.||+|... .++..+|+|.++..... ....+.+|+.+++.++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36899999999999864 34567999988765432 2356888999999999999999999999988999999999999
Q ss_pred CHHHHhcccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcc
Q 022309 155 SLEDHLLGLTP-EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233 (299)
Q Consensus 155 ~L~~~l~~~~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~ 233 (299)
+|.+++..... .....++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999864321 2234567788899999999999999999 9999999999999999999999999997532222111
Q ss_pred cccccccCccccCcccccCC-------CCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 234 VSTRVMGTHGYCAPEYATTG-------KLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~-------~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
......+++.|+|||++.+. .++.++||||||+++|||++ |..||...+..+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 217 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ 217 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH
Confidence 12234567889999988542 35789999999999999996 999998766544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=271.89 Aligned_cols=211 Identities=27% Similarity=0.437 Sum_probs=173.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCC--------------cEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETG--------------QVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLI 135 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~--------------~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~ 135 (299)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+...... ....+.+|+.+++.++||||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 357999999999999999999875432 35899998754322 235688999999999999999999
Q ss_pred eEEecCCeeEEEEEecCCCCHHHHhcccC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 022309 136 GYCAEGTQRLLVYEYMPLGSLEDHLLGLT--------PEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNI 207 (299)
Q Consensus 136 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Ni 207 (299)
+++......++||||+.+++|.+++.... .....+++.+++.++.|++.||+|||+++ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999985321 01124678899999999999999999999 99999999999
Q ss_pred EecCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh--CCCCCCCCchh
Q 022309 208 LLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT--GRPAMDDSQGH 284 (299)
Q Consensus 208 lv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt--g~~pf~~~~~~ 284 (299)
+++.++.++|+|||++................++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 999999999999999975433222222223345678999999988889999999999999999998 67888876543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=270.43 Aligned_cols=215 Identities=32% Similarity=0.405 Sum_probs=177.8
Q ss_pred HHHHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhc-CCCcceeeeeEEecC---
Q 022309 66 QLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEG--- 141 (299)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~--- 141 (299)
.+....++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++...
T Consensus 16 ~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred cCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 33445678999999999999999999999999999999986542 2245677889999888 899999999998643
Q ss_pred --CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcc
Q 022309 142 --TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSD 219 (299)
Q Consensus 142 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~D 219 (299)
...++||||+.+++|.+++.........+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~d 171 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVD 171 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEee
Confidence 3579999999999999988643334467899999999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccCccccCcccccCC-----CCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 220 FGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTG-----KLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 220 fg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
||++........ ......|+..|+|||.+... .++.++|||||||++|+|++|.+||...+..+.
T Consensus 172 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~ 241 (291)
T cd06639 172 FGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT 241 (291)
T ss_pred cccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH
Confidence 999875432211 12234578899999987543 367899999999999999999999987665433
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=270.73 Aligned_cols=204 Identities=26% Similarity=0.400 Sum_probs=172.9
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
++|++++.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 468999999999999999999998999999998865422 2235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN-KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
+++++|..++.... ....+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999998885321 13478999999999999999999996 57 999999999999999999999999998753221
Q ss_pred CCcccccccccCccccCcccccCC------CCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTG------KLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
......+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+.
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 212 (286)
T cd06622 157 ----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY 212 (286)
T ss_pred ----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch
Confidence 12234578889999998554 357899999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=272.14 Aligned_cols=213 Identities=29% Similarity=0.430 Sum_probs=175.0
Q ss_pred hhcCCCCCceecccCceEEEEEEEC-------CCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhc-CCCcceeeeeEEec
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLA-------ETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLM-RHPNLVHLIGYCAE 140 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~ 140 (299)
..++|.+.+.||+|+||.||+|+.. .++..||+|.+..... .....+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3567899999999999999999752 2345799998875432 2336788999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 022309 141 GTQRLLVYEYMPLGSLEDHLLGLTP------------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNIL 208 (299)
Q Consensus 141 ~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nil 208 (299)
....+++|||+.+++|.+++..... ....++..++..++.|++.||.|||+++ ++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 9999999999999999999864321 1235778889999999999999999999 999999999999
Q ss_pred ecCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 209 LGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 209 v~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 99999999999999976433222222222345678999999988889999999999999999998 789997665443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=266.90 Aligned_cols=207 Identities=29% Similarity=0.457 Sum_probs=173.4
Q ss_pred cCCCCCceecccCceEEEEEEECCCC---cEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETG---QVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.+|++.+.||+|+||.||+|.+..++ ..+|+|.++..... ....+..|+.+++.++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56889999999999999999886444 37999998754322 235788899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||+++++|.+++.. ....+++.++..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 999999999999963 2346789999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCccc-ccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 228 TGDKSHV-STRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 228 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
....... .....++..|+|||.+.+..++.++|+||||+++|++++ |..||...+..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~ 216 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ 216 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH
Confidence 3221111 111223567999999988889999999999999999887 99999876543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=266.53 Aligned_cols=208 Identities=25% Similarity=0.333 Sum_probs=173.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCc----EEEEEEcCCCC--cccHHHHHHHHHHHhhcCCCcceeeeeEEec-CCe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQ----VVAVKQLDDTG--FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAE-GTQ 143 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~~ 143 (299)
...|+.+..||+|.||.||+|....++. .+|||.++.+. ..-.....+|+.+++.++||||+.+..+|.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 4569999999999999999997654433 68999997542 2223567899999999999999999998876 778
Q ss_pred eEEEEEecCCCCHHHHhcccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCC----CceEEc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTP-EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKG----FHPKLS 218 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~----~~~kl~ 218 (299)
.++++||.+. +|..+|...+. ....++...+..|+.||+.|+.|||++. |+||||||.||||..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 9999999974 89998864332 2356889999999999999999999999 9999999999999876 899999
Q ss_pred cccccccCCCCCCcc-cccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 219 DFGLAKFGPTGDKSH-VSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 219 Dfg~a~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
|||+|+.+...-... ....++-|..|.|||++.+. .|+++.||||+|||+.||||-+|.|...+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 999999765443332 23346678899999999886 49999999999999999999999997554
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=267.06 Aligned_cols=205 Identities=29% Similarity=0.425 Sum_probs=173.3
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--c--------HHHHHHHHHHHhhcCCCcceeeeeEEecCC
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--G--------EKEFLVEVLMLSLMRHPNLVHLIGYCAEGT 142 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~--------~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 142 (299)
+|.+.+.||+|+||.||+|.+..+++.||+|.++..... . .+.+..|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 478889999999999999999889999999988542111 0 135678999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccc
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL 222 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~ 222 (299)
..++||||+.+++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccc
Confidence 99999999999999999853 357889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccCccccCcccccCCC--CCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 223 AKFGPTGDKSHVSTRVMGTHGYCAPEYATTGK--LTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 223 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
+................++..|+|||.+.... ++.++|+||||+++|+|++|..||...+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 218 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI 218 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH
Confidence 97543221111222345788999999987654 788999999999999999999999765543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=264.80 Aligned_cols=209 Identities=32% Similarity=0.444 Sum_probs=179.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
++|++.+.||.|+||+||+|....++..+++|++...... ....+.+|+.+++.++|+||+++++.+..+...++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4699999999999999999999889999999998754322 346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+.+++|.+++..... ...+++..+..++.|++.||.+||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999864211 246889999999999999999999999 9999999999999999999999999987544332
Q ss_pred Ccc--cccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 231 KSH--VSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 231 ~~~--~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
... ......|+..|+|||.+... .++.++|+||||+++|+|++|..||...+..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~ 213 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM 213 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh
Confidence 221 22334688899999998776 6889999999999999999999999876543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=268.45 Aligned_cols=201 Identities=27% Similarity=0.374 Sum_probs=177.7
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
+|++.+.||.|+||.||+|.+..+++.||+|.+.+... ...+.+.+|+.+++.++||||+++++.+.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 48889999999999999999998999999999975432 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+.|++|.+++.. ..++++.++..++.|+++||.|||+++ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999853 357899999999999999999999999 999999999999999999999999998754332
Q ss_pred CCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 1 12234578889999999888899999999999999999999999987764
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=267.27 Aligned_cols=205 Identities=29% Similarity=0.383 Sum_probs=162.6
Q ss_pred ceecccCceEEEEEEEC--CCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCC
Q 022309 78 NFLGQGGFGAVYKGKLA--ETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLG 154 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~ 154 (299)
+.||+|+||.||+|... .....+++|.+...... ....+.+|+.+++.++||||+++++.+......++||||+.++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 36999999999999653 24457888987654322 2356788999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcc
Q 022309 155 SLEDHLLGLTPE-MKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233 (299)
Q Consensus 155 ~L~~~l~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~ 233 (299)
+|.+++...... ....++..+..++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999653221 233467888999999999999999999 9999999999999999999999999986432221111
Q ss_pred cccccccCccccCcccccC-------CCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 234 VSTRVMGTHGYCAPEYATT-------GKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
......+++.|+|||++.. ..++.++|||||||++|||++ |.+||....+.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~ 217 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ 217 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH
Confidence 1122345677999998643 356789999999999999999 788997765443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=265.38 Aligned_cols=205 Identities=30% Similarity=0.466 Sum_probs=173.9
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc------cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ------GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
+|++.+.||+|+||.||+|.. .+++.+|+|.+...... ....+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 488899999999999999987 47889999988643221 12457889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
++||+++++|.+++. ...++++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 80 FMEFVPGGSISSILN----RFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 999999999999995 3356889999999999999999999999 999999999999999999999999998753
Q ss_pred CCC----CCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 227 PTG----DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 227 ~~~----~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
... ..........|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~ 215 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA 215 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH
Confidence 211 11111223458889999999988889999999999999999999999998665433
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=266.08 Aligned_cols=205 Identities=35% Similarity=0.495 Sum_probs=171.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|++.++||+|+||.||+|.+..+ ..||+|.+..... ..+.+.+|+.+++.++||||+++++.+.+ ...++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 81 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence 45699999999999999999988655 4599999875432 34678899999999999999999998754 567999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+.+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 82 MSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 9999999999632 2245788999999999999999999999 9999999999999999999999999997543322
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
.. ......++..|+|||.+.+..++.++||||||+++|+|++ |.+||......
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~ 210 (262)
T cd05071 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 210 (262)
T ss_pred cc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH
Confidence 11 1112345678999999988889999999999999999999 88899766543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=265.56 Aligned_cols=203 Identities=29% Similarity=0.431 Sum_probs=172.0
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEec
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYM 151 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 151 (299)
++|++.+.||+|+||.||+|.... +..+|+|.+.... .....+.+|+.+++.++||||+++++++.+....+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 458889999999999999998754 4569999887543 33467889999999999999999999999888899999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCC
Q 022309 152 PLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231 (299)
Q Consensus 152 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~ 231 (299)
.+++|.+++... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 82 SNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 999999998532 236899999999999999999999999 99999999999999999999999999875432211
Q ss_pred cccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCch
Q 022309 232 SHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQG 283 (299)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 283 (299)
. ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.
T Consensus 156 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~ 207 (256)
T cd05113 156 T-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN 207 (256)
T ss_pred e-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 1 1112235567999999988889999999999999999999 9999976654
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=267.33 Aligned_cols=207 Identities=31% Similarity=0.486 Sum_probs=174.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCc----EEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQ----VVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 145 (299)
..+|++.+.||+|+||.||+|.+..+++ .+|+|.+...... ....+.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3568999999999999999999876654 5899988765432 23568889999999999999999999987 6789
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
+||||+.+++|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 85 ~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccc
Confidence 99999999999999863 2345899999999999999999999998 99999999999999999999999999976
Q ss_pred CCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 226 GPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
..............++..|+|||.+....++.++|+||||+++||+++ |..||.....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 218 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV 218 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH
Confidence 543322222222224567999999988889999999999999999999 99999876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=266.97 Aligned_cols=208 Identities=34% Similarity=0.466 Sum_probs=175.7
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhc-CCCcceeeeeEEecCC------
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGT------ 142 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~------ 142 (299)
..++|++.+.||+|++|.||+|.+..+++.+++|++..... ....+.+|+.+++.+ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 35789999999999999999999998899999999876542 346788999999998 7999999999996544
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccc
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL 222 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~ 222 (299)
..++||||+++++|.+++.........+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 489999999999999998654333467899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccCccccCcccccC-----CCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 223 AKFGPTGDKSHVSTRVMGTHGYCAPEYATT-----GKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 223 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
+...... ........|++.|+|||.+.. ..++.++||||||+++|+|++|.+||...+.
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 223 (275)
T cd06608 160 SAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP 223 (275)
T ss_pred ceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch
Confidence 8753221 122233568889999998753 3467889999999999999999999976543
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=271.83 Aligned_cols=211 Identities=28% Similarity=0.438 Sum_probs=172.7
Q ss_pred hcCCCCCceecccCceEEEEEEEC-------CCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhc-CCCcceeeeeEEecC
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLA-------ETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEG 141 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 141 (299)
.++|.+.+.||+|+||.||+|.+. .....+|+|.++.... .....+..|+.+++.+ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357899999999999999999863 2345799998875432 2235678899999998 699999999999988
Q ss_pred CeeEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEe
Q 022309 142 TQRLLVYEYMPLGSLEDHLLGLTP------------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL 209 (299)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv 209 (299)
...+++|||+.+++|.+++..... ....+++.++..++.|++.||.|||+++ ++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 899999999999999999964221 1245888999999999999999999999 9999999999999
Q ss_pred cCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 210 GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 210 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
+.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999975432221111112234467999999988889999999999999999999 89999766543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=280.61 Aligned_cols=210 Identities=30% Similarity=0.424 Sum_probs=173.0
Q ss_pred hcCCCCCceecccCceEEEEEEEC-----CCCcEEEEEEcCCCCccc-HHHHHHHHHHHhhcC-CCcceeeeeEEecCCe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLA-----ETGQVVAVKQLDDTGFQG-EKEFLVEVLMLSLMR-HPNLVHLIGYCAEGTQ 143 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~ 143 (299)
.++|.+.+.||+|+||.||+|++. .+++.||+|+++...... .+.+.+|+.++..+. ||||+++++++.....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 456888999999999999999864 345689999997643222 346888999999997 9999999999999889
Q ss_pred eEEEEEecCCCCHHHHhcccCC----------------------------------------------------------
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTP---------------------------------------------------------- 165 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~---------------------------------------------------------- 165 (299)
.++||||+.+|+|.+++.....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999864211
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEe
Q 022309 166 ------------------------------------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL 209 (299)
Q Consensus 166 ------------------------------------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv 209 (299)
....+++..++.++.|++.||+|||+.+ ++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 1124677788999999999999999998 9999999999999
Q ss_pred cCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCch
Q 022309 210 GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQG 283 (299)
Q Consensus 210 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 283 (299)
+.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 9999999999999975432221111222356788999999988889999999999999999998 8999976543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=263.92 Aligned_cols=205 Identities=34% Similarity=0.518 Sum_probs=171.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|++.+.||+|+||.||+|.+. ++..+|+|.+..... ..+.+.+|+.+++.++|+||+++++++.. ...+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEY 81 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEe
Confidence 457999999999999999999876 456799999876443 35678999999999999999999998854 567899999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+.+++|.+++... ....+++.+++.++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 82 MSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 9999999998642 2345889999999999999999999999 9999999999999999999999999997543222
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++ |.+||...+..
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~ 210 (260)
T cd05070 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR 210 (260)
T ss_pred cc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 11 1112234567999999988889999999999999999999 89999776543
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=258.36 Aligned_cols=215 Identities=30% Similarity=0.432 Sum_probs=176.5
Q ss_pred HHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH-HHHHHHHHHHhhc-CCCcceeeeeEEecCCeeE
Q 022309 68 VAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE-KEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~ 145 (299)
....++.+.+..||.|+.|.|+++..+.+|...|||.+.......+ +.++..+.++.+. ++|+||+.+++|..+...+
T Consensus 88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF 167 (391)
T ss_pred ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence 3445667788899999999999999999999999999987765443 5667777766655 5899999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
|.||.|. ..+..++. ....++++..+-.+...++.||.||..++. |+|||+||+|||+|+.|++||||||.+..
T Consensus 168 IcMelMs-~C~ekLlk---rik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGr 241 (391)
T KOG0983|consen 168 ICMELMS-TCAEKLLK---RIKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGR 241 (391)
T ss_pred HHHHHHH-HHHHHHHH---HhcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccce
Confidence 9999984 34444443 234779999999999999999999997543 99999999999999999999999999976
Q ss_pred CCCCCCcccccccccCccccCcccccC---CCCCcccceehhHHHHHHHHhCCCCCCCCchhhhhhHHH
Q 022309 226 GPTGDKSHVSTRVMGTHGYCAPEYATT---GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVDW 291 (299)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~ 291 (299)
.... .......|.+.|||||.+.- ..|+..+||||||++++||.||..||...+.+-+++...
T Consensus 242 lvdS---kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv 307 (391)
T KOG0983|consen 242 LVDS---KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV 307 (391)
T ss_pred eecc---cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH
Confidence 4332 22334579999999999854 368899999999999999999999999977666655443
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=263.94 Aligned_cols=201 Identities=30% Similarity=0.474 Sum_probs=174.7
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-----ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-----QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
+|+..+.||+|++|.||+|.+..+++.|++|.+..... ...+.+..|+.+++.++|+||+++++++.++...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47888999999999999999988899999998865432 1235688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
+||+++++|.+++. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLK----KYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999985 3356889999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCCcccccccccCccccCcccccCCC-CCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGK-LTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
... ......|+..|++||.+.... ++.++|+||||+++|+|++|.+||.....
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~ 207 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG 207 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH
Confidence 222 123345888999999987766 88999999999999999999999977653
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=269.19 Aligned_cols=205 Identities=39% Similarity=0.600 Sum_probs=169.7
Q ss_pred CCceecccCceEEEEEEEC----CCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 76 DTNFLGQGGFGAVYKGKLA----ETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 76 ~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
+.+.||.|.||.||+|... ..+..|+||.++..... ..+.+.+|+..++.++||||+++++++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999987 34678999999654333 357899999999999999999999999988889999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+.+|+|.+++... ....+++.+++.|+.|++.||.|||+++ ++|+||+++||+++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 9999999999753 2467899999999999999999999999 9999999999999999999999999997652222
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
.............|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~ 213 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE 213 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2222333456778999999988889999999999999999999 789998875443
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=275.66 Aligned_cols=210 Identities=29% Similarity=0.410 Sum_probs=170.3
Q ss_pred hcCCCCCceecccCceEEEEEEE-----CCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhc-CCCcceeeeeEEecC-C
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKL-----AETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLM-RHPNLVHLIGYCAEG-T 142 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~-~ 142 (299)
.++|++.+.||+|+||.||+|.+ ..+++.||+|.++..... ....+.+|+.++..+ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46799999999999999999984 346788999999754322 235688899999999 689999999987554 4
Q ss_pred eeEEEEEecCCCCHHHHhcccCCC--------------------------------------------------------
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTPE-------------------------------------------------------- 166 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~-------------------------------------------------------- 166 (299)
..+++|||+.+|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 678999999999999998532110
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcccccccc
Q 022309 167 -------MKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVM 239 (299)
Q Consensus 167 -------~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 239 (299)
...+++.++..++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 124678888999999999999999999 9999999999999999999999999997543222111122233
Q ss_pred cCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCch
Q 022309 240 GTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQG 283 (299)
Q Consensus 240 g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 283 (299)
++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 287 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 287 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc
Confidence 5667999999988889999999999999999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=283.87 Aligned_cols=217 Identities=26% Similarity=0.376 Sum_probs=183.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH---HHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.+-|..++.||-|+||.|.++.-.+|...||.|.+++...-.. .-+..|-.||...+.+-||++|..|.+++++|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 4457778899999999999999999999999999987654333 3456788999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC-
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG- 226 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~- 226 (299)
|+|+.||++-.+|. +.+-|++..+..++.+|..|++++|..| +|||||||+|||||.+|++||+||||+.-+
T Consensus 708 MdYIPGGDmMSLLI----rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLI----RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EeccCCccHHHHHH----HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccce
Confidence 99999999999884 4577899999999999999999999999 999999999999999999999999998521
Q ss_pred --------CCCCCc-------------------------------ccccccccCccccCcccccCCCCCcccceehhHHH
Q 022309 227 --------PTGDKS-------------------------------HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVV 267 (299)
Q Consensus 227 --------~~~~~~-------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~i 267 (299)
..++.. ......+||+.|+|||++....|+-.+|.||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 111100 00112369999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCchhh--hhhHHHHhh
Q 022309 268 LLELITGRPAMDDSQGHE--RMLVDWVTL 294 (299)
Q Consensus 268 l~elltg~~pf~~~~~~~--~~~~~~~~~ 294 (299)
||||+.|++||.+..+-+ ..++.|-..
T Consensus 861 l~em~~g~~pf~~~tp~~tq~kv~nw~~~ 889 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQYKVINWRNF 889 (1034)
T ss_pred HHHHhhCCCCccCCCCCcceeeeeehhhc
Confidence 999999999997766633 346777543
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=270.25 Aligned_cols=202 Identities=32% Similarity=0.455 Sum_probs=175.0
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
+.|+..+.||+|+||.||+|.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 346778889999999999999988999999999875432 2335688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+.+++|.+++. ...+++..+..++.|++.|+.|||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 84 LGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred cCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 99999999884 256889999999999999999999999 9999999999999999999999999997543221
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||....+
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 206 (277)
T cd06642 156 --IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP 206 (277)
T ss_pred --hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch
Confidence 112224578889999999888899999999999999999999999976543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=268.90 Aligned_cols=205 Identities=26% Similarity=0.371 Sum_probs=176.0
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
++|++.+.||+|++|.||+|.+..+++.||+|.++.... .....+.+|+.+++.++|+||+++++++..++..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 368999999999999999999999999999998875432 223678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+.++.+..+.. ....+++.+++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 998866665552 3356899999999999999999999999 999999999999999999999999999765433
Q ss_pred CCcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
.. .......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||...+..
T Consensus 154 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~ 208 (288)
T cd07833 154 PA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI 208 (288)
T ss_pred cc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 22 122335678899999999887 7899999999999999999999999876544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=268.17 Aligned_cols=211 Identities=26% Similarity=0.387 Sum_probs=174.9
Q ss_pred hhcCCCCCceecccCceEEEEEEECC----CCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEec-CCe
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAE----TGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAE-GTQ 143 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~~ 143 (299)
..++|++.+.||+|+||.||+|.+.. ++..|++|.+..... .....+.+|+.+++.++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35679999999999999999999865 357899998865432 234568889999999999999999998765 467
Q ss_pred eEEEEEecCCCCHHHHhcccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPE----MKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSD 219 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~D 219 (299)
.+++++++.+++|.+++...... ...+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 78999999999999998643221 156889999999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCch
Q 022309 220 FGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQG 283 (299)
Q Consensus 220 fg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 283 (299)
||+++...............++..|+|||.+.+..++.++||||||+++|++++ |.+||...+.
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 225 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP 225 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH
Confidence 999975433322222222345677999999988889999999999999999999 9999987654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=270.54 Aligned_cols=203 Identities=32% Similarity=0.457 Sum_probs=173.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4688999999999999999999888999999988654322 23567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+++++|.++.. ....+++.+++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 999988887763 3345899999999999999999999999 999999999999999999999999998754332
Q ss_pred CCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
. .......++..|+|||.+.+ ..++.++||||||+++|+|++|.+||...+.
T Consensus 154 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~ 206 (286)
T cd07846 154 G--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD 206 (286)
T ss_pred c--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch
Confidence 2 12223457889999998865 3477899999999999999999999976554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=270.27 Aligned_cols=202 Identities=29% Similarity=0.403 Sum_probs=172.5
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-----cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-----GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... ....+..|+.+++.++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488889999999999999999989999999999765433 234567899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||+ +++|.+++... ...+++..++.++.||++||+|||+++ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 88999999531 136899999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
.... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||...+.
T Consensus 154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~ 208 (298)
T cd07841 154 SPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD 208 (298)
T ss_pred CCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc
Confidence 3221 1222346788999998854 4578899999999999999999888876654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=262.70 Aligned_cols=206 Identities=26% Similarity=0.367 Sum_probs=177.4
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC--cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG--FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
+|++.+.||+|+||.+|++.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5889999999999999999999999999999986432 22335788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+.+++|.+.+... ....+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999999988532 2245789999999999999999999999 9999999999999999999999999997543221
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.......|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+..+
T Consensus 156 --~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~ 208 (256)
T cd08218 156 --ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN 208 (256)
T ss_pred --hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH
Confidence 11223457889999999988889999999999999999999999998765443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=271.73 Aligned_cols=208 Identities=25% Similarity=0.328 Sum_probs=173.0
Q ss_pred CCCCCceecccCceEEEEEEECC--CCcEEEEEEcCCCC---cccHHHHHHHHHHHhhcCCCcceeeeeEEecC--CeeE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAE--TGQVVAVKQLDDTG---FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG--TQRL 145 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~~ 145 (299)
+|++.+.||+|++|.||+|.+.. +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48889999999999999999988 89999999997643 22235678899999999999999999999888 7899
Q ss_pred EEEEecCCCCHHHHhcccCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC----CCceEEccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEM-KPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK----GFHPKLSDF 220 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~----~~~~kl~Df 220 (299)
+||||+. ++|.+.+....... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999996 47777775433222 37899999999999999999999999 999999999999999 899999999
Q ss_pred cccccCCCCCCc-ccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 221 GLAKFGPTGDKS-HVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 221 g~a~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
|++......... .......+++.|+|||.+.+. .++.++|||||||++|+|++|.+||...+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 222 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK 222 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccc
Confidence 999764332221 112234578889999987664 5788999999999999999999999866543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=262.94 Aligned_cols=202 Identities=30% Similarity=0.423 Sum_probs=179.1
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
++|++.+.||+|++|.||+|.+..+++.|++|.+..... .....+..|+..+..++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368899999999999999999999999999999876544 3346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN-KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
+++++|.+++.. ...+++..++.++.|++.||+|||+ .+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 999999999953 3678999999999999999999999 99 999999999999999999999999999764322
Q ss_pred CCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
... .....++..|+|||.+.+..++.++|+||||+++|+|++|.+||...+
T Consensus 154 ~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 154 LDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred CCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 221 123457889999999988889999999999999999999999998775
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=269.28 Aligned_cols=202 Identities=30% Similarity=0.412 Sum_probs=176.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
.++|++++.||+|+||+||++.+..+++.||+|++..... .....+.+|+.+++.++||||+++++.+...+.+++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 3568899999999999999999998999999998865432 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN-KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
|+++++|.+++. ...++++..+..++.|++.||.|||+ .+ ++||||+|+||++++++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 84 FMDCGSLDRIYK----KGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred cCCCCCHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 999999999884 33568999999999999999999997 57 99999999999999999999999999864321
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
. ......|+..|+|||++.+..++.++|+|||||++|+|++|..||.....
T Consensus 157 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 157 S----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred h----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 1 11234688999999999888899999999999999999999999986554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=265.25 Aligned_cols=206 Identities=28% Similarity=0.455 Sum_probs=172.7
Q ss_pred cCCCCCceecccCceEEEEEEECCCCc---EEEEEEcCCCC-cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQ---VVAVKQLDDTG-FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
++|+..+.||+|+||.||+|.+..++. .+++|.+.... ....+.+..|+.+++.++||||+++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 468888999999999999999876554 79999887543 22346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||+.+++|.+++.. ....+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 85 TEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999853 2356889999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCCcccc-cccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCch
Q 022309 228 TGDKSHVS-TRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQG 283 (299)
Q Consensus 228 ~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 283 (299)
........ .....++.|+|||.+.+..++.++|||||||++|+|++ |..||...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~ 216 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN 216 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence 22221111 11123457999999988889999999999999999998 9999976654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=274.27 Aligned_cols=212 Identities=30% Similarity=0.420 Sum_probs=172.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCC-------CcEEEEEEcCCCCcc-cHHHHHHHHHHHhhc-CCCcceeeeeEEecC
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAET-------GQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLM-RHPNLVHLIGYCAEG 141 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 141 (299)
..+|++++.||+|+||.||+|.+... +..||+|.+...... ....+.+|+.+++.+ +||||+++++++...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 35699999999999999999986432 236899988754322 235788999999999 899999999999998
Q ss_pred CeeEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEe
Q 022309 142 TQRLLVYEYMPLGSLEDHLLGLTP------------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL 209 (299)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv 209 (299)
...++++||+.+++|.+++..... ....++..++..++.|++.||.|||+++ ++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 999999999999999999864221 2235788899999999999999999999 9999999999999
Q ss_pred cCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 210 GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 210 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
+.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...+.++
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999975432211111112234567999999988889999999999999999998 899997765433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=276.77 Aligned_cols=211 Identities=28% Similarity=0.431 Sum_probs=184.0
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH-HHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE-KEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
...+...+.++||+|.||.|.+|... .+..||+|.++.....+. .+|.+|+++|.+++||||++++++|..++.+++|
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 34567889999999999999999874 368999999988766665 7899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
+||++.|+|.+++...... .+......+|+.||+.|++||.+.+ +|||||.+.|+|++.++++||+|||+++...
T Consensus 614 ~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccc
Confidence 9999999999999753221 1355666789999999999999999 9999999999999999999999999998766
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh--CCCCCCCCchhh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT--GRPAMDDSQGHE 285 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt--g~~pf~~~~~~~ 285 (299)
.++........+-..+|||+|.+...+++.++|+|+||+++||+++ .+.||.+...++
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~ 748 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ 748 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH
Confidence 6666666666677889999999999999999999999999999876 688998776443
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=262.99 Aligned_cols=201 Identities=27% Similarity=0.342 Sum_probs=168.2
Q ss_pred HHHhhcCCCCCcee--cccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCe
Q 022309 67 LVAATDNFKDTNFL--GQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQ 143 (299)
Q Consensus 67 ~~~~~~~y~~~~~l--g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 143 (299)
.....++|++.+.+ |+|+||.||++.+..++..+|+|.+........ |+.....+ +||||+++++.+...+.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 34445677887777 999999999999999999999999865432211 22222222 79999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC-ceEEccccc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF-HPKLSDFGL 222 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~-~~kl~Dfg~ 222 (299)
.++||||+++++|.+++. ....+++.+++.++.|++.||.|||+.+ ++||||+|+||+++.++ .++|+|||+
T Consensus 84 ~~iv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLK----KEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred eEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 999999999999999995 3348899999999999999999999999 99999999999999988 999999999
Q ss_pred cccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 223 AKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 223 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
+...... ....++..|+|||++.+..++.++||||||+++|+|++|..||.....++
T Consensus 157 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 213 (267)
T PHA03390 157 CKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213 (267)
T ss_pred ceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch
Confidence 8753221 12357889999999988889999999999999999999999998655443
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=262.18 Aligned_cols=204 Identities=32% Similarity=0.461 Sum_probs=176.7
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
+|++.+.||+|+||.||+|.+..+++.|++|.+...... ....+..|+.+++.++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588999999999999999999889999999998765443 346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+++++|.+++. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHh----hcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999999985 3345788999999999999999999999 9999999999999999999999999987643322
Q ss_pred Cccc--ccccccCccccCcccccCCC---CCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 231 KSHV--STRVMGTHGYCAPEYATTGK---LTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 231 ~~~~--~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
.... .....+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~ 211 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN 211 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc
Confidence 2111 11245788999999987766 78899999999999999999999976643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=262.24 Aligned_cols=197 Identities=31% Similarity=0.468 Sum_probs=164.2
Q ss_pred eecccCceEEEEEEE--CCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCC
Q 022309 79 FLGQGGFGAVYKGKL--AETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLG 154 (299)
Q Consensus 79 ~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~ 154 (299)
.||+|+||.||+|.+ ..++..+|+|+++..... ..+.+..|+.+++.++||||+++++++.. ...++||||+.++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999965 456789999998654322 23568889999999999999999998864 4678999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCccc
Q 022309 155 SLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHV 234 (299)
Q Consensus 155 ~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~ 234 (299)
+|.+++. ....+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++...........
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999984 3356899999999999999999999999 99999999999999999999999999975433222111
Q ss_pred -ccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCch
Q 022309 235 -STRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQG 283 (299)
Q Consensus 235 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 283 (299)
.....++..|+|||.+....++.++|+|||||++|||++ |.+||...+.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 204 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG 204 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 111234578999999988889999999999999999998 9999987654
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=266.54 Aligned_cols=203 Identities=28% Similarity=0.375 Sum_probs=174.8
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecC--CeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG--TQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~~lv~ 148 (299)
++|+..+.||.|++|.||+|.+..+++.+|+|.+..... .....+.+|+.+++.++||||+++++++.+. ..+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 368889999999999999999999999999999875433 2346788999999999999999999988543 4689999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+++++|.+++.........+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887543344566889999999999999999999999 99999999999999999999999999865322
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCC
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDS 281 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 281 (299)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 11 12345778899999998888999999999999999999999999866
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=262.56 Aligned_cols=202 Identities=33% Similarity=0.494 Sum_probs=171.0
Q ss_pred ceecccCceEEEEEEECC-CCc--EEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCC
Q 022309 78 NFLGQGGFGAVYKGKLAE-TGQ--VVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~-~~~--~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
+.||+|++|.||+|.+.. +++ .||+|.+..... ...+.+.+|+.+++.++||||+++++.+.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999855 333 699999987665 445678999999999999999999999988 888999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcc
Q 022309 154 GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233 (299)
Q Consensus 154 ~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~ 233 (299)
++|.+++..... ..+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999964321 56899999999999999999999999 9999999999999999999999999997653322211
Q ss_pred -cccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 234 -VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 234 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 208 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ 208 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 1122456778999999988889999999999999999999 999997665544
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=262.46 Aligned_cols=204 Identities=32% Similarity=0.486 Sum_probs=172.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.+.|+++++||+|+||.||+|... +++.||+|.+.... .....+.+|+.+++.++|+||+++++++. .+..+++||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 467999999999999999999865 57789999987554 33467889999999999999999999875 4568999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+.+++|.+++... ....+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 82 MENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 9999999988542 2356889999999999999999999999 9999999999999999999999999997543221
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCch
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQG 283 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 283 (299)
.. ......++..|+|||.+.+..++.++||||||+++|+|++ |.+||...+.
T Consensus 157 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 209 (260)
T cd05067 157 YT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN 209 (260)
T ss_pred cc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh
Confidence 11 1122335678999999988889999999999999999999 9999976654
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=265.71 Aligned_cols=201 Identities=32% Similarity=0.401 Sum_probs=176.1
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
++|++.+.||+|++|.||+|.+..+++.+++|.+..... .....+.+|+.+++.++||||+++++.+..+...++++|+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 358888999999999999999999999999999876543 2346688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN-KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
+.+++|.+++... ...+++..+..++.|++.||+|||+ .+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 9999999998642 2678999999999999999999999 88 999999999999999999999999998653221
Q ss_pred CCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
. .....++..|+|||.+.+..++.++||||||+++|+|++|..||...+
T Consensus 155 ~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 203 (265)
T cd06605 155 L----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEN 203 (265)
T ss_pred H----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccc
Confidence 1 111568889999999988889999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=261.40 Aligned_cols=199 Identities=28% Similarity=0.448 Sum_probs=164.3
Q ss_pred eecccCceEEEEEEEC--CCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCCC
Q 022309 79 FLGQGGFGAVYKGKLA--ETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGS 155 (299)
Q Consensus 79 ~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~ 155 (299)
.||+|+||.||+|.+. .++..||+|++...... ..+.+.+|+.+++.++||||+++++++.. ...++||||+.+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999774 44567999988755322 23568899999999999999999998864 56799999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCccc-
Q 022309 156 LEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHV- 234 (299)
Q Consensus 156 L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~- 234 (299)
|.+++.. ....+++.+++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++...........
T Consensus 81 L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9999853 2356899999999999999999999999 99999999999999999999999999975432222111
Q ss_pred ccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 235 STRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 235 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 205 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP 205 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence 111223568999999988889999999999999999996 99999876553
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=263.42 Aligned_cols=203 Identities=29% Similarity=0.431 Sum_probs=171.7
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEec
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYM 151 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 151 (299)
+.+.....||+|+||.||+|.+..++..|++|.+........+.+.+|+.+++.++|+||+++++++..++..++|+||+
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 87 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV 87 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence 34444568999999999999999899999999987765555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC-CCceEEccccccccCCC
Q 022309 152 PLGSLEDHLLGLTPEMKPL--DWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK-GFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 152 ~~~~L~~~l~~~~~~~~~~--~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~-~~~~kl~Dfg~a~~~~~ 228 (299)
.+++|.+++... ..++ ++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.++|+|||++.....
T Consensus 88 ~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 88 PGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred CCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 999999998632 2334 78888999999999999999999 999999999999976 67999999999875432
Q ss_pred CCCcccccccccCccccCcccccCCC--CCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGK--LTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|.+||...+
T Consensus 162 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 162 INP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred CCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 211 122235788999999986543 7889999999999999999999997654
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=266.24 Aligned_cols=209 Identities=31% Similarity=0.436 Sum_probs=173.6
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhc-CCCcceeeeeEEec------C
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLM-RHPNLVHLIGYCAE------G 141 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~------~ 141 (299)
...+.|++.+.||+|+||.||+|.+..+++.+|+|.+.... .....+..|+.+++.+ +|+||+++++++.. .
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 34578999999999999999999999999999999886543 2335677888888888 79999999999853 4
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccc
Q 022309 142 TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFG 221 (299)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg 221 (299)
...+++|||+.+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg 166 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFG 166 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCc
Confidence 5789999999999999988642 2345788889999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccCccccCccccc-----CCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 222 LAKFGPTGDKSHVSTRVMGTHGYCAPEYAT-----TGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 222 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
++....... .......|++.|+|||.+. +..++.++|+|||||++|+|++|.+||......+
T Consensus 167 ~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~ 233 (282)
T cd06636 167 VSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR 233 (282)
T ss_pred chhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh
Confidence 987532111 1122356888999999875 3457889999999999999999999997765433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=266.18 Aligned_cols=203 Identities=34% Similarity=0.482 Sum_probs=169.1
Q ss_pred cCCCCCceecccCceEEEEEEE----CCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEec--CCeeE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKL----AETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAE--GTQRL 145 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~ 145 (299)
.+|++++.||+|+||.||+|.. ..+++.||+|.+........+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4688999999999999999974 45788999999876654555678899999999999999999998643 34678
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
+||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 99999999999999853 2345889999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCccc-ccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCC
Q 022309 226 GPTGDKSHV-STRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDD 280 (299)
Q Consensus 226 ~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 280 (299)
......... .....++..|+|||.+.+..++.++||||||+++|||++|..|+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 543222111 1112234569999999888899999999999999999998776543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=261.32 Aligned_cols=199 Identities=35% Similarity=0.528 Sum_probs=166.4
Q ss_pred ceecccCceEEEEEEECCCC---cEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCC
Q 022309 78 NFLGQGGFGAVYKGKLAETG---QVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
++||+|+||.||+|....++ ..+|+|.+...... ..+.+..|+.+++.++||||+++++++.. +..++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 46999999999999875544 78999999765442 34678899999999999999999998764 467999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcc
Q 022309 154 GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233 (299)
Q Consensus 154 ~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~ 233 (299)
++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 80 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 999999953 346899999999999999999999999 9999999999999999999999999997643322211
Q ss_pred c-ccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 234 V-STRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 234 ~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |.+||...+..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~ 205 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA 205 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 1 111123467999999988889999999999999999998 99999876653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=268.86 Aligned_cols=226 Identities=23% Similarity=0.328 Sum_probs=187.5
Q ss_pred CCCccHHHHHHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCC--C----cce
Q 022309 59 ENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRH--P----NLV 132 (299)
Q Consensus 59 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~----nIv 132 (299)
...+-+.......++|.++..+|+|.||.|..+.+..++..||||+++....- .++..-|+.+|.++.+ | -+|
T Consensus 76 dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv 154 (415)
T KOG0671|consen 76 DGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCV 154 (415)
T ss_pred CceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEE
Confidence 33345566666789999999999999999999999999999999999765322 3456678999998842 3 378
Q ss_pred eeeeEEecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEec--
Q 022309 133 HLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLG-- 210 (299)
Q Consensus 133 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~-- 210 (299)
.+.+||...++.+||+|.+ |.|+.+++.. +...+++..++..|+.|+++++++||+.+ ++|-||||+|||+.
T Consensus 155 ~m~~wFdyrghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss 228 (415)
T KOG0671|consen 155 QMRDWFDYRGHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSS 228 (415)
T ss_pred eeehhhhccCceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEecc
Confidence 8999999999999999998 6799999975 45678999999999999999999999999 99999999999983
Q ss_pred ------------------CCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHH
Q 022309 211 ------------------KGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELI 272 (299)
Q Consensus 211 ------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell 272 (299)
++..++|+|||.|..... .....+.|..|.|||++.+-.++.++||||+||||+||.
T Consensus 229 ~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Ely 303 (415)
T KOG0671|consen 229 EYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELY 303 (415)
T ss_pred ceEEEeccCCccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEee
Confidence 134689999999986322 224567899999999999999999999999999999999
Q ss_pred hCCCCCCCCchhhhh--hHHHHhhhh
Q 022309 273 TGRPAMDDSQGHERM--LVDWVTLFF 296 (299)
Q Consensus 273 tg~~pf~~~~~~~~~--~~~~~~~~~ 296 (299)
||...|+..++-|++ ....+.++.
T Consensus 304 tG~~LFqtHen~EHLaMMerIlGp~P 329 (415)
T KOG0671|consen 304 TGETLFQTHENLEHLAMMERILGPIP 329 (415)
T ss_pred ccceecccCCcHHHHHHHHHhhCCCc
Confidence 999999988865543 444444443
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=262.81 Aligned_cols=205 Identities=27% Similarity=0.406 Sum_probs=176.2
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEec--CCeeEEEE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAE--GTQRLLVY 148 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~lv~ 148 (299)
+|++.+.||.|+||.||++.+..+++.||+|.+...... ..+.+..|+.+++.++||||+++++.+.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 488899999999999999999999999999998754332 23567889999999999999999998753 45678999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEecCCCCCCEEecCCCceEEcccccc
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLH-----NKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA 223 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH-----~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a 223 (299)
||+++++|.+++........++++.+++.++.|++.||.||| +.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999654444567899999999999999999999 777 999999999999999999999999999
Q ss_pred ccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 224 KFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+
T Consensus 158 ~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 158 KILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred ccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 86433221 1223468899999999988889999999999999999999999998775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=264.31 Aligned_cols=201 Identities=31% Similarity=0.496 Sum_probs=174.0
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcC---CCcceeeeeEEecCCeeEEEE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMR---HPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~lv~ 148 (299)
.|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.+. ||||+++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 47888999999999999999999999999999875432 33456888999999886 999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+.+++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999998842 37889999999999999999999999 99999999999999999999999999976543
Q ss_pred CCCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
.. .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+.
T Consensus 154 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~ 207 (277)
T cd06917 154 NS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA 207 (277)
T ss_pred Cc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 32 12223468889999998865 4578899999999999999999999976654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=265.37 Aligned_cols=202 Identities=31% Similarity=0.449 Sum_probs=169.1
Q ss_pred cCCCCCceecccCceEEEEEEE----CCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecC--Cee
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKL----AETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG--TQR 144 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~ 144 (299)
..|++++.||+|+||.||+|.. ..++..||+|.+..... .....+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3478999999999999999974 45688999999875432 2235788999999999999999999998765 567
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
++||||++|++|.+++.. ....+++.+++.++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence 899999999999999853 2245889999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCc-ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCC
Q 022309 225 FGPTGDKS-HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMD 279 (299)
Q Consensus 225 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 279 (299)
........ .......++..|+|||.+.+..++.++||||||+++|+|+++..|+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence 64332221 11223456778999999988889999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=265.06 Aligned_cols=201 Identities=26% Similarity=0.402 Sum_probs=175.1
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecC
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMP 152 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 152 (299)
.|...+.||+|++|.||++.+..+++.+++|.+........+.+.+|+.+++.++||||+++++++...+..++++||+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 35556899999999999999988999999998875544445668899999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCc
Q 022309 153 LGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKS 232 (299)
Q Consensus 153 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~ 232 (299)
+++|.+++.. .++++.++..++.|++.||+|||+++ ++||||+|+||+++.++.++|+|||++........
T Consensus 100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~- 170 (285)
T cd06648 100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP- 170 (285)
T ss_pred CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence 9999999843 56889999999999999999999999 99999999999999999999999998864322211
Q ss_pred ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 233 HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 233 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~ 220 (285)
T cd06648 171 -RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP 220 (285)
T ss_pred -ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH
Confidence 12234588899999999888899999999999999999999999976554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=259.90 Aligned_cols=199 Identities=34% Similarity=0.491 Sum_probs=168.8
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCCCH
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSL 156 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L 156 (299)
+.||+|+||.||+|.+.. ++.|++|.+...... ....+..|+.+++.++|+||+++++++.+....++|||++.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 469999999999999877 999999998765544 346788999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCccccc
Q 022309 157 EDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVST 236 (299)
Q Consensus 157 ~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 236 (299)
.+++.. ....+++..+..++.|++.||+|||+++ ++||||+|+||+++.++.++|+|||++.............
T Consensus 80 ~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 80 LTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 999853 2346788999999999999999999999 9999999999999999999999999997543211111111
Q ss_pred ccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCch
Q 022309 237 RVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQG 283 (299)
Q Consensus 237 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 283 (299)
...++..|+|||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~ 201 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN 201 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH
Confidence 1223567999999988889999999999999999999 8899976653
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=266.85 Aligned_cols=211 Identities=30% Similarity=0.506 Sum_probs=173.9
Q ss_pred hcCCCCCceecccCceEEEEEEEC-----CCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLA-----ETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQR 144 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 144 (299)
.++|++.+.||+|+||.||+|.+. .++..||+|.+...... ....+.+|+.+++.++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467999999999999999999874 36788999998754332 235688899999999999999999999998999
Q ss_pred EEEEEecCCCCHHHHhcccCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 022309 145 LLVYEYMPLGSLEDHLLGLTP------------------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGN 206 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~------------------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~N 206 (299)
+++|||+.+++|.+++..... ....+++.+++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999863211 1234788899999999999999999999 9999999999
Q ss_pred EEecCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 207 ILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 207 ilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
|+++.++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|+|++ |..||...+..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999874322211111122234567999999988889999999999999999998 88898765543
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=261.62 Aligned_cols=207 Identities=35% Similarity=0.515 Sum_probs=175.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
..++|++.+.||+|+||.||+|.+. ++..||+|.+.... ...+++.+|+.+++.++|+||+++++++......++|||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 3567999999999999999999975 45779999987544 345678999999999999999999999998889999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
++++++|.+++... ....+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 82 YMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred ccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccch
Confidence 99999999999642 2246889999999999999999999999 999999999999999999999999998754321
Q ss_pred CCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
.. .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..
T Consensus 157 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 211 (261)
T cd05034 157 EY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR 211 (261)
T ss_pred hh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 11 11112234567999999988889999999999999999999 99999765543
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=269.21 Aligned_cols=207 Identities=30% Similarity=0.428 Sum_probs=173.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEecC--CeeEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAEG--TQRLL 146 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~~l 146 (299)
.++|++.+.||+|+||.||+|.+..+++.||+|.++...... ...+.+|+.+++.++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999999999999999986443222 23466799999999999999999998755 46899
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
||||+. ++|.+++... ...+++.+++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...
T Consensus 86 v~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999996 4888888532 366899999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
..... ......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+..+.
T Consensus 159 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~ 217 (309)
T cd07845 159 GLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ 217 (309)
T ss_pred CCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 33221 1122345778999999865 4578999999999999999999999987765443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=264.05 Aligned_cols=193 Identities=33% Similarity=0.461 Sum_probs=160.9
Q ss_pred eecccCceEEEEEEECCCCcEEEEEEcCCCCccc---HHHHHHHHHHHh---hcCCCcceeeeeEEecCCeeEEEEEecC
Q 022309 79 FLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG---EKEFLVEVLMLS---LMRHPNLVHLIGYCAEGTQRLLVYEYMP 152 (299)
Q Consensus 79 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~---~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 152 (299)
.||+|+||.||++.+..+++.||+|.+.+..... ...+..|..+++ ..+||||+.+++.+...+..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999886543221 223344444333 3479999999999999899999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCc
Q 022309 153 LGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKS 232 (299)
Q Consensus 153 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~ 232 (299)
+++|.+++. ....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--- 150 (279)
T cd05633 81 GGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--- 150 (279)
T ss_pred CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc---
Confidence 999999884 3356899999999999999999999999 999999999999999999999999998643221
Q ss_pred ccccccccCccccCccccc-CCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 233 HVSTRVMGTHGYCAPEYAT-TGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 233 ~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
......|++.|+|||.+. +..++.++|+||+||++|+|++|..||....
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 151 -KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred -CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence 112346899999999886 4568899999999999999999999997554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=259.41 Aligned_cols=204 Identities=28% Similarity=0.409 Sum_probs=175.8
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
+|++.+.||+|++|.||+|.+..+++.+|+|.+...... ....+..|+.+++.++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588899999999999999999999999999998754322 235788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCC-CceEEccccccccCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKG-FHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~-~~~kl~Dfg~a~~~~~~ 229 (299)
+++++|.+++... ....+++..+..++.|++.||+|||+++ ++|+||+|+||+++.+ +.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999999642 2345889999999999999999999999 9999999999999855 46899999999764322
Q ss_pred CCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
. ......++..|+|||.+.+..++.++||||||+++|+|++|..||...+..
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 207 (256)
T cd08220 156 S---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP 207 (256)
T ss_pred c---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH
Confidence 1 122345788999999998888899999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=261.75 Aligned_cols=203 Identities=24% Similarity=0.358 Sum_probs=161.9
Q ss_pred eecccCceEEEEEEECCC--CcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCCC
Q 022309 79 FLGQGGFGAVYKGKLAET--GQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGS 155 (299)
Q Consensus 79 ~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~ 155 (299)
.||+|+||.||+|....+ ...+++|.+..... .....+.+|+.+++.++||||+++++.+......++||||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975432 34567777664432 234678999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcccc
Q 022309 156 LEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVS 235 (299)
Q Consensus 156 L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~ 235 (299)
|.+++..........+...+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999653333345677788899999999999999999 999999999999999999999999998642221111122
Q ss_pred cccccCccccCcccccC-------CCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 236 TRVMGTHGYCAPEYATT-------GKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 236 ~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
....++..|+|||++.. ..++.++||||||+++|||++ |.+||...+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~ 215 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR 215 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 23457889999998743 235778999999999999997 57788765543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=264.82 Aligned_cols=206 Identities=30% Similarity=0.441 Sum_probs=174.4
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEec
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYM 151 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 151 (299)
+|++++.||+|++|.||+|.+..+++.||+|+++..... ....+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 488999999999999999999999999999998765332 2356778999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCC
Q 022309 152 PLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231 (299)
Q Consensus 152 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~ 231 (299)
.+ +|.+++.... ....+++.++..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~- 154 (284)
T cd07836 81 DK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV- 154 (284)
T ss_pred Cc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-
Confidence 75 8888875432 2356899999999999999999999999 9999999999999999999999999997532211
Q ss_pred cccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 232 SHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.......+++.|++||.+.+. .++.++||||||+++|+|++|.+||...+..+
T Consensus 155 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~ 208 (284)
T cd07836 155 -NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED 208 (284)
T ss_pred -cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 112223568889999987554 57889999999999999999999998776544
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=265.52 Aligned_cols=205 Identities=27% Similarity=0.397 Sum_probs=173.3
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
+|++++.||.|++|.||+|.+..+++.||+|.+...... ....+..|+.+++.++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 488899999999999999999999999999988754322 235688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+. ++|.+++... ....+++.+++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 5898888542 2356889999999999999999999999 9999999999999999999999999987543221
Q ss_pred CcccccccccCccccCcccccCCC-CCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGK-LTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
. ......+++.|+|||.+.+.. ++.++||||||+++|+|+||..||...+..+
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~ 208 (284)
T cd07860 155 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 208 (284)
T ss_pred c--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 1 122234678899999886644 6888999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=268.53 Aligned_cols=205 Identities=33% Similarity=0.500 Sum_probs=170.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCc----EEEEEEcCCCCccc-HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQ----VVAVKQLDDTGFQG-EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 145 (299)
.++|+..+.||+|+||.||+|.+..+++ .+|+|.+....... ...+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 3568889999999999999999877776 46888886543222 24678899999999999999999998764 467
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
+++|++.+|+|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 85 ~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccc
Confidence 99999999999999853 2346888999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCc
Q 022309 226 GPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQ 282 (299)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~ 282 (299)
..............++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~ 216 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP 216 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 433222212222345678999999988889999999999999999998 899997654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=259.73 Aligned_cols=204 Identities=38% Similarity=0.535 Sum_probs=173.5
Q ss_pred CCCCceecccCceEEEEEEECCCC----cEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETG----QVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
+++.+.||.|+||.||+|.+..++ ..||+|.+...... ..+.+..|+.+++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 457789999999999999998766 88999999765433 4567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
|++.+++|.+++.... ...+++.++..++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999985321 112899999999999999999999999 99999999999999999999999999976543
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCch
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQG 283 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 283 (299)
....... ...+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||...+.
T Consensus 156 ~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~ 210 (258)
T smart00219 156 DDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN 210 (258)
T ss_pred ccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 3211111 2236788999999988889999999999999999998 8899986554
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=262.84 Aligned_cols=202 Identities=31% Similarity=0.448 Sum_probs=174.9
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
+-|++++.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++..+...++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 347888999999999999999988999999998865432 2235688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+.+++|.+++.. ..+++..+..++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 84 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 999999998842 46889999999999999999999999 9999999999999999999999999987543221
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||.....
T Consensus 156 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 206 (277)
T cd06641 156 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP 206 (277)
T ss_pred --hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch
Confidence 112234578889999999888889999999999999999999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=260.91 Aligned_cols=193 Identities=32% Similarity=0.438 Sum_probs=170.5
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEcCCCCcc---cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCCCH
Q 022309 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSL 156 (299)
Q Consensus 80 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L 156 (299)
||.|++|.||+|.+..+++.|++|++.+.... ..+.+.+|+.+++.++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999988999999998754322 336788999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCccccc
Q 022309 157 EDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVST 236 (299)
Q Consensus 157 ~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 236 (299)
.+++. ....+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~----~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILR----DRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 99995 3355889999999999999999999999 9999999999999999999999999997643322 122
Q ss_pred ccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 237 RVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 237 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
...+++.|++||.+.+..++.++|+||||+++|+|++|..||...+
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 3467889999999988889999999999999999999999998776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=261.54 Aligned_cols=200 Identities=31% Similarity=0.492 Sum_probs=164.7
Q ss_pred ceecccCceEEEEEEECCCCc--EEEEEEcCCCCc-ccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEEEEEecCC
Q 022309 78 NFLGQGGFGAVYKGKLAETGQ--VVAVKQLDDTGF-QGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
+.||+|+||.||+|.+..++. .+++|.+..... .....+..|+.++..+ +||||+++++++...+..+++|||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999987775 468888864332 2335788899999999 899999999999999999999999999
Q ss_pred CCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccc
Q 022309 154 GSLEDHLLGLTP------------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFG 221 (299)
Q Consensus 154 ~~L~~~l~~~~~------------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg 221 (299)
++|.+++..... ....+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999864211 1235789999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCch
Q 022309 222 LAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQG 283 (299)
Q Consensus 222 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 283 (299)
++...... ........+..|+|||.+.+..++.++||||||+++|+|++ |..||...+.
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~ 217 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 217 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH
Confidence 98532111 01111223567999999988889999999999999999997 9999976554
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=275.47 Aligned_cols=205 Identities=23% Similarity=0.269 Sum_probs=171.3
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~l 146 (299)
....|++++.||+||.+.||++.... ...||+|.+..... .-...+..|+..|.+| .|.+|+++||+-..++.+||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 34569999999999999999998753 45677776643322 2235689999999999 58999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
|||+-+ .+|..+|.... ...+.-.+..+..||++|+.++|..| |||.||||.|+|+.+ |.+||+|||.|...
T Consensus 438 vmE~Gd-~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 438 VMECGD-IDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAI 509 (677)
T ss_pred Eeeccc-ccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhccc
Confidence 999864 69999996422 22332478899999999999999999 999999999999987 59999999999988
Q ss_pred CCCCCcccccccccCccccCcccccCC-----------CCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATTG-----------KLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
.....+......+||+.||+||.+... +.++++||||||||||+|+.|++||.+...
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n 577 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN 577 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH
Confidence 777777777788999999999988332 256789999999999999999999987653
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=262.46 Aligned_cols=207 Identities=27% Similarity=0.431 Sum_probs=171.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCC---CcEEEEEEcCCCC-cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAET---GQVVAVKQLDDTG-FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
.++|.+.+.||+|+||.||+|.+... ...|++|...... ....+.+..|+.+++.++||||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 35688899999999999999987543 3468999887554 2334678899999999999999999999876 45689
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
||||+++++|.+++.. ....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 84 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeec
Confidence 9999999999999953 2245899999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
..... .......++..|+|||.+....++.++||||||+++|+|++ |..||...+..+
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~ 216 (270)
T cd05056 158 EDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND 216 (270)
T ss_pred ccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 33211 11112234567999999988889999999999999999996 999998776544
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=260.08 Aligned_cols=198 Identities=32% Similarity=0.474 Sum_probs=168.2
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEe-cCCeeEEEEEe
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA-EGTQRLLVYEY 150 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~-~~~~~~lv~e~ 150 (299)
++|++.+.||+|+||.||++.. .+..|++|.++... ..+.+..|+.+++.++|+||+++++++. .+...+++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 5689999999999999999987 47789999886542 3457889999999999999999999764 45678999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+++++|.+++... ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 82 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 9999999998642 2235788999999999999999999999 9999999999999999999999999987532211
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCch
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQG 283 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 283 (299)
....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+.
T Consensus 157 -----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~ 205 (256)
T cd05082 157 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205 (256)
T ss_pred -----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 12234567999999988889999999999999999998 9999976554
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=287.92 Aligned_cols=207 Identities=20% Similarity=0.260 Sum_probs=160.6
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCC-cEEEEEEc--------------CC---CCcccHHHHHHHHHHHhhcCCCc
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETG-QVVAVKQL--------------DD---TGFQGEKEFLVEVLMLSLMRHPN 130 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~--------------~~---~~~~~~~~~~~E~~~l~~l~h~n 130 (299)
...++|++++.||+|+||+||+|...... ...+.|.+ .+ ........+.+|+.+++.++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 34578999999999999999998764322 22222211 00 11112245788999999999999
Q ss_pred ceeeeeEEecCCeeEEEEEecCCCCHHHHhcccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEe
Q 022309 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLT-PEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL 209 (299)
Q Consensus 131 Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv 209 (299)
|+++++++...+..++|++++. ++|.+++.... .........++..++.||+.||+|||+++ |+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999985 57777764321 11223346778899999999999999999 9999999999999
Q ss_pred cCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCC-CCCC
Q 022309 210 GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP-AMDD 280 (299)
Q Consensus 210 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~-pf~~ 280 (299)
+.++.+||+|||++........ .......|++.|+|||++.+..++.++|||||||++|||++|.. ||..
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~ 371 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGD 371 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccC
Confidence 9999999999999976432221 12233579999999999999999999999999999999999875 4543
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=266.33 Aligned_cols=205 Identities=26% Similarity=0.386 Sum_probs=173.2
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEecC--CeeEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAEG--TQRLLV 147 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~~lv 147 (299)
++|++.+.||+|+||.||+|.+..+++.+++|.++...... ...+.+|+.+++.++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46899999999999999999999999999999997543222 23567899999999999999999998777 789999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
+||+. ++|.+++... ...+++.+++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++....
T Consensus 85 ~e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99997 4998888532 246899999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCCcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||...+..+
T Consensus 158 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~ 214 (293)
T cd07843 158 SPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID 214 (293)
T ss_pred CCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 321 112234578889999988654 46889999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=260.19 Aligned_cols=204 Identities=34% Similarity=0.481 Sum_probs=170.2
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEec
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYM 151 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 151 (299)
++|++.+.||+|++|.||+|.+..+ ..+|+|.+.... ...+.+.+|+.+++.++||||+++++++.. ...+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence 5689999999999999999988654 468999886543 334678889999999999999999998854 5678999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCC
Q 022309 152 PLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231 (299)
Q Consensus 152 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~ 231 (299)
.+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 83 GKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 999999999642 2245788999999999999999999999 99999999999999999999999999975432221
Q ss_pred cccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 232 SHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
. ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 158 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 210 (260)
T cd05069 158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR 210 (260)
T ss_pred c-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 1 1112235677999999988889999999999999999999 89999876543
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=272.22 Aligned_cols=201 Identities=27% Similarity=0.341 Sum_probs=171.6
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEecC------
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG------ 141 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------ 141 (299)
..++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 45789999999999999999999999999999999865322 2235677899999999999999999988543
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccc
Q 022309 142 TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFG 221 (299)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg 221 (299)
...++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence 34689999996 588887742 2788999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 222 LAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 222 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
++....... ......+++.|+|||.+.+..++.++|||||||++|+|++|..||...+.
T Consensus 164 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~ 222 (353)
T cd07850 164 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH 222 (353)
T ss_pred cceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 997543211 12234578899999999998999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=271.95 Aligned_cols=204 Identities=26% Similarity=0.409 Sum_probs=170.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCC-----ee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT-----QR 144 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-----~~ 144 (299)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 4689999999999999999999999999999999864322 22356788999999999999999998875443 47
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
++++|++. ++|.+.+. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELME-TDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhcc-cCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence 89999996 58888773 256899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCc-ccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 225 FGPTGDKS-HVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 225 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
........ .......|++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~ 215 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY 215 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 54322211 11223468899999998654 4688999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=263.78 Aligned_cols=204 Identities=34% Similarity=0.477 Sum_probs=168.6
Q ss_pred ceecccCceEEEEEEECCCC------cEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 78 NFLGQGGFGAVYKGKLAETG------QVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
+.||+|+||.||+|...... +.+|+|.+..... .....+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36899999999999986443 6899998865432 2346788999999999999999999999998999999999
Q ss_pred cCCCCHHHHhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC-----ceEEccccc
Q 022309 151 MPLGSLEDHLLGLTP---EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF-----HPKLSDFGL 222 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~-----~~kl~Dfg~ 222 (299)
+++++|.+++..... ....+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999964321 2244788999999999999999999999 99999999999999877 899999999
Q ss_pred cccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 223 AKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 223 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
+................++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~ 220 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ 220 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH
Confidence 975433222222222345678999999988889999999999999999998 99999766543
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=264.86 Aligned_cols=208 Identities=25% Similarity=0.326 Sum_probs=171.2
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcC-CCcceeeeeEEecCCe-----
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMR-HPNLVHLIGYCAEGTQ----- 143 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~----- 143 (299)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4689999999999999999999999999999988654322 2356788999999995 6999999999876655
Q ss_pred eEEEEEecCCCCHHHHhcccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC-CCceEEcccc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPE-MKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK-GFHPKLSDFG 221 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~-~~~~kl~Dfg 221 (299)
.++||||+++ +|.+++...... ...+++..++.++.||+.||.|||+++ ++||||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 888888643222 356899999999999999999999999 999999999999998 8899999999
Q ss_pred ccccCCCCCCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 222 LAKFGPTGDKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 222 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
++........ ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+..+
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~ 219 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 9875422211 1122346788999998755 457899999999999999999999998765543
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=263.21 Aligned_cols=196 Identities=32% Similarity=0.429 Sum_probs=168.6
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCCCH
Q 022309 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSL 156 (299)
Q Consensus 80 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L 156 (299)
||+|+||+||+|.+..+++.||+|.+..... .....+..|+.+++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6899999999999999999999999865322 2234567899999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCccccc
Q 022309 157 EDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVST 236 (299)
Q Consensus 157 ~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 236 (299)
.+++... ....+++.++..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++...... ....
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~ 152 (277)
T cd05577 81 KYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIK 152 (277)
T ss_pred HHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccc
Confidence 9998642 2246899999999999999999999999 999999999999999999999999998754321 1122
Q ss_pred ccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 237 RVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 237 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
...++..|+|||.+.+..++.++||||||+++|+|++|..||...+.
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 34577889999999888899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=260.54 Aligned_cols=194 Identities=26% Similarity=0.370 Sum_probs=161.1
Q ss_pred ceecccCceEEEEEEECCC------------CcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeE
Q 022309 78 NFLGQGGFGAVYKGKLAET------------GQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 145 (299)
+.||+|+||.||+|+.... ...+++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 4689999999999985322 2358999887654444457888999999999999999999999988899
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCc-------eEEc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFH-------PKLS 218 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~-------~kl~ 218 (299)
++|||+++++|..++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 99999999999888753 3356899999999999999999999999 999999999999987654 8999
Q ss_pred cccccccCCCCCCcccccccccCccccCccccc-CCCCCcccceehhHHHHHHHH-hCCCCCCCCch
Q 022309 219 DFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYAT-TGKLTAKSDIFSFGVVLLELI-TGRPAMDDSQG 283 (299)
Q Consensus 219 Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~ell-tg~~pf~~~~~ 283 (299)
|||++..... .....++..|+|||.+. +..++.++|||||||++|+|+ +|..||.....
T Consensus 155 d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 215 (262)
T cd05077 155 DPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL 215 (262)
T ss_pred CCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch
Confidence 9999864321 11235778899999886 456889999999999999998 58899876553
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=258.79 Aligned_cols=201 Identities=35% Similarity=0.542 Sum_probs=173.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|++.+.||+|++|.||+|.. .++.||+|.+..... ..+.+..|+.+++.++|+||+++++++.+....++|||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 35689999999999999999987 478899999976643 456788999999999999999999999988899999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+.+++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999998542 2236899999999999999999999999 9999999999999999999999999997642211
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
. ....+..|+|||.+.+..++.++||||||+++|+|++ |..||...+..
T Consensus 157 ~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 206 (256)
T cd05039 157 D-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 206 (256)
T ss_pred c-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 1 2234567999999988889999999999999999998 99999776543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=260.85 Aligned_cols=193 Identities=33% Similarity=0.468 Sum_probs=161.6
Q ss_pred eecccCceEEEEEEECCCCcEEEEEEcCCCCccc---HHHHHHHHH---HHhhcCCCcceeeeeEEecCCeeEEEEEecC
Q 022309 79 FLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG---EKEFLVEVL---MLSLMRHPNLVHLIGYCAEGTQRLLVYEYMP 152 (299)
Q Consensus 79 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~---~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 152 (299)
.||+|+||.||+|.+..+++.||+|.+.+..... ...+..|.. .++...||||+++++.+...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999999899999999987543221 122334433 3444579999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCc
Q 022309 153 LGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKS 232 (299)
Q Consensus 153 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~ 232 (299)
|++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 81 g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--- 150 (278)
T cd05606 81 GGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--- 150 (278)
T ss_pred CCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc---
Confidence 999999884 3457899999999999999999999999 999999999999999999999999998643221
Q ss_pred ccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 233 HVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 233 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
......|+..|+|||.+.+. .++.++||||+|+++|+|++|..||....
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~ 200 (278)
T cd05606 151 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (278)
T ss_pred -CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence 12234689999999998754 68899999999999999999999998663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=262.62 Aligned_cols=206 Identities=31% Similarity=0.441 Sum_probs=179.4
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
..+.|++.+.||+|++|.||+|.+..++..|++|++..... ....+..|+.+++.++|+||+++++.+......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 34668889999999999999999988899999999976543 45678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+++++|.+++.... ..+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999996421 37899999999999999999999999 999999999999999999999999998643322
Q ss_pred CCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
.. ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..
T Consensus 170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~ 222 (286)
T cd06614 170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL 222 (286)
T ss_pred hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH
Confidence 11 122345788899999998888999999999999999999999999876554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=256.64 Aligned_cols=199 Identities=34% Similarity=0.498 Sum_probs=167.0
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCccc-HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCCCH
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG-EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSL 156 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L 156 (299)
+.||+|+||.||+|... ++..+|+|.+....... ...+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 46999999999999864 67889999987654322 34688899999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCccccc
Q 022309 157 EDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVST 236 (299)
Q Consensus 157 ~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 236 (299)
.+++.. ....+++.++..++.|++.+|.|||+.+ ++||||+|+||+++.++.++|+|||++......... ...
T Consensus 80 ~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~ 152 (250)
T cd05085 80 LSFLRK---KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSG 152 (250)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCC
Confidence 998853 2345789999999999999999999999 999999999999999999999999998753222111 111
Q ss_pred ccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 237 RVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 237 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
...++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~ 201 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ 201 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH
Confidence 1234567999999988889999999999999999998 99999766543
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=263.30 Aligned_cols=207 Identities=26% Similarity=0.362 Sum_probs=171.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
++|++.+.||+|++|.||+|.+..+++.||+|.+...... ....+..|+.+++.++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 4689999999999999999999989999999998654322 23567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC-CCceEEccccccccCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK-GFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~-~~~~kl~Dfg~a~~~~~ 228 (299)
|++ ++|.+.+... ....+++..++.++.||+.||+|||+++ ++|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 5888877432 2234678889999999999999999999 999999999999985 56799999999975322
Q ss_pred CCCcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
.. .......+++.|+|||.+.+. .++.++||||||+++|+|+||.+||...+..+.
T Consensus 156 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~ 212 (294)
T PLN00009 156 PV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE 212 (294)
T ss_pred Cc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 21 112234578899999988664 578899999999999999999999987665443
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=255.27 Aligned_cols=202 Identities=32% Similarity=0.486 Sum_probs=179.2
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecC
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMP 152 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 152 (299)
.|++.+.||+|++|.||++.+..+++.+++|++..........+.+|+.+++.++|+||+++++++..+...++++||+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 47888999999999999999988899999999987655456788999999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCc
Q 022309 153 LGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKS 232 (299)
Q Consensus 153 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~ 232 (299)
+++|.+++... ...+++..+..++.|++.||.+||+.+ ++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999998532 257899999999999999999999999 99999999999999999999999999976543321
Q ss_pred ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 233 HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 233 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 202 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP 202 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch
Confidence 2334688899999999888889999999999999999999999987743
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=257.11 Aligned_cols=205 Identities=28% Similarity=0.444 Sum_probs=180.1
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
+|++.+.||.|++|.||++.+..+++.|++|++..... .....+..|+.+++.++|||++++.+.+..+...++|+|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 58889999999999999999998999999999976543 3446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+++++|.+.+.........+++.++..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999754333477899999999999999999999999 9999999999999999999999999997643322
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
.......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 12233468889999999988889999999999999999999999997765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=305.23 Aligned_cols=211 Identities=31% Similarity=0.393 Sum_probs=180.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
.-+|+...+||.|.||.||.|.+..+|+..|+|.++-..... -..+.+|..++..++|||+|++|++-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 457888899999999999999999999999999886543332 256788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
|||+||+|.+.+. ..+-.++.....+..|++.|++|||++| ||||||||.||+++.+|.+|++|||.|.....
T Consensus 1314 EyC~~GsLa~ll~----~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLE----HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHHH----hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 9999999999994 4445677777888999999999999999 99999999999999999999999999976433
Q ss_pred CCC--cccccccccCccccCcccccCCC---CCcccceehhHHHHHHHHhCCCCCCCCchhhhhh
Q 022309 229 GDK--SHVSTRVMGTHGYCAPEYATTGK---LTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288 (299)
Q Consensus 229 ~~~--~~~~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 288 (299)
... ........||+.|||||++.+.. -..++|||||||++.||+||+.||...+.+.++.
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIM 1451 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIM 1451 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHH
Confidence 311 11122467999999999997643 5668999999999999999999999998877654
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=264.61 Aligned_cols=201 Identities=25% Similarity=0.389 Sum_probs=173.5
Q ss_pred CCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCC
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
|....+||+|+||.||++....+++.||+|.+..........+.+|+.+++.++|+||+++++.+...+..++||||+++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 33346899999999999999999999999998655444456788899999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcc
Q 022309 154 GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233 (299)
Q Consensus 154 ~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~ 233 (299)
++|.+++. ...+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++....... .
T Consensus 102 ~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~ 171 (292)
T cd06657 102 GALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--P 171 (292)
T ss_pred CcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--c
Confidence 99999873 245789999999999999999999999 9999999999999999999999999986543221 1
Q ss_pred cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 234 VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
......|++.|+|||.+.+..++.++|+||+|+++|+|++|.+||...+..
T Consensus 172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~ 222 (292)
T cd06657 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL 222 (292)
T ss_pred cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 122345788999999998888899999999999999999999999766543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=261.37 Aligned_cols=208 Identities=28% Similarity=0.423 Sum_probs=173.3
Q ss_pred cCCCCCceecccCceEEEEEEECC-----CCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAE-----TGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 145 (299)
++|++++.||+|+||.||+|+... +.+.|++|.+...... ....+.+|+.+++.++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 578999999999999999999753 3467999988654333 2367889999999999999999999999988999
Q ss_pred EEEEecCCCCHHHHhcccCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPE-----MKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDF 220 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Df 220 (299)
+||||+++++|.+++...... ...+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999643211 126899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCch
Q 022309 221 GLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQG 283 (299)
Q Consensus 221 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 283 (299)
|++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~ 224 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD 224 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch
Confidence 9986432211 111222346677999999988888999999999999999999 8889976543
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=265.51 Aligned_cols=208 Identities=28% Similarity=0.399 Sum_probs=170.8
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCC-----
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT----- 142 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~----- 142 (299)
..++|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 346799999999999999999999999999999988643322 2234567999999999999999999886543
Q ss_pred ---eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcc
Q 022309 143 ---QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSD 219 (299)
Q Consensus 143 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~D 219 (299)
..++||||+. ++|.+.+.. ....+++.+++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECc
Confidence 4599999996 588887753 2346899999999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCCc--ccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 220 FGLAKFGPTGDKS--HVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 220 fg~a~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
||++......... .......++..|+|||.+.+. .++.++||||||+++|+|++|.+||...+..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~ 230 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ 230 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999754332211 111234577889999987664 4788999999999999999999999876643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=261.16 Aligned_cols=205 Identities=27% Similarity=0.442 Sum_probs=173.4
Q ss_pred CCCCCceecccCceEEEEEEECC-CCcEEEEEEcCCCCc----------ccHHHHHHHHHHHhh-cCCCcceeeeeEEec
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAE-TGQVVAVKQLDDTGF----------QGEKEFLVEVLMLSL-MRHPNLVHLIGYCAE 140 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~-l~h~nIv~~~~~~~~ 140 (299)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ....++..|+.++.. ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999977 678999998753221 112446678887764 799999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEecCCCceEEcc
Q 022309 141 GTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN-KADPPVIYRDLKAGNILLGKGFHPKLSD 219 (299)
Q Consensus 141 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~dikp~Nilv~~~~~~kl~D 219 (299)
++..+++|||+++++|.+++.........+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999886543445678999999999999999999996 67 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 220 FGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 220 fg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
||++....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|.+||...+.
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~ 218 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM 218 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH
Confidence 99997643322 22335688899999999888899999999999999999999999976653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=258.66 Aligned_cols=194 Identities=27% Similarity=0.390 Sum_probs=164.9
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCccc---HHHHHHHHHH-HhhcCCCcceeeeeEEecCCeeEEEEEecCC
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG---EKEFLVEVLM-LSLMRHPNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~-l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
+.||+|+||.||+|.+..+++.||+|.+.+..... ...+..|..+ ....+|+||+++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999999999999999987543222 1233445444 3455899999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcc
Q 022309 154 GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233 (299)
Q Consensus 154 ~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~ 233 (299)
++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++.....
T Consensus 82 ~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIK----TLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 99999984 3356899999999999999999999999 99999999999999999999999999875322
Q ss_pred cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 234 VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
.....+++.|+|||.+.+..++.++||||||+++|+|++|.+||...+..
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 199 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD 199 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH
Confidence 22345788899999998888899999999999999999999999776543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=264.30 Aligned_cols=206 Identities=18% Similarity=0.202 Sum_probs=158.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCC---CcEEEEEEcCCCCccc--H---------HHHHHHHHHHhhcCCCcceeeee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAET---GQVVAVKQLDDTGFQG--E---------KEFLVEVLMLSLMRHPNLVHLIG 136 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~--~---------~~~~~E~~~l~~l~h~nIv~~~~ 136 (299)
.++|++.+.||+|+||.||+|.+..+ +..+|+|+........ + .....+...+..+.|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46799999999999999999998777 6677777643322111 1 11122334455678999999998
Q ss_pred EEecCC----eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCC
Q 022309 137 YCAEGT----QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKG 212 (299)
Q Consensus 137 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~ 212 (299)
++.... ..+++++++. .++.+.+.. ....++..+..++.|++.||+|||+.+ |+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 765443 3467888764 467666632 234578889999999999999999999 9999999999999999
Q ss_pred CceEEccccccccCCCCCCc-----ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 213 FHPKLSDFGLAKFGPTGDKS-----HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 213 ~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
+.++|+|||+|+........ .......||+.|+|||+..+..++.++|||||||++|||++|.+||......
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~ 239 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN 239 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence 99999999999754322111 1112246999999999999999999999999999999999999999877443
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=263.40 Aligned_cols=200 Identities=36% Similarity=0.526 Sum_probs=171.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc---cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.+.|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++.+++.+++..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 35689999999999999999999989999999998644322 225688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
+||+. +++.+.+.. ....+++.++..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++....
T Consensus 94 ~e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 94 MEYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HHhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 99997 577777743 2356899999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCCcccccccccCccccCccccc---CCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYAT---TGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
.. ....+++.|+|||++. ...++.++||||||+++|+|++|.+||...+.
T Consensus 167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~ 219 (307)
T cd06607 167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (307)
T ss_pred CC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH
Confidence 22 2245788899999874 34588899999999999999999999976553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=242.58 Aligned_cols=217 Identities=26% Similarity=0.357 Sum_probs=180.9
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc-HHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG-EKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv 147 (299)
..+....+..||+|++|.|-+.++..+|...|+|.++..-... .+.++.|+.+.... .+|.+|.+|+.+......+|.
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 3455666788999999999999999999999999997654333 36678888877655 799999999999888999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
||.|+ .||..+-.........+++..+-+|+..+..||.|||++-. ++|||+||+|||++..|++|+||||.+....
T Consensus 124 ME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 124 MELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 99996 58888776655677889999999999999999999998643 9999999999999999999999999997643
Q ss_pred CCCCcccccccccCccccCcccccC----CCCCcccceehhHHHHHHHHhCCCCCCCCchhhhhhHHHH
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATT----GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVDWV 292 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~ 292 (299)
..- ..+-..|...|||||.+.. ..|+.++||||||+++.||.+++.||+.-...-+.+-+.|
T Consensus 201 dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 201 DSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred hhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence 221 1122457888999998744 3689999999999999999999999998877777776665
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=257.07 Aligned_cols=203 Identities=30% Similarity=0.514 Sum_probs=172.1
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEec
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYM 151 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 151 (299)
++|++.+.||+|+||.||+|.+. ++..+|+|.+.... .....+..|+.+++.++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 46888999999999999999885 46789999887543 33467889999999999999999999999989999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCC
Q 022309 152 PLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231 (299)
Q Consensus 152 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~ 231 (299)
.+++|.+++.. ....+++..++.++.|++.||++||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 82 EHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 99999998853 2346789999999999999999999999 99999999999999999999999999875422211
Q ss_pred cccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCch
Q 022309 232 SHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQG 283 (299)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 283 (299)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 156 -~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 207 (256)
T cd05112 156 -TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN 207 (256)
T ss_pred -cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 11112234568999999988889999999999999999998 9999986653
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=256.75 Aligned_cols=205 Identities=29% Similarity=0.442 Sum_probs=171.4
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
..++|++.+.||+|+||.||++.+. .+..+++|.+.... .....+.+|+.+++.++|+||+++++.+.+ ...+++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 3567999999999999999999865 45669999887542 234678889999999999999999999887 67899999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+.+++|.+++... ....+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 81 FMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred eCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 99999999999642 2345788899999999999999999999 999999999999999999999999999754322
Q ss_pred CCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCch
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQG 283 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 283 (299)
... ......++..|+|||.+....++.++|+|||||++|++++ |..||...+.
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 209 (260)
T cd05073 156 EYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209 (260)
T ss_pred Ccc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH
Confidence 211 1112235667999999988889999999999999999999 9999987654
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=259.84 Aligned_cols=198 Identities=31% Similarity=0.482 Sum_probs=171.0
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCCCH
Q 022309 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSL 156 (299)
Q Consensus 80 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L 156 (299)
||.|+||.||++.+..+++.+++|.+..... .....+.+|+.+++.++||||+++++.+..+...++++||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999998999999999876543 2345688899999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCC-----
Q 022309 157 EDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK----- 231 (299)
Q Consensus 157 ~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~----- 231 (299)
.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLEN----VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 999853 347899999999999999999999999 99999999999999999999999999875432211
Q ss_pred -cccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 232 -SHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 232 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
........++..|+|||...+..++.++|+||||+++|+|++|..||...+..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~ 207 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE 207 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 11222345788899999998888899999999999999999999999876644
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=278.33 Aligned_cols=207 Identities=28% Similarity=0.358 Sum_probs=184.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.++++++..||-|+||.|=++........+|+|++++... .+.+-+..|-.++..++.|.||++|-.|.++.+.|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 4568888999999999999998866555689998876443 3445678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
||-|-||.|+..+ ...+.++..++..++.-+++|++|||++| |+.|||||+|.+++.+|-+||.|||.|+...
T Consensus 499 mEaClGGElWTiL----rdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 499 MEACLGGELWTIL----RDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred HHhhcCchhhhhh----hhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 9999999999999 46688999999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
.+. ...+++|||.|.|||++.+...+.++|.||||+++||||+|.|||...++....
T Consensus 572 ~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY 628 (732)
T KOG0614|consen 572 SGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY 628 (732)
T ss_pred cCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH
Confidence 433 345689999999999999999999999999999999999999999999886543
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=255.09 Aligned_cols=203 Identities=30% Similarity=0.443 Sum_probs=178.1
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEecC--CeeEEEE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG--TQRLLVY 148 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~~lv~ 148 (299)
+|+..+.||+|++|.||+|.+..+++.|++|++..... ...+.+.+|+.+++.++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 47788999999999999999998999999999876543 3346788999999999999999999999888 8899999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
|++.+++|.+++.. ...+++.+++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999853 237899999999999999999999999 99999999999999999999999999976544
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
...........++..|+|||.+.+..++.++||||||+++|+|++|..||...+
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 332111233468889999999988889999999999999999999999998776
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=257.69 Aligned_cols=198 Identities=33% Similarity=0.495 Sum_probs=168.5
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEec
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYM 151 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 151 (299)
++|++.+.||+|+||.||++.. +++.||+|.++... ....+.+|+.+++.++||||+++++++..+ ..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 4589999999999999999874 67889999986542 345788999999999999999999998765 478999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCC
Q 022309 152 PLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231 (299)
Q Consensus 152 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~ 231 (299)
.+++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 81 SKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 999999999642 2345789999999999999999999999 9999999999999999999999999987532211
Q ss_pred cccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 232 SHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |.+||...+..
T Consensus 155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 204 (254)
T cd05083 155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK 204 (254)
T ss_pred ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH
Confidence 11234567999999988889999999999999999998 99999776543
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=260.93 Aligned_cols=204 Identities=26% Similarity=0.402 Sum_probs=172.2
Q ss_pred CCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEec
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYM 151 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 151 (299)
|++.+.||.|++|.||+|.+..++..||+|++...... ....+..|+.+++.++||||+++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67889999999999999999999999999998754322 2356788999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCC
Q 022309 152 PLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231 (299)
Q Consensus 152 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~ 231 (299)
+ ++|.+++.... ...+++.+++.++.|++.||+|||+++ ++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 68999885422 146899999999999999999999999 99999999999999999999999999975322211
Q ss_pred cccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 232 SHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
......+++.|+|||.+.+. .++.++||||||+++|+|++|.+||...+...
T Consensus 155 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 207 (283)
T cd07835 155 --TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID 207 (283)
T ss_pred --ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 11223468889999987654 57889999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=254.36 Aligned_cols=202 Identities=35% Similarity=0.523 Sum_probs=178.0
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
+|++.+.||+|++|.||++.+..+++.|++|.+..... .....+.+|+.+++.++|||++++++++.+....+++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 48889999999999999999998999999999976654 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+.+++|.+++. ....+++..++.++.|++.||.+||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIK----KFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 99999999985 3367899999999999999999999999 9999999999999999999999999997644322
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
.. .....++..|+|||...+..++.++|+||||+++|+|++|..||...+.
T Consensus 154 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~ 204 (254)
T cd06627 154 KD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP 204 (254)
T ss_pred cc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH
Confidence 21 2334578899999998887788999999999999999999999987654
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=261.34 Aligned_cols=196 Identities=27% Similarity=0.417 Sum_probs=162.7
Q ss_pred ceecccCceEEEEEEECCCCc-------EEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 78 NFLGQGGFGAVYKGKLAETGQ-------VVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
+.||+|+||.||+|.+..++. .+++|.+........+.+..|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998865443 4888887655444446788899999999999999999999998899999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCc--------eEEccccc
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFH--------PKLSDFGL 222 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~--------~kl~Dfg~ 222 (299)
+++++|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+||+++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 999999999863 2246789999999999999999999999 999999999999987654 69999999
Q ss_pred cccCCCCCCcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhC-CCCCCCCchhh
Q 022309 223 AKFGPTGDKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITG-RPAMDDSQGHE 285 (299)
Q Consensus 223 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg-~~pf~~~~~~~ 285 (299)
+..... .....+++.|+|||++.+. .++.++||||||+++|+|++| .+||...+...
T Consensus 155 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~ 213 (258)
T cd05078 155 SITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK 213 (258)
T ss_pred ccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH
Confidence 864321 1224578889999998764 578899999999999999998 57776655443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=257.55 Aligned_cols=192 Identities=28% Similarity=0.434 Sum_probs=162.5
Q ss_pred ceecccCceEEEEEEECCCC----------cEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 78 NFLGQGGFGAVYKGKLAETG----------QVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
+.||+|+||.||+|.+..++ ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999997766 35788877654333 5778899999999999999999999887 678999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC-------ceEEccc
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF-------HPKLSDF 220 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~-------~~kl~Df 220 (299)
|||+.+++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++ .++|+||
T Consensus 79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999998532 236889999999999999999999999 99999999999999887 7999999
Q ss_pred cccccCCCCCCcccccccccCccccCcccccCC--CCCcccceehhHHHHHHHHh-CCCCCCCCch
Q 022309 221 GLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTG--KLTAKSDIFSFGVVLLELIT-GRPAMDDSQG 283 (299)
Q Consensus 221 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 283 (299)
|++..... .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||...+.
T Consensus 153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~ 212 (259)
T cd05037 153 GIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS 212 (259)
T ss_pred Cccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc
Confidence 99975322 1123466789999998776 78899999999999999999 5888877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=268.82 Aligned_cols=206 Identities=24% Similarity=0.351 Sum_probs=172.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEe----cCCee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCA----EGTQR 144 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~----~~~~~ 144 (299)
.++|++.+.||+|++|.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 3679999999999999999999999999999999875432 23356778999999999999999999875 33467
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
++||||+. ++|.+++. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999995 58988884 3456899999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCc--ccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 225 FGPTGDKS--HVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 225 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
........ .......|+..|+|||.+.+ ..++.++|||||||++|+|++|.+||...+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~ 218 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV 218 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH
Confidence 54322211 11223468889999998865 45889999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=261.28 Aligned_cols=194 Identities=27% Similarity=0.387 Sum_probs=159.5
Q ss_pred eecccCceEEEEEEECCC------------------------CcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceee
Q 022309 79 FLGQGGFGAVYKGKLAET------------------------GQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHL 134 (299)
Q Consensus 79 ~lg~G~~g~V~~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~ 134 (299)
.||+|+||.||+|....+ ...|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 699999999999975321 23588998865543334568889999999999999999
Q ss_pred eeEEecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC-
Q 022309 135 IGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF- 213 (299)
Q Consensus 135 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~- 213 (299)
++++......++||||+++++|..++.. ....+++..+..++.|++.||+|||+++ |+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence 9999999999999999999999998853 3356889999999999999999999999 99999999999997643
Q ss_pred ------ceEEccccccccCCCCCCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHH-hCCCCCCCCchh
Q 022309 214 ------HPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELI-TGRPAMDDSQGH 284 (299)
Q Consensus 214 ------~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell-tg~~pf~~~~~~ 284 (299)
.++|+|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||......
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 4899999998542111 12246778999998865 56889999999999999985 699999876543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=262.52 Aligned_cols=209 Identities=28% Similarity=0.394 Sum_probs=173.0
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEecCC----
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT---- 142 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~---- 142 (299)
...++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 345789999999999999999999999999999999875432 22356778999999999999999999987654
Q ss_pred ------eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceE
Q 022309 143 ------QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPK 216 (299)
Q Consensus 143 ------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~k 216 (299)
..++|+||+++ ++.+.+.. ....+++.+++.++.|++.||+|||+.+ |+|+||+|+||++++++.++
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence 78999999976 77777753 2356899999999999999999999999 99999999999999999999
Q ss_pred EccccccccCCCCCCcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 217 LSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 217 l~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
|+|||++........ .......++..|+|||.+.+. .++.++|||||||++|+|++|.+||...+..+
T Consensus 157 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~ 225 (302)
T cd07864 157 LADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA 225 (302)
T ss_pred eCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 999999976433221 111223457789999987653 57889999999999999999999998765433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=258.43 Aligned_cols=205 Identities=30% Similarity=0.446 Sum_probs=178.9
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
+|++.+.||+|++|.||++.+..+++.+++|.+...... ....+.+|+.+++.++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 488899999999999999999999999999998754322 235677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+++++|.+++.........+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998653333467899999999999999999999999 999999999999999999999999999765332
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~ 207 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ 207 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 122245788999999998888999999999999999999999999877653
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=260.43 Aligned_cols=205 Identities=33% Similarity=0.486 Sum_probs=172.3
Q ss_pred cCCCCCceecccCceEEEEEEEC----CCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEec--CCee
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLA----ETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAE--GTQR 144 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~ 144 (299)
..|++.+.||+|+||.||+|... .+++.||+|.+...... ....+.+|+.+++.+.||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45888899999999999999864 34789999999766543 35678999999999999999999999877 5578
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
+++|||+++++|.+++.. ....+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 999999999999999963 2235899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCccc-ccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 225 FGPTGDKSHV-STRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 225 ~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
.......... .....++..|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 216 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPP 216 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccccc
Confidence 6542222111 111234567999999988889999999999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=267.54 Aligned_cols=203 Identities=27% Similarity=0.400 Sum_probs=171.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC--cccHHHHHHHHHHHhhcCCCcceeeeeEEecC-----Ce
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG--FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG-----TQ 143 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-----~~ 143 (299)
.++|.+.+.||+|+||+||+|.+..+++.||+|.+.... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357999999999999999999999999999999987532 22235677899999999999999999987544 34
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA 223 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a 223 (299)
.++|+||+. ++|.+++. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999995 68988884 3467899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 224 KFGPTGDKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
....... .......++..|+|||.+.+ ..++.++|||||||++|+|++|.+||...+.
T Consensus 156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 214 (337)
T cd07858 156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY 214 (337)
T ss_pred cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh
Confidence 7543221 12233457889999998765 4688999999999999999999999977654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=259.95 Aligned_cols=203 Identities=28% Similarity=0.408 Sum_probs=172.5
Q ss_pred CCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC--cccHHHHHHHHHHHhhcCCCcceeeeeEEecC--CeeEEEEE
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG--FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG--TQRLLVYE 149 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~~lv~e 149 (299)
|++.+.||+|++|.||+|.+..+++.+|+|.+.... ......+..|+.+++.++|||++++++++.+. ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999999999999999997653 22335688899999999999999999999887 78999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+.+ +|.+++.. ....+++.+++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9974 88888853 2257899999999999999999999999 999999999999999999999999999764333
Q ss_pred CCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
.. .......++..|+|||.+.+ ..++.++||||||+++|+|++|.+||...+..
T Consensus 154 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~ 208 (287)
T cd07840 154 NS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL 208 (287)
T ss_pred Cc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 21 11222346788999998765 45788999999999999999999999877653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=261.47 Aligned_cols=205 Identities=32% Similarity=0.481 Sum_probs=177.5
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcC-CCcceeeeeEEecCCeeEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMR-HPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv 147 (299)
++|++.+.||+|++|.||+|.+..+++.||+|++..... .....+..|+.+++.+. ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 468999999999999999999999999999999875332 22356788999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
||++.+++|.+++. ....+++.+++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIR----KYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999995 3347999999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCCc------------------ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 228 TGDKS------------------HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 228 ~~~~~------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
..... .......++..|+|||.+.+..++.++|+||||++++++++|..||...+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 22211 112234578899999999888889999999999999999999999987763
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=267.61 Aligned_cols=222 Identities=29% Similarity=0.417 Sum_probs=182.4
Q ss_pred HHHHHHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-ccH------HHHHHHHHHHhhcCCCcceeeee
Q 022309 64 YRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGE------KEFLVEVLMLSLMRHPNLVHLIG 136 (299)
Q Consensus 64 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~------~~~~~E~~~l~~l~h~nIv~~~~ 136 (299)
|.+-....++|-++.+||+|+|+.||+|.+...++.||+|+-..... .++ +-..+|..+.+.|+||.||++|+
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 33344556789999999999999999999999999999997643321 111 23567899999999999999999
Q ss_pred EEe-cCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEec---CC
Q 022309 137 YCA-EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLG---KG 212 (299)
Q Consensus 137 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~---~~ 212 (299)
+|. +.+.++-|+|||+|-+|.=+| +..+.+++.++..|+.||+.||.||... .+||+|-||||.|||+. ..
T Consensus 535 yfslDtdsFCTVLEYceGNDLDFYL----KQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gtac 609 (775)
T KOG1151|consen 535 YFSLDTDSFCTVLEYCEGNDLDFYL----KQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTAC 609 (775)
T ss_pred eeeeccccceeeeeecCCCchhHHH----HhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCccc
Confidence 995 456788999999999998888 4567789999999999999999999987 59999999999999995 45
Q ss_pred CceEEccccccccCCCCCCcc-----cccccccCccccCcccccCC----CCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 213 FHPKLSDFGLAKFGPTGDKSH-----VSTRVMGTHGYCAPEYATTG----KLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 213 ~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~----~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
|.+||+||||++......... ......||..|++||++.-. +.+.++||||+|||+|.++.|+.||.....
T Consensus 610 GeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs 689 (775)
T KOG1151|consen 610 GEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS 689 (775)
T ss_pred ceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence 889999999998764443332 23346799999999987433 467899999999999999999999998877
Q ss_pred hhhhhHH
Q 022309 284 HERMLVD 290 (299)
Q Consensus 284 ~~~~~~~ 290 (299)
...++..
T Consensus 690 QQdILqe 696 (775)
T KOG1151|consen 690 QQDILQE 696 (775)
T ss_pred HHHHHhh
Confidence 6666543
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=258.85 Aligned_cols=201 Identities=27% Similarity=0.359 Sum_probs=167.2
Q ss_pred CCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcC-CCcceeeeeEEecC--CeeEEEEE
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMR-HPNLVHLIGYCAEG--TQRLLVYE 149 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~--~~~~lv~e 149 (299)
|++++.||+|+||.||+|.+..+++.||+|.++.... .......+|+.+++.+. |+||+++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 6788999999999999999999999999999875422 22234457888888884 99999999999887 88999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+. ++|.+.+.. ....+++.+++.++.|++.||.|||+.+ ++||||+|+||+++. +.++|+|||++......
T Consensus 81 ~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 588888753 2356899999999999999999999999 999999999999999 99999999999754322
Q ss_pred CCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.. .....+++.|+|||.+.. ..++.++|||||||++|||++|.+||...+..+
T Consensus 153 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~ 206 (282)
T cd07831 153 PP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD 206 (282)
T ss_pred CC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH
Confidence 11 122457889999997644 457889999999999999999999998766533
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=257.31 Aligned_cols=208 Identities=31% Similarity=0.433 Sum_probs=168.2
Q ss_pred CCCCceecccCceEEEEEEEC---CCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEecCC------
Q 022309 74 FKDTNFLGQGGFGAVYKGKLA---ETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT------ 142 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~------ 142 (299)
|++.+.||+|+||.||+|... .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 667889999999999999864 3578999999875432 23456888999999999999999999885432
Q ss_pred eeEEEEEecCCCCHHHHhccc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccc
Q 022309 143 QRLLVYEYMPLGSLEDHLLGL--TPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDF 220 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Df 220 (299)
..+++++|+.+++|.+++... ......+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 246889999999998887421 122235788999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 221 GLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 221 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
|++................+++.|++||.+.+..++.++||||||+++|+|++ |.+||...+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~ 222 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS 222 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH
Confidence 99975433222212223345678999999988889999999999999999999 89999766543
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=260.57 Aligned_cols=201 Identities=29% Similarity=0.403 Sum_probs=170.0
Q ss_pred CCCCCceecccCceEEEEEEEC---CCCcEEEEEEcCCCCc----ccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCee
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLA---ETGQVVAVKQLDDTGF----QGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQR 144 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 144 (299)
+|++.+.||+|+||.||+|.+. .+++.||+|.+..... ...+.+..|+.+++.+ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4788999999999999999874 4789999999875332 2235677899999999 589999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
++||||+++++|.+++. ...++++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLS----QRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccce
Confidence 99999999999999985 3356889999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCcccccccccCccccCcccccCC--CCCcccceehhHHHHHHHHhCCCCCCCC
Q 022309 225 FGPTGDKSHVSTRVMGTHGYCAPEYATTG--KLTAKSDIFSFGVVLLELITGRPAMDDS 281 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~ 281 (299)
....... .......|+..|+|||.+.+. .++.++||||||+++|+|++|..||...
T Consensus 154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 211 (290)
T cd05613 154 EFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211 (290)
T ss_pred ecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence 5432221 112234588899999998653 4678899999999999999999999743
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=256.10 Aligned_cols=206 Identities=27% Similarity=0.424 Sum_probs=175.9
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
+|++.+.||+|+||.||+|.+..++..+|+|.+..... ...+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 47889999999999999999999999999999865422 2345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC-ceEEccccccccCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF-HPKLSDFGLAKFGPTG 229 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~-~~kl~Dfg~a~~~~~~ 229 (299)
+.+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++ .++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999998642 2235789999999999999999999999 99999999999998875 4699999998754322
Q ss_pred CCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
. .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+
T Consensus 156 ~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 209 (257)
T cd08225 156 M--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ 209 (257)
T ss_pred c--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 1 12223458889999999988889999999999999999999999998665443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=266.69 Aligned_cols=205 Identities=27% Similarity=0.381 Sum_probs=171.5
Q ss_pred HHHHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEecC--
Q 022309 66 QLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG-- 141 (299)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-- 141 (299)
.+....++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++...
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 344466889999999999999999999998999999999875422 2235677899999999999999999988543
Q ss_pred ----CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEE
Q 022309 142 ----TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKL 217 (299)
Q Consensus 142 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl 217 (299)
...+++++++ +++|.+++. ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 3467888876 789988874 245889999999999999999999999 999999999999999999999
Q ss_pred ccccccccCCCCCCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 218 SDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 218 ~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
+|||++..... ......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+..
T Consensus 162 ~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 224 (345)
T cd07877 162 LDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 224 (345)
T ss_pred ecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999875321 1123457889999998866 46888999999999999999999999766543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=266.86 Aligned_cols=206 Identities=30% Similarity=0.434 Sum_probs=171.3
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC--cccHHHHHHHHHHHhhc-CCCcceeeeeEEecC--Cee
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG--FQGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEG--TQR 144 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~--~~~ 144 (299)
..++|++.+.||+|+||.||+|.+..+++.+|+|.+.... ......+.+|+.+++.+ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467999999999999999999998889999999885432 22335577899999999 999999999988643 367
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
++||||+. ++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 599888842 26788899999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCc---ccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 225 FGPTGDKS---HVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 225 ~~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
........ .......|++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~ 219 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL 219 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH
Confidence 54333221 12233568899999998755 45788999999999999999999999766544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=265.55 Aligned_cols=208 Identities=26% Similarity=0.341 Sum_probs=172.2
Q ss_pred hcCCCC-CceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--------------HHHHHHHHHHHhhcCCCcceeee
Q 022309 71 TDNFKD-TNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--------------EKEFLVEVLMLSLMRHPNLVHLI 135 (299)
Q Consensus 71 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~nIv~~~ 135 (299)
.++|.. .+.||+|+||.||+|.+..+++.||+|.+....... ...+.+|+.+++.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 356664 467999999999999999999999999986543222 12467899999999999999999
Q ss_pred eEEecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCce
Q 022309 136 GYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHP 215 (299)
Q Consensus 136 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~ 215 (299)
+++..++..++|||++. ++|.+++. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCE
Confidence 99999999999999997 58999884 3456899999999999999999999999 9999999999999999999
Q ss_pred EEccccccccCCCCC------------CcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 216 KLSDFGLAKFGPTGD------------KSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 216 kl~Dfg~a~~~~~~~------------~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
+|+|||++....... .........+++.|+|||.+.+. .++.++|+|||||++|+|++|.+||...+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999987543110 01111223467889999998764 46889999999999999999999998777
Q ss_pred hhhh
Q 022309 283 GHER 286 (299)
Q Consensus 283 ~~~~ 286 (299)
..+.
T Consensus 239 ~~~~ 242 (335)
T PTZ00024 239 EIDQ 242 (335)
T ss_pred HHHH
Confidence 6543
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=255.51 Aligned_cols=200 Identities=34% Similarity=0.522 Sum_probs=160.4
Q ss_pred ceecccCceEEEEEEECC---CCcEEEEEEcCCCC-cccHHHHHHHHHHHhhcCCCcceeeeeEEe-cCCeeEEEEEecC
Q 022309 78 NFLGQGGFGAVYKGKLAE---TGQVVAVKQLDDTG-FQGEKEFLVEVLMLSLMRHPNLVHLIGYCA-EGTQRLLVYEYMP 152 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~-~~~~~~lv~e~~~ 152 (299)
+.||+|+||.||+|.+.. .+..+|+|.+.... ....+.+.+|+.+++.++||||+++++++. .++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998643 34579999886432 223457788999999999999999999765 4556789999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCc
Q 022309 153 LGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKS 232 (299)
Q Consensus 153 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~ 232 (299)
+++|.+++.. .....++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 9999999853 2234577788899999999999999999 999999999999999999999999999753221111
Q ss_pred c--cccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCch
Q 022309 233 H--VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQG 283 (299)
Q Consensus 233 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 283 (299)
. ......++..|+|||.+.+..++.++|||||||++|||++ |.+||...+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~ 208 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS 208 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 1 1112345678999999988889999999999999999999 4677765543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=274.27 Aligned_cols=199 Identities=22% Similarity=0.310 Sum_probs=174.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH--------HHHHHHHHHHhhcC---CCcceeeeeEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE--------KEFLVEVLMLSLMR---HPNLVHLIGYCA 139 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~E~~~l~~l~---h~nIv~~~~~~~ 139 (299)
...|..++.+|+|+||.|++|.++.+...|+||.|.+...-.. -.+-.|+.+|..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 4569999999999999999999999999999999976532211 12456999999987 999999999999
Q ss_pred cCCeeEEEEEec-CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEc
Q 022309 140 EGTQRLLVYEYM-PLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLS 218 (299)
Q Consensus 140 ~~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~ 218 (299)
+++++||+||.- +|.+|.++|. ....+++.++..|+.|++.|+++||++| |+|||||-+||.++.+|.+||+
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEe
Confidence 999999999974 5669999994 5577999999999999999999999999 9999999999999999999999
Q ss_pred cccccccCCCCCCcccccccccCccccCcccccCCCC-CcccceehhHHHHHHHHhCCCCCCC
Q 022309 219 DFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKL-TAKSDIFSFGVVLLELITGRPAMDD 280 (299)
Q Consensus 219 Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~ 280 (299)
|||.|.+.. +.....++||..|.|||++.+.+| +..-|||+||++||.++..+.||+.
T Consensus 713 dfgsaa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 713 DFGSAAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eccchhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999997643 334455789999999999999886 6779999999999999999999975
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=261.34 Aligned_cols=198 Identities=35% Similarity=0.523 Sum_probs=169.7
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc---HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG---EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
.|...+.||+|+||.||+|.+..++..||+|.+....... ...+..|+.+++.++|||++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3778899999999999999999899999999986543222 2467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+.| +|.+.+.. ...++++.++..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 106 ~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 106 YCLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP- 177 (317)
T ss_pred CCCC-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence 9974 78777743 2356899999999999999999999999 99999999999999999999999999865322
Q ss_pred CCcccccccccCccccCccccc---CCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 230 DKSHVSTRVMGTHGYCAPEYAT---TGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
.....|++.|+|||.+. ...++.++|||||||++|+|++|.+||...+.
T Consensus 178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~ 229 (317)
T cd06635 178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 229 (317)
T ss_pred -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH
Confidence 12245788999999873 35688899999999999999999999977654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=261.02 Aligned_cols=204 Identities=27% Similarity=0.376 Sum_probs=167.9
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcC-CCcceeeeeEEecCCeeEEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMR-HPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e 149 (299)
++|+..+.||+|+||.||++.+..+++.||+|.+...... ....+.+|+.++..+. |+||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 3566778999999999999999999999999998754322 3456888999998885 9999999999998889999999
Q ss_pred ecCCCCHHHHhccc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 150 YMPLGSLEDHLLGL-TPEMKPLDWNTRMKIAAGAARGLEYLHNK-ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 150 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
++. +++.++.... ......+++..+..++.|++.||+|||+. + ++||||||+||+++.++.++|+|||++....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 985 4665543211 11236789999999999999999999974 7 9999999999999999999999999997533
Q ss_pred CCCCcccccccccCccccCcccccCC---CCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTG---KLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
... ......|++.|+|||.+.+. .++.++|||||||++|+|++|.+||...+
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 160 DSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred cCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 221 11223578899999998766 68899999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=265.69 Aligned_cols=205 Identities=29% Similarity=0.418 Sum_probs=175.6
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC--cccHHHHHHHHHHHhhcCCCcceeeeeEEecCC-----eeE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG--FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT-----QRL 145 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-----~~~ 145 (299)
+|++.+.||+|++|.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999999889999999987643 233467889999999999999999999987765 789
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
++|+|+. ++|.+++. ...++++..++.++.|++.||++||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIK----SPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 58888884 3347899999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCCc-ccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 226 GPTGDKS-HVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 226 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
....... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||...+..+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~ 214 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID 214 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH
Confidence 5433210 112234578899999999887 78999999999999999999999998776543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=267.30 Aligned_cols=206 Identities=26% Similarity=0.383 Sum_probs=170.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecC---------
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG--------- 141 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--------- 141 (299)
..+|++.+.||.|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36799999999999999999999999999999998766555556788999999999999999999876543
Q ss_pred -----CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEec-CCCce
Q 022309 142 -----TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLG-KGFHP 215 (299)
Q Consensus 142 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~-~~~~~ 215 (299)
...++||||+. ++|.+++. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++ .++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence 35789999997 58888773 246889999999999999999999999 99999999999997 45678
Q ss_pred EEccccccccCCCCCCc-ccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 216 KLSDFGLAKFGPTGDKS-HVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 216 kl~Dfg~a~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
+|+|||++......... .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~ 226 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999754221111 11122357888999997654 567889999999999999999999998765433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=265.91 Aligned_cols=200 Identities=28% Similarity=0.406 Sum_probs=170.6
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCC-----
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT----- 142 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~----- 142 (299)
..++|++++.||+|+||.||+|.+..++..||+|.+...... ....+.+|+.+++.++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 467899999999999999999999999999999998653222 2346788999999999999999999986553
Q ss_pred -eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccc
Q 022309 143 -QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFG 221 (299)
Q Consensus 143 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg 221 (299)
.+++|||++ +++|.+++. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999998 779988874 256899999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 222 LAKFGPTGDKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 222 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
++...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+.
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 221 (343)
T cd07880 164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH 221 (343)
T ss_pred cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99753221 122457889999998866 4578899999999999999999999987654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=258.87 Aligned_cols=203 Identities=27% Similarity=0.390 Sum_probs=174.8
Q ss_pred CCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEec
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYM 151 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 151 (299)
|++.+.||+|++|.||+|.+..+++.+++|.+...... ....+.+|+.+++.++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 67789999999999999999989999999998755433 3456888999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCC
Q 022309 152 PLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231 (299)
Q Consensus 152 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~ 231 (299)
.+ +|.+.+.. ....+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 75 88888753 2357899999999999999999999999 9999999999999999999999999997654332
Q ss_pred cccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 232 SHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||...+..+
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~ 206 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID 206 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 112234578889999998776 68899999999999999999999998776544
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=261.82 Aligned_cols=207 Identities=29% Similarity=0.404 Sum_probs=169.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEecC-------
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAEG------- 141 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------- 141 (299)
.++|++.+.||+|++|.||+|.+..+++.+|+|.+....... ...+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999999999999999886543222 24567899999999999999999887443
Q ss_pred -CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccc
Q 022309 142 -TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDF 220 (299)
Q Consensus 142 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Df 220 (299)
...++|+||+. ++|.+.+.. ....+++.++..++.|+++||+|||+++ ++|+||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence 34689999986 477777743 3356899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcc---------cccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 221 GLAKFGPTGDKSH---------VSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 221 g~a~~~~~~~~~~---------~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
|++.......... ......+++.|+|||.+.+. .++.++|||||||++|+|++|.+||...+..
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~ 233 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9997543221111 11224568889999987654 5788999999999999999999999876653
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=257.23 Aligned_cols=213 Identities=27% Similarity=0.365 Sum_probs=170.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhh-cCCCcceeeeeEEecCCeeEEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSL-MRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~-l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
++.+-+..||.|+||+|++..++.+|+..|||.++.... .+.++++.|..+..+ -+.||||++|+....++..||.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 455667889999999999999999999999999987654 344678888876654 478999999999888888999999
Q ss_pred ecCCCCHHHHhcc-cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 150 YMPLGSLEDHLLG-LTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 150 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
.|+ .+|..+... .......++++....|......||+||...-. |+|||+||+|||++..|.+||||||.+....
T Consensus 144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv- 219 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLV- 219 (361)
T ss_pred HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHH-
Confidence 996 576655432 12234678888888898889999999987433 9999999999999999999999999986432
Q ss_pred CCCcccccccccCccccCcccccCC--CCCcccceehhHHHHHHHHhCCCCCCCCchhhhhhHH
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTG--KLTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVD 290 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~ 290 (299)
.+...+...|...|||||.+... .|+.++|+||||++|||+.||..||..-+..-.-+.+
T Consensus 220 --~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~ 281 (361)
T KOG1006|consen 220 --DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQ 281 (361)
T ss_pred --HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHH
Confidence 12223335688889999998543 5899999999999999999999999876653333333
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=256.08 Aligned_cols=201 Identities=27% Similarity=0.436 Sum_probs=176.5
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHH---HHHHHHHHhhc-CCCcceeeeeEEecCCeeE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE---FLVEVLMLSLM-RHPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~ 145 (299)
..++|.++++||+|+|.+|.+++.+.|.+.||+|++++.-..+.++ +..|..+.... +||.+|-+..+|+.+..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3467999999999999999999999999999999998765444332 45676777654 7999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
+|.||++||+|-=.+ .+.+.++++.+..+..+|+.||.|||++| |+.||||.+|||++..|++||+|+|+++.
T Consensus 328 fvieyv~ggdlmfhm----qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEecCcceeeeh----hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence 999999999985444 35578999999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCC
Q 022309 226 GPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMD 279 (299)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 279 (299)
.-.+ .....+++|||.|.|||++.+..|+..+|.|+|||+++||+.|+.||+
T Consensus 401 ~l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 401 GLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred CCCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 3222 223456899999999999999999999999999999999999999995
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=269.24 Aligned_cols=212 Identities=28% Similarity=0.457 Sum_probs=177.6
Q ss_pred HHHhhcCCCCCceecccCceEEEEEEECCC--C--cEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecC
Q 022309 67 LVAATDNFKDTNFLGQGGFGAVYKGKLAET--G--QVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG 141 (299)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 141 (299)
+.......+..+.||+|.||.||.|....- | -.||||..+.... .+.+.|..|+.+++.++||||+++++++.+.
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~ 463 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ 463 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc
Confidence 334445566678899999999999987432 3 3589998877443 3457899999999999999999999999875
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccc
Q 022309 142 TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFG 221 (299)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg 221 (299)
..|||||.+..|.|..+|.. +...++......++.||+.||+|||+.. +|||||..+||||.....+||+|||
T Consensus 464 -P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 464 -PMWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred -ceeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccc
Confidence 57999999999999999974 4567888999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhhh
Q 022309 222 LAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHER 286 (299)
Q Consensus 222 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~ 286 (299)
++++......... ....-...|||||.+.-..++.++|||.|||.+||++. |..||..-.+.+.
T Consensus 537 LSR~~ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV 601 (974)
T KOG4257|consen 537 LSRYLEDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV 601 (974)
T ss_pred hhhhccccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce
Confidence 9998654433222 23344567999999999999999999999999999887 8999987665543
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=263.09 Aligned_cols=201 Identities=30% Similarity=0.412 Sum_probs=171.1
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEec-CCeeE
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAE-GTQRL 145 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~~~~ 145 (299)
...++|++++.||.|+||.||+|.+..+++.||+|.+.+... ...+.+..|+.+++.++||||+++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 356789999999999999999999999999999998864322 234667889999999999999999999865 45788
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
+++|++ +++|.+++. ..++++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++..
T Consensus 87 lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 87 FVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 999998 568988874 246788889999999999999999999 99999999999999999999999999874
Q ss_pred CCCCCCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 226 GPTGDKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
.... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|.+||...+.
T Consensus 158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~ 211 (328)
T cd07856 158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH 211 (328)
T ss_pred cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 3211 122357888999998765 5688999999999999999999999977654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=261.37 Aligned_cols=205 Identities=26% Similarity=0.339 Sum_probs=166.5
Q ss_pred ceeccc--CceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCC
Q 022309 78 NFLGQG--GFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 78 ~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
..||.| +||+||++.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 9999999999999999999998754322 235678899999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC-Cc
Q 022309 154 GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD-KS 232 (299)
Q Consensus 154 ~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~-~~ 232 (299)
++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++||+.+....... ..
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999886432 245889999999999999999999999 9999999999999999999999998653221110 00
Q ss_pred cc----ccccccCccccCcccccCC--CCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 233 HV----STRVMGTHGYCAPEYATTG--KLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 233 ~~----~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
.. .....++..|+|||++.+. .++.++|||||||++|+|++|.+||......+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~ 219 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML 219 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH
Confidence 00 0112245679999998764 4788999999999999999999999887654443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=254.59 Aligned_cols=202 Identities=29% Similarity=0.429 Sum_probs=168.6
Q ss_pred CCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhc---CCCcceeeeeEEecCCe-----
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLM---RHPNLVHLIGYCAEGTQ----- 143 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~~----- 143 (299)
|++.+.||+|+||.||+|.+..+++.||+|.+....... ...+.+|+.+++.+ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999998889999999997543222 24566677766655 69999999999987776
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA 223 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a 223 (299)
.+++||++. ++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999997 48988885422 235899999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 224 KFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
....... ......++..|+|||.+.+..++.++|+|||||++|+|++|.+||......
T Consensus 155 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~ 212 (287)
T cd07838 155 RIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA 212 (287)
T ss_pred eeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH
Confidence 7643221 112234788899999998888999999999999999999999999876644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=257.38 Aligned_cols=198 Identities=36% Similarity=0.526 Sum_probs=169.2
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc---HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG---EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
.|...+.||+|+||.||+|.+..+++.|++|.+....... ...+..|+.+++.++|||++++++++.+....++|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 3777788999999999999999999999999986543222 2467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+. ++|.+++.. ...++++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 102 ~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~- 173 (313)
T cd06633 102 YCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP- 173 (313)
T ss_pred cCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence 996 578777753 3356899999999999999999999999 99999999999999999999999999864221
Q ss_pred CCcccccccccCccccCccccc---CCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 230 DKSHVSTRVMGTHGYCAPEYAT---TGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
.....|+..|+|||.+. +..++.++|||||||++|+|++|.+||...+.
T Consensus 174 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~ 225 (313)
T cd06633 174 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 225 (313)
T ss_pred -----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 12346888999999974 35678899999999999999999999976553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=261.05 Aligned_cols=203 Identities=28% Similarity=0.362 Sum_probs=167.0
Q ss_pred CCCCCceecccCceEEEEEEECCC--CcEEEEEEcCCCCcc--cHHHHHHHHHHHhhc-CCCcceeeeeEEecC----Ce
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAET--GQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLM-RHPNLVHLIGYCAEG----TQ 143 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~----~~ 143 (299)
+|++.+.||+|+||.||++.+..+ +..||+|.+...... ..+.+.+|+.+++.+ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 478889999999999999999877 889999998653222 235678899999988 599999999875322 45
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA 223 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a 223 (299)
.+++++++. ++|.+++. ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 688899885 68998884 4467899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCc--ccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 224 KFGPTGDKS--HVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 224 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
......... .......|++.|+|||.+.+ ..++.++||||||+++|+|++|.+||...+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~ 215 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY 215 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH
Confidence 754322111 11223468899999998755 4688999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=255.67 Aligned_cols=204 Identities=29% Similarity=0.458 Sum_probs=167.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
.++|++.+.||+|++|.||+|.+..+++.||+|.++..... ....+..|+.++... .||||+++++++.++...+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 36689999999999999999999988999999999754322 234566677666555 5999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN-KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
||+. ++|.+++.. ....+++.++..++.|++.||+|||+ .+ ++||||+|+||++++++.++|+|||++....
T Consensus 94 e~~~-~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 94 ELMS-TCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eccC-cCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 9985 577777643 23478999999999999999999997 57 9999999999999999999999999987543
Q ss_pred CCCCcccccccccCccccCcccccCCC----CCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGK----LTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
.... .....+++.|+|||.+.+.. ++.++||||||+++|+|++|..||.....+
T Consensus 167 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 224 (296)
T cd06618 167 DSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE 224 (296)
T ss_pred CCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH
Confidence 2211 12234778899999986553 788999999999999999999999764443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=262.23 Aligned_cols=200 Identities=27% Similarity=0.415 Sum_probs=168.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCC------
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT------ 142 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~------ 142 (299)
.++|.+.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 46899999999999999999999989999999998754222 2345788999999999999999999986543
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccc
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL 222 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~ 222 (299)
.+++|+||+. .+|.+++. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence 4589999986 47776552 35788999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 223 AKFGPTGDKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 223 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
+...... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+...
T Consensus 164 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~ 222 (342)
T cd07879 164 ARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 222 (342)
T ss_pred CcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 8753221 123457888999999866 458889999999999999999999998776543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=257.36 Aligned_cols=199 Identities=24% Similarity=0.255 Sum_probs=162.8
Q ss_pred CceEEEEEEECCCCcEEEEEEcCCCC--cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCCCHHHHhc
Q 022309 84 GFGAVYKGKLAETGQVVAVKQLDDTG--FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLL 161 (299)
Q Consensus 84 ~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 161 (299)
++|.||.++...+++.||+|++.... ......+..|+.+++.++||||+++++++.+....+++|||+.+++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 44556666666789999999987542 2334678899999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCC-----ccccc
Q 022309 162 GLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK-----SHVST 236 (299)
Q Consensus 162 ~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~ 236 (299)
.. ....+++..+..++.|++.||+|||+++ |+||||||+||+++.++.++|+|||.+........ .....
T Consensus 92 ~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 92 TH--FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred Hh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 42 2245889999999999999999999999 99999999999999999999999998864322111 11112
Q ss_pred ccccCccccCcccccC--CCCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 237 RVMGTHGYCAPEYATT--GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 237 ~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
...++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.....
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~ 219 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML 219 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 2346778999999866 35888999999999999999999999877654443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=267.63 Aligned_cols=200 Identities=31% Similarity=0.397 Sum_probs=170.8
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
..+.|.+...+|.|+|+.|-.+.+..+++.+++|++.+.. .+..+|+.++... +||||+++.+.+.+....|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3567888899999999999999999999999999997662 2233456555444 7999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEe-cCCCceEEccccccccCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL-GKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv-~~~~~~kl~Dfg~a~~~~ 227 (299)
|.+.|+.+.+.+.. .+....++..|+.||+.|+.|||++| ++||||||+|||+ ++.++++|+|||.++..+
T Consensus 396 e~l~g~ell~ri~~-----~~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRS-----KPEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHh-----cchhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 99999999888842 22333788889999999999999999 9999999999999 688999999999998644
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
.. ..+.+-|..|.|||++...+|+.++|+||||++||+||+|..||.......+
T Consensus 468 ~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e 521 (612)
T KOG0603|consen 468 RS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE 521 (612)
T ss_pred hh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH
Confidence 32 3345678899999999999999999999999999999999999987776633
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=281.35 Aligned_cols=146 Identities=31% Similarity=0.448 Sum_probs=132.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc---HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG---EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++++.||+|+||.||+|.+..+++.||||+++...... ...+..|+.+++.++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67999999999999999999999999999999997644322 256788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
||+.|++|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.++|+|||+++
T Consensus 84 Ey~~g~~L~~li~----~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLH----IYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999985 3356888999999999999999999999 9999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=263.79 Aligned_cols=202 Identities=28% Similarity=0.396 Sum_probs=171.7
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCe----
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQ---- 143 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~---- 143 (299)
..++|++.+.||+|++|.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++.+++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 35679999999999999999999999999999999865322 223567789999999999999999988765554
Q ss_pred --eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccc
Q 022309 144 --RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFG 221 (299)
Q Consensus 144 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg 221 (299)
.++|+|++ +++|.+++.. ..+++..++.++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 6799998842 56899999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 222 LAKFGPTGDKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 222 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|++||...+..+
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~ 223 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID 223 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 99754221 223457888999998865 367889999999999999999999998766543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=257.02 Aligned_cols=200 Identities=35% Similarity=0.518 Sum_probs=169.5
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
..|+..+.||+|+||.||+|++..+++.+++|.+..... .....+.+|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 347778899999999999999999999999998864322 22346778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+. ++|.+.+.. ...++++.++..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9996 588777742 2356889999999999999999999999 99999999999999999999999999875422
Q ss_pred CCCcccccccccCccccCccccc---CCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYAT---TGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
. ....+++.|+|||.+. ...++.++|||||||++|+|++|..||...+..
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 220 (308)
T cd06634 168 A------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220 (308)
T ss_pred c------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH
Confidence 1 2245788999999874 345788999999999999999999999776543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=248.04 Aligned_cols=195 Identities=35% Similarity=0.461 Sum_probs=170.4
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEcCCCCcc---cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCCCH
Q 022309 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSL 156 (299)
Q Consensus 80 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L 156 (299)
||+|+||.||++.+..+++.+++|.+...... ....+..|+.+++.++||||+++++.+..+...+++||++.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999999888999999998765433 235688899999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCccccc
Q 022309 157 EDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVST 236 (299)
Q Consensus 157 ~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 236 (299)
.+++. ....+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~ 151 (250)
T cd05123 81 FSHLS----KEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN 151 (250)
T ss_pred HHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence 99995 3346899999999999999999999999 9999999999999999999999999997643221 1223
Q ss_pred ccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 237 RVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 237 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
...++..|+|||.+.+...+.++|+||||+++|+|++|..||...+.
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~ 198 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR 198 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH
Confidence 34578899999999888889999999999999999999999976664
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=252.87 Aligned_cols=203 Identities=32% Similarity=0.427 Sum_probs=171.0
Q ss_pred CCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcC-CCcceeeeeEEecCCeeEEEEEec
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMR-HPNLVHLIGYCAEGTQRLLVYEYM 151 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e~~ 151 (299)
|++.+.||+|++|.||+|....+++.|++|.+..... .......+|+..++.++ ||||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 6788999999999999999998999999999865432 22334567889999998 999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCC
Q 022309 152 PLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231 (299)
Q Consensus 152 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~ 231 (299)
+++|.+.+.... ...+++.+++.++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 789998885421 246899999999999999999999999 9999999999999999999999999997543221
Q ss_pred cccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 232 SHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+..+
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~ 206 (283)
T cd07830 154 --PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID 206 (283)
T ss_pred --CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH
Confidence 1123457888999998744 457889999999999999999999997766543
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=255.09 Aligned_cols=201 Identities=30% Similarity=0.398 Sum_probs=169.0
Q ss_pred CCCCCceecccCceEEEEEEEC---CCCcEEEEEEcCCCCcc----cHHHHHHHHHHHhhc-CCCcceeeeeEEecCCee
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLA---ETGQVVAVKQLDDTGFQ----GEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQR 144 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 144 (299)
+|++.+.||+|++|.||++.+. .+++.||+|.+++.... ....+..|+.++..+ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788899999999999999864 46788999998754322 224577899999999 699999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
++||||+.+++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHh----hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccc
Confidence 99999999999999884 3356889999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCcccccccccCccccCcccccCCC--CCcccceehhHHHHHHHHhCCCCCCCC
Q 022309 225 FGPTGDKSHVSTRVMGTHGYCAPEYATTGK--LTAKSDIFSFGVVLLELITGRPAMDDS 281 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~ 281 (299)
....... .......|+..|+|||.+.+.. .+.++|+||||+++|+|++|..||...
T Consensus 154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 211 (288)
T cd05583 154 EFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD 211 (288)
T ss_pred ccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence 5433221 1122345788999999987654 778999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=277.90 Aligned_cols=210 Identities=29% Similarity=0.469 Sum_probs=181.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCc---EEEEEEcCCCCccc-HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQ---VVAVKQLDDTGFQG-EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
.+.-.|.++||.|.||.|++|..+..++ .||||.++...... ..+|+.|+.|+-+++||||+++.++........|
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 3456778899999999999999976664 59999998655433 4689999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
|+|||++|+|+.+|.. +...++..+...+++.|+.|+.||-+++ +|||||...||||+.+..+|++|||+++..
T Consensus 708 iTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred EhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeec
Confidence 9999999999999974 4467899999999999999999999999 999999999999999999999999999976
Q ss_pred CCCCCccccccc--ccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhhhh
Q 022309 227 PTGDKSHVSTRV--MGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHERM 287 (299)
Q Consensus 227 ~~~~~~~~~~~~--~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~ 287 (299)
.++... .+.+. .-..+|.|||.+...+++.++||||+||++||.++ |+.||-+.++++.+
T Consensus 782 edd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI 844 (996)
T KOG0196|consen 782 EDDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI 844 (996)
T ss_pred ccCCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH
Confidence 544322 22221 12458999999999999999999999999999777 99999888876654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=289.90 Aligned_cols=207 Identities=33% Similarity=0.580 Sum_probs=172.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
...|...+.||+|+||.||+|.+..++..||+|.+....... ..|+..++.++||||+++++++.+....++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 345778889999999999999998899999999986543222 3467889999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+++++|.+++. .+++.++..++.|++.||+|||....++|+||||||+||+++.++..++. ||.+.....
T Consensus 765 ~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-- 834 (968)
T PLN00113 765 IEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-- 834 (968)
T ss_pred CCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence 99999999993 37889999999999999999995534449999999999999998887775 665543211
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhhhhHHHHhhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVDWVTLF 295 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 295 (299)
.....+++.|+|||++.+..++.++|||||||++|||+||+.||+........+.+|+++.
T Consensus 835 ----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~ 895 (968)
T PLN00113 835 ----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYC 895 (968)
T ss_pred ----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHh
Confidence 1123578899999999988999999999999999999999999976655555667776543
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=252.68 Aligned_cols=202 Identities=32% Similarity=0.438 Sum_probs=173.1
Q ss_pred CCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC--cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEec
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG--FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYM 151 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 151 (299)
|+..+.||+|++|.||+|+...+++.||+|.+.... ......+..|+.+++.++|+||+++++++.+....++|+|++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 567789999999999999999999999999997653 222356788999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCC
Q 022309 152 PLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231 (299)
Q Consensus 152 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~ 231 (299)
. ++|.+++... ...+++.+++.++.|++.||++||+++ ++||||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 5899999632 146899999999999999999999999 99999999999999999999999999976433221
Q ss_pred cccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 232 SHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
......++..|+|||.+.+. .++.++||||||+++|+|++|.+||...+..
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 205 (282)
T cd07829 154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI 205 (282)
T ss_pred --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH
Confidence 12223467789999998766 7889999999999999999999999876643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=250.78 Aligned_cols=205 Identities=27% Similarity=0.330 Sum_probs=171.7
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-----ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-----QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
+|.+.+.||+|+||.||++.+..++..+++|.++.... .....+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58899999999999999999987777777776653221 1224567789999999999999999999988899999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
+||+.+++|.+++.........+++.+++.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988654445567899999999999999999999999 999999999999976 569999999987543
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
.... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~ 210 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF 210 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 2221 22234578899999999888889999999999999999999999975543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=249.81 Aligned_cols=211 Identities=28% Similarity=0.412 Sum_probs=175.4
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCC--CCcccHHHHHHHHHHHhhcCCCcceeeeeEEec-------
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDD--TGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAE------- 140 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~------- 140 (299)
..+.|+-+.+||+|.||.||+|+...+++.||+|++-- ....-.....+|+.+|..++|+|++.+++.|..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 34567788899999999999999999999999986632 222223567899999999999999999988732
Q ss_pred -CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcc
Q 022309 141 -GTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSD 219 (299)
Q Consensus 141 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~D 219 (299)
...+|+||.+|+ .+|..++. .....++..++..++.+++.||.|+|+.. |+|||+|+.|+||+.+|.++|+|
T Consensus 95 ~r~t~ylVf~~ce-hDLaGlLs---n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklAD 167 (376)
T KOG0669|consen 95 DRATFYLVFDFCE-HDLAGLLS---NRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLAD 167 (376)
T ss_pred ccceeeeeHHHhh-hhHHHHhc---CccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeec
Confidence 234799999997 48988885 34467899999999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCCcc--cccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 220 FGLAKFGPTGDKSH--VSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 220 fg~a~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
||+++.....++.. .++..+-|+.|.+||.+.+. .|+++.|||+.||++.||.||.+.|....+..++
T Consensus 168 FGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql 238 (376)
T KOG0669|consen 168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQL 238 (376)
T ss_pred cccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHH
Confidence 99997543333222 12334568899999988775 6999999999999999999999999988876664
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=282.58 Aligned_cols=199 Identities=30% Similarity=0.435 Sum_probs=160.9
Q ss_pred HHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEec------
Q 022309 68 VAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAE------ 140 (299)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~------ 140 (299)
....++|+.++.||+||||.||+++++-+|..||||+|...... ....+.+|+.++++++|||||+++..|.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 45667899999999999999999999999999999999866422 22568899999999999999988743200
Q ss_pred ------------------------------------------------------------------------C-------
Q 022309 141 ------------------------------------------------------------------------G------- 141 (299)
Q Consensus 141 ------------------------------------------------------------------------~------- 141 (299)
.
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0
Q ss_pred ----------------------------------CeeEEEEEecCCCCHHHHhcccCCCCCCC-CHHHHHHHHHHHHHHH
Q 022309 142 ----------------------------------TQRLLVYEYMPLGSLEDHLLGLTPEMKPL-DWNTRMKIAAGAARGL 186 (299)
Q Consensus 142 ----------------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~-~~~~~~~i~~ql~~~l 186 (299)
..+||-||||+..++.+++.. .... ....+|++++||++||
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~----N~~~~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR----NHFNSQRDEAWRLFREILEGL 710 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh----cccchhhHHHHHHHHHHHHHH
Confidence 124788999987777777742 1211 5788999999999999
Q ss_pred HHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC----------------CCCCcccccccccCccccCcccc
Q 022309 187 EYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP----------------TGDKSHVSTRVMGTHGYCAPEYA 250 (299)
Q Consensus 187 ~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~----------------~~~~~~~~~~~~g~~~y~aPE~~ 250 (299)
.|+|++| +|||||||.|||++++..|||+|||+|.... .+......+..+||..|+|||++
T Consensus 711 aYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 9999999 9999999999999999999999999997511 11111233456899999999999
Q ss_pred cCCC---CCcccceehhHHHHHHHHh
Q 022309 251 TTGK---LTAKSDIFSFGVVLLELIT 273 (299)
Q Consensus 251 ~~~~---~~~~~DiwslG~il~ellt 273 (299)
.+.. |+.|+|||||||+|+||+.
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc
Confidence 7654 9999999999999999974
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=256.99 Aligned_cols=198 Identities=34% Similarity=0.561 Sum_probs=167.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhh--cCCCcceeeeeEEecCC----ee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSL--MRHPNLVHLIGYCAEGT----QR 144 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~~~~~~~~----~~ 144 (299)
....+.++.||+|.||.||+|+. +++.||||++... +.+.+..|..+.+. +.|+||+++++.-...+ .+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 45677789999999999999998 5699999999643 45678888887775 58999999999876555 78
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh------CCCCCeEecCCCCCCEEecCCCceEEc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN------KADPPVIYRDLKAGNILLGKGFHPKLS 218 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~------~~~~~i~H~dikp~Nilv~~~~~~kl~ 218 (299)
+||++|.+.|+|.++|.. ..+++....+|+..|++||+|||. +..++|+|||||..||||.++++..|+
T Consensus 284 wLVt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred eEEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 999999999999999953 668999999999999999999996 236889999999999999999999999
Q ss_pred cccccccCCCCCCcccccccccCccccCcccccCCC-CC-----cccceehhHHHHHHHHhCCCCC
Q 022309 219 DFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGK-LT-----AKSDIFSFGVVLLELITGRPAM 278 (299)
Q Consensus 219 Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-----~~~DiwslG~il~elltg~~pf 278 (299)
|||+|.....+.........+||.+|||||++.+.. .. .+.||||+|.+||||+++..-+
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 999998766555555555578999999999997652 22 3689999999999999975544
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=245.62 Aligned_cols=182 Identities=26% Similarity=0.308 Sum_probs=155.8
Q ss_pred cCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCCCHHHHhcc
Q 022309 83 GGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLG 162 (299)
Q Consensus 83 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 162 (299)
|.+|.||++++..+++.||+|.+.... ....|...+....||||+++++++.+....+++|||+.|++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999999999999999997653 233444555556799999999999999999999999999999999853
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcccccccccCc
Q 022309 163 LTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTH 242 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~ 242 (299)
...+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||.+...... .....++.
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~ 146 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVEN 146 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCc
Confidence 345899999999999999999999999 999999999999999999999999987643221 12234567
Q ss_pred cccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCC
Q 022309 243 GYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDS 281 (299)
Q Consensus 243 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 281 (299)
.|+|||.+.+..++.++|+||+|+++|+|++|..||...
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~ 185 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECH 185 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence 899999998888999999999999999999999887643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=237.41 Aligned_cols=207 Identities=20% Similarity=0.350 Sum_probs=174.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcC-CCcceeeeeEEecCC--eeEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMR-HPNLVHLIGYCAEGT--QRLL 146 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~--~~~l 146 (299)
..++|++++++|+|-++.||.|.+..+++.++||++++. ..+.+.+|+.+|+.+. ||||+++++...+.. .+.+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 457899999999999999999999999999999999764 4567899999999996 999999999987654 4679
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCC-CceEEcccccccc
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKG-FHPKLSDFGLAKF 225 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~-~~~kl~Dfg~a~~ 225 (299)
++|+++..+...+. ..++...+..++.|++.||.|||++| |+|||+||.|++|+.. ..++|+|+|+|.+
T Consensus 113 iFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred HhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhh
Confidence 99999988777665 45677889999999999999999999 9999999999999854 5799999999998
Q ss_pred CCCCCCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhhhhhHHHH
Q 022309 226 GPTGDKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVDWV 292 (299)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~ 292 (299)
+.++..... .+.+..|..||++-. +.|+..-|+|||||++..|+..+.||.....+..-++..+
T Consensus 183 YHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIa 247 (338)
T KOG0668|consen 183 YHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIA 247 (338)
T ss_pred cCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHH
Confidence 766544332 246778999998855 5689999999999999999999888766555544444433
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=267.85 Aligned_cols=217 Identities=31% Similarity=0.453 Sum_probs=184.4
Q ss_pred HHHHHHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhc-CCCcceeeeeEEe---
Q 022309 64 YRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLM-RHPNLVHLIGYCA--- 139 (299)
Q Consensus 64 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~--- 139 (299)
+.......+.|++.++||.|.+|.||+++.+.+++..|+|+..... ...++++.|.++++.. +|||++.++++|.
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 3334445677999999999999999999999999999999876553 3446678888999876 7999999999984
Q ss_pred --cCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEE
Q 022309 140 --EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKL 217 (299)
Q Consensus 140 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl 217 (299)
.++.+|+|||||.|||..|++.+.. ...+.|..+..|++.++.|+.+||+.. ++|||||=.|||++.++.|||
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 3468999999999999999998754 578899999999999999999999999 999999999999999999999
Q ss_pred ccccccccCCCCCCcccccccccCccccCcccccCC-----CCCcccceehhHHHHHHHHhCCCCCCCCchhhhhh
Q 022309 218 SDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTG-----KLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288 (299)
Q Consensus 218 ~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 288 (299)
+|||++.... .......+.+|||.|||||++.-. .|+..+|+||||++..||--|.||+.+..+...++
T Consensus 165 vDFGvSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF 238 (953)
T KOG0587|consen 165 VDFGVSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF 238 (953)
T ss_pred eeeeeeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc
Confidence 9999986422 223344567899999999998443 37788999999999999999999999887765554
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=265.60 Aligned_cols=207 Identities=31% Similarity=0.487 Sum_probs=176.1
Q ss_pred CCCCCceecccCceEEEEEEECC-CCc--EEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAE-TGQ--VVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~-~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
...+.++||+|.||+|++|.+.. +|+ .||||+++..... ...+|.+|+.++.+++|+|++++|++..+ .-..|||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 34556789999999999998854 333 5899999876555 55889999999999999999999999988 5678999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
|.+.+|+|.+.|.. .....|.......++.||+.|+.||.+++ +|||||...|+++.....|||+||||.+....
T Consensus 190 ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 99999999999976 34467788888999999999999999999 99999999999999999999999999987655
Q ss_pred CCCcccccc-cccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 229 GDKSHVSTR-VMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 229 ~~~~~~~~~-~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
.+..+.... ..-...|+|||.+....++.++|+|++||++|||+| |+-||-+..+..
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q 323 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ 323 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH
Confidence 554443332 223446999999999999999999999999999999 789998776543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=247.76 Aligned_cols=206 Identities=29% Similarity=0.424 Sum_probs=167.6
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhh--cCCCcceeeeeEEecCC----e
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSL--MRHPNLVHLIGYCAEGT----Q 143 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~~~~~~~~----~ 143 (299)
......+.+.||+|.||.||+|.+ -|+.||||++... ++..+.+|.++.+- ++|+||+.+++.-..++ .
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhheeEEEEEecCccccceeeccc--cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 345678889999999999999999 5789999999643 56778888888764 69999999998875443 5
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEecCCCCCCEEecCCCceEEc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN-----KADPPVIYRDLKAGNILLGKGFHPKLS 218 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-----~~~~~i~H~dikp~Nilv~~~~~~kl~ 218 (299)
+|+|++|-+.|||.|+|. ...++....++++..++.||++||- +|.|.|.|||||..||||.+++..-|+
T Consensus 284 LwLvTdYHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEeeecccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 789999999999999994 3778999999999999999999994 688999999999999999999999999
Q ss_pred cccccccCCCCC--CcccccccccCccccCcccccCCC----C--CcccceehhHHHHHHHHhC----------CCCCCC
Q 022309 219 DFGLAKFGPTGD--KSHVSTRVMGTHGYCAPEYATTGK----L--TAKSDIFSFGVVLLELITG----------RPAMDD 280 (299)
Q Consensus 219 Dfg~a~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~----~--~~~~DiwslG~il~elltg----------~~pf~~ 280 (299)
|+|||-...... ........+||.+|||||++.... + -..+||||||.++||+..+ .+||.+
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 999996433221 112233467999999999996642 1 1358999999999998762 468865
Q ss_pred Cchhh
Q 022309 281 SQGHE 285 (299)
Q Consensus 281 ~~~~~ 285 (299)
--+.+
T Consensus 439 ~Vp~D 443 (513)
T KOG2052|consen 439 VVPSD 443 (513)
T ss_pred CCCCC
Confidence 44433
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=246.60 Aligned_cols=205 Identities=27% Similarity=0.403 Sum_probs=171.9
Q ss_pred CCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC--cccHHHHHHHHHHHhhcCCCcceeeeeEEecCC-----eeEE
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG--FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT-----QRLL 146 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-----~~~l 146 (299)
.+-.+.||-|+||.||.+.+..+|+.||+|++.... ....+.+.+|+++|..++|.|++..++...-.. ..|.
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 445678999999999999999999999999886432 233467899999999999999999888764332 2467
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
++|.++ .+|..++ -+..+++...+.-+..||+.||.|||+.+ |+||||||.|.|++.+..+||||||+|+..
T Consensus 135 ~TELmQ-SDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 135 LTELMQ-SDLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHH-hhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence 888885 5777777 46688999999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
...+. ...+..+-|.+|.|||++.+. .|+.+.||||+|||+.|||..+..|..-++-+++
T Consensus 207 e~d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL 267 (449)
T KOG0664|consen 207 DQRDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQL 267 (449)
T ss_pred chhhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHH
Confidence 43332 233344578899999999775 5999999999999999999999999988887664
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=234.23 Aligned_cols=212 Identities=34% Similarity=0.450 Sum_probs=181.2
Q ss_pred CCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecC
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMP 152 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 152 (299)
|.+.+.||+|++|.||++.+..+++.+++|.+...... ..+.+.+|+..++.++|+|++++++++......++++|++.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 56778999999999999999888999999999876554 55788899999999999999999999999899999999999
Q ss_pred CCCHHHHhcccCCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCC
Q 022309 153 LGSLEDHLLGLTPEMKP-LDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231 (299)
Q Consensus 153 ~~~L~~~l~~~~~~~~~-~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~ 231 (299)
+++|.+++... .. +++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 81 GGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 99999998532 23 789999999999999999999998 99999999999999999999999999976543321
Q ss_pred cccccccccCccccCcccc-cCCCCCcccceehhHHHHHHHHhCCCCCCC-CchhhhhhHHHHh
Q 022309 232 SHVSTRVMGTHGYCAPEYA-TTGKLTAKSDIFSFGVVLLELITGRPAMDD-SQGHERMLVDWVT 293 (299)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~~~~~ 293 (299)
.......++..|++||.+ ....++.++|+|+||+++++|++|++||.. .+..+.+...|..
T Consensus 154 -~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~ 216 (225)
T smart00221 154 -ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSF 216 (225)
T ss_pred -ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhc
Confidence 112234577889999998 666788899999999999999999999977 5556566666653
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=260.12 Aligned_cols=214 Identities=29% Similarity=0.436 Sum_probs=183.6
Q ss_pred HHHHHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCee
Q 022309 65 RQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQR 144 (299)
Q Consensus 65 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 144 (299)
..+.....+...-.+||-|.||.||.|.++.-...||||.++... ...++|++|+.+++.++|||+|+++++|..+..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 444445555666788999999999999999888999999987653 5568899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
|||+|||..|+|.++|..+. ...++....+.++.||..|++||..++ +|||||...|.||.++..+|+.||||++
T Consensus 339 YIiTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred EEEEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhh
Confidence 99999999999999997653 355677788899999999999999999 9999999999999999999999999999
Q ss_pred cCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 225 FGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
+...+... ......-...|.|||.+....++.++|||+|||+|||+.| |-.||.+.+-..
T Consensus 414 lMtgDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq 474 (1157)
T KOG4278|consen 414 LMTGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 474 (1157)
T ss_pred hhcCCcee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH
Confidence 86543322 2222223567999999999999999999999999999998 899998776543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=264.28 Aligned_cols=205 Identities=34% Similarity=0.504 Sum_probs=178.6
Q ss_pred CCCCceecccCceEEEEEEECCCCc----EEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQ----VVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
.+..++||+|+||+||+|.+...++ +||+|++..... ...+++..|+.++.+++|||++++++++..+. +-||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 4556889999999999999865555 588898865443 34578999999999999999999999998765 78999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
+|+++|+|.+++.. .+.++..+..+.|..||++||.|||.+. ++||||..+||||.+-..+||.|||+|+....
T Consensus 777 q~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 99999999999975 4467888999999999999999999999 99999999999999999999999999998766
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
...........-.+.|||-|.+....|+.++|||||||++||++| |..||+....+|
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e 908 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE 908 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH
Confidence 666555554555678999999999999999999999999999999 999998877654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=254.73 Aligned_cols=219 Identities=23% Similarity=0.266 Sum_probs=187.4
Q ss_pred CCCccHHHHHHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcC------CCcce
Q 022309 59 ENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMR------HPNLV 132 (299)
Q Consensus 59 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv 132 (299)
+..+.+......-++|.+....|+|-||+|..|.+..-|..||||+|........ .=++|+.+|++|+ .-|++
T Consensus 419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~K-tGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHK-TGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhh-hhhHHHHHHHHhhccCchhhhHHH
Confidence 4456677778888999999999999999999999998899999999987755443 3467999999995 35899
Q ss_pred eeeeEEecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCC
Q 022309 133 HLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKG 212 (299)
Q Consensus 133 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~ 212 (299)
+++..|...+++|||||.+. .+|.++|..+. ..-.+....+..++.||+.||..|-..| |+|.||||+||||+++
T Consensus 498 rl~r~F~hknHLClVFE~Ls-lNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPLS-LNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNES 572 (752)
T ss_pred HHHHHhhhcceeEEEehhhh-chHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccC
Confidence 99999999999999999985 69999997654 4456888999999999999999999999 9999999999999976
Q ss_pred -CceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 213 -FHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 213 -~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
..+||||||.|....... .+.+.-+..|.|||++.|.+|+...|+||+||+||||.||...|.+..++.++
T Consensus 573 k~iLKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML 644 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQML 644 (752)
T ss_pred cceeeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHH
Confidence 468999999997643221 12233567899999999999999999999999999999999999998877654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=243.42 Aligned_cols=140 Identities=24% Similarity=0.309 Sum_probs=117.2
Q ss_pred HHHHHHhh-cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcC-----C---Ccceee
Q 022309 64 YRQLVAAT-DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMR-----H---PNLVHL 134 (299)
Q Consensus 64 ~~~~~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~nIv~~ 134 (299)
......+. .+|.+.++||-|.|++||+|.+..+.+.||+|+++... .-.+....|+.+|+.++ | .+||++
T Consensus 69 V~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 69 VRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred eeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 33444555 78999999999999999999999999999999987552 12245678999998873 2 479999
Q ss_pred eeEEec----CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEe
Q 022309 135 IGYCAE----GTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL 209 (299)
Q Consensus 135 ~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv 209 (299)
++.|.. +.+.+||+|++ |.+|..+|.. ...+.++...+..|++||+.||.|||... +|+|-||||+|||+
T Consensus 148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred eccceecCCCCcEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 999954 45789999998 8899999975 45678999999999999999999999843 49999999999998
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=229.01 Aligned_cols=212 Identities=22% Similarity=0.375 Sum_probs=172.3
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhc-CCCcceeeeeE-EecCCeeEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLM-RHPNLVHLIGY-CAEGTQRLLV 147 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~-~~~~~~~~lv 147 (299)
..+.|.+.+.||+|-||.+-+|.++.++..+++|.+.... ...++|.+|..---.| .|.||+.-|+. |+..+.++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 4567999999999999999999999999999999987654 3457788887654444 58999998875 6777788999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEec--CCCceEEcccccccc
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLG--KGFHPKLSDFGLAKF 225 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~--~~~~~kl~Dfg~a~~ 225 (299)
+||++.|+|.+-+. ...+.+.....++.|++.|+.|||+++ +||||||.+||||- +.-++||||||+...
T Consensus 101 qE~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred eccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccc
Confidence 99999999998773 266888999999999999999999999 99999999999993 334899999999864
Q ss_pred CCCCCCcccccccccCccccCcccccCC-----CCCcccceehhHHHHHHHHhCCCCCCCCchhhhhhHHHHhhh
Q 022309 226 GPTGDKSHVSTRVMGTHGYCAPEYATTG-----KLTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVDWVTLF 295 (299)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 295 (299)
.. ... .....+..|.+||+.... ...+.+|+|+||+++|.+|||.+||+.....+.-..+|..+.
T Consensus 173 ~g--~tV---~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~ 242 (378)
T KOG1345|consen 173 VG--TTV---KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWL 242 (378)
T ss_pred cC--cee---hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHh
Confidence 21 111 112245568999976332 256789999999999999999999998777777777777653
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=226.06 Aligned_cols=189 Identities=35% Similarity=0.525 Sum_probs=166.4
Q ss_pred CceEEEEEEECCCCcEEEEEEcCCCCccc-HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCCCHHHHhcc
Q 022309 84 GFGAVYKGKLAETGQVVAVKQLDDTGFQG-EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLG 162 (299)
Q Consensus 84 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 162 (299)
+||.||+|....+++.+++|++....... ...+.+|+..++.++|+||+++++.+......++++|++.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999999889999999997665444 57889999999999999999999999998999999999999999999853
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcccccccccCc
Q 022309 163 LTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTH 242 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~ 242 (299)
...++...++.++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++.
T Consensus 81 ----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 ----RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred ----ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 233889999999999999999999999 9999999999999999999999999997644322 223345788
Q ss_pred cccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 243 GYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 243 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
.|++||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~ 190 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD 190 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 8999999988888999999999999999999999998743
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-32 Score=245.38 Aligned_cols=207 Identities=23% Similarity=0.311 Sum_probs=152.2
Q ss_pred hhcCCCCCceecccCceEEEEEEEC----------------CCCcEEEEEEcCCCCcccHHH--------------HHHH
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLA----------------ETGQVVAVKQLDDTGFQGEKE--------------FLVE 119 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 119 (299)
..++|++.++||+|+||+||+|... ..++.||||.+........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3568999999999999999999752 234679999986543222222 3346
Q ss_pred HHHHhhcCCCcc-----eeeeeEEec--------CCeeEEEEEecCCCCHHHHhcccCC--------------------C
Q 022309 120 VLMLSLMRHPNL-----VHLIGYCAE--------GTQRLLVYEYMPLGSLEDHLLGLTP--------------------E 166 (299)
Q Consensus 120 ~~~l~~l~h~nI-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~ 166 (299)
+.++..++|.++ ++++++|.. ....++|+||+.+++|.+++..... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 666777766543 666776642 3467999999999999998863211 0
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcccccccccCccccC
Q 022309 167 MKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCA 246 (299)
Q Consensus 167 ~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~a 246 (299)
...+++..+..++.|++.+|.|||+.+ |+||||||+||+++.++.++|+|||++........ .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 123456788899999999999999999 99999999999999999999999999965322211 11112235789999
Q ss_pred cccccCCC--------------------CC--cccceehhHHHHHHHHhCCC-CCCC
Q 022309 247 PEYATTGK--------------------LT--AKSDIFSFGVVLLELITGRP-AMDD 280 (299)
Q Consensus 247 PE~~~~~~--------------------~~--~~~DiwslG~il~elltg~~-pf~~ 280 (299)
||.+.... ++ .+.||||+||++|+|++|.. ||.+
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 99875432 11 24699999999999999975 7754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=252.69 Aligned_cols=203 Identities=22% Similarity=0.265 Sum_probs=144.3
Q ss_pred hhcCCCCCceecccCceEEEEEEECCC----CcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeE------Ee
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAET----GQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGY------CA 139 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~------~~ 139 (299)
..++|++.+.||+|+||.||+|.+..+ +..||+|.+...... +....| .++...+.++..+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 457899999999999999999999888 899999987643211 111111 1112222233322222 23
Q ss_pred cCCeeEEEEEecCCCCHHHHhcccCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 022309 140 EGTQRLLVYEYMPLGSLEDHLLGLTPE----------------MKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLK 203 (299)
Q Consensus 140 ~~~~~~lv~e~~~~~~L~~~l~~~~~~----------------~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dik 203 (299)
.+...++|+||+.+++|.+++...... ........+..++.|++.||.|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 556789999999999999988532100 011123456789999999999999999 9999999
Q ss_pred CCCEEecC-CCceEEccccccccCCCCCCcccccccccCccccCcccccCCC----------------------CCcccc
Q 022309 204 AGNILLGK-GFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGK----------------------LTAKSD 260 (299)
Q Consensus 204 p~Nilv~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----------------------~~~~~D 260 (299)
|+|||++. ++.+||+|||+|....... ........+++.|+|||.+.... ++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 5899999999997543221 22334567899999999663322 334569
Q ss_pred eehhHHHHHHHHhCCCCCCC
Q 022309 261 IFSFGVVLLELITGRPAMDD 280 (299)
Q Consensus 261 iwslG~il~elltg~~pf~~ 280 (299)
||||||++|||+++..|++.
T Consensus 362 VwSlGviL~el~~~~~~~~~ 381 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDS 381 (566)
T ss_pred cHHHHHHHHHHHhCcCCCch
Confidence 99999999999997766543
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=252.12 Aligned_cols=221 Identities=30% Similarity=0.467 Sum_probs=178.0
Q ss_pred HHhhcCCCCCceecccCceEEEEEEEC----C---CCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhc-CCCcceeeeeEE
Q 022309 68 VAATDNFKDTNFLGQGGFGAVYKGKLA----E---TGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLM-RHPNLVHLIGYC 138 (299)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~V~~~~~~----~---~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 138 (299)
....++..+.+.||+|.||.|++|... . ....||||..+..... +.+.+..|+.++..+ .|+||+.+++++
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 344455667779999999999999753 1 1457999998754433 457789999999988 699999999999
Q ss_pred ecCCeeEEEEEecCCCCHHHHhcccC---C-------CC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 022309 139 AEGTQRLLVYEYMPLGSLEDHLLGLT---P-------EM--KPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGN 206 (299)
Q Consensus 139 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~-------~~--~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~N 206 (299)
..+...++|+||+..|+|.+++...+ . .. ..++....+.++.||+.|++||++.. ++||||..+|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhh
Confidence 99889999999999999999997543 0 01 23888999999999999999999999 9999999999
Q ss_pred EEecCCCceEEccccccccCCCCCCccccccccc--CccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCch
Q 022309 207 ILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMG--THGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQG 283 (299)
Q Consensus 207 ilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g--~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 283 (299)
||+.++..+||+|||+|+........... ...| ...|||||.+....|+.++||||+||+|||++| |..||.+-..
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 99999999999999999854333222211 1112 345999999999999999999999999999999 8999988654
Q ss_pred hhhhhHHHHh
Q 022309 284 HERMLVDWVT 293 (299)
Q Consensus 284 ~~~~~~~~~~ 293 (299)
.+.+ .+++.
T Consensus 528 ~~~l-~~~l~ 536 (609)
T KOG0200|consen 528 TEEL-LEFLK 536 (609)
T ss_pred HHHH-HHHHh
Confidence 5555 33543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=233.85 Aligned_cols=219 Identities=27% Similarity=0.396 Sum_probs=183.7
Q ss_pred HHHHHhhcCCCCCceecccCceEEEEEEECC---CCcEEEEEEcCCCCcccHHHHHHHHHHHhhc-CCCcceeeeeEEec
Q 022309 65 RQLVAATDNFKDTNFLGQGGFGAVYKGKLAE---TGQVVAVKQLDDTGFQGEKEFLVEVLMLSLM-RHPNLVHLIGYCAE 140 (299)
Q Consensus 65 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~ 140 (299)
+.+....+.|..+.+||+|+|++||++.+.. .++.||+|.+... .....+..|+++|..+ .+.||+++.+++..
T Consensus 29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 3355567789999999999999999999877 7889999999766 3456788999999888 58999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCC-CceEEcc
Q 022309 141 GTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKG-FHPKLSD 219 (299)
Q Consensus 141 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~-~~~kl~D 219 (299)
.+...+|+||++..+..++. ..++..++..+++.++.||.++|.+| |+||||||+|++++.. +.-.|+|
T Consensus 107 nd~v~ivlp~~~H~~f~~l~-------~~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvD 176 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLY-------RSLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVD 176 (418)
T ss_pred CCeeEEEecccCccCHHHHH-------hcCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEe
Confidence 99999999999999999888 44668899999999999999999999 9999999999999854 6778999
Q ss_pred ccccccC-----------------CC--C-----------------------CCcccccccccCccccCcccccCC-CCC
Q 022309 220 FGLAKFG-----------------PT--G-----------------------DKSHVSTRVMGTHGYCAPEYATTG-KLT 256 (299)
Q Consensus 220 fg~a~~~-----------------~~--~-----------------------~~~~~~~~~~g~~~y~aPE~~~~~-~~~ 256 (299)
||+|... .. + ..........||++|.|||++... ..+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 9999710 00 0 000011123599999999998665 478
Q ss_pred cccceehhHHHHHHHHhCCCCCCCCchhhhhhHHHHhhh
Q 022309 257 AKSDIFSFGVVLLELITGRPAMDDSQGHERMLVDWVTLF 295 (299)
Q Consensus 257 ~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 295 (299)
+++||||.|||+..++++..||.....+-..+.+.++.+
T Consensus 257 taiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tif 295 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIF 295 (418)
T ss_pred CccceeeccceeehhhccccccccCccccchHHHHHHHh
Confidence 899999999999999999999998888888888877654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=226.99 Aligned_cols=204 Identities=26% Similarity=0.341 Sum_probs=172.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC--cccHHHHHHHHHHHhhcCCCcceeeeeEEecC------C
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG--FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG------T 142 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------~ 142 (299)
..+|.-++.+|.|.- .|..+.+.-.++.||+|...... ....+...+|..++..+.|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 456888889999999 78888888899999999886442 23346778999999999999999999998533 2
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccc
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL 222 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~ 222 (299)
..|+|||+++ .+|...+. ..++-..+..|+.|++.|+.|||+.+ |+||||||+||++..+..+||.|||+
T Consensus 95 e~y~v~e~m~-~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVIL------MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred hHHHHHHhhh-hHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchh
Confidence 4689999996 58988885 44677888999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhhhhHHHH
Q 022309 223 AKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVDWV 292 (299)
Q Consensus 223 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~ 292 (299)
|+... .....+.++.+..|.|||++.+-.|...+||||+||++.||++|...|.+.+ .+.+|.
T Consensus 165 ar~e~---~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d----~idQ~~ 227 (369)
T KOG0665|consen 165 ARTED---TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD----HIDQWN 227 (369)
T ss_pred hcccC---cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch----HHHHHH
Confidence 98532 2234556788999999999999889999999999999999999999999665 455565
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=244.33 Aligned_cols=208 Identities=29% Similarity=0.395 Sum_probs=183.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|+.+..+|+|++|.||++++..+++..|+|+++.....+-+-+..|+-+++.++||||+.+++.|...+..+|.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 46799999999999999999999999999999999877666667788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
|.||+|.+... ...++++.++...+++.++|++|||+++ -+|||||=.||+++..|.+||.|||.+-.+..
T Consensus 94 cgggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita-- 164 (829)
T KOG0576|consen 94 CGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA-- 164 (829)
T ss_pred cCCCcccceee----ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh--
Confidence 99999999773 5688999999999999999999999999 89999999999999999999999999854322
Q ss_pred CcccccccccCccccCcccc---cCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYA---TTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~---~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
.......+.||++|||||+. ....|...+|||++|++..|+---.+|..+.-+...+
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l 224 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL 224 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH
Confidence 22334457899999999975 4456889999999999999998888887766655444
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-30 Score=215.03 Aligned_cols=220 Identities=25% Similarity=0.348 Sum_probs=180.2
Q ss_pred HHHHHHhhcCCCCCceecccCceEEEEEEECCC-----CcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeE
Q 022309 64 YRQLVAATDNFKDTNFLGQGGFGAVYKGKLAET-----GQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGY 137 (299)
Q Consensus 64 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~ 137 (299)
...+.....+++....+-+|.||.||.|.+.+. .+.|.+|.++..... +-..+..|...+..+.|||+.++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 344556677889899999999999999976532 344666766543322 23567889999999999999999998
Q ss_pred Eec-CCeeEEEEEecCCCCHHHHhcccC----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCC
Q 022309 138 CAE-GTQRLLVYEYMPLGSLEDHLLGLT----PEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKG 212 (299)
Q Consensus 138 ~~~-~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~ 212 (299)
..+ ....+.++.+...|+|..++..++ ...+.++..+...++.|++.|++|||+++ ++|.||..+|.+|++.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 754 456788899999999999997432 22345677888899999999999999999 9999999999999999
Q ss_pred CceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhhh
Q 022309 213 FHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHER 286 (299)
Q Consensus 213 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~ 286 (299)
.++||+|=.+++..-+.+.............||+||.+.+..|+.++|+|||||++|||+| |..||.+.|+.|.
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm 507 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM 507 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH
Confidence 9999999999987666665555554556678999999999999999999999999999999 8999999998664
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=200.39 Aligned_cols=184 Identities=39% Similarity=0.576 Sum_probs=159.2
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCCCHHH
Q 022309 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLED 158 (299)
Q Consensus 80 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~ 158 (299)
||+|++|.||++....+++.+++|.+...... ....+.+|+..++.+.|++|+++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999888999999999765432 24678999999999999999999999999899999999999999999
Q ss_pred HhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC-CCceEEccccccccCCCCCCcccccc
Q 022309 159 HLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK-GFHPKLSDFGLAKFGPTGDKSHVSTR 237 (299)
Q Consensus 159 ~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~ 237 (299)
++... ...++...++.++.+++.++++||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKEN---EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 98532 146889999999999999999999999 999999999999999 89999999999976433321 1222
Q ss_pred cccCccccCcccccCC-CCCcccceehhHHHHHHH
Q 022309 238 VMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLEL 271 (299)
Q Consensus 238 ~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el 271 (299)
..+...|++||.+... .++.++|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 4577789999998776 788899999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=236.29 Aligned_cols=202 Identities=30% Similarity=0.390 Sum_probs=162.2
Q ss_pred CCCCceecccCce-EEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEEEEEec
Q 022309 74 FKDTNFLGQGGFG-AVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLLVYEYM 151 (299)
Q Consensus 74 y~~~~~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~ 151 (299)
|.--+.+|.|+.| .||+|.. .++.||||.+-... ..-..+|+..|+.. +||||+++++.-.+....||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 3444678999997 4899988 67899999875432 23567899999887 6999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC---C--CceEEccccccccC
Q 022309 152 PLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK---G--FHPKLSDFGLAKFG 226 (299)
Q Consensus 152 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~---~--~~~kl~Dfg~a~~~ 226 (299)
. .+|.+++...............+.+..|++.||++||+.+ ||||||||.||||+. + .+++|+|||+++..
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 6 5999999752111111111455788999999999999999 999999999999975 2 57899999999876
Q ss_pred CCCCCcc-cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhC-CCCCCCCchh
Q 022309 227 PTGDKSH-VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITG-RPAMDDSQGH 284 (299)
Q Consensus 227 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~ 284 (299)
..+..+. ......||-+|+|||++.....+.++||+||||++|+.++| ..||.+.-..
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R 721 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER 721 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh
Confidence 5444332 23456799999999999998888899999999999999996 8999887654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-30 Score=203.02 Aligned_cols=206 Identities=25% Similarity=0.336 Sum_probs=173.4
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCC-CcceeeeeEEecCCeeEEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRH-PNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~~~~~lv~ 148 (299)
....|.++++||+|+||.+|+|....+|+.||||+-... .....+..|..+.+.+++ ..|..+..+..+..+-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 346799999999999999999999999999999976443 223457789999999975 78889999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCC---CceEEcccccccc
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKG---FHPKLSDFGLAKF 225 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~---~~~kl~Dfg~a~~ 225 (299)
+.+ |.+|.++..-+. +.++..+++-++-|++.-++|+|.++ ++||||||+|+|..-+ ..+.|+|||+|+.
T Consensus 91 dLL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ecc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence 998 899999886543 56889999999999999999999999 9999999999999643 4689999999986
Q ss_pred CCCCCCcc-----cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 226 GPTGDKSH-----VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 226 ~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
+.+..... ......||.+|.+--...+...+...|+-|+|.+|..+.-|..||++....
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 54332221 112357999999998888888899999999999999999999999877654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=205.70 Aligned_cols=203 Identities=23% Similarity=0.322 Sum_probs=172.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEEEEEe
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
-.|++.++||+|+||.++.|.+.-+++.||||.-... .+...+..|....+.| ..++|..+|.+..++-+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 4599999999999999999999999999999975433 2234567788888877 469999999999999888999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC-----ceEEcccccccc
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF-----HPKLSDFGLAKF 225 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~-----~~kl~Dfg~a~~ 225 (299)
+ |.+|.|+..-+. +.|+..++..++.|++.-++|+|+++ +|.|||||+|+||...+ .+.|+|||+|+.
T Consensus 106 L-GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred h-CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 8 889988775332 56899999999999999999999999 99999999999997543 588999999988
Q ss_pred CCCCCCcccc-----cccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 226 GPTGDKSHVS-----TRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 226 ~~~~~~~~~~-----~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
+.+....... ....||.+||+--...+.+.+...|+-|||-+++++|-|..||++...
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 7655443221 235699999999999999999999999999999999999999987654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=214.13 Aligned_cols=205 Identities=24% Similarity=0.242 Sum_probs=169.2
Q ss_pred CCCCCceecccCceEEEEEEECCCC-cEEEEEEcCCCCcccHHHHHHHHHHHhhcC----CCcceeeeeEE-ecCCeeEE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETG-QVVAVKQLDDTGFQGEKEFLVEVLMLSLMR----HPNLVHLIGYC-AEGTQRLL 146 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~----h~nIv~~~~~~-~~~~~~~l 146 (299)
+|.+.+.||+|+||.||.|.+..++ +.+|+|............+..|..++..+. .+++..+++.+ ..+...+|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 7999999999999999999997764 678999876553333336777888888876 36899999999 57778899
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCC-----CceEEcccc
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKG-----FHPKLSDFG 221 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~-----~~~kl~Dfg 221 (299)
||+.+ |.+|.++..... .+.++..++..++.|++.+|.+||+.| ++||||||+|+++... ..+.|+|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99987 899999875433 578999999999999999999999999 9999999999999865 468999999
Q ss_pred ccc--cCCCCCCc---cc---ccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 222 LAK--FGPTGDKS---HV---STRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 222 ~a~--~~~~~~~~---~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
+++ ........ .. .....||..|+++.+..+...+++.|+||++.++.+|+.|..||.....
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 998 32222111 11 1235599999999999999999999999999999999999999966553
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=214.20 Aligned_cols=179 Identities=23% Similarity=0.196 Sum_probs=135.4
Q ss_pred HHHHhhcCCCCCceecccCceEEEEEEECC-CCcEEEEEEcCCCC-----cccHHHHHHHHHHHhhcCCCccee-eeeEE
Q 022309 66 QLVAATDNFKDTNFLGQGGFGAVYKGKLAE-TGQVVAVKQLDDTG-----FQGEKEFLVEVLMLSLMRHPNLVH-LIGYC 138 (299)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~-~~~~~ 138 (299)
+.....++|.+.+.||+|+||+||+|.+.. +++.||||++.... ......+.+|+.+++.++|+||++ +++.
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 344556789999999999999999999876 67788999875331 112356899999999999999985 4432
Q ss_pred ecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCEEecCCCceEE
Q 022309 139 AEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDL-KAGNILLGKGFHPKL 217 (299)
Q Consensus 139 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~di-kp~Nilv~~~~~~kl 217 (299)
+..++||||++|++|.. +. . .. ...++.|++++|.|||++| |+|||| ||+|||++.++.++|
T Consensus 91 ---~~~~LVmE~~~G~~L~~-~~---~----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikL 153 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHL-AR---P----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAV 153 (365)
T ss_pred ---CCcEEEEEccCCCCHHH-hC---c----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEE
Confidence 35799999999999963 21 1 11 1467889999999999999 999999 999999999999999
Q ss_pred ccccccccCCCCCCccc------ccccccCccccCcccccCCC------CCccccee
Q 022309 218 SDFGLAKFGPTGDKSHV------STRVMGTHGYCAPEYATTGK------LTAKSDIF 262 (299)
Q Consensus 218 ~Dfg~a~~~~~~~~~~~------~~~~~g~~~y~aPE~~~~~~------~~~~~Diw 262 (299)
+|||+|+.......... .....+++.|+|||.+.... .+..+|-|
T Consensus 154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 99999986543221111 12456888899999885432 23346666
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-25 Score=192.13 Aligned_cols=203 Identities=37% Similarity=0.564 Sum_probs=171.1
Q ss_pred CCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc---HHHHHHHHHHHhhcCCC-cceeeeeEEecCCeeEEEEE
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG---EKEFLVEVLMLSLMRHP-NLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~-nIv~~~~~~~~~~~~~lv~e 149 (299)
|.+.+.||.|+||.||++.+. ..+++|.+....... ...+.+|+.+++.+.|+ +|+++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 677889999999999999986 788999987654433 56788999999999988 79999999987777899999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC-ceEEccccccccCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF-HPKLSDFGLAKFGPT 228 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~-~~kl~Dfg~a~~~~~ 228 (299)
++.++++.+++...... ..+....+..++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||++.....
T Consensus 79 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 79 YVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred cCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 99999999777431111 36889999999999999999999999 99999999999999988 799999999975433
Q ss_pred CCCcc----cccccccCccccCcccccC---CCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 229 GDKSH----VSTRVMGTHGYCAPEYATT---GKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 229 ~~~~~----~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
..... ......|+..|++||.+.+ ..++...|+||+|++++++++|..||.....
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 32221 2345679999999999987 5788899999999999999999999877664
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-26 Score=187.53 Aligned_cols=172 Identities=15% Similarity=0.117 Sum_probs=133.8
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHH---------HHHHHHHHhhcCCCcceeeeeEEe
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE---------FLVEVLMLSLMRHPNLVHLIGYCA 139 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~nIv~~~~~~~ 139 (299)
...++|++++.+|.|+||.||++.. ++..+|+|++.......+.. +.+|+..+.++.|++|..+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 4578999999999999999999655 46689999997654443332 578999999999999999998865
Q ss_pred cC--------CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC
Q 022309 140 EG--------TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK 211 (299)
Q Consensus 140 ~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~ 211 (299)
.. ...+++|||++|.+|.++.. +++ ....+++.+|..||+.| ++|||++|+||+++.
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~ 170 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSK 170 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeC
Confidence 33 35789999999999988641 222 24569999999999999 999999999999999
Q ss_pred CCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHH
Q 022309 212 GFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELI 272 (299)
Q Consensus 212 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell 272 (299)
+| ++|+|||........... ........++.++|+||||+++..+.
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 88 999999988643111000 11234445677899999999987654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.7e-27 Score=226.54 Aligned_cols=149 Identities=15% Similarity=0.194 Sum_probs=114.0
Q ss_pred cCC-CcceeeeeEE-------ecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 022309 126 MRH-PNLVHLIGYC-------AEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPV 197 (299)
Q Consensus 126 l~h-~nIv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i 197 (299)
++| .||++++++| .....++.++|++ +++|.+++.. ....+++.+++.++.||++||+|||+++ |
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 345 5788888877 3334667888987 5699999953 2356899999999999999999999999 9
Q ss_pred EecCCCCCCEEecCC-------------------CceEEccccccccCCCCCC--------------cccccccccCccc
Q 022309 198 IYRDLKAGNILLGKG-------------------FHPKLSDFGLAKFGPTGDK--------------SHVSTRVMGTHGY 244 (299)
Q Consensus 198 ~H~dikp~Nilv~~~-------------------~~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~g~~~y 244 (299)
+||||||+||||+.. +.+||+|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999654 4456666666643110000 0001113578899
Q ss_pred cCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCC
Q 022309 245 CAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDS 281 (299)
Q Consensus 245 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 281 (299)
+|||++.+..++.++|||||||+||||++|.+||...
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~ 218 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK 218 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH
Confidence 9999999999999999999999999999999998643
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-25 Score=178.00 Aligned_cols=138 Identities=15% Similarity=0.094 Sum_probs=108.4
Q ss_pred CceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH--------------------------HHHHHHHHHHhhcCCCc
Q 022309 77 TNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE--------------------------KEFLVEVLMLSLMRHPN 130 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--------------------------~~~~~E~~~l~~l~h~n 130 (299)
...||+|++|.||+|.+. +|+.||+|+++....... .....|+..+..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999987 899999999975422110 11234889999998877
Q ss_pred ceeeeeEEecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCCCCEEe
Q 022309 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL-HNKADPPVIYRDLKAGNILL 209 (299)
Q Consensus 131 Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~l-H~~~~~~i~H~dikp~Nilv 209 (299)
+......... ..+|||||+.|+++..... ...+++..++..++.|++.+|.++ |+.| |+||||||+||++
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli 151 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLY 151 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence 7544333222 2389999999877655432 235688999999999999999999 6889 9999999999999
Q ss_pred cCCCceEEcccccccc
Q 022309 210 GKGFHPKLSDFGLAKF 225 (299)
Q Consensus 210 ~~~~~~kl~Dfg~a~~ 225 (299)
++ +.++|+|||+|..
T Consensus 152 ~~-~~v~LiDFG~a~~ 166 (190)
T cd05147 152 HD-GKLYIIDVSQSVE 166 (190)
T ss_pred EC-CcEEEEEcccccc
Confidence 84 7899999999974
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=170.12 Aligned_cols=140 Identities=17% Similarity=0.102 Sum_probs=110.6
Q ss_pred CCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--------------------------HHHHHHHHHHHhhcCCC
Q 022309 76 DTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--------------------------EKEFLVEVLMLSLMRHP 129 (299)
Q Consensus 76 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~ 129 (299)
+.+.||+|++|.||+|.+. +|+.||||+++...... ...+..|...+..+.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 89999999987642110 11235788899999999
Q ss_pred cceeeeeEEecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEE
Q 022309 130 NLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN-KADPPVIYRDLKAGNIL 208 (299)
Q Consensus 130 nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~dikp~Nil 208 (299)
+|.....+.... .++||||+.|+++..... ...+++..++..++.|++.++.++|+ .| |+||||||+||+
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIl 150 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNIL 150 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEE
Confidence 875544443332 489999999875543321 22457788999999999999999999 99 999999999999
Q ss_pred ecCCCceEEccccccccC
Q 022309 209 LGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 209 v~~~~~~kl~Dfg~a~~~ 226 (299)
++ ++.++|+|||++...
T Consensus 151 l~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 151 YH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred EE-CCCEEEEEcccceec
Confidence 99 789999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-24 Score=171.33 Aligned_cols=117 Identities=28% Similarity=0.292 Sum_probs=98.2
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcc
Q 022309 154 GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233 (299)
Q Consensus 154 ~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~ 233 (299)
|+|.+++.. ...++++.+++.++.|++.||+|||+++ ||+||+++.++.+++ ||++......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc----
Confidence 688898853 2457999999999999999999999865 999999999999999 9999764321
Q ss_pred cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhhhhHHH
Q 022309 234 VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVDW 291 (299)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~ 291 (299)
...|++.|+|||++.+..++.++|||||||++|||++|.+||.........+..+
T Consensus 63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 117 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEIL 117 (176)
T ss_pred ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHH
Confidence 1258899999999999999999999999999999999999998765544444433
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-25 Score=205.66 Aligned_cols=205 Identities=25% Similarity=0.312 Sum_probs=165.9
Q ss_pred CCCceecccCceEEEEEEECCCCcEEEEEEcCCC--CcccH----HHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 75 KDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDT--GFQGE----KEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 75 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~----~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
.....+|.|++|.|+.+......+.++.|..... ..... ..+-.|..+-..+.|||++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999999988888777776666655411 11111 12455777777889999998888776666666669
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
|||++ +|..++. ....+...++-.++.|++.|++|||+.| +.|||+|++|+++..+|.+||+|||.+.....
T Consensus 401 E~~~~-Dlf~~~~----~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVM----SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHh----cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99998 9999994 3357888999999999999999999999 99999999999999999999999999976554
Q ss_pred CCCc--ccccccccCccccCcccccCCCCCc-ccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 229 GDKS--HVSTRVMGTHGYCAPEYATTGKLTA-KSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 229 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~-~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
+... ......+|+..|+|||++.+..|++ ..||||.|++++.|++|+.||......++.
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~ 534 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNS 534 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccc
Confidence 4444 5566688999999999999999876 589999999999999999999766655443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.4e-23 Score=164.19 Aligned_cols=189 Identities=19% Similarity=0.147 Sum_probs=138.7
Q ss_pred CCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH----HHHHHHHHHHhhcC-CCcceeeeeEEecCCeeEEEE
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE----KEFLVEVLMLSLMR-HPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~ 148 (299)
..+...|++|+||+|+++.. .+..++.+.+.....-.. ..+.+|+.+|+.+. +++|++++++ +..+++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34567899999999997765 567788776654432111 24788999999995 5889999886 3468999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCEEecCCCceEEccccccccCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDL-KAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~di-kp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
+|+.|.+|...+. . ....++.|++.+|.++|++| |+|||| ||+|||++.++.++|+|||+|....
T Consensus 78 eyI~G~~L~~~~~----~-------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 78 SYLAGAAMYQRPP----R-------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred eeecCccHHhhhh----h-------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 9999999875441 1 11357789999999999999 999999 7999999999999999999997533
Q ss_pred CCCCc-c--c--------ccccccCccccCcccccCC-CCC-cccceehhHHHHHHHHhCCCCCCCCc
Q 022309 228 TGDKS-H--V--------STRVMGTHGYCAPEYATTG-KLT-AKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 228 ~~~~~-~--~--------~~~~~g~~~y~aPE~~~~~-~~~-~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
....- . . .....+++.|++|+...-- ..+ ...+.++.|+-+|.++||..|+....
T Consensus 144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 22110 0 0 0112367778888754222 223 45788999999999999998865443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=164.99 Aligned_cols=138 Identities=20% Similarity=0.269 Sum_probs=108.8
Q ss_pred CCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhc-----CCCcceeeeeEEecCC---e-eE
Q 022309 75 KDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLM-----RHPNLVHLIGYCAEGT---Q-RL 145 (299)
Q Consensus 75 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~~~~~~~~~~---~-~~ 145 (299)
.-.+.||+|+||.||. ++.++.. +||++........+.+.+|+.+++.+ +||||+++++++.++. . +.
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 3457899999999995 7666665 69988765545567899999999999 5799999999998874 3 33
Q ss_pred EEEEe--cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEecCCCCCCEEecCC----CceEEc
Q 022309 146 LVYEY--MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGL-EYLHNKADPPVIYRDLKAGNILLGKG----FHPKLS 218 (299)
Q Consensus 146 lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l-~~lH~~~~~~i~H~dikp~Nilv~~~----~~~kl~ 218 (299)
+|+|| +.+++|.+++.. ..+++. ..++.|++.++ +|||+++ |+||||||+|||++.. +.++|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEE
Confidence 78999 556899999953 235544 35577778777 9999999 9999999999999743 479999
Q ss_pred c-cccccc
Q 022309 219 D-FGLAKF 225 (299)
Q Consensus 219 D-fg~a~~ 225 (299)
| ||....
T Consensus 152 Dg~G~~~~ 159 (210)
T PRK10345 152 DNIGESTF 159 (210)
T ss_pred ECCCCcce
Confidence 9 555543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.9e-23 Score=195.45 Aligned_cols=197 Identities=23% Similarity=0.276 Sum_probs=157.6
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcC---CCcceeeeeEEecCCeeEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMR---HPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~l 146 (299)
..+.|.|-+.||+|+||+||.|.... |+.||||+-+....-+ |.-=..++.+|+ -+.|..+..++.-.+..++
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 35668888999999999999999876 9999999876654322 111112233333 3556667776666677799
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC-------CCceEEcc
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK-------GFHPKLSD 219 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~-------~~~~kl~D 219 (299)
|+||.+.|+|.+++. ..+.+++..+..++.|++..++.||..+ |||+||||+|+|+.. ...++|+|
T Consensus 772 v~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 999999999999995 5677899999999999999999999999 999999999999953 34689999
Q ss_pred ccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCC
Q 022309 220 FGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPA 277 (299)
Q Consensus 220 fg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 277 (299)
||.+.....-.........++|-.+--+|+..|..++..+|.|.|+.+++.||.|..-
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9998644333333344556788889999999999999999999999999999999653
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-23 Score=171.23 Aligned_cols=202 Identities=22% Similarity=0.360 Sum_probs=159.1
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCC--CcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDT--GFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
...++.+|.+...|..|+|++..+ .+++|++... ......+|..|.-.|+.+.||||+.+++.|....++.++..|
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 355567899999999999999644 4555666432 333346799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
++.|+|++.+... ..-..+..++.+++..++.|++|||+.. +.|.---|....|+|+++.+.+|.- +-+++
T Consensus 269 mp~gslynvlhe~--t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kf----- 339 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKF----- 339 (448)
T ss_pred ccchHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-cccee-----
Confidence 9999999999753 2345677899999999999999999984 5555557999999999998777641 11221
Q ss_pred CcccccccccCccccCcccccCCCCC---cccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLT---AKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~---~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
+.........|.||+||.+...+-+ .++|+|||++++|||.|.+.||.+.++.|.
T Consensus 340 -sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec 397 (448)
T KOG0195|consen 340 -SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC 397 (448)
T ss_pred -eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh
Confidence 1111122457889999999776543 479999999999999999999999988765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.9e-24 Score=189.51 Aligned_cols=187 Identities=30% Similarity=0.400 Sum_probs=156.8
Q ss_pred eecccCceEEEEEEE---CCCCcEEEEEEcCCCCcccH--HHHHHHHHHHhhcC-CCcceeeeeEEecCCeeEEEEEecC
Q 022309 79 FLGQGGFGAVYKGKL---AETGQVVAVKQLDDTGFQGE--KEFLVEVLMLSLMR-HPNLVHLIGYCAEGTQRLLVYEYMP 152 (299)
Q Consensus 79 ~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e~~~ 152 (299)
++|+|+||.|+++.- ...+..||+|+..+...... .....|..++...+ ||.++++...++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998643 34577899998876543332 22344667777776 9999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCc
Q 022309 153 LGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKS 232 (299)
Q Consensus 153 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~ 232 (299)
||.|...+. ....+.+.....+...++-+++++|+.+ +++||+|++||+++.+|++++.|||+++..-.....
T Consensus 81 gg~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 999988883 4466778888888999999999999999 999999999999999999999999999864332221
Q ss_pred ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCC
Q 022309 233 HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDD 280 (299)
Q Consensus 233 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 280 (299)
+||..|||||++. .....+|.||||+++++|+||..||..
T Consensus 154 ------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 ------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 7999999999997 567789999999999999999999988
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-22 Score=168.79 Aligned_cols=203 Identities=22% Similarity=0.298 Sum_probs=130.6
Q ss_pred CCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCC----------CcceeeeeEE--
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRH----------PNLVHLIGYC-- 138 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h----------~nIv~~~~~~-- 138 (299)
+...+.||.|+++.||.+.+..|++.+|+|+...... ...+.+.+|......+.+ -.++..++..
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4556789999999999999999999999998853321 122556666655544322 1222222221
Q ss_pred -------ecC---C-----eeEEEEEecCCCCHHHHhcc---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 022309 139 -------AEG---T-----QRLLVYEYMPLGSLEDHLLG---LTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYR 200 (299)
Q Consensus 139 -------~~~---~-----~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~ 200 (299)
... . +.+++|+.+. ++|.+++.. .......+.......+..|+++.+++||+.| ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 111 1 2367888875 588887642 1111122333334566689999999999999 9999
Q ss_pred CCCCCCEEecCCCceEEccccccccCCCCCCcccccccccCccccCcccccC--------CCCCcccceehhHHHHHHHH
Q 022309 201 DLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATT--------GKLTAKSDIFSFGVVLLELI 272 (299)
Q Consensus 201 dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell 272 (299)
||+|+|++++.+|.++|+||+...... . .... ...+..|.+||.... ..++.+.|.|+||+++|.|.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g--~--~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAG--T--RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETT--E--EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecC--c--eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999999876421 1 1111 234567999997633 24778899999999999999
Q ss_pred hCCCCCCCCchhh
Q 022309 273 TGRPAMDDSQGHE 285 (299)
Q Consensus 273 tg~~pf~~~~~~~ 285 (299)
+|..||+......
T Consensus 245 C~~lPf~~~~~~~ 257 (288)
T PF14531_consen 245 CGRLPFGLSSPEA 257 (288)
T ss_dssp HSS-STCCCGGGS
T ss_pred HccCCCCCCCccc
Confidence 9999998765443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-22 Score=189.50 Aligned_cols=175 Identities=29% Similarity=0.449 Sum_probs=130.8
Q ss_pred HHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 68 VAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
....++|..++.|..|++|.||+++++.+.+.+|+| +.+.. .+.+ .++.....|.+|
T Consensus 79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-----lilR--nilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-----LILR--NILTFAGNPFVV--------------- 135 (1205)
T ss_pred CCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccc-----hhhh--ccccccCCccee---------------
Confidence 344578999999999999999999999999999994 44332 1111 022223344333
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|+-...+. ..++++. +++.+++|||+.+ |+|||+||+|.+|+.-|++|++|||+++..-
T Consensus 136 ------gDc~tllk----~~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 ------GDCATLLK----NIGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred ------chhhhhcc----cCCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhh
Confidence 34444442 2234433 2377899999999 9999999999999999999999999986421
Q ss_pred CCC-------------CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 228 TGD-------------KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 228 ~~~-------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
... .......++|||.|.|||++..+.|++.+|+|++|+|+||.+.|..||....++|-
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel 266 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL 266 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH
Confidence 110 01111235899999999999999999999999999999999999999999876654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.4e-21 Score=160.03 Aligned_cols=142 Identities=15% Similarity=0.107 Sum_probs=111.4
Q ss_pred CCCCCceecccCceEEEEEE-ECCCCcEEEEEEcCCCCcc------------------------cHHHHHHHHHHHhhcC
Q 022309 73 NFKDTNFLGQGGFGAVYKGK-LAETGQVVAVKQLDDTGFQ------------------------GEKEFLVEVLMLSLMR 127 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 127 (299)
-|.+.+.||+|++|.||+|. +..+|+.||+|+++..... ....+..|+..+..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 6678999999998754211 0123567999999987
Q ss_pred CC--cceeeeeEEecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 022309 128 HP--NLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAG 205 (299)
Q Consensus 128 h~--nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~ 205 (299)
+. .+.++++. ...++||||+.|.+|..... ....+...++..++.|++.++.+||+.+. ++||||||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~ 178 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEY 178 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChh
Confidence 53 34445543 23489999999988866542 22345666778999999999999998763 999999999
Q ss_pred CEEecCCCceEEcccccccc
Q 022309 206 NILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 206 Nilv~~~~~~kl~Dfg~a~~ 225 (299)
||+++ ++.++|+|||.+..
T Consensus 179 NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred hEEEE-CCCEEEEEChhhhc
Confidence 99999 78999999999874
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-20 Score=154.32 Aligned_cols=135 Identities=22% Similarity=0.329 Sum_probs=113.1
Q ss_pred CceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--------HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 77 TNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--------EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++.||+|++|.||+|.. .+..+++|+........ ...+.+|+.++..+.|++|.....++.+....+++|
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 36799999999999987 67789999765433221 134678999999999999887777776777889999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
||++|++|.+++... .. ....++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++|+|||++..
T Consensus 79 e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999988421 12 77889999999999999999 99999999999999 78899999999975
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-21 Score=184.95 Aligned_cols=196 Identities=29% Similarity=0.278 Sum_probs=149.3
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-ccH---HHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGE---KEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~---~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++...+.||++.|=+|.+|++.+ |. |+||++-+... -.. .+..+|++ ....++||++++.-+...+...|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 57778999999999999999864 44 88998865432 222 23334444 55669999999998887777888999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC-
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP- 227 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~- 227 (299)
+|+. .+|.|.+. .+..+...+...|+.|++.||..+|..| |+|||||.+||||+.-.-+.|+||..-+..-
T Consensus 101 qyvk-hnLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 101 QYVK-HNLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHHh-hhhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccC
Confidence 9985 59999993 4455678888999999999999999999 9999999999999998889999998764311
Q ss_pred CCCCcccccccc----cCccccCcccccCC----------C-CCcccceehhHHHHHHHHh-CCCCCC
Q 022309 228 TGDKSHVSTRVM----GTHGYCAPEYATTG----------K-LTAKSDIFSFGVVLLELIT-GRPAMD 279 (299)
Q Consensus 228 ~~~~~~~~~~~~----g~~~y~aPE~~~~~----------~-~~~~~DiwslG~il~ellt-g~~pf~ 279 (299)
+.++......+. .-.+|.|||.+... . .+++.||+|+||+++||++ |.|||.
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 111211121122 22369999977331 1 4678999999999999999 799995
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-19 Score=148.49 Aligned_cols=131 Identities=21% Similarity=0.331 Sum_probs=105.6
Q ss_pred eecccCceEEEEEEECCCCcEEEEEEcCCCCccc--------HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 79 FLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--------EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 79 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.||+|++|.||+|.. ++..+++|......... ...+.+|+.++..+.|+++.....++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999985 57789999865432111 14567899999999988766555555566677899999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
++|++|.+.+... .. .++.|++.+|.+||+.+ ++|||++|+||+++ ++.++++|||++...
T Consensus 79 ~~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 79 IEGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ECCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999999987421 10 78899999999999999 99999999999999 789999999999753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=147.16 Aligned_cols=135 Identities=17% Similarity=0.078 Sum_probs=107.2
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc----------------------cHHHHHHHHHHHhhcCCC-
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ----------------------GEKEFLVEVLMLSLMRHP- 129 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~h~- 129 (299)
.|.+.+.||+|+||.||++... +++.||||++...... .......|..++..+.++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4888899999999999999875 7999999987643210 012356788888888777
Q ss_pred -cceeeeeEEecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 022309 130 -NLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNIL 208 (299)
Q Consensus 130 -nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nil 208 (299)
.+++.++. ...++||||++|++|.+... ......++.+++.++.++|+.+ ++||||+|+||+
T Consensus 95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nil 157 (198)
T cd05144 95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNIL 157 (198)
T ss_pred CCCCceeec----CCceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEE
Confidence 44455442 34589999999999876542 0235678899999999999999 999999999999
Q ss_pred ecCCCceEEcccccccc
Q 022309 209 LGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 209 v~~~~~~kl~Dfg~a~~ 225 (299)
+++++.++|+|||++..
T Consensus 158 l~~~~~~~liDfg~~~~ 174 (198)
T cd05144 158 VDDDEKIYIIDWPQMVS 174 (198)
T ss_pred EcCCCcEEEEECCcccc
Confidence 99999999999999964
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-19 Score=168.02 Aligned_cols=137 Identities=20% Similarity=0.311 Sum_probs=110.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--------cHHHHHHHHHHHhhcCCCcceeeeeEEecCCe
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--------GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQ 143 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 143 (299)
..|...+.||+|+||+||+|..... .+++|+....... ..+.+.+|+.+++.++|++|+....++.....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 4456788999999999999987543 3444432211111 12457889999999999999988777777777
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA 223 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a 223 (299)
.++||||++|++|.+++. ....++.|++.+|.+||+.+ ++||||||+||++ .++.++|+|||++
T Consensus 411 ~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccc
Confidence 899999999999999883 35678999999999999999 9999999999999 5779999999999
Q ss_pred ccC
Q 022309 224 KFG 226 (299)
Q Consensus 224 ~~~ 226 (299)
+..
T Consensus 475 ~~~ 477 (535)
T PRK09605 475 KYS 477 (535)
T ss_pred ccC
Confidence 853
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-20 Score=165.35 Aligned_cols=144 Identities=26% Similarity=0.340 Sum_probs=117.6
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccc
Q 022309 142 TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFG 221 (299)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg 221 (299)
.++||.|++|.-.+|.+|+.... .....+....+.++.|++.|++| ++ .+|+|+||.||++..+..+||.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhh
Confidence 35789999999999999996432 33456778899999999999999 78 9999999999999999999999999
Q ss_pred ccccCCCCC----CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-----------------CCCC--C
Q 022309 222 LAKFGPTGD----KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-----------------GRPA--M 278 (299)
Q Consensus 222 ~a~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-----------------g~~p--f 278 (299)
+........ .........||+.||+||.+.+..|+.++||||||++|+||+. |..| |
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~ip~~~ 481 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGIIPPEF 481 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCCChHH
Confidence 986543322 1223345679999999999999999999999999999999998 6666 6
Q ss_pred CCCchhhhhhHHHH
Q 022309 279 DDSQGHERMLVDWV 292 (299)
Q Consensus 279 ~~~~~~~~~~~~~~ 292 (299)
-...+.+--+.+|.
T Consensus 482 ~~d~p~e~~ll~~l 495 (516)
T KOG1033|consen 482 LQDYPEEYTLLQQL 495 (516)
T ss_pred hhcCcHHHHHHHHh
Confidence 66666665555554
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.7e-19 Score=149.52 Aligned_cols=146 Identities=25% Similarity=0.280 Sum_probs=109.0
Q ss_pred CCCcceeeeeEEe---------------------------cCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHH
Q 022309 127 RHPNLVHLIGYCA---------------------------EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIA 179 (299)
Q Consensus 127 ~h~nIv~~~~~~~---------------------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~ 179 (299)
+|||||++..+|. +...+|+||..+. .+|.+++.. ...+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence 5999999987763 2234689999886 599999953 334566778899
Q ss_pred HHHHHHHHHHHhCCCCCeEecCCCCCCEEec--CC--CceEEccccccccCCCC----CCcccccccccCccccCccccc
Q 022309 180 AGAARGLEYLHNKADPPVIYRDLKAGNILLG--KG--FHPKLSDFGLAKFGPTG----DKSHVSTRVMGTHGYCAPEYAT 251 (299)
Q Consensus 180 ~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~--~~--~~~kl~Dfg~a~~~~~~----~~~~~~~~~~g~~~y~aPE~~~ 251 (299)
.|+++|+.|||.+| |.|||+|.+|||+. .+ ..+.|.|||++--.... .........-|...-||||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999999 99999999999993 33 35789999987421110 0111112234677889999875
Q ss_pred CCC------CCcccceehhHHHHHHHHhCCCCCCCC
Q 022309 252 TGK------LTAKSDIFSFGVVLLELITGRPAMDDS 281 (299)
Q Consensus 252 ~~~------~~~~~DiwslG~il~elltg~~pf~~~ 281 (299)
..+ --.++|.|+.|.+.||+++...||+..
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r 460 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR 460 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCccccc
Confidence 432 113799999999999999999999873
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.7e-18 Score=138.57 Aligned_cols=135 Identities=19% Similarity=0.123 Sum_probs=96.4
Q ss_pred CceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH--HH----------------------HHHHHHHHhhcCCC--c
Q 022309 77 TNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE--KE----------------------FLVEVLMLSLMRHP--N 130 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~----------------------~~~E~~~l~~l~h~--n 130 (299)
.+.||+|+||+||+|.+. +++.||||++........ .. ...|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 567999999999999986 789999998875432111 11 12445555555433 2
Q ss_pred ceeeeeEEecCCeeEEEEEecCCCCHHH-HhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEE
Q 022309 131 LVHLIGYCAEGTQRLLVYEYMPLGSLED-HLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN-KADPPVIYRDLKAGNIL 208 (299)
Q Consensus 131 Iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~dikp~Nil 208 (299)
+.+.++. ...++||||+.++.+.. .+... .. ..++..++.+++.++.++|+ .+ |+|+||||+||+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nil 147 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RL-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNIL 147 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh-----hh-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEE
Confidence 4444443 23589999999854321 11110 00 15678899999999999999 88 999999999999
Q ss_pred ecCCCceEEccccccccC
Q 022309 209 LGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 209 v~~~~~~kl~Dfg~a~~~ 226 (299)
++ ++.++|+|||++...
T Consensus 148 i~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred EE-CCcEEEEECcccccc
Confidence 99 889999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.3e-20 Score=172.13 Aligned_cols=217 Identities=24% Similarity=0.315 Sum_probs=173.9
Q ss_pred cCCCCCceecccCceEEEEEEECC-CCcEEEEEEcCCCC--cccHHHHHHHHHHHhhcC-CCcceeeeeEEecCCeeEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAE-TGQVVAVKQLDDTG--FQGEKEFLVEVLMLSLMR-HPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv 147 (299)
..|.+.+.||+|+|+.|-+..... ....+|.|.+.... .........|..+-..+. |+|++.+++...+....+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 457888889999999999887743 34457777665443 111233445777777776 99999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCCEEecCCC-ceEEcccccccc
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLH-NKADPPVIYRDLKAGNILLGKGF-HPKLSDFGLAKF 225 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH-~~~~~~i~H~dikp~Nilv~~~~-~~kl~Dfg~a~~ 225 (299)
+++.+|+++.+.+.. ......+...+..++.|+..++.|+| ..+ +.|+||||+|.+++..+ .+++.|||+|..
T Consensus 100 ~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999988731 22235667788899999999999999 888 99999999999999999 999999999987
Q ss_pred CCC-CCCccccccccc-CccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhhhhhHHHHh
Q 022309 226 GPT-GDKSHVSTRVMG-THGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVDWVT 293 (299)
Q Consensus 226 ~~~-~~~~~~~~~~~g-~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 293 (299)
... ..........+| ++.|+|||...+. ...+..|+||.|+++..+++|..|+............|..
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~ 245 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKS 245 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecc
Confidence 655 333444445678 9999999999884 4567899999999999999999999888877766666653
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.7e-18 Score=130.56 Aligned_cols=135 Identities=20% Similarity=0.176 Sum_probs=112.9
Q ss_pred CCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCC--CcceeeeeEEecCCeeEEEEEecCC
Q 022309 76 DTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRH--PNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 76 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
+++.||+|.++.||++... +..+++|....... ...+..|+.+++.+.+ .++++++.+....+..+++|||+.|
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 4678999999999999984 37899999866543 4678889999999976 5899999988887889999999988
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 154 GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 154 ~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
..+... +......++.+++++++.+|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 766432 4456677899999999999985334499999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.7e-17 Score=138.69 Aligned_cols=135 Identities=19% Similarity=0.180 Sum_probs=103.7
Q ss_pred ceec-ccCceEEEEEEECCCCcEEEEEEcCCCCc-------------ccHHHHHHHHHHHhhcCCCcc--eeeeeEEecC
Q 022309 78 NFLG-QGGFGAVYKGKLAETGQVVAVKQLDDTGF-------------QGEKEFLVEVLMLSLMRHPNL--VHLIGYCAEG 141 (299)
Q Consensus 78 ~~lg-~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~nI--v~~~~~~~~~ 141 (299)
..|| .|+.|+||.+.. .+..++||.+..... .....+.+|+.++..+.|++| ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 888889998877 377899998753221 122457889999999998875 6677664332
Q ss_pred C-e---eEEEEEecCC-CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceE
Q 022309 142 T-Q---RLLVYEYMPL-GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPK 216 (299)
Q Consensus 142 ~-~---~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~k 216 (299)
. . .++|||+++| .+|.+++.. .++++. .+.|++.+|.+||+.| |+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEE
Confidence 2 2 2599999997 689888742 344443 3578999999999999 99999999999999988999
Q ss_pred EccccccccC
Q 022309 217 LSDFGLAKFG 226 (299)
Q Consensus 217 l~Dfg~a~~~ 226 (299)
|+|||.+...
T Consensus 183 LIDfg~~~~~ 192 (239)
T PRK01723 183 LIDFDRGELR 192 (239)
T ss_pred EEECCCcccC
Confidence 9999999753
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3e-17 Score=147.06 Aligned_cols=157 Identities=30% Similarity=0.458 Sum_probs=128.0
Q ss_pred HhhcCCCcceeeeeEEecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-EecC
Q 022309 123 LSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPV-IYRD 201 (299)
Q Consensus 123 l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i-~H~d 201 (299)
|+.+.|.|+.++++.+.++...++|.+||.-|+|.|.+.. ....++..-...+++.++.||+|||+-- | .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeee
Confidence 4578999999999999999999999999999999999964 4567888888899999999999999754 5 9999
Q ss_pred CCCCCEEecCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCC-------CCcccceehhHHHHHHHHhC
Q 022309 202 LKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGK-------LTAKSDIFSFGVVLLELITG 274 (299)
Q Consensus 202 ikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-------~~~~~DiwslG~il~elltg 274 (299)
+++.|.+++..+.+||+|||+.................-...|.|||.+.+.. .+.+.|+||+|++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999987653211111111122345699999997742 35579999999999999999
Q ss_pred CCCCCCCchhh
Q 022309 275 RPAMDDSQGHE 285 (299)
Q Consensus 275 ~~pf~~~~~~~ 285 (299)
.-||+.....+
T Consensus 155 ~~~~~~~~~~~ 165 (484)
T KOG1023|consen 155 SGPFDLRNLVE 165 (484)
T ss_pred cCccccccccC
Confidence 99998755443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.2e-14 Score=132.16 Aligned_cols=170 Identities=18% Similarity=0.188 Sum_probs=129.5
Q ss_pred EEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCCCHHHHhcccCCCCCC
Q 022309 90 KGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKP 169 (299)
Q Consensus 90 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 169 (299)
.|..+.++.+|.|..++...........+.++.++.++||||+++++.+..++..|+|+|.+. .|..++..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------
Confidence 466677888999998876654333556777888999999999999999999999999999985 77777743
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcccccccccCccccCccc
Q 022309 170 LDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEY 249 (299)
Q Consensus 170 ~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~ 249 (299)
+....+...+.||+.||.+||..+. ++|++|..+.|+|+..|..||++|-++........ ......--..|..|+.
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEE 176 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhh
Confidence 3356777788999999999985432 99999999999999999999999998864322221 0111111223667766
Q ss_pred ccCCCCCcccceehhHHHHHHHHhC
Q 022309 250 ATTGKLTAKSDIFSFGVVLLELITG 274 (299)
Q Consensus 250 ~~~~~~~~~~DiwslG~il~elltg 274 (299)
+.... -..|.|.|||++++++.|
T Consensus 177 ~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 IDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCccc--cchhhhhHHHHHHHHhCc
Confidence 54333 246999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.4e-14 Score=114.87 Aligned_cols=131 Identities=18% Similarity=0.083 Sum_probs=96.8
Q ss_pred CceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcce-eeeeEEecCCeeEEEEEecCCCC
Q 022309 77 TNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLV-HLIGYCAEGTQRLLVYEYMPLGS 155 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~~~~~~~~~~~~~lv~e~~~~~~ 155 (299)
++.|+.|.++.||++.. .+..|++|....... ....+..|+.+++.+.+.+++ +++.+.. ...++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 45789999999999987 477899998765432 223567889999888655544 4555433 23579999999987
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 156 LEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA--DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 156 L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
+.+.. .....++.+++++|+.||+.+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 78 l~~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 75420 011345678999999999887 12249999999999999 66899999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.8e-15 Score=137.55 Aligned_cols=144 Identities=19% Similarity=0.159 Sum_probs=94.5
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--------------------------c-------------
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--------------------------G------------- 112 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------------------------~------------- 112 (299)
..|+. +.||+|++|.||+|+...+|+.||||+.++.-.. +
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34666 7899999999999999888999999999754110 0
Q ss_pred -HHHHHHHHHHHhhc----CCCcceeeeeEEe-cCCeeEEEEEecCCCCHHHHh--cccCCCCCCCCHHHHHHHHHHHHH
Q 022309 113 -EKEFLVEVLMLSLM----RHPNLVHLIGYCA-EGTQRLLVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRMKIAAGAAR 184 (299)
Q Consensus 113 -~~~~~~E~~~l~~l----~h~nIv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l--~~~~~~~~~~~~~~~~~i~~ql~~ 184 (299)
+-++.+|+.-+..+ .+.+.+.+-.++. .....+|||||++|+.+.+.. .........+.+..+..++.|++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF- 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence 01233444333333 2333333333332 134568999999999998742 11111111344444455555544
Q ss_pred HHHHHHhCCCCCeEecCCCCCCEEecCCC----ceEEccccccccC
Q 022309 185 GLEYLHNKADPPVIYRDLKAGNILLGKGF----HPKLSDFGLAKFG 226 (299)
Q Consensus 185 ~l~~lH~~~~~~i~H~dikp~Nilv~~~~----~~kl~Dfg~a~~~ 226 (299)
..| ++|+|++|.||+++.++ .++++|||++...
T Consensus 278 ------~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 278 ------RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred ------hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 467 99999999999999887 9999999999754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.8e-14 Score=130.56 Aligned_cols=139 Identities=24% Similarity=0.188 Sum_probs=94.9
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCccc----------------------------------------HHHHH
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG----------------------------------------EKEFL 117 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~ 117 (299)
+.||+|++|.||+|+.. +|+.||||+.++.-... +-++.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999975 68999999886532110 01234
Q ss_pred HHHHHHhhc----CCCcceeeeeEE-ecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 022309 118 VEVLMLSLM----RHPNLVHLIGYC-AEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAAR-GLEYLHN 191 (299)
Q Consensus 118 ~E~~~l~~l----~h~nIv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~-~l~~lH~ 191 (299)
+|+..+..+ .+.+-+.+-..+ ...+..++||||++|++|.+..... ....+ ...++.+++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~---~~~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD---EAGLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH---hcCCC---HHHHHHHHHHHHHHHHHh
Confidence 455544444 222222222222 2234568999999999998876321 11122 2345556655 4678899
Q ss_pred CCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 192 KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 192 ~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
.| ++|+|++|.||+++.++.++|+|||++...
T Consensus 276 ~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 276 DG---FFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred CC---ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 99 999999999999999999999999999754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.1e-14 Score=131.01 Aligned_cols=201 Identities=28% Similarity=0.246 Sum_probs=158.6
Q ss_pred hcCCCCCceecc--cCceEEEEEEE--CCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCe
Q 022309 71 TDNFKDTNFLGQ--GGFGAVYKGKL--AETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQ 143 (299)
Q Consensus 71 ~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 143 (299)
...+.+...+|. |.+|.||.+.. ..++..+|+|.-+.... .....-.+|+...+.+ .|+|.++.+..+...+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 455778889999 99999999998 88899999997443222 2233344566655555 48999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEecCCCCCCEEecCC-CceEEc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAAR----GLEYLHNKADPPVIYRDLKAGNILLGKG-FHPKLS 218 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~----~l~~lH~~~~~~i~H~dikp~Nilv~~~-~~~kl~ 218 (299)
.++-+|++ +.+|..+... ....++...++..+.+..+ ||.++|+.+ ++|-|+||.||+...+ ...+++
T Consensus 193 lfiqtE~~-~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred ceeeeccc-cchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecC
Confidence 99999998 4788777753 3344788889999999999 999999999 9999999999999998 889999
Q ss_pred cccccccCCCCCCcccc---cccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCC
Q 022309 219 DFGLAKFGPTGDKSHVS---TRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMD 279 (299)
Q Consensus 219 Dfg~a~~~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 279 (299)
|||+......+.-.... ....|...|++||+.. .-++..+|++++|.++.+..+|..++-
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhccccc
Confidence 99998765444422222 2235788899999874 457889999999999999998865543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.4e-13 Score=108.30 Aligned_cols=136 Identities=14% Similarity=0.051 Sum_probs=98.6
Q ss_pred CceecccCceEEEEEEECC------CCcEEEEEEcCCCCc---------------------cc-HHHH----HHHHHHHh
Q 022309 77 TNFLGQGGFGAVYKGKLAE------TGQVVAVKQLDDTGF---------------------QG-EKEF----LVEVLMLS 124 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~---------------------~~-~~~~----~~E~~~l~ 124 (299)
...||.|--+.||.|.... .+..+|||+.+.... .. .+.+ .+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999998653 357899997753211 00 1122 37888998
Q ss_pred hcCC--CcceeeeeEEecCCeeEEEEEecCCCCHHH-HhcccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEec
Q 022309 125 LMRH--PNLVHLIGYCAEGTQRLLVYEYMPLGSLED-HLLGLTPEMKPLDWNTRMKIAAGAARGLEYL-HNKADPPVIYR 200 (299)
Q Consensus 125 ~l~h--~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~l-H~~~~~~i~H~ 200 (299)
++.. -++++++++ ...+|||||+.+..+.. .+. ...++..++..+..|++.+|..| |..+ ++|+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 8853 567777765 34589999997643321 221 12345566778889999999998 8888 9999
Q ss_pred CCCCCCEEecCCCceEEcccccccc
Q 022309 201 DLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 201 dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
||++.||++.. +.+.|+|||.+-.
T Consensus 150 DLs~~NIL~~~-~~v~iIDF~qav~ 173 (197)
T cd05146 150 DLSEYNMLWHD-GKVWFIDVSQSVE 173 (197)
T ss_pred CCCHHHEEEEC-CcEEEEECCCcee
Confidence 99999999974 6899999998864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=8.5e-13 Score=102.80 Aligned_cols=131 Identities=25% Similarity=0.340 Sum_probs=99.9
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH--------HHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE--------KEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
..+++|+-+.++.+.. -|..+++|.=.+.....+ ....+|+.+++++.--.|.-.+-+..+.+...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4688999999999866 344467774433333332 345779999998876666655555666677789999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
|++|..|.+.+... ...++..+-.-+.-||..| |+|+||.++||+++... +.++||||+.+
T Consensus 80 ~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999888531 1456677777788899999 99999999999998864 99999999985
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.2e-12 Score=101.64 Aligned_cols=143 Identities=20% Similarity=0.256 Sum_probs=106.6
Q ss_pred CCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH--------HHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 76 DTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE--------KEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 76 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.+..|.+|+-+.|+++.. .|+.+.||.=.......+ ....+|+.+|.++.--.|.-..-++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 577899999999999987 688888885433333332 4567899999988765655544455555666899
Q ss_pred EEecCC-CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC---ceEEcccccc
Q 022309 148 YEYMPL-GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF---HPKLSDFGLA 223 (299)
Q Consensus 148 ~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~---~~kl~Dfg~a 223 (299)
|||++| .++.+++..... .+....-...++.++-+.+.-||..+ |+|+||..+||++..++ .+.|+|||++
T Consensus 89 ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecch
Confidence 999987 477887764321 22222333788899999999999998 99999999999996554 4689999999
Q ss_pred cc
Q 022309 224 KF 225 (299)
Q Consensus 224 ~~ 225 (299)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 75
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.40 E-value=4.4e-12 Score=104.85 Aligned_cols=143 Identities=20% Similarity=0.257 Sum_probs=108.5
Q ss_pred CceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCC--CcceeeeeEEecCC---eeEEEEEe
Q 022309 77 TNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRH--PNLVHLIGYCAEGT---QRLLVYEY 150 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~---~~~lv~e~ 150 (299)
.+.|+.|..+.+|++... +|+.+++|........ ....+..|+.+++.+.+ .++.+++.+..... ..++|||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred ceecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 357899999999999874 3578999988654321 34567889999999875 34677777766542 56899999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA------------------------------------- 193 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~------------------------------------- 193 (299)
++|.++.+.+. . ..+++.+...++.+++++|..||+..
T Consensus 82 i~G~~l~~~~~----~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 82 VDGRVLRDRLL----R-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred eCCEecCCCCC----C-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99988876542 1 34667777788888888888888521
Q ss_pred ----------------CCCeEecCCCCCCEEecC--CCceEEcccccccc
Q 022309 194 ----------------DPPVIYRDLKAGNILLGK--GFHPKLSDFGLAKF 225 (299)
Q Consensus 194 ----------------~~~i~H~dikp~Nilv~~--~~~~kl~Dfg~a~~ 225 (299)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 244799999999999998 66789999999874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.9e-13 Score=123.01 Aligned_cols=197 Identities=25% Similarity=0.255 Sum_probs=148.4
Q ss_pred hhcCCCCCceecccCceEEEEEEEC-CCCcEEEEEEcCCCCcccHH--HHHHHHHHHhhc-CCCcceeeeeEEecCCeeE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLA-ETGQVVAVKQLDDTGFQGEK--EFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~ 145 (299)
...+|..+..||.|.|+.|+.+... .++..|++|.+.+....... .-..|+.+...+ .|.+++.++..|...+..+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3457888999999999999987655 78889999988654433322 234455555555 5889999888887777888
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCC-CceEEccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKG-FHPKLSDFGLAK 224 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~-~~~kl~Dfg~a~ 224 (299)
+--||++++++...+. ....+.+...+.+..|++.++.++|+.. ++|+|++|+||++.++ +..++.|||++.
T Consensus 343 ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred CchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 9999999998877662 2345677888999999999999999998 9999999999999886 778899999986
Q ss_pred cCCCCCCcccccccccCccc-cCcccccCCCCCcccceehhHHHHHHHHhCCCC
Q 022309 225 FGPTGDKSHVSTRVMGTHGY-CAPEYATTGKLTAKSDIFSFGVVLLELITGRPA 277 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y-~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 277 (299)
......... ...+..| .++.......+..+.|++|||..+.+.++|.+.
T Consensus 416 ~~~~~~~~~----~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 416 RLAFSSGVF----HHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred ccceecccc----cccccccccchhhccccccccccccccccccccccccCccc
Confidence 321111111 1123334 355555566788899999999999999988653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=8.6e-14 Score=131.85 Aligned_cols=209 Identities=23% Similarity=0.233 Sum_probs=154.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc---HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG---EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.+.+.+.+-+-+|+++.++.+.-..++...++|+........ .+....+-.++-...+|-++...-.+......+++
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 355777788999999999999888888777777554332111 12222222232223456666555555556678999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
++|+.+++|...+.. ....++.-+...+..+.+++++||+.. +.|+|++|.|.++..++..++.|||+.....
T Consensus 883 ~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 999999999998853 345666667778888999999999987 8999999999999999999999998432110
Q ss_pred C-------------------------CC----CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCC
Q 022309 228 T-------------------------GD----KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAM 278 (299)
Q Consensus 228 ~-------------------------~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 278 (299)
. .. .........||+.|.+||.+.+......+|+|++|++++|.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 00 001122356899999999999999999999999999999999999999
Q ss_pred CCCchhhh
Q 022309 279 DDSQGHER 286 (299)
Q Consensus 279 ~~~~~~~~ 286 (299)
....++..
T Consensus 1036 na~tpq~~ 1043 (1205)
T KOG0606|consen 1036 NAETPQQI 1043 (1205)
T ss_pred CCcchhhh
Confidence 98876543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=7.5e-13 Score=111.06 Aligned_cols=188 Identities=25% Similarity=0.304 Sum_probs=128.3
Q ss_pred EEEEEEECCCCcEEEEEEcCC----CCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCC-----eeEEEEEecCCCCHH
Q 022309 87 AVYKGKLAETGQVVAVKQLDD----TGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT-----QRLLVYEYMPLGSLE 157 (299)
Q Consensus 87 ~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-----~~~lv~e~~~~~~L~ 157 (299)
.||++-+...|.+|+.-.++- .....++....=..-|-.+.|.|||++..++.+.. ...++.||+.-|++.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 355555555555555443321 11111122222223344567999999998885543 467999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC---CCccc
Q 022309 158 DHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG---DKSHV 234 (299)
Q Consensus 158 ~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~---~~~~~ 234 (299)
.+|.........+......+|+.||+.||.|||+. +|+|+|+++..+.|++..+|-+|+.-- --...... .....
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~PpiihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~E 238 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAE 238 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhh
Confidence 99987666666777888889999999999999998 699999999999999998888886521 11100000 00001
Q ss_pred ccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCC
Q 022309 235 STRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276 (299)
Q Consensus 235 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 276 (299)
.....+-++|.+||.=....-+.++|||++|....+|..|+.
T Consensus 239 k~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 239 KSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred hhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence 111236678999987555556678999999999999998865
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.8e-10 Score=102.47 Aligned_cols=171 Identities=19% Similarity=0.213 Sum_probs=127.8
Q ss_pred CceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEe----cCCeeEEEEEecCC-CCHHH
Q 022309 84 GFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA----EGTQRLLVYEYMPL-GSLED 158 (299)
Q Consensus 84 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~----~~~~~~lv~e~~~~-~~L~~ 158 (299)
--.+.|++....+|..|++|.+.-.........-.-++.++++.|+|||++.++|. .+..+++|++|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 34678999999999999999994332222222233467899999999999999885 44567899999765 47777
Q ss_pred HhcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 159 HLLGLTP-----------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 159 ~l~~~~~-----------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
....... .....++..+|.++.|+..||.++|+.| +..+-|.|.+|+++.+.+++|...|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 6542211 2235678999999999999999999999 9999999999999999899998888776432
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCC
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 276 (299)
.+. -|.+.+. .+-|.=.||.++.-|.||..
T Consensus 445 ~d~----------------~~~le~~---Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDP----------------TEPLESQ---QQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC----------------CcchhHH---hhhhHHHHHHHHHHHhhccc
Confidence 211 0112222 24688899999999999943
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.5e-10 Score=92.63 Aligned_cols=124 Identities=22% Similarity=0.172 Sum_probs=80.5
Q ss_pred EEEEEEECCCCcEEEEEEcCCCCcc----------------------c----HHHHHHHHHHHhhcCCC--cceeeeeEE
Q 022309 87 AVYKGKLAETGQVVAVKQLDDTGFQ----------------------G----EKEFLVEVLMLSLMRHP--NLVHLIGYC 138 (299)
Q Consensus 87 ~V~~~~~~~~~~~vavK~~~~~~~~----------------------~----~~~~~~E~~~l~~l~h~--nIv~~~~~~ 138 (299)
.||.|... ++..+|+|+.+..... . .....+|...|..+... ++++++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 38888874 5789999977532110 0 12357799999999765 567777553
Q ss_pred ecCCeeEEEEEecC--CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEecCCCCCCEEecCCCce
Q 022309 139 AEGTQRLLVYEYMP--LGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEY-LHNKADPPVIYRDLKAGNILLGKGFHP 215 (299)
Q Consensus 139 ~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~-lH~~~~~~i~H~dikp~Nilv~~~~~~ 215 (299)
..+|||||+. |..+..+... .++......++.+++..+.. +|..| ++|+||++.||+++.+ .+
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred ----CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence 3479999998 6555443321 11134456677788885555 57888 9999999999999987 99
Q ss_pred EEcccccccc
Q 022309 216 KLSDFGLAKF 225 (299)
Q Consensus 216 kl~Dfg~a~~ 225 (299)
.|+|||.+..
T Consensus 146 ~iIDf~qav~ 155 (188)
T PF01163_consen 146 YIIDFGQAVD 155 (188)
T ss_dssp EE--GTTEEE
T ss_pred EEEecCccee
Confidence 9999999864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.20 E-value=5e-10 Score=94.86 Aligned_cols=141 Identities=15% Similarity=0.110 Sum_probs=99.6
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCccc-----------HHHHHHHHHHHhhcCCCcc--eeeeeEEec----
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG-----------EKEFLVEVLMLSLMRHPNL--VHLIGYCAE---- 140 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~nI--v~~~~~~~~---- 140 (299)
+.+-+.....|+++.. .|+.|.||......... ...+.+|...+..+...+| ++++.+...
T Consensus 28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 4444455555667654 57789999774332110 1146788888888754333 334444432
Q ss_pred -CCeeEEEEEecCCC-CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC-------
Q 022309 141 -GTQRLLVYEYMPLG-SLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK------- 211 (299)
Q Consensus 141 -~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~------- 211 (299)
....++|+|++++. +|.+++.... ..+.+......++.+++..+.-||..| |+|+|+++.|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCC
Confidence 22467999999876 8988874321 234566778899999999999999999 999999999999975
Q ss_pred CCceEEcccccccc
Q 022309 212 GFHPKLSDFGLAKF 225 (299)
Q Consensus 212 ~~~~kl~Dfg~a~~ 225 (299)
++.+.|+||+.+..
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 46899999999864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=5e-10 Score=97.48 Aligned_cols=195 Identities=17% Similarity=0.207 Sum_probs=131.7
Q ss_pred CCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhh-cCCCcceeeeeE------E-ecCCeeEE
Q 022309 75 KDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSL-MRHPNLVHLIGY------C-AEGTQRLL 146 (299)
Q Consensus 75 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~~~~~------~-~~~~~~~l 146 (299)
...+.||+|+.+.+|-.-.. +. .+.|++.........+...| |.. -.||-+..=+.| . ......-+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa~~aqk~a~---la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPAAQAQKVAE---LAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchh--hc-hhheeecCCCchHHHHHHHH---hccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 34577999999999964332 22 34588877655544433332 222 255544331111 1 12223568
Q ss_pred EEEecCCCCHHHHhcc---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccc
Q 022309 147 VYEYMPLGSLEDHLLG---LTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA 223 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a 223 (299)
+|..+.|..-...+.. .........+..+++.++.++.+.+.||..| .+-+|+.++|+||++++.+.|.|=..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccce
Confidence 8888877533322321 1122334678899999999999999999999 899999999999999999999985443
Q ss_pred ccCCCCCCcccccccccCccccCccccc-----CCCCCcccceehhHHHHHHHHhC-CCCCCCC
Q 022309 224 KFGPTGDKSHVSTRVMGTHGYCAPEYAT-----TGKLTAKSDIFSFGVVLLELITG-RPAMDDS 281 (299)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg-~~pf~~~ 281 (299)
... .........+|...|.+||... +...+...|.+.||++++++|.| +.||.+.
T Consensus 165 qi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 165 QIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred eec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 322 2333344467999999999764 34566789999999999999997 8999643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.6e-09 Score=89.68 Aligned_cols=135 Identities=19% Similarity=0.089 Sum_probs=100.5
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc----------------------ccHHHHHHHHHHHhhcCCC-
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF----------------------QGEKEFLVEVLMLSLMRHP- 129 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~- 129 (299)
-+.+...||-|--|.||.|.+. .|..+|||.=+.... .......+|..+|..|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 3567789999999999999986 688999995432110 0113457889999988655
Q ss_pred -cceeeeeEEecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 022309 130 -NLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNIL 208 (299)
Q Consensus 130 -nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nil 208 (299)
.|.+.+++ +...+|||+++|..|...- ++....-.++..|++-+.-+-..| |+|+|+++=||+
T Consensus 171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIl 234 (304)
T COG0478 171 VKVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNIL 234 (304)
T ss_pred CCCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEE
Confidence 78888876 4568999999987665422 123344455666666666666778 999999999999
Q ss_pred ecCCCceEEccccccc
Q 022309 209 LGKGFHPKLSDFGLAK 224 (299)
Q Consensus 209 v~~~~~~kl~Dfg~a~ 224 (299)
++++|.+.++||--+.
T Consensus 235 V~~dg~~~vIDwPQ~v 250 (304)
T COG0478 235 VTEDGDIVVIDWPQAV 250 (304)
T ss_pred EecCCCEEEEeCcccc
Confidence 9999999999997665
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.2e-08 Score=83.50 Aligned_cols=105 Identities=24% Similarity=0.253 Sum_probs=81.2
Q ss_pred HHHHHHHHHHhhcCCC--cceeeeeEEecC----CeeEEEEEecCCC-CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 022309 114 KEFLVEVLMLSLMRHP--NLVHLIGYCAEG----TQRLLVYEYMPLG-SLEDHLLGLTPEMKPLDWNTRMKIAAGAARGL 186 (299)
Q Consensus 114 ~~~~~E~~~l~~l~h~--nIv~~~~~~~~~----~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l 186 (299)
....+|...+..+... .+++.+++.... ...++|+|++++. +|.+++... ...+......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHH
Confidence 4567788777776433 344555555442 2347999999874 799888532 2256677789999999999
Q ss_pred HHHHhCCCCCeEecCCCCCCEEecCCC---ceEEcccccccc
Q 022309 187 EYLHNKADPPVIYRDLKAGNILLGKGF---HPKLSDFGLAKF 225 (299)
Q Consensus 187 ~~lH~~~~~~i~H~dikp~Nilv~~~~---~~kl~Dfg~a~~ 225 (299)
.-||..| |+|+|+++.|||++.++ .+.|+||+.++.
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999 99999999999999887 899999998875
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.88 E-value=6.8e-08 Score=78.06 Aligned_cols=139 Identities=16% Similarity=0.106 Sum_probs=100.8
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEcCCC---C---cccHHHHHHHHHHHhhcCCC--cceeeeeEEec--C--CeeEEE
Q 022309 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDT---G---FQGEKEFLVEVLMLSLMRHP--NLVHLIGYCAE--G--TQRLLV 147 (299)
Q Consensus 80 lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~h~--nIv~~~~~~~~--~--~~~~lv 147 (299)
-|.||.+.|+.... .|+.+-+|.-..- . ......|.+|...+..+..- .++++...... . -..+||
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 56689999998765 3457888866411 0 22457899999999988542 24444422111 1 135799
Q ss_pred EEecCC-CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCc--eEEccccccc
Q 022309 148 YEYMPL-GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFH--PKLSDFGLAK 224 (299)
Q Consensus 148 ~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~--~kl~Dfg~a~ 224 (299)
+|-+.| .+|.+++... ...+.+..+...++.+++.++.-||..| +.|+|+.+.||+++.++. +.++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997753 5888887431 2245677777899999999999999999 999999999999986667 9999998775
Q ss_pred c
Q 022309 225 F 225 (299)
Q Consensus 225 ~ 225 (299)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.7e-08 Score=81.80 Aligned_cols=138 Identities=15% Similarity=0.129 Sum_probs=91.0
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHH---------HHHHHHHHhhcCC---Ccceeeee
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE---------FLVEVLMLSLMRH---PNLVHLIG 136 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h---~nIv~~~~ 136 (299)
....+|.+.+.+-......|.+-.. +++.+++|..+......+.. ..+++..+..+.. ..+..++-
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 3457788888888887777776554 67889999876544322221 2233333333322 22222222
Q ss_pred E-----EecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC
Q 022309 137 Y-----CAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK 211 (299)
Q Consensus 137 ~-----~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~ 211 (299)
+ +.-....+++|||++|..|.+... +++ .+...+.+++.-||+.| +.|+|..|.|++++.
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEEC
Confidence 2 222345579999999988876541 222 24456778899999999 999999999999996
Q ss_pred CCceEEccccccc
Q 022309 212 GFHPKLSDFGLAK 224 (299)
Q Consensus 212 ~~~~kl~Dfg~a~ 224 (299)
++ ++++||+..+
T Consensus 171 ~~-i~iID~~~k~ 182 (229)
T PF06176_consen 171 NG-IRIIDTQGKR 182 (229)
T ss_pred Cc-EEEEECcccc
Confidence 54 9999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.87 E-value=7.6e-08 Score=79.84 Aligned_cols=140 Identities=14% Similarity=0.126 Sum_probs=86.9
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCc--ceeeeeEEecCCeeEEEEEecCCCC
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPN--LVHLIGYCAEGTQRLLVYEYMPLGS 155 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~~~~~~~~~~~~~lv~e~~~~~~ 155 (299)
..||+|..+.||+. .+..+++|...... ......+|..+++.+..-. +.+++++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 57899999999983 24467889886532 3456788999998886443 5778888877777889999999863
Q ss_pred -HHHHh---------------------cccCCCCCCCCHHHHHHHHHHH----------HH-HHHHHHhC-CCCCeEecC
Q 022309 156 -LEDHL---------------------LGLTPEMKPLDWNTRMKIAAGA----------AR-GLEYLHNK-ADPPVIYRD 201 (299)
Q Consensus 156 -L~~~l---------------------~~~~~~~~~~~~~~~~~i~~ql----------~~-~l~~lH~~-~~~~i~H~d 201 (299)
+...+ +........++. ....+..++ .. ...+|.+. ..+.++|+|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~-~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQS-YKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHH-HHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 21111 111001111110 000111011 11 11222211 133478999
Q ss_pred CCCCCEEecCCCceEEcccccccc
Q 022309 202 LKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 202 ikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
+.|.||+++.++ +.|+||+.+..
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999888 99999999864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=2e-08 Score=92.14 Aligned_cols=140 Identities=21% Similarity=0.189 Sum_probs=89.5
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCccc----------------------------------------HHHHH
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG----------------------------------------EKEFL 117 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~ 117 (299)
+.|+.++-|.||+|+... |+.||||+.++.-... +-++.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 579999999999999864 9999999876532110 01234
Q ss_pred HHHHHHhhcC-----CCcceeeeeEEecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022309 118 VEVLMLSLMR-----HPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK 192 (299)
Q Consensus 118 ~E~~~l~~l~-----h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~ 192 (299)
+|+.-+..++ .++|.=..=++...+.-.++|||++|..+.+...- ....++...+.....++. +..+=..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l---~~~g~d~k~ia~~~~~~f--~~q~~~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL---KSAGIDRKELAELLVRAF--LRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH---HhcCCCHHHHHHHHHHHH--HHHHHhc
Confidence 4554444442 23332222222333456899999999988887421 113444333333222222 2222235
Q ss_pred CCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 193 ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 193 ~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
| ++|.|..|.||+++.+|.+.+.|||+....
T Consensus 285 g---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 285 G---FFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred C---ccccCCCccceEEecCCcEEEEcCcceecC
Confidence 7 999999999999999999999999998754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.3e-09 Score=96.74 Aligned_cols=187 Identities=18% Similarity=0.114 Sum_probs=135.8
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCc-ceeeeeEEecCCeeEEEEEe
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPN-LVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~lv~e~ 150 (299)
..|.....+++|+++++++.+...+...+ .+++... ....-++++|.+++||| .+..++-+..++..++++++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 34555566889999999998876554444 6665433 44556788999999999 77777778888889999999
Q ss_pred cCCC-CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 151 MPLG-SLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 151 ~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
+.++ +...... .....+...+...+.+.-+.+++++|+.- -+|+| ||+..+ +..++.||+.+......
T Consensus 316 ~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 316 CSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hcCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence 9876 2221111 12233444455566777788899999865 58998 777666 57899999988654332
Q ss_pred CCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCC
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAM 278 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 278 (299)
. ......+++.++|||+.....+....|.|++|+-..+|--|.+|-
T Consensus 385 ~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 385 M---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred c---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 2 334467899999999999999999999999998777777776654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.67 E-value=5.6e-07 Score=75.66 Aligned_cols=142 Identities=18% Similarity=0.132 Sum_probs=85.4
Q ss_pred eecccCc-eEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcC-CCcceeeeeEEecCCeeEEEEEecCCCCH
Q 022309 79 FLGQGGF-GAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMR-HPNLVHLIGYCAEGTQRLLVYEYMPLGSL 156 (299)
Q Consensus 79 ~lg~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e~~~~~~L 156 (299)
.|..|.. ..||+.... +..+.+|...... ...+.+|+.+++.+. +--+.+++++....+..++||++++|.++
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 3455555 788988653 4678888775443 335677888888773 44566788887776678999999999877
Q ss_pred HHHhc-------------------ccCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHHh----
Q 022309 157 EDHLL-------------------GLTPEMKPLDWN--TRMKIAA--------------------GAARGLEYLHN---- 191 (299)
Q Consensus 157 ~~~l~-------------------~~~~~~~~~~~~--~~~~i~~--------------------ql~~~l~~lH~---- 191 (299)
..... .......++... ....... .+...+..|-.
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 64321 110000111100 0000000 01111222211
Q ss_pred CCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 192 KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 192 ~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
...+.++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 1134489999999999999987788999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.64 E-value=3e-07 Score=76.42 Aligned_cols=145 Identities=20% Similarity=0.241 Sum_probs=83.8
Q ss_pred CceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCC--cceeeeeEEe---cCCeeEEEEEec
Q 022309 77 TNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHP--NLVHLIGYCA---EGTQRLLVYEYM 151 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~~~~~~~---~~~~~~lv~e~~ 151 (299)
++.|+.|..+.||+..... ..+++|..... .....+..|..+++.+... .+.+++.... .....+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 4678999999999998754 58999987654 3446678888888887533 3566776442 233468999999
Q ss_pred CCCCHHH----------------Hhc---ccCCCCCCCCHHHH--H----H---H------------HHHHHH-HHHHHH
Q 022309 152 PLGSLED----------------HLL---GLTPEMKPLDWNTR--M----K---I------------AAGAAR-GLEYLH 190 (299)
Q Consensus 152 ~~~~L~~----------------~l~---~~~~~~~~~~~~~~--~----~---i------------~~ql~~-~l~~lH 190 (299)
+|.++.. .+. .......+...... . . . ...+.. .++.++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9987777 111 11011111111000 0 0 0 011222 233333
Q ss_pred h----CCCCCeEecCCCCCCEEec-CCCceEEcccccccc
Q 022309 191 N----KADPPVIYRDLKAGNILLG-KGFHPKLSDFGLAKF 225 (299)
Q Consensus 191 ~----~~~~~i~H~dikp~Nilv~-~~~~~kl~Dfg~a~~ 225 (299)
+ .....++|+|+.|.||+++ +++.+-|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2 1234499999999999999 666668999998864
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1e-08 Score=94.41 Aligned_cols=100 Identities=23% Similarity=0.361 Sum_probs=75.7
Q ss_pred HHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCccc-------ccccccCccccCcccccCC
Q 022309 181 GAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHV-------STRVMGTHGYCAPEYATTG 253 (299)
Q Consensus 181 ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~ 253 (299)
+++.|+.|+|..- .+||++|.|++|.++.++..||+.|+.+.....+..... ..-..-...|.|||.+.+.
T Consensus 107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 4558999999753 499999999999999999999999998754332111000 0001235579999999888
Q ss_pred CCCcccceehhHHHHHHHH-hCCCCCCCCc
Q 022309 254 KLTAKSDIFSFGVVLLELI-TGRPAMDDSQ 282 (299)
Q Consensus 254 ~~~~~~DiwslG~il~ell-tg~~pf~~~~ 282 (299)
..+.++|++|+|+++|.+. .|.+.+....
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~ 214 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANG 214 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccC
Confidence 8889999999999999998 5666665553
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=3.9e-07 Score=83.54 Aligned_cols=138 Identities=19% Similarity=0.129 Sum_probs=88.4
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCccc-------------------------------------HHHHHHHH
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG-------------------------------------EKEFLVEV 120 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------------------------------------~~~~~~E~ 120 (299)
+.||..+.|.||+|+.+. |+.||||+-++.-... +-+|.+|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 579999999999999875 9999999765432110 11234444
Q ss_pred HHH----hhcCCCc------ceeeeeEEecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022309 121 LML----SLMRHPN------LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLH 190 (299)
Q Consensus 121 ~~l----~~l~h~n------Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH 190 (299)
+-. +.+.|-+ |.++|-.+. ....++|||++|..+.|.-.- ....++...+..-+.+...-+-+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~~~qIf-- 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAYLEQIF-- 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHHHHHHH--
Confidence 322 2234444 444444333 345899999999877665321 22445555444433333322222
Q ss_pred hCCCCCeEecCCCCCCEEecC----CCceEEccccccccC
Q 022309 191 NKADPPVIYRDLKAGNILLGK----GFHPKLSDFGLAKFG 226 (299)
Q Consensus 191 ~~~~~~i~H~dikp~Nilv~~----~~~~kl~Dfg~a~~~ 226 (299)
..| ++|.|-.|.||+++. ++.+.+.|||+....
T Consensus 319 ~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 319 KTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred hcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 236 999999999999983 678999999998753
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.4e-06 Score=84.10 Aligned_cols=79 Identities=13% Similarity=0.254 Sum_probs=57.3
Q ss_pred CceecccCceEEEEEEECCCC--cEEEEEEcCCCCc-ccHHHHHHHHHHHhhcC-CCcc--eeeeeEEecC---CeeEEE
Q 022309 77 TNFLGQGGFGAVYKGKLAETG--QVVAVKQLDDTGF-QGEKEFLVEVLMLSLMR-HPNL--VHLIGYCAEG---TQRLLV 147 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nI--v~~~~~~~~~---~~~~lv 147 (299)
++.++.|.+..+|+......+ ..+++|+...... .....+.+|+.+++.+. |.+| .+++.++.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 567899999999998764332 4678887654322 23356889999999985 6664 7778877654 357899
Q ss_pred EEecCCCC
Q 022309 148 YEYMPLGS 155 (299)
Q Consensus 148 ~e~~~~~~ 155 (299)
||+++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998864
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.3e-06 Score=71.85 Aligned_cols=149 Identities=19% Similarity=0.154 Sum_probs=97.9
Q ss_pred cHHHHHHhhcCCCCCce---ecccCceEEEEEEECCCCcEEEEEEcCCCCcccHH-------------------H-----
Q 022309 63 TYRQLVAATDNFKDTNF---LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEK-------------------E----- 115 (299)
Q Consensus 63 ~~~~~~~~~~~y~~~~~---lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-------------------~----- 115 (299)
+...+....++..+... |++|-.+.||+|.. .++..+|+|+++......+. .
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 34445555566655554 55677788999876 45889999988654322110 0
Q ss_pred HHHHHHHHhhcC--CCcceeeeeEEecCCeeEEEEEecCCC-CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-
Q 022309 116 FLVEVLMLSLMR--HPNLVHLIGYCAEGTQRLLVYEYMPLG-SLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN- 191 (299)
Q Consensus 116 ~~~E~~~l~~l~--h~nIv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~- 191 (299)
..+|..-|..+. +-.+.+.+.+.. -.+|||++... .-.-.| ..-++...++..+..++++.+.-|-.
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~L-----kDv~~e~~e~~~~~~~~v~~~~~l~~~ 185 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRL-----KDVPLELEEAEGLYEDVVEYMRRLYKE 185 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCc-----ccCCcCchhHHHHHHHHHHHHHHHHHh
Confidence 234555555553 344555665543 37999998432 111111 11233344678888899999888877
Q ss_pred CCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 192 KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 192 ~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
.+ +||+||+.=|||+. ++.+.|||||-|-.
T Consensus 186 a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 186 AG---LVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred cC---cccccchhhheEEE-CCeEEEEECccccc
Confidence 67 99999999999999 77999999998864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.4e-06 Score=67.94 Aligned_cols=130 Identities=18% Similarity=0.207 Sum_probs=92.3
Q ss_pred CCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCccee-eeeEEecCCeeEEEEEecC
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVH-LIGYCAEGTQRLLVYEYMP 152 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~-~~~~~~~~~~~~lv~e~~~ 152 (299)
-+..+.|++|.+|.||+|.. .+..+|+|+-+.+ .....+..|+++|..+.--++.+ +|.+..+ ++.|||++
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~ 95 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYID 95 (201)
T ss_pred hhhhhhhhcccccEEEEeec--cCceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhc
Confidence 34467899999999999988 4568999977655 33467889999999998766654 4444332 45699999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC-CCCEEecCCCceEEcccccccc
Q 022309 153 LGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLK-AGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 153 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dik-p~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
|..|.+.-.. .+..++. .+++..--|-..| |-|+.|+ |...++..++.+.|+||..|..
T Consensus 96 G~~L~~~~~~-------~~rk~l~----~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 96 GRPLGKLEIG-------GDRKHLL----RVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred Ccchhhhhhc-------ccHHHHH----HHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 9888876631 1233333 3455555566678 9999886 5555555555999999999984
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.44 E-value=9.3e-06 Score=65.64 Aligned_cols=128 Identities=19% Similarity=0.227 Sum_probs=90.1
Q ss_pred CceecccCceEEEEEEECCCCcEEEEEEcCCCC----------------cccHHHHHHHHHHHhhcC------CCcceee
Q 022309 77 TNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG----------------FQGEKEFLVEVLMLSLMR------HPNLVHL 134 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~nIv~~ 134 (299)
...||+|+.-.||. ++. ....+||+..... .....+..+|+.-...+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~--HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEE--CCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 45799999999995 443 4456889887665 112345566666555554 7899999
Q ss_pred eeEEecCCeeEEEEEecCC------CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 022309 135 IGYCAEGTQRLLVYEYMPL------GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNIL 208 (299)
Q Consensus 135 ~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nil 208 (299)
+++..++-..-+|+|.+.. .+|.+++. ...++. . +...+-+-..||-..+ |+.+|++|.||+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv 150 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIV 150 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEE
Confidence 9999999999999998632 37888883 234544 3 3334445566777777 999999999999
Q ss_pred ecCC--C--ceEEcc
Q 022309 209 LGKG--F--HPKLSD 219 (299)
Q Consensus 209 v~~~--~--~~kl~D 219 (299)
+... + .+.|+|
T Consensus 151 ~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 151 VQRRDSGEFRLVLID 165 (199)
T ss_pred EEecCCCceEEEEEe
Confidence 9543 2 577776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.43 E-value=3.4e-06 Score=70.49 Aligned_cols=74 Identities=15% Similarity=0.155 Sum_probs=46.8
Q ss_pred CceecccCce-EEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCC---cceeeeeEEecC---CeeEEEEE
Q 022309 77 TNFLGQGGFG-AVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHP---NLVHLIGYCAEG---TQRLLVYE 149 (299)
Q Consensus 77 ~~~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~~~~~~~~~---~~~~lv~e 149 (299)
++.|+.|+.. .||+. +..+++|..... .....+.+|+.+++.+... .+.++++..... ...+++|+
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~ 74 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR 74 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence 3457766666 58875 235778875542 2345788899999887532 345555544332 23588999
Q ss_pred ecCCCCHH
Q 022309 150 YMPLGSLE 157 (299)
Q Consensus 150 ~~~~~~L~ 157 (299)
+++|.++.
T Consensus 75 ~i~G~~l~ 82 (235)
T cd05155 75 WLEGETAT 82 (235)
T ss_pred eecCCCCC
Confidence 99987663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.2e-05 Score=69.71 Aligned_cols=78 Identities=10% Similarity=0.025 Sum_probs=55.7
Q ss_pred CCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCC---CcceeeeeEEec---CCeeEEEE
Q 022309 75 KDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRH---PNLVHLIGYCAE---GTQRLLVY 148 (299)
Q Consensus 75 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~~~~~~~~---~~~~~lv~ 148 (299)
.-.+.||.|..+.||..... +..+++|..+.. .....+..|+..++.+.. -.++++++++.. .+..+|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 17 SRVECISEQPYAALWALYDS--QGNPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred heeeecCCccceeEEEEEcC--CCCEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 33567999999999997642 234677874331 123578889999988853 467888887754 35689999
Q ss_pred EecCCCCH
Q 022309 149 EYMPLGSL 156 (299)
Q Consensus 149 e~~~~~~L 156 (299)
|+++|.++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998754
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.2e-05 Score=67.09 Aligned_cols=75 Identities=17% Similarity=0.138 Sum_probs=48.3
Q ss_pred CceecccCceEEEEEEECC-CCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCc-ceeeeeEEecCCeeEEEEEecCCC
Q 022309 77 TNFLGQGGFGAVYKGKLAE-TGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPN-LVHLIGYCAEGTQRLLVYEYMPLG 154 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~lv~e~~~~~ 154 (299)
++.|..|-...+|++.... .++.|++|...... ....+..+|+.+++.+...+ .++++.... + .++|||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-ELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-cceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCC
Confidence 3567778888999987543 35788999775432 22234457888888875433 444554432 1 4899999987
Q ss_pred CH
Q 022309 155 SL 156 (299)
Q Consensus 155 ~L 156 (299)
++
T Consensus 78 ~l 79 (235)
T cd05157 78 TL 79 (235)
T ss_pred cC
Confidence 65
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.25 E-value=7.2e-06 Score=65.91 Aligned_cols=103 Identities=25% Similarity=0.270 Sum_probs=79.9
Q ss_pred HHHHHHhhcCC-CcceeeeeEEecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 022309 118 VEVLMLSLMRH-PNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPP 196 (299)
Q Consensus 118 ~E~~~l~~l~h-~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~ 196 (299)
.|..+++.+.+ +++++++|+|-. +++.|+...+++...... .......++..+.+|+.++++.+.+++..-...
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 47788888865 699999999843 788999976665432100 012234688999999999999999999854444
Q ss_pred eEecCCCCCCEEecCCCceEEcccccccc
Q 022309 197 VIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 197 i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
+.-.|++++|+-++++|++|++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999987753
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.21 E-value=3.4e-05 Score=65.32 Aligned_cols=140 Identities=14% Similarity=0.003 Sum_probs=79.1
Q ss_pred eecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcc-eeeeeEEecCCeeEEEEEecCCCCHH
Q 022309 79 FLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNL-VHLIGYCAEGTQRLLVYEYMPLGSLE 157 (299)
Q Consensus 79 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~e~~~~~~L~ 157 (299)
.+..|-...+|+... +++.+++|........-..+..+|..+++.+....+ .+++.... -++|+||++|..+.
T Consensus 3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 355677788998763 567888997654322211245778888888864333 34444432 26899999986653
Q ss_pred H--------------H---hcccCCCCCCCCHH-HHHHHHHHH---------HHHHHHHHhC-----CCCCeEecCCCCC
Q 022309 158 D--------------H---LLGLTPEMKPLDWN-TRMKIAAGA---------ARGLEYLHNK-----ADPPVIYRDLKAG 205 (299)
Q Consensus 158 ~--------------~---l~~~~~~~~~~~~~-~~~~i~~ql---------~~~l~~lH~~-----~~~~i~H~dikp~ 205 (299)
. . ++.......+++.. .+..+..++ ...+..+-.. ...-++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 2 1 11111111122211 111211111 1112222211 0123899999999
Q ss_pred CEEecCCCceEEcccccccc
Q 022309 206 NILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 206 Nilv~~~~~~kl~Dfg~a~~ 225 (299)
||+++.++ +.|+||..|..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99999877 78999998874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.19 E-value=3.3e-05 Score=62.14 Aligned_cols=125 Identities=29% Similarity=0.436 Sum_probs=87.7
Q ss_pred cCCCCCceecccCc-eEEEEEEECCCCcEEEEEEcCC---CC-------cc-----------cHHHHHHHHHHHhhcC--
Q 022309 72 DNFKDTNFLGQGGF-GAVYKGKLAETGQVVAVKQLDD---TG-------FQ-----------GEKEFLVEVLMLSLMR-- 127 (299)
Q Consensus 72 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~vavK~~~~---~~-------~~-----------~~~~~~~E~~~l~~l~-- 127 (299)
.+++.++.||.|.- |.||++.. .|+.||+|++.. .. .. ....|..|.....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67888999999999 99999998 678999998321 00 00 0124677877777664
Q ss_pred -CCcc--eeeeeEEecC------------------CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 022309 128 -HPNL--VHLIGYCAEG------------------TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGL 186 (299)
Q Consensus 128 -h~nI--v~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l 186 (299)
+.++ |++++|..-. ....||.||++... .+.. .-+.+|.+-+
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~----~~~~~~~~dl 177 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI----RDIPQMLRDL 177 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch----hHHHHHHHHH
Confidence 4566 8888887322 12357778765432 1222 2345677778
Q ss_pred HHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccc
Q 022309 187 EYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA 223 (299)
Q Consensus 187 ~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a 223 (299)
..+|..| |+-+|+++.|.. .=+|+|||.+
T Consensus 178 ~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 178 KILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 8899999 999999999986 2388999875
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.10 E-value=0.00011 Score=65.77 Aligned_cols=76 Identities=18% Similarity=0.117 Sum_probs=53.0
Q ss_pred CceecccCceEEEEEEECCCCcEEEEEEcCCCC-------cccHHHHHHHHHHHhhcC---CCcceeeeeEEecCCeeEE
Q 022309 77 TNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG-------FQGEKEFLVEVLMLSLMR---HPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~l 146 (299)
.+.||.|.+..||++.....++.++||.-.+.. .........|...|+.+. -.++++++.+.. ...++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence 467999999999999986444689999854211 112345667777777752 346777887743 45689
Q ss_pred EEEecCCC
Q 022309 147 VYEYMPLG 154 (299)
Q Consensus 147 v~e~~~~~ 154 (299)
|||++++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99998753
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.04 E-value=5.2e-05 Score=65.58 Aligned_cols=144 Identities=15% Similarity=0.077 Sum_probs=83.3
Q ss_pred CceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCc--ceeeeeE------EecCCeeEEEE
Q 022309 77 TNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPN--LVHLIGY------CAEGTQRLLVY 148 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~~~~~------~~~~~~~~lv~ 148 (299)
++.|..|....+|+... ++..+++|+... .....+..|+.++..+.+.+ +++++.. ....+..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 45677788789998765 345689998764 23345667777777774332 4454432 23344568999
Q ss_pred EecCCCCHHH-----------Hh---cccCCC-C------CCCCHHHH----------HHHHHHHHHHHHHHHh----CC
Q 022309 149 EYMPLGSLED-----------HL---LGLTPE-M------KPLDWNTR----------MKIAAGAARGLEYLHN----KA 193 (299)
Q Consensus 149 e~~~~~~L~~-----------~l---~~~~~~-~------~~~~~~~~----------~~i~~ql~~~l~~lH~----~~ 193 (299)
++++|..+.. .+ +..... . ....+... ......+..++.++.. .-
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999866421 11 110000 0 00010000 0011112334444443 11
Q ss_pred CCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 194 DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 194 ~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
...++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 23399999999999999987778999998864
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00017 Score=62.83 Aligned_cols=145 Identities=14% Similarity=0.125 Sum_probs=80.9
Q ss_pred CceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCc--ceeeeeE------EecCCeeEEEE
Q 022309 77 TNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPN--LVHLIGY------CAEGTQRLLVY 148 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~~~~~------~~~~~~~~lv~ 148 (299)
++.++.|....+|+... ++..+++|...... ....+..|..++..+.... +++++.. ....+..++++
T Consensus 27 i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT--DVGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred ccccCCccccceEEEEe--CCCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 45677787789998764 23468889875432 2344556667776664222 3444332 12235678999
Q ss_pred EecCCCCHH-----------HHh---cccCCCC-----C--CCC-HHHHH------------HHHHHHHHHHHHHHh---
Q 022309 149 EYMPLGSLE-----------DHL---LGLTPEM-----K--PLD-WNTRM------------KIAAGAARGLEYLHN--- 191 (299)
Q Consensus 149 e~~~~~~L~-----------~~l---~~~~~~~-----~--~~~-~~~~~------------~i~~ql~~~l~~lH~--- 191 (299)
+|++|..+. ..+ +...... . ..+ +.... .....+...++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 999885431 111 1100000 0 000 00000 001123334555532
Q ss_pred -CCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 192 -KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 192 -~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
.-...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 1123499999999999999887778999999864
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00046 Score=59.77 Aligned_cols=141 Identities=18% Similarity=0.258 Sum_probs=83.6
Q ss_pred CCCCceecccCceEEEEEEECCCCcEEEEEEcCC--CCcccHHHHHHHHHHHhhcCC--CcceeeeeEEecCC--eeEEE
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDD--TGFQGEKEFLVEVLMLSLMRH--PNLVHLIGYCAEGT--QRLLV 147 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~--~~~lv 147 (299)
..+++.+..|..-.+|.... +++.+++. ... ..........+|..+++.+.- --+...++.+.++. ..+.|
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGD--TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred CceeeeccCCcccceEEEec--CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 34455554444445565554 37788888 332 222233556678888877643 33445566665555 67999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHH-HHHHHHHH---------------------------------------
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIA-AGAARGLE--------------------------------------- 187 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~-~ql~~~l~--------------------------------------- 187 (299)
|+|++|..+.+.+.. .... ..++ ..+...|.
T Consensus 104 ~~~veGe~~~~~~~~-----~~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~ 174 (321)
T COG3173 104 MEWVEGEVVWSALPP-----ESLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELG 174 (321)
T ss_pred EEEecceeccCcCCc-----ccch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhcc
Confidence 999998533322210 0000 0111 13333333
Q ss_pred -----------HHHhC-----CCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 188 -----------YLHNK-----ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 188 -----------~lH~~-----~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
+|+.+ +.+.++|+|+.+.||+++.++-+=++||+++.+.
T Consensus 175 ~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 175 GRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred CCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 33332 1267899999999999999888999999999864
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.0015 Score=57.18 Aligned_cols=144 Identities=11% Similarity=0.085 Sum_probs=75.5
Q ss_pred CceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCc--ceeeee------EEecCCeeEEEE
Q 022309 77 TNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPN--LVHLIG------YCAEGTQRLLVY 148 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~~~~------~~~~~~~~~lv~ 148 (299)
.+.|+.|....+|+.... +..+++|++. . .....+..|..+++.+...+ +.+++. +....+..++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~ 101 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT--QGEYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV 101 (319)
T ss_pred cchhccccccceEEEEeC--CCcEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence 345667777889988753 3368899875 2 12234444555555553211 333332 122345678999
Q ss_pred EecCCCCH-----------HHHhc---ccCCC-------CCCCCH-HHHH-H-----------HHHH-HHHHHHHHHhC-
Q 022309 149 EYMPLGSL-----------EDHLL---GLTPE-------MKPLDW-NTRM-K-----------IAAG-AARGLEYLHNK- 192 (299)
Q Consensus 149 e~~~~~~L-----------~~~l~---~~~~~-------~~~~~~-~~~~-~-----------i~~q-l~~~l~~lH~~- 192 (299)
+|++|..+ ...+. ..... ...+.+ .... . .+.+ +...++.+.+.
T Consensus 102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 181 (319)
T PRK05231 102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA 181 (319)
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence 99998643 11111 11000 000101 1110 0 1111 11122233211
Q ss_pred ---CCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 193 ---ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 193 ---~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
-..+++|+|+.|.||+++.+...-|+||+.+..
T Consensus 182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 123499999999999999765567999999864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00056 Score=59.35 Aligned_cols=143 Identities=21% Similarity=0.269 Sum_probs=82.0
Q ss_pred ceecccCceEEEEEEECC------CCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcc-eeeeeEEecCCeeEEEEEe
Q 022309 78 NFLGQGGFGAVYKGKLAE------TGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNL-VHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~e~ 150 (299)
+.+..|-...+|+..... +++.|++|+..... ....+..+|..++..+....+ .+++.++.. .+|++|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 445566667889887543 25789999876543 223456778888887754333 455555532 368999
Q ss_pred cCCCCHHHH--------------h---cccCCCC--C---CCC--HHHHHH--------------------------HHH
Q 022309 151 MPLGSLEDH--------------L---LGLTPEM--K---PLD--WNTRMK--------------------------IAA 180 (299)
Q Consensus 151 ~~~~~L~~~--------------l---~~~~~~~--~---~~~--~~~~~~--------------------------i~~ 180 (299)
++|.++... + +...... . ..+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 888765331 1 1111110 0 111 001100 111
Q ss_pred HHHHHHHHHHh------CCCCCeEecCCCCCCEEecCC----CceEEcccccccc
Q 022309 181 GAARGLEYLHN------KADPPVIYRDLKAGNILLGKG----FHPKLSDFGLAKF 225 (299)
Q Consensus 181 ql~~~l~~lH~------~~~~~i~H~dikp~Nilv~~~----~~~kl~Dfg~a~~ 225 (299)
++...+..+-. .....++|+|+.+.||+++.+ +.+.|+||..|..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22222334432 123448999999999999984 8899999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00042 Score=59.50 Aligned_cols=73 Identities=18% Similarity=0.273 Sum_probs=47.3
Q ss_pred CceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcC---CCcceeeeeEEecCCeeEEEEEecCC
Q 022309 77 TNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMR---HPNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
.+.++.|....+|+.. .+++.+.||.-.. .....+..|+.-|+.+. --.+++++.+....+..++||||++.
T Consensus 22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEE--SSSSEEEEEE--TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eEecCCCChhheEEEE--CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 4678889999999877 5788899997652 22345777888777773 45688899998877778999999876
Q ss_pred C
Q 022309 154 G 154 (299)
Q Consensus 154 ~ 154 (299)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 5
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0011 Score=58.32 Aligned_cols=72 Identities=17% Similarity=0.117 Sum_probs=46.3
Q ss_pred eecccCceEEEEEEECCCCcEEEEEEcCCC------C-cccHHHHHHHHHHHhhcC--CC-cceeeeeEEecCCeeEEEE
Q 022309 79 FLGQGGFGAVYKGKLAETGQVVAVKQLDDT------G-FQGEKEFLVEVLMLSLMR--HP-NLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 79 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~--h~-nIv~~~~~~~~~~~~~lv~ 148 (299)
.||.|....||++.+...++.++||.-.+- . .........|...|+... -| .++++|.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 589999999999998544468999966421 1 122244556777776653 34 45555554 334557999
Q ss_pred EecC
Q 022309 149 EYMP 152 (299)
Q Consensus 149 e~~~ 152 (299)
|+++
T Consensus 80 EdL~ 83 (370)
T TIGR01767 80 EDLS 83 (370)
T ss_pred hhCc
Confidence 9985
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.001 Score=56.90 Aligned_cols=31 Identities=29% Similarity=0.423 Sum_probs=26.0
Q ss_pred CCeEecCCCCCCEEecCCCc-eEEcccccccc
Q 022309 195 PPVIYRDLKAGNILLGKGFH-PKLSDFGLAKF 225 (299)
Q Consensus 195 ~~i~H~dikp~Nilv~~~~~-~kl~Dfg~a~~ 225 (299)
+-++|+|+.|.||+++.++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 34899999999999997555 45999999975
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00022 Score=70.25 Aligned_cols=152 Identities=23% Similarity=0.198 Sum_probs=109.9
Q ss_pred HHHHHHHHhhcCCCcceeeeeEEecCCee----EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022309 116 FLVEVLMLSLMRHPNLVHLIGYCAEGTQR----LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN 191 (299)
Q Consensus 116 ~~~E~~~l~~l~h~nIv~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~ 191 (299)
...|...+.+..|+|++.++.+..+.... .+..+++...++...+. ....++..+++.+..++..||.|+|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHHHHH
Confidence 45577788888999999999987655433 24566777788888774 45678889999999999999999999
Q ss_pred CCCCCeEecCCCCC---CEEecCCCceEEc--cccccccCCCCCCcccccccccCccccCcccccCCCCCc--ccceehh
Q 022309 192 KADPPVIYRDLKAG---NILLGKGFHPKLS--DFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTA--KSDIFSF 264 (299)
Q Consensus 192 ~~~~~i~H~dikp~---Nilv~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~--~~Diwsl 264 (299)
.. ..|.-+..+ +..++..+.+.++ ||+............ ...-+..+.++|......+.. ..|+|.+
T Consensus 305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred hc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHH
Confidence 86 666665555 4445555666666 888877544332221 122345578888876665544 4799999
Q ss_pred HHHHHHHHhCCCC
Q 022309 265 GVVLLELITGRPA 277 (299)
Q Consensus 265 G~il~elltg~~p 277 (299)
|..+..+..|..+
T Consensus 379 gll~~~~~~~~~i 391 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDI 391 (1351)
T ss_pred HHHHhhhhhcCcc
Confidence 9999999988654
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.57 E-value=5.4e-06 Score=83.04 Aligned_cols=177 Identities=15% Similarity=0.056 Sum_probs=122.9
Q ss_pred EEEEEcCCCCcccH-----HHHHHHHHHHhhcCCCcceeeeeEEec--CCeeEEEEEecCCCCHHHHhcccCCCCCCCCH
Q 022309 100 VAVKQLDDTGFQGE-----KEFLVEVLMLSLMRHPNLVHLIGYCAE--GTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDW 172 (299)
Q Consensus 100 vavK~~~~~~~~~~-----~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 172 (299)
+.+|+.+....... +....|..-++...|+++.....-... ...-+.+++++.+|.+.+.+..-.....++..
T Consensus 1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence 45565554333322 223344445555689988877665532 33457899999999999999765555555555
Q ss_pred HHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcccccccccCccccCcccc
Q 022309 173 NTRMKIAAGAARGLEYLHNKA--DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYA 250 (299)
Q Consensus 173 ~~~~~i~~ql~~~l~~lH~~~--~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~ 250 (299)
.-+.....+......-+|+.. ..-.+|+++|+.|.+|..+..+++.++|+.+...+ .........+++.|+.|++.
T Consensus 1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~ 1412 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIK 1412 (2724)
T ss_pred chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHH
Confidence 555444444466666666542 22258999999999999999999999999983211 11222335678889999988
Q ss_pred cCCCCCcccceehhHHHHHHHHhCCCCC
Q 022309 251 TTGKLTAKSDIFSFGVVLLELITGRPAM 278 (299)
Q Consensus 251 ~~~~~~~~~DiwslG~il~elltg~~pf 278 (299)
..-.++.++|+|..|+.+|++.-|.++|
T Consensus 1413 N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1413 NEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 8888888899999999999998888876
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0024 Score=57.27 Aligned_cols=73 Identities=14% Similarity=0.083 Sum_probs=49.2
Q ss_pred CceecccCceEEEEEEECCCCcEEEEEEcCCCCc-------ccHHHHHHHHHHHhhcC---CCcceeeeeEEecCCeeEE
Q 022309 77 TNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-------QGEKEFLVEVLMLSLMR---HPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~l 146 (299)
.+.||.|....||+..+ .+..++||+-..-.. ........|+..|+.+. -.++++++.++.+ ..++
T Consensus 37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vl 112 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALI 112 (418)
T ss_pred EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEE
Confidence 56789999999999886 345689997652110 12233344566666553 2578888888774 4578
Q ss_pred EEEecCC
Q 022309 147 VYEYMPL 153 (299)
Q Consensus 147 v~e~~~~ 153 (299)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 9999976
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0027 Score=56.21 Aligned_cols=143 Identities=18% Similarity=0.183 Sum_probs=80.7
Q ss_pred ceecccCceEEEEEEECC----CCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcce-eeeeEEecCCeeEEEEEecC
Q 022309 78 NFLGQGGFGAVYKGKLAE----TGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLV-HLIGYCAEGTQRLLVYEYMP 152 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~~~~~~~~~~~~~lv~e~~~ 152 (299)
..|..|-.-.+|++.... .++.|++|...... ...-+...|..+++.+...++. ++++.+... .|.+|++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-ELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-CeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 445557777899886432 24679999876543 2223346788888887654443 455555332 5789988
Q ss_pred CCCHHHH-----------------hcccCCC--CCCCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 022309 153 LGSLEDH-----------------LLGLTPE--MKPLDWNTRMKIAAGA-----------------ARGLEYL----HN- 191 (299)
Q Consensus 153 ~~~L~~~-----------------l~~~~~~--~~~~~~~~~~~i~~ql-----------------~~~l~~l----H~- 191 (299)
+.+|... ++..... ..+.....+..+..++ ...+..| .+
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7665321 1111000 0011122222332221 1111122 21
Q ss_pred CCCCCeEecCCCCCCEEecC-CCceEEcccccccc
Q 022309 192 KADPPVIYRDLKAGNILLGK-GFHPKLSDFGLAKF 225 (299)
Q Consensus 192 ~~~~~i~H~dikp~Nilv~~-~~~~kl~Dfg~a~~ 225 (299)
....-++|+|+++.||++++ ++.+.|+||..|..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11233899999999999986 46899999998875
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0002 Score=61.52 Aligned_cols=134 Identities=14% Similarity=0.020 Sum_probs=93.6
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc----------------------cHHHHHHHHHHHhhcCC--
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ----------------------GEKEFLVEVLMLSLMRH-- 128 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~h-- 128 (299)
-+.++..||-|--+.||.+-+. .|...++|.-+....+ ..-...+|...++.|.-
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 4778899999999999999875 5788888843211100 01234567777777743
Q ss_pred CcceeeeeEEecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 022309 129 PNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNIL 208 (299)
Q Consensus 129 ~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nil 208 (299)
=-+++.+++ +..++|||+++|..|...-. -. .+-.+...+..-+--|-.+| +||+|..-=||+
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~-------v~---d~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNim 234 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRH-------VE---DPPTLYDDLMGLIVRLANHG---LIHGDFNEFNIM 234 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeee-------cC---ChHHHHHHHHHHHHHHHHcC---ceecccchheeE
Confidence 235555655 45689999999887765331 11 12234455566666788888 999999999999
Q ss_pred ecCCCceEEccccccc
Q 022309 209 LGKGFHPKLSDFGLAK 224 (299)
Q Consensus 209 v~~~~~~kl~Dfg~a~ 224 (299)
|.+++.++++||--.-
T Consensus 235 v~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 235 VKDDDKIVVIDFPQMV 250 (465)
T ss_pred EecCCCEEEeechHhh
Confidence 9999999999997553
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0049 Score=53.63 Aligned_cols=30 Identities=23% Similarity=0.207 Sum_probs=25.9
Q ss_pred CCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 195 ~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
..++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 34999999999999988 6789999997764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0044 Score=54.54 Aligned_cols=143 Identities=16% Similarity=0.189 Sum_probs=78.0
Q ss_pred ceecccCceEEEEEEECCC---CcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcce-eeeeEEecCCeeEEEEEecCC
Q 022309 78 NFLGQGGFGAVYKGKLAET---GQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLV-HLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~~~~~~~~~~~~~lv~e~~~~ 153 (299)
+.|..|---.+|+...... +..|++|+..... ...-+-.+|..+++.+..-++. ++++++.. + +|.+|++|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t-~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT-DYVIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCc-CeEechHHHHHHHHHHHhcCCCCceeEEeCC-c---EeehhhcC
Confidence 3454466667888765432 3378899876543 2223446688888888655553 45555532 2 58888887
Q ss_pred CCHHH--------------Hh---cccCCC-CC-CCCHHHHHHHHHHH----------------------HHHHHH----
Q 022309 154 GSLED--------------HL---LGLTPE-MK-PLDWNTRMKIAAGA----------------------ARGLEY---- 188 (299)
Q Consensus 154 ~~L~~--------------~l---~~~~~~-~~-~~~~~~~~~i~~ql----------------------~~~l~~---- 188 (299)
.+|.. .+ +..... .. +-....+..+..++ ..-+..
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 65521 11 111000 00 11122222222221 111221
Q ss_pred HHhCC-CCCeEecCCCCCCEEecC-CCceEEcccccccc
Q 022309 189 LHNKA-DPPVIYRDLKAGNILLGK-GFHPKLSDFGLAKF 225 (299)
Q Consensus 189 lH~~~-~~~i~H~dikp~Nilv~~-~~~~kl~Dfg~a~~ 225 (299)
+.+.+ +.-++|+|+.+.||++++ ++.++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11111 122799999999999975 47899999999864
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0043 Score=55.37 Aligned_cols=74 Identities=19% Similarity=0.187 Sum_probs=48.5
Q ss_pred CceecccCceEEEEEEECCCCcEEEEEEcCC---CC---cccHHHHHHHHHHHhhcC--CC-cceeeeeEEecCCeeEEE
Q 022309 77 TNFLGQGGFGAVYKGKLAETGQVVAVKQLDD---TG---FQGEKEFLVEVLMLSLMR--HP-NLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~---~~~~~~~~~E~~~l~~l~--h~-nIv~~~~~~~~~~~~~lv 147 (299)
.+.||.|.-.-||++.+...++.|+||+-.. .. .........|..+|+... .| .++++|.+- .....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D--~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD--SVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC--cHHhhHH
Confidence 5679999999999999844456799996632 11 122345566777777653 34 455566553 3455788
Q ss_pred EEecC
Q 022309 148 YEYMP 152 (299)
Q Consensus 148 ~e~~~ 152 (299)
||+++
T Consensus 112 MEdL~ 116 (409)
T PRK12396 112 MEDLS 116 (409)
T ss_pred HHhCc
Confidence 88875
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0021 Score=56.12 Aligned_cols=74 Identities=20% Similarity=0.191 Sum_probs=56.5
Q ss_pred cCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcc
Q 022309 140 EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSD 219 (299)
Q Consensus 140 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~D 219 (299)
+..+.|++|++- |+++. .+ .....+++..++.+.+..++-+.. +.++-|||+...||+|+ +|++.|+|
T Consensus 297 e~~y~yl~~kdh-gt~is-~i-------k~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLID 364 (488)
T COG5072 297 ETLYLYLHFKDH-GTPIS-II-------KADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLID 364 (488)
T ss_pred CceEEEEEEecC-Cceee-ee-------ecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEE
Confidence 334567788863 54443 33 233568888999998888877776 34589999999999999 89999999
Q ss_pred cccccc
Q 022309 220 FGLAKF 225 (299)
Q Consensus 220 fg~a~~ 225 (299)
|-+++.
T Consensus 365 fklsRl 370 (488)
T COG5072 365 FKLSRL 370 (488)
T ss_pred eeeeec
Confidence 999985
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.014 Score=50.86 Aligned_cols=30 Identities=17% Similarity=0.200 Sum_probs=27.6
Q ss_pred CeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 196 PVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 196 ~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
.++|+|+.+.||+++.++.+-++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 399999999999999998999999998875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.035 Score=45.66 Aligned_cols=74 Identities=22% Similarity=0.251 Sum_probs=47.9
Q ss_pred eecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcC---CCcceeeeeEEecCCeeEEEEEecCCCC
Q 022309 79 FLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMR---HPNLVHLIGYCAEGTQRLLVYEYMPLGS 155 (299)
Q Consensus 79 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~lv~e~~~~~~ 155 (299)
.+.-|.--..|...+ ....+.+|+-... ....|..|+.=|+.+. .-++.+++.+....++.|+|+||++.+.
T Consensus 23 ~v~gG~inea~~v~d--g~~~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 23 EVSGGDINEAWRLRD--GTDPFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred ccCCccccceeEeec--CCcceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 344444444444433 3456888864322 2355777776666653 4568889999999999999999998654
Q ss_pred HH
Q 022309 156 LE 157 (299)
Q Consensus 156 L~ 157 (299)
+.
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 43
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.039 Score=48.38 Aligned_cols=142 Identities=20% Similarity=0.302 Sum_probs=78.5
Q ss_pred eecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCc------ceeeee----EEecCCeeEEEE
Q 022309 79 FLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPN------LVHLIG----YCAEGTQRLLVY 148 (299)
Q Consensus 79 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~~~~----~~~~~~~~~lv~ 148 (299)
.|.+ .-..+|+.... +..+++|+.... ....++..|...+..+.-.. +...-+ ........+-++
T Consensus 33 ~l~s-~eN~~f~~~~~--~g~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf 107 (331)
T COG2334 33 GLNS-EENSNFRVQTE--DGRYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF 107 (331)
T ss_pred cccc-ccCceEEEEec--CCCeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence 3444 45578887763 334489988765 34455666777776663211 222211 222223778899
Q ss_pred EecCCCCHHH------------Hh-------cccC----CCCCCCCHHH-------------HHHHHHHHHHHHHHHHhC
Q 022309 149 EYMPLGSLED------------HL-------LGLT----PEMKPLDWNT-------------RMKIAAGAARGLEYLHNK 192 (299)
Q Consensus 149 e~~~~~~L~~------------~l-------~~~~----~~~~~~~~~~-------------~~~i~~ql~~~l~~lH~~ 192 (299)
+|++|..+.. .+ .... .......+.. ......++...++.+.+.
T Consensus 108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 9999877762 01 0110 0000111110 011233344444444432
Q ss_pred C-----C--CCeEecCCCCCCEEecCCCc-eEEcccccccc
Q 022309 193 A-----D--PPVIYRDLKAGNILLGKGFH-PKLSDFGLAKF 225 (299)
Q Consensus 193 ~-----~--~~i~H~dikp~Nilv~~~~~-~kl~Dfg~a~~ 225 (299)
- . ..+||+|+.|.||+++.+.. +-++||+-+..
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 1 1 22899999999999998875 88999998864
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.028 Score=49.53 Aligned_cols=139 Identities=17% Similarity=0.128 Sum_probs=88.5
Q ss_pred CCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc---------c------------H-H--H--HHHHHHHHhhcCCC
Q 022309 76 DTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---------G------------E-K--E--FLVEVLMLSLMRHP 129 (299)
Q Consensus 76 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~------------~-~--~--~~~E~~~l~~l~h~ 129 (299)
+-..|..|--+-||.|.. .+|..+|||+++.+-.. . . + . ..+|+.-|.++...
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 345788899999999876 46888999987532110 0 0 1 1 23466666666554
Q ss_pred cceeeeeEEecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEe
Q 022309 130 NLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL 209 (299)
Q Consensus 130 nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv 209 (299)
.|.-.--... ....|||+++- .+ .+.... -....++...+..+-.|++.-+.-|-+.. .+||.||+-=|+|+
T Consensus 227 GIP~PePIlL--k~hVLVM~FlG-rd--gw~aPk-LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLG-RD--GWAAPK-LKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY 298 (520)
T ss_pred CCCCCCceee--ecceEeeeecc-CC--CCcCcc-cccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence 4432211111 23479999984 21 111110 12245667778888888888888777643 29999999999999
Q ss_pred cCCCceEEccccccc
Q 022309 210 GKGFHPKLSDFGLAK 224 (299)
Q Consensus 210 ~~~~~~kl~Dfg~a~ 224 (299)
-. |.+.|+|.+-+-
T Consensus 299 hd-G~lyiIDVSQSV 312 (520)
T KOG2270|consen 299 HD-GKLYIIDVSQSV 312 (520)
T ss_pred EC-CEEEEEEccccc
Confidence 76 578899977654
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.064 Score=48.18 Aligned_cols=76 Identities=14% Similarity=0.204 Sum_probs=45.2
Q ss_pred CceecccCceEEEEEEECCCC-c-----EEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcce-eeeeEEecCCeeEEEEE
Q 022309 77 TNFLGQGGFGAVYKGKLAETG-Q-----VVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLV-HLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~~-~-----~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~~~~~~~~~~~~~lv~e 149 (299)
++.|..|--..+|++...... . .|.++..... ...--+-.+|..+++.+...++. ++++.+.. +++.|
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 445656777899998754321 2 2444433211 11112346688899888665554 45555543 58999
Q ss_pred ecCCCCHH
Q 022309 150 YMPLGSLE 157 (299)
Q Consensus 150 ~~~~~~L~ 157 (299)
|++|.+|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99987653
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.14 Score=44.95 Aligned_cols=71 Identities=15% Similarity=0.093 Sum_probs=41.9
Q ss_pred cCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCc--ceeee---e--EEecCCeeEEEEEecCCCC
Q 022309 83 GGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPN--LVHLI---G--YCAEGTQRLLVYEYMPLGS 155 (299)
Q Consensus 83 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~~~---~--~~~~~~~~~lv~e~~~~~~ 155 (299)
+.-..||+... .++..+++|+.+... .....+..|+..+..+.... ++... + ....++..+.++++++|..
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 34457888765 346679999886432 24456667777776663211 22211 1 1233456788999998764
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.13 Score=47.17 Aligned_cols=75 Identities=13% Similarity=0.084 Sum_probs=45.3
Q ss_pred CceecccCceEEEEEEECCC--------CcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcce-eeeeEEecCCeeEEE
Q 022309 77 TNFLGQGGFGAVYKGKLAET--------GQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLV-HLIGYCAEGTQRLLV 147 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~~~~~~~~~~~~~lv 147 (299)
++.|..|---.+|++..... ++.|.+++.-... ..-.+...|..+++.+...+|- ++++.+.. +.|
T Consensus 110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t-e~lIdR~~E~~v~~~ls~~gi~P~l~~~f~g----g~I 184 (442)
T PTZ00296 110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV-DELYNPISEFEVYKTMSKYRIAPQLLNTFSG----GRI 184 (442)
T ss_pred EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc-cceeCHHHHHHHHHHHHHCCCCCceEEEeCC----CEE
Confidence 44566666678888875421 4678888875432 2222445677777777654444 45555432 467
Q ss_pred EEecCCCCH
Q 022309 148 YEYMPLGSL 156 (299)
Q Consensus 148 ~e~~~~~~L 156 (299)
.+|++|.+|
T Consensus 185 ~efi~g~~l 193 (442)
T PTZ00296 185 EEWLYGDPL 193 (442)
T ss_pred EEeeCCccC
Confidence 899987644
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.11 Score=44.67 Aligned_cols=29 Identities=31% Similarity=0.360 Sum_probs=24.8
Q ss_pred eEecCCCCCCEEecCC--C---ceEEcccccccc
Q 022309 197 VIYRDLKAGNILLGKG--F---HPKLSDFGLAKF 225 (299)
Q Consensus 197 i~H~dikp~Nilv~~~--~---~~kl~Dfg~a~~ 225 (299)
++|||+.++|||+..+ | .++++||-+++.
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~ 250 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY 250 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeeccccccC
Confidence 7999999999999654 3 689999988874
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.097 Score=42.99 Aligned_cols=102 Identities=13% Similarity=0.069 Sum_probs=64.4
Q ss_pred EEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHH
Q 022309 100 VAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKI 178 (299)
Q Consensus 100 vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i 178 (299)
..+|+++..... ...-+..+..+++++. .|+++..- +.-.+-++.|+|-.... .. ..+
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-------------~~----~N~ 146 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-------------NF----SNF 146 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------------ch----hHH
Confidence 455666554444 4456677777777653 56666621 22345588898842111 00 011
Q ss_pred HHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccc
Q 022309 179 AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA 223 (299)
Q Consensus 179 ~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a 223 (299)
+..=+.+|.-.|+. +...+|||-.|+||+-++.|.+||.|-+..
T Consensus 147 i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 147 ITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence 11124567778853 344999999999999999999999998764
|
The function of this family is unknown. |
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.11 Score=43.89 Aligned_cols=79 Identities=16% Similarity=0.068 Sum_probs=52.7
Q ss_pred CceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEec-CCCC
Q 022309 77 TNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYM-PLGS 155 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~-~~~~ 155 (299)
...+..|..+.|+.++. .+|...++|+.........+ . .....|+..+-...|++++.-.+ .-.|++|.+ .+.+
T Consensus 7 ~~~~~~g~~s~V~pv~~-~dG~~avLKl~~p~~~~~~E-~-~g~~~L~~w~G~GaVrll~~d~~--~~AlLLErl~~g~~ 81 (253)
T PF04655_consen 7 DGPPAHGSSSLVVPVRR-ADGTPAVLKLAPPHAEAEHE-A-RGEAALRWWNGRGAVRLLAADPE--RGALLLERLDPGRS 81 (253)
T ss_pred CCCCCCCcceEEEEEEc-CCCCeEEEEecCCcccchhh-h-hHHhHhheeCCCCceeeeccccc--cchhhhhhccCCCc
Confidence 34566789999999975 46899999987654321111 1 11245777777888999988643 347889998 4456
Q ss_pred HHHHh
Q 022309 156 LEDHL 160 (299)
Q Consensus 156 L~~~l 160 (299)
|.+..
T Consensus 82 L~~~~ 86 (253)
T PF04655_consen 82 LASLP 86 (253)
T ss_pred hhhcc
Confidence 66554
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.31 Score=49.55 Aligned_cols=30 Identities=37% Similarity=0.328 Sum_probs=25.7
Q ss_pred CeEecCCCCCCEEecCCC--ceE-Ecccccccc
Q 022309 196 PVIYRDLKAGNILLGKGF--HPK-LSDFGLAKF 225 (299)
Q Consensus 196 ~i~H~dikp~Nilv~~~~--~~k-l~Dfg~a~~ 225 (299)
.+||+|+.+.||+++.++ .+. |+|||-+..
T Consensus 204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 204 QVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred ceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 399999999999998775 565 999999864
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 299 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-56 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-55 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-46 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-45 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-44 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-44 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-43 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-42 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-27 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-24 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-24 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-24 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-23 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-22 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-22 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-22 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-22 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-22 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-22 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-22 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-22 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-22 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-22 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-22 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-22 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-22 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-22 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-22 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-22 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-22 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-22 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-22 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-22 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-22 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-22 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-22 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-22 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-22 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-22 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-22 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-22 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-22 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-22 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-22 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-22 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-22 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-22 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-22 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-22 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-22 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-22 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-22 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-22 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-22 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-22 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-22 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-21 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-21 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-21 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-21 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-21 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-21 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-21 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-21 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-21 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-21 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-21 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-21 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-21 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-21 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-21 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-21 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-21 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-21 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-21 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-21 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-21 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-21 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-21 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-21 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-21 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-21 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-21 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-21 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-21 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-20 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-20 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-20 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-20 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-20 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-20 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-20 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-20 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-20 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-20 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-20 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-20 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-20 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-20 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-19 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-19 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-19 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-19 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-19 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-19 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-19 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-19 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-19 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-19 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-18 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-18 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-18 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-18 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-18 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-18 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-18 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-18 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-18 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-18 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-18 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-18 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-18 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-18 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-18 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-18 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-18 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-18 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-17 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-17 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-17 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-16 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-16 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-14 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-14 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-14 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-14 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-14 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-14 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-14 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-14 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-14 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-14 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-14 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-14 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-14 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-14 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-14 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-14 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-14 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-14 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-14 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-14 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-14 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-14 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-14 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-14 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-14 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-14 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-14 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-14 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-14 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-14 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-14 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-14 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-13 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-13 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-13 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-13 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-13 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-13 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-13 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-13 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-13 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-13 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-13 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-13 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-13 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-12 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-12 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-12 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-12 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-12 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-12 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-12 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-11 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-08 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 6e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 4e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-06 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-05 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-05 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 424 bits (1092), Expect = e-151
Identities = 108/252 (42%), Positives = 151/252 (59%), Gaps = 6/252 (2%)
Query: 43 RNTLDDTLSAHENKNKEN-TFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVA 101
N+++D LS+ E+ L AT+NF +G G FG VYKG L + G VA
Sbjct: 9 TNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-GAKVA 67
Query: 102 VKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLL 161
+K+ QG +EF E+ LS RHP+LV LIG+C E + +L+Y+YM G+L+ HL
Sbjct: 68 LKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY 127
Query: 162 GLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFG 221
G + W R++I GAARGL YLH +I+RD+K+ NILL + F PK++DFG
Sbjct: 128 GSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFG 184
Query: 222 LAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDS 281
++K G D++H+ST V GT GY PEY G+LT KSD++SFGVVL E++ R A+ S
Sbjct: 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244
Query: 282 QGHERM-LVDWV 292
E + L +W
Sbjct: 245 LPREMVNLAEWA 256
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 422 bits (1088), Expect = e-150
Identities = 102/256 (39%), Positives = 156/256 (60%), Gaps = 20/256 (7%)
Query: 47 DDTLSAHENKNKENTFTYRQLVAATDNFKD------TNFLGQGGFGAVYKGKLAETGQVV 100
+ +L + + +F++ +L T+NF + N +G+GGFG VYKG + V
Sbjct: 2 NKSLEVSDTRFH--SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTV 57
Query: 101 AVKQL----DDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSL 156
AVK+L D T + +++F E+ +++ +H NLV L+G+ ++G LVY YMP GSL
Sbjct: 58 AVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
Query: 157 EDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPK 216
D L L PL W+ R KIA GAA G+ +LH + I+RD+K+ NILL + F K
Sbjct: 118 LDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAK 173
Query: 217 LSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
+SDFGLA+ ++ +++R++GT Y APE G++T KSDI+SFGVVLLE+ITG P
Sbjct: 174 ISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLP 232
Query: 277 AMDDSQGHERMLVDWV 292
A+D+ + ++L+D
Sbjct: 233 AVDEHRE-PQLLLDIK 247
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 420 bits (1081), Expect = e-149
Identities = 117/237 (49%), Positives = 155/237 (65%), Gaps = 6/237 (2%)
Query: 60 NTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG-EKEFLV 118
F+ R+L A+DNF + N LG+GGFG VYKG+L G +VAVK+L + QG E +F
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQT 76
Query: 119 EVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKI 178
EV M+S+ H NL+ L G+C T+RLLVY YM GS+ L PLDW R +I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 179 AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRV 238
A G+ARGL YLH+ DP +I+RD+KA NILL + F + DFGLAK D +HV+T V
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTAV 195
Query: 239 MGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ---GHERMLVDWV 292
GT G+ APEY +TGK + K+D+F +GV+LLELITG+ A D ++ + ML+DWV
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 2e-82
Identities = 66/259 (25%), Positives = 100/259 (38%), Gaps = 25/259 (9%)
Query: 51 SAHENKNKENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF 110
H + + L + + +G FG V+K +L + VAVK
Sbjct: 3 HHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDK 60
Query: 111 QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG----TQRLLVYEYMPLGSLEDHLLGLTPE 166
Q + EV L M+H N++ IG G L+ + GSL D L
Sbjct: 61 QSW-QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---- 115
Query: 167 MKPLDWNTRMKIAAGAARGLEYLHNKAD-------PPVIYRDLKAGNILLGKGFHPKLSD 219
+ WN IA ARGL YLH P + +RD+K+ N+LL ++D
Sbjct: 116 -NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174
Query: 220 FGLAKFGPTGDKSHVSTRVMGTHGYCAPEYA-----TTGKLTAKSDIFSFGVVLLELITG 274
FGLA G + + +GT Y APE + D+++ G+VL EL +
Sbjct: 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234
Query: 275 RPAMDDSQ-GHERMLVDWV 292
A D + + +
Sbjct: 235 CTAADGPVDEYMLPFEEEI 253
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 2e-68
Identities = 62/256 (24%), Positives = 101/256 (39%), Gaps = 36/256 (14%)
Query: 62 FTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFL--VE 119
+ DN K +G+G +GAVYKG L + VAVK + F+
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSF---ANRQNFINEKN 57
Query: 120 VLMLSLMRHPNLVHLIGYCAEG-----TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNT 174
+ + LM H N+ I + LLV EY P GSL +L + DW +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVS 112
Query: 175 RMKIAAGAARGLEYLHN------KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF--- 225
++A RGL YLH P + +RDL + N+L+ +SDFGL+
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 226 ---GPTGDKSHVSTRVMGTHGYCAPEYA-------TTGKLTAKSDIFSFGVVLLELITGR 275
G++ + + +GT Y APE + D+++ G++ E+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 276 PAMDDSQGHERMLVDW 291
+ + + +
Sbjct: 233 TDLFPGESVPEYQMAF 248
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 9e-66
Identities = 67/211 (31%), Positives = 113/211 (53%), Gaps = 27/211 (12%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE-------KEFLVEVLMLSLMRHPNLV 132
+G+GGFG V+KG+L + VVA+K L +GE +EF EV ++S + HPN+V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 133 HLIGYCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN 191
L G +V E++P G L LL + P+ W+ ++++ A G+EY+ N
Sbjct: 87 KLYGLM---HNPPRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 192 KADPPVIYRDLKAGNILLGKG-----FHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCA 246
+ +PP+++RDL++ NI L K++DFGL++ H + ++G + A
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQWMA 194
Query: 247 PE-YATTGKL-TAKSDIFSFGVVLLELITGR 275
PE + T K+D +SF ++L ++TG
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 4e-65
Identities = 72/198 (36%), Positives = 109/198 (55%), Gaps = 8/198 (4%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE--KEFLVEVLMLSLMRHPNLVHLIGY 137
+G G FG V++ + G VAVK L + F E EFL EV ++ +RHPN+V +G
Sbjct: 45 IGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 138 CAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPV 197
+ +V EY+ GSL L + LD R+ +A A+G+ YLHN+ +PP+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAR-EQLDERRRLSMAYDVAKGMNYLHNR-NPPI 160
Query: 198 IYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTA 257
++R+LK+ N+L+ K + K+ DFGL++ + S S GT + APE
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNE 218
Query: 258 KSDIFSFGVVLLELITGR 275
KSD++SFGV+L EL T +
Sbjct: 219 KSDVYSFGVILWELATLQ 236
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 1e-63
Identities = 69/206 (33%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNL 131
+ +G+G FG V K K + VA+KQ++ K F+VE+ LS + HPN+
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNI 63
Query: 132 VHLIGYCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLH 190
V L G C + LV EY GSL + L G P M ++G+ YLH
Sbjct: 64 VKLYGAC---LNPVCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLH 119
Query: 191 NKADPPVIYRDLKAGNILL-GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEY 249
+ +I+RDLK N+LL G K+ DFG A D T G+ + APE
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEV 174
Query: 250 ATTGKLTAKSDIFSFGVVLLELITGR 275
+ K D+FS+G++L E+IT R
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRR 200
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 5e-62
Identities = 67/218 (30%), Positives = 103/218 (47%), Gaps = 26/218 (11%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQL----DDTGFQGEKEFLVEVLMLSLMRHPNLVHLI 135
+G GGFG VY+ G VAVK D+ Q + E + ++++HPN++ L
Sbjct: 15 IGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 136 GYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADP 195
G C + LV E+ G L L G K + + + A ARG+ YLH++A
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 196 PVIYRDLKAGNILLGKGFHP--------KLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAP 247
P+I+RDLK+ NIL+ + K++DFGLA+ G + + AP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAAGAYAWMAP 183
Query: 248 EYATTGKLTAKSDIFSFGVVLLELITGR---PAMDDSQ 282
E + SD++S+GV+L EL+TG +D
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA 221
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 7e-62
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 18/213 (8%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA 139
LG+G FG K ETG+V+ +K+L + ++ FL EV ++ + HPN++ IG
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 140 EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIY 199
+ + + EY+ G+L + W+ R+ A A G+ YLH+ +I+
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIH 131
Query: 200 RDLKAGNILLGKGFHPKLSDFGLAKF------------GPTGDKSHVSTRVMGTHGYCAP 247
RDL + N L+ + + ++DFGLA+ V+G + AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 248 EYATTGKLTAKSDIFSFGVVLLELITGRPAMDD 280
E K D+FSFG+VL E+I A D
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 3e-61
Identities = 49/203 (24%), Positives = 87/203 (42%), Gaps = 19/203 (9%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQL--DDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGY 137
L + G ++KG+ G + VK L D + ++F E L + HPN++ ++G
Sbjct: 18 LNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 138 CAEGTQRLL--VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADP 195
C + +MP GSL + L T +D + +K A ARG+ +LH +P
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTL-EP 132
Query: 196 PVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE---YATT 252
+ L + ++++ + ++S + S S M + APE
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVK-------FSFQSPGRMYAPAWVAPEALQKKPE 185
Query: 253 GKLTAKSDIFSFGVVLLELITGR 275
+D++SF V+L EL+T
Sbjct: 186 DTNRRSADMWSFAVLLWELVTRE 208
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-59
Identities = 69/201 (34%), Positives = 102/201 (50%), Gaps = 15/201 (7%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE--KEFLVEVLMLSLMRHPNLVHLIGY 137
+G G FG VYKGK VAVK L+ T + + F EV +L RH N++ +GY
Sbjct: 32 IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 138 CAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPV 197
Q +V ++ SL HL + + IA ARG++YLH K +
Sbjct: 89 STAP-QLAIVTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYLHAK---SI 141
Query: 198 IYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE---YATTGK 254
I+RDLK+ NI L + K+ DFGLA SH ++ G+ + APE +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 255 LTAKSDIFSFGVVLLELITGR 275
+ +SD+++FG+VL EL+TG+
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ 222
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 3e-57
Identities = 51/210 (24%), Positives = 82/210 (39%), Gaps = 24/210 (11%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE--KEFLVEVLMLSLMRHPNLVHLIGY 137
+G+G FG VY G+ VA++ +D + K F EV+ RH N+V +G
Sbjct: 41 IGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 138 CAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPV 197
C ++ +L + LD N +IA +G+ YLH K +
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GI 151
Query: 198 IYRDLKAGNILLGKGFHPKLSDFGLAKF---GPTGDKSHVSTRVMGTHGYCAPEYATTGK 254
+++DLK+ N+ G ++DFGL G + G + APE
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 255 L---------TAKSDIFSFGVVLLELITGR 275
+ SD+F+ G + EL
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 7e-57
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 29/214 (13%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFL--VEVLMLSLMRHPNLVHLIGY 137
+G+G +G V++G G+ VAVK + EK + E+ ++RH N++ I
Sbjct: 16 VGKGRYGEVWRGSW--QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 138 CAEG----TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLH--- 190
TQ L+ Y +GSL D+L ++ LD + ++I A GL +LH
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 191 --NKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF--GPTGDKSHVSTRVMGTHGYCA 246
+ P + +RDLK+ NIL+ K ++D GLA T + +GT Y A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 247 PE------YATTGKLTAKSDIFSFGVVLLELITG 274
PE + DI++FG+VL E+
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 2e-56
Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 29/214 (13%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFL--VEVLMLSLMRHPNLVHLIGY 137
+G+G +G V+ GK G+ VAVK E + E+ LMRH N++ I
Sbjct: 45 IGKGRYGEVWMGKW--RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 138 CAEG----TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA 193
+G TQ L+ +Y GSL D+L + LD + +K+A + GL +LH +
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 194 D-----PPVIYRDLKAGNILLGKGFHPKLSDFGLAKF--GPTGDKSHVSTRVMGTHGYCA 246
P + +RDLK+ NIL+ K ++D GLA T + +GT Y
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 247 PE------YATTGKLTAKSDIFSFGVVLLELITG 274
PE + +D++SFG++L E+
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 8e-55
Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 29/232 (12%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFL--VEVLMLSLMRHPNLVHLIGY 137
+G+G FG V++GK G+ VAVK + E+ + E+ ++RH N++ I
Sbjct: 50 IGKGRFGEVWRGKW--RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 138 C----AEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLH--- 190
TQ LV +Y GSL D+L + +K+A A GL +LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 191 --NKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF--GPTGDKSHVSTRVMGTHGYCA 246
+ P + +RDLK+ NIL+ K ++D GLA T +GT Y A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 247 PE------YATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVDWV 292
PE + ++DI++ G+V E+ + ++ D V
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 8e-48
Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 19/212 (8%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYC 138
+G+G FG V+ G+L +VAVK + + +FL E +L HPN+V LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 139 AEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVI 198
+ +V E + G L E L T +++ AA G+EYL +K I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCI 235
Query: 199 YRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGY----CAPEYATTGK 254
+RDL A N L+ + K+SDFG+++ G G APE G+
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVY----AASGGLRQVPVKWTAPEALNYGR 291
Query: 255 LTAKSDIFSFGVVLLELIT-GR---PAMDDSQ 282
+++SD++SFG++L E + G P + + Q
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-45
Identities = 67/205 (32%), Positives = 102/205 (49%), Gaps = 21/205 (10%)
Query: 80 LGQGGFGAVYKGKL----AETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLI 135
LG+G FG+V + TG +VAVKQL +G +++F E+ +L + +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 136 GYCAEGTQR--LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA 193
G ++ LV EY+P G L D L LD + + ++ +G+EYL ++
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLGSRR 147
Query: 194 DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG-----YCAPE 248
++RDL A NIL+ H K++DFGLAK P +V G + APE
Sbjct: 148 ---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR----EPGQSPIFWYAPE 200
Query: 249 YATTGKLTAKSDIFSFGVVLLELIT 273
+ + +SD++SFGVVL EL T
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-45
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 17/210 (8%)
Query: 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE--KEFLVEVLMLSLMRHPNL 131
K +G+G F VYKG ET VA +L D + F E ML ++HPN+
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87
Query: 132 VHLIGYC---AEGTQRLLVY-EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLE 187
V +G + +++ E M G+L+ +L K + +GL+
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQ 143
Query: 188 YLHNKADPPVIYRDLKAGNILL-GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCA 246
+LH + PP+I+RDLK NI + G K+ D GLA ++ + V+GT + A
Sbjct: 144 FLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMA 198
Query: 247 PEYATTGKLTAKSDIFSFGVVLLELITGRP 276
PE D+++FG+ +LE+ T
Sbjct: 199 PEMYEEK-YDESVDVYAFGMCMLEMATSEY 227
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-44
Identities = 69/205 (33%), Positives = 101/205 (49%), Gaps = 21/205 (10%)
Query: 80 LGQGGFGAVYKGKL----AETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLI 135
LG+G FG+V + TG+VVAVK+L + + ++F E+ +L ++H N+V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 136 GYCAEGTQR--LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA 193
G C +R L+ EY+P GSL D+L +D ++ + +G+EYL K
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTKR 134
Query: 194 DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG-----YCAPE 248
I+RDL NIL+ K+ DFGL K P + G + APE
Sbjct: 135 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK----EPGESPIFWYAPE 187
Query: 249 YATTGKLTAKSDIFSFGVVLLELIT 273
T K + SD++SFGVVL EL T
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFT 212
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-44
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 24/209 (11%)
Query: 80 LGQGGFGAVYKGKLAETGQ----VVAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVHL 134
LG G FG VYKG G+ VA+K+L + T + KE L E +++ + +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 135 IGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKAD 194
+G C + L+ + MP G L D++ + + A+G+ YL ++
Sbjct: 83 LGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNWCVQIAKGMNYLEDRR- 137
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG-----YCAPEY 249
+++RDL A N+L+ H K++DFGLAK +K + G + A E
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY-----HAEGGKVPIKWMALES 190
Query: 250 ATTGKLTAKSDIFSFGVVLLELIT--GRP 276
T +SD++S+GV + EL+T +P
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-44
Identities = 69/205 (33%), Positives = 102/205 (49%), Gaps = 21/205 (10%)
Query: 80 LGQGGFGAVYKGKL----AETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLI 135
LG+G FG+V + TG+VVAVK+L + + ++F E+ +L ++H N+V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 136 GYCAEGTQR--LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA 193
G C +R L+ EY+P GSL D+L +D ++ + +G+EYL K
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTKR 165
Query: 194 DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG-----YCAPE 248
I+RDL NIL+ K+ DFGL K P + + G + APE
Sbjct: 166 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK----EPGESPIFWYAPE 218
Query: 249 YATTGKLTAKSDIFSFGVVLLELIT 273
T K + SD++SFGVVL EL T
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFT 243
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-44
Identities = 70/222 (31%), Positives = 101/222 (45%), Gaps = 25/222 (11%)
Query: 80 LGQGGFGAVYKGKL----AETGQVVAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVHL 134
LG+G FG V TG++VAVK L D G Q + E+ +L + H +++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 135 IGYCAEGTQR--LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK 192
G C + LV EY+PLGSL D+L + + L + A G+ YLH +
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHAQ 153
Query: 193 ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG-----YCAP 247
I+RDL A N+LL K+ DFGLAK P G + + + G + AP
Sbjct: 154 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWYAP 206
Query: 248 EYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHERML 288
E K SD++SFGV L EL+T + ++
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI 248
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 6e-44
Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 23/225 (10%)
Query: 80 LGQGGFGAVYKGKL----AETGQVVAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVHL 134
LG+G FG V + TG+ VAVK L ++G + E+ +L + H N+V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 135 IGYCAEGTQR--LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK 192
G C E L+ E++P GSL+++L ++ ++K A +G++YL ++
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 193 ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG-----YCAP 247
++RDL A N+L+ K+ DFGL K T + + + AP
Sbjct: 146 Q---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK----DDRDSPVFWYAP 198
Query: 248 EYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHERMLVDW 291
E K SD++SFGV L EL+T +M+
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT 243
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 5e-43
Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 22/204 (10%)
Query: 80 LGQGGFGAVYKGKLAETGQ----VVAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVHL 134
LG G FG V+KG G+ V +K + D +G Q + +L + + H ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 135 IGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKAD 194
+G C G+ LV +Y+PLGSL DH+ + P + A+G+ YL
Sbjct: 81 LGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQL---LLNWGVQIAKGMYYLEEHG- 135
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG-----YCAPEY 249
+++R+L A N+LL +++DFG+A P DK ++ + + A E
Sbjct: 136 --MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ-----LLYSEAKTPIKWMALES 188
Query: 250 ATTGKLTAKSDIFSFGVVLLELIT 273
GK T +SD++S+GV + EL+T
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMT 212
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 6e-43
Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 11/207 (5%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA 139
LG G +G VY+G + VAVK L + +EFL E ++ ++HPNLV L+G C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 140 EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIY 199
++ E+M G+L D+L + + + +A + +EYL K I+
Sbjct: 287 REPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIH 341
Query: 200 RDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKS 259
R+L A N L+G+ K++DFGL++ TGD + APE K + KS
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 260 DIFSFGVVLLELIT-GR---PAMDDSQ 282
D+++FGV+L E+ T G P +D SQ
Sbjct: 401 DVWAFGVLLWEIATYGMSPYPGIDLSQ 427
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 5e-42
Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 80 LGQGGFGAVYKGKLAETGQV--VAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVHLIG 136
LG G FG+V +G + VA+K L T +E + E ++ + +P +V LIG
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 137 YCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPP 196
C + +LV E G L L+G + + + + ++ + G++YL K
Sbjct: 78 VC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN--- 130
Query: 197 VIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG-----YCAPEYAT 251
++RDL A N+LL + K+SDFGL+K D S + G + APE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD----SYYTARSAGKWPLKWYAPECIN 186
Query: 252 TGKLTAKSDIFSFGVVLLELIT-GR---PAMDDSQ 282
K +++SD++S+GV + E ++ G+ M +
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-42
Identities = 69/219 (31%), Positives = 104/219 (47%), Gaps = 35/219 (15%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA 139
LG G +G VY+G + VAVK L + +EFL E ++ ++HPNLV L+G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 140 EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIY 199
++ E+M G+L D+L + + + +A + +EYL K I+
Sbjct: 80 REPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIH 134
Query: 200 RDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGY------------CAP 247
RDL A N L+G+ K++DFGL+ R+M Y AP
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLS-------------RLMTGDTYTAHAGAKFPIKWTAP 181
Query: 248 EYATTGKLTAKSDIFSFGVVLLELIT-GR---PAMDDSQ 282
E K + KSD+++FGV+L E+ T G P +D SQ
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 220
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 7e-42
Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 29/213 (13%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYC 138
+G+G FG V G G VAVK + +D + FL E +++ +RH NLV L+G
Sbjct: 201 IGKGEFGDVMLGDY--RGNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 139 AEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPV 197
E L +V EYM GSL D+L + L + +K + +EYL
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---F 310
Query: 198 IYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRV----MGTHGYCAPEYATTG 253
++RDL A N+L+ + K+SDFGL K + + ++ APE
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWT------APEALREK 361
Query: 254 KLTAKSDIFSFGVVLLELIT-GR---PAMDDSQ 282
K + KSD++SFG++L E+ + GR P +
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 394
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 9e-42
Identities = 58/248 (23%), Positives = 94/248 (37%), Gaps = 23/248 (9%)
Query: 51 SAHENKNKENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF 110
H + + F ++ ++ LG+GGF V + G A+K++
Sbjct: 8 HHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ 67
Query: 111 QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQR----LLVYEYMPLGSLEDHLLGLTPE 166
Q +E E M L HPN++ L+ YC L+ + G+L + + L +
Sbjct: 68 QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDK 127
Query: 167 MKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226
L + + + G RGLE +H +RDLK NILLG P L D G
Sbjct: 128 GNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184
Query: 227 PTGDKSHVSTRVM-------GTHGYCAPE------YATTGKLTAKSDIFSFGVVLLELIT 273
+ + T Y APE + + ++D++S G VL ++
Sbjct: 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMF 241
Query: 274 GRPAMDDS 281
G D
Sbjct: 242 GEGPYDMV 249
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 9e-42
Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 22/204 (10%)
Query: 80 LGQGGFGAVYKGKLAETGQ----VVAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVHL 134
LG G FG VYKG G+ VA+K+L + T + KE L E +++ + +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 135 IGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKAD 194
+G C + L+ + MP G L D++ + + A+G+ YL ++
Sbjct: 83 LGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNWCVQIAKGMNYLEDRR- 137
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG-----YCAPEY 249
+++RDL A N+L+ H K++DFGLAK +K + G + A E
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY-----HAEGGKVPIKWMALES 190
Query: 250 ATTGKLTAKSDIFSFGVVLLELIT 273
T +SD++S+GV + EL+T
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-41
Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 25/216 (11%)
Query: 80 LGQGGFGAVYKGKLAETGQV--VAVKQL--DDTGFQGEKEFLVEVLMLSLMRHPNLVHLI 135
LG G FG V KG V VAVK L + + E L E ++ + +P +V +I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 136 GYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADP 195
G C E +LV E LG L +L + + + +++ + G++YL
Sbjct: 85 GIC-EAESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEESN-- 137
Query: 196 PVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG-----YCAPEYA 250
++RDL A N+LL + K+SDFGL+K + + THG + APE
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE----NYYKAQTHGKWPVKWYAPECI 192
Query: 251 TTGKLTAKSDIFSFGVVLLELIT-GR---PAMDDSQ 282
K ++KSD++SFGV++ E + G+ M S+
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-41
Identities = 61/273 (22%), Positives = 103/273 (37%), Gaps = 21/273 (7%)
Query: 18 KINEDKDSPGPSRIDTVERQETPARRNTLDDTLSAHENKNKENTFTYRQLVAATDNFKDT 77
++ ++ + ++ + R + S + ++ +F +F+
Sbjct: 10 GVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFF-------QQSFQRL 62
Query: 78 NFLGQGGFGAVYKGKLAETGQVVAVKQ--LDDTGFQGEKEFLVEV-LMLSLMRHPNLVHL 134
+ LG G +G V+K + E G++ AVK+ G + L EV + +HP V L
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 135 IGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKAD 194
EG L E SL+ H L L +LH++
Sbjct: 123 EQAWEEGGILYLQTELCG-PSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHSQG- 177
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGK 254
+++ D+K NI LG KL DFGL T V G Y APE G
Sbjct: 178 --LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAPE-LLQGS 231
Query: 255 LTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
+D+FS G+ +LE+ +G +++
Sbjct: 232 YGTAADVFSLGLTILEVACNMELPHGGEGWQQL 264
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-41
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 80 LGQGGFGAVYKGKL-----AETGQVVAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVH 133
LGQG FG VY+G E VA+K + + + EFL E ++ ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 134 LIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEM------KPLDWNTRMKIAAGAARGLE 187
L+G ++G L++ E M G L+ +L L P M P + +++A A G+
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 188 YLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD--KSHVSTRV----MGT 241
YL+ ++RDL A N ++ + F K+ DFG+ + D + + M
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 207
Query: 242 HGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
+PE G T SD++SFGVVL E+ T
Sbjct: 208 ----SPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-41
Identities = 64/216 (29%), Positives = 100/216 (46%), Gaps = 31/216 (14%)
Query: 80 LGQGGFGAVYKGKL-----AETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHL 134
LG+G FG V+ + + +VAVK L + ++F E +L++++H ++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 135 IGYCAEGTQRLLVYEYMPLGSLEDHL-----------LGLTPEMKPLDWNTRMKIAAGAA 183
G C EG L+V+EYM G L L G PL + +A+ A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 184 RGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD--KSHVSTRV--- 238
G+ YL ++RDL N L+G+G K+ DFG+++ + D + T +
Sbjct: 169 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 239 -MGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
M PE K T +SD++SFGVVL E+ T
Sbjct: 226 WM------PPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-41
Identities = 52/210 (24%), Positives = 87/210 (41%), Gaps = 36/210 (17%)
Query: 80 LGQGGFGAVYKGKLAETGQV---VAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVHLI 135
LG+G FG VY+G VAVK D +++F+ E +++ + HP++V LI
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 136 GYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADP 195
G E ++ E P G L +L +K L + + + + YL +
Sbjct: 80 GII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLT---LVLYSLQICKAMAYLESIN-- 133
Query: 196 PVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGY----------- 244
++RD+ NIL+ KL DFGL+ R + Y
Sbjct: 134 -CVHRDIAVRNILVASPECVKLGDFGLS-------------RYIEDEDYYKASVTRLPIK 179
Query: 245 -CAPEYATTGKLTAKSDIFSFGVVLLELIT 273
+PE + T SD++ F V + E+++
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-41
Identities = 63/230 (27%), Positives = 106/230 (46%), Gaps = 36/230 (15%)
Query: 80 LGQGGFGAVYKGKL-----AETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHL 134
LG+G FG V+ + + +VAVK L D K+F E +L+ ++H ++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 135 IGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEM------------KPLDWNTRMKIAAGA 182
G C +G ++V+EYM G L L P+ L + + IA+
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 183 ARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD--KSHVSTRV-- 238
A G+ YL ++ ++RDL N L+G K+ DFG+++ + D + T +
Sbjct: 143 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 239 --MGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GR---PAMDDSQ 282
M PE K T +SD++SFGV+L E+ T G+ + +++
Sbjct: 200 RWM------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 243
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-41
Identities = 65/211 (30%), Positives = 93/211 (44%), Gaps = 25/211 (11%)
Query: 80 LGQGGFGAVYKGKL-----AETGQVVAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVH 133
LG G FG VY+G++ + VAVK L + Q E +FL+E L++S H N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 134 LIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEM---KPLDWNTRMKIAAGAARGLEYLH 190
IG + R ++ E M G L+ L P L + +A A G +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 191 NKADPPVIYRDLKAGNILL---GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGY--- 244
I+RD+ A N LL G G K+ DFG+A+ G
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS-----YYRKGGCAMLPV 209
Query: 245 --CAPEYATTGKLTAKSDIFSFGVVLLELIT 273
PE G T+K+D +SFGV+L E+ +
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 6e-41
Identities = 68/280 (24%), Positives = 126/280 (45%), Gaps = 23/280 (8%)
Query: 2 SPNCPCFGWRKKKTKPKINEDKDSPGPSRIDTVERQETPARRNTLDDTLSAHENKNKENT 61
P P ++ +N D +P P+RI + ++ ++ ++ + + K+
Sbjct: 270 LPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKK 329
Query: 62 FTYRQLVAATDNFKDTNFLGQGGFGAVYKGKL-AETGQV-VAVKQL-DDTGFQGEKEFLV 118
++ + + LG G FG+V +G Q+ VA+K L T +E +
Sbjct: 330 LFLKRDNLLIADIE----LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR 385
Query: 119 EVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKI 178
E ++ + +P +V LIG C + +LV E G L L+G E + + ++
Sbjct: 386 EAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAEL 441
Query: 179 AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRV 238
+ G++YL K ++R+L A N+LL + K+SDFGL+K D S
Sbjct: 442 LHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD----SYYT 494
Query: 239 MGTHG-----YCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
+ G + APE K +++SD++S+GV + E ++
Sbjct: 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-41
Identities = 66/205 (32%), Positives = 88/205 (42%), Gaps = 22/205 (10%)
Query: 80 LGQGGFGAVYKGKLAETGQV---VAVKQL---DDTGFQGEKEFLVEVLMLSLMRHPNLVH 133
LG G FG V +G+ VAVK L + + +F+ EV + + H NL+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 134 LIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA 193
L G +V E PLGSL D L T + A A G+ YL +K
Sbjct: 86 LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEGMGYLESKR 141
Query: 194 DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG-----YCAPE 248
I+RDL A N+LL K+ DFGL + P D +V H +CAPE
Sbjct: 142 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ----EHRKVPFAWCAPE 194
Query: 249 YATTGKLTAKSDIFSFGVVLLELIT 273
T + SD + FGV L E+ T
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 9e-41
Identities = 76/285 (26%), Positives = 117/285 (41%), Gaps = 32/285 (11%)
Query: 11 RKKKTKPKINEDKDSPGPSRIDTVERQETPARRNTLDDTLSAHENKNKENTFTY--RQLV 68
R+ I + SPG I ++E T + + L + +LV
Sbjct: 17 RRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELV 76
Query: 69 AATDNF---------KDTNFLGQGGFGAVYKGKLAETGQV---VAVKQL-DDTGFQGEKE 115
A + +G+G FG VY G L + AVK L T +
Sbjct: 77 QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ 136
Query: 116 FLVEVLMLSLMRHPNLVHLIGYCAEG-TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNT 174
FL E +++ HPN++ L+G C L+V YM G L + + T D
Sbjct: 137 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD--- 193
Query: 175 RMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHV 234
+ A+G+++L +K ++RDL A N +L + F K++DFGLA+ + V
Sbjct: 194 LIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 250
Query: 235 STRVMG------THGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
+ A E T K T KSD++SFGV+L EL+T
Sbjct: 251 HNKTGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-40
Identities = 66/205 (32%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 80 LGQGGFGAVYKGKLAETGQV---VAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVHLI 135
+G+G FG VY G L + AVK L T +FL E +++ HPN++ L+
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 136 GYCAEG-TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKAD 194
G C L+V YM G L + + T D + A+G++YL +K
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKYLASKK- 148
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYC------APE 248
++RDL A N +L + F K++DFGLA+ + V G A E
Sbjct: 149 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----YYSVHNKTGAKLPVKWMALE 202
Query: 249 YATTGKLTAKSDIFSFGVVLLELIT 273
T K T KSD++SFGV+L EL+T
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-40
Identities = 65/211 (30%), Positives = 93/211 (44%), Gaps = 25/211 (11%)
Query: 80 LGQGGFGAVYKGKL-----AETGQVVAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVH 133
LG G FG VY+G++ + VAVK L + Q E +FL+E L++S H N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 134 LIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEM---KPLDWNTRMKIAAGAARGLEYLH 190
IG + R ++ E M G L+ L P L + +A A G +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 191 NKADPPVIYRDLKAGNILL---GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGY--- 244
I+RD+ A N LL G G K+ DFG+A+ G
Sbjct: 199 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG-----YYRKGGCAMLPV 250
Query: 245 --CAPEYATTGKLTAKSDIFSFGVVLLELIT 273
PE G T+K+D +SFGV+L E+ +
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-40
Identities = 56/230 (24%), Positives = 90/230 (39%), Gaps = 46/230 (20%)
Query: 80 LGQGGFGAVYKGKLAETGQV-------VAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLV 132
LGQG F ++KG E G V +K LD + F M+S + H +LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 133 HLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK 192
G C G + +LV E++ GSL+ +L + L ++++A A + +L
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW---KLEVAKQLAAAMHFLEEN 132
Query: 193 ADPPVIYRDLKAGNILLGKGFHP--------KLSDFGLAKFGPTGDKSHVSTRVMGTHGY 244
+I+ ++ A NILL + KLSD G++ +
Sbjct: 133 T---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-------------ITVLPKDI 176
Query: 245 C-------APEYATTGKL-TAKSDIFSFGVVLLELIT-GR---PAMDDSQ 282
PE K +D +SFG L E+ + G A+D +
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-40
Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 80 LGQGGFGAVYKGKLAETGQV----VAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVHL 134
+G G FG VYKG L + VA+K L + +FL E ++ H N++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 135 IGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKAD 194
G ++ +++ EYM G+L+ L E + + G A G++YL N
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGMKYLANMN- 167
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTH---GYCAPEYAT 251
++RDL A NIL+ K+SDFGL++ D + G + APE +
Sbjct: 168 --YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 252 TGKLTAKSDIFSFGVVLLELIT 273
K T+ SD++SFG+V+ E++T
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMT 245
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-40
Identities = 54/210 (25%), Positives = 84/210 (40%), Gaps = 36/210 (17%)
Query: 80 LGQGGFGAVYKGKLAETGQV---VAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVHLI 135
+G+G FG V++G VA+K + T ++FL E L + HP++V LI
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 136 GYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADP 195
G ++ E LG L L + + A + L YL +K
Sbjct: 83 GVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLAS---LILYAYQLSTALAYLESKR-- 136
Query: 196 PVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGY----------- 244
++RD+ A N+L+ KL DFGL+ R M Y
Sbjct: 137 -FVHRDIAARNVLVSSNDCVKLGDFGLS-------------RYMEDSTYYKASKGKLPIK 182
Query: 245 -CAPEYATTGKLTAKSDIFSFGVVLLELIT 273
APE + T+ SD++ FGV + E++
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-40
Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 47/225 (20%)
Query: 80 LGQGGFGAVYKGKL-----AETGQVVAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVH 133
LG+ FG VYKG L E Q VA+K L D +EF E ++ + ++HPN+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 134 LIGYCAEGTQRLLVYEYMPLGSLEDHL------------LGLTPEMKPLDWNTRMKIAAG 181
L+G + +++ Y G L + L L+ + + A
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 182 AARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGT 241
A G+EYL + V+++DL N+L+ + K+SD GL R +
Sbjct: 137 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLF-------------REVYA 180
Query: 242 HGYC-------------APEYATTGKLTAKSDIFSFGVVLLELIT 273
Y APE GK + SDI+S+GVVL E+ +
Sbjct: 181 ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-40
Identities = 66/220 (30%), Positives = 98/220 (44%), Gaps = 29/220 (13%)
Query: 80 LGQGGFGAVYKGKLAETGQ---VVAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVHLI 135
+G+G FG VY G+ + Q A+K L T Q + FL E L++ + HPN++ LI
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 136 GYCAEGT-QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKAD 194
G ++ YM G L + D + ARG+EYL +
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL---ISFGLQVARGMEYLAEQK- 144
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAKF----GPTGDKSHVSTRV----MGTHGYCA 246
++RDL A N +L + F K++DFGLA+ + H R+ A
Sbjct: 145 --FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT------A 196
Query: 247 PEYATTGKLTAKSDIFSFGVVLLELIT-GR---PAMDDSQ 282
E T + T KSD++SFGV+L EL+T G +D
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-40
Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 80 LGQGGFGAVYKGKLAETGQ---VVAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVHLI 135
+G G FG V G+L + VA+K L + ++FL E ++ HPN++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 136 GYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADP 195
G + ++V EYM GSL+ L + + + G A G++YL +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDMG-- 167
Query: 196 PVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTH---GYCAPEYATT 252
++RDL A NIL+ K+SDFGL + D + G + +PE
Sbjct: 168 -YVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 253 GKLTAKSDIFSFGVVLLELIT 273
K T+ SD++S+G+VL E+++
Sbjct: 225 RKFTSASDVWSYGIVLWEVMS 245
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-40
Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 19/203 (9%)
Query: 80 LGQGGFGAVYKGKLAETGQ---VVAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVHLI 135
+G G G V G+L GQ VA+K L + ++FL E ++ HPN++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 136 GYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADP 195
G G ++V EYM GSL+ L + + + G G+ YL +
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYLSDLG-- 171
Query: 196 PVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG-----YCAPEYA 250
++RDL A N+L+ K+SDFGL++ + T G + APE
Sbjct: 172 -YVHRDLAARNVLVDSNLVCKVSDFGLSRV----LEDDPDAAYTTTGGKIPIRWTAPEAI 226
Query: 251 TTGKLTAKSDIFSFGVVLLELIT 273
++ SD++SFGVV+ E++
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLA 249
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-40
Identities = 73/207 (35%), Positives = 104/207 (50%), Gaps = 13/207 (6%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA 139
LGQG FG V+ G T +V A+K L G + FL E ++ +RH LV L +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 140 EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIY 199
E +V EYM GSL D L K L + +AA A G+ Y+ ++
Sbjct: 250 E-EPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 303
Query: 200 RDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKS 259
RDL+A NIL+G+ K++DFGLA+ ++ + APE A G+ T KS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 260 DIFSFGVVLLELIT-GR---PAMDDSQ 282
D++SFG++L EL T GR P M + +
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNRE 389
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-40
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA 139
+G G FG V+ G +V A+K + + G E++F+ E ++ + HP LV L G C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKV-AIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 140 EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIY 199
E LV E+M G L D+L + + G+ YL VI+
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLRTQRGLFAAET---LLGMCLDVCEGMAYLEEAC---VIH 127
Query: 200 RDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGY------------CAP 247
RDL A N L+G+ K+SDFG+ R + Y +P
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMT-------------RFVLDDQYTSSTGTKFPVKWASP 174
Query: 248 EYATTGKLTAKSDIFSFGVVLLELIT-GR---PAMDDSQ 282
E + + ++KSD++SFGV++ E+ + G+ +S+
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-40
Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 80 LGQGGFGAVYKGKLAETGQV--VAVKQL-DDTGFQGEKEFLVEV-LMLSLMRHPNLVHLI 135
+G+G FG V K ++ + G A+K++ + ++F E+ ++ L HPN+++L+
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 136 GYCAEGTQRLLVYEYMPLGSLEDHL------------LGLTPEMKPLDWNTRMKIAAGAA 183
G C L EY P G+L D L L + AA A
Sbjct: 93 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 184 RGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRV----M 239
RG++YL K I+RDL A NIL+G+ + K++DFGL++ K R+ M
Sbjct: 153 RGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT-MGRLPVRWM 208
Query: 240 GTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT--GRP 276
A E T SD++S+GV+L E+++ G P
Sbjct: 209 ------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-40
Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 8/221 (3%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE---FLVEVLMLSLMRH 128
NF+ +G+G F VY+ G VA+K++ K + E+ +L + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 129 PNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEY 188
PN++ E + +V E G L + + + + T K LE+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE 248
+H++ V++RD+K N+ + KL D GL +F + + + V GT Y +PE
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLV-GTPYYMSPE 206
Query: 249 YATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLV 289
KSDI+S G +L E+ + + + L
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC 247
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-40
Identities = 64/212 (30%), Positives = 104/212 (49%), Gaps = 27/212 (12%)
Query: 80 LGQGGFGAVYKGKL---AETGQVVAVKQL--DDTGFQGEKEFLVEVLMLSLMRHPNLVHL 134
LG+G FG+V +G L T VAVK + D++ + +EFL E + HPN++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 135 IGYCAEGTQR-----LLVYEYMPLGSLEDHLLGLTPEMKP--LDWNTRMKIAAGAARGLE 187
+G C E + + +++ +M G L +LL E P + T +K A G+E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 188 YLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD--KSHVSTRV----MGT 241
YL N+ ++RDL A N +L ++DFGL+K +GD + ++ +
Sbjct: 162 YLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI-- 216
Query: 242 HGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
A E T+KSD+++FGV + E+ T
Sbjct: 217 ----AIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 7e-40
Identities = 66/239 (27%), Positives = 102/239 (42%), Gaps = 19/239 (7%)
Query: 42 RRNTLDDTLSAHENKNKENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVA 101
T D+ K K + YR+ +G+G FG V++ K +TG A
Sbjct: 31 GPETEDNEGVLLTEKLKPVDYEYRE---EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCA 87
Query: 102 VKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLL 161
VK++ F+ E E++ + + P +V L G EG + E + GSL +
Sbjct: 88 VKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK 142
Query: 162 GLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK-GFHPKLSDF 220
+M L + + A GLEYLH + +++ D+KA N+LL G L DF
Sbjct: 143 ----QMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDF 195
Query: 221 GLAK-FGPTGDKSHVSTR--VMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
G A P G + T + GT + APE AK DI+S ++L ++ G
Sbjct: 196 GHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-40
Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 80 LGQGGFGAVYKGKLAETGQV-VAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYC 138
LG G FG V GK GQ VAVK + + G E EF E + + HP LV G C
Sbjct: 16 LGSGQFGVVKLGKW--KGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 139 AEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVI 198
++ +V EY+ G L ++L ++P +++ G+ +L + I
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQ---LLEMCYDVCEGMAFLESHQ---FI 126
Query: 199 YRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGY------------CA 246
+RDL A N L+ + K+SDFG+ R + Y A
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMT-------------RYVLDDQYVSSVGTKFPVKWSA 173
Query: 247 PEYATTGKLTAKSDIFSFGVVLLELIT-GR---PAMDDSQ 282
PE K ++KSD+++FG+++ E+ + G+ +S+
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE 213
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-39
Identities = 72/221 (32%), Positives = 102/221 (46%), Gaps = 41/221 (18%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA 139
LG G FG V+ G +V AVK L G FL E ++ ++H LV L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKV-AVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 140 EGTQR--LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPV 197
TQ ++ EYM GSL D L TP L N + +AA A G+ ++ +
Sbjct: 78 --TQEPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEERN---Y 130
Query: 198 IYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGY------------C 245
I+RDL+A NIL+ K++DFGLA R++ + Y
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLA-------------RLIEDNEYTAREGAKFPIKWT 177
Query: 246 APEYATTGKLTAKSDIFSFGVVLLELIT-GR---PAMDDSQ 282
APE G T KSD++SFG++L E++T GR P M + +
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-39
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 37/219 (16%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA 139
LG G FG V GK V A+K + + G E EF+ E ++ + H LV L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDV-AIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 140 EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIY 199
+ ++ EYM G L ++L + + +++ +EYL +K ++
Sbjct: 90 KQRPIFIITEYMANGCLLNYLREMRHRFQTQQ---LLEMCKDVCEAMEYLESKQ---FLH 143
Query: 200 RDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGY------------CAP 247
RDL A N L+ K+SDFGL+ R + Y P
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLS-------------RYVLDDEYTSSVGSKFPVRWSPP 190
Query: 248 EYATTGKLTAKSDIFSFGVVLLELIT-GR---PAMDDSQ 282
E K ++KSDI++FGV++ E+ + G+ +S+
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-39
Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 28/213 (13%)
Query: 80 LGQGGFGAVYKGKL---AETGQVVAVKQL--DDTGFQGEKEFLVEVLMLSLMRHPNLVHL 134
LG+G FG+V + +L + VAVK L D +EFL E + HP++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 135 IGYCAEG------TQRLLVYEYMPLGSLEDHLLGLTPEMKP--LDWNTRMKIAAGAARGL 186
+G +++ +M G L LL P L T ++ A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 187 EYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD--KSHVSTRV----MG 240
EYL ++ I+RDL A N +L + ++DFGL++ +GD + ++++ +
Sbjct: 151 EYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL- 206
Query: 241 THGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
A E T SD+++FGV + E++T
Sbjct: 207 -----ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-39
Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 36/221 (16%)
Query: 80 LGQGGFGAVYKGKL-------AETGQVVAVKQL-DDTGFQGEKEFLVEV-LMLSLMRHPN 130
LG+G FG V + + VAVK L DD + + + E+ +M + +H N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEM------------KPLDWNTRMKI 178
+++L+G C + ++ EY G+L ++L P + + + +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 179 AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD--KSHVST 236
ARG+EYL ++ I+RDL A N+L+ + K++DFGLA+ D K +
Sbjct: 163 TYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 237 RV----MGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
R+ M APE T +SD++SFGV++ E+ T
Sbjct: 220 RLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-39
Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 29/213 (13%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYC 138
+G+G FG V G G VAVK + +D + FL E +++ +RH NLV L+G
Sbjct: 29 IGKGEFGDVMLGDY--RGNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 139 AEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPV 197
E L +V EYM GSL D+L + L + +K + +EYL
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---F 138
Query: 198 IYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRV----MGTHGYCAPEYATTG 253
++RDL A N+L+ + K+SDFGL K + + ++ APE
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWT------APEALREK 189
Query: 254 KLTAKSDIFSFGVVLLELIT-GR---PAMDDSQ 282
K + KSD++SFG++L E+ + GR P +
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-39
Identities = 73/207 (35%), Positives = 104/207 (50%), Gaps = 13/207 (6%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA 139
LGQG FG V+ G T +V A+K L G + FL E ++ +RH LV L +
Sbjct: 275 LGQGCFGEVWMGTWNGTTRV-AIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 140 EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIY 199
E +V EYM GSL D L K L + +AA A G+ Y+ ++
Sbjct: 333 E-EPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 386
Query: 200 RDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKS 259
RDL+A NIL+G+ K++DFGLA+ ++ + APE A G+ T KS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 260 DIFSFGVVLLELIT-GR---PAMDDSQ 282
D++SFG++L EL T GR P M + +
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNRE 472
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-39
Identities = 67/208 (32%), Positives = 103/208 (49%), Gaps = 13/208 (6%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV-EVLMLSLMRHP 129
+ F +G+G FG V+KG T +VVA+K +D + E E + E+ +LS P
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 130 NLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL 189
+ G + T+ ++ EY+ GS D L E PLD I +GL+YL
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYL 135
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL-AKFGPTGDKSHVSTRVMGTHGYCAPE 248
H++ I+RD+KA N+LL + KL+DFG+ + T K + +GT + APE
Sbjct: 136 HSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT---FVGTPFWMAPE 189
Query: 249 YATTGKLTAKSDIFSFGVVLLELITGRP 276
+K+DI+S G+ +EL G P
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEP 217
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-39
Identities = 65/221 (29%), Positives = 101/221 (45%), Gaps = 41/221 (18%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA 139
LG G FG V+ + +V AVK + G + FL E ++ ++H LV L
Sbjct: 196 LGAGQFGEVWMATYNKHTKV-AVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVV- 252
Query: 140 EGTQR--LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPV 197
T+ ++ E+M GSL D L + E + +A A G+ ++ +
Sbjct: 253 --TKEPIYIITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---Y 305
Query: 198 IYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGY------------C 245
I+RDL+A NIL+ K++DFGLA RV+ + Y
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLA-------------RVIEDNEYTAREGAKFPIKWT 352
Query: 246 APEYATTGKLTAKSDIFSFGVVLLELIT-GR---PAMDDSQ 282
APE G T KSD++SFG++L+E++T GR P M + +
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 393
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 4e-39
Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 22/203 (10%)
Query: 80 LGQGGFGAVYKGKLAETGQV---VAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVHLI 135
+G+G FG V++G VA+K + T ++FL E L + HP++V LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 136 GYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADP 195
G ++ E LG L L + + A + L YL +K
Sbjct: 458 GVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLAS---LILYAYQLSTALAYLESKR-- 511
Query: 196 PVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG-----YCAPEYA 250
++RD+ A N+L+ KL DFGL+++ ST + G + APE
Sbjct: 512 -FVHRDIAARNVLVSSNDCVKLGDFGLSRY------MEDSTYYKASKGKLPIKWMAPESI 564
Query: 251 TTGKLTAKSDIFSFGVVLLELIT 273
+ T+ SD++ FGV + E++
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILM 587
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-39
Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 8/212 (3%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLV-EVLMLSLMRHP 129
++++ +G G +G K + G+++ K+LD + EK+ LV EV +L ++HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 130 NLVHLIGYCAEGTQRLL--VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLE 187
N+V + T L V EY G L + T E + LD +++ L+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 188 YLHNKADPP--VIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYC 245
H ++D V++RDLK N+ L + KL DFGLA+ D S T V GT Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKTFV-GTPYYM 183
Query: 246 APEYATTGKLTAKSDIFSFGVVLLELITGRPA 277
+PE KSDI+S G +L EL P
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-39
Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 12/207 (5%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPN 130
+ F LG+G +G+VYK ETGQ+VA+KQ+ +E + E+ ++ P+
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLH 190
+V G + T +V EY GS+ D ++ L K L + I +GLEYLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRN--KTLTEDEIATILQSTLKGLEYLH 142
Query: 191 NKADPPVIYRDLKAGNILLGKGFHPKLSDFGL-AKFGPTGDKSHVSTRVMGTHGYCAPEY 249
I+RD+KAGNILL H KL+DFG+ + T K + V+GT + APE
Sbjct: 143 FMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT---VIGTPFWMAPEV 196
Query: 250 ATTGKLTAKSDIFSFGVVLLELITGRP 276
+DI+S G+ +E+ G+P
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGKP 223
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-39
Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 36/221 (16%)
Query: 80 LGQGGFGAVYKGKL-------AETGQVVAVKQL-DDTGFQGEKEFLVEV-LMLSLMRHPN 130
LG+G FG V + + VAVK L DD + + + E+ +M + +H N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEM------------KPLDWNTRMKI 178
+++L+G C + ++ EY G+L ++L P + + + +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 179 AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD--KSHVST 236
ARG+EYL ++ I+RDL A N+L+ + K++DFGLA+ D K +
Sbjct: 209 TYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 237 RV----MGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
R+ M APE T +SD++SFGV++ E+ T
Sbjct: 266 RLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-38
Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 12/207 (5%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPN 130
+ +GQG G VY TGQ VA++Q++ ++ + E+L++ ++PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLH 190
+V+ + G + +V EY+ GSL D + +D + + LE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLH 133
Query: 191 NKADPPVIYRDLKAGNILLGKGFHPKLSDFGL-AKFGPTGDKSHVSTRVMGTHGYCAPEY 249
+ VI+RD+K+ NILLG KL+DFG A+ P K T V GT + APE
Sbjct: 134 SNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMV-GTPYWMAPEV 187
Query: 250 ATTGKLTAKSDIFSFGVVLLELITGRP 276
T K DI+S G++ +E+I G P
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEP 214
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-38
Identities = 58/224 (25%), Positives = 102/224 (45%), Gaps = 15/224 (6%)
Query: 57 NKENTFTYRQLVAATD---NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE 113
+++ R +V D +G+G G V + +G+ VAVK +D Q
Sbjct: 27 HEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR 86
Query: 114 KEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWN 173
+ EV+++ +H N+V + G + ++ E++ G+L D + L+
Sbjct: 87 ELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV-----SQVRLNEE 141
Query: 174 TRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL-AKFGPTGDKS 232
+ + L YLH + VI+RD+K+ +ILL KLSDFG A+ K
Sbjct: 142 QIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 198
Query: 233 HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
+ V GT + APE + + DI+S G++++E++ G P
Sbjct: 199 K--SLV-GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP 239
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-38
Identities = 61/226 (26%), Positives = 106/226 (46%), Gaps = 41/226 (18%)
Query: 80 LGQGGFGAVYKGKL-----AETGQVVAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVH 133
+G+G FG V++ + E +VAVK L ++ + +F E +++ +PN+V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 134 LIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEM--------------------KPLDWN 173
L+G CA G L++EYM G L + L ++P PL
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 174 TRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD--K 231
++ IA A G+ YL + ++RDL N L+G+ K++DFGL++ + D K
Sbjct: 175 EQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 232 SHVSTRV----MGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
+ + + M PE + T +SD++++GVVL E+ +
Sbjct: 232 ADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-38
Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 35/220 (15%)
Query: 80 LGQGGFGAVYKGKL-----AETGQVVAVKQL-DDTGFQGEKEFLVEV-LMLSLMRHPNLV 132
LG+G FG V + T + VAVK L + + + E+ +++ + H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 133 HLIGYC-AEGTQRLLVYEYMPLGSLEDHLLGLTPEM------------KPLDWNTRMKIA 179
+L+G C G +++ E+ G+L +L E L + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 180 AGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD--KSHVSTR 237
A+G+E+L ++ I+RDL A NILL + K+ DFGLA+ R
Sbjct: 155 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 238 V----MGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
+ M APE T +SD++SFGV+L E+ +
Sbjct: 212 LPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-38
Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 36/221 (16%)
Query: 80 LGQGGFGAVYKGKL-------AETGQVVAVKQL-DDTGFQGEKEFLVEV-LMLSLMRHPN 130
LG+G FG V + VAVK L D + + + E+ +M + +H N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTR------------MKI 178
+++L+G C + ++ EY G+L ++L P +N +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 179 AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD--KSHVST 236
A ARG+EYL +K I+RDL A N+L+ + K++DFGLA+ D K +
Sbjct: 197 AYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 237 RV----MGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
R+ M APE T +SD++SFGV+L E+ T
Sbjct: 254 RLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-38
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 12/214 (5%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV-EVLMLSLMRHPN 130
D+++ +G G V A + VA+K+++ Q + L+ E+ +S HPN
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWN-TRMKIAA---GAARGL 186
+V + LV + + GS+ D + + + + IA GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 187 EYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL-AKFGPTGDKSHVSTR--VMGTHG 243
EYLH I+RD+KAGNILLG+ +++DFG+ A GD + R +GT
Sbjct: 135 EYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 244 YCAPEYATTGKL-TAKSDIFSFGVVLLELITGRP 276
+ APE + K+DI+SFG+ +EL TG
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAA 225
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-38
Identities = 64/226 (28%), Positives = 100/226 (44%), Gaps = 41/226 (18%)
Query: 80 LGQGGFGAVYKGKLA-----ETGQVVAVKQL-DDTGFQGEKEFLVEVLMLSLMRHPNLVH 133
LG+G FG V K VAVK L ++ ++ L E +L + HP+++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 134 LIGYCAEGTQRLLVYEYMPLGSLEDHL--------------------LGLTPEMKPLDWN 173
L G C++ LL+ EY GSL L P+ + L
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 174 TRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD--K 231
+ A ++G++YL A+ +++RDL A NIL+ +G K+SDFGL++ D
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 232 SHVSTRV----MGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
R+ M A E T +SD++SFGV+L E++T
Sbjct: 208 KRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-37
Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 15/212 (7%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPN 130
+ ++ LG G FG VYK K ETG + A K ++ + ++++VE+ +L+ HP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLH 190
+V L+G + ++ E+ P G+++ +L L + L + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLH 134
Query: 191 NKADPPVIYRDLKAGNILLGKGFHPKLSDFGL-AKFGPTGDKSHVSTRVMGTHGYCAPEY 249
+K +I+RDLKAGN+L+ +L+DFG+ AK T K +GT + APE
Sbjct: 135 SKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS---FIGTPYWMAPEV 188
Query: 250 ATTGKLT-----AKSDIFSFGVVLLELITGRP 276
+ K+DI+S G+ L+E+ P
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-37
Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV----------EVL 121
++F+ LG+G FG VY + ++ ++A+K L K L EV
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF-------KAQLEKAGVEHQLRREVE 61
Query: 122 MLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAG 181
+ S +RHPN++ L GY + T+ L+ EY PLG++ L ++ D
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 117
Query: 182 AARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVM-G 240
A L Y H+K VI+RD+K N+LLG K++DFG + P + G
Sbjct: 118 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-----SSRRTDLCG 169
Query: 241 THGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDS 281
T Y PE K D++S GV+ E + G+P + +
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-37
Identities = 60/231 (25%), Positives = 103/231 (44%), Gaps = 17/231 (7%)
Query: 53 HENKNKENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-Q 111
H + + + T + + + +G+G FG K E G+ +K+++ +
Sbjct: 5 HHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS 64
Query: 112 GEKEFLV-EVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLL----GLTPE 166
E+E EV +L+ M+HPN+V E +V +Y G L + L E
Sbjct: 65 KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE 124
Query: 167 MKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226
+ LDW ++ L+++H++ +++RD+K+ NI L K +L DFG+A+
Sbjct: 125 DQILDWFVQI------CLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175
Query: 227 PTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPA 277
+ GT Y +PE KSDI++ G VL EL T + A
Sbjct: 176 -NSTVELARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-37
Identities = 60/228 (26%), Positives = 91/228 (39%), Gaps = 50/228 (21%)
Query: 80 LGQGGFGAVYKGKL-----AETGQVVAVKQL-DDTGFQGEKEFLVEV-LMLSLMRHPNLV 132
LG G FG V + ++ VAVK L + + E+ ++ L H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 133 HLIGYCAEGTQRLLVYEYMPLGSLEDHL--------------LGLTPEMKPLDWNTRMKI 178
+L+G C G L++ EY G L + L + + LD +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 179 AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRV 238
+ A+G+ +L +K I+RDL A NILL G K+ DFGLA R
Sbjct: 151 SYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLA-------------RD 194
Query: 239 MGTHGYC-------------APEYATTGKLTAKSDIFSFGVVLLELIT 273
+ APE T +SD++S+G+ L EL +
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-37
Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 32/217 (14%)
Query: 80 LGQGGFGAVYKGKLA-----ETGQVVAVKQL-DDTGFQGEKEFLVEV-LMLSLMRHPNLV 132
LG G FG V + + VAVK L ++ + E+ +M L +H N+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 133 HLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTR----------MKIAAGA 182
+L+G C G L++ EY G L + L + ++ + ++
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 183 ARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD--KSHVSTRV-- 238
A+G+ +L A I+RD+ A N+LL G K+ DFGLA+ + R+
Sbjct: 174 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 239 --MGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
M APE T +SD++S+G++L E+ +
Sbjct: 231 KWM------APESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-37
Identities = 48/214 (22%), Positives = 82/214 (38%), Gaps = 25/214 (11%)
Query: 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE--KEFLVEVLMLSLMRHPNL--VH 133
+G GG V++ L E Q+ A+K ++ + + E+ L+ ++ + +
Sbjct: 34 KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 134 LIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA 193
L Y +V E L L + K +D R + +H
Sbjct: 93 LYDYEITDQYIYMVMECGN-IDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQHG 147
Query: 194 DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE----- 248
+++ DLK N L+ G KL DFG+A S V +GT Y PE
Sbjct: 148 ---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 249 ------YATTGKLTAKSDIFSFGVVLLELITGRP 276
+ K++ KSD++S G +L + G+
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-37
Identities = 51/267 (19%), Positives = 90/267 (33%), Gaps = 35/267 (13%)
Query: 25 SPGPSRIDTVERQETPARRNTLDDTLSAHENKNKENTFTYRQLVAATDNFKDTNFLGQGG 84
++ + + D S+ Y L +G GG
Sbjct: 19 ETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL----------KQIGSGG 68
Query: 85 FGAVYKGKLAETGQVVAVKQLDDTGFQGE--KEFLVEVLMLSLMRHPNL--VHLIGYCAE 140
V++ L E Q+ A+K ++ + + E+ L+ ++ + + L Y
Sbjct: 69 SSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 127
Query: 141 GTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYR 200
+V E L L + K +D R + +H +++
Sbjct: 128 DQYIYMVMECGN-IDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHS 179
Query: 201 DLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE-----------Y 249
DLK N L+ G KL DFG+A S V +G Y PE
Sbjct: 180 DLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENG 238
Query: 250 ATTGKLTAKSDIFSFGVVLLELITGRP 276
+ K++ KSD++S G +L + G+
Sbjct: 239 KSKSKISPKSDVWSLGCILYYMTYGKT 265
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-37
Identities = 56/233 (24%), Positives = 99/233 (42%), Gaps = 17/233 (7%)
Query: 51 SAHENKNKENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF 110
S + + + D D LG+G +G VY G+ +A+K++ +
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60
Query: 111 QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLED---HLLGLTPEM 167
+ + E+ + ++H N+V +G +E + E +P GSL G +
Sbjct: 61 RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120
Query: 168 KPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLG-KGFHPKLSDFGLAKFG 226
+ +I GL+YLH+ +++RD+K N+L+ K+SDFG +K
Sbjct: 121 EQTIGFYTKQI----LEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173
Query: 227 PTGDKSHVSTRVMGTHGYCAPE---YATTGKLTAKSDIFSFGVVLLELITGRP 276
+ + GT Y APE G +DI+S G ++E+ TG+P
Sbjct: 174 AGINPCTET--FTGTLQYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGKP 223
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-37
Identities = 58/240 (24%), Positives = 99/240 (41%), Gaps = 36/240 (15%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPN 130
+F++ LGQG FG V K + A + A+K++ T + L EV++L+ + H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 131 LVHLIGYCAEGTQRL-------------LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMK 177
+V E + + EY G+L D + E + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWR 120
Query: 178 IAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF------------ 225
+ L Y+H++ +I+RDLK NI + + + K+ DFGLAK
Sbjct: 121 LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 226 -GPTGDKSHVSTRVMGTHGYCAPE-YATTGKLTAKSDIFSFGVVLLELITG-RPAMDDSQ 282
G ++++ + GT Y A E TG K D++S G++ E+I M+
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVN 236
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 7e-37
Identities = 54/225 (24%), Positives = 93/225 (41%), Gaps = 27/225 (12%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE-FLVEVLMLSLMRHPN 130
+F+ LG+GGFG V++ K A+K++ + +E + EV L+ + HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 131 LVHLIGYCAEGT---------QRLLVY---EYMPLGSLEDHLLGLTPEMKPLDWNTRMKI 178
+V E ++ +Y + +L+D + ++ + + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKD-WMNGRCTIEERERSVCLHI 123
Query: 179 AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK----------FGPT 228
A +E+LH+K +++RDLK NI K+ DFGL
Sbjct: 124 FLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
T +GT Y +PE + K DIFS G++L EL+
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-37
Identities = 58/229 (25%), Positives = 99/229 (43%), Gaps = 31/229 (13%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNL 131
+FK+ +G GGFG V+K K G+ +K++ ++ EV L+ + H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHVNI 66
Query: 132 VHLIGYCAEGTQRL----------------LVYEYMPLGSLEDHLLGLTPEMKPLDWNTR 175
VH G + E+ G+LE + + LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLA 124
Query: 176 MKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK-FGPTGDKSHV 234
+++ +G++Y+H+K +I RDLK NI L K+ DFGL G +
Sbjct: 125 LELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--- 178
Query: 235 STRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQ 282
TR GT Y +PE ++ + D+++ G++L EL+ A + S+
Sbjct: 179 -TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK 226
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-37
Identities = 48/214 (22%), Positives = 82/214 (38%), Gaps = 25/214 (11%)
Query: 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE--KEFLVEVLMLSLMRHPNL--VH 133
+G GG V++ L E Q+ A+K ++ + + E+ L+ ++ + +
Sbjct: 15 KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73
Query: 134 LIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA 193
L Y +V E L L + K +D R + +H
Sbjct: 74 LYDYEITDQYIYMVMECGN-IDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQHG 128
Query: 194 DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE----- 248
+++ DLK N L+ G KL DFG+A S V +GT Y PE
Sbjct: 129 ---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 249 ------YATTGKLTAKSDIFSFGVVLLELITGRP 276
+ K++ KSD++S G +L + G+
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 2e-36
Identities = 50/239 (20%), Positives = 92/239 (38%), Gaps = 19/239 (7%)
Query: 52 AHENKNKENTFTYRQLVAATDN---FKDTNFLGQG--GFGAVYKGKLAETGQVVAVKQLD 106
AH + + ++ + + ++ +G+G V + TG+ V V++++
Sbjct: 2 AHHHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN 61
Query: 107 -DTGFQGEKEFLV-EVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLT 164
+ FL E+ + L HPN+V + +V +M GS +D L+
Sbjct: 62 LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTH 120
Query: 165 PEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFG-LA 223
M ++ I G + L+Y+H+ ++R +KA +IL+ LS
Sbjct: 121 F-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNL 176
Query: 224 KFGPTGDKSHV----STRVMGTHGYCAPEYATTGKL--TAKSDIFSFGVVLLELITGRP 276
G + V + + +PE AKSDI+S G+ EL G
Sbjct: 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-36
Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 41/226 (18%)
Query: 80 LGQGGFGAVYKGKL-----AETGQVVAVKQL-DDTGFQGEKEFLVEV-LMLSLMRHPNLV 132
LG G FG V VAVK L + + + E+ +M L H N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 133 HLIGYCAEGTQRLLVYEYMPLGSLEDHL-------------------LGLTPEMKPLDWN 173
+L+G C L++EY G L ++L L ++ L +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 174 TRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD--K 231
+ A A+G+E+L K+ ++RDL A N+L+ G K+ DFGLA+ +
Sbjct: 173 DLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 232 SHVSTRV----MGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
+ R+ M APE G T KSD++S+G++L E+ +
Sbjct: 230 VRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-36
Identities = 49/231 (21%), Positives = 81/231 (35%), Gaps = 34/231 (14%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQ--LDDTGFQGEKEFLVEV-LMLSLMR 127
T F + +G G FG+V+K G + A+K+ G E+ L EV L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 128 HPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLE 187
H ++V AE L+ EY GSL D + M + RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 188 YLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFG--------------LAKFGPTGDKSH 233
Y+H+ + +++ D+K NI + + P + + G S
Sbjct: 130 YIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 234 VSTRVMGTHGYCAPE-------YATTGKLTAKSDIFSFGVVLLELITGRPA 277
G + A E + K+DIF+ + ++ P
Sbjct: 187 PQVEE-GDSRFLANEVLQENYTH------LPKADIFALALTVVCAAGAEPL 230
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-36
Identities = 70/226 (30%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLS-LMRHP 129
F+ +G G +G VYKG+ +TGQ+ A+K +D TG E+E E+ ML H
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHR 81
Query: 130 NLVHLIG------YCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAA--- 180
N+ G Q LV E+ GS+ D L+ T L IA
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKG-NTLK---EEWIAYICR 136
Query: 181 GAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL-AKFGPTGDKSHVSTRVM 239
RGL +LH VI+RD+K N+LL + KL DFG+ A+ T + + +
Sbjct: 137 EILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FI 190
Query: 240 GTHGYCAPEYATTGKLT-----AKSDIFSFGVVLLELITGRPAMDD 280
GT + APE + KSD++S G+ +E+ G P + D
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-36
Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 23/223 (10%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEV-LMLSLMRHPNLVHLIGYC 138
L +GGF VY+ + +G+ A+K+L + + + EV M L HPN+V
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 139 AEGTQR-------LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN 191
+ G + L+ + G L + L + PL +T +KI R ++++H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR-GPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 192 KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF---GPTGDKSHVSTRVM-------GT 241
+ PP+I+RDLK N+LL KL DFG A P S ++ T
Sbjct: 155 Q-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 242 HGYCAPE-YATTGKL--TAKSDIFSFGVVLLELITGRPAMDDS 281
Y PE K DI++ G +L L + +D
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-36
Identities = 42/233 (18%), Positives = 87/233 (37%), Gaps = 33/233 (14%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV-----------------EVLM 122
L QG F + + + + A+K+ + + + +++F E+ +
Sbjct: 39 LNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 123 LSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTP----EMKPLDWNTRMKI 178
++ +++ + G + ++YEYM S+ + I
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 179 AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRV 238
Y+HN+ + + +RD+K NIL+ K KLSDFG +++ +
Sbjct: 157 IKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK---KIKG-S 210
Query: 239 MGTHGYCAPEYATTGKLT---AKSDIFSFGVVLLELITGRPAMDDSQGHERML 288
GT+ + PE + + + AK DI+S G+ L + +
Sbjct: 211 RGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-36
Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 20/216 (9%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV-----EVLMLSLM 126
D+F LG+G FG VY + + ++A+K L + Q EKE + E+ + S +
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKS--QLEKEGVEHQLRREIEIQSHL 71
Query: 127 RHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGL 186
RHPN++ + Y + + L+ E+ P G L L + D A L
Sbjct: 72 RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ----KHGRFDEQRSATFMEELADAL 127
Query: 187 EYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVM-GTHGYC 245
Y H + VI+RD+K N+L+G K++DFG + P+ R M GT Y
Sbjct: 128 HYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-----RRRTMCGTLDYL 179
Query: 246 APEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDS 281
PE K D++ GV+ E + G P D
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-35
Identities = 74/217 (34%), Positives = 104/217 (47%), Gaps = 29/217 (13%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMR 127
F D +G G FGAVY + +VVA+K++ +G Q ++ + EV L +R
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 128 HPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAA---GAAR 184
HPN + G LV EY GS D LL + KPL ++IAA GA +
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASD-LLEVHK--KPLQ---EVEIAAVTHGALQ 165
Query: 185 GLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTR--VMGTH 242
GL YLH+ +I+RD+KAGNILL + KL DFG A S ++ +GT
Sbjct: 166 GLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTP 214
Query: 243 GYCAPEYATTGKLT---AKSDIFSFGVVLLELITGRP 276
+ APE K D++S G+ +EL +P
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-35
Identities = 55/220 (25%), Positives = 91/220 (41%), Gaps = 22/220 (10%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV-EVLMLSLMRHPN 130
+ ++ LGQG V++G+ +TG + A+K ++ F + + E +L + H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 131 LVHLIGYCAEGTQRL--LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEY 188
+V L E T R L+ E+ P GSL L + L + + + G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNH 127
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHP----KLSDFGLAKFGPTGDKSHVSTRVMGTHGY 244
L +++R++K GNI+ G KL+DFG A+ D + GT Y
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEEY 181
Query: 245 CAPE--------YATTGKLTAKSDIFSFGVVLLELITGRP 276
P+ K A D++S GV TG
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 56/233 (24%), Positives = 95/233 (40%), Gaps = 28/233 (12%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV-EVLMLSLMRHPN 130
+ ++ LGQG V++G+ +TG + A+K ++ F + + E +L + H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 131 LVHLIGYCAEGTQRL--LVYEYMPLGSLEDHLL--GLTPEMKPLDWNTRMK-IAAGAARG 185
+V L E T R L+ E+ P GSL L + ++ ++ + G
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG----G 124
Query: 186 LEYLHNKADPPVIYRDLKAGNILLGKGFHP----KLSDFGLAKFGPTGDKSHVSTRVMGT 241
+ +L +++R++K GNI+ G KL+DFG A+ D + GT
Sbjct: 125 MNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GT 178
Query: 242 HGYCAPE--------YATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286
Y P+ K A D++S GV TG +G R
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-34
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV----EVLMLSLMRHPNLVHLI 135
LG GG VY + VA+K + + ++E L EV S + H N+V +I
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFI-PPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 136 GYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADP 195
E LV EY+ +L +++ PL +T + G+++ H+
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHAHDMR-- 131
Query: 196 PVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVST-RVMGTHGYCAPEYATTGK 254
+++RD+K NIL+ K+ DFG+AK + S T V+GT Y +PE A
Sbjct: 132 -IVHRDIKPQNILIDSNKTLKIFDFGIAKA--LSETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 255 LTAKSDIFSFGVVLLELITGRP 276
+DI+S G+VL E++ G P
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEP 210
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-34
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 11/206 (5%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLD-DTGFQGEKEFLVEVLMLSLMRHPN 130
D+F+ + LG G G V+K +G V+A K + + + + E+ +L P
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLH 190
+V G + + E+M GSL+ + + + K++ +GL YL
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQ----VLKKAGRIPEQILGKVSIAVIKGLTYLR 148
Query: 191 NKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYA 250
K +++RD+K NIL+ KL DFG++ G D S ++ V GT Y +PE
Sbjct: 149 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLID-SMANSFV-GTRSYMSPERL 202
Query: 251 TTGKLTAKSDIFSFGVVLLELITGRP 276
+ +SDI+S G+ L+E+ GR
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRY 228
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-34
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 16/213 (7%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLD-DTGFQGEKEFLVEV-LMLSLMRHP 129
D+ + LG+G +G V K + +GQ++AVK++ Q +K L+++ + + + P
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 130 NLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL 189
V G + E M SL+ + + + + + KIA + LE+L
Sbjct: 67 FTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG--DKSHVSTRVMGTHGYCAP 247
H+K VI+RD+K N+L+ K+ DFG++ G G Y AP
Sbjct: 126 HSKLS--VIHRDVKPSNVLINALGQVKMCDFGIS-----GYLVDDVAKDIDAGCKPYMAP 178
Query: 248 E----YATTGKLTAKSDIFSFGVVLLELITGRP 276
E + KSDI+S G+ ++EL R
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRF 211
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-34
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 14/207 (6%)
Query: 79 FLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEK---EFLVEVLMLSLMRHPNLVHLI 135
FLG+GGF ++ A+T +V A K + + + +E+ + + H ++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 136 GYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADP 195
G+ + +V E SL + K L G +YLH
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRNR-- 135
Query: 196 PVIYRDLKAGNILLGKGFHPKLSDFGLA-KFGPTGDKSHVSTRVMGTHGYCAPEYATTGK 254
VI+RDLK GN+ L + K+ DFGLA K G++ V GT Y APE +
Sbjct: 136 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKG 191
Query: 255 LTAKSDIFSFGVVLLELITGRPAMDDS 281
+ + D++S G ++ L+ G+P + S
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPFETS 218
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-34
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 14/207 (6%)
Query: 79 FLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEK---EFLVEVLMLSLMRHPNLVHLI 135
FLG+GGF ++ A+T +V A K + + + +E+ + + H ++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 136 GYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADP 195
G+ + +V E SL + K L G +YLH
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRNR-- 161
Query: 196 PVIYRDLKAGNILLGKGFHPKLSDFGLA-KFGPTGDKSHVSTRVMGTHGYCAPEYATTGK 254
VI+RDLK GN+ L + K+ DFGLA K G++ V GT Y APE +
Sbjct: 162 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKG 217
Query: 255 LTAKSDIFSFGVVLLELITGRPAMDDS 281
+ + D++S G ++ L+ G+P + S
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPFETS 244
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 6e-34
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 13/214 (6%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG---EKEFLVEVLMLSLMRH 128
++FK N LG+G F VY+ + TG VA+K +D + EV + ++H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 129 PNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEY 188
P+++ L Y + LV E G + +L +KP N G+ Y
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARHFMHQIITGMLY 127
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA-KFGPTGDKSHVSTRVMGTHGYCAP 247
LH+ +++RDL N+LL + + K++DFGLA + +K + GT Y +P
Sbjct: 128 LHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GTPNYISP 181
Query: 248 EYATTGKLTAKSDIFSFGVVLLELITGRPAMDDS 281
E AT +SD++S G + L+ GRP D
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD 215
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 8e-34
Identities = 65/220 (29%), Positives = 88/220 (40%), Gaps = 19/220 (8%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV-EVLMLSLMRHPNLVHLI--- 135
LG GGFG V + +TG+ VA+KQ +E E+ ++ + HPN+V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 136 ---GYCAEGTQRLLVYEYMPLGSLEDHLLGLTPE-MKPLDWNTRMKIAAGAARGLEYLHN 191
A LL EY G L +L E L + + + L YLH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYL--NQFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 192 KADPPVIYRDLKAGNILLGKGFHP---KLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE 248
+I+RDLK NI+L G K+ D G AK G+ V GT Y APE
Sbjct: 140 NR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT--EFV-GTLQYLAPE 193
Query: 249 YATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288
K T D +SFG + E ITG + +
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWH 233
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-33
Identities = 40/226 (17%), Positives = 73/226 (32%), Gaps = 26/226 (11%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGK-----LAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSL 125
+ + LG+G F VY+ A+ Q +K EF + ++
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP---ANPWEFYIGTQLMER 120
Query: 126 MR---HPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHL-LGLTPEMKPLDWNTRMKIAAG 181
++ + +LV E G+L + + L K + + A
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 182 AARGLEYLHNKADPPVIYRDLKAGNILLGKGFHP-----------KLSDFGLAKFGPTGD 230
+E +H+ +I+ D+K N +LG GF L D G +
Sbjct: 181 MLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237
Query: 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
K + T T G+ E + + D F + ++ G
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 49/205 (23%), Positives = 77/205 (37%), Gaps = 26/205 (12%)
Query: 80 LGQGGFGAVYKGK-LAETGQVVAVKQLDDTGFQGEKE-FLVEVLMLSLMRHPNLVHLIGY 137
+ GG G +Y G+ V +K L +G + + E L+ + HP++V + +
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 138 CAEGTQRL-----LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK 192
+ +V EY+ SL+ L + L YLH+
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI 201
Query: 193 ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK-FGPTGDKSHVSTRVMGTHGYCAPEYAT 251
++Y DLK NI+L + KL D G G + GT G+ APE
Sbjct: 202 ---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG-------YLYGTPGFQAPEIVR 250
Query: 252 TGKLTAKSDIFSFGVVLLELITGRP 276
T +DI++ G L L P
Sbjct: 251 -TGPTVATDIYTVGRTLAALTLDLP 274
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-33
Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 13/224 (5%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE-KEFLVEV-LMLSLMRHP 129
++ KD +G+G +G+V K +GQ++AVK++ T + E K+ L+++ +++ P
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 130 NLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL 189
+V G + E M + + + + KI + L +L
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL-AKFGPTGDKSHVSTRVMGTHGYCAPE 248
+I+RD+K NILL + + KL DFG+ + + K TR G Y APE
Sbjct: 142 KENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK----TRDAGCRPYMAPE 195
Query: 249 ----YATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288
A+ +SD++S G+ L EL TGR L
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL 239
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-33
Identities = 65/210 (30%), Positives = 95/210 (45%), Gaps = 12/210 (5%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEF---LVEVLMLSLMRH 128
D F D LG+GGFG V+ ++ TG++ A K+L+ + K + +VE +L+ +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 129 PNLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKI-AAGAARGL 186
+V L Y E L LV M G + H+ + + R A GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQIVSGL 302
Query: 187 EYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCA 246
E+LH + +IYRDLK N+LL + ++SD GLA G GT G+ A
Sbjct: 303 EHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTPGFMA 357
Query: 247 PEYATTGKLTAKSDIFSFGVVLLELITGRP 276
PE + D F+ GV L E+I R
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARG 387
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 2e-32
Identities = 42/292 (14%), Positives = 84/292 (28%), Gaps = 53/292 (18%)
Query: 29 SRIDTVERQETPARRNTLDDTLSAHENKNKENTFTYRQLVAATD-NFKDTNFLGQGGFGA 87
+RI + T + D+L + N F + LGQ A
Sbjct: 29 NRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYA 88
Query: 88 VYKGKLAETGQVVAVKQLDDTGFQGEKE----------------------------FLVE 119
+ ETG+ V T F+
Sbjct: 89 YLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148
Query: 120 VLMLSLMRHPNLVHLIGYCAEGT--QRLLVYEYM--PLGSLEDHLLGLTPEMKPLDWNTR 175
++ + ++ + + R +Y M L + + LL + K L + R
Sbjct: 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHAR 208
Query: 176 MKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVS 235
+++ R L LH+ +++ L+ +I+L + L+ F +
Sbjct: 209 LQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV------RDGAR 259
Query: 236 TRVMGTHGYCAPEY-----------ATTGKLTAKSDIFSFGVVLLELITGRP 276
+ G+ PE +T D ++ G+V+ +
Sbjct: 260 VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 2e-32
Identities = 34/291 (11%), Positives = 64/291 (21%), Gaps = 42/291 (14%)
Query: 19 INEDKDSPGPSRIDTVERQETPARRNTLDDTLSAHENKNKENTFTYRQLVAATDNFKDTN 78
D I + ++ + +N E T L K
Sbjct: 10 FMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDS-LLSQGERKLKLVE 68
Query: 79 FLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE---FLVEVLMLSLMRHPNLVHLI 135
L G V+ + E + A+K E + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 136 GYC--------------------------AEGTQRLLVYEYMP--LGSLEDHLLGLTPEM 167
LL+ L L L +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 168 KPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227
+ A R L +K +++ N+ + L D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW--K 243
Query: 228 TGDKSHVSTRVMGTHGYCAPEY--ATTGKLTAKSDIFSFGVVLLELITGRP 276
G + S+ Y E+ A+T T + + G+ + +
Sbjct: 244 VGTRGPASS---VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-32
Identities = 70/210 (33%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEF---LVEVLMLSLMRH 128
+ F+ LG+GGFG V ++ TG++ A K+L+ + K L E +L +
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 129 PNLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKI-AAGAARGL 186
+V L Y E L LV M G L+ H+ + P R AA GL
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA---RAVFYAAEICCGL 299
Query: 187 EYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCA 246
E LH + ++YRDLK NILL H ++SD GLA P G RV GT GY A
Sbjct: 300 EDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVGYMA 353
Query: 247 PEYATTGKLTAKSDIFSFGVVLLELITGRP 276
PE + T D ++ G +L E+I G+
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQS 383
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-32
Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV----EVLMLSLMRHPNLVHL- 134
LG GG V+ + + VAVK L + F + E + + HP +V +
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 135 -IGYCAEGTQRLLVY---EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLH 190
G AE L Y EY+ +L D + P+ +++ A A + L + H
Sbjct: 79 DTG-EAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSH 133
Query: 191 NKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVST-RVMGTHGYCAPEY 249
+I+RD+K NI++ K+ DFG+A+ S T V+GT Y +PE
Sbjct: 134 QNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 250 ATTGKLTAKSDIFSFGVVLLELITGRP 276
A + A+SD++S G VL E++TG P
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 48/202 (23%), Positives = 80/202 (39%), Gaps = 15/202 (7%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQL-----DDTGFQGEKEFLVEVLMLSLMRHPNLVHL 134
+G+GG G VY+ + ++VA+K + D F+ E ++ P++V +
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFR--TRMQREARTAGRLQEPHVVPI 99
Query: 135 IGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKAD 194
+ Q + + L L PL + I L+ H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLR----RQGPLAPPRAVAIVRQIGSALDAAHAAG- 154
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGK 254
+RD+K NIL+ L DFG+A + + +GT Y APE +
Sbjct: 155 --ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSESH 211
Query: 255 LTAKSDIFSFGVVLLELITGRP 276
T ++DI++ VL E +TG P
Sbjct: 212 ATYRADIYALTCVLYECLTGSP 233
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 2e-31
Identities = 43/295 (14%), Positives = 84/295 (28%), Gaps = 60/295 (20%)
Query: 26 PGPSRIDTVERQETPARRNTLDDTLSAHENKNKENTFT--YRQLVAATDNFKDTNFLGQG 83
P + T E ++ A + + E+ R LV LGQ
Sbjct: 37 PQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRG-------TVLGQE 89
Query: 84 GFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE---------------------------- 115
A + ETG+ V T
Sbjct: 90 DPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 149
Query: 116 FLVEVLMLSLMRHPNLVHLIGYCAEG--TQRLLVYEYM--PLGSLEDHLLGLTPEMKPLD 171
F+ ++ + ++ + + R +Y M L + + LL + K L
Sbjct: 150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 209
Query: 172 WNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231
+ R+++ R L LH+ +++ L+ +I+L + L+ F +
Sbjct: 210 HHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV------R 260
Query: 232 SHVSTRVMGTHGYCAPEY----------ATTGKLTAKSDIFSFGVVLLELITGRP 276
S G+ PE +T D ++ G+ + +
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-31
Identities = 61/246 (24%), Positives = 100/246 (40%), Gaps = 33/246 (13%)
Query: 46 LDDTLSAHENKNKENTFTYRQLVAATDNFKDTNFLGQGGFGA-VYKGKLAETGQVVAVKQ 104
+ + S ++ E T +F + LG G G VY+G + VAVK+
Sbjct: 1 MGSSPSLEQDDGDEETSVVI---VGKISFCPKDVLGHGAEGTIVYRGMF--DNRDVAVKR 55
Query: 105 LDDTGFQG-EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLL-- 161
+ F ++E V++L S HPN++ + + + E +L++++
Sbjct: 56 ILPECFSFADRE--VQLLRESD-EHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQK 111
Query: 162 -GLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL-----GKGFHP 215
++P+ + GL +LH+ +++RDLK NIL+
Sbjct: 112 DFAHLGLEPIT------LLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKA 162
Query: 216 KLSDFGLAKFGPTGDKS-HVSTRVMGTHGYCAPEY---ATTGKLTAKSDIFSFGVVLLEL 271
+SDFGL K G S + V GT G+ APE T DIFS G V +
Sbjct: 163 MISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222
Query: 272 IT-GRP 276
I+ G
Sbjct: 223 ISEGSH 228
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 77/278 (27%), Positives = 115/278 (41%), Gaps = 32/278 (11%)
Query: 13 KKTKPKINEDKDSPGPSRIDTVERQETPARRNTLDDTLSAHENKNKENTFTYRQLVAATD 72
+ + + + + P + E + S + + + +
Sbjct: 130 EHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMN 189
Query: 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQL---------DDTGFQGEKEFLVEVLML 123
+F +G+GGFG VY + A+TG++ A+K L +T E+ L V
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV--- 246
Query: 124 SLMRHPNLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRMKI-A 179
S P +V + Y +L + + M G L HL G+ E M+ A
Sbjct: 247 STGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE-------ADMRFYA 298
Query: 180 AGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVM 239
A GLE++HN+ V+YRDLK NILL + H ++SD GLA K H V
Sbjct: 299 AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH--ASV- 351
Query: 240 GTHGYCAPEYATTGKLTAKS-DIFSFGVVLLELITGRP 276
GTHGY APE G S D FS G +L +L+ G
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-30
Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 20/226 (8%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLD-DTGFQGEKEFLVEV-LMLSLMRHP 129
++ ++ +G G G V+K + +TG V+AVKQ+ + K L+++ ++L P
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 130 NLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL 189
+V G T + E M + + P+ K+ + L YL
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKR----MQGPIPERILGKMTVAIVKALYYL 140
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG--DKSHVSTRVMGTHGYCAP 247
K VI+RD+K NILL + KL DFG++ G R G Y AP
Sbjct: 141 KEKHG--VIHRDVKPSNILLDERGQIKLCDFGIS-----GRLVDDKAKDRSAGCAAYMAP 193
Query: 248 E-----YATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288
E T ++D++S G+ L+EL TG+ + + +L
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL 239
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-30
Identities = 63/244 (25%), Positives = 95/244 (38%), Gaps = 35/244 (14%)
Query: 51 SAHENKNKENTFTYRQ---LVAATDNFKDT----NFLGQGGFGAVYKGKLAETGQVVAVK 103
S EN + + + + + LG G +G V + T A+K
Sbjct: 9 SGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIK 68
Query: 104 QLDDTGFQGEKEFLV--EVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLL 161
+ T + EV +L L+ HPN++ L + + LV E G L D ++
Sbjct: 69 IIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII 128
Query: 162 --GLTPEMKPLDWNTRMKIAAGAAR----GLEYLHNKADPPVIYRDLKAGNILL---GKG 212
E+ AA + G+ YLH +++RDLK N+LL K
Sbjct: 129 HRMKFNEVD----------AAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKD 175
Query: 213 FHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELI 272
K+ DFGL+ K +GT Y APE K K D++S GV+L L+
Sbjct: 176 ALIKIVDFGLSAVFENQKKMK---ERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILL 231
Query: 273 TGRP 276
G P
Sbjct: 232 AGYP 235
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-29
Identities = 66/222 (29%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 71 TDNFKDT----NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE---FLVEVLML 123
T F D LG+G FG V K TGQ AVK + + + + L EV +L
Sbjct: 21 TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLL 80
Query: 124 SLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLL--GLTPEMKPLDWNTRMKIAAG 181
+ HPN++ L + + LV E G L D ++ E+ AA
Sbjct: 81 KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD----------AAR 130
Query: 182 AAR----GLEYLHNKADPPVIYRDLKAGNILL---GKGFHPKLSDFGLAKFGPTGDKSHV 234
R G+ Y+H +++RDLK N+LL K + ++ DFGL+ K
Sbjct: 131 IIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK- 186
Query: 235 STRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
+GT Y APE G K D++S GV+L L++G P
Sbjct: 187 --DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCP 225
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-29
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 18/212 (8%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEF---LVEVLMLSLMRH 128
++FK LG+G F V + T + A+K L+ E + E ++S + H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 129 PNLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRMKI-AAGAAR 184
P V L + + ++L Y G L ++ +G E T + A
Sbjct: 90 PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE-------TCTRFYTAEIVS 141
Query: 185 GLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGY 244
LEYLH K +I+RDLK NILL + H +++DFG AK K + +GT Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 198
Query: 245 CAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
+PE T SD+++ G ++ +L+ G P
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLP 230
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 65/237 (27%), Positives = 99/237 (41%), Gaps = 31/237 (13%)
Query: 51 SAHENKNKENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF 110
H + +EN + + + LG+G FG V K K T Q AVK ++
Sbjct: 4 HHHHSSGRENLYFQGTF---AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA 60
Query: 111 QGEKEFLV--EVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLL--GLTPE 166
+ + + EV +L + HPN++ L + + +V E G L D ++ E
Sbjct: 61 KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE 120
Query: 167 MKPLDWNTRMKIAAGAAR----GLEYLHNKADPPVIYRDLKAGNILL---GKGFHPKLSD 219
AA + G+ Y+H +++RDLK NILL K K+ D
Sbjct: 121 HD----------AARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIID 167
Query: 220 FGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
FGL+ K +GT Y APE G K D++S GV+L L++G P
Sbjct: 168 FGLSTCFQQNTKMK---DRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTP 220
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-28
Identities = 58/276 (21%), Positives = 92/276 (33%), Gaps = 56/276 (20%)
Query: 53 HENKNKENTFTYRQLVAATDNFKDT----NFLGQGGFGAVYKGKLAETGQVVAVK----- 103
H + + + + +GQG +G V +T + A+K
Sbjct: 3 HHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN 62
Query: 104 QLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGL 163
++ + + EV ++ + HPN+ L + LV E G L D L
Sbjct: 63 KIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVF 122
Query: 164 TPEMKPLDWNTRMKIAAG-----------------------------AAR-------GLE 187
+ +K + L
Sbjct: 123 IDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182
Query: 188 YLHNKADPPVIYRDLKAGNILLG--KGFHPKLSDFGLAKF---GPTGDKSHVSTRVMGTH 242
YLHN+ + +RD+K N L K F KL DFGL+K G+ ++T+ GT
Sbjct: 183 YLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTP 238
Query: 243 GYCAPE--YATTGKLTAKSDIFSFGVVLLELITGRP 276
+ APE T K D +S GV+L L+ G
Sbjct: 239 YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAV 274
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-28
Identities = 62/277 (22%), Positives = 111/277 (40%), Gaps = 31/277 (11%)
Query: 12 KKKTKPKINEDKDSPGPSRIDTVERQETPARRNTLDDTLSAHENKNKENTFTYRQLVAAT 71
+ ++ NE K+ + + ++ D F +R + A
Sbjct: 29 DQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDI------PAPPAPFDHRIVTAKQ 82
Query: 72 DNFKD------TNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSL 125
T LG G FG V+K + TG +A K + G + ++E E+ +++
Sbjct: 83 GAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQ 142
Query: 126 MRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAAR- 184
+ H NL+ L +LV EY+ G L D ++ + + LD +
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD-------TILFMKQ 195
Query: 185 ---GLEYLHNKADPPVIYRDLKAGNILL-GKGFHP-KLSDFGLAKFGPTGDKSHVSTRVM 239
G+ ++H +++ DLK NIL + K+ DFGLA+ +K V
Sbjct: 196 ICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NF 249
Query: 240 GTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
GT + APE ++ +D++S GV+ L++G
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLS 286
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-28
Identities = 56/228 (24%), Positives = 89/228 (39%), Gaps = 39/228 (17%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLD-------------DTGFQGEKEFL 117
+++ LG G +G V K A+K + + +E
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 118 VEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLL--GLTPEMKPLDWNTR 175
E+ +L + HPN++ L + LV E+ G L + ++ E
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECD------- 147
Query: 176 MKIAAGAAR----GLEYLHNKADPPVIYRDLKAGNILL---GKGFHPKLSDFGLAKFGPT 228
AA + G+ YLH +++RD+K NILL + K+ DFGL+ F
Sbjct: 148 ---AANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201
Query: 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
K +GT Y APE K K D++S GV++ L+ G P
Sbjct: 202 DYKLR---DRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYP 245
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 59/231 (25%), Positives = 95/231 (41%), Gaps = 28/231 (12%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV-EVLMLSLMRHPNLVHLIGYC 138
LG+G +G V T + VAVK +D E + E+ + ++ H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 139 AEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAAR--------GLEYLH 190
EG + L EY G L D + + M A+ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEP----------DIGMPEPD--AQRFFHQLMAGVVYLH 122
Query: 191 NKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYA 250
+ +RD+K N+LL + + K+SDFGLA ++ + ++ GT Y APE
Sbjct: 123 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-L 178
Query: 251 TTGKL--TAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVDWVTL-FFCM 298
+ D++S G+VL ++ G D + DW +
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 229
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-27
Identities = 57/220 (25%), Positives = 88/220 (40%), Gaps = 34/220 (15%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV----EVLMLSLMRHPNLVHL- 134
LG+G +G V + +ET AVK L + E+ +L +RH N++ L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 135 -IGYCAEGTQRLLVYEYMPLGSLE--DHLLGLTPEMKPLDWNTRMKIAAGAAR------- 184
+ Y E + +V EY G E D + R + A
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-----------EKRFPVCQ--AHGYFCQLI 119
Query: 185 -GLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG 243
GLEYLH++ ++++D+K GN+LL G K+S G+A+ G+
Sbjct: 120 DGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 244 YCAPEYATTGKL--TAKSDIFSFGVVLLELITGRPAMDDS 281
+ PE A K DI+S GV L + TG +
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD 216
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 60/263 (22%), Positives = 102/263 (38%), Gaps = 23/263 (8%)
Query: 24 DSPGPSRIDTVERQETPARRNTLDDTLSAHENKNKENTFTYRQLVAATDNFKDT----NF 79
D R V+ Q R + + + + + + D+ D
Sbjct: 105 DERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEE 164
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA 139
LG G FG V++ TG A K + ++ E+ +S++RHP LV+L
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 140 EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAAR----GLEYLHNKADP 195
+ + +++YE+M G L + + +M + A R GL ++H
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDE-------AVEYMRQVCKGLCHMHENN-- 275
Query: 196 PVIYRDLKAGNILLG--KGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTG 253
++ DLK NI+ + KL DFGL V GT + APE A
Sbjct: 276 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEGK 331
Query: 254 KLTAKSDIFSFGVVLLELITGRP 276
+ +D++S GV+ L++G
Sbjct: 332 PVGYYTDMWSVGVLSYILLSGLS 354
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-27
Identities = 59/231 (25%), Positives = 95/231 (41%), Gaps = 28/231 (12%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV-EVLMLSLMRHPNLVHLIGYC 138
LG+G +G V T + VAVK +D E + E+ + ++ H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 139 AEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAAR--------GLEYLH 190
EG + L EY G L D + + M A+ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEP----------DIGMPEPD--AQRFFHQLMAGVVYLH 122
Query: 191 NKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYA 250
+ +RD+K N+LL + + K+SDFGLA ++ + ++ GT Y APE
Sbjct: 123 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-L 178
Query: 251 TTGKL--TAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVDWVTL-FFCM 298
+ D++S G+VL ++ G D + DW +
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 229
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-27
Identities = 59/239 (24%), Positives = 92/239 (38%), Gaps = 47/239 (19%)
Query: 80 LGQGGFGAV-YKGKLAETGQVVAVKQLDDTGFQGEKEFL------VEVLMLSLMRHPNLV 132
LG G G V ++G G+ VAVK++ +F +++L S HPN++
Sbjct: 23 LGYGSSGTVVFQGSF--QGRPVAVKRML-------IDFCDIALMEIKLLTESD-DHPNVI 72
Query: 133 HLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAA---GAARGLEYL 189
+ E +L+D + + L + A G+ +L
Sbjct: 73 RYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 190 HNKADPPVIYRDLKAGNILL-------------GKGFHPKLSDFGLAKFGPTGDKSHVST 236
H+ +I+RDLK NIL+ + +SDFGL K +G S +
Sbjct: 132 HSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 237 R--VMGTHGYCAPE-------YATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285
GT G+ APE T +LT DIFS G V +++ G+ D E
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-27
Identities = 56/259 (21%), Positives = 94/259 (36%), Gaps = 48/259 (18%)
Query: 47 DDTLSAHENKNKENTFTYRQLVAATDNFKDTNF---------LGQGGFGAVYKGKLAETG 97
+ ++ ++NK F + L + LG G G V +T
Sbjct: 103 NSEIALSLSRNK--VFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTC 160
Query: 98 QVVAVKQLD--------DTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149
+ VA++ + E+ +L + HP ++ + + + +V E
Sbjct: 161 KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLE 219
Query: 150 YMPLGSLEDHLL--GLTPEMKPLDWNTRMKIAAGAAR----GLEYLHNKADPPVIYRDLK 203
M G L D ++ E ++YLH +I+RDLK
Sbjct: 220 LMEGGELFDKVVGNKRLKE----------ATCKLYFYQMLLAVQYLHENG---IIHRDLK 266
Query: 204 AGNILL---GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE---YATTGKLTA 257
N+LL + K++DFG +K G+ S + T GT Y APE T
Sbjct: 267 PENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC-GTPTYLAPEVLVSVGTAGYNR 323
Query: 258 KSDIFSFGVVLLELITGRP 276
D +S GV+L ++G P
Sbjct: 324 AVDCWSLGVILFICLSGYP 342
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-27
Identities = 64/286 (22%), Positives = 109/286 (38%), Gaps = 37/286 (12%)
Query: 12 KKKTKPKINEDKDSPGPSRIDTVERQETPARRNTLDDTLSAHENKNKENTFTYRQLVAAT 71
+++ + I +D P S E ++ + + L ++ +
Sbjct: 34 REQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFY 93
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVL---------M 122
+ + +G+G V + TG AVK ++ T + E L EV +
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 123 LSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLL--GLTPEMKPLDWNTRMKIAA 180
+ HP+++ LI + LV++ M G L D+L E +
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKE----------TR 203
Query: 181 GAAR----GLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVST 236
R + +LH +++RDLK NILL +LSDFG + G+K +
Sbjct: 204 SIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--LRE 258
Query: 237 RVMGTHGYCAPE------YATTGKLTAKSDIFSFGVVLLELITGRP 276
GT GY APE T + D+++ GV+L L+ G P
Sbjct: 259 LC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-27
Identities = 65/269 (24%), Positives = 118/269 (43%), Gaps = 43/269 (15%)
Query: 29 SRIDTVERQETPARRNTLDDTLSAHENKNKE--NTFTYRQLVAATDNFKDTNFLGQGGFG 86
S ++ + + P+ ++ + +K T ++ DT +G G FG
Sbjct: 9 SFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFG 68
Query: 87 AVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRL- 145
VY+ KL ++G++VA+K++ Q ++ E+ ++ + H N+V L + ++
Sbjct: 69 VVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124
Query: 146 -----LVYEYMP--LGSLEDHLLGLTPEMKPLDWNTRM-KIAAGAARGLEYLHNKADPPV 197
LV +Y+P + + H + + M ++ R L Y+H+ +
Sbjct: 125 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL----FRSLAYIHSFG---I 177
Query: 198 IYRDLKAGNILLGKGFHP-KLSDFGLAKFGPTGDK--SHVSTRVMGTHGYCAPE------ 248
+RD+K N+LL KL DFG AK G+ S++ +R Y APE
Sbjct: 178 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIFGAT 232
Query: 249 -YATTGKLTAKSDIFSFGVVLLELITGRP 276
Y T+ D++S G VL EL+ G+P
Sbjct: 233 DY------TSSIDVWSAGCVLAELLLGQP 255
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 9e-27
Identities = 64/223 (28%), Positives = 104/223 (46%), Gaps = 42/223 (18%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQL----DDTGFQGEKEFLVEVLMLSLMR 127
+ ++ +G+G +G V+K + +TGQ+VA+K+ DD +K L E+ ML ++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVI--KKIALREIRMLKQLK 60
Query: 128 HPNLVHLIGYCAEGTQRLLVYEYMP---LGSLEDHLLGLTPEM-KPLDWNTRMKIAAGAA 183
HPNLV+L+ + LV+EY L L+ + G+ + K + W T
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT--------L 112
Query: 184 RGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK-FG-PTGDKSH-VSTRVMG 240
+ + + H I+RD+K NIL+ K KL DFG A+ P+ V+TR
Sbjct: 113 QAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR--- 166
Query: 241 THGYCAPE-------YATTGKLTAKSDIFSFGVVLLELITGRP 276
Y +PE Y D+++ G V EL++G P
Sbjct: 167 --WYRSPELLVGDTQYGPP------VDVWAIGCVFAELLSGVP 201
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 55/205 (26%), Positives = 87/205 (42%), Gaps = 19/205 (9%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE-FLVEVLMLSLMRHPNLVHLIGYC 138
LG G FG V+ + +G +K ++ Q E E+ +L + HPN++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 139 AEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAAR----GLEYLHNKAD 194
+ +V E G L + ++ K L A + L Y H++
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALS----EGYVAELMKQMMNALAYFHSQH- 144
Query: 195 PPVIYRDLKAGNILL---GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYAT 251
V+++DLK NIL K+ DFGLA+ + + + GT Y APE
Sbjct: 145 --VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAA-GTALYMAPE-VF 198
Query: 252 TGKLTAKSDIFSFGVVLLELITGRP 276
+T K DI+S GVV+ L+TG
Sbjct: 199 KRDVTFKCDIWSAGVVMYFLLTGCL 223
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 31/214 (14%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV--EVLMLSLMRHPNLVHLIGY 137
+G+G F V + TG+ VA+K +D T + EV ++ ++ HPN+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 138 CAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAAR--------GLEYL 189
L+ EY G + D+L+ + RMK AR ++Y
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVA----------HGRMK--EKEARSKFRQIVSAVQYC 130
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEY 249
H K +++RDLKA N+LL + K++DFG + G K G Y APE
Sbjct: 131 HQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GAPPYAAPE- 183
Query: 250 ATTGKL--TAKSDIFSFGVVLLELITGRPAMDDS 281
GK + D++S GV+L L++G D
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 26/206 (12%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA 139
LG G F V+ K TG++ A+K + + + E+ +L ++H N+V L
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 140 EGTQRLLVYEYMPLGSLEDHLL--GLTPEMKPLDWNTRMKIAAGAAR----GLEYLHNKA 193
T LV + + G L D +L G+ E K A+ + ++YLH
Sbjct: 77 STTHYYLVMQLVSGGELFDRILERGVYTE----------KDASLVIQQVLSAVKYLHENG 126
Query: 194 DPPVIYRDLKAGNILL---GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYA 250
+++RDLK N+L + ++DFGL+K +++ + + GT GY APE
Sbjct: 127 ---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVL 179
Query: 251 TTGKLTAKSDIFSFGVVLLELITGRP 276
+ D +S GV+ L+ G P
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYP 205
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-26
Identities = 53/206 (25%), Positives = 82/206 (39%), Gaps = 26/206 (12%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA 139
+G+G +G V T A K++ + F E+ ++ + HPN++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 140 EGTQRLLVYEYMPLGSLEDHLL--GLTPEMKPLDWNTRMKIAAGAAR----GLEYLHNKA 193
+ T LV E G L + ++ + E AA + + Y H
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRESD----------AARIMKDVLSAVAYCHKLN 126
Query: 194 DPPVIYRDLKAGNILL---GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYA 250
V +RDLK N L KL DFGLA G + T+V GT Y +P+
Sbjct: 127 ---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--MRTKV-GTPYYVSPQ-V 179
Query: 251 TTGKLTAKSDIFSFGVVLLELITGRP 276
G + D +S GV++ L+ G P
Sbjct: 180 LEGLYGPECDEWSAGVMMYVLLCGYP 205
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-26
Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 38/227 (16%)
Query: 68 VAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQ--LDDTGFQGEKEF----LVEVL 121
++++ FK LG G + VYKG TG VA+K+ LD E+ + E+
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-----EEGTPSTAIREIS 55
Query: 122 MLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPL---GSLEDHLLGLTPEMKPLDWNTRMKI 178
++ ++H N+V L + LV+E+M ++ +G TP + L+ N
Sbjct: 56 LMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTP--RGLELNLVKYF 113
Query: 179 AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK-FG-PTGDKSHVST 236
+GL + H +++RDLK N+L+ K KL DFGLA+ FG P S
Sbjct: 114 QWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS--- 167
Query: 237 RVMGTHGYCAPE-------YATTGKLTAKSDIFSFGVVLLELITGRP 276
V+ T Y AP+ Y+T+ DI+S G +L E+ITG+P
Sbjct: 168 EVV-TLWYRAPDVLMGSRTYSTS------IDIWSCGCILAEMITGKP 207
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-26
Identities = 47/237 (19%), Positives = 96/237 (40%), Gaps = 31/237 (13%)
Query: 54 ENKNKENTFTYRQLVAATDNFKDT----NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG 109
++ + + + + D LG G FG V++ TG+V K ++
Sbjct: 29 FYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY 88
Query: 110 FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLL----GLTP 165
+ E+ +++ + HP L++L + + +L+ E++ G L D + ++
Sbjct: 89 PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMS- 147
Query: 166 EMKPLDWNTRMKIAAGAAR----GLEYLHNKADPPVIYRDLKAGNILLG--KGFHPKLSD 219
E + R GL+++H + +++ D+K NI+ K K+ D
Sbjct: 148 EAE----------VINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIID 194
Query: 220 FGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
FGLA + V T + APE + +D+++ GV+ L++G
Sbjct: 195 FGLATKLNPDEIVKV---TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS 248
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-26
Identities = 74/268 (27%), Positives = 109/268 (40%), Gaps = 21/268 (7%)
Query: 17 PKINEDKDSPGPSRIDTVERQETPARRNTLDDTLSAHENKNKENTFTYRQLVAATDNFKD 76
P+ E+ + + D +++Q + E + + + F+
Sbjct: 93 PEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEY 152
Query: 77 TNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEF---LVEVLMLSLMRHPNLVH 133
LG+G FG V K TG+ A+K L + E L E +L RHP L
Sbjct: 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 134 LIGYCAEGTQRL-LVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRMKI-AAGAARGLEYL 189
L Y + RL V EY G L HL + E R + A L+YL
Sbjct: 213 LK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSE-------DRARFYGAEIVSALDYL 264
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVM-GTHGYCAPE 248
H++ + V+YRDLK N++L K H K++DFGL K G + + GT Y APE
Sbjct: 265 HSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---TMKTFCGTPEYLAPE 319
Query: 249 YATTGKLTAKSDIFSFGVVLLELITGRP 276
D + GVV+ E++ GR
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMCGRL 347
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 57/241 (23%), Positives = 88/241 (36%), Gaps = 35/241 (14%)
Query: 53 HENKNKENTFTYRQLVAATDNFKDT-----NFLGQGGFGAVYKGKLAETGQVVAVKQLDD 107
H + + ++ D LG G G V + TGQ A+K L D
Sbjct: 5 HHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD 64
Query: 108 TGFQGEKEFLVEV-LMLSLMRHPNLVHLIGYCAEGTQR----LLVYEYMPLGSLEDHLLG 162
+ + EV P++V ++ L++ E M G L +
Sbjct: 65 S-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ- 118
Query: 163 LTPEMKPLDWNTRMKIAAGAAR----GLEYLHNKADPPVIYRDLKAGNILL---GKGFHP 215
E + R AA R +++LH+ + +RD+K N+L K
Sbjct: 119 ---ERGDQAFTERE--AAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVL 170
Query: 216 KLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGR 275
KL+DFG AK + T T Y APE K D++S GV++ L+ G
Sbjct: 171 KLTDFGFAKETTQNA---LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGF 226
Query: 276 P 276
P
Sbjct: 227 P 227
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 42/223 (18%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQL----DDTGFQGEKEFLVEVLMLSLMR 127
+ +++ +G+G +G V K + +TG++VA+K+ DD +K + E+ +L +R
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMV--KKIAMREIKLLKQLR 82
Query: 128 HPNLVHLIGYCAEGTQRLLVYEYMP---LGSLEDHLLGLTPEM-KPLDWNTRMKIAAGAA 183
H NLV+L+ C + + LV+E++ L LE GL ++ + +
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQI--------I 134
Query: 184 RGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK-FG-PTGDKSH-VSTRVMG 240
G+ + H+ +I+RD+K NIL+ + KL DFG A+ P V+TR
Sbjct: 135 NGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR--- 188
Query: 241 THGYCAPE-------YATTGKLTAKSDIFSFGVVLLELITGRP 276
Y APE Y D+++ G ++ E+ G P
Sbjct: 189 --WYRAPELLVGDVKYGKA------VDVWAIGCLVTEMFMGEP 223
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-25
Identities = 63/208 (30%), Positives = 93/208 (44%), Gaps = 28/208 (13%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV--EVLMLSLMRHPNLVHLIGY 137
LG+G FG V K K T Q AVK ++ + + + EV +L + HPN++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 138 CAEGTQRLLVYEYMPLGSLEDHLL--GLTPEMKPLDWNTRMKIAAGAAR----GLEYLHN 191
+ + +V E G L D ++ E AA + G+ Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD----------AARIIKQVFSGITYMHK 139
Query: 192 KADPPVIYRDLKAGNILL---GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE 248
+++RDLK NILL K K+ DFGL+ K + R+ GT Y APE
Sbjct: 140 HN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRI-GTAYYIAPE 193
Query: 249 YATTGKLTAKSDIFSFGVVLLELITGRP 276
G K D++S GV+L L++G P
Sbjct: 194 -VLRGTYDEKCDVWSAGVILYILLSGTP 220
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 61/231 (26%), Positives = 94/231 (40%), Gaps = 38/231 (16%)
Query: 71 TDNFKDT-----NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEV-LMLS 124
+ F+D + LG+G V T Q AVK ++ EV ++
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66
Query: 125 LMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLL--GLTPEMKPLDWNTRMKIAAGA 182
H N++ LI + E + LV+E M GS+ H+ E++ A+
Sbjct: 67 CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELE----------ASVV 116
Query: 183 AR----GLEYLHNKADPPVIYRDLKAGNILLGKGFHP---KLSDFGLAK-FGPTGDKSHV 234
+ L++LHNK + +RDLK NIL K+ DF L GD S +
Sbjct: 117 VQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI 173
Query: 235 STRVM----GTHGYCAPE-----YATTGKLTAKSDIFSFGVVLLELITGRP 276
ST + G+ Y APE + D++S GV+L L++G P
Sbjct: 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-25
Identities = 55/221 (24%), Positives = 89/221 (40%), Gaps = 31/221 (14%)
Query: 71 TDNFKDT----NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV--EVLMLS 124
+ F D LG+G F V + TG A K ++ + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 125 LMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLL--GLTPEMKPLDWNTRMKIAAGA 182
++HPN+V L E + LV++ + G L + ++ E A+
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE----------ADASHC 110
Query: 183 AR----GLEYLHNKADPPVIYRDLKAGNILL---GKGFHPKLSDFGLAKFGPTGDKSHVS 235
+ + Y H+ +++R+LK N+LL KG KL+DFGLA +
Sbjct: 111 IQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WH 165
Query: 236 TRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
GT GY +PE + DI++ GV+L L+ G P
Sbjct: 166 GFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 205
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-25
Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 53/228 (23%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQ--LDDTGFQGEKEF----LVEVLMLSL 125
+ + + LG+G + VYKGK T +VA+K+ L+ E+ + EV +L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH-----EEGAPCTAIREVSLLKD 56
Query: 126 MRHPNLVHLIGYCAEGTQRLLVYEYMPL---GSLEDHLLGLTPE-----MKPLDWNTRMK 177
++H N+V L LV+EY+ L+D + + L
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQL------- 109
Query: 178 IAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK-FG-PTGDKSHVS 235
RGL Y H + V++RDLK N+L+ + KL+DFGLA+ PT +
Sbjct: 110 -----LRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN-- 159
Query: 236 TRVMGTHGYCAPE-------YATTGKLTAKSDIFSFGVVLLELITGRP 276
V+ T Y P+ Y+T D++ G + E+ TGRP
Sbjct: 160 -EVV-TLWYRPPDILLGSTDYSTQ------IDMWGVGCIFYEMATGRP 199
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-25
Identities = 68/227 (29%), Positives = 106/227 (46%), Gaps = 47/227 (20%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE-----FLVEVLMLSLM 126
++ +FLG+G F VYK + T Q+VA+K++ K+ L E+ +L +
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 127 RHPNLVHLIGYCAEGTQRLLVYEYMPL---GSLEDHLLGLTPE-----MKPLDWNTRMKI 178
HPN++ L+ + LV+++M ++D+ L LTP M
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT-------- 121
Query: 179 AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK-FG-PTGDKSHVST 236
+GLEYLH +++RDLK N+LL + KL+DFGLAK FG P +H
Sbjct: 122 ----LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH--- 171
Query: 237 RVMGTHGYCAPE-------YATTGKLTAKSDIFSFGVVLLELITGRP 276
+V+ T Y APE Y D+++ G +L EL+ P
Sbjct: 172 QVV-TRWYRAPELLFGARMYGVG------VDMWAVGCILAELLLRVP 211
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-25
Identities = 65/237 (27%), Positives = 104/237 (43%), Gaps = 54/237 (22%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE-F----LVEVLMLSLM 126
++ +GQG FG V+K + +TGQ VA+K++ + EKE F L E+ +L L+
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLL 73
Query: 127 RHPNLVHLIGYCAEGTQRL--------LVYEYMPL---GSLEDHLLGLTPE-----MKPL 170
+H N+V+LI C LV+++ G L + L+ T M+ L
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 133
Query: 171 DWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA-KFG-PT 228
GL Y+H +++RD+KA N+L+ + KL+DFGLA F
Sbjct: 134 ------------LNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 229 GDKSHVSTRVMGTHGYCAPE-------YATTGKLTAKSDIFSFGVVLLELITGRPAM 278
+ + T + T Y PE Y D++ G ++ E+ T P M
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDYGP------PIDLWGAGCIMAEMWTRSPIM 229
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-25
Identities = 59/263 (22%), Positives = 103/263 (39%), Gaps = 54/263 (20%)
Query: 38 ETPARRNTLDDTLSAHENKNKENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETG 97
TL+ + + + + D ++ LG+G +G VYK T
Sbjct: 4 HHHHHMGTLEAQTQGPGSMSVSAAPSATSI----DRYRRITKLGEGTYGEVYKAIDTVTN 59
Query: 98 QVVAVKQ--LDDTGFQGEKE-----FLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150
+ VA+K+ L+ E+E + EV +L ++H N++ L + L++EY
Sbjct: 60 ETVAIKRIRLEH-----EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY 114
Query: 151 MP--LGSLEDHLLGLTP-EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNI 207
L D ++ +K + G+ + H++ ++RDLK N+
Sbjct: 115 AENDLKKYMDKNPDVSMRVIKSFLYQL--------INGVNFCHSRR---CLHRDLKPQNL 163
Query: 208 LLGKGFHP-----KLSDFGLAK-FG-PTGDKSHVSTRVMGTHGYCAPE-------YATTG 253
LL K+ DFGLA+ FG P +H ++ T Y PE Y+T
Sbjct: 164 LLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII-TLWYRPPEILLGSRHYST-- 217
Query: 254 KLTAKSDIFSFGVVLLELITGRP 276
DI+S + E++ P
Sbjct: 218 ----SVDIWSIACIWAEMLMKTP 236
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 60/226 (26%), Positives = 94/226 (41%), Gaps = 32/226 (14%)
Query: 65 RQLVAATDNFKDT----NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEV 120
+QL + F D +G G + + T AVK +D + +E +E+
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IEI 68
Query: 121 LMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLL--GLTPEMKPLDWNTRMKI 178
+L +HPN++ L +G +V E M G L D +L E +
Sbjct: 69 -LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSERE---------- 117
Query: 179 AAGAAR----GLEYLHNKADPPVIYRDLKAGNILL-GKGFHP---KLSDFGLAKFGPTGD 230
A+ +EYLH + V++RDLK NIL + +P ++ DFG AK +
Sbjct: 118 ASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174
Query: 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
+ T T + APE A DI+S GV+L ++TG
Sbjct: 175 GL-LMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYT 218
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEF---LVEVLMLSLMRH 128
D+F+ +G+G FG V + +T ++ A+K ++ E E+ ++ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 129 PNLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRMKI-AAGAAR 184
P LV+L Y + + + +V + + G L HL E +K+
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKE-------ETVKLFICELVM 126
Query: 185 GLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGY 244
L+YL N+ +I+RD+K NILL + H ++DF +A P + T + GT Y
Sbjct: 127 ALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPY 180
Query: 245 CAPEYATTGKLTAKS---DIFSFGVVLLELITGRP 276
APE ++ K S D +S GV EL+ GR
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-24
Identities = 66/217 (30%), Positives = 99/217 (45%), Gaps = 36/217 (16%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV-----EVLMLSLMRHPNLVHL 134
LG G FG V G+ TG VAVK L+ + +V E+ L L RHP+++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLD--VVGKIKREIQNLKLFRHPHIIKL 76
Query: 135 IGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAAR--------GL 186
+ T +V EY+ G L D++ + R++ AR +
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICK----------HGRVEEME--ARRLFQQILSAV 124
Query: 187 EYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCA 246
+Y H V++RDLK N+LL + K++DFGL+ G+ S G+ Y A
Sbjct: 125 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAA 178
Query: 247 PEYATTGKL--TAKSDIFSFGVVLLELITGRPAMDDS 281
PE +G+L + DI+S GV+L L+ G DD
Sbjct: 179 PE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-24
Identities = 58/219 (26%), Positives = 85/219 (38%), Gaps = 38/219 (17%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVL----------MLSLMRHP 129
LG+G V + T + AVK +D TG V+ L + + HP
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 130 NLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLL--GLTPEMKPLDWNTRMKIAAGAAR--- 184
N++ L T LV++ M G L D+L E K R
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE----------KETRKIMRALL 134
Query: 185 -GLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG 243
+ LH +++RDLK NILL + KL+DFG + G+K + GT
Sbjct: 135 EVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVC-GTPS 188
Query: 244 YCAPE------YATTGKLTAKSDIFSFGVVLLELITGRP 276
Y APE + D++S GV++ L+ G P
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-24
Identities = 55/220 (25%), Positives = 85/220 (38%), Gaps = 38/220 (17%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLD------DTGFQGEKEFLV--EVLMLSLMRHPNL 131
LG G FG V+ E + V VK + D + K V E+ +LS + H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 132 VHLIGYCAEGTQRLLVYE-YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAAR------ 184
+ ++ LV E + L + D + R+ A
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFI----------DRHPRLDEPL--ASYIFRQL 139
Query: 185 --GLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTH 242
+ YL K +I+RD+K NI++ + F KL DFG A + G + GT
Sbjct: 140 VSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTI 193
Query: 243 GYCAPEYATTGKL--TAKSDIFSFGVVLLELITGRPAMDD 280
YCAPE G + +++S GV L L+ +
Sbjct: 194 EYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-24
Identities = 59/213 (27%), Positives = 91/213 (42%), Gaps = 32/213 (15%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVK-----QLDDTGFQGEKEFLV-EVLMLSLMRHPNLVH 133
LG G F V K + TG+ A K +L + +E + EV +L +RHPN++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 134 LIGYCAEGTQRLLVYEYMPLGSLEDHLL--GLTPEMKPLDWNTRMKIAAGAAR----GLE 187
L T +L+ E + G L D L E + A + G+
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDE----------ATQFLKQILDGVH 122
Query: 188 YLHNKADPPVIYRDLKAGNILL----GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG 243
YLH+K + + DLK NI+L KL DFG+A G++ + GT
Sbjct: 123 YLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTPE 176
Query: 244 YCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
+ APE L ++D++S GV+ L++G
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 209
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 3e-24
Identities = 70/244 (28%), Positives = 115/244 (47%), Gaps = 51/244 (20%)
Query: 53 HENKNKENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQ--LDDTGF 110
H + +EN + + + ++ +G+G +G VYK K G++VA+K+ LD
Sbjct: 6 HHSSGRENLYFQGLM----EKYQKLEKVGEGTYGVVYKAK-DSQGRIVALKRIRLDA--- 57
Query: 111 QGEKE-----FLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPL---GSLEDHLLG 162
E E + E+ +L + HPN+V LI LV+E+M L+++ G
Sbjct: 58 --EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTG 115
Query: 163 LTP-EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFG 221
L ++K + RG+ + H +++RDLK N+L+ KL+DFG
Sbjct: 116 LQDSQIKIY---LYQLL-----RGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFG 164
Query: 222 LAK-FG-PTGDKSHVSTRVMGTHGYCAPE-------YATTGKLTAKSDIFSFGVVLLELI 272
LA+ FG P +H V+ T Y AP+ Y+T+ DI+S G + E+I
Sbjct: 165 LARAFGIPVRSYTH---EVV-TLWYRAPDVLMGSKKYSTS------VDIWSIGCIFAEMI 214
Query: 273 TGRP 276
TG+P
Sbjct: 215 TGKP 218
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-24
Identities = 55/217 (25%), Positives = 86/217 (39%), Gaps = 37/217 (17%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLD--------DTGFQGEKEFLVEVLMLSLMRHPNL 131
LG G G V +T + VA+K + E+ +L + HP +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 132 VHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRM--KIAAGAAR----G 185
+ + + + +V E M G L D ++G N R+
Sbjct: 78 IKIKNFF-DAEDYYIVLELMEGGELFDKVVG----------NKRLKEATCKLYFYQMLLA 126
Query: 186 LEYLHNKADPPVIYRDLKAGNILL---GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTH 242
++YLH +I+RDLK N+LL + K++DFG +K G+ S + T GT
Sbjct: 127 VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC-GTP 180
Query: 243 GYCAPE---YATTGKLTAKSDIFSFGVVLLELITGRP 276
Y APE T D +S GV+L ++G P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 4e-24
Identities = 67/217 (30%), Positives = 97/217 (44%), Gaps = 26/217 (11%)
Query: 72 DNFKDTNFLGQGGFGAVY---KGKLAETGQVVAVKQLD-DTGFQGEKEF---LVEVLMLS 124
+ F+ LG+GG+G V+ K A TG++ A+K L + K+ E +L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 125 LMRHPNLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRMKI-AA 180
++HP +V LI Y + +L L+ EY+ G L L G+ E A
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFME-------DTACFYLA 128
Query: 181 GAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVM- 239
+ L +LH K +IYRDLK NI+L H KL+DFGL K T
Sbjct: 129 EISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT---VTHTFC 182
Query: 240 GTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
GT Y APE D +S G ++ +++TG P
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 4e-24
Identities = 39/210 (18%), Positives = 90/210 (42%), Gaps = 21/210 (10%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA 139
LG+G FG V++ + + K + G + E+ +L++ RH N++HL
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 140 EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAAR----GLEYLHNKADP 195
+ ++++E++ + + + E+ + L++LH+
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNERE-------IVSYVHQVCEALQFLHSHN-- 122
Query: 196 PVIYRDLKAGNILLG--KGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTG 253
+ + D++ NI+ + K+ +FG A+ GD + + Y APE
Sbjct: 123 -IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHD 178
Query: 254 KLTAKSDIFSFGVVLLELITG-RPAMDDSQ 282
++ +D++S G ++ L++G P + ++
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETN 208
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 5e-24
Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 55/229 (24%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQ--LDDTGFQGEKE-----FLVEVLMLS 124
+ + +G+G +G VYK + G+ A+K+ L+ E E + E+ +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEK-----EDEGIPSTTIREISILK 55
Query: 125 LMRHPNLVHLIGYCAEGTQRLLVYEYMPL---GSLEDHLLGLTPE-----MKPLDWNTRM 176
++H N+V L + +LV+E++ L+ GL + L
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL------ 109
Query: 177 KIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK-FG-PTGDKSHV 234
G+ Y H++ V++RDLK N+L+ + K++DFGLA+ FG P +H
Sbjct: 110 ------LNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH- 159
Query: 235 STRVMGTHGYCAPE-------YATTGKLTAKSDIFSFGVVLLELITGRP 276
++ T Y AP+ Y+TT DI+S G + E++ G P
Sbjct: 160 --EIV-TLWYRAPDVLMGSKKYSTT------IDIWSVGCIFAEMVNGTP 199
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 5e-24
Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 47/226 (20%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQ--LDDTGFQGEKE-----FLVEVLMLS 124
++ +G+G +G V+K K ET ++VA+K+ LDD + E L E+ +L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-----DDEGVPSSALREICLLK 56
Query: 125 LMRHPNLVHLIGYCAEGTQRLLVYEYMPL---GSLEDHLLGLTP-EMKPLDWNTRMKIAA 180
++H N+V L + LV+E+ + L P +K +
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF---LFQLL-- 111
Query: 181 GAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK-FG-PTGDKSHVSTRV 238
+GL + H++ V++RDLK N+L+ + KL++FGLA+ FG P S V
Sbjct: 112 ---KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EV 162
Query: 239 MGTHGYCAPE-------YATTGKLTAKSDIFSFGVVLLELIT-GRP 276
+ T Y P+ Y+T+ D++S G + EL GRP
Sbjct: 163 V-TLWYRPPDVLFGAKLYSTS------IDMWSAGCIFAELANAGRP 201
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 6e-24
Identities = 57/243 (23%), Positives = 91/243 (37%), Gaps = 25/243 (10%)
Query: 47 DDTLSAHENKNKENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLD 106
+ + + K T +Q+ ++F+ +G+G FG V KL +V A+K L+
Sbjct: 49 EKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN 108
Query: 107 DTGFQGEKE---FLVEVLMLSLMRHPNLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHLL- 161
E F E +L + L Y + L LV +Y G L L
Sbjct: 109 KWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSK 167
Query: 162 --GLTPEMKPLDWNTRMKI-AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLS 218
PE + A ++ +H ++RD+K NIL+ H +L+
Sbjct: 168 FEDRLPE-------EMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLA 217
Query: 219 DFGLAKFGPTGDKSHVSTRVMGTHGYCAPE-----YATTGKLTAKSDIFSFGVVLLELIT 273
DFG S V GT Y +PE G+ + D +S GV + E++
Sbjct: 218 DFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
Query: 274 GRP 276
G
Sbjct: 277 GET 279
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 9e-24
Identities = 69/222 (31%), Positives = 100/222 (45%), Gaps = 38/222 (17%)
Query: 72 DNFKDTNFLGQGGFGAVY---KGKLAETGQVVAVKQLDDTGFQGEKEFL-----VEVLM- 122
F+ LGQG FG V+ K ++ Q+ A+K L +K L V M
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-------KKATLKVRDRVRTKME 76
Query: 123 ---LSLMRHPNLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRM 176
L + HP +V L Y + +L L+ +++ G L L + E +
Sbjct: 77 RDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE-------EDV 128
Query: 177 KI-AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVS 235
K A A L++LH+ +IYRDLK NILL + H KL+DFGL+K +K
Sbjct: 129 KFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---K 182
Query: 236 TRVM-GTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
GT Y APE T +D +SFGV++ E++TG
Sbjct: 183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 9e-24
Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 42/225 (18%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPN 130
+ + +G G FG V++ KL E+ +V A+K++ Q ++ E+ ++ +++HPN
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEV-AIKKV----LQDKRFKNRELQIMRIVKHPN 93
Query: 131 LVHLIGYCAEGTQRL------LVYEYMP--LGSLEDHLLGLTPEMKPLDWNTRM-KIAAG 181
+V L + + LV EY+P + H L M L M ++
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLL-- 151
Query: 182 AARGLEYLHNKADPPVIYRDLKAGNILLGKGFHP-KLSDFGLAK-FGPTGDKSH-VSTRV 238
R L Y+H+ + +RD+K N+LL KL DFG AK + +R
Sbjct: 152 --RSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY 206
Query: 239 MGTHGYCAPE-------YATTGKLTAKSDIFSFGVVLLELITGRP 276
Y APE Y T DI+S G V+ EL+ G+P
Sbjct: 207 -----YRAPELIFGATNY------TTNIDIWSTGCVMAELMQGQP 240
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-23
Identities = 59/213 (27%), Positives = 85/213 (39%), Gaps = 32/213 (15%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLD------DTGFQGEKEFLVEVLMLSLMRHPNLVH 133
LG G F V K + TG A K + +E EV +L + HPN++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 134 LIGYCAEGTQRLLVYEYMPLGSLEDHLL--GLTPEMKPLDWNTRMKIAAGAAR----GLE 187
L T +L+ E + G L D L E + A + G+
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE----------ATSFIKQILDGVN 129
Query: 188 YLHNKADPPVIYRDLKAGNILL----GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG 243
YLH K + + DLK NI+L H KL DFGLA G + + GT
Sbjct: 130 YLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPE 183
Query: 244 YCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
+ APE L ++D++S GV+ L++G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-23
Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 27/208 (12%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV--EVLMLSLMRHPNLVHLIGY 137
LG+G F V + TG A K ++ + E + ++HPN+V L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 138 CAEGTQRLLVYEYMPLGSLEDHLL--GLTPEMKPLDWNTRMKIAAGAAR----GLEYLHN 191
E + LV++ + G L + ++ E A+ + + Y H+
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREFYSE----------ADASHCIQQILESIAYCHS 146
Query: 192 KADPPVIYRDLKAGNILL---GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE 248
+++R+LK N+LL KG KL+DFGLA + GT GY +PE
Sbjct: 147 NG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFA-GTPGYLSPE 200
Query: 249 YATTGKLTAKSDIFSFGVVLLELITGRP 276
+ DI++ GV+L L+ G P
Sbjct: 201 VLKKDPYSKPVDIWACGVILYILLVGYP 228
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-23
Identities = 55/213 (25%), Positives = 86/213 (40%), Gaps = 32/213 (15%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLD------DTGFQGEKEFLVEVLMLSLMRHPNLVH 133
LG G F V K + TG A K + ++ EV +L ++HPN++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 134 LIGYCAEGTQRLLVYEYMPLGSLEDHLL--GLTPEMKPLDWNTRMKIAAGAAR----GLE 187
L T +L+ E + G L D L E + A + G+
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE----------ATEFLKQILNGVY 128
Query: 188 YLHNKADPPVIYRDLKAGNILL----GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG 243
YLH+ + + DLK NI+L K+ DFGLA G++ + GT
Sbjct: 129 YLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPE 182
Query: 244 YCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
+ APE L ++D++S GV+ L++G
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-23
Identities = 49/207 (23%), Positives = 82/207 (39%), Gaps = 28/207 (13%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEV-LMLSLMRHPNLVHLIGYC 138
LG+G F K ++ Q AVK + ++ E+ + HPN+V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 139 AEGTQRLLVYEYMPLGSLEDHLL--GLTPEMKPLDWNTRMKIAAGAAR----GLEYLHNK 192
+ LV E + G L + + E A+ R + ++H+
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKHFSE----------TEASYIMRKLVSAVSHMHDV 125
Query: 193 ADPPVIYRDLKAGNILL---GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEY 249
V++RDLK N+L K+ DFG A+ P ++ + T T Y APE
Sbjct: 126 G---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC-FTLHYAAPEL 180
Query: 250 ATTGKLTAKSDIFSFGVVLLELITGRP 276
D++S GV+L +++G+
Sbjct: 181 LNQNGYDESCDLWSLGVILYTMLSGQV 207
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-23
Identities = 56/241 (23%), Positives = 92/241 (38%), Gaps = 19/241 (7%)
Query: 47 DDTLSAHENKNKENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLD 106
D ++ + +++ D+F+ +G+G F V K+ +TGQV A+K ++
Sbjct: 36 DKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMN 95
Query: 107 DTGFQGEKE---FLVEVLMLSLMRHPNLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHLLG 162
E F E +L + L + + L LV EY G L L
Sbjct: 96 KWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSK 154
Query: 163 LTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL 222
+ P + R A ++ +H ++RD+K NILL + H +L+DFG
Sbjct: 155 FGERI-PAEM-ARF-YLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGS 208
Query: 223 AKFGPTGDKSHVSTRVMGTHGYCAPE-------YATTGKLTAKSDIFSFGVVLLELITGR 275
V GT Y +PE TG + D ++ GV E+ G+
Sbjct: 209 CLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
Query: 276 P 276
Sbjct: 268 T 268
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-23
Identities = 56/234 (23%), Positives = 99/234 (42%), Gaps = 42/234 (17%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLD---------------------DTGFQGEKEFLV 118
+G+G +G V A+K L G + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 119 -----EVLMLSLMRHPNLVHLIGYCAEGTQRLL--VYEYMPLGSLEDHLLGLTPEMKPLD 171
E+ +L + HPN+V L+ + + L V+E + G + + P +KPL
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-----VPTLKPLS 135
Query: 172 WNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231
+ +G+EYLH + +I+RD+K N+L+G+ H K++DFG++ G
Sbjct: 136 EDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE-FKGSD 191
Query: 232 SHVSTRVMGTHGYCAPEYATTGKLT---AKSDIFSFGVVLLELITGR-PAMDDS 281
+ +S V GT + APE + + D+++ GV L + G+ P MD+
Sbjct: 192 ALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-23
Identities = 58/220 (26%), Positives = 86/220 (39%), Gaps = 44/220 (20%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV--EVLMLSLMRHPNLVHLIGY 137
+G G FG + T ++VAVK ++ E V E++ +RHPN+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN---VQREIINHRSLRHPNIVRFKEV 84
Query: 138 CAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAAR--------GLEYL 189
T ++ EY G L + + R AR G+ Y
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICN----------AGRFSED--EARFFFQQLLSGVSYC 132
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHP--KLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAP 247
H+ + +RDLK N LL P K+ DFG +K + + V GT Y AP
Sbjct: 133 HSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIAP 186
Query: 248 E------YATTGKLTAKSDIFSFGVVLLELITGRPAMDDS 281
E Y GK +D++S GV L ++ G +D
Sbjct: 187 EVLLRQEYD--GK---IADVWSCGVTLYVMLVGAYPFEDP 221
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-23
Identities = 58/213 (27%), Positives = 84/213 (39%), Gaps = 32/213 (15%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLD------DTGFQGEKEFLVEVLMLSLMRHPNLVH 133
LG G F V K + TG A K + +E EV +L + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 134 LIGYCAEGTQRLLVYEYMPLGSLEDHLL--GLTPEMKPLDWNTRMKIAAGAAR----GLE 187
L T +L+ E + G L D L E + A + G+
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE----------ATSFIKQILDGVN 129
Query: 188 YLHNKADPPVIYRDLKAGNILL----GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG 243
YLH K + + DLK NI+L H KL DFGLA G + + GT
Sbjct: 130 YLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPE 183
Query: 244 YCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
+ APE L ++D++S GV+ L++G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 3e-23
Identities = 60/246 (24%), Positives = 98/246 (39%), Gaps = 34/246 (13%)
Query: 47 DDTLSAHENKNKENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLD 106
+ + ++ K+ R L ++++ +G+G FG V + T +V A+K L
Sbjct: 44 NKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS 103
Query: 107 DTGFQGEKE---FLVEVLMLSLMRHPNLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHLLG 162
+ F E +++ P +V L Y + + L +V EYMP G L + +
Sbjct: 104 KFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM-- 160
Query: 163 LTPEMKPLDWNTRMKIAAGAAR--------GLEYLHNKADPPVIYRDLKAGNILLGKGFH 214
+ + AR L+ +H+ I+RD+K N+LL K H
Sbjct: 161 -----------SNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGH 206
Query: 215 PKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE----YATTGKLTAKSDIFSFGVVLLE 270
KL+DFG T V GT Y +PE G + D +S GV L E
Sbjct: 207 LKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 265
Query: 271 LITGRP 276
++ G
Sbjct: 266 MLVGDT 271
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-23
Identities = 53/212 (25%), Positives = 87/212 (41%), Gaps = 27/212 (12%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV-----EVLMLSLMRHPNLVHL 134
+G+G F V + ETGQ AVK +D F E + +++HP++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 135 IGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAAR----GLEYLH 190
+ + +V+E+M L ++ +A+ R L Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYS----EAVASHYMRQILEALRYCH 147
Query: 191 NKADPPVIYRDLKAGNILL---GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAP 247
+ +I+RD+K +LL KL FG+A G+ V+ +GT + AP
Sbjct: 148 DNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPHFMAP 202
Query: 248 E---YATTGKLTAKSDIFSFGVVLLELITGRP 276
E GK D++ GV+L L++G
Sbjct: 203 EVVKREPYGK---PVDVWGCGVILFILLSGCL 231
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-23
Identities = 62/227 (27%), Positives = 90/227 (39%), Gaps = 39/227 (17%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEF----LVEVLMLSLM 126
D F+ GQG FG V GK TG VA+K++ Q + F L + L+++
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV----IQ-DPRFRNRELQIMQDLAVL 76
Query: 127 RHPNLVHLIGYCAEGTQR-------LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIA 179
HPN+V L Y +R +V EY+P +L
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 180 AGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHP-KLSDFGLAK-FGPTGDKSH-VST 236
R + LH + V +RD+K N+L+ + KL DFG AK P+ + +
Sbjct: 136 FQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICS 194
Query: 237 RVMGTHGYCAPE-------YATTGKLTAKSDIFSFGVVLLELITGRP 276
R Y APE Y T DI+S G + E++ G P
Sbjct: 195 RY-----YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGEP 230
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 4e-23
Identities = 66/215 (30%), Positives = 97/215 (45%), Gaps = 32/215 (14%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV---EVLMLSLMRHPNLVHLIG 136
LG G FG V GK TG VAVK L+ + E+ L L RHP+++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 137 YCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAAR--------GLEY 188
+ + +V EY+ G L D++ N R+ +R G++Y
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICK----------NGRLDEKE--SRRLFQQILSGVDY 131
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE 248
H V++RDLK N+LL + K++DFGL+ G+ S G+ Y APE
Sbjct: 132 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE 185
Query: 249 YATTGKL--TAKSDIFSFGVVLLELITGRPAMDDS 281
+G+L + DI+S GV+L L+ G DD
Sbjct: 186 -VISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD 219
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 98.2 bits (244), Expect = 5e-23
Identities = 77/294 (26%), Positives = 111/294 (37%), Gaps = 39/294 (13%)
Query: 2 SPNCPCFGWRKKKTKPKINEDKDSPGPSRIDTVERQETPARRNTLDDTLSAHENKNKENT 61
GW K ++ + E + P P + + + NT
Sbjct: 267 LQKAGVDGWFKLLSQEE-GEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANT 325
Query: 62 FTYRQLVAATDNFKDTNF-----LGQGGFGAVYKGKLAETGQVVAVKQL--------DDT 108
+ D K T+F LG+G FG V + T ++ AVK L DD
Sbjct: 326 ISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDV 385
Query: 109 GF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHL--LGLT 164
EK L + P L L C + RL V EY+ G L H+ +G
Sbjct: 386 ECTMVEKRVLALP-----GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRF 439
Query: 165 PEMKPLDWNTRMKI-AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA 223
E AA A GL +L +K +IYRDLK N++L H K++DFG+
Sbjct: 440 KE-------PHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC 489
Query: 224 KFGPTGDKSHVSTRVM-GTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
K +T+ GT Y APE D ++FGV+L E++ G+
Sbjct: 490 KENIWDGV---TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-23
Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 27/218 (12%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA 139
LG+G VY+ K T + A+K L T +K E+ +L + HPN++ L
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 140 EGTQRLLVYEYMPLGSLEDHLL--GLTPEMKPLDWNTRMKIAAGAAR----GLEYLHNKA 193
T+ LV E + G L D ++ G E + AA A + + YLH
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGYYSE----------RDAADAVKQILEAVAYLHENG 168
Query: 194 DPPVIYRDLKAGNILL---GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYA 250
+++RDLK N+L K++DFGL+K + T GT GYCAPE
Sbjct: 169 ---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL--MKTVC-GTPGYCAPEIL 222
Query: 251 TTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288
+ D++S G++ L+ G D +G + M
Sbjct: 223 RGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF 260
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-23
Identities = 47/223 (21%), Positives = 83/223 (37%), Gaps = 40/223 (17%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLD----DTGFQGEKEFLV--EVLMLSLMRH--PNL 131
LG GGFG+VY G VA+K ++ + V EV++L + +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 132 VHLIGYCAEGTQRLLVYEY-MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAAR------ 184
+ L+ + +L+ E P+ L D + ++ AR
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITE----------RGALQ--EELARSFFWQV 158
Query: 185 --GLEYLHNKADPPVIYRDLKAGNILL-GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGT 241
+ + HN V++RD+K NIL+ KL DFG + GT
Sbjct: 159 LEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFD-GT 211
Query: 242 HGYCAPEYATTGKL--TAKSDIFSFGVVLLELITGRPAMDDSQ 282
Y PE+ + ++S G++L +++ G + +
Sbjct: 212 RVYSPPEW-IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 253
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 6e-23
Identities = 59/280 (21%), Positives = 101/280 (36%), Gaps = 34/280 (12%)
Query: 10 WRKKKTKPKINEDKDSPGPSRIDTVERQETPARRNTLDDTLSAHENKNKENTFTYRQLVA 69
+ P + +P P P + + + A
Sbjct: 3 SNSQGQSPPVPFPAPAPPPQP----PTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNA 58
Query: 70 ATDNFKDTN-FLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEV-LMLSLMR 127
D++K T+ LG G G V + T + A+K L D + EV L +
Sbjct: 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQ 113
Query: 128 HPNLVHLIGYCAEGTQR----LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAA 183
P++V ++ L+V E + G L + + + R A+
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTERE--ASEIM 167
Query: 184 R----GLEYLHNKADPPVIYRDLKAGNILL---GKGFHPKLSDFGLAKFGPTGDKSHVST 236
+ ++YLH+ + +RD+K N+L KL+DFG AK + + ++T
Sbjct: 168 KSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTT 222
Query: 237 RVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
T Y APE K D++S GV++ L+ G P
Sbjct: 223 PC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 261
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-23
Identities = 67/213 (31%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEF---LVEVLMLSLMRH 128
++F LG+G FG V + TG+ A+K L + E + E +L RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 129 PNLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRMKI-AAGAAR 184
P L L Y + RL V EY G L HL + E R + A
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTE-------ERARFYGAEIVS 116
Query: 185 GLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVM-GTHG 243
LEYLH++ V+YRD+K N++L K H K++DFGL K G + + + GT
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFCGTPE 170
Query: 244 YCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
Y APE D + GVV+ E++ GR
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 7e-23
Identities = 61/239 (25%), Positives = 96/239 (40%), Gaps = 60/239 (25%)
Query: 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEV--------- 120
AT ++ +G G +G VYK + +G VA+K + +
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR---VPNGGGGGGGLPISTVREVA 63
Query: 121 --LMLSLMRHPNLVHLI----GYCAEGTQRL-LVYEYMP--LGSLEDHL--LGLTPE--- 166
L HPN+V L+ + ++ LV+E++ L + D GL E
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK 123
Query: 167 --MKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224
M+ RGL++LH +++RDLK NIL+ G KL+DFGLA+
Sbjct: 124 DLMRQF------------LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168
Query: 225 -FGPTGDKSHVSTRVMGTHGYCAPE------YATTGKLTAKSDIFSFGVVLLELITGRP 276
+ + V+ T Y APE YAT D++S G + E+ +P
Sbjct: 169 IYSYQMALTP---VVV-TLWYRAPEVLLQSTYATP------VDMWSVGCIFAEMFRRKP 217
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-23
Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 33/215 (15%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV---EVLMLSLMRHPNLVHLIG 136
LG+G FG V +T Q VA+K + + + E+ L L+RHP+++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 137 YCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAAR--------GLEY 188
T ++V EY G L D+++ RM R +EY
Sbjct: 77 VITTPTDIVMVIEYAG-GELFDYIVE----------KKRMTEDE--GRRFFQQIICAIEY 123
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE 248
H +++RDLK N+LL + K++DFGL+ G+ S G+ Y APE
Sbjct: 124 CHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE 177
Query: 249 YATTGKL--TAKSDIFSFGVVLLELITGRPAMDDS 281
GKL + D++S G+VL ++ GR DD
Sbjct: 178 -VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-23
Identities = 65/247 (26%), Positives = 105/247 (42%), Gaps = 27/247 (10%)
Query: 41 ARRNTLDDTLSAHENKNKENTFTYRQLVAATDNFKDTNF-----LGQGGFGAVYKGKLAE 95
A++ + +++ K KE+ F + + + + F LG G FG V K E
Sbjct: 6 AKKGSEQESVKEFLAKAKED-FLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE 64
Query: 96 TGQVVAVKQLDDTGFQGEKEF---LVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMP 152
+G A+K LD K+ L E +L + P LV L + + +V EY+
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 153 LGSLEDHL--LGLTPEMKPLDWNTRMKI-AAGAARGLEYLHNKADPPVIYRDLKAGNILL 209
G + HL +G E + AA EYLH+ +IYRDLK N+L+
Sbjct: 125 GGEMFSHLRRIGRFSE-------PHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLI 174
Query: 210 GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLL 269
+ + +++DFG AK + + GT APE + D ++ GV++
Sbjct: 175 DQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWALGVLIY 229
Query: 270 ELITGRP 276
E+ G P
Sbjct: 230 EMAAGYP 236
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-22
Identities = 52/246 (21%), Positives = 93/246 (37%), Gaps = 38/246 (15%)
Query: 53 HENKNKENTFTYRQ---LVAATDNFKDT-----NFLGQGGFGAVYKGKLAETGQVVAVKQ 104
H + + + + +NF + LG+G F V + TGQ A K
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKF 61
Query: 105 LDDTGFQGEKEFLV--EVLMLSLMRH-PNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLL 161
L + + E+ +L L + P +++L ++ +L+ EY G + L
Sbjct: 62 LKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCL 121
Query: 162 ----GLTPEMKPLDWNTRMKIAAGAAR----GLEYLHNKADPPVIYRDLKAGNILL---G 210
+ E + G+ YLH +++ DLK NILL
Sbjct: 122 PELAEMVSE----------NDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIY 168
Query: 211 KGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLE 270
K+ DFG+++ + +MGT Y APE +T +D+++ G++
Sbjct: 169 PLGDIKIVDFGMSRKIGHACELRE---IMGTPEYLAPEILNYDPITTATDMWNIGIIAYM 225
Query: 271 LITGRP 276
L+T
Sbjct: 226 LLTHTS 231
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-22
Identities = 59/227 (25%), Positives = 93/227 (40%), Gaps = 34/227 (14%)
Query: 72 DNFKDTNF-LGQGGFGAVYKG--KLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRH 128
D F+ +G+G +G VYK K + + A+KQ++ TG E+ +L ++H
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKH 77
Query: 129 PNLVHLIGYCAEGTQRL--LVYEYMP--LGSLEDHLLGLTPEMKPLDWNTRM--KIAAGA 182
PN++ L R L+++Y L + KP+ M +
Sbjct: 78 PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 183 ARGLEYLHNKADPPVIYRDLKAGNILLGKGFHP----KLSDFGLA-KFG-PTGDKSHVST 236
G+ YLH V++RDLK NIL+ K++D G A F P + +
Sbjct: 138 LDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194
Query: 237 RVMGTHGYCAPE-------YATTGKLTAKSDIFSFGVVLLELITGRP 276
V+ T Y APE Y DI++ G + EL+T P
Sbjct: 195 VVV-TFWYRAPELLLGARHYTKA------IDIWAIGCIFAELLTSEP 234
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 52/208 (25%), Positives = 86/208 (41%), Gaps = 26/208 (12%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLV--EVLMLSLMRHPNLVHLIGY 137
LG+G F V + GQ A ++ + E + L++HPN+V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 138 CAEGTQRLLVYEYMPLGSLEDHLL--GLTPEMKPLDWNTRMKIAAGAAR----GLEYLHN 191
+E L+++ + G L + ++ E A+ + + + H
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD----------ASHCIQQILEAVLHCHQ 128
Query: 192 KADPPVIYRDLKAGNILL---GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE 248
V++R+LK N+LL KG KL+DFGLA G++ GT GY +PE
Sbjct: 129 MG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFA-GTPGYLSPE 183
Query: 249 YATTGKLTAKSDIFSFGVVLLELITGRP 276
D+++ GV+L L+ G P
Sbjct: 184 VLRKDPYGKPVDLWACGVILYILLVGYP 211
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-22
Identities = 69/222 (31%), Positives = 100/222 (45%), Gaps = 39/222 (17%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVE------------ 119
++F LG+G FG V+ + +T Q A+K L +K+ ++
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL-------KKDVVLMDDDVECTMVEKR 69
Query: 120 VLMLSLMRHPNLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRM 176
VL L+ HP L H+ + + L V EY+ G L H+ +R
Sbjct: 70 VLSLA-WEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDL-------SRA 120
Query: 177 KI-AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVS 235
AA GL++LH+K ++YRDLK NILL K H K++DFG+ K GD
Sbjct: 121 TFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA---K 174
Query: 236 TRVM-GTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
T GT Y APE K D +SFGV+L E++ G+
Sbjct: 175 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-22
Identities = 47/217 (21%), Positives = 85/217 (39%), Gaps = 40/217 (18%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLD----DTGFQGEKEFLV--EVLMLSLMR----HP 129
LG+GGFG V+ G VA+K + EV +L + HP
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 130 NLVHLIGYCAEGTQRLLVYEY-MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAAR---- 184
++ L+ + +LV E +P L D++ + G +R
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE----------KGPLG--EGPSRCFFG 146
Query: 185 ----GLEYLHNKADPPVIYRDLKAGNILL-GKGFHPKLSDFGLAKFGPTGDKSHVSTRVM 239
+++ H++ V++RD+K NIL+ + KL DFG +
Sbjct: 147 QVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE---PYTDFD- 199
Query: 240 GTHGYCAPEYATTGKLT-AKSDIFSFGVVLLELITGR 275
GT Y PE+ + + + ++S G++L +++ G
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-22
Identities = 71/294 (24%), Positives = 110/294 (37%), Gaps = 54/294 (18%)
Query: 20 NEDKDSPGPSRIDTVERQETPARRNTLDDTLSAHENKNKENTFTYRQLVAATDNFKDTNF 79
E+ S G + + + + + T+ L +NF+
Sbjct: 9 EEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVG-------IENFELLKV 61
Query: 80 LGQGGFGAVY---KGKLAETGQVVAVKQLDDTGFQGEKEFLVE-------------VLML 123
LG G +G V+ K +TG++ A+K L K +V+ VL
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLK-------KATIVQKAKTTEHTRTERQVLEH 114
Query: 124 SLMRHPNLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRMKI-A 179
+ P LV L Y + +L L+ +Y+ G L HL E ++I
Sbjct: 115 IR-QSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTE-------HEVQIYV 165
Query: 180 AGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVM 239
LE+LH +IYRD+K NILL H L+DFGL+K +
Sbjct: 166 GEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC- 221
Query: 240 GTHGYCAPE---YATTGKLTAKSDIFSFGVVLLELITGRP---AMDDSQGHERM 287
GT Y AP+ +G A D +S GV++ EL+TG + +
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 274
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-22
Identities = 68/282 (24%), Positives = 105/282 (37%), Gaps = 64/282 (22%)
Query: 12 KKKTKPKINEDKDSPGPSRIDTVERQETPARRNTLDDTLSAHENKNKENTFTYRQLVAAT 71
+ +P++ +P P+ + + D F + ++
Sbjct: 3 SQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSD-------------FHFLKV---- 45
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVE------------ 119
+G+G FG V + AVK L K+ +++
Sbjct: 46 --------IGKGSFGKVLLARHKAEEVFYAVKVLQ-------KKAILKKKEEKHIMSERN 90
Query: 120 VLMLSLMRHPNLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRM 176
VL+ + ++HP LV L + + +L V +Y+ G L HL E R
Sbjct: 91 VLLKN-VKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLE-------PRA 141
Query: 177 KI-AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVS 235
+ AA A L YLH+ ++YRDLK NILL H L+DFGL K + +
Sbjct: 142 RFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS---T 195
Query: 236 TRVM-GTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
T GT Y APE D + G VL E++ G P
Sbjct: 196 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 5e-22
Identities = 40/197 (20%), Positives = 70/197 (35%), Gaps = 25/197 (12%)
Query: 106 DDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHL---LG 162
+ V++ + N V + + + + +L+D +
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 163 LTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL 222
L + + ++IA +E+LH+K +++RDLK NI K+ DFGL
Sbjct: 158 LEDREHGVCLHIFIQIA----EAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGL 210
Query: 223 AK----------FGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELI 272
T +GT Y +PE + K DIFS G++L EL+
Sbjct: 211 VTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270
Query: 273 TGRPAMDDSQGHERMLV 289
ER+ +
Sbjct: 271 YSFST-----QMERVRI 282
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 5e-08
Identities = 16/66 (24%), Positives = 31/66 (46%), Gaps = 1/66 (1%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLD-DTGFQGEKEFLVEVLMLSLMRHPN 130
+F+ +G+GGFG V++ K A+K++ ++ + EV L+ + HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 131 LVHLIG 136
+V
Sbjct: 66 IVRYFN 71
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 5e-22
Identities = 56/245 (22%), Positives = 98/245 (40%), Gaps = 42/245 (17%)
Query: 52 AHENKNKENTFTYR---QLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDT 108
+K N ++ +++ +G G G V A + VA+K+L
Sbjct: 2 GSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 61
Query: 109 GFQGE---KEFLVEVLMLSLMRHPNLVHLIG-YCAEGTQRL-----LVYEYMP--LGSL- 156
FQ + K E++++ + H N++ L+ + + + +V E M L +
Sbjct: 62 -FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI 120
Query: 157 -----EDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK 211
+ + L +M G+++LH+ A +I+RDLK NI++
Sbjct: 121 QMELDHERMSYLLYQM---------------LCGIKHLHS-AG--IIHRDLKPSNIVVKS 162
Query: 212 GFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLEL 271
K+ DFGLA T S + T + T Y APE DI+S G ++ E+
Sbjct: 163 DCTLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219
Query: 272 ITGRP 276
I G
Sbjct: 220 IKGGV 224
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 8e-22
Identities = 66/219 (30%), Positives = 92/219 (42%), Gaps = 33/219 (15%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQL--------DDTGF-QGEKEFLVEVLM 122
+F LG+G FG V + T ++ AVK L DD EK L
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG- 78
Query: 123 LSLMRHPNLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRMKI- 178
+ P L L C + RL V EY+ G L H+ +G E
Sbjct: 79 ----KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE-------PHAVFY 126
Query: 179 AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRV 238
AA A GL +L +K +IYRDLK N++L H K++DFG+ K +T+
Sbjct: 127 AAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKT 180
Query: 239 M-GTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
GT Y APE D ++FGV+L E++ G+
Sbjct: 181 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 1e-21
Identities = 67/213 (31%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEF---LVEVLMLSLMRH 128
+F+ LG G FG V+ + G+ A+K L K+ E LMLS++ H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 129 PNLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRMKI-AAGAAR 184
P ++ + + Q++ ++ +Y+ G L L P K AA
Sbjct: 66 PFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPN-------PVAKFYAAEVCL 117
Query: 185 GLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVM-GTHG 243
LEYLH+K +IYRDLK NILL K H K++DFG AK+ P T + GT
Sbjct: 118 ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD------VTYTLCGTPD 168
Query: 244 YCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
Y APE +T D +SFG+++ E++ G
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 201
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-21
Identities = 63/237 (26%), Positives = 101/237 (42%), Gaps = 62/237 (26%)
Query: 72 DNFKDTNFLGQGGFGAVYKGK-LAETGQVVAVKQ--LDDTGFQGEKE-----FLVEV--- 120
++ +G+G +G V+K + L G+ VA+K+ + +E + EV
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-----GEEGMPLSTIREVAVL 65
Query: 121 LMLSLMRHPNLVHLI----GYCAEGTQRL-LVYEYMP--LGSLEDHL--LGLTPE----- 166
L HPN+V L + +L LV+E++ L + D + G+ E
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 125
Query: 167 MKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK-F 225
M L RGL++LH+ V++RDLK NIL+ KL+DFGLA+ +
Sbjct: 126 MFQL------------LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY 170
Query: 226 GPTGDKSHVSTRVMGTHGYCAPE------YATTGKLTAKSDIFSFGVVLLELITGRP 276
+ V+ T Y APE YAT D++S G + E+ +P
Sbjct: 171 SFQMALTS---VVV-TLWYRAPEVLLQSSYATP------VDLWSVGCIFAEMFRRKP 217
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 2e-21
Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 17/212 (8%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMR 127
+++ +G G G V A + VA+K+L FQ + K E++++ +
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 119
Query: 128 HPNLVHLIG-YCAEGTQRLL--VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAAR 184
H N++ L+ + + T VY M L + LD +
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV----IQMELDHERMSYLLYQMLC 175
Query: 185 GLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGY 244
G+++LH A +I+RDLK NI++ K+ DFGLA+ T S + T + T Y
Sbjct: 176 GIKHLH-SAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 229
Query: 245 CAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
APE DI+S G ++ E++ +
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-21
Identities = 63/274 (22%), Positives = 108/274 (39%), Gaps = 46/274 (16%)
Query: 20 NEDKDSPGPSRIDTVERQETPARRNTLDDTLSAHENKNKENTFTYRQLVAATDNFKDTNF 79
+ D P+ + + + + ++ E+ ++ +F
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLG-------LQDFDLLRV 59
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVE------------VLMLSLMR 127
+G+G + V +L +T ++ A++ + +KE + + V +
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVV-------KKELVNDDEDIDWVQTEKHVFEQAS-N 111
Query: 128 HPNLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRMKI-AAGAA 183
HP LV L C + RL V EY+ G L H+ PE + +A +
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE-------EHARFYSAEIS 163
Query: 184 RGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVM-GTH 242
L YLH + +IYRDLK N+LL H KL+D+G+ K G +T GT
Sbjct: 164 LALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTP 217
Query: 243 GYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
Y APE D ++ GV++ E++ GR
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 251
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 8e-21
Identities = 69/222 (31%), Positives = 98/222 (44%), Gaps = 39/222 (17%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVE------------ 119
DNF+ LG+G FG V ++ ETG + AVK L +K+ +++
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVL-------KKDVILQDDDVECTMTEKR 75
Query: 120 VLMLSLMRHPNLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRM 176
+L L+ HP L L C + RL V E++ G L H+ E R
Sbjct: 76 ILSLA-RNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE-------ARA 126
Query: 177 KI-AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVS 235
+ AA L +LH+K +IYRDLK N+LL H KL+DFG+ K G +
Sbjct: 127 RFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV---T 180
Query: 236 TRVM-GTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
T GT Y APE D ++ GV+L E++ G
Sbjct: 181 TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHA 222
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-20
Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 39/222 (17%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVE------------ 119
+F +G+G + V +L +T ++ A+K + +KE + +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVV-------KKELVNDDEDIDWVQTEKH 61
Query: 120 VLMLSLMRHPNLVHLIGYCAEGTQRL-LVYEYMPLGSLEDHL--LGLTPEMKPLDWNTRM 176
V + HP LV L C + RL V EY+ G L H+ PE
Sbjct: 62 VFEQAS-NHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE-------EHA 112
Query: 177 KI-AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVS 235
+ +A + L YLH + +IYRDLK N+LL H KL+D+G+ K G +
Sbjct: 113 RFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---T 166
Query: 236 TRVM-GTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
T GT Y APE D ++ GV++ E++ GR
Sbjct: 167 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 208
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-20
Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMR 127
++D +G G +GAV TG VA+K+L FQ E K E+ +L MR
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMR 82
Query: 128 HPNLVHLIG-YCAEGTQRL-----LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAG 181
H N++ L+ + + T LV +M LG + + L + +
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFM------GTDLGKLMKHEKLGEDRIQFLVYQ 136
Query: 182 AARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGT 241
+GL Y+H A +I+RDLK GN+ + + K+ DFGLA+ + +V TR
Sbjct: 137 MLKGLRYIHA-AG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW--- 190
Query: 242 HGYCAPEYA-TTGKLTAKSDIFSFGVVLLELITGRP 276
Y APE + T DI+S G ++ E+ITG+
Sbjct: 191 --YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-20
Identities = 59/224 (26%), Positives = 97/224 (43%), Gaps = 42/224 (18%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMR 127
+ +G G +G+V +G+ VA+K+L FQ E K E+L+L M+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-FQSEIFAKRAYRELLLLKHMQ 81
Query: 128 HPNLVHLI-----GYCAEGTQRL-LVYEYMP--LGSL------EDHLLGLTPEMKPLDWN 173
H N++ L+ LV +M L + E+ + L +M
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQM------ 135
Query: 174 TRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233
+GL+Y+H+ A V++RDLK GN+ + + K+ DFGLA+ +
Sbjct: 136 ---------LKGLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY 183
Query: 234 VSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRP 276
V TR Y APE + DI+S G ++ E++TG+
Sbjct: 184 VVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 8e-20
Identities = 69/255 (27%), Positives = 110/255 (43%), Gaps = 62/255 (24%)
Query: 53 HENKNKENTFTYRQLVAAT-----DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDD 107
H + ++E YRQ + T + +++ + +G G +G+V +TG VAVK+L
Sbjct: 5 HHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR 64
Query: 108 TGFQGE---KEFLVEVLMLSLMRHPNLVHLI-----GYCAEGTQRL-LVYEYMP--LGSL 156
FQ K E+ +L M+H N++ L+ E + LV M L ++
Sbjct: 65 P-FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 123
Query: 157 -------EDH-------LLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDL 202
+DH +L RGL+Y+H+ AD +I+RDL
Sbjct: 124 VKCQKLTDDHVQFLIYQIL----------------------RGLKYIHS-AD--IIHRDL 158
Query: 203 KAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKL-TAKSDI 261
K N+ + + K+ DFGLA+ +V+TR Y APE DI
Sbjct: 159 KPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-----YRAPEIMLNWMHYNQTVDI 213
Query: 262 FSFGVVLLELITGRP 276
+S G ++ EL+TGR
Sbjct: 214 WSVGCIMAELLTGRT 228
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 9e-20
Identities = 26/202 (12%), Positives = 49/202 (24%), Gaps = 45/202 (22%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLD-----DTGFQGEKEFLVEVLMLSLMRHPNLVHL 134
G ++ + VA+ +D +E L L LS + P + +
Sbjct: 39 HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVL--QETLSRTLRLSRIDKPGVARV 96
Query: 135 IGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKAD 194
+ L+V E++ GSL++ ++ A + H
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAH---R 147
Query: 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGK 254
V + + L+
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA------ 179
Query: 255 LTAKSDIFSFGVVLLELITGRP 276
+ DI G L L+ R
Sbjct: 180 -NPQDDIRGIGASLYALLVNRW 200
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-19
Identities = 49/253 (19%), Positives = 95/253 (37%), Gaps = 65/253 (25%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPN 130
+ + LG G FG V + E+G+ A+K++ Q + E+ ++ ++ H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV----LQDPRYKNRELDIMKVLDHVN 61
Query: 131 LVHLI---------------------GYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKP 169
++ L+ + ++ + + ++ L + E P
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 170 LDWNTRMKIAAGAA----------------RGLEYLHNKADPPVIYRDLKAGNILLGKGF 213
+ +K + R + ++H+ + +RD+K N+L+
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKD 178
Query: 214 HP-KLSDFGLAKFGPTGDK--SHVSTRVMGTHGYCAPE-------YATTGKLTAKSDIFS 263
+ KL DFG AK + +++ +R Y APE Y T D++S
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEY------TPSIDLWS 227
Query: 264 FGVVLLELITGRP 276
G V ELI G+P
Sbjct: 228 IGCVFGELILGKP 240
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-19
Identities = 59/232 (25%), Positives = 100/232 (43%), Gaps = 53/232 (22%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMR 127
+ + +++G+G +G V VA+K++ F+ + + L E+ +L R
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFR 83
Query: 128 HPNLVHLIG-YCAEGTQRL----LVYEYMP--LGSL-------EDH-------LLGLTPE 166
H N++ + A +++ +V + M L L DH +L
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL----- 138
Query: 167 MKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK-F 225
RGL+Y+H+ A+ V++RDLK N+LL K+ DFGLA+
Sbjct: 139 -----------------RGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVA 178
Query: 226 GPTGDKSHVSTRVMGTHGYCAPEYA-TTGKLTAKSDIFSFGVVLLELITGRP 276
P D + T + T Y APE + T DI+S G +L E+++ RP
Sbjct: 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 9e-19
Identities = 55/247 (22%), Positives = 92/247 (37%), Gaps = 76/247 (30%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMR 127
+ +F+ + LG+G +G V TG++VA+K+++ F L E+ +L +
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE--PFDKPLFALRTLREIKILKHFK 67
Query: 128 HPNLVHLIG-YCAEGTQRL----LVYEYM-----------PLGSLEDH-------LLGLT 164
H N++ + + + ++ E M L +DH L
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLS--DDHIQYFIYQTL--- 122
Query: 165 PEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA- 223
R ++ LH ++ VI+RDLK N+L+ K+ DFGLA
Sbjct: 123 -------------------RAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLAR 160
Query: 224 ---KFGPTGDKSHVSTRVM----GTHGYCAPE-------YATTGKLTAKSDIFSFGVVLL 269
+ + M T Y APE Y + D++S G +L
Sbjct: 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY------SRAMDVWSCGCILA 214
Query: 270 ELITGRP 276
EL RP
Sbjct: 215 ELFLRRP 221
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-18
Identities = 57/244 (23%), Positives = 95/244 (38%), Gaps = 68/244 (27%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMR 127
+ D LG GG G V+ + + VA+K++ K L E+ ++ +
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI---VLTDPQSVKHALREIKIIRRLD 66
Query: 128 HPNLVHLIG-YCAEGTQRL-------------LVYEYM-----------PLGSLEDH--- 159
H N+V + G+Q +V EYM PL LE+H
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL--LEEHARL 124
Query: 160 ----LLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL-GKGFH 214
LL RGL+Y+H+ A+ V++RDLK N+ + +
Sbjct: 125 FMYQLL----------------------RGLKYIHS-AN--VLHRDLKPANLFINTEDLV 159
Query: 215 PKLSDFGLAK-FGPTGDKSHVSTRVMGTHGYCAPE-YATTGKLTAKSDIFSFGVVLLELI 272
K+ DFGLA+ P + + T Y +P + T D+++ G + E++
Sbjct: 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 219
Query: 273 TGRP 276
TG+
Sbjct: 220 TGKT 223
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-18
Identities = 47/217 (21%), Positives = 92/217 (42%), Gaps = 35/217 (16%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMR-HP 129
D+++ LG+G + V++ + V VK L +K+ E+ +L +R P
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGP 91
Query: 130 NLVHL--IGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPE-----MKPLDWNTRMKIAAGA 182
N++ L I LV+E++ + LT M +
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEI------------ 139
Query: 183 ARGLEYLHNKADPPVIYRDLKAGNILL-GKGFHPKLSDFGLAKFGPTGDK--SHVSTRVM 239
+ L+Y H+ +++RD+K N+++ + +L D+GLA+F G + V++R
Sbjct: 140 LKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY- 195
Query: 240 GTHGYCAPEYATTGKLTAKS-DIFSFGVVLLELITGR 275
+ PE ++ S D++S G +L +I +
Sbjct: 196 ----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 228
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 7e-18
Identities = 57/278 (20%), Positives = 91/278 (32%), Gaps = 85/278 (30%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKL-----AETGQVVAVKQL-DDTGFQGEKEFLVEVLMLS- 124
D K LG+G FG V + T + VAVK L + + + E+ +L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 125 --------------------------LMRHPNLVH--------LIGYCAEGTQRLLVYEY 150
+ NL + Y +G + +Y
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141
Query: 151 M-----------------------------PLGSLEDHLLGLTPEMKPLDWNTRMKIAAG 181
+ L +E+ L + +
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201
Query: 182 AARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD--KSHVSTRV- 238
A+G+E+L ++ I+RDL A NILL + K+ DFGLA+ R+
Sbjct: 202 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 239 ---MGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT 273
M APE T +SD++SFGV+L E+ +
Sbjct: 259 LKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 57/229 (24%), Positives = 92/229 (40%), Gaps = 40/229 (17%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE-----------KEFLVE 119
+ F+ G +GAV G + G VA+K++ +T G K L E
Sbjct: 21 QSPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79
Query: 120 VLMLSLMRHPNLVHLIG-YCAEGTQRL----LVYEYMP--LGS-LEDHLLGLTPE-MKPL 170
+ +L+ HPN++ L + + LV E M L + D + ++P+ ++
Sbjct: 80 IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYF 139
Query: 171 DWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230
++ GL LH A V++RDL GNILL + DF LA+
Sbjct: 140 MYHI--------LLGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 231 KS--HVSTRVMGTHGYCAPEY-ATTGKLTAKSDIFSFGVVLLELITGRP 276
+V+ R Y APE T D++S G V+ E+ +
Sbjct: 189 NKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 61/293 (20%), Positives = 102/293 (34%), Gaps = 94/293 (32%)
Query: 53 HENKNKENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG 112
H + + F + V DN+ + +G+G +G VY T + VA+K+++ F+
Sbjct: 7 HSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FED 65
Query: 113 E---KEFLVEVLMLSLMRHPNLVHLIG-YCAEGTQRL----LVYEYMP--LGSL------ 156
K L E+ +L+ ++ ++ L + + +V E L L
Sbjct: 66 LIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIF 125
Query: 157 --EDH-------LLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNI 207
E+H LL G ++H + +I+RDLK N
Sbjct: 126 LTEEHIKTILYNLL----------------------LGENFIHE-SG--IIHRDLKPANC 160
Query: 208 LLGKGFHPKLSDFGLAKFGPTGDKS-------------------------HVSTRVMGTH 242
LL + K+ DFGLA+ + + HV TR
Sbjct: 161 LLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTR----- 215
Query: 243 GYCAPE-------YATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288
Y APE Y T DI+S G + EL+ + + + L
Sbjct: 216 WYRAPELILLQENY------TKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 7e-16
Identities = 61/314 (19%), Positives = 107/314 (34%), Gaps = 71/314 (22%)
Query: 23 KDSPGPSRIDTVERQETPARRNTLDDTLSAHENKNKENTFTYRQLVAATDNFKDTNFLGQ 82
++ + ++ + + H +K + D ++ + +G
Sbjct: 4 HEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGT 63
Query: 83 GGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMRHPNLVHL----I 135
G +G V + +VVA+K++ F+ K L E+ +L+ + H ++V + I
Sbjct: 64 GSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVI 122
Query: 136 GYCAEGTQRL-LVYEYMP--LGSLEDHLLGLTPE-MKPLDWNTRMKIAAGAARGLEYLHN 191
E L +V E L + LT +K L +N G++Y+H
Sbjct: 123 PKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNL--------LVGVKYVH- 173
Query: 192 KADPPVIYRDLKAGNILLGKGFHPKLSDFGLA-KFGPTGDKS------------------ 232
A +++RDLK N L+ + K+ DFGLA + +
Sbjct: 174 SAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 233 -----------HVSTRVMGTHGYCAPE-------YATTGKLTAKSDIFSFGVVLLELITG 274
HV TR Y APE Y T D++S G + EL+
Sbjct: 232 HTKNLKRQLTGHVVTR-----WYRAPELILLQENY------TEAIDVWSIGCIFAELLNM 280
Query: 275 RPAMDDSQGHERML 288
L
Sbjct: 281 IKENVAYHADRGPL 294
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 9e-16
Identities = 57/250 (22%), Positives = 101/250 (40%), Gaps = 72/250 (28%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMR 127
++ LG+G +G V+K TG+VVAVK++ D FQ + E+++L+ +
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELS 66
Query: 128 -HPNLVHLIG-YCAEGTQRL-LVYEYM-----------PLGSLEDH-------LLGLTPE 166
H N+V+L+ A+ + + LV++YM L H L+
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILE--PVHKQYVVYQLI----- 119
Query: 167 MKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226
+ ++YLH +++RD+K NILL H K++DFGL++
Sbjct: 120 -----------------KVIKYLH-SGG--LLHRDMKPSNILLNAECHVKVADFGLSRSF 159
Query: 227 PTGDKSHVSTRVMGTHGYCAP--------EYATT------------GKLTAKSDIFSFGV 266
+ + + +Y T K T D++S G
Sbjct: 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGC 219
Query: 267 VLLELITGRP 276
+L E++ G+P
Sbjct: 220 ILGEILCGKP 229
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 60/234 (25%), Positives = 102/234 (43%), Gaps = 30/234 (12%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQ--LDDTGFQGEKEFLVEVLMLSLMRHP 129
+ F+ +G G FG +Y G +T + VA+K + Q E ++ + L
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYE--SKIYRI-LQGGT 63
Query: 130 NLVHLIGYCAEGTQRLLVYEYMPLG-SLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEY 188
+ ++ + EG +LV + LG SLED + + L T + +A +E+
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDL--LGPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEF 118
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPK---LSDFGLAK-FGPTGDKSHVSTR----VMG 240
+H+K+ ++RD+K N L+G G + DFGLAK + T H+ R + G
Sbjct: 119 VHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
Query: 241 THGYCAPEYATTGK-LTAKSDIFSFGVVLLELITGR------PAMDDSQGHERM 287
T Y A G + + D+ S G VL+ + G A Q +E++
Sbjct: 176 TARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-15
Identities = 46/209 (22%), Positives = 76/209 (36%), Gaps = 50/209 (23%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEV-LMLSLMRHPNLVHLIGYC 138
LG G G V + T + A+K L D + EV L + P++V ++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 80
Query: 139 AEGTQR----LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAAR----GLEYLH 190
L+V E + G L + + + R A+ + ++YLH
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTERE--ASEIMKSIGEAIQYLH 134
Query: 191 NKADPPVIYRDLKAGNILL---GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAP 247
+ + +RD+K N+L KL+DFG AK + Y
Sbjct: 135 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--------ETTGE-----KY--- 175
Query: 248 EYATTGKLTAKSDIFSFGVVLLELITGRP 276
K D++S GV++ L+ G P
Sbjct: 176 -----DK---SCDMWSLGVIMYILLCGYP 196
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-15
Identities = 60/234 (25%), Positives = 94/234 (40%), Gaps = 30/234 (12%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQ--LDDTGFQGEKEFLVEVLMLSLMRHP 129
+ ++ +G G FG +Y G G+ VA+K + Q E + +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI---YKMMQGGV 65
Query: 130 NLVHLIGYCAEGTQRLLVYEYMPLG-SLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEY 188
+ + AEG ++V E LG SLED + + T + +A +EY
Sbjct: 66 GIPTIRWCGAEGDYNVMVMEL--LGPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEY 120
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPK---LSDFGLAK-FGPTGDKSHVSTR----VMG 240
+H+K I+RD+K N L+G G + DFGLAK + H+ R + G
Sbjct: 121 IHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 177
Query: 241 THGYCAPEYATTGK-LTAKSDIFSFGVVLLELITGR------PAMDDSQGHERM 287
T Y A G + + D+ S G VL+ G A Q +ER+
Sbjct: 178 TARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 230
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-15
Identities = 57/217 (26%), Positives = 89/217 (41%), Gaps = 26/217 (11%)
Query: 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVK--QLDDTGFQGEKEFLVEVLMLSLMRHPN 130
NF+ +G G FG + GK T + VA+K + Q E+ L
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF---YKQLGSGDG 66
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLG-SLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL 189
+ + + G +V E LG SLED L L + T + IA +EY+
Sbjct: 67 IPQVYYFGPCGKYNAMVLEL--LGPSLED-LFDLCD--RTFSLKTVLMIAIQLISRMEYV 121
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPK-----LSDFGLAK-FGPTGDKSHVSTR----VM 239
H+K +IYRD+K N L+G+ + + DF LAK + K H+ R +
Sbjct: 122 HSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLT 178
Query: 240 GTHGYCAPEYATTGK-LTAKSDIFSFGVVLLELITGR 275
GT Y GK + + D+ + G + + + G
Sbjct: 179 GTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 5e-15
Identities = 56/236 (23%), Positives = 96/236 (40%), Gaps = 32/236 (13%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQ--LDDTGFQGEKEFLVEVLMLSLMRHP 129
++K +G+G FG +++G Q VA+K Q E+ L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT---YKLLAGCT 66
Query: 130 NLVHLIGYCAEGTQRLLVYEYMPLG-SLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEY 188
+ ++ + EG +LV + LG SLED LL L + T A ++
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDL--LGPSLED-LLDLCG--RKFSVKTVAMAAKQMLARVQS 121
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPK-----LSDFGLAK-FGPTGDKSHVSTR----V 238
+H K+ ++YRD+K N L+G+ + DFG+ K + K H+ R +
Sbjct: 122 IHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 178
Query: 239 MGTHGYCAPEYATTGK-LTAKSDIFSFGVVLLELITGR------PAMDDSQGHERM 287
GT Y G+ + + D+ + G V + + G A + Q +ER+
Sbjct: 179 SGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 233
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.1 bits (160), Expect = 1e-12
Identities = 42/255 (16%), Positives = 70/255 (27%), Gaps = 69/255 (27%)
Query: 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQL---DDTGFQGEK-----EFLVEVL 121
T+ + +G+G FG V++ VA+K + G E L E++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 122 ML---------SLMRHPNLVHLIG-YCAEG-----------------------------T 142
+ R + L +C +G
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 143 QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDL 202
Q +V E+ G + + K T I L +RDL
Sbjct: 136 QLFIVLEFEFGGIDLEQM-----RTKLSSLATAKSILHQLTASLAVAEAS--LRFEHRDL 188
Query: 203 KAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAP--EYATTGKLTAKSD 260
GN+LL K KL K + + + G +Y +
Sbjct: 189 HWGNVLLKKTSLKKLHYTLNGK-----------SSTIPSCGLQVSIIDYTLSRLERDGIV 237
Query: 261 IFSFGVVLLELITGR 275
+F + +L TG
Sbjct: 238 VFCDVSMDEDLFTGD 252
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 49/223 (21%), Positives = 90/223 (40%), Gaps = 42/223 (18%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEF----LVEVLMLSLMR-------- 127
LG G F V+ K VA+K + +G+K + E+ +L +
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIV-----RGDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 128 ---HPNLVHLIGY----CAEGTQRLLVYEYMPLG-SLEDHLLGLTPEMKPLDWNTRMKIA 179
+++ L+ + G ++V+E LG +L L+ + + +I+
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFE--VLGENLLA-LIKKYEH-RGIPLIYVKQIS 137
Query: 180 AGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHP------KLSDFGLAKFGPTGDKSH 233
GL+Y+H + +I+ D+K N+L+ P K++D G A + +
Sbjct: 138 KQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 195
Query: 234 VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
+ TR Y +PE +DI+S ++ ELITG
Sbjct: 196 IQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 3e-11
Identities = 45/237 (18%), Positives = 85/237 (35%), Gaps = 48/237 (20%)
Query: 73 NFKDTNFLGQGGFGAVYKGKLAETGQV--------VAVK-QLDDTGFQGEKEFLVEVL-- 121
+K +F + G +Y+ T ++K D E+ F
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 122 -------MLSLMRHPNLVHLIGY-CAEGTQRLLVYEYMPLG-SLEDHLLGLTPEMKPLDW 172
L + +G+ + R LV LG SL+ L ++P+ L
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPS--LGRSLQS-ALDVSPK-HVLSE 158
Query: 173 NTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPK--LSDFGLAK-FGPTG 229
+ +++A LE+LH ++ ++ A NI + + L+ +G A + P+G
Sbjct: 159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
Query: 230 DKSHVSTR------VMGTHGYCAPEYATT----GK-LTAKSDIFSFGVVLLELITGR 275
HV+ G E+ + G + +SD+ S G +L+ + G
Sbjct: 216 --KHVAYVEGSRSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 5e-11
Identities = 58/224 (25%), Positives = 91/224 (40%), Gaps = 38/224 (16%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQL-DDTGF--QGEKEFLVEVLMLSLMR 127
D ++ + +G+G FG V K + VA+K + + F Q +EV +L LM
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMN 108
Query: 128 HP------NLVHLIGY-------CAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNT 174
+VHL + C LV+E + +L D LL T + + N
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLC-------LVFEMLSY-NLYD-LLRNTNF-RGVSLNL 158
Query: 175 RMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHP--KLSDFGLAKFGPTGDKS 232
K A L +L + +I+ DLK NILL K+ DFG +
Sbjct: 159 TRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ 217
Query: 233 HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
++ +R Y +PE D++S G +L+E+ TG P
Sbjct: 218 YIQSRF-----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 8e-11
Identities = 53/259 (20%), Positives = 82/259 (31%), Gaps = 74/259 (28%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMR-----HPNLVHL 134
LG G F V+ + + VA+K + E L E+ +L +R PN +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREMV 103
Query: 135 IGYC-------AEGTQRLLVYEYMPLG-SLEDHLLGLTPEMKPLDWNTRMKIAAGAARGL 186
+ GT +V+E LG L ++ + L KI +GL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFE--VLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGL 159
Query: 187 EYLHNKADPPVIYRDLKAGNILLG------------------------------------ 210
+YLH K +I+ D+K NILL
Sbjct: 160 DYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217
Query: 211 -------------KGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTA 257
+ K++D G A + + TR Y + E
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNT 272
Query: 258 KSDIFSFGVVLLELITGRP 276
+DI+S + EL TG
Sbjct: 273 PADIWSTACMAFELATGDY 291
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 42/217 (19%)
Query: 79 FLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEF----LVEVLMLSLMRH------ 128
+G+G FG V K + Q VA+K + + EK F E+ +L +R
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRN-----EKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 129 PNLVHLIGY-------CAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAG 181
N++H++ C + +E + + +L + L+ + K A
Sbjct: 159 MNVIHMLENFTFRNHIC-------MTFELLSM-NLYE-LIKKNKF-QGFSLPLVRKFAHS 208
Query: 182 AARGLEYLHNKADPPVIYRDLKAGNILLGKGFHP--KLSDFGLAKFGPTGDKSHVSTRVM 239
+ L+ LH +I+ DLK NILL + K+ DFG + + +++ +R
Sbjct: 209 ILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF- 264
Query: 240 GTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276
Y APE + D++S G +L EL+TG P
Sbjct: 265 ----YRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 3e-10
Identities = 45/232 (19%), Positives = 81/232 (34%), Gaps = 55/232 (23%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVK----------QLDDTGFQGEKEFL---------VEV 120
+G GGFG +Y + A L E +F +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS-----ELKFYQRVAKKDCIKKW 99
Query: 121 LMLSLMRHPNLVHLIGY----CAEGTQRLLVYEYMPLG-SLEDHLLGLTPEMKPLDWNTR 175
+ + + + G + R +V E LG L+ + +T
Sbjct: 100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMER--LGIDLQKISG----QNGTFKKSTV 153
Query: 176 MKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPK--LSDFGLAK-FGPTGDKS 232
+++ LEY+H ++ D+KA N+LLG + L+D+GL+ + P G+
Sbjct: 154 LQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
Query: 233 HVSTRV----MGTHGYCAPEYATT----GK-LTAKSDIFSFGVVLLELITGR 275
GT E+ + G L+ +SD+ G +L + G+
Sbjct: 211 QYQENPRKGHNGT-----IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 5e-09
Identities = 41/229 (17%), Positives = 80/229 (34%), Gaps = 46/229 (20%)
Query: 80 LGQGGFGAVYKGKLA-----ETGQVVAVKQLDDTGFQ-----------GEKEFLVEVLML 123
+GQGGFG +Y + + VK + E + + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 124 SLMRHPNLVHLIGYCAEGTQ----RLLVYEYMPLG-SLEDHLLGLTPEMKPLDWNTRMKI 178
+++ + G R ++ + G L+ + K T +++
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDR--FGSDLQK-IYEANA--KRFSRKTVLQL 157
Query: 179 AAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPK--LSDFGLAK-FGPTGDKSHVS 235
+ LEY+H ++ D+KA N+LL + L D+GLA + P G +
Sbjct: 158 SLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA 214
Query: 236 TR----VMGTHGYCAPEYATT----GK-LTAKSDIFSFGVVLLELITGR 275
GT E+ + G + + D+ G +++ +TG
Sbjct: 215 ADPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 59/254 (23%), Positives = 87/254 (34%), Gaps = 94/254 (37%)
Query: 79 FLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEF----LVEVLMLSLMRH-----P 129
+G G FG V + + + AVK + + K++ +E +L +++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVV-----RNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 130 NLVHLIGY-------CAEGTQRLLVYEYMPLG-SLEDHL-----LGLTPEMKPLDWNTRM 176
N+V G C L++E PLG SL + + G E +
Sbjct: 97 NIVKYHGKFMYYDHMC-------LIFE--PLGPSLYEIITRNNYNGFHIED------IK- 140
Query: 177 KIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHP--------------------- 215
+ L YL + + DLK NILL +
Sbjct: 141 LYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 216 ----KLSDFGLAKFGPTGDKSH---VSTRVMGTHGYCAPE------YATTGKLTAKSDIF 262
KL DFG A F H ++TR Y APE + SD++
Sbjct: 198 STGIKLIDFGCATFK---SDYHGSIINTR----Q-YRAPEVILNLGWDV------SSDMW 243
Query: 263 SFGVVLLELITGRP 276
SFG VL EL TG
Sbjct: 244 SFGCVLAELYTGSL 257
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 48/250 (19%), Positives = 80/250 (32%), Gaps = 90/250 (36%)
Query: 79 FLGQGGFGAVYKGK-LAETGQVVAVKQLDDTGFQGEKEF----LVEVLMLSLMRHP---- 129
LG+G FG V + A VA+K + + ++ +E+ +L ++
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKII-----RNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 130 --NLVHLIGY-------CAEGTQRLLVYEYMPLG-SLEDHL-----LGLTPEMKPLDWNT 174
V + + C + +E LG + + L
Sbjct: 81 KFLCVLMSDWFNFHGHMC-------IAFE--LLGKNTFEFLKENNFQPYPLPH------V 125
Query: 175 RMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHP------------------- 215
R +A L +LH + + + DLK NIL
Sbjct: 126 R-HMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181
Query: 216 KLSDFGLAKFGPTGDKSH---VSTRVMGTHGYCAPE------YATTGKLTAKSDIFSFGV 266
+++DFG A F + H V+TR Y PE +A D++S G
Sbjct: 182 RVADFGSATFD---HEHHTTIVATRH-----YRPPEVILELGWAQ------PCDVWSIGC 227
Query: 267 VLLELITGRP 276
+L E G
Sbjct: 228 ILFEYYRGFT 237
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 4e-06
Identities = 52/247 (21%), Positives = 85/247 (34%), Gaps = 84/247 (34%)
Query: 79 FLGQGGFGAVYKGK-LAETGQVVAVKQLDDTGFQGEKEF----LVEVLMLSLMRHP---- 129
LG+G FG V + G+ VAVK + + + E+ +L +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIV-----KNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 130 --NLVHLIGY-------CAEGTQRLLVYEYMPLG-SLEDHL-----LGLTPEMKPLDWNT 174
V ++ + C +V+E LG S D + L +
Sbjct: 76 TFRCVQMLEWFEHHGHIC-------IVFE--LLGLSTYDFIKENGFLPFRLDH------I 120
Query: 175 RMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHP------------------- 215
R K+A + + +LH + + DLK NIL + +
Sbjct: 121 R-KMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 216 KLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE------YATTGKLTAKSDIFSFGVVLL 269
K+ DFG A + + VSTR Y APE ++ D++S G +L+
Sbjct: 177 KVVDFGSATYDDEHHSTLVSTRH-----YRAPEVILALGWSQ------PCDVWSIGCILI 225
Query: 270 ELITGRP 276
E G
Sbjct: 226 EYYLGFT 232
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 39.8 bits (92), Expect = 9e-04
Identities = 42/258 (16%), Positives = 76/258 (29%), Gaps = 75/258 (29%)
Query: 1 MSPNCPCFGWRKKKTKPKINEDKDSPGPSRIDTVERQETPARRNTL--DDTLSAHENKNK 58
+ N + + K E + PS T E R+ L D+ + A N ++
Sbjct: 87 LRIN---YKFLMSPIK---TEQRQ---PSM-MTRMYIEQ---RDRLYNDNQVFAKYNVSR 133
Query: 59 ENTFTYRQLVAATDNFKDTNFL---GQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE 115
+ +L A + + G G G K VA+ Q + +
Sbjct: 134 LQPYL--KLRQALLELRPAKNVLIDGVLGSG---K-------TWVALDVCLSYKVQCKMD 181
Query: 116 FLVEVLMLSLMRHPNLVHLIGYCAEGTQRL-----LVYEYMP-LGSLEDHLLGLTPEMKP 169
F ++ L+L C L L+Y+ P S DH
Sbjct: 182 F--KIFWLNL----------KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSS-------- 221
Query: 170 LDWNTRMKIAAGAARGLEYLHNKADPP--VIYRDLKAGNILLGKGFHPKLSDFG---LAK 224
N +++I + A L +K ++ +++ F + L
Sbjct: 222 ---NIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW--NAF-----NLSCKILLT 271
Query: 225 FGPTGDKSHVSTRVMGTH 242
T K V+ +
Sbjct: 272 ---TRFKQ-VTDFLSAAT 285
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 299 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.97 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.95 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.81 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.59 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.4 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.37 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.3 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.09 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.91 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.86 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.79 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.76 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.68 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.59 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.46 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.34 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.2 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.2 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.97 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.87 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.86 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.75 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.71 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.61 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.56 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.48 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.31 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.22 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.98 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.33 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 92.36 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.0 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 89.78 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.13 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=398.58 Aligned_cols=207 Identities=27% Similarity=0.391 Sum_probs=187.1
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC---cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG---FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++++.||+|+||+||+|++..+++.||||++.+.. ....+.+.+|+.+++.++|||||+++++|.+++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999999999999999997532 223467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||++||+|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 112 Ey~~gG~L~~~i~----~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999995 3367999999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
........+.+||+.|||||++.+..|+.++|||||||++|+|++|.+||...+..+
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~ 241 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL 241 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 444445556789999999999999999999999999999999999999998776543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-58 Score=401.00 Aligned_cols=206 Identities=25% Similarity=0.380 Sum_probs=186.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.+.|++++.||+|+||+||+|++..+|+.||||++........+.+.+|+.+++.++|||||+++++|.+++.+||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 35699999999999999999999999999999999766555667789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
|+||+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 153 ~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 223 (346)
T 4fih_A 153 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE- 223 (346)
T ss_dssp CTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred CCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC-
Confidence 999999999853 56999999999999999999999999 999999999999999999999999999864322
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
.......+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+.
T Consensus 224 -~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~ 278 (346)
T 4fih_A 224 -VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA 278 (346)
T ss_dssp -SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred -CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence 2234457899999999999999999999999999999999999999988765443
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-58 Score=398.68 Aligned_cols=208 Identities=25% Similarity=0.373 Sum_probs=179.0
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
++|++++.||+|+||+||+|++..+++.||||++.+..... .+.+.+|+.+++.++|||||++++++.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999999999999999997654332 3678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
||+||+|.+++... ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+....
T Consensus 104 y~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~- 177 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS- 177 (350)
T ss_dssp CCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH-
T ss_pred CCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC-
Confidence 99999999999642 3356789999999999999999999999 99999999999999999999999999985421
Q ss_pred CCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
........+||+.|||||++.+..|+.++|||||||++|||+||.+||...+..+.
T Consensus 178 -~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~ 233 (350)
T 4b9d_A 178 -TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL 233 (350)
T ss_dssp -HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred -CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence 11223456799999999999999999999999999999999999999988765443
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=400.60 Aligned_cols=206 Identities=25% Similarity=0.380 Sum_probs=187.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.+.|++++.||+|+||+||+|++..+|+.||||++........+.+.+|+.+++.++|||||+++++|.+++.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 35799999999999999999999999999999999876666667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
|+||+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|......
T Consensus 230 ~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~- 300 (423)
T 4fie_A 230 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE- 300 (423)
T ss_dssp CTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS-
T ss_pred CCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC-
Confidence 999999999853 46899999999999999999999999 999999999999999999999999999864332
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
.......+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+.
T Consensus 301 -~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~ 355 (423)
T 4fie_A 301 -VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA 355 (423)
T ss_dssp -CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred -CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence 2233457899999999999999999999999999999999999999988765443
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-56 Score=375.86 Aligned_cols=202 Identities=27% Similarity=0.432 Sum_probs=167.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc---cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++++.||+|+||+||+|.+..+++.||+|++.+.... ....+.+|+.+++.++|||||++++++.+++.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999999999999999999764332 2357899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+ +|+|.+++. ...++++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHH----HSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 679999985 3467999999999999999999999999 99999999999999999999999999976432
Q ss_pred CCCcccccccccCccccCcccccCCCC-CcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKL-TAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
. ......+||+.|+|||++.+..| +.++|||||||++|+|+||.+||.+.+..
T Consensus 165 ~---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~ 218 (275)
T 3hyh_A 165 G---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP 218 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred C---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH
Confidence 2 22345689999999999988876 57999999999999999999999876644
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-56 Score=385.02 Aligned_cols=202 Identities=27% Similarity=0.322 Sum_probs=176.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEec
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYM 151 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 151 (299)
+.|++.++||+|+||+||+|++..+|+.||||+++.... ..+|+.+++.++|||||++++++.+++.+||||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 458888999999999999999999999999999976532 246999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC-ceEEccccccccCCCCC
Q 022309 152 PLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF-HPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 152 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~-~~kl~Dfg~a~~~~~~~ 230 (299)
+||+|.+++.. ..++++.++..++.||+.||+|||+++ |+||||||+|||++.+| .+||+|||+|+......
T Consensus 133 ~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 133 EGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp TTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999953 367999999999999999999999999 99999999999999987 69999999998654322
Q ss_pred Ccc---cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 231 KSH---VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 231 ~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
... .....+||+.|||||++.+..|+.++|||||||++|||+||.+||...+..+
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 263 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 263 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH
Confidence 111 1234679999999999999999999999999999999999999998765543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=385.80 Aligned_cols=206 Identities=30% Similarity=0.394 Sum_probs=175.5
Q ss_pred cCCCCCceecccCceEEEEEEEC---CCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLA---ETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
++|++++.||+|+||+||+|++. .+++.||+|++++.... ....+.+|+.+++.++|||||++++++.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 56999999999999999999884 46789999999764322 23467889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
||||++||+|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999995 3367999999999999999999999999 999999999999999999999999999854
Q ss_pred CCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
... .......+||+.|||||++.+..|+.++|||||||++|||+||.+||...+..+.
T Consensus 177 ~~~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~ 234 (304)
T 3ubd_A 177 IDH--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET 234 (304)
T ss_dssp ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cCC--CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH
Confidence 322 2233456899999999999999999999999999999999999999988765543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-56 Score=380.87 Aligned_cols=211 Identities=31% Similarity=0.475 Sum_probs=182.1
Q ss_pred cCCCCCceecccCceEEEEEEEC-----CCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLA-----ETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
++|.+.+.||+|+||+||+|++. .++..||||+++.......++|.+|+.+++.++|||||++++++.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56888999999999999999874 3578899999987665556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEE
Q 022309 147 VYEYMPLGSLEDHLLGLT---------PEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKL 217 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl 217 (299)
||||+++|+|.++|.... .....+++.+++.++.|++.||+|||+++ |+||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999996421 23457999999999999999999999999 999999999999999999999
Q ss_pred ccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 218 SDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 218 ~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
+|||+|+.....+.........||+.|||||++.+..|+.++|||||||++|||+| |++||.+.+..+
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~ 238 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE 238 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 99999976433333333334569999999999999999999999999999999999 899999877544
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-55 Score=373.10 Aligned_cols=204 Identities=30% Similarity=0.467 Sum_probs=175.0
Q ss_pred CCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEec----CCeeEEE
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAE----GTQRLLV 147 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~----~~~~~lv 147 (299)
|++.++||+|+||+||+|.+..++..||+|++...... ..+.+.+|+.+++.++|||||+++++|.+ +..++||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 35667899999999999999999999999999654322 23678999999999999999999999864 3568999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEec-CCCceEEccccccccC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLG-KGFHPKLSDFGLAKFG 226 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~-~~~~~kl~Dfg~a~~~ 226 (299)
|||++||+|.+++. ....+++.++..++.||+.||+|||+++ ++|+||||||+|||++ .++.+||+|||+|+..
T Consensus 108 mEy~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 108 TELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 99999999999995 3467999999999999999999999874 5699999999999997 4799999999999853
Q ss_pred CCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
.. ......+||+.|||||++.+ .|+.++|||||||++|||+||.+||.+.+....+
T Consensus 183 ~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~ 238 (290)
T 3fpq_A 183 RA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI 238 (290)
T ss_dssp CT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH
T ss_pred CC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHH
Confidence 22 23345689999999999865 6999999999999999999999999876654443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=378.55 Aligned_cols=211 Identities=32% Similarity=0.516 Sum_probs=176.1
Q ss_pred cCCCCCceecccCceEEEEEEEC-----CCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLA-----ETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
++|.+.++||+|+||+||+|++. .+++.||||+++.......++|.+|+.+++.++|||||++++++.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45778899999999999999864 3678999999987665556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCce
Q 022309 147 VYEYMPLGSLEDHLLGLTP-----------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHP 215 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~ 215 (299)
||||+++|+|.+++..... ...++++.+++.++.|++.||+|||+++ |+||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999965322 2356999999999999999999999999 9999999999999999999
Q ss_pred EEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 216 KLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 216 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
||+|||+|+.....+.........||+.|||||++.+..|+.++|||||||++|||+| |++||...+..+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~ 268 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999986544433334445679999999999999999999999999999999999 899998876544
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-54 Score=371.91 Aligned_cols=207 Identities=31% Similarity=0.481 Sum_probs=172.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
.+++++.+.||+|+||+||+|++. ..||||+++..... ..+.|.+|+.+++.++|||||++++++.+ +.++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 467888999999999999999864 35999998754332 23678999999999999999999998865 5689999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||++||+|.+++.. ...++++.++..|+.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 111 Ey~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 111 QWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp ECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 99999999999963 3467999999999999999999999999 99999999999999999999999999986544
Q ss_pred CCCcccccccccCccccCcccccC---CCCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATT---GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
..........+||+.|||||++.+ ..|+.++|||||||++|||+||++||.+.+..+.+
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~ 246 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI 246 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH
Confidence 333334455689999999999864 35899999999999999999999999877655443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-54 Score=371.50 Aligned_cols=211 Identities=30% Similarity=0.456 Sum_probs=180.2
Q ss_pred cCCCCCceecccCceEEEEEEEC-----CCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLA-----ETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 145 (299)
+.+++++.||+|+||+||+|... .+++.||||+++.... ...+.|.+|+.+++.++|||||++++++.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34677899999999999999863 4678999999975432 33478999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC
Q 022309 146 LVYEYMPLGSLEDHLLGLTP------------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF 213 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~ 213 (299)
|||||+++|+|.++|..... ....+++.+++.++.|++.||+|||+++ |+||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999964321 1246899999999999999999999999 99999999999999999
Q ss_pred ceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 214 HPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 214 ~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
.+||+|||+|+.....+.........||+.|||||++.+..|+.++|||||||++|||+| |.+||.+.+..+
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~ 255 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 255 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999986543333333445679999999999999999999999999999999999 899998876543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-53 Score=363.55 Aligned_cols=204 Identities=26% Similarity=0.408 Sum_probs=164.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCC--------
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT-------- 142 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-------- 142 (299)
++|++++.||+|+||+||+|++..+++.||||+++..... ..+.+.+|+.+++.++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4599999999999999999999999999999999754432 2357889999999999999999999986543
Q ss_pred ----eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEc
Q 022309 143 ----QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLS 218 (299)
Q Consensus 143 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~ 218 (299)
..||||||++||+|.+++.... .....++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence 3689999999999999996422 2234556778999999999999999999 9999999999999999999999
Q ss_pred cccccccCCCCCCc----------ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 219 DFGLAKFGPTGDKS----------HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 219 Dfg~a~~~~~~~~~----------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
|||+|+........ ......+||+.|||||++.+..|+.++|||||||++|||++ ||....
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~ 231 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM 231 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence 99999764332211 11233579999999999999999999999999999999996 786543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=373.53 Aligned_cols=209 Identities=25% Similarity=0.364 Sum_probs=179.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEec------CC
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAE------GT 142 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~------~~ 142 (299)
.++|++++.||+|+||+||+|++..+|+.||||++++.... ..+.+.+|+.+|+.++|||||++++++.. ..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 36799999999999999999999999999999999765432 23568899999999999999999998753 35
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccc
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL 222 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~ 222 (299)
..||||||++ |+|.+++. ...++++.++..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecce
Confidence 7899999996 67999994 4578999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCC--CcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 223 AKFGPTGD--KSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 223 a~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
|+...... ........+||+.|+|||++.+. .++.++||||+||++|||++|.+||.+.+..+++
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l 272 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQL 272 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHH
Confidence 97643221 12233457899999999998775 5699999999999999999999999988765554
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=368.72 Aligned_cols=222 Identities=27% Similarity=0.357 Sum_probs=186.8
Q ss_pred cHHHHHHhhcCCCCCceecccCceEEEEEEECCC-----CcEEEEEEcCCCCccc-HHHHHHHHHHHhhcCC-Ccceeee
Q 022309 63 TYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAET-----GQVVAVKQLDDTGFQG-EKEFLVEVLMLSLMRH-PNLVHLI 135 (299)
Q Consensus 63 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h-~nIv~~~ 135 (299)
...+.....++|++.+.||+|+||+||+|.+..+ ++.||||.+....... .+.+.+|+.++..++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 3344555678899999999999999999997543 3689999997654333 3678999999999965 9999999
Q ss_pred eEEecC-CeeEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 022309 136 GYCAEG-TQRLLVYEYMPLGSLEDHLLGLTP------------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDL 202 (299)
Q Consensus 136 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~di 202 (299)
++|.++ ..++||||||++|+|.++|..... ....+++.+++.++.||+.||+|||+++ |+||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 998664 568999999999999999964221 1345899999999999999999999999 999999
Q ss_pred CCCCEEecCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCC
Q 022309 203 KAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDS 281 (299)
Q Consensus 203 kp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~ 281 (299)
||+|||+++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |.+||.+.
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999986544443334455679999999999999999999999999999999998 99999887
Q ss_pred chhhhh
Q 022309 282 QGHERM 287 (299)
Q Consensus 282 ~~~~~~ 287 (299)
+..+.+
T Consensus 292 ~~~~~~ 297 (353)
T 4ase_A 292 KIDEEF 297 (353)
T ss_dssp CCSHHH
T ss_pred CHHHHH
Confidence 655543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-52 Score=365.04 Aligned_cols=211 Identities=23% Similarity=0.327 Sum_probs=178.6
Q ss_pred HHhhcCCCCCceecccCceEEEEEEEC---CCCcEEEEEEcCCCCcccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCe
Q 022309 68 VAATDNFKDTNFLGQGGFGAVYKGKLA---ETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQ 143 (299)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 143 (299)
....++|++.+.||+|+||+||+|+++ .+++.||+|.+.+. .....+.+|+.+++.+ +||||+++++++.+.++
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 345688999999999999999999874 46789999998765 3456788999999988 69999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCC-CceEEccccc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKG-FHPKLSDFGL 222 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~-~~~kl~Dfg~ 222 (299)
++|||||++|++|.+++ ..+++.++..++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+
T Consensus 95 ~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 99999999999999998 35899999999999999999999999 9999999999999876 7999999999
Q ss_pred cccCCCCCC--------------------------cccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCC
Q 022309 223 AKFGPTGDK--------------------------SHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGR 275 (299)
Q Consensus 223 a~~~~~~~~--------------------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~ 275 (299)
|+....... .......+||+.|+|||++.+. .|+.++||||+||++|||++|+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 975432211 0112335799999999999776 4899999999999999999999
Q ss_pred CCCCCCchhhhhhHH
Q 022309 276 PAMDDSQGHERMLVD 290 (299)
Q Consensus 276 ~pf~~~~~~~~~~~~ 290 (299)
+||...+.+...+..
T Consensus 245 ~Pf~~~~~~~~~l~~ 259 (361)
T 4f9c_A 245 YPFYKASDDLTALAQ 259 (361)
T ss_dssp SSSSCCSSHHHHHHH
T ss_pred CCCCCCCCHHHHHHH
Confidence 999776665554443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=378.08 Aligned_cols=207 Identities=25% Similarity=0.375 Sum_probs=186.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|++++.||+|+||+||+|.++.+|+.||+|++........+.+.+|+.+|+.++|||||+++++|.++..++|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 36899999999999999999999999999999999876655667789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCC--CceEEccccccccCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKG--FHPKLSDFGLAKFGPT 228 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~--~~~kl~Dfg~a~~~~~ 228 (299)
++||+|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+....
T Consensus 236 ~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999999853 3467999999999999999999999999 9999999999999854 8999999999986533
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
. ......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+.
T Consensus 310 ~---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~ 364 (573)
T 3uto_A 310 K---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET 364 (573)
T ss_dssp T---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred C---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence 2 223446799999999999999999999999999999999999999988776554
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-51 Score=379.40 Aligned_cols=202 Identities=33% Similarity=0.455 Sum_probs=175.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHH---HHHHhhcCCCcceeeeeEEecCCee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVE---VLMLSLMRHPNLVHLIGYCAEGTQR 144 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E---~~~l~~l~h~nIv~~~~~~~~~~~~ 144 (299)
.++|+++++||+|+||+||+|++..+|+.||+|++.+... .....+.+| +.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 3679999999999999999999999999999999965321 122233333 5666777999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
||||||++||+|.++|.. ...+++..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+|.
T Consensus 268 ylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999953 467999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 225 FGPTGDKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
..... ...+.+||+.|||||++.+ ..|+.++|||||||++|||++|.+||...+.
T Consensus 341 ~~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~ 396 (689)
T 3v5w_A 341 DFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396 (689)
T ss_dssp ECSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC
T ss_pred ecCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 64322 2334689999999999964 5799999999999999999999999976544
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=353.62 Aligned_cols=202 Identities=28% Similarity=0.379 Sum_probs=162.2
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCC----eeEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT----QRLLV 147 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~----~~~lv 147 (299)
.+|.+.+.||+|+||+||+|++ +|+.||||++.... ........|+..+..++|||||++++++.+++ .++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 3577889999999999999998 68999999996542 11222345666667889999999999997654 57999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEecCCCCCCEEecCCCceEEccccc
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK-----ADPPVIYRDLKAGNILLGKGFHPKLSDFGL 222 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-----~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~ 222 (299)
|||+++|+|.+++.. .++++..+..++.|++.||+|||++ ..++|+||||||+|||++.++.+||+|||+
T Consensus 80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 999999999999953 5689999999999999999999987 122399999999999999999999999999
Q ss_pred cccCCCCCCc--ccccccccCccccCcccccCC------CCCcccceehhHHHHHHHHhCCCCCCCC
Q 022309 223 AKFGPTGDKS--HVSTRVMGTHGYCAPEYATTG------KLTAKSDIFSFGVVLLELITGRPAMDDS 281 (299)
Q Consensus 223 a~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg~~pf~~~ 281 (299)
|+........ ......+||+.|||||++.+. .++.++|||||||++|||+||.+||...
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~ 221 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcc
Confidence 9764332221 122345799999999999764 3677999999999999999998876543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=324.56 Aligned_cols=206 Identities=29% Similarity=0.447 Sum_probs=185.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|++++.||+|+||+||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999999999999999999766556667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
++|++|.+++.. ..+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999953 46899999999999999999999999 9999999999999999999999999987643322
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.
T Consensus 171 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 224 (297)
T 3fxz_A 171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224 (297)
T ss_dssp --CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred --cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 223345799999999999999999999999999999999999999987765443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=329.85 Aligned_cols=206 Identities=30% Similarity=0.393 Sum_probs=181.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC---cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG---FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.++|++++.||+|+||+||+|++..+++.||+|++++.. ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357999999999999999999999999999999996532 22345688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||++|++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||++....
T Consensus 84 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999999853 356899999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|.+||...+..+
T Consensus 157 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 212 (337)
T 1o6l_A 157 SD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212 (337)
T ss_dssp CT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cC--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH
Confidence 21 122344679999999999999999999999999999999999999998776543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=327.88 Aligned_cols=206 Identities=29% Similarity=0.374 Sum_probs=182.9
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc------cHHHHHHHHHHHhhcCCCcceeeeeEEecCCe
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ------GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQ 143 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 143 (299)
..++|++.+.||+|+||.||+|.+..+++.||+|++.+.... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 346799999999999999999999999999999999764332 24678999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC----ceEEcc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF----HPKLSD 219 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~----~~kl~D 219 (299)
.++||||+.|++|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|
T Consensus 90 ~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 90 VVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 999999999999999994 4467999999999999999999999999 99999999999998776 799999
Q ss_pred ccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 220 FGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 220 fg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+
T Consensus 163 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~ 225 (361)
T 2yab_A 163 FGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 225 (361)
T ss_dssp CSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred cCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99997643321 2234579999999999999899999999999999999999999998776543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=333.46 Aligned_cols=207 Identities=31% Similarity=0.462 Sum_probs=177.4
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~ 145 (299)
..++|++++.||+|+||.||+|++..+++.||+|++++... .....+..|..+++.+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 34789999999999999999999999999999999975421 2235577899999887 7999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
+||||++|++|.+++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 101 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999999953 356999999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 226 GPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.... .......+||+.|+|||++.+..++.++|||||||++|||++|.+||...+..+
T Consensus 174 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~ 231 (353)
T 3txo_A 174 GICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD 231 (353)
T ss_dssp SCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH
Confidence 3222 223344679999999999988889999999999999999999999998876544
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=339.33 Aligned_cols=214 Identities=24% Similarity=0.269 Sum_probs=184.4
Q ss_pred HHHHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCC
Q 022309 66 QLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT 142 (299)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 142 (299)
+.....++|+++++||+|+||+||+|++..+++.||+|++.+... .....+.+|+.++..++||||+++++++.+++
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 334456789999999999999999999999999999999865321 11234788999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccc
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL 222 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~ 222 (299)
..++||||+.||+|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhh
Confidence 99999999999999999963 2467999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccCccccCccccc-----CCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 223 AKFGPTGDKSHVSTRVMGTHGYCAPEYAT-----TGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 223 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
|....... .......+||+.|+|||++. ...++.++|||||||++|||++|.+||...+..+.
T Consensus 222 a~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~ 289 (437)
T 4aw2_A 222 CLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 289 (437)
T ss_dssp CEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred hhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH
Confidence 97543322 22233467999999999986 45689999999999999999999999988775543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=326.69 Aligned_cols=205 Identities=27% Similarity=0.440 Sum_probs=181.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
.++|++++.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46799999999999999999999999999999999754322 2356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+++++|.+++.. ...+++.+++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999953 356899999999999999999999999 99999999999999999999999999975433
Q ss_pred CCCcccccccccCccccCcccccCCCCC-cccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLT-AKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.. .....+||+.|+|||++.+..+. .++|||||||++|+|++|.+||...+..+
T Consensus 167 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 221 (328)
T 3fe3_A 167 GG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221 (328)
T ss_dssp SC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 22 23446799999999999888765 78999999999999999999998876543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=324.38 Aligned_cols=203 Identities=33% Similarity=0.491 Sum_probs=181.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC---cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG---FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.++|++++.||+|+||.||+|++..+++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357999999999999999999999999999999986532 12345678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||++|++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||++....
T Consensus 85 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999953 357899999999999999999999999 9999999999999999999999999997642
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
. .....+||+.|+|||++.+..++.++|||||||++|||++|.+||...+..+
T Consensus 158 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 210 (318)
T 1fot_A 158 D-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210 (318)
T ss_dssp S-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred C-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 2 2234579999999999999999999999999999999999999998776543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=326.32 Aligned_cols=215 Identities=26% Similarity=0.390 Sum_probs=184.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
.++|++++.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 46899999999999999999999999999999998654322 23568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+++++|.+++. ....+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 999999999884 4467999999999999999999999999 999999999999999999999999999764333
Q ss_pred CCcccccccccCccccCcccccCCCC-CcccceehhHHHHHHHHhCCCCCCCCchhhhhhHHHH
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKL-TAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVDWV 292 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~ 292 (299)
..........||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+|.
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 222 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 222 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh
Confidence 33333345679999999999987765 7789999999999999999999988776655555544
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=332.67 Aligned_cols=202 Identities=27% Similarity=0.411 Sum_probs=178.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc---HHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG---EKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~l 146 (299)
.++|++++.||+|+||+||+|++..+++.||+|++++..... ...+..|..++..+ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999999999999999997643322 24577899998876 89999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
||||++||+|..++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999853 357999999999999999999999999 999999999999999999999999999753
Q ss_pred CCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCC
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDS 281 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 281 (299)
... .......+||+.|+|||++.+..++.++|||||||++|||++|.+||...
T Consensus 204 ~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 204 LRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp CCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred ccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 221 22334567999999999999999999999999999999999999999643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=337.09 Aligned_cols=209 Identities=24% Similarity=0.316 Sum_probs=181.7
Q ss_pred HHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCee
Q 022309 68 VAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQR 144 (299)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 144 (299)
....++|++++.||+|+||+||+|++..+++.||+|++.+... .....+.+|+.+++.++||||+++++++.++...
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 3446789999999999999999999999999999999865221 1224578899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
++||||++||+|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 145 ~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp EEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeE
Confidence 999999999999999853 45899999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCcccccccccCccccCcccccCCC----CCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 225 FGPTGDKSHVSTRVMGTHGYCAPEYATTGK----LTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
...... .......+||+.|+|||++.+.. ++.++|||||||++|||++|.+||...+..+
T Consensus 217 ~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 280 (410)
T 3v8s_A 217 KMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 280 (410)
T ss_dssp ECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred eeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh
Confidence 643221 12233567999999999997765 7889999999999999999999998876544
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=327.20 Aligned_cols=208 Identities=33% Similarity=0.504 Sum_probs=181.4
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC---cccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCee
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG---FQGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQR 144 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 144 (299)
...++|++.+.||+|+||.||+|++..+++.||+|++++.. ......+..|..++..+ +||||+++++++.+....
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999999999999999997542 12335677888888876 999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
++||||++||+|.+++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 999999999999999953 356899999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 225 FGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|.+||...+..+
T Consensus 167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 225 (345)
T 1xjd_A 167 ENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 225 (345)
T ss_dssp CCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred hcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 532221 22345679999999999999999999999999999999999999998776543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=317.60 Aligned_cols=208 Identities=28% Similarity=0.389 Sum_probs=178.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc---HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG---EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.++|++++.||+|+||.||+|.+..+++.||+|.+....... .+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999999999999999986543332 25688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||++|++|.+++.. ..++++.+++.++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++....
T Consensus 90 ~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 999999999999953 357899999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
... ........||+.|+|||++.+..++.++||||||+++|+|++|.+||...+..+.
T Consensus 163 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~ 220 (294)
T 4eqm_A 163 ETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI 220 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH
T ss_pred ccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 221 1222345699999999999999999999999999999999999999988775443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=326.61 Aligned_cols=207 Identities=29% Similarity=0.402 Sum_probs=181.2
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~ 145 (299)
..++|++++.||+|+||.||+|.+..+++.||+|++.+... .....+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 34679999999999999999999999999999999875421 2345678899999887 8999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
+||||++||+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||++..
T Consensus 98 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999999953 356899999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 226 GPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.... .......+||+.|+|||++.+..++.++|||||||++|||++|.+||...+..+
T Consensus 171 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~ 228 (353)
T 2i0e_A 171 NIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 228 (353)
T ss_dssp CCCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH
Confidence 3221 122344679999999999999999999999999999999999999998776543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=323.93 Aligned_cols=205 Identities=26% Similarity=0.384 Sum_probs=180.9
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
..++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 456799999999999999999999999999999999765432 235688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCC---CceEEccccccc
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKG---FHPKLSDFGLAK 224 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~---~~~kl~Dfg~a~ 224 (299)
|||+.|++|.+.+. ....+++.+++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.
T Consensus 107 ~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 99999999999984 4467899999999999999999999999 9999999999999865 459999999997
Q ss_pred cCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 225 FGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..
T Consensus 180 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~ 236 (362)
T 2bdw_A 180 EVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 236 (362)
T ss_dssp CCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 643221 223457999999999999989999999999999999999999999877643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=318.69 Aligned_cols=205 Identities=19% Similarity=0.298 Sum_probs=182.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 467999999999999999999999999999999987543 3445688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC--CCceEEccccccccCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK--GFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~--~~~~kl~Dfg~a~~~~~ 228 (299)
++|++|.+++.. ....+++.+++.++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999953 3356899999999999999999999999 999999999999987 78999999999986543
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+
T Consensus 157 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 210 (321)
T 1tki_A 157 GD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210 (321)
T ss_dssp TC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred CC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH
Confidence 22 2234569999999999998889999999999999999999999998776543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=323.49 Aligned_cols=200 Identities=28% Similarity=0.419 Sum_probs=177.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc---HHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG---EKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv 147 (299)
++|++++.||+|+||.||+|++..+++.||+|++.+..... ...+.+|..+++.+ +||||+++++++.+....++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56999999999999999999999999999999997654332 24577899999887 899999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||++|++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 89 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999853 356899999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCC
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDD 280 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 280 (299)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|.+||..
T Consensus 162 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 162 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CC--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 21 1223446799999999999999999999999999999999999999975
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=317.25 Aligned_cols=212 Identities=47% Similarity=0.802 Sum_probs=186.2
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
...++|++.+.||+|+||.||+|.+. +++.||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 114 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY 114 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEE
T ss_pred HHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 35678999999999999999999964 68999999988766556678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+++++|.+++.........+++.+++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 999999999999654434456899999999999999999999999 99999999999999999999999999976433
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
...........||+.|+|||++.+..++.++||||||+++|+|++|..||....+.
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~ 247 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR 247 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS
T ss_pred ccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH
Confidence 33333334456899999999998889999999999999999999999999876543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=332.41 Aligned_cols=207 Identities=25% Similarity=0.363 Sum_probs=180.7
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
...++|++++.||+|+||.||+|.+..+++.||+|++....... .+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34577999999999999999999999999999999997654332 3568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEec---CCCceEEcccccc
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLG---KGFHPKLSDFGLA 223 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~---~~~~~kl~Dfg~a 223 (299)
||||+.|++|.+.+.. ...+++.++..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 88 v~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp EECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 9999999999999853 366999999999999999999999999 99999999999998 4678999999999
Q ss_pred ccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 224 KFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..
T Consensus 161 ~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~ 219 (444)
T 3soa_A 161 IEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH 219 (444)
T ss_dssp BCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred EEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH
Confidence 7643322 2223467999999999999989999999999999999999999999877644
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=315.61 Aligned_cols=207 Identities=29% Similarity=0.457 Sum_probs=181.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|++.+.||+|+||+||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++++.++...++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 36799999999999999999999999999999998766555567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+++++|.+++.. ....+++.+++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999964 2467899999999999999999999999 9999999999999999999999999997643222
Q ss_pred Ccc------------cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 231 KSH------------VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 231 ~~~------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~ 227 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP 227 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSC
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhh
Confidence 111 11145799999999999999999999999999999999999999876543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=324.68 Aligned_cols=202 Identities=29% Similarity=0.368 Sum_probs=180.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.++|++++.||+|+||.||+|++..+++.||+|++.+... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 3679999999999999999999999999999999865321 2345688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||++|++|.+++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 120 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999999953 356899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
.. ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..
T Consensus 193 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 244 (350)
T 1rdq_E 193 GR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244 (350)
T ss_dssp SC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH
Confidence 21 23457999999999999999999999999999999999999999877654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=325.42 Aligned_cols=207 Identities=23% Similarity=0.314 Sum_probs=179.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC-----cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG-----FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 145 (299)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999999999999999985321 123567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCc---eEEccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFH---PKLSDFGL 222 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~---~kl~Dfg~ 222 (299)
+||||++|++|.+.+.........+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999888643333456899999999999999999999999 999999999999986654 99999999
Q ss_pred cccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 223 AKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 223 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
+...... ........||+.|+|||++.+..++.++|||||||++|+|++|.+||...+
T Consensus 180 a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (351)
T 3c0i_A 180 AIQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK 237 (351)
T ss_dssp CEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH
T ss_pred eeEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH
Confidence 9764332 122334579999999999999899999999999999999999999998754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=317.63 Aligned_cols=205 Identities=28% Similarity=0.380 Sum_probs=181.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc------cHHHHHHHHHHHhhcCCCcceeeeeEEecCCee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ------GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQR 144 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 144 (299)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 35699999999999999999999999999999998754322 346789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC----ceEEccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF----HPKLSDF 220 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~----~~kl~Df 220 (299)
++||||+++++|.+++. ....+++.+++.++.|++.||.|||+++ |+||||||+||+++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 99999999999999994 4467999999999999999999999999 99999999999999877 8999999
Q ss_pred cccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 221 GLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 221 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+
T Consensus 163 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 224 (326)
T 2y0a_A 163 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224 (326)
T ss_dssp TTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred CCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH
Confidence 9997643222 2234569999999999998899999999999999999999999998766543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=326.29 Aligned_cols=201 Identities=27% Similarity=0.390 Sum_probs=178.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC---cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG---FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++++.||+|+||.||+|.+..+++.||+|++.+.. ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 67999999999999999999999999999999986532 123357889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+.|++|.+++. ....+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++.....
T Consensus 95 e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999995 3467999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCcccccccccCccccCcccccC---CCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATT---GKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+
T Consensus 168 ~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~ 221 (384)
T 4fr4_A 168 E---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS 221 (384)
T ss_dssp T---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT
T ss_pred C---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC
Confidence 2 22344679999999999864 458999999999999999999999997544
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=332.54 Aligned_cols=212 Identities=25% Similarity=0.271 Sum_probs=182.8
Q ss_pred HHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc---cHHHHHHHHHHHhhcCCCcceeeeeEEecCCee
Q 022309 68 VAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQR 144 (299)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 144 (299)
....++|++++.||+|+||.||+|++..+++.||+|++.+.... ....+.+|..++..++||||+++++++.+.+..
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 34467899999999999999999999999999999999653211 223478899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
++||||++||+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 137 ~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp EEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhhe
Confidence 9999999999999999632 246899999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCcccccccccCccccCccccc-------CCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 225 FGPTGDKSHVSTRVMGTHGYCAPEYAT-------TGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
....... ......+||+.|+|||++. +..++.++|||||||++|||++|.+||...+..+.
T Consensus 211 ~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~ 278 (412)
T 2vd5_A 211 KLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET 278 (412)
T ss_dssp ECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred eccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH
Confidence 6433221 1223457999999999986 35689999999999999999999999988776543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=314.30 Aligned_cols=201 Identities=26% Similarity=0.379 Sum_probs=180.5
Q ss_pred CCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCC
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
|...+.||+|+||.||+|.+..+|+.||||++........+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 67778999999999999999989999999999876666667889999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcc
Q 022309 154 GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233 (299)
Q Consensus 154 ~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~ 233 (299)
++|.+++. ...+++.++..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....... .
T Consensus 127 ~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 196 (321)
T 2c30_A 127 GALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--P 196 (321)
T ss_dssp CBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--C
T ss_pred CCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCc--c
Confidence 99999984 256899999999999999999999999 9999999999999999999999999987643221 1
Q ss_pred cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 234 VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~ 247 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV 247 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 223457999999999999989999999999999999999999999876543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=327.44 Aligned_cols=206 Identities=30% Similarity=0.390 Sum_probs=173.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc---cHHHHHHHHHH-HhhcCCCcceeeeeEEecCCeeEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVLM-LSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~-l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
.++|++++.||+|+||.||+|++..+++.||+|++.+.... ....+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 35799999999999999999999999999999999765332 22445667666 567899999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
||||++|++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999953 356899999999999999999999999 999999999999999999999999999753
Q ss_pred CCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
... .......+||+.|+|||++.+..++.++|||||||++|||++|.+||...+..+
T Consensus 190 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~ 246 (373)
T 2r5t_A 190 IEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 246 (373)
T ss_dssp BCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH
T ss_pred ccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 221 122345679999999999999999999999999999999999999998876544
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=323.63 Aligned_cols=205 Identities=22% Similarity=0.334 Sum_probs=182.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|++++.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 46799999999999999999999999999999999766545556789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC--CCceEEccccccccCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK--GFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~--~~~~kl~Dfg~a~~~~~ 228 (299)
+.|++|.+++.. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++. .+.+||+|||++.....
T Consensus 130 ~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999999853 3357899999999999999999999999 999999999999974 47899999999986533
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..
T Consensus 204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~ 256 (387)
T 1kob_A 204 DE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 256 (387)
T ss_dssp TS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred Cc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH
Confidence 22 223346999999999999999999999999999999999999999887654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=317.95 Aligned_cols=206 Identities=30% Similarity=0.439 Sum_probs=172.0
Q ss_pred hcCCCCCceecccCceEEEEEEEC---CCCcEEEEEEcCCCCc----ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLA---ETGQVVAVKQLDDTGF----QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQ 143 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 143 (299)
.++|++++.||+|+||.||+|++. .+++.||+|++++... .....+.+|+.+++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 467999999999999999999985 6899999999976532 223457789999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA 223 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a 223 (299)
.++||||++|++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999953 356899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 224 KFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
...... ........||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+
T Consensus 169 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 228 (327)
T 3a62_A 169 KESIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK 228 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH
Confidence 743221 122334579999999999998889999999999999999999999998776543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=309.64 Aligned_cols=210 Identities=24% Similarity=0.330 Sum_probs=177.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
++|++++.||+|+||+||+|.+..+++.||+|++....... ...+.+|+.+++.++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999999999999999997544332 3678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+.+ +|.+.+.. ....+++.+++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9975 66666542 3467999999999999999999999999 999999999999999999999999999764322
Q ss_pred CCcccccccccCccccCcccccCCC-CCcccceehhHHHHHHHHhCCCCCCCCchhhhhhHH
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGK-LTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVD 290 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~ 290 (299)
........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.........+..
T Consensus 155 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~ 214 (292)
T 3o0g_A 155 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 214 (292)
T ss_dssp --CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHH
T ss_pred --cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHH
Confidence 12233456899999999997765 799999999999999999988776555444444443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=334.89 Aligned_cols=207 Identities=30% Similarity=0.440 Sum_probs=183.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.++|++++.||+|+||.||+|++..+++.||+|++.+... .....+..|+.+++.++||||+++++++.+....++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 3679999999999999999999999999999999965322 2235688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||++|++|.+++.........+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++....
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999765444567999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
... ......+||+.|+|||++.+..++.++|||||||++|||++|.+||...+
T Consensus 341 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 341 AGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp TTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred CCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 322 12234579999999999999999999999999999999999999998764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=319.88 Aligned_cols=212 Identities=29% Similarity=0.430 Sum_probs=180.8
Q ss_pred hcCCCCCceecccCceEEEEEEEC-------CCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhc-CCCcceeeeeEEecC
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLA-------ETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLM-RHPNLVHLIGYCAEG 141 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 141 (299)
.++|++.+.||+|+||.||+|.+. .++..||+|+++..... ..+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467999999999999999999874 34567999999765332 235788999999999 899999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEe
Q 022309 142 TQRLLVYEYMPLGSLEDHLLGLTP------------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL 209 (299)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv 209 (299)
+..++||||+.+++|.+++..... ....+++.+++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999975321 1245889999999999999999999999 9999999999999
Q ss_pred cCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 210 GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 210 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
+.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |.+||...+..+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~ 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999999999986543332223334457889999999999999999999999999999999 999998766543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=320.20 Aligned_cols=214 Identities=25% Similarity=0.313 Sum_probs=184.9
Q ss_pred CccHHHHHHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcC-----CCcceeee
Q 022309 61 TFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMR-----HPNLVHLI 135 (299)
Q Consensus 61 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~nIv~~~ 135 (299)
.+.+.......++|++++.||+|+||.||+|.+..+++.||+|++.... .....+..|+.+++.+. ||||++++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 3445555566789999999999999999999999999999999997432 33356778999999886 99999999
Q ss_pred eEEecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC----
Q 022309 136 GYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK---- 211 (299)
Q Consensus 136 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~---- 211 (299)
+++...+..++|||++ +++|.+++... ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence 9999999999999999 89999999652 2346899999999999999999999999 999999999999975
Q ss_pred ---------------------CCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHH
Q 022309 212 ---------------------GFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLE 270 (299)
Q Consensus 212 ---------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~e 270 (299)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 789999999999753321 234568999999999999999999999999999999
Q ss_pred HHhCCCCCCCCchhhh
Q 022309 271 LITGRPAMDDSQGHER 286 (299)
Q Consensus 271 lltg~~pf~~~~~~~~ 286 (299)
|++|.+||...+..+.
T Consensus 252 ll~g~~pf~~~~~~~~ 267 (360)
T 3llt_A 252 LYTGSLLFRTHEHMEH 267 (360)
T ss_dssp HHHSSCSCCCSSHHHH
T ss_pred HHHCCCCCCCCcHHHH
Confidence 9999999988765543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=319.18 Aligned_cols=201 Identities=28% Similarity=0.428 Sum_probs=176.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3679999999999999999999999999999999864321 1235688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||+ +|+|.+++.. ...+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 6799998853 356899999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCcccccccccCccccCcccccCCCC-CcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKL-TAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
.. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||....
T Consensus 160 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 212 (336)
T 3h4j_B 160 DG---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212 (336)
T ss_dssp TS---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSS
T ss_pred CC---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCcc
Confidence 32 22334579999999999988776 689999999999999999999997654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=323.07 Aligned_cols=208 Identities=18% Similarity=0.209 Sum_probs=176.3
Q ss_pred hhcCCCCCceecccCceEEEEE-----EECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcC---CCcceeeeeEEecC
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKG-----KLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMR---HPNLVHLIGYCAEG 141 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~ 141 (299)
..++|++.+.||+|+||+||+| .+..+++.||+|++... ....+..|+.+++.+. |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 4567999999999999999999 46678899999999754 3456777777777776 99999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC---------
Q 022309 142 TQRLLVYEYMPLGSLEDHLLGLTP-EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK--------- 211 (299)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~--------- 211 (299)
+..++||||+++|+|.+++..... ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 999999999999999999964221 3467999999999999999999999999 999999999999998
Q ss_pred --CCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 212 --GFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 212 --~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
++.+||+|||+|...............+||+.|+|||++.+..++.++|||||||++|||++|..||...+.
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 899999999999654322333344556799999999999999999999999999999999999999965433
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=315.20 Aligned_cols=214 Identities=52% Similarity=0.851 Sum_probs=186.8
Q ss_pred CccHHHHHHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEe
Q 022309 61 TFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCA 139 (299)
Q Consensus 61 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 139 (299)
.+.+.++....++|++.+.||+|+||.||+|.+. +++.||+|++...... ....+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 4567788888999999999999999999999854 6889999999765322 2346889999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCeEecCCCCCCEEecCCCceE
Q 022309 140 EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK---ADPPVIYRDLKAGNILLGKGFHPK 216 (299)
Q Consensus 140 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~~~~i~H~dikp~Nilv~~~~~~k 216 (299)
+....++||||+.+++|.+++........++++..++.++.|++.||+|||++ + |+||||||+|||++.++.++
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCCEE
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCCEE
Confidence 99999999999999999999986555556799999999999999999999999 7 99999999999999999999
Q ss_pred EccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCC
Q 022309 217 LSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMD 279 (299)
Q Consensus 217 l~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 279 (299)
|+|||++....... ........||+.|+|||++.+..++.++||||||+++|+|++|.+||.
T Consensus 175 l~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 175 VGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp ECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred eccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 99999998653322 222334569999999999988889999999999999999999999996
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=317.68 Aligned_cols=208 Identities=29% Similarity=0.405 Sum_probs=168.8
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4577999999999999999999999999999999997553 34567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC---CCceEEccccccccC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK---GFHPKLSDFGLAKFG 226 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~---~~~~kl~Dfg~a~~~ 226 (299)
|+++++|.+++. ....+++.+++.++.|++.||.|||+++ |+||||||+||+++. ++.+||+|||++...
T Consensus 129 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 129 LVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 999999999994 4466899999999999999999999999 999999999999975 889999999999754
Q ss_pred CCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhhhhH
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLV 289 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 289 (299)
... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......+.++.
T Consensus 202 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 261 (349)
T 2w4o_A 202 EHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFR 261 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHH
T ss_pred Ccc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHH
Confidence 321 122345689999999999998999999999999999999999999987776554433
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=317.02 Aligned_cols=209 Identities=27% Similarity=0.404 Sum_probs=174.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH---HHHHHHHHHHhhcCCCcceeeeeEEecCCe----
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMRHPNLVHLIGYCAEGTQ---- 143 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~---- 143 (299)
.++|++.+.||+|+||.||+|.+..+++.||+|++........ ..+.+|+.+++.++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 4789999999999999999999999999999999976543332 467899999999999999999999876543
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA 223 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a 223 (299)
.++||||++|++|.+++.. ..++++.+++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 4999999999999999953 357899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCc-ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 224 KFGPTGDKS-HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 224 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+.
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~ 227 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 227 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 754332221 222335689999999999999999999999999999999999999988775543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=310.19 Aligned_cols=203 Identities=24% Similarity=0.409 Sum_probs=172.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--------------------------cHHHHHHHHHHHh
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--------------------------GEKEFLVEVLMLS 124 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~ 124 (299)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46799999999999999999999999999999998654321 1245889999999
Q ss_pred hcCCCcceeeeeEEec--CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 022309 125 LMRHPNLVHLIGYCAE--GTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDL 202 (299)
Q Consensus 125 ~l~h~nIv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~di 202 (299)
.++||||+++++++.+ ....++||||+++++|.+++ ...++++.+++.++.|++.||+|||+++ |+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 9999999999999986 56889999999999998765 3357999999999999999999999999 999999
Q ss_pred CCCCEEecCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCC---CCcccceehhHHHHHHHHhCCCCCC
Q 022309 203 KAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGK---LTAKSDIFSFGVVLLELITGRPAMD 279 (299)
Q Consensus 203 kp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~il~elltg~~pf~ 279 (299)
||+||+++.++.+||+|||++....... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 9999999999999999999997643322 2233457999999999997765 4778999999999999999999998
Q ss_pred CCch
Q 022309 280 DSQG 283 (299)
Q Consensus 280 ~~~~ 283 (299)
..+.
T Consensus 242 ~~~~ 245 (298)
T 2zv2_A 242 DERI 245 (298)
T ss_dssp CSSH
T ss_pred CccH
Confidence 7654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=312.05 Aligned_cols=210 Identities=28% Similarity=0.397 Sum_probs=166.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
.++|++++.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4679999999999999999999999999999999875432 233678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 150 YMPLGSLEDHLLGL--TPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 150 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|++ ++|.+++... ......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5999988542 122346899999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
... .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...+..+.
T Consensus 160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 217 (317)
T 2pmi_A 160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ 217 (317)
T ss_dssp SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 221 122335689999999998764 689999999999999999999999988776543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=310.05 Aligned_cols=206 Identities=28% Similarity=0.397 Sum_probs=174.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
.++|++++.||+|+||+||+|.+. +++.||+|++....... ...+.+|+.+++.++||||+++++++.++...++||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 467999999999999999999995 58999999997543222 356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+.+ +|.+.+.. ....+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 99 e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 99 EFMEK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp ECCSE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred cCCCC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99975 88888753 3456899999999999999999999999 99999999999999999999999999976432
Q ss_pred CCCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.
T Consensus 172 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 228 (311)
T 3niz_A 172 PV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ 228 (311)
T ss_dssp CC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH
T ss_pred Cc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 21 22233568999999999876 5689999999999999999999999987765544
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=319.59 Aligned_cols=214 Identities=21% Similarity=0.277 Sum_probs=182.9
Q ss_pred hhcCCCCCceeccc--CceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeE
Q 022309 70 ATDNFKDTNFLGQG--GFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 70 ~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 145 (299)
..++|++++.||+| +||.||+|.+..+++.||||++....... ...+.+|+.+++.++||||+++++++.+++..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 34679999999999 99999999999999999999997543222 356788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
+||||+++++|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++..
T Consensus 103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccccee
Confidence 999999999999999642 2356899999999999999999999999 99999999999999999999999999854
Q ss_pred CCCCC-----CcccccccccCccccCcccccC--CCCCcccceehhHHHHHHHHhCCCCCCCCchhhhhh
Q 022309 226 GPTGD-----KSHVSTRVMGTHGYCAPEYATT--GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288 (299)
Q Consensus 226 ~~~~~-----~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 288 (299)
..... .........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 247 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 247 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 21111 0111222468999999999987 578999999999999999999999998876655543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=315.12 Aligned_cols=204 Identities=23% Similarity=0.296 Sum_probs=178.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+ +||||+++++++......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 467999999999999999999999999999999986543 234688899999999 99999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCc-----eEEccccccc
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFH-----PKLSDFGLAK 224 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~-----~kl~Dfg~a~ 224 (299)
|+ +++|.+++... ...+++.+++.++.|++.||+|||+++ |+||||||+|||++.++. ++|+|||++.
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 86 LL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred eC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99 89999999642 367999999999999999999999999 999999999999998887 9999999998
Q ss_pred cCCCCCCcc-----cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 225 FGPTGDKSH-----VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 225 ~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
......... ......||+.|+|||++.+..++.++|||||||++|||++|..||...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~ 222 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA 222 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc
Confidence 643322211 12346799999999999999999999999999999999999999987543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=331.28 Aligned_cols=206 Identities=31% Similarity=0.398 Sum_probs=172.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC---cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG---FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.++|++++.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999999999999999987532 22235577899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN-KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+ ++ |+||||||+|||++.++.+||+|||++...
T Consensus 227 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999853 3578999999999999999999998 88 999999999999999999999999999753
Q ss_pred CCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
... .......+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+
T Consensus 300 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 356 (446)
T 4ejn_A 300 IKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 356 (446)
T ss_dssp CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cCC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH
Confidence 222 222334679999999999999999999999999999999999999998776543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=320.58 Aligned_cols=209 Identities=28% Similarity=0.432 Sum_probs=168.5
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcC-CCcceeeeeEEecCC--ee
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMR-HPNLVHLIGYCAEGT--QR 144 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~--~~ 144 (299)
..++|++++.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.+. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 45789999999999999999999999999999999865422 23356788999999997 999999999997544 68
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
++||||+. ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 87 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999997 589998853 46899999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCC-------------------CcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 225 FGPTGD-------------------KSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 225 ~~~~~~-------------------~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
...... ........+||+.|+|||++.+ ..++.++|||||||++|||++|.+||...+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 542210 1112234579999999999876 57899999999999999999999999988765
Q ss_pred hhh
Q 022309 285 ERM 287 (299)
Q Consensus 285 ~~~ 287 (299)
+++
T Consensus 238 ~~~ 240 (388)
T 3oz6_A 238 NQL 240 (388)
T ss_dssp HHH
T ss_pred HHH
Confidence 543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=310.00 Aligned_cols=211 Identities=33% Similarity=0.524 Sum_probs=172.5
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
..++|++.+.||+|+||+||+|.+ +++.||+|++....... .+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 356799999999999999999987 68899999997654333 25688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||+++++|.+++.... ....+++..++.++.|++.||+|||+++ ++|+||||||+||+++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999999999996321 1123899999999999999999999874 459999999999999999999999999997532
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.
T Consensus 191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~ 247 (309)
T 3p86_A 191 ST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV 247 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH
T ss_pred cc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 22 1122345699999999999999999999999999999999999999988765543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=313.39 Aligned_cols=209 Identities=28% Similarity=0.444 Sum_probs=177.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCc---EEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQ---VVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
.++|++.+.||+|+||.||+|.+..+++ .||||++...... ..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 4679999999999999999999976554 5999999765332 34678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
||||+++++|.+++.. ....+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++...
T Consensus 128 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999963 3357899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCcc-cccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 227 PTGDKSH-VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 227 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
....... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~ 262 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD 262 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 4332211 2223346778999999988899999999999999999999 999998776543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=318.80 Aligned_cols=223 Identities=27% Similarity=0.383 Sum_probs=186.1
Q ss_pred ccHHHHHHhhcCCCCCceecccCceEEEEEE-----ECCCCcEEEEEEcCCCCccc-HHHHHHHHHHHhhc-CCCcceee
Q 022309 62 FTYRQLVAATDNFKDTNFLGQGGFGAVYKGK-----LAETGQVVAVKQLDDTGFQG-EKEFLVEVLMLSLM-RHPNLVHL 134 (299)
Q Consensus 62 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l-~h~nIv~~ 134 (299)
+.........++|++.+.||+|+||.||+|. +..+++.||||++....... .+.+.+|+.++..+ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 3445555667889999999999999999998 55677899999997654333 35689999999999 78999999
Q ss_pred eeEEecCC-eeEEEEEecCCCCHHHHhcccCCC-----------------------------------------------
Q 022309 135 IGYCAEGT-QRLLVYEYMPLGSLEDHLLGLTPE----------------------------------------------- 166 (299)
Q Consensus 135 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~----------------------------------------------- 166 (299)
++++.+.+ ..++||||+++++|.+++......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99997755 489999999999999999753221
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCC
Q 022309 167 ---------------MKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231 (299)
Q Consensus 167 ---------------~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~ 231 (299)
...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++........
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122889999999999999999999999 99999999999999999999999999986544333
Q ss_pred cccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhhhh
Q 022309 232 SHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHERM 287 (299)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~ 287 (299)
........||+.|+|||++.+..++.++|||||||++|+|++ |.+||...+..+.+
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 305 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 305 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH
Confidence 333445668999999999999999999999999999999998 99999877655443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=306.55 Aligned_cols=206 Identities=25% Similarity=0.371 Sum_probs=174.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
++|++++.||+|+||.||+|.+ .+++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 5799999999999999999998 67899999999754322 23678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
++.+ +|.+++.. ....+++.+++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 81 HLDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CCSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ecCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 9975 99998863 3367899999999999999999999999 999999999999999999999999999754221
Q ss_pred CCcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
. .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...+..+.+
T Consensus 154 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 210 (288)
T 1ob3_A 154 V--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL 210 (288)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred c--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 1 122334689999999998664 5899999999999999999999999887765443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=331.47 Aligned_cols=205 Identities=31% Similarity=0.457 Sum_probs=181.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC---cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG---FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.++|++++.||+|+||.||+|.+..+++.||+|++.+.. ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999999999999999986532 12345678999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||++||+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||++....
T Consensus 263 mEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp ECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 9999999999998642 2345899999999999999999999999 9999999999999999999999999998653
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
... .....+||+.|+|||++.+..++.++|||||||++|||++|.+||...+.
T Consensus 338 ~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~ 390 (576)
T 2acx_A 338 EGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 390 (576)
T ss_dssp TTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS
T ss_pred cCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc
Confidence 322 22335799999999999998999999999999999999999999987643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=317.98 Aligned_cols=202 Identities=25% Similarity=0.353 Sum_probs=167.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|++++.||+|+||+||+|++..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 4679999999999999999999999999999999976543 335688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCc--eEEccccccccCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFH--PKLSDFGLAKFGPT 228 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~--~kl~Dfg~a~~~~~ 228 (299)
+.+++|.+++.. ...+++.+++.++.|++.||+|||+++ |+||||||+||+++.++. +||+|||++.....
T Consensus 98 ~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 98 ASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999853 356899999999999999999999999 999999999999987765 99999999974222
Q ss_pred CCCcccccccccCccccCcccccCCCCCcc-cceehhHHHHHHHHhCCCCCCCCch
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAK-SDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~ 283 (299)
. .......||+.|+|||++.+..++.+ +|||||||++|+|++|.+||...+.
T Consensus 171 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (361)
T 3uc3_A 171 H---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred c---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence 1 12234569999999999988877655 8999999999999999999987654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=303.82 Aligned_cols=216 Identities=26% Similarity=0.389 Sum_probs=185.9
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
..++|++++.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 34679999999999999999999999999999999864432 33467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+++++|.+++. ....+++.+++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 85 EYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp ECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EecCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 9999999999884 3467899999999999999999999999 99999999999999999999999999975433
Q ss_pred CCCcccccccccCccccCcccccCCCC-CcccceehhHHHHHHHHhCCCCCCCCchhhhhhHHHH
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKL-TAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVDWV 292 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~ 292 (299)
...........|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+.....+..|.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 222 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 222 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh
Confidence 222222334578999999999987765 7789999999999999999999988776555555544
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=309.87 Aligned_cols=206 Identities=26% Similarity=0.398 Sum_probs=177.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCC--eeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT--QRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--~~~lv 147 (299)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 4679999999999999999999999999999999975432 33466789999999999999999999987665 77999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEe----cCCCceEEcccccc
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL----GKGFHPKLSDFGLA 223 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv----~~~~~~kl~Dfg~a 223 (299)
|||+++++|.+++.... ....+++.+++.++.|++.||+|||+++ |+||||||+||++ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 99999999999996432 2234899999999999999999999999 9999999999999 77888999999999
Q ss_pred ccCCCCCCcccccccccCccccCccccc--------CCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 224 KFGPTGDKSHVSTRVMGTHGYCAPEYAT--------TGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
....... ......||+.|+|||++. +..++.++|||||||++|+|++|..||...+.
T Consensus 164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 228 (319)
T 4euu_A 164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228 (319)
T ss_dssp EECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTC
T ss_pred eecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 8643322 223356999999999885 56789999999999999999999999975443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=309.31 Aligned_cols=205 Identities=29% Similarity=0.364 Sum_probs=181.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc------cHHHHHHHHHHHhhcCCCcceeeeeEEecCCee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ------GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQR 144 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 144 (299)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 45699999999999999999999999999999998754322 246789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC----ceEEccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF----HPKLSDF 220 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~----~~kl~Df 220 (299)
++||||+++++|.+++. ....+++..++.++.|++.||+|||+++ |+||||||+||+++.++ .++|+||
T Consensus 91 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 99999999999999995 3467899999999999999999999999 99999999999999887 7999999
Q ss_pred cccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 221 GLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 221 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
|++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+
T Consensus 164 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 225 (321)
T 2a2a_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 225 (321)
T ss_dssp TTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred ccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 9997643321 2234568999999999998899999999999999999999999998766543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=327.08 Aligned_cols=203 Identities=24% Similarity=0.308 Sum_probs=171.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC--cccHHHHHHHHHHHhhcCCCcceeeeeEEecC------C
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG--FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG------T 142 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------~ 142 (299)
.++|++++.||+|+||+||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999999999999999997542 22346688999999999999999999999654 3
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccc
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL 222 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~ 222 (299)
..++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 56999999975 5777663 34889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 223 AKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 223 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
|+..... ......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..++
T Consensus 211 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~ 271 (464)
T 3ttj_A 211 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 271 (464)
T ss_dssp C-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred eeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9754321 223446799999999999999999999999999999999999999988775544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=302.69 Aligned_cols=205 Identities=24% Similarity=0.332 Sum_probs=182.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
..++|++.+.||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 34679999999999999999999999999999999987655667789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEe---cCCCceEEccccccccC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL---GKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv---~~~~~~kl~Dfg~a~~~ 226 (299)
|+++++|.+++.. ...+++.+++.++.|++.||+|||+++ |+||||||+||++ +.++.++|+|||++...
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 9999999998853 356899999999999999999999999 9999999999999 78899999999999764
Q ss_pred CCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.... ......||+.|+|||++.+. ++.++||||||+++|+|++|..||...+..+
T Consensus 160 ~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 214 (277)
T 3f3z_A 160 KPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE 214 (277)
T ss_dssp CTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH
Confidence 3322 22335699999999998654 8999999999999999999999998776543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=325.28 Aligned_cols=204 Identities=30% Similarity=0.461 Sum_probs=180.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.++|.+.+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3679999999999999999999999999999999865321 2235688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||++|++|.+++. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999994 4467999999999999999999999999 9999999999999999999999999998653
Q ss_pred CCCCcccccccccCccccCcccccCCCC-CcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKL-TAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+..
T Consensus 168 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~ 222 (476)
T 2y94_A 168 DGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP 222 (476)
T ss_dssp TTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH
T ss_pred ccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH
Confidence 322 2334579999999999988765 68999999999999999999999876543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=316.82 Aligned_cols=200 Identities=27% Similarity=0.382 Sum_probs=172.7
Q ss_pred CceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCCCCH
Q 022309 77 TNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSL 156 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L 156 (299)
.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56899999999999999999999999999876655667899999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEe--cCCCceEEccccccccCCCCCCccc
Q 022309 157 EDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL--GKGFHPKLSDFGLAKFGPTGDKSHV 234 (299)
Q Consensus 157 ~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv--~~~~~~kl~Dfg~a~~~~~~~~~~~ 234 (299)
.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++....... .
T Consensus 174 ~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~ 244 (373)
T 2x4f_A 174 FDRIID---ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---K 244 (373)
T ss_dssp HHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---B
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---c
Confidence 998853 3356899999999999999999999999 9999999999999 567899999999998653322 1
Q ss_pred ccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 235 STRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 235 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 295 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE 295 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 223469999999999988889999999999999999999999998776543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=339.52 Aligned_cols=207 Identities=29% Similarity=0.394 Sum_probs=181.5
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC---cccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG---FQGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~ 145 (299)
..++|++++.||+|+||.||+|.+..+++.||||++++.. ......+..|..++..+ +||+|+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3567999999999999999999999999999999987532 12235677888999887 7999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
|||||++|++|.+++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 419 lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999999953 356999999999999999999999999 99999999999999999999999999985
Q ss_pred CCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 226 GPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
..... ......+||+.|+|||++.+..|+.++|||||||++|||++|.+||...+..+
T Consensus 492 ~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~ 549 (674)
T 3pfq_A 492 NIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 549 (674)
T ss_dssp CCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH
Confidence 32222 22345679999999999999999999999999999999999999998876544
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=306.87 Aligned_cols=210 Identities=29% Similarity=0.421 Sum_probs=175.4
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-----ccHHHHHHHHHHHhhcC---CCcceeeeeEEec
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-----QGEKEFLVEVLMLSLMR---HPNLVHLIGYCAE 140 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~ 140 (299)
...++|++++.||+|+||+||+|.+..+++.||+|++..... .....+.+|+.+++.+. ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 346789999999999999999999999999999999864321 12246677887777664 9999999999976
Q ss_pred CC-----eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCce
Q 022309 141 GT-----QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHP 215 (299)
Q Consensus 141 ~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~ 215 (299)
.. ..++|||++. ++|.+++... ....+++.+++.++.|++.||+|||+++ |+||||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCE
Confidence 55 4789999997 5999999642 2244899999999999999999999999 9999999999999999999
Q ss_pred EEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 216 KLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 216 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+.+
T Consensus 160 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 228 (308)
T 3g33_A 160 KLADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 228 (308)
T ss_dssp EECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH
T ss_pred EEeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999754322 2223457899999999999999999999999999999999999999887765543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=320.17 Aligned_cols=212 Identities=30% Similarity=0.413 Sum_probs=177.1
Q ss_pred hcCCCCCceecccCceEEEEEE-----ECCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGK-----LAETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQR 144 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 144 (299)
.++|++++.||+|+||.||+|. +..+++.||||++...... ....+.+|+.+++.++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 4679999999999999999999 4456789999999754322 335688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC---ceEEc
Q 022309 145 LLVYEYMPLGSLEDHLLGLT---PEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF---HPKLS 218 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~---~~kl~ 218 (299)
++||||+++++|.+++.... .....+++.+++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999996532 22245899999999999999999999999 99999999999999555 59999
Q ss_pred cccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 219 DFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 219 Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |.+||...+..+
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~ 294 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 294 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999964322112222233568899999999988899999999999999999998 999998776543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=307.07 Aligned_cols=208 Identities=26% Similarity=0.405 Sum_probs=175.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
.++|++++.||+|+||.||+|.+..+++.||+|++....... .+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 367999999999999999999999999999999986654332 356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+.+++|.+++. ....+++..+..++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~l~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 82 EYCDHTVLHELDR----YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp ECCSEEHHHHHHH----TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EeCCCchHHHHHh----hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 9999999988874 3466899999999999999999999999 99999999999999999999999999976432
Q ss_pred CCCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
.. .......|++.|+|||++.+ ..++.++||||||+++|+|++|.+||...+..+..
T Consensus 155 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 212 (311)
T 4agu_A 155 PS--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL 212 (311)
T ss_dssp -------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cc--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 21 22234568999999999876 56899999999999999999999999888765543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=310.33 Aligned_cols=195 Identities=26% Similarity=0.372 Sum_probs=153.4
Q ss_pred CceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcC-CCcceeeeeEEecCCeeEEEEEecCCCC
Q 022309 77 TNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMR-HPNLVHLIGYCAEGTQRLLVYEYMPLGS 155 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e~~~~~~ 155 (299)
.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++.+. ||||+++++++.++...++||||+++++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 37899999999999999999999999998643 3466788999999997 9999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC---ceEEccccccccCCCCCCc
Q 022309 156 LEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF---HPKLSDFGLAKFGPTGDKS 232 (299)
Q Consensus 156 L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~---~~kl~Dfg~a~~~~~~~~~ 232 (299)
|.+++.. ...+++.+++.++.|++.||+|||+++ |+||||||+||+++.++ .++|+|||++.......
T Consensus 93 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-- 163 (325)
T 3kn6_A 93 LFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-- 163 (325)
T ss_dssp HHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--
Confidence 9999953 367999999999999999999999999 99999999999997665 89999999997643322
Q ss_pred ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 233 HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 233 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
.......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 214 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDR 214 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC----
T ss_pred CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 223345689999999999999999999999999999999999999986543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=320.68 Aligned_cols=210 Identities=30% Similarity=0.459 Sum_probs=179.4
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
..++|++.+.||+|+||.||+|.+..+++.||+|.++..... ....+.+|+.+++.++||||+++++++..+...++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 356799999999999999999999989999999998754322 2356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+++++|.+++.. ....+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 192 e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 192 ELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp ECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 99999999999963 2246899999999999999999999999 99999999999999999999999999975332
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
...........+++.|+|||++.+..++.++|||||||++|||++ |..||...+..+
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~ 323 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 211111112235678999999988889999999999999999998 999998776543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=309.20 Aligned_cols=205 Identities=25% Similarity=0.383 Sum_probs=172.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCC-------
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT------- 142 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~------- 142 (299)
.++|++++.||+|+||.||+|++..+++.||||++...... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 46799999999999999999999999999999999754322 3467899999999999999999999985543
Q ss_pred --------------------------------------------------eeEEEEEecCCCCHHHHhcccCCCCCCCCH
Q 022309 143 --------------------------------------------------QRLLVYEYMPLGSLEDHLLGLTPEMKPLDW 172 (299)
Q Consensus 143 --------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 172 (299)
..++||||+++++|.+++.... .....++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchhh
Confidence 3799999999999999997532 2244566
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCc----------ccccccccCc
Q 022309 173 NTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKS----------HVSTRVMGTH 242 (299)
Q Consensus 173 ~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~g~~ 242 (299)
..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 778999999999999999999 999999999999999999999999999765433211 1123356999
Q ss_pred cccCcccccCCCCCcccceehhHHHHHHHHhCCCCCC
Q 022309 243 GYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMD 279 (299)
Q Consensus 243 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 279 (299)
.|+|||++.+..++.++|||||||++|+|++|..|+.
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 9999999999999999999999999999999988763
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=316.94 Aligned_cols=200 Identities=27% Similarity=0.341 Sum_probs=165.8
Q ss_pred hcCCCCC-ceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHH-hhcCCCcceeeeeEEec----CCee
Q 022309 71 TDNFKDT-NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLML-SLMRHPNLVHLIGYCAE----GTQR 144 (299)
Q Consensus 71 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~~~~~~~~----~~~~ 144 (299)
.++|.+. +.||+|+||+||+|.+..+++.||||++... ..+.+|+.++ +..+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3567776 6899999999999999999999999998632 4567788877 45589999999999865 5678
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC---CCceEEcccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK---GFHPKLSDFG 221 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~---~~~~kl~Dfg 221 (299)
++||||++|++|.+++... ....+++.+++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecc
Confidence 9999999999999999642 2346899999999999999999999999 999999999999997 7899999999
Q ss_pred ccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 222 LAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 222 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.
T Consensus 210 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 268 (400)
T 1nxk_A 210 FAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_dssp TCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred cccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence 99854321 122345789999999999999999999999999999999999999987654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=313.36 Aligned_cols=214 Identities=29% Similarity=0.504 Sum_probs=181.0
Q ss_pred HhhcCCCCCceecccCceEEEEEEEC-----CCCcEEEEEEcCCCCccc-HHHHHHHHHHHhhcCCCcceeeeeEEecCC
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLA-----ETGQVVAVKQLDDTGFQG-EKEFLVEVLMLSLMRHPNLVHLIGYCAEGT 142 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 142 (299)
...++|++++.||+|+||.||+|.+. .+++.||+|++....... ...+.+|+.+++.++||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34578999999999999999999986 345899999997654332 367899999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTPE--------------------MKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDL 202 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~--------------------~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~di 202 (299)
..++||||+++++|.+++...... ...+++.+++.++.||+.||.|||+++ |+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 999999999999999999753211 257899999999999999999999999 999999
Q ss_pred CCCCEEecCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCC
Q 022309 203 KAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDS 281 (299)
Q Consensus 203 kp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~ 281 (299)
||+||+++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999975432222222233568889999999988899999999999999999999 99999877
Q ss_pred chhh
Q 022309 282 QGHE 285 (299)
Q Consensus 282 ~~~~ 285 (299)
+..+
T Consensus 281 ~~~~ 284 (343)
T 1luf_A 281 AHEE 284 (343)
T ss_dssp CHHH
T ss_pred ChHH
Confidence 6543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=314.10 Aligned_cols=202 Identities=32% Similarity=0.458 Sum_probs=172.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCC----eeEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT----QRLL 146 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~----~~~l 146 (299)
.++|++.+.||+|+||.||+|.+. ++.||||++.... ........|+.+++.++||||+++++++.... .+++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 467999999999999999999884 7899999996542 22345667899999999999999999997744 3699
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeEecCCCCCCEEecCCCceE
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK----------ADPPVIYRDLKAGNILLGKGFHPK 216 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~----------~~~~i~H~dikp~Nilv~~~~~~k 216 (299)
||||+++++|.+++.. ..+++.+++.++.|++.||+|||+. + |+||||||+|||++.++.+|
T Consensus 100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEE
T ss_pred EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEE
Confidence 9999999999999953 4589999999999999999999998 8 99999999999999999999
Q ss_pred EccccccccCCCCCCcccccccccCccccCcccccCC-----CCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 217 LSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTG-----KLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 217 l~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
|+|||++................||+.|+|||++.+. .++.++|||||||++|||++|.+||.....
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 243 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence 9999999765443333333446799999999999763 456688999999999999999999976543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=313.75 Aligned_cols=217 Identities=25% Similarity=0.296 Sum_probs=178.0
Q ss_pred HHHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCC-----CcccHHHHHHHHHHHhhcCCCcceeeeeEEecC
Q 022309 67 LVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDT-----GFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG 141 (299)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 141 (299)
+....++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 445667899999999999999999999999999999998643 223346788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCC------------------------------------CCCCCHHHHHHHHHHHHHH
Q 022309 142 TQRLLVYEYMPLGSLEDHLLGLTPE------------------------------------MKPLDWNTRMKIAAGAARG 185 (299)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~~------------------------------------~~~~~~~~~~~i~~ql~~~ 185 (299)
+..++||||++|++|.+++...... ...+++..++.++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999998521110 1234678889999999999
Q ss_pred HHHHHhCCCCCeEecCCCCCCEEecCCC--ceEEccccccccCCCCC--CcccccccccCccccCcccccC--CCCCccc
Q 022309 186 LEYLHNKADPPVIYRDLKAGNILLGKGF--HPKLSDFGLAKFGPTGD--KSHVSTRVMGTHGYCAPEYATT--GKLTAKS 259 (299)
Q Consensus 186 l~~lH~~~~~~i~H~dikp~Nilv~~~~--~~kl~Dfg~a~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~ 259 (299)
|+|||+++ |+||||||+||+++.++ .+||+|||++....... .........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999999 99999999999998776 89999999997532211 1112334569999999999865 5788999
Q ss_pred ceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 260 DIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 260 DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
|||||||++|+|++|..||...+..+.
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~ 284 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADT 284 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHH
Confidence 999999999999999999987765543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=307.68 Aligned_cols=212 Identities=29% Similarity=0.404 Sum_probs=180.9
Q ss_pred hcCCCCCceecccCceEEEEEEEC-----CCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLA-----ETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQR 144 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 144 (299)
.++|++.+.||+|+||.||+|.+. .+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 467999999999999999999883 45688999999765332 236788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 022309 145 LLVYEYMPLGSLEDHLLGLTP--------------------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKA 204 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp 204 (299)
++||||+++++|.+++..... ....+++.+++.++.|++.||.|||+++ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999975322 1235889999999999999999999999 99999999
Q ss_pred CCEEecCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCch
Q 022309 205 GNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQG 283 (299)
Q Consensus 205 ~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 283 (299)
+||+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||...+.
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999976543333223334457889999999988889999999999999999999 9999987665
Q ss_pred hh
Q 022309 284 HE 285 (299)
Q Consensus 284 ~~ 285 (299)
.+
T Consensus 259 ~~ 260 (314)
T 2ivs_A 259 ER 260 (314)
T ss_dssp GG
T ss_pred HH
Confidence 43
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=313.58 Aligned_cols=199 Identities=27% Similarity=0.365 Sum_probs=172.8
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
..++|++.+.||+|+||.||+|.+..+++.||+|++.+... ...+|+.++..+ +||||+++++++.++...++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 45679999999999999999999999999999999976532 234577788777 7999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCC----CceEEccccccc
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKG----FHPKLSDFGLAK 224 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~----~~~kl~Dfg~a~ 224 (299)
||++|++|.+.+. ....+++.++..++.||+.||+|||+++ |+||||||+|||+... +.+||+|||++.
T Consensus 96 E~~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 96 ELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp CCCCSCBHHHHHH----TCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 9999999999995 3467999999999999999999999999 9999999999998543 359999999997
Q ss_pred cCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCC
Q 022309 225 FGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDS 281 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 281 (299)
...... ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 169 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 169 QLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp ECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred cCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 643322 2233457899999999998888999999999999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=301.34 Aligned_cols=206 Identities=26% Similarity=0.386 Sum_probs=180.1
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
..++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.+++..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 357899999999999999999999999999999998654322 235688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCc---eEEccccccc
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFH---PKLSDFGLAK 224 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~---~kl~Dfg~a~ 224 (299)
|||+.+++|.+.+.. ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++. ++|+|||++.
T Consensus 84 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 84 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 999999999998853 356899999999999999999999999 999999999999976654 9999999997
Q ss_pred cCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 225 FGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
...... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+
T Consensus 157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 214 (284)
T 3kk8_A 157 EVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 214 (284)
T ss_dssp ECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH
Confidence 543222 2233568999999999999999999999999999999999999998766543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=310.59 Aligned_cols=206 Identities=28% Similarity=0.404 Sum_probs=171.1
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH-HHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE-KEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
++|++++.||+|+||.||+|.+..+++.||+|++........ ..+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 579999999999999999999999999999999975432221 2455799999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+. ++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~- 153 (324)
T 3mtl_A 82 LD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP- 153 (324)
T ss_dssp CS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC-
Confidence 97 589988864 3356899999999999999999999999 999999999999999999999999999753322
Q ss_pred CcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.
T Consensus 154 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 209 (324)
T 3mtl_A 154 -TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ 209 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred -ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 122233468999999999876 5689999999999999999999999988776554
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=307.66 Aligned_cols=206 Identities=28% Similarity=0.355 Sum_probs=173.6
Q ss_pred hcCCCCC-ceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEEEE
Q 022309 71 TDNFKDT-NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 71 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
.+.|++. +.||+|+||.||+|.+..+++.||||++..........+.+|+.++..+ +||||+++++++.+++..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4678885 7899999999999999999999999999776555667889999999884 7999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCc---eEEcccccccc
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFH---PKLSDFGLAKF 225 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~---~kl~Dfg~a~~ 225 (299)
||+++++|.+++.. ...+++.+++.++.|++.||+|||+++ |+||||||+||+++.++. +||+|||++..
T Consensus 91 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 99999999999953 356899999999999999999999999 999999999999988765 99999999875
Q ss_pred CCCCCC-----cccccccccCccccCcccccC-----CCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 226 GPTGDK-----SHVSTRVMGTHGYCAPEYATT-----GKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 226 ~~~~~~-----~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 231 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccc
Confidence 432111 111223469999999999865 4578899999999999999999999987653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=300.31 Aligned_cols=206 Identities=30% Similarity=0.481 Sum_probs=179.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|++++.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.++...++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 467999999999999999999987 47789999997654 3456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+++++|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++.......
T Consensus 87 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 87 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp CTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 999999999963 3356899999999999999999999999 9999999999999999999999999997543221
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
........+++.|+|||++.+..++.++||||||+++|+|++ |.+||...+..+
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~ 215 (269)
T 4hcu_A 161 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 215 (269)
T ss_dssp -HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred -cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH
Confidence 112223456778999999988899999999999999999999 999998776543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=322.29 Aligned_cols=204 Identities=23% Similarity=0.314 Sum_probs=159.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEec-----CCe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAE-----GTQ 143 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-----~~~ 143 (299)
.++|++++.||+|+||+||+|.+..+++.||||++...... ..+.+.+|+.+++.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 46899999999999999999999999999999999754322 33678899999999999999999999843 356
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA 223 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a 223 (299)
.|+|||++ +++|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 132 ~~lv~e~~-~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence 89999998 579999885 3467999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCc-------------------------ccccccccCccccCcccc-cCCCCCcccceehhHHHHHHHHh----
Q 022309 224 KFGPTGDKS-------------------------HVSTRVMGTHGYCAPEYA-TTGKLTAKSDIFSFGVVLLELIT---- 273 (299)
Q Consensus 224 ~~~~~~~~~-------------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~ellt---- 273 (299)
+........ ......+||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 864322111 122345789999999976 55679999999999999999999
Q ss_pred -------CCCCCCCCc
Q 022309 274 -------GRPAMDDSQ 282 (299)
Q Consensus 274 -------g~~pf~~~~ 282 (299)
|.++|.+.+
T Consensus 284 ~~~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSS 299 (458)
T ss_dssp TCSSGGGCCCSCC---
T ss_pred cccccccccccCCCCc
Confidence 777776554
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=312.60 Aligned_cols=213 Identities=30% Similarity=0.411 Sum_probs=181.8
Q ss_pred hhcCCCCCceecccCceEEEEEEECC-------CCcEEEEEEcCCCCccc-HHHHHHHHHHHhhc-CCCcceeeeeEEec
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAE-------TGQVVAVKQLDDTGFQG-EKEFLVEVLMLSLM-RHPNLVHLIGYCAE 140 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l-~h~nIv~~~~~~~~ 140 (299)
..++|++.+.||+|+||.||+|.+.. .+..||+|++....... ...+.+|+.+++.+ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 34679999999999999999999753 33579999997654332 36788999999999 99999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 022309 141 GTQRLLVYEYMPLGSLEDHLLGLTP------------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNIL 208 (299)
Q Consensus 141 ~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nil 208 (299)
++..++||||+++++|.+++..... ....+++.+++.++.|++.||+|||+++ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999975321 1246899999999999999999999999 999999999999
Q ss_pred ecCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 209 LGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 209 v~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
++.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||...+..+
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999986544333233334567889999999999999999999999999999999 999998776443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=307.83 Aligned_cols=214 Identities=27% Similarity=0.409 Sum_probs=163.6
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCc---EEEEEEcCCCC--cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCe
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQ---VVAVKQLDDTG--FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQ 143 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 143 (299)
...++|++.+.||+|+||.||+|.+..++. .||+|++.... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345679999999999999999999877665 89999997653 2334678999999999999999999999987765
Q ss_pred e------EEEEEecCCCCHHHHhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCce
Q 022309 144 R------LLVYEYMPLGSLEDHLLGLT--PEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHP 215 (299)
Q Consensus 144 ~------~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~ 215 (299)
. ++||||+.+++|.+++.... .....+++.+++.++.|++.||+|||+++ |+||||||+||+++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence 5 89999999999999985422 22236899999999999999999999999 9999999999999999999
Q ss_pred EEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 216 KLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 216 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~ 247 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH
Confidence 9999999976543333233334457888999999999999999999999999999999 999998766543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=313.13 Aligned_cols=202 Identities=29% Similarity=0.405 Sum_probs=170.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEecCC------
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAEGT------ 142 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~------ 142 (299)
.++|++++.||+|+||.||+|.+..+++.||||++....... .+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467999999999999999999999999999999996543222 356889999999999999999999997653
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccc
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL 222 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~ 222 (299)
.+++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 7899999853 56899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 223 AKFGPTGDKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 223 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
++.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..++
T Consensus 175 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 234 (367)
T 1cm8_A 175 ARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 234 (367)
T ss_dssp CEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 986432 1234578999999999877 6799999999999999999999999998776544
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=310.33 Aligned_cols=208 Identities=30% Similarity=0.474 Sum_probs=175.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcE----EEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQV----VAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 145 (299)
.++|++++.||+|+||.||+|.+..+++. ||+|.+..... .....+.+|+.+++.++||||+++++++.+ ...+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccE
Confidence 36799999999999999999999888775 77777754332 223567789999999999999999999864 5688
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
+||||+.+++|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 91 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccc
Confidence 99999999999999963 2357889999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 226 GPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
..............+++.|+|||++.+..++.++|||||||++|+|++ |..||......+
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 225 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE 225 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH
Confidence 654444444445668889999999998899999999999999999999 999998765433
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=310.81 Aligned_cols=203 Identities=26% Similarity=0.354 Sum_probs=178.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--------cHHHHHHHHHHHhhcCCCcceeeeeEEecC
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--------GEKEFLVEVLMLSLMRHPNLVHLIGYCAEG 141 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 141 (299)
..++|++++.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 456799999999999999999999999999999999765422 223577899999999999999999999999
Q ss_pred CeeEEEEEecCCC-CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccc
Q 022309 142 TQRLLVYEYMPLG-SLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDF 220 (299)
Q Consensus 142 ~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Df 220 (299)
+..++|||++.++ +|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999998666 9999995 3457999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccCccccCcccccCCCC-CcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 221 GLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKL-TAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 221 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
|++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||....
T Consensus 175 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 234 (335)
T 3dls_A 175 GSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234 (335)
T ss_dssp TTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG
T ss_pred ccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH
Confidence 9998643322 2234569999999999988776 789999999999999999999997643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=300.05 Aligned_cols=205 Identities=30% Similarity=0.498 Sum_probs=159.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 3579999999999999999999999999999999864321 1235688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||+++++|.+++.. ...++++.+++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 999999999999963 3367899999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
.... ......|++.|+|||++.+..++.++||||||+++|+|++|.+||...+.
T Consensus 164 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 217 (278)
T 3cok_A 164 MPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV 217 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC
T ss_pred CCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH
Confidence 2221 12235689999999999888899999999999999999999999986553
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=309.54 Aligned_cols=214 Identities=28% Similarity=0.428 Sum_probs=179.1
Q ss_pred hhcCCCCCceecccCceEEEEEEE-----CCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhc-CCCcceeeeeEEecCC
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKL-----AETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGT 142 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~ 142 (299)
..++|++.+.||+|+||.||+|.+ ..++..||+|++..... ...+.+.+|+.+++.+ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 346799999999999999999997 34567899999975432 2336789999999999 8999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTPE-------------------MKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLK 203 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~-------------------~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dik 203 (299)
..++||||+++++|.+++...... ...+++..++.++.||+.||+|||+++ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999653211 134789999999999999999999999 9999999
Q ss_pred CCCEEecCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCc
Q 022309 204 AGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQ 282 (299)
Q Consensus 204 p~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~ 282 (299)
|+||+++.++.++|+|||++................||+.|+|||++.+..++.++||||||+++|+|+| |..||...+
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999975433333333334567889999999988899999999999999999998 999998776
Q ss_pred hhhh
Q 022309 283 GHER 286 (299)
Q Consensus 283 ~~~~ 286 (299)
..+.
T Consensus 280 ~~~~ 283 (344)
T 1rjb_A 280 VDAN 283 (344)
T ss_dssp CSHH
T ss_pred cHHH
Confidence 5443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=304.24 Aligned_cols=204 Identities=26% Similarity=0.404 Sum_probs=178.1
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
..++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 34679999999999999999999999999999999986654455678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEe---cCCCceEEccccccccC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL---GKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv---~~~~~~kl~Dfg~a~~~ 226 (299)
|+++++|.+++.. ...+++.+++.++.|++.||.|||+++ |+||||||+||++ +.++.++|+|||++...
T Consensus 87 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 9999999999853 356899999999999999999999999 9999999999999 77889999999999753
Q ss_pred CCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
... ......|++.|+|||++.+..++.++||||||+++|+|++|.+||...+..
T Consensus 160 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 213 (304)
T 2jam_A 160 QNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES 213 (304)
T ss_dssp CCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred CCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 221 223346899999999999989999999999999999999999999876543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=310.00 Aligned_cols=208 Identities=23% Similarity=0.324 Sum_probs=171.2
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
..++|++++.||+|+||+||+|.+..+++.||+|++....... ...+.+|+.+++.++||||+++++++.++...++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 4567999999999999999999999999999999997554332 34577899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEec-----CCCceEEccccc
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLG-----KGFHPKLSDFGL 222 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~-----~~~~~kl~Dfg~ 222 (299)
|||+.+ +|.+++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++ ..+.+||+|||+
T Consensus 112 ~e~~~~-~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EECCSE-EHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EecCCC-CHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999974 99999853 356899999999999999999999999 99999999999994 555699999999
Q ss_pred cccCCCCCCcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 223 AKFGPTGDKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 223 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
+...... ........||+.|+|||++.+. .++.++|||||||++|+|++|.+||...+..+.+
T Consensus 184 a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 247 (329)
T 3gbz_A 184 ARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL 247 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH
Confidence 9754322 1122334689999999999775 4899999999999999999999999887765543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=309.37 Aligned_cols=208 Identities=31% Similarity=0.491 Sum_probs=170.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcE----EEEEEcCCCC-cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQV----VAVKQLDDTG-FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 145 (299)
.++|++++.||+|+||+||+|.+..+++. ||+|.+.... ....+.+.+|+.+++.++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 35699999999999999999999877765 4778775432 234467899999999999999999999998765 67
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
+|++++.+++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 93 ~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeE
Confidence 89999999999999964 3367899999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 226 GPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
..............+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+..+
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 227 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH
Confidence 544333333334557889999999999999999999999999999999 999998766543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=303.10 Aligned_cols=208 Identities=27% Similarity=0.354 Sum_probs=176.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC-cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG-FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
.++|++.+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 356999999999999999999999999999999987543 2345778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEe---cCCCceEEccccccccC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL---GKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv---~~~~~~kl~Dfg~a~~~ 226 (299)
|+++++|.+.+.........+++..++.++.|++.||+|||+++ |+||||||+||++ +.++.++|+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988643333467899999999999999999999999 9999999999999 45678999999999754
Q ss_pred CCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
... .......|++.|+|||++. ..++.++||||||+++|+|++|..||...+..+
T Consensus 178 ~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~ 232 (285)
T 3is5_A 178 KSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE 232 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH
Confidence 322 1223456899999999985 568899999999999999999999998776543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=318.07 Aligned_cols=200 Identities=25% Similarity=0.320 Sum_probs=167.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEecC-----Ce
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG-----TQ 143 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-----~~ 143 (299)
.++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4789999999999999999999999999999999976432 2336788999999999999999999999766 56
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA 223 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a 223 (299)
.++|||++. ++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 105 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999986 59999995 3467999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCc--------------------ccccccccCccccCcccc-cCCCCCcccceehhHHHHHHHHhCCCCC
Q 022309 224 KFGPTGDKS--------------------HVSTRVMGTHGYCAPEYA-TTGKLTAKSDIFSFGVVLLELITGRPAM 278 (299)
Q Consensus 224 ~~~~~~~~~--------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~pf 278 (299)
+........ ......+||+.|+|||++ .+..++.++|||||||++|||++|..||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 864332211 122456799999999986 5566999999999999999999843333
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=301.10 Aligned_cols=204 Identities=32% Similarity=0.526 Sum_probs=177.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 4679999999999999999999999999999999864321 2235688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||+++++|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999853 356899999999999999999999999 9999999999999999999999999986432
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 214 (279)
T 3fdn_A 161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH
Confidence 21 2233568999999999999899999999999999999999999998776543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=300.96 Aligned_cols=204 Identities=22% Similarity=0.304 Sum_probs=177.8
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.+++.+ +|+||+++++++.+....++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 3567999999999999999999999999999999986543 334678899999998 7999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCc-----eEEcccccc
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFH-----PKLSDFGLA 223 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~-----~kl~Dfg~a 223 (299)
||+ +++|.+++.. ...++++.+++.++.|++.||+|||+++ |+||||||+||+++.++. ++|+|||++
T Consensus 86 e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 86 DLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp ECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999 8999999964 2356899999999999999999999999 999999999999987765 999999999
Q ss_pred ccCCCCCCc-----ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 224 KFGPTGDKS-----HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 224 ~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 222 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence 765433221 11234569999999999999999999999999999999999999998754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=307.25 Aligned_cols=209 Identities=26% Similarity=0.406 Sum_probs=176.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEec--------
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAE-------- 140 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~-------- 140 (299)
.++|++++.||+|+||.||+|.+..+++.||+|++....... ...+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 367999999999999999999999999999999986543322 3567899999999999999999999876
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccc
Q 022309 141 GTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDF 220 (299)
Q Consensus 141 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Df 220 (299)
.+..++||||+.+ +|.+.+.. ....+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccc
Confidence 3468999999975 77777753 3356999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCC--cccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 221 GLAKFGPTGDK--SHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 221 g~a~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
|++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 237 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ 237 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 99976432221 122234568999999999876 4589999999999999999999999998776544
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=323.12 Aligned_cols=205 Identities=30% Similarity=0.458 Sum_probs=180.5
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
..++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++.+....++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 34679999999999999999999999999999999865432 345678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEe---cCCCceEEcccccc
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL---GKGFHPKLSDFGLA 223 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv---~~~~~~kl~Dfg~a 223 (299)
||||+.+++|.+.+. ....+++.+++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 999999999999985 3467899999999999999999999999 9999999999999 56789999999999
Q ss_pred ccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 224 KFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
....... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||...+..+
T Consensus 177 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 234 (484)
T 3nyv_A 177 THFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD 234 (484)
T ss_dssp HHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 7643322 2234569999999999866 68999999999999999999999998876543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=297.32 Aligned_cols=207 Identities=28% Similarity=0.424 Sum_probs=179.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|++++.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.+++.++||||+++++++.++...++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 467999999999999999999886 56789999997654 3456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+++++|.+++.. ....+++.+++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 85 ISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred cCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999999964 2346899999999999999999999999 9999999999999999999999999997643322
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHER 286 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~ 286 (299)
. .......+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+.
T Consensus 159 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 214 (268)
T 3sxs_A 159 Y-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV 214 (268)
T ss_dssp E-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred h-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH
Confidence 1 12223446778999999988889999999999999999999 9999987765543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=307.86 Aligned_cols=209 Identities=28% Similarity=0.416 Sum_probs=173.6
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc-----HHHHHHHHHHHhhcCCCcceeeeeEEecCCee
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG-----EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQR 144 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 144 (299)
..++|++++.||+|+||.||+|.+..+++.||+|++....... ...+.+|+.+++.++||||+++++++.+....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4578999999999999999999999999999999997543221 24678999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
++||||+.+ +|.+++.. ....+++.+++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999985 89888853 3356889999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 225 FGPTGDKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
...... .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...+..+.+
T Consensus 161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~ 222 (346)
T 1ua2_A 161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL 222 (346)
T ss_dssp TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 643222 223345689999999998664 4889999999999999999999999887765543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=312.79 Aligned_cols=209 Identities=28% Similarity=0.444 Sum_probs=167.8
Q ss_pred hcCCCCCceecccCceEEEEEEEC---CCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLA---ETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
.++|++.+.||+|+||.||+|++. .++..||||.++..... ..+.+.+|+.+++.++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 457999999999999999999886 45678999999765322 34678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
||||+++++|.+++.. ....+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 124 v~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 9999999999999963 3356899999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCcc-cccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 227 PTGDKSH-VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 227 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
....... ......+++.|+|||++.+..++.++||||||+++|||++ |..||...+..+
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~ 258 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 3322111 1112335778999999998999999999999999999998 999998766543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=306.95 Aligned_cols=208 Identities=27% Similarity=0.467 Sum_probs=176.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
.++|++++.||+|+||.||+|.+..+++.||+|++....... .+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 467999999999999999999999999999999986543332 355788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+.+++|.+++. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++.....
T Consensus 104 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 9999988888764 3456899999999999999999999999 99999999999999999999999999975432
Q ss_pred CCCcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
.. .......|++.|+|||++.+. .++.++|||||||++|+|++|.+||...+..+.+
T Consensus 177 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 234 (331)
T 4aaa_A 177 PG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQL 234 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred Cc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 21 222345689999999998775 6899999999999999999999999888765543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=299.52 Aligned_cols=206 Identities=26% Similarity=0.387 Sum_probs=181.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc---cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 46799999999999999999999999999999998654322 235688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||+++++|.+++.. ...+++.+++.++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999998853 357899999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
... .......|++.|+|||++.+..++.++||||||+++|+|++|..||......+
T Consensus 167 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 222 (294)
T 2rku_A 167 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 222 (294)
T ss_dssp STT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred cCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 222 12233568999999999988889999999999999999999999998776543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=308.63 Aligned_cols=201 Identities=35% Similarity=0.521 Sum_probs=175.8
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc---HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG---EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
+.|++++.||+|+||.||+|.+..+++.||||++....... ...+.+|+.+++.++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45899999999999999999999999999999997543322 256889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+. |+|.+++.. ...++++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 588887753 2367899999999999999999999999 99999999999999999999999999975432
Q ss_pred CCCcccccccccCccccCccccc---CCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYAT---TGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.....||+.|+|||++. +..++.++|||||||++|||++|.+||...+..+
T Consensus 207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 260 (348)
T 1u5q_A 207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 260 (348)
T ss_dssp ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 12356999999999984 5678999999999999999999999998766543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=304.95 Aligned_cols=206 Identities=33% Similarity=0.485 Sum_probs=173.8
Q ss_pred hcCCCCCceecccCceEEEEEE----ECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecC--Cee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGK----LAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG--TQR 144 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~ 144 (299)
.++|++++.||+|+||+||+|. +..+++.||+|++........+.+.+|+.+++.++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 4679999999999999999998 5678999999999876555557789999999999999999999998543 458
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
++||||+++++|.+++.. ....+++.+++.++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 999999999999999964 2345899999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCc-ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 225 FGPTGDKS-HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 225 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
........ .......+++.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~ 221 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP 221 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCCh
Confidence 64332221 12223457778999999999999999999999999999999999987543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=306.47 Aligned_cols=206 Identities=26% Similarity=0.392 Sum_probs=181.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4679999999999999999999999999999999865432 2335688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||+.+++|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999998853 357899999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
... .......|++.|+|||++.+..++.++||||||+++|+|++|..||......+
T Consensus 193 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 248 (335)
T 2owb_A 193 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 248 (335)
T ss_dssp STT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred cCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH
Confidence 222 12233568999999999998889999999999999999999999998776543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=316.31 Aligned_cols=206 Identities=26% Similarity=0.376 Sum_probs=169.0
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--------ccHHHHHHHHHHHhhcCCCcceeeeeEEec
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--------QGEKEFLVEVLMLSLMRHPNLVHLIGYCAE 140 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 140 (299)
...++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 456889999999999999999999999999999999865321 112357899999999999999999999865
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC---ceEE
Q 022309 141 GTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF---HPKL 217 (299)
Q Consensus 141 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~---~~kl 217 (299)
...++||||+++++|.+++. ....+++.+++.++.|++.||+|||+++ |+||||||+|||++.++ .+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -CceEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence 45789999999999999884 4467999999999999999999999999 99999999999997544 5999
Q ss_pred ccccccccCCCCCCcccccccccCccccCcccccC---CCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 218 SDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATT---GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 218 ~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
+|||++..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.......
T Consensus 284 ~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~ 351 (419)
T 3i6u_A 284 TDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 351 (419)
T ss_dssp CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC
T ss_pred eecccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH
Confidence 99999986432 222334679999999999854 567889999999999999999999998765443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=298.03 Aligned_cols=205 Identities=29% Similarity=0.407 Sum_probs=178.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc------cHHHHHHHHHHHhhcCCCcceeeeeEEecCCee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ------GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQR 144 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 144 (299)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 45699999999999999999999999999999998654322 356789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC----ceEEccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF----HPKLSDF 220 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~----~~kl~Df 220 (299)
++||||+++++|.+++.. ...+++.+++.++.|++.||.|||+++ ++||||||+||+++.++ .++|+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEec
Confidence 999999999999999953 356899999999999999999999999 99999999999998877 8999999
Q ss_pred cccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 221 GLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 221 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
|++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+
T Consensus 157 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 218 (283)
T 3bhy_A 157 GIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE 218 (283)
T ss_dssp TTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred ccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH
Confidence 9997643221 2233468999999999998899999999999999999999999998776543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=312.50 Aligned_cols=207 Identities=25% Similarity=0.363 Sum_probs=173.6
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEec---------
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAE--------- 140 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--------- 140 (299)
..++|++++.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 4578999999999999999999999999999999886442 223469999999999999999999843
Q ss_pred -----------------------------CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022309 141 -----------------------------GTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN 191 (299)
Q Consensus 141 -----------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~ 191 (299)
....++||||+. ++|.+.+.........+++..++.++.||+.||+|||+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp -----------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 334789999997 58888776433455789999999999999999999999
Q ss_pred CCCCCeEecCCCCCCEEec-CCCceEEccccccccCCCCCCcccccccccCccccCcccccCC-CCCcccceehhHHHHH
Q 022309 192 KADPPVIYRDLKAGNILLG-KGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLL 269 (299)
Q Consensus 192 ~~~~~i~H~dikp~Nilv~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ 269 (299)
++ |+||||||+||+++ .++.+||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|
T Consensus 160 ~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 160 LG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp TT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred Cc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 99 99999999999997 68899999999998643322 22335689999999998775 4899999999999999
Q ss_pred HHHhCCCCCCCCchhhhh
Q 022309 270 ELITGRPAMDDSQGHERM 287 (299)
Q Consensus 270 elltg~~pf~~~~~~~~~ 287 (299)
+|++|.+||...+..+.+
T Consensus 234 ell~g~~pf~~~~~~~~~ 251 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQL 251 (383)
T ss_dssp HHHHSSCSSCCSSHHHHH
T ss_pred HHHhCCCCCCCCChHHHH
Confidence 999999999987765543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=303.47 Aligned_cols=212 Identities=29% Similarity=0.427 Sum_probs=181.8
Q ss_pred hcCCCCCceecccCceEEEEEEE-----CCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhc-CCCcceeeeeEEecCCe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKL-----AETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQ 143 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 143 (299)
.++|++.+.||+|+||.||+|.+ ..+++.||+|.+...... ..+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46799999999999999999985 457789999999765432 346788999999999 99999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEe
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTP--------------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL 209 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv 209 (299)
.++||||+++++|.+++..... ....+++.+++.++.|++.||.|||+++ |+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999965321 1235899999999999999999999999 9999999999999
Q ss_pred cCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 210 GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 210 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
+.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 9999999999999986544433333334557889999999988899999999999999999999 999998766543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=322.39 Aligned_cols=204 Identities=28% Similarity=0.438 Sum_probs=174.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
.++|++++.||+|+||+||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4569999999999999999999999999999999976432 23467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCC---CceEEcccccccc
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKG---FHPKLSDFGLAKF 225 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~---~~~kl~Dfg~a~~ 225 (299)
||+.+++|.+.+.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||++.. +.+||+|||++..
T Consensus 116 e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999998853 356899999999999999999999999 9999999999999764 5599999999976
Q ss_pred CCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 226 GPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.... .......||+.|+|||++. ..++.++|||||||++|+|++|.+||...+..+
T Consensus 189 ~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 244 (494)
T 3lij_A 189 FENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE 244 (494)
T ss_dssp CBTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CCCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 4322 2233457999999999986 468999999999999999999999998876543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=322.85 Aligned_cols=204 Identities=29% Similarity=0.434 Sum_probs=177.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC--cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG--FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
.++|++++.||+|+||+||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 467999999999999999999999999999999986432 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEec---CCCceEEcccccccc
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLG---KGFHPKLSDFGLAKF 225 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~---~~~~~kl~Dfg~a~~ 225 (299)
||+.+++|.+.+.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 101 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999998853 356899999999999999999999999 99999999999995 456799999999975
Q ss_pred CCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 226 GPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.... .......||+.|+|||++.+ .++.++|||||||++|+|++|.+||...+..+
T Consensus 174 ~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 229 (486)
T 3mwu_A 174 FQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD 229 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 4332 12234579999999999876 58999999999999999999999998776543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=298.65 Aligned_cols=205 Identities=31% Similarity=0.440 Sum_probs=181.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
.+.|++++.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 3569999999999999999999999999999999975543 334778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+.+++|.+++. ..++++.+++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++......
T Consensus 101 ~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999999999984 257899999999999999999999999 999999999999999999999999999754322
Q ss_pred CCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
. .......|++.|+|||++.+..++.++||||||+++|+|++|.+||...+..+
T Consensus 173 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 226 (303)
T 3a7i_A 173 Q--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK 226 (303)
T ss_dssp B--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred c--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH
Confidence 1 12234568999999999999899999999999999999999999998766543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=321.33 Aligned_cols=205 Identities=27% Similarity=0.427 Sum_probs=176.6
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-------------cHHHHHHHHHHHhhcCCCcceeeee
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-------------GEKEFLVEVLMLSLMRHPNLVHLIG 136 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~E~~~l~~l~h~nIv~~~~ 136 (299)
..++|++++.||+|+||+||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 357899999999999999999999999999999998754322 2356889999999999999999999
Q ss_pred EEecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC---
Q 022309 137 YCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF--- 213 (299)
Q Consensus 137 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~--- 213 (299)
++.+....++||||++|++|.+.+.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence 99999999999999999999998853 356899999999999999999999999 99999999999998775
Q ss_pred ceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 214 HPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 214 ~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|.+||...+..+
T Consensus 187 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 254 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD 254 (504)
T ss_dssp SEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 69999999998653321 223456999999999986 468999999999999999999999998876543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=296.08 Aligned_cols=205 Identities=33% Similarity=0.605 Sum_probs=175.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH-------HHHHHHHHHHhhcCCCcceeeeeEEecCCe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE-------KEFLVEVLMLSLMRHPNLVHLIGYCAEGTQ 143 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 143 (299)
.++|++.+.||+|+||.||+|.+..+++.||+|++........ +.+.+|+.+++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 3679999999999999999999999999999999865433221 56889999999999999999999997665
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCc-----eEEc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFH-----PKLS 218 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~-----~kl~ 218 (299)
++||||+++++|.+.+.. ...++++..++.++.|++.||+|||+++ ++|+||||||+||+++.++. ++|+
T Consensus 97 -~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred -eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 699999999999998863 4467999999999999999999999874 45999999999999988776 9999
Q ss_pred cccccccCCCCCCcccccccccCccccCccccc--CCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 219 DFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYAT--TGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 219 Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
|||++..... ......||+.|+|||++. ...++.++|||||||++|+|++|..||...+..+.
T Consensus 172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 236 (287)
T 4f0f_A 172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236 (287)
T ss_dssp CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH
T ss_pred CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH
Confidence 9999974321 233456899999999983 45578899999999999999999999987665444
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=302.42 Aligned_cols=201 Identities=27% Similarity=0.290 Sum_probs=168.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv 147 (299)
.++|+++++||+|+||+||+|.+..+++.||||++....... ......|+..+..+ +||||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 467999999999999999999999999999999986543322 23445555555544 899999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
||++ +++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 136 ~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred Eecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999 67999988642 356999999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
.. .......||+.|+|||++.+ .++.++|||||||++|||++|..||...+
T Consensus 209 ~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~ 259 (311)
T 3p1a_A 209 TA---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE 259 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH
T ss_pred cC---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 22 12233569999999999876 78999999999999999999977765543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=312.80 Aligned_cols=204 Identities=22% Similarity=0.290 Sum_probs=169.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcC--CCcceeeeeEEecCCeeEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMR--HPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~--h~nIv~~~~~~~~~~~~~l 146 (299)
..+|++++.||+|+||.||+|.+.. ++.||||++...... ....+.+|+.+++.+. ||||+++++++..++..++
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 3569999999999999999999865 899999998754332 2367889999999996 5999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
||| +.+++|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++...
T Consensus 134 v~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EEE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred EEe-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 999 567899999963 357889999999999999999999999 99999999999996 579999999999865
Q ss_pred CCCCCcccccccccCccccCcccccC-----------CCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATT-----------GKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
............+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||......
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~ 273 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH
Confidence 43333333345679999999999865 36888999999999999999999999875443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=308.48 Aligned_cols=203 Identities=22% Similarity=0.296 Sum_probs=168.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCC--CcceeeeeEEecCCeeEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRH--PNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~~~~l 146 (299)
.++|++++.||+|+||.||+|.+. +++.||+|++....... .+.+.+|+.+++.++| |||+++++++.++...++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 467999999999999999999884 68899999987554332 3568899999999976 999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
|||+ .+++|.+++.. ...+++.++..++.|++.||.|||+++ |+||||||+|||++ ++.+||+|||++...
T Consensus 87 v~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 87 VMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 9995 57899999953 467899999999999999999999999 99999999999997 578999999999865
Q ss_pred CCCCCcccccccccCccccCcccccC-----------CCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATT-----------GKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
.............||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.....
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 225 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 225 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh
Confidence 44333333445679999999999864 5688899999999999999999999986544
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=308.70 Aligned_cols=202 Identities=25% Similarity=0.319 Sum_probs=168.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCC------
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT------ 142 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~------ 142 (299)
.++|++++.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46799999999999999999999999999999999754322 2356889999999999999999999997655
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccc
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL 222 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~ 222 (299)
..++||||+.+ +|.+.+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence 67999999974 7888874 34889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 223 AKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 223 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
+...... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+
T Consensus 174 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 233 (371)
T 2xrw_A 174 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID 233 (371)
T ss_dssp -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9754221 12234578999999999999899999999999999999999999998877544
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=300.51 Aligned_cols=204 Identities=21% Similarity=0.332 Sum_probs=176.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcC-CCcceeeeeEEec--CCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMR-HPNLVHLIGYCAE--GTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~--~~~~~lv 147 (299)
.++|++++.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++.++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36799999999999999999999999999999998743 3567899999999997 9999999999987 6678999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC-ceEEccccccccC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF-HPKLSDFGLAKFG 226 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~-~~kl~Dfg~a~~~ 226 (299)
|||+.+++|.+++. .+++.+++.++.|++.||+|||+++ |+||||||+|||++.++ .++|+|||++...
T Consensus 112 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999999999883 4889999999999999999999999 99999999999999776 8999999999764
Q ss_pred CCCCCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhhhhhHH
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVD 290 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~ 290 (299)
..... .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||.........+..
T Consensus 182 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~ 243 (330)
T 3nsz_A 182 HPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 243 (330)
T ss_dssp CTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH
T ss_pred CCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHH
Confidence 33222 233468999999999877 66899999999999999999999999766554444433
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=302.10 Aligned_cols=206 Identities=23% Similarity=0.308 Sum_probs=171.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc---HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG---EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.++|++.+.||+|+||.||+|.+..+++.||+|++....... .+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999999999999999997653333 25688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||+++++|.+++.. ..++++.+++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999953 356899999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
.... .......|++.|+|||++.+..++.++||||||+++|+|++|..||...+..
T Consensus 186 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 241 (309)
T 2h34_A 186 DEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS 241 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH
T ss_pred cccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH
Confidence 2211 1223456899999999999889999999999999999999999999876543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=298.13 Aligned_cols=204 Identities=28% Similarity=0.447 Sum_probs=179.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC---cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG---FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367999999999999999999999999999999986432 12245788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999999953 356899999999999999999999999 9999999999999999999999999986543
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+
T Consensus 166 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 219 (284)
T 2vgo_A 166 SL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219 (284)
T ss_dssp SS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred cc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH
Confidence 21 1233568999999999999899999999999999999999999998766543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=304.07 Aligned_cols=217 Identities=24% Similarity=0.339 Sum_probs=183.8
Q ss_pred ccHHHHHHhhcCCCCC-ceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhc-CCCcceeeeeE
Q 022309 62 FTYRQLVAATDNFKDT-NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLM-RHPNLVHLIGY 137 (299)
Q Consensus 62 ~~~~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~~~~~ 137 (299)
..+.......++|.+. +.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.+ .||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3455566677889888 899999999999999999999999999875432 2356788999999988 56999999999
Q ss_pred EecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC---CCc
Q 022309 138 CAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK---GFH 214 (299)
Q Consensus 138 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~---~~~ 214 (299)
+.+....++||||+.+++|.+++.. .....+++.+++.++.|++.||+|||+++ |+||||||+||+++. ++.
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCC
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCc
Confidence 9999999999999999999998853 23367899999999999999999999999 999999999999987 789
Q ss_pred eEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 215 PKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 215 ~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
++|+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+.
T Consensus 173 ~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 241 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET 241 (327)
T ss_dssp EEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH
Confidence 9999999998643221 22335699999999999999999999999999999999999999988765544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=310.20 Aligned_cols=202 Identities=27% Similarity=0.392 Sum_probs=160.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEecC------C
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG------T 142 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------~ 142 (299)
.++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4689999999999999999999999999999999975432 2346788999999999999999999998654 5
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccc
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL 222 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~ 222 (299)
..++|+|++ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 579999998 6899888842 57999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 223 AKFGPTGDKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 223 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
++.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..++
T Consensus 179 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 238 (367)
T 2fst_X 179 ARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 238 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 975322 1234578999999999877 6789999999999999999999999988776443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=296.34 Aligned_cols=217 Identities=44% Similarity=0.748 Sum_probs=183.1
Q ss_pred CccHHHHHHhhcCCCCC------ceecccCceEEEEEEECCCCcEEEEEEcCCCC----cccHHHHHHHHHHHhhcCCCc
Q 022309 61 TFTYRQLVAATDNFKDT------NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG----FQGEKEFLVEVLMLSLMRHPN 130 (299)
Q Consensus 61 ~~~~~~~~~~~~~y~~~------~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~n 130 (299)
.+.+.++...+++|... +.||+|+||.||+|.+ +++.||+|++.... ....+.+.+|+.+++.++|||
T Consensus 14 ~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp ECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred cccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 35566666666666655 8999999999999987 68899999986532 122467889999999999999
Q ss_pred ceeeeeEEecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEec
Q 022309 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLG 210 (299)
Q Consensus 131 Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~ 210 (299)
|+++++++.+.+..++||||+++++|.+++.... ...++++..++.++.|++.||.|||+++ ++||||||+||+++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 9999999999999999999999999999986432 2356899999999999999999999999 99999999999999
Q ss_pred CCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 211 KGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 211 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
.++.++|+|||++................|++.|+|||++.+ .++.++||||||+++|+|++|.+||......
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence 999999999999976543333333344579999999998865 5788999999999999999999999876543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=303.44 Aligned_cols=212 Identities=29% Similarity=0.434 Sum_probs=178.4
Q ss_pred hcCCCCCceecccCceEEEEEEEC-------CCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhc-CCCcceeeeeEEecC
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLA-------ETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLM-RHPNLVHLIGYCAEG 141 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 141 (299)
.++|++.+.||+|+||.||+|.+. .++..||+|++...... ....+.+|+.+++.+ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467999999999999999999975 45678999999765432 235688999999999 899999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEe
Q 022309 142 TQRLLVYEYMPLGSLEDHLLGLTP------------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL 209 (299)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv 209 (299)
+..++||||+++++|.+++..... ....+++.+++.++.||+.||.|||+++ |+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999975321 1234889999999999999999999999 9999999999999
Q ss_pred cCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 210 GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 210 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
+.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 9999999999999976543332222333457889999999988889999999999999999999 999998776543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=298.21 Aligned_cols=206 Identities=28% Similarity=0.425 Sum_probs=175.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|++++.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 467999999999999999999886 57789999997654 3456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+.+++|.+++.. ....+++.+++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++.......
T Consensus 101 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 101 MANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred cCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 999999999964 2356899999999999999999999999 9999999999999999999999999997543221
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
........+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+
T Consensus 175 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~ 229 (283)
T 3gen_A 175 -YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229 (283)
T ss_dssp -HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred -cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH
Confidence 111222346788999999998899999999999999999998 999998766543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=300.28 Aligned_cols=208 Identities=24% Similarity=0.363 Sum_probs=169.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc---cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35699999999999999999999999999999999754322 235688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||+++++|.+++.........+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999998654334567899999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
... .......|++.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 241 (310)
T 2wqm_A 188 SKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 241 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C
T ss_pred CCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 221 122335689999999999988999999999999999999999999976543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=303.85 Aligned_cols=221 Identities=28% Similarity=0.379 Sum_probs=183.7
Q ss_pred HHHHHHhhcCCCCCceecccCceEEEEEEE-----CCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhc-CCCcceeeee
Q 022309 64 YRQLVAATDNFKDTNFLGQGGFGAVYKGKL-----AETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLM-RHPNLVHLIG 136 (299)
Q Consensus 64 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~~~~ 136 (299)
........++|++.+.||+|+||.||+|.+ ..+++.||+|++...... ....+.+|+.++..+ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 344445567899999999999999999985 456789999999765433 235688999999999 7899999999
Q ss_pred EEecCC-eeEEEEEecCCCCHHHHhcccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 022309 137 YCAEGT-QRLLVYEYMPLGSLEDHLLGLTPE------------MKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLK 203 (299)
Q Consensus 137 ~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dik 203 (299)
++...+ ..++||||+.+++|.+++...... ...+++..++.++.|++.||.|||+++ |+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCc
Confidence 987654 589999999999999999653221 123889999999999999999999999 9999999
Q ss_pred CCCEEecCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCc
Q 022309 204 AGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQ 282 (299)
Q Consensus 204 p~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~ 282 (299)
|+||+++.++.++|+|||++................|++.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999999986544333333344567889999999998899999999999999999998 999998776
Q ss_pred hhhhh
Q 022309 283 GHERM 287 (299)
Q Consensus 283 ~~~~~ 287 (299)
..+.+
T Consensus 256 ~~~~~ 260 (316)
T 2xir_A 256 IDEEF 260 (316)
T ss_dssp CSHHH
T ss_pred hhHHH
Confidence 55443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=300.39 Aligned_cols=201 Identities=26% Similarity=0.386 Sum_probs=174.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCC-------cEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETG-------QVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQ 143 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 143 (299)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+........+.+.+|+.+++.++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 467999999999999999999998776 4799999977655566789999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCc--------e
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFH--------P 215 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~--------~ 215 (299)
.++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999964 2244899999999999999999999999 999999999999998877 9
Q ss_pred EEccccccccCCCCCCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhC-CCCCCCCch
Q 022309 216 KLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITG-RPAMDDSQG 283 (299)
Q Consensus 216 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg-~~pf~~~~~ 283 (299)
+|+|||++..... .....|++.|+|||++.+ ..++.++||||||+++|+|++| .+||...+.
T Consensus 161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~ 224 (289)
T 4fvq_A 161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS 224 (289)
T ss_dssp EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch
Confidence 9999999964321 123457889999999987 6789999999999999999995 555555443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=310.51 Aligned_cols=207 Identities=18% Similarity=0.224 Sum_probs=169.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCC-----CcEEEEEEcCCCCcccH-----------HHHHHHHHHHhhcCCCcceee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAET-----GQVVAVKQLDDTGFQGE-----------KEFLVEVLMLSLMRHPNLVHL 134 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~nIv~~ 134 (299)
.++|++.+.||+|+||.||+|.+..+ ++.||+|++........ .....|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 45799999999999999999998764 57899999875532111 123445667778889999999
Q ss_pred eeEEecC----CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEec
Q 022309 135 IGYCAEG----TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLG 210 (299)
Q Consensus 135 ~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~ 210 (299)
++++... ...++||||+ |++|.+++.. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 9998664 4579999999 9999999964 3367999999999999999999999999 99999999999999
Q ss_pred --CCCceEEccccccccCCCCCCc-----ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 211 --KGFHPKLSDFGLAKFGPTGDKS-----HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 211 --~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
.++.+||+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999754322111 111234599999999999999999999999999999999999999986443
Q ss_pred h
Q 022309 284 H 284 (299)
Q Consensus 284 ~ 284 (299)
.
T Consensus 267 ~ 267 (364)
T 3op5_A 267 D 267 (364)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=305.35 Aligned_cols=208 Identities=31% Similarity=0.491 Sum_probs=170.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEE----EEEEcCCCC-cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVV----AVKQLDDTG-FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----avK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 145 (299)
.++|++++.||+|+||.||+|.+..+++.+ |+|.+.... ......+.+|+.+++.++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467999999999999999999998887754 667665432 334577899999999999999999999998765 78
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
+|++++.+++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++..
T Consensus 93 ~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 99999999999999964 3356899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 226 GPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
..............+++.|+|||++.+..++.++|||||||++|+|++ |.+||...+..+
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~ 227 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Confidence 543333333334457889999999999999999999999999999999 999998766543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=305.62 Aligned_cols=210 Identities=26% Similarity=0.381 Sum_probs=180.6
Q ss_pred HHHHHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--------cHHHHHHHHHHHhhc-CCCcceeee
Q 022309 65 RQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--------GEKEFLVEVLMLSLM-RHPNLVHLI 135 (299)
Q Consensus 65 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~h~nIv~~~ 135 (299)
.......++|++.+.||+|+||.||+|.+..+|+.||||++...... ..+.+.+|+.+++.+ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 33445567899999999999999999999989999999998654321 124577899999998 899999999
Q ss_pred eEEecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCce
Q 022309 136 GYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHP 215 (299)
Q Consensus 136 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~ 215 (299)
+++......++||||++|++|.+++.. ...+++..+..++.|++.||.|||+.| |+||||||+||+++.++.+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 999999999999999999999999953 356899999999999999999999999 9999999999999999999
Q ss_pred EEccccccccCCCCCCcccccccccCccccCcccccC------CCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 216 KLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATT------GKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 216 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
+|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..
T Consensus 240 kl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 311 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI 311 (365)
T ss_dssp EECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH
Confidence 999999997644322 2234579999999998853 35888999999999999999999999876543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=310.16 Aligned_cols=204 Identities=27% Similarity=0.373 Sum_probs=179.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
.++|++++.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 46799999999999999999999999999999999765322 23678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK-ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+||+++.++.++|+|||++.....
T Consensus 112 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999953 35689999999999999999999986 8 99999999999999999999999999864211
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+
T Consensus 185 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 237 (360)
T 3eqc_A 185 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237 (360)
T ss_dssp ----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHH
T ss_pred ----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 12233568999999999999999999999999999999999999998776544
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=312.41 Aligned_cols=205 Identities=22% Similarity=0.319 Sum_probs=177.4
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhc------CCCcceeeeeEEecCCe
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLM------RHPNLVHLIGYCAEGTQ 143 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~nIv~~~~~~~~~~~ 143 (299)
...+|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+ +|+||+++++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 3467999999999999999999999999999999997542 2235677788888776 57799999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCc--eEEcccc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFH--PKLSDFG 221 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~--~kl~Dfg 221 (299)
.++|||++. ++|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence 999999996 6999988652 3345899999999999999999999999 999999999999999887 9999999
Q ss_pred ccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 222 LAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 222 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
++..... ......||+.|+|||++.+..++.++|||||||++|||++|.+||...+..+.
T Consensus 248 ~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~ 307 (429)
T 3kvw_A 248 SSCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ 307 (429)
T ss_dssp TCEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9975322 12235789999999999998999999999999999999999999988876554
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=298.16 Aligned_cols=209 Identities=26% Similarity=0.335 Sum_probs=164.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH--HHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE--KEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
.++|++++.||+|+||.||+|.+..+++.||+|++........ ..+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 4679999999999999999999999999999999976533222 23444555678889999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK-ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
||++ ++|.+++.........+++..++.++.|++.||+|||++ + |+||||||+||+++.++.++|+|||++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 488887754333457899999999999999999999998 9 9999999999999999999999999997543
Q ss_pred CCCCcccccccccCccccCcccc----cCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYA----TTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
.. .......||+.|+|||++ .+..++.++||||||+++|+|++|..||........
T Consensus 162 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 221 (290)
T 3fme_A 162 DD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ 221 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH
T ss_pred cc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH
Confidence 22 122234689999999996 455788999999999999999999999986544433
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=306.69 Aligned_cols=207 Identities=26% Similarity=0.378 Sum_probs=176.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc-HHHHHHHHHHHhhcCCCcceeeeeEEecC-----Cee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG-EKEFLVEVLMLSLMRHPNLVHLIGYCAEG-----TQR 144 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-----~~~ 144 (299)
.++|++++.||+|+||.||+|.+..+++.||+|++....... ...+.+|+.+++.++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 467999999999999999999999999999999997543222 36788999999999999999999999654 367
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
++|||++. ++|.+++.. ..+++.+++.++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999997 599998853 46899999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCc-ccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 225 FGPTGDKS-HVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 225 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 240 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 240 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH
Confidence 64322211 11234579999999998654 4589999999999999999999999988775544
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=297.10 Aligned_cols=208 Identities=33% Similarity=0.499 Sum_probs=164.3
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
..++|++.+.||+|+||.||+|.+. ..||+|+++..... ..+.+.+|+.+++.++||||++++++. .....++|
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 3567999999999999999999864 35999998755433 236688999999999999999999965 44568999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||+.+++|.+++.. ....+++.+++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++....
T Consensus 98 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 98 TQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence 999999999999953 3467899999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCCcccccccccCccccCccccc---CCCCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYAT---TGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
............||+.|+|||++. +..++.++||||||+++|+|++|..||...+..+.+
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 234 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 234 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH
Confidence 323333334457999999999986 566888999999999999999999999876654443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=296.20 Aligned_cols=204 Identities=23% Similarity=0.321 Sum_probs=175.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~l 146 (299)
..++|++++.||+|+||.||+|.+..+++.||+|++..... .....+.+|+..+..+ +||||+++++++.+++..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 34679999999999999999999999999999999875432 3346788899999988 99999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC---------------
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK--------------- 211 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~--------------- 211 (299)
||||+++++|.+++.........+++.+++.++.||+.||+|||+++ |+||||||+||+++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999643223366899999999999999999999999 999999999999984
Q ss_pred ----CCceEEccccccccCCCCCCcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 212 ----GFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 212 ----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
...++|+|||++...... ....|++.|+|||++.+. .++.++||||||+++|+|++|.+|+...+
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH
T ss_pred ccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh
Confidence 447999999999764322 123589999999999766 56789999999999999999998876554
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=313.73 Aligned_cols=205 Identities=28% Similarity=0.403 Sum_probs=170.8
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEec------CCeeE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAE------GTQRL 145 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~------~~~~~ 145 (299)
.+|++++.||+|+||.||+|++..+++.||||++.... ....+|+.+++.++||||+++++++.. ..+.+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46999999999999999999999999999999986432 223469999999999999999998843 12467
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCC-CceEEccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKG-FHPKLSDFGLAK 224 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~-~~~kl~Dfg~a~ 224 (299)
+||||+.+ +|.+.+.........+++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999975 677766433334577999999999999999999999999 9999999999999955 678999999998
Q ss_pred cCCCCCCcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 225 FGPTGDKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|.+||...+..+++
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l 266 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 266 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 6433221 2335789999999998765 6899999999999999999999999988765544
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=298.40 Aligned_cols=208 Identities=30% Similarity=0.462 Sum_probs=182.7
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
..++|++.+.||+|+||.||+|.+..++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4567999999999999999999999999999999997543 345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+++++|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++......
T Consensus 90 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 90 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp CCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred cCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 99999999999652 3356899999999999999999999999 999999999999999999999999999865432
Q ss_pred CCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
. ........+++.|+|||++.+..++.++||||||+++|+|++ |.+||...+..
T Consensus 165 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~ 219 (288)
T 3kfa_A 165 T-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 219 (288)
T ss_dssp S-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred c-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 2 222333457888999999988899999999999999999999 99999876643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=319.91 Aligned_cols=209 Identities=29% Similarity=0.459 Sum_probs=182.2
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
..++|++.+.||+|+||.||+|.+..++..||||.++... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 3466889999999999999999999889999999997653 345789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+.+++|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 297 ~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 297 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp CCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred ccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 99999999999642 2356899999999999999999999999 999999999999999999999999999864322
Q ss_pred CCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
. ........+++.|+|||++.+..++.++|||||||++|||++ |..||...+..+
T Consensus 372 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~ 427 (495)
T 1opk_A 372 T-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 427 (495)
T ss_dssp C-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred c-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 1 112223446778999999988889999999999999999999 999998776543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=293.30 Aligned_cols=204 Identities=31% Similarity=0.483 Sum_probs=167.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc----cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ----GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
.++|++.+.||+|+||.||+|.+ +++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 36799999999999999999998 4889999998754322 23578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC--------CCceEEc
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK--------GFHPKLS 218 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~--------~~~~kl~ 218 (299)
||||+++++|.+++. ...+++.+++.++.|++.||.|||+++-.+|+||||||+||+++. ++.++|+
T Consensus 84 v~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 999999999999984 357899999999999999999999987455889999999999986 6789999
Q ss_pred cccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 219 DFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 219 Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
|||++....... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+...
T Consensus 159 Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 221 (271)
T 3dtc_A 159 DFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA 221 (271)
T ss_dssp CCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH
T ss_pred cCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999997543221 223468999999999998899999999999999999999999998776543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=298.38 Aligned_cols=206 Identities=33% Similarity=0.470 Sum_probs=176.2
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
..++|++++.||+|+||.||+|.+..+++.||+|.+.... ....+.+|+.+++.++||||+++++++......++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4567999999999999999999999999999999997542 34678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+.+++|.+++.. ....+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 105 ~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 105 YCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp CCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred cCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999999999852 2367899999999999999999999999 999999999999999999999999999754322
Q ss_pred CCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
........|++.|+|||++.+..++.++||||||+++|+|++|..||...+...
T Consensus 179 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 232 (314)
T 3com_A 179 --MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR 232 (314)
T ss_dssp --BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred --ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 112234568999999999998889999999999999999999999998766543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=313.76 Aligned_cols=205 Identities=25% Similarity=0.385 Sum_probs=175.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCC--eeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT--QRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--~~~lv 147 (299)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4679999999999999999999999999999999975432 23466789999999999999999999997655 67999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEe----cCCCceEEcccccc
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL----GKGFHPKLSDFGLA 223 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv----~~~~~~kl~Dfg~a 223 (299)
|||+++++|.+++.... ....+++.+++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 99999999999996432 2234899999999999999999999999 9999999999999 77788999999999
Q ss_pred ccCCCCCCcccccccccCccccCcccccC--------CCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 224 KFGPTGDKSHVSTRVMGTHGYCAPEYATT--------GKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+
T Consensus 164 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~ 227 (396)
T 4eut_A 164 RELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (396)
T ss_dssp EECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred eEccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 764322 22234569999999999865 457789999999999999999999997544
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=303.64 Aligned_cols=208 Identities=27% Similarity=0.369 Sum_probs=175.5
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEe----cCCeeE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA----EGTQRL 145 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~----~~~~~~ 145 (299)
..++|++++.||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++. .....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 3467999999999999999999999999999999987655455577899999999999999999999986 334788
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
+||||+.+++|.+++.........+++.+++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999999754445577999999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCCCcc-------cccccccCccccCcccccCCC---CCcccceehhHHHHHHHHhCCCCCCC
Q 022309 226 GPTGDKSH-------VSTRVMGTHGYCAPEYATTGK---LTAKSDIFSFGVVLLELITGRPAMDD 280 (299)
Q Consensus 226 ~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~il~elltg~~pf~~ 280 (299)
........ ......|++.|+|||++.+.. ++.++||||||+++|+|++|..||..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 32111110 011235799999999987654 68899999999999999999999964
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=300.42 Aligned_cols=204 Identities=26% Similarity=0.383 Sum_probs=172.6
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--------ccHHHHHHHHHHHhhcCCCcceeeeeEEecC
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--------QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG 141 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 141 (299)
..++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 34679999999999999999999999999999999875432 1124578999999999999999999999776
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCc---eEEc
Q 022309 142 TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFH---PKLS 218 (299)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~---~kl~ 218 (299)
. .++||||+++++|.+++. ....+++.+++.++.|++.||.|||+++ |+||||||+||+++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEc
Confidence 5 799999999999999984 4467899999999999999999999999 999999999999987654 9999
Q ss_pred cccccccCCCCCCcccccccccCccccCccccc---CCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 219 DFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYAT---TGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 219 Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
|||++..... ........|++.|+|||++. ...++.++|||||||++|+|++|.+||......
T Consensus 160 Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 225 (322)
T 2ycf_A 160 DFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 225 (322)
T ss_dssp CCTTCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS
T ss_pred cCccceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH
Confidence 9999976432 11223456899999999973 456889999999999999999999999876544
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=297.23 Aligned_cols=207 Identities=26% Similarity=0.418 Sum_probs=165.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCC---CcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAET---GQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
.++|++.+.||+|+||.||+|.+..+ +..||+|.+...... ..+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-CccEE
Confidence 46799999999999999999998653 457999998764322 23568899999999999999999999854 56889
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
||||+.+++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++...
T Consensus 93 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 93 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 9999999999999963 2356899999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
..... .......+++.|+|||++.+..++.++||||||+++|+|++ |.+||...+..+
T Consensus 167 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~ 225 (281)
T 1mp8_A 167 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 225 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred Ccccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH
Confidence 32221 11223456788999999988899999999999999999997 999998766543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=295.71 Aligned_cols=209 Identities=27% Similarity=0.350 Sum_probs=174.9
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC----cccHHHHHHHHHHHhhcCCCcceeeeeEE--ecCCe
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG----FQGEKEFLVEVLMLSLMRHPNLVHLIGYC--AEGTQ 143 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~--~~~~~ 143 (299)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++ .+...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3478999999999999999999999999999999997542 12346789999999999999999999998 44557
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA 223 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a 223 (299)
.++||||+.++ |.+++... ....+++.+++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccc
Confidence 89999999876 77777543 2467899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCcccccccccCccccCcccccCCC--CCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 224 KFGPTGDKSHVSTRVMGTHGYCAPEYATTGK--LTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
................|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 219 (305)
T 2wtk_C 157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY 219 (305)
T ss_dssp EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Confidence 7654333333334456899999999987654 477999999999999999999999876543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=306.33 Aligned_cols=212 Identities=28% Similarity=0.423 Sum_probs=179.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCc-----EEEEEEcCCCCcc-cHHHHHHHHHHHhhc-CCCcceeeeeEEecCCe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQ-----VVAVKQLDDTGFQ-GEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQ 143 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 143 (299)
.++|++.+.||+|+||.||+|.+..+++ .||+|.+...... ..+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 4679999999999999999999976654 7999999765432 346688999999999 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTP----------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF 213 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~ 213 (299)
.++||||+++++|.+++..... ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCC
Confidence 9999999999999999863210 1346899999999999999999999999 99999999999999999
Q ss_pred ceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 214 HPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 214 ~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |.+||.......
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 999999999975433332223334557889999999988899999999999999999999 999998765443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=300.56 Aligned_cols=208 Identities=27% Similarity=0.441 Sum_probs=175.8
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
..++|++++.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++..++..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 45779999999999999999999999999999999987665666789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.....
T Consensus 97 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 169 (302)
T 2j7t_A 97 FCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK- 169 (302)
T ss_dssp CCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH-
T ss_pred eCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccc-
Confidence 9999999998853 2356899999999999999999999999 99999999999999999999999998753110
Q ss_pred CCcccccccccCccccCcccc-----cCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYA-----TTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~-----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.........|++.|+|||++ .+..++.++||||||+++|+|++|.+||...+..+
T Consensus 170 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 229 (302)
T 2j7t_A 170 -TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 229 (302)
T ss_dssp -HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred -cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH
Confidence 01112234689999999988 46678899999999999999999999998776543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=297.74 Aligned_cols=212 Identities=26% Similarity=0.389 Sum_probs=177.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEe--cCCeeEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCA--EGTQRLL 146 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~--~~~~~~l 146 (299)
.++|++++.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 46799999999999999999999999999999999755432 2356889999999999999999999874 4568899
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA--DPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
||||+++++|.+++.........+++..++.++.|++.||+|||+.+ ..+++||||||+||+++.++.++|+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999754334456899999999999999999999865 2349999999999999999999999999997
Q ss_pred cCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 225 FGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
..... ........|++.|+|||++.+..++.++||||||+++|+|++|.+||...+..
T Consensus 165 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 222 (279)
T 2w5a_A 165 ILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK 222 (279)
T ss_dssp HC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred eeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH
Confidence 64322 11223356899999999998888999999999999999999999999887643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=308.46 Aligned_cols=203 Identities=29% Similarity=0.401 Sum_probs=173.6
Q ss_pred cCCCCCceecccCceEEEEEEEC---CCCcEEEEEEcCCCCc----ccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCe
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLA---ETGQVVAVKQLDDTGF----QGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQ 143 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 143 (299)
++|++++.||+|+||.||+|++. .+++.||||+++.... .....+.+|+.+++.+ .||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 67999999999999999999984 5889999999875432 2235567799999998 69999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA 223 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a 223 (299)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999953 356899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCcccccccccCccccCcccccCC--CCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 224 KFGPTGDKSHVSTRVMGTHGYCAPEYATTG--KLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
....... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||...+
T Consensus 207 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 207 KEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp EECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred eecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 7543221 1223345799999999999763 47889999999999999999999997544
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=301.64 Aligned_cols=212 Identities=29% Similarity=0.463 Sum_probs=179.7
Q ss_pred hhcCCCCCceecccCceEEEEEEEC-----CCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCe
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLA-----ETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQ 143 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 143 (299)
..++|++.+.||+|+||.||+|.+. .+++.||+|.+...... ....+.+|+.+++.++||||+++++++.+...
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 102 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 102 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence 4567999999999999999999875 35788999999755332 33568899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEE
Q 022309 144 RLLVYEYMPLGSLEDHLLGLT------PEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKL 217 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl 217 (299)
.++||||+.+++|.+++.... ....++++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|
T Consensus 103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEE
Confidence 999999999999999986421 12256789999999999999999999999 999999999999999999999
Q ss_pred ccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 218 SDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 218 ~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |.+||...+..
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 247 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 247 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH
Confidence 99999975432222222233457889999999988889999999999999999999 89999876644
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=316.19 Aligned_cols=203 Identities=19% Similarity=0.196 Sum_probs=163.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCC---CcccHHHHHHHHH---HHhhcCCCcceeee-------eE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDT---GFQGEKEFLVEVL---MLSLMRHPNLVHLI-------GY 137 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~h~nIv~~~-------~~ 137 (299)
.++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999999889999999999743 2233467889994 55555899999998 66
Q ss_pred EecCC-----------------eeEEEEEecCCCCHHHHhcccC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 022309 138 CAEGT-----------------QRLLVYEYMPLGSLEDHLLGLT---PEMKPLDWNTRMKIAAGAARGLEYLHNKADPPV 197 (299)
Q Consensus 138 ~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i 197 (299)
+.+.+ ..++||||+ +|+|.+++.... .....+++..++.++.||+.||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 65543 278999999 579999996421 11123345888899999999999999999 9
Q ss_pred EecCCCCCCEEecCCCceEEccccccccCCCCCCcccccccccCccccCcccccCC-----------CCCcccceehhHH
Q 022309 198 IYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTG-----------KLTAKSDIFSFGV 266 (299)
Q Consensus 198 ~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~DiwslG~ 266 (299)
+||||||+|||++.++.+||+|||++.... .......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 999999999999999999999999998522 12334567 999999999877 7999999999999
Q ss_pred HHHHHHhCCCCCCCCch
Q 022309 267 VLLELITGRPAMDDSQG 283 (299)
Q Consensus 267 il~elltg~~pf~~~~~ 283 (299)
++|||++|..||...+.
T Consensus 302 il~elltg~~Pf~~~~~ 318 (377)
T 3byv_A 302 VIYWIWCADLPITKDAA 318 (377)
T ss_dssp HHHHHHHSSCCC-----
T ss_pred HHHHHHHCCCCCccccc
Confidence 99999999999976654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=297.01 Aligned_cols=200 Identities=31% Similarity=0.465 Sum_probs=166.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhh--cCCCcceeeeeEEec----CCee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSL--MRHPNLVHLIGYCAE----GTQR 144 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~~~~~~----~~~~ 144 (299)
.++|++++.||+|+||+||+|.+ +++.||+|++... ....+..|..++.. ++||||+++++++.. ....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 46799999999999999999998 6899999998653 34455666666665 799999999998643 3457
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCEEecCCCceE
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLH--------NKADPPVIYRDLKAGNILLGKGFHPK 216 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH--------~~~~~~i~H~dikp~Nilv~~~~~~k 216 (299)
++||||+++++|.+++. ...+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+|
T Consensus 82 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEE
T ss_pred EEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEE
Confidence 89999999999999993 357899999999999999999999 888 99999999999999999999
Q ss_pred EccccccccCCCCCCcc--cccccccCccccCcccccCC------CCCcccceehhHHHHHHHHhC----------CCCC
Q 022309 217 LSDFGLAKFGPTGDKSH--VSTRVMGTHGYCAPEYATTG------KLTAKSDIFSFGVVLLELITG----------RPAM 278 (299)
Q Consensus 217 l~Dfg~a~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg----------~~pf 278 (299)
|+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||++| .+||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999997543222211 12234799999999999776 455789999999999999999 8999
Q ss_pred CCCch
Q 022309 279 DDSQG 283 (299)
Q Consensus 279 ~~~~~ 283 (299)
.....
T Consensus 234 ~~~~~ 238 (301)
T 3q4u_A 234 YDVVP 238 (301)
T ss_dssp TTTSC
T ss_pred cccCC
Confidence 76543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=300.31 Aligned_cols=215 Identities=31% Similarity=0.445 Sum_probs=169.6
Q ss_pred HHhhcCCCCCceecccCceEEEEEEECC---CCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEecCC
Q 022309 68 VAATDNFKDTNFLGQGGFGAVYKGKLAE---TGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAEGT 142 (299)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 142 (299)
....++|++.+.||+|+||.||+|.+.. ++..||+|.+....... .+.+.+|+.+++.++||||+++++++.+..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 3445789999999999999999998754 45689999997553332 356889999999999999999999997655
Q ss_pred -----eeEEEEEecCCCCHHHHhccc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCce
Q 022309 143 -----QRLLVYEYMPLGSLEDHLLGL--TPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHP 215 (299)
Q Consensus 143 -----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~ 215 (299)
..++||||+.+++|.+++... ......+++.+++.++.|++.||.|||+++ |+||||||+||+++.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcE
Confidence 348999999999999998432 133467999999999999999999999999 9999999999999999999
Q ss_pred EEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 216 KLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 216 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
+|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 257 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH
Confidence 9999999976433322222333457889999999999899999999999999999999 899998766543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=306.63 Aligned_cols=203 Identities=19% Similarity=0.219 Sum_probs=166.8
Q ss_pred hcCCCCCceecccCceEEEEEEECC---CCcEEEEEEcCCCCccc-----------HHHHHHHHHHHhhcCCCcceeeee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAE---TGQVVAVKQLDDTGFQG-----------EKEFLVEVLMLSLMRHPNLVHLIG 136 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~nIv~~~~ 136 (299)
.++|++.+.||+|+||.||+|.+.. ++..+|+|++....... ...+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 3679999999999999999999987 78899999987653221 123567888899999999999999
Q ss_pred EEec----CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCC
Q 022309 137 YCAE----GTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKG 212 (299)
Q Consensus 137 ~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~ 212 (299)
++.. ....++||||+ +++|.+++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence 9987 77899999999 9999999953 247999999999999999999999999 9999999999999887
Q ss_pred C--ceEEccccccccCCCCCC-----cccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCC
Q 022309 213 F--HPKLSDFGLAKFGPTGDK-----SHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDS 281 (299)
Q Consensus 213 ~--~~kl~Dfg~a~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 281 (299)
+ .+||+|||++........ ........||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 263 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN 263 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 7 999999999975432211 11123457999999999999989999999999999999999999999653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=311.66 Aligned_cols=202 Identities=32% Similarity=0.471 Sum_probs=174.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCC-eeEEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT-QRLLVY 148 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~~lv~ 148 (299)
..++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.+++.++||||+++++++.+.. ..++||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 3467899999999999999999984 7899999997653 4467899999999999999999999987655 789999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+++++|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 267 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp ECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 999999999999642 2234789999999999999999999999 99999999999999999999999999975321
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
. .....+++.|+|||++.+..++.++|||||||++|||++ |..||...+..+
T Consensus 342 ~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~ 394 (450)
T 1k9a_A 342 T-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 394 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT
T ss_pred c-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 1 112357889999999999999999999999999999998 999998766543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=292.39 Aligned_cols=206 Identities=30% Similarity=0.456 Sum_probs=175.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEec----CCeeE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAE----GTQRL 145 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~----~~~~~ 145 (299)
..|++.+.||+|+||.||+|.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 458888999999999999999999999999999875432 233668899999999999999999998865 45689
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEec-CCCceEEccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLG-KGFHPKLSDFGLAK 224 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~-~~~~~kl~Dfg~a~ 224 (299)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||||||+||+++ .++.++|+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 99999999999999953 356899999999999999999999874 4599999999999997 78999999999997
Q ss_pred cCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 225 FGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
..... ......|++.|+|||++.+ .++.++||||||+++|+|++|..||.........
T Consensus 181 ~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 238 (290)
T 1t4h_A 181 LKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI 238 (290)
T ss_dssp GCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH
T ss_pred ccccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH
Confidence 53322 2234568999999998864 5899999999999999999999999876554443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=292.76 Aligned_cols=204 Identities=29% Similarity=0.438 Sum_probs=171.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC---cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG---FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467999999999999999999999999999999986432 12235788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||+++++|.+++.. ...+++.+++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999953 356899999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCcccccccccCccccCcccccCCCC-CcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKL-TAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
... ......|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+..
T Consensus 163 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 217 (276)
T 2h6d_A 163 DGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP 217 (276)
T ss_dssp C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH
Confidence 321 1223468999999999987765 68999999999999999999999876543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=303.54 Aligned_cols=207 Identities=32% Similarity=0.445 Sum_probs=179.5
Q ss_pred hcCCCCCceecccCceEEEEEE----ECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEe--cCCee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGK----LAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA--EGTQR 144 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~--~~~~~ 144 (299)
.++|++++.||+|+||.||+|. +..+++.||+|++........+.+.+|+.+++.++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 3679999999999999999999 56788999999998776555677899999999999999999999886 45668
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
++||||+++++|.+++... ...+++.+++.++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 9999999999999999642 246899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCcc-cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 225 FGPTGDKSH-VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 225 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
......... ......|++.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~ 235 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA 235 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccc
Confidence 654332221 22334588889999999888899999999999999999999999876543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=309.43 Aligned_cols=202 Identities=25% Similarity=0.320 Sum_probs=173.3
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcC--------CCcceeeeeEEe--
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMR--------HPNLVHLIGYCA-- 139 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~nIv~~~~~~~-- 139 (299)
..++|++++.||+|+||+||+|++..+++.||+|++.... .....+.+|+.+++.++ |+||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 3578999999999999999999999999999999997542 23466888999999885 788999999987
Q ss_pred --cCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEecCCC---
Q 022309 140 --EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK-ADPPVIYRDLKAGNILLGKGF--- 213 (299)
Q Consensus 140 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~~~~i~H~dikp~Nilv~~~~--- 213 (299)
.....++||||+ +++|.+.+.. .....+++.+++.++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhh
Confidence 556789999999 5677776653 2335689999999999999999999998 8 99999999999998775
Q ss_pred ----------------------------------------------ceEEccccccccCCCCCCcccccccccCccccCc
Q 022309 214 ----------------------------------------------HPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAP 247 (299)
Q Consensus 214 ----------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aP 247 (299)
.++|+|||++...... .....||+.|+||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aP 262 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSL 262 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCC
Confidence 7999999999764321 2335689999999
Q ss_pred ccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 248 EYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 248 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
|++.+..++.++|||||||++|+|++|.+||...+.
T Consensus 263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 298 (397)
T 1wak_A 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSG 298 (397)
T ss_dssp HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcc
Confidence 999998999999999999999999999999986654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=292.35 Aligned_cols=206 Identities=27% Similarity=0.389 Sum_probs=174.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEec
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYM 151 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 151 (299)
++|.....||+|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34555669999999999999999999999999997765555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC-CCceEEccccccccCCCCC
Q 022309 152 PLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK-GFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 152 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~-~~~~kl~Dfg~a~~~~~~~ 230 (299)
++++|.+++.... ....+++..++.++.|++.||.|||+++ ++||||||+||+++. ++.++|+|||++.......
T Consensus 102 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 102 PGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp SEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 9999999996432 2345678999999999999999999999 999999999999987 8999999999997643221
Q ss_pred CcccccccccCccccCcccccCCC--CCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGK--LTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
.......|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+.
T Consensus 178 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (295)
T 2clq_A 178 --PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 230 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS
T ss_pred --CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc
Confidence 1223456899999999986643 78899999999999999999999976544
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=291.65 Aligned_cols=206 Identities=30% Similarity=0.474 Sum_probs=178.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|++.+.||+|+||.||+|.+. +++.||+|.+..... ..+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 467999999999999999999986 578899999976543 446789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 85 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp CTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc
Confidence 999999999964 2356899999999999999999999999 9999999999999999999999999997543211
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
........+++.|+|||++.+..++.++||||||+++|+|++ |.+||...+..+
T Consensus 159 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 213 (267)
T 3t9t_A 159 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213 (267)
T ss_dssp -HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred -ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH
Confidence 111223456788999999988889999999999999999999 899998766543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=300.58 Aligned_cols=207 Identities=30% Similarity=0.490 Sum_probs=174.7
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEE--EEEEcCCCC-cccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVV--AVKQLDDTG-FQGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--avK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv 147 (299)
++|++.+.||+|+||.||+|.+..++..+ |+|.+.... ......+.+|+.+++.+ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67999999999999999999998888865 999886532 22345688999999999 899999999999999999999
Q ss_pred EEecCCCCHHHHhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCce
Q 022309 148 YEYMPLGSLEDHLLGLT------------PEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHP 215 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~ 215 (299)
|||+++++|.+++.... .....+++.+++.++.||+.||.|||+++ |+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999996432 22357899999999999999999999999 9999999999999999999
Q ss_pred EEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 216 KLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 216 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
+|+|||++..... ........+++.|+|||++.+..++.++||||||+++|+|++ |.+||...+..
T Consensus 182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~ 248 (327)
T 1fvr_A 182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 248 (327)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH
Confidence 9999999974221 111222356888999999988889999999999999999998 99999877643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=297.50 Aligned_cols=202 Identities=31% Similarity=0.431 Sum_probs=172.7
Q ss_pred cCCCCCceecccCceEEEEEE----ECCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecC--Cee
Q 022309 72 DNFKDTNFLGQGGFGAVYKGK----LAETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG--TQR 144 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~ 144 (299)
.+|++++.||+|+||.||+|. +..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 458999999999999999999 567899999999975432 3346789999999999999999999999876 668
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
++||||+++++|.+++.. ....+++.+++.++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 999999999999999953 2356899999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCc-ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCC
Q 022309 225 FGPTGDKS-HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMD 279 (299)
Q Consensus 225 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 279 (299)
........ .......||..|+|||++.+..++.++||||||+++|+|++|..|+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 65433221 22334568888999999988889999999999999999999998864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=296.92 Aligned_cols=207 Identities=26% Similarity=0.373 Sum_probs=169.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEe-----------
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA----------- 139 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~----------- 139 (299)
.++|++++.||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 478999999999999999999999999999999987665455577899999999999999999999873
Q ss_pred ---cCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEec-CCCce
Q 022309 140 ---EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLG-KGFHP 215 (299)
Q Consensus 140 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~-~~~~~ 215 (299)
+....++||||+. ++|.+++. ..++++..++.++.|++.||+|||+++ |+||||||+||+++ .++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence 4467899999997 59999984 256899999999999999999999999 99999999999997 56799
Q ss_pred EEccccccccCCCCCC-cccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 216 KLSDFGLAKFGPTGDK-SHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 216 kl~Dfg~a~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
||+|||++........ ........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+.
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 233 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ 233 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999976432211 112233457899999998865 6789999999999999999999999988775443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=293.37 Aligned_cols=206 Identities=30% Similarity=0.371 Sum_probs=178.2
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc---------ccHHHHHHHHHHHhhcC-CCcceeeeeEE
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---------QGEKEFLVEVLMLSLMR-HPNLVHLIGYC 138 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~ 138 (299)
...++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 345789999999999999999999999999999999975431 11245788999999995 99999999999
Q ss_pred ecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEc
Q 022309 139 AEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLS 218 (299)
Q Consensus 139 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~ 218 (299)
......++||||+++++|.+++.. ...+++.+++.++.|++.||.|||+++ ++||||||+||+++.++.++|+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEe
Confidence 999999999999999999999953 357899999999999999999999999 9999999999999999999999
Q ss_pred cccccccCCCCCCcccccccccCccccCccccc------CCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 219 DFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYAT------TGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 219 Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
|||++....... ......|++.|+|||++. ...++.++||||||+++|+|++|..||...+..
T Consensus 167 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 235 (298)
T 1phk_A 167 DFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 235 (298)
T ss_dssp CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH
Confidence 999997643322 223356899999999884 456888999999999999999999999876543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=297.63 Aligned_cols=209 Identities=31% Similarity=0.448 Sum_probs=173.2
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhc-CCCcceeeeeEEec------CC
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLM-RHPNLVHLIGYCAE------GT 142 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~------~~ 142 (299)
..++|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 4577999999999999999999999999999999986543 3446788999999998 89999999999976 46
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccc
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL 222 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~ 222 (299)
..++||||+++++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 175 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcC
Confidence 789999999999999999642 2356899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccCccccCccccc-----CCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 223 AKFGPTGDKSHVSTRVMGTHGYCAPEYAT-----TGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 223 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
+...... ........|++.|+|||++. +..++.++|||||||++|+|++|.+||...+..+.
T Consensus 176 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 242 (326)
T 2x7f_A 176 SAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA 242 (326)
T ss_dssp TC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred ceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH
Confidence 8754221 11223356899999999986 45688999999999999999999999987765443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=301.10 Aligned_cols=211 Identities=31% Similarity=0.438 Sum_probs=172.2
Q ss_pred hcCCCCCceecccCceEEEEEE-----ECCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGK-----LAETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQR 144 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 144 (299)
.++|++++.||+|+||.||+|. +..+++.||+|.+..... .....+.+|+.+++.++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 4679999999999999999999 556788999999975432 2345788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC---CCceEEc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTP---EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK---GFHPKLS 218 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~---~~~~kl~ 218 (299)
++||||+++++|.+++..... ....+++.+++.++.|++.||.|||+++ |+||||||+||+++. +..++|+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999975322 1245889999999999999999999999 999999999999984 4469999
Q ss_pred cccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 219 DFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 219 Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
|||++................|++.|+|||++.+..++.++||||||+++|+|++ |..||...+..
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 252 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 252 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH
Confidence 9999864322222222333567889999999988889999999999999999998 99999876644
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=302.68 Aligned_cols=201 Identities=25% Similarity=0.411 Sum_probs=172.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEecCCee----
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQR---- 144 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~---- 144 (299)
.++|.+.+.||+|+||.||+|.+..+++.||+|++....... ...+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467999999999999999999999999999999997653332 35688999999999999999999999877654
Q ss_pred --EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccc
Q 022309 145 --LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL 222 (299)
Q Consensus 145 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~ 222 (299)
++||||+. ++|.+.+. ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.++|+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 58888773 34899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 223 AKFGPTGDKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 223 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
+..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.
T Consensus 191 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 250 (371)
T 4exu_A 191 ARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 250 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 975322 1233568999999999877 6789999999999999999999999988765443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=301.64 Aligned_cols=212 Identities=27% Similarity=0.343 Sum_probs=171.9
Q ss_pred HHHHHHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc-----------HHHHHHHHHHHhhcCCCcce
Q 022309 64 YRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG-----------EKEFLVEVLMLSLMRHPNLV 132 (299)
Q Consensus 64 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~nIv 132 (299)
...+....++|++.+.||+|+||.||+|.+.. ++.||||++....... .+.+.+|+.+++.++||||+
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 34566778999999999999999999999865 8999999986532221 25688999999999999999
Q ss_pred eeeeEEec-----CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 022309 133 HLIGYCAE-----GTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNI 207 (299)
Q Consensus 133 ~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Ni 207 (299)
++++++.. ....++||||+. ++|.+.+.. ....+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence 99999843 346799999997 588888863 3457899999999999999999999999 99999999999
Q ss_pred EecCCCceEEccccccccCCCCCCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 208 LLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 208 lv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
+++.++.++|+|||++...... .......|++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999999743222 12233568999999999877 6789999999999999999999999988765443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=293.31 Aligned_cols=205 Identities=25% Similarity=0.347 Sum_probs=170.8
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEE-ecCCeeEEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYC-AEGTQRLLVY 148 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~-~~~~~~~lv~ 148 (299)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.+++.++|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 4578999999999999999999999999999999875442 224578899999999988877666554 6777889999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEe---cCCCceEEcccccccc
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL---GKGFHPKLSDFGLAKF 225 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv---~~~~~~kl~Dfg~a~~ 225 (299)
|++ +++|.+++.. ....+++.+++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++..
T Consensus 85 e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Ecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999 8999999863 2356899999999999999999999999 9999999999999 7889999999999976
Q ss_pred CCCCCCcc-----cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 226 GPTGDKSH-----VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 226 ~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccch
Confidence 43332211 12245789999999999999999999999999999999999999986543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=297.43 Aligned_cols=215 Identities=30% Similarity=0.419 Sum_probs=162.5
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
...++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 446789999999999999999999988999999998865432 2345688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccc----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccc
Q 022309 148 YEYMPLGSLEDHLLGL----TPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA 223 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a 223 (299)
|||+++++|.+++... ......+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999998531 112456899999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCC---cccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 224 KFGPTGDK---SHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 224 ~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
........ ........|++.|+|||++.+ ..++.++||||||+++|+|++|..||...+....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 235 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV 235 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH
Confidence 75432211 112233568999999999865 4688999999999999999999999987665443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=291.85 Aligned_cols=208 Identities=29% Similarity=0.449 Sum_probs=175.2
Q ss_pred hcCCCCCc-eecccCceEEEEEEEC--CCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 71 TDNFKDTN-FLGQGGFGAVYKGKLA--ETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 71 ~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
.++|.+.+ .||+|+||.||+|.+. .++..||+|++...... ..+.+.+|+.+++.++||||+++++++. .+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEE
Confidence 35677777 9999999999999864 46788999999865322 3467889999999999999999999994 456899
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
|||++.+++|.+++.. ....+++.+++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeee
Confidence 9999999999999953 3466899999999999999999999999 999999999999999999999999999765
Q ss_pred CCCCCcc-cccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 227 PTGDKSH-VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 227 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 221 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 3322211 1223456889999999988889999999999999999998 999998766543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=299.35 Aligned_cols=208 Identities=29% Similarity=0.438 Sum_probs=170.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCC----cEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETG----QVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 145 (299)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+...... ....+.+|+.+++.++||||+++++++.+....+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 467888999999999999999886543 45999999765322 3356889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
+||||+++++|.+++.. ....+++.+++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 123 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999963 3357899999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCCcc-cccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 226 GPTGDKSH-VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 226 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
........ ......+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~ 257 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH 257 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH
Confidence 43322111 1122346788999999998899999999999999999999 99999876654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=291.39 Aligned_cols=203 Identities=26% Similarity=0.346 Sum_probs=173.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEE-ecCCeeEEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYC-AEGTQRLLVYE 149 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~-~~~~~~~lv~e 149 (299)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++|++++..+..+ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 4689999999999999999999999999999999865432 34688999999999988866665554 66778899999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEe---cCCCceEEccccccccC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL---GKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv---~~~~~~kl~Dfg~a~~~ 226 (299)
|+ +++|.+++.. ....+++.+++.++.|++.||+|||+++ |+||||||+||++ +.++.+||+|||++...
T Consensus 86 ~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 8999999963 2357999999999999999999999999 9999999999999 47889999999999764
Q ss_pred CCCCCcc-----cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 227 PTGDKSH-----VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 227 ~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 3332211 1234579999999999999999999999999999999999999998654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=290.64 Aligned_cols=205 Identities=29% Similarity=0.420 Sum_probs=170.7
Q ss_pred CCCCCceecccCceEEEEEEECCCCc---EEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCee-EEE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQ---VVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQR-LLV 147 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~-~lv 147 (299)
.|++.+.||+|+||.||+|.+..+++ .||+|.+...... ..+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 46677999999999999999755444 7999998764432 336788999999999999999999999766655 899
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||+.+++|.+++.. ....+++.+++.++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++....
T Consensus 102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999963 3467899999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCC--cccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhC-CCCCCCCch
Q 022309 228 TGDK--SHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITG-RPAMDDSQG 283 (299)
Q Consensus 228 ~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~ 283 (299)
.... ........+++.|+|||.+.+..++.++||||||+++|+|++| .+||...+.
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~ 234 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP 234 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH
Confidence 2211 1122234578899999999999999999999999999999995 555554443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=296.42 Aligned_cols=205 Identities=22% Similarity=0.331 Sum_probs=176.7
Q ss_pred hhcCCCCCceecccCceEEEEEEE-CCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCC------cceeeeeEEecCC
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKL-AETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHP------NLVHLIGYCAEGT 142 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------nIv~~~~~~~~~~ 142 (299)
..++|++++.||+|+||.||+|.+ ..+++.||+|++.... .....+.+|+.+++.++|+ +|+++++++...+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 356899999999999999999998 5688999999997542 2345678899999888765 4999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC-----------
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK----------- 211 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~----------- 211 (299)
..++||||+ +++|.+++... ...++++.+++.++.|++.||+|||+++ |+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC---
T ss_pred cEEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcc
Confidence 999999999 88999998642 2246899999999999999999999999 999999999999987
Q ss_pred --------CCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 212 --------GFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 212 --------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
++.++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred ccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 668999999999763221 2335689999999999998999999999999999999999999988776
Q ss_pred hhh
Q 022309 284 HER 286 (299)
Q Consensus 284 ~~~ 286 (299)
.+.
T Consensus 240 ~~~ 242 (339)
T 1z57_A 240 KEH 242 (339)
T ss_dssp HHH
T ss_pred HHH
Confidence 543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=287.41 Aligned_cols=204 Identities=24% Similarity=0.364 Sum_probs=173.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecC--CeeEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEG--TQRLL 146 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~~l 146 (299)
.++|++.+.||+|+||.||+|.+ +++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+. ...++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 35799999999999999999998 4889999999765433 235789999999999999999999999877 77899
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
||||+++++|.+++... ....+++.+++.++.|++.||+|||+++ ++++||||||+||+++.++.++|+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EEECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeee
Confidence 99999999999999642 2236899999999999999999999864 55999999999999999999999988887532
Q ss_pred CCCCCcccccccccCccccCcccccCCCCCc---ccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATTGKLTA---KSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
. .....||+.|+|||++.+..++. ++||||||+++|+|++|..||...+..+.
T Consensus 164 ~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 219 (271)
T 3kmu_A 164 Q-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI 219 (271)
T ss_dssp S-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH
T ss_pred c-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH
Confidence 1 12245899999999998766554 79999999999999999999987765443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=312.86 Aligned_cols=208 Identities=29% Similarity=0.432 Sum_probs=176.9
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
...++|++.+.||+|+||.||+|.+. ++..||||.++... ...+.+.+|+.+++.++||||+++++++. ....++||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 34567999999999999999999986 46789999997654 45678999999999999999999999987 55789999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+.+|+|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 262 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred eecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 999999999999632 1135788999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
.. ........+++.|+|||++....++.++|||||||++|||++ |..||...+..+
T Consensus 337 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~ 393 (454)
T 1qcf_A 337 NE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 393 (454)
T ss_dssp HH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred Cc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 11 111122346778999999988899999999999999999999 999998776544
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=293.91 Aligned_cols=207 Identities=30% Similarity=0.453 Sum_probs=172.7
Q ss_pred hcCCCCCc-eecccCceEEEEEEE--CCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeE
Q 022309 71 TDNFKDTN-FLGQGGFGAVYKGKL--AETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 71 ~~~y~~~~-~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 145 (299)
.++|++.+ .||+|+||.||+|.+ ..+++.||+|++....... .+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 46788888 999999999999954 5667899999997653322 46788999999999999999999999 556789
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
+||||+.+++|.+++.. ...+++.+++.++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++..
T Consensus 94 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 99999999999999953 356899999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCCcc-cccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 226 GPTGDKSH-VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 226 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
........ ......+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 228 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 54332221 1222346788999999988889999999999999999999 999998766543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=305.55 Aligned_cols=205 Identities=27% Similarity=0.406 Sum_probs=167.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCC------ee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT------QR 144 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~------~~ 144 (299)
..+|++.+.||+|+||+||+|.+..+++ ||+|++.... ....+|+.+++.++||||+++++++.... ..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 3569999999999999999999987666 7888775432 12236899999999999999999985433 37
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEec-CCCceEEcccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLG-KGFHPKLSDFGLA 223 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~-~~~~~kl~Dfg~a 223 (299)
++||||+.+ ++.+.+.........+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 114 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 114 NLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 899999976 454444322233467999999999999999999999999 99999999999999 7899999999999
Q ss_pred ccCCCCCCcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 224 KFGPTGDKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
+....... .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||...+..+.+
T Consensus 190 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l 251 (394)
T 4e7w_A 190 KILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL 251 (394)
T ss_dssp EECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 76433222 2345689999999998765 5899999999999999999999999988766554
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=299.53 Aligned_cols=212 Identities=26% Similarity=0.317 Sum_probs=164.7
Q ss_pred HHHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCC----
Q 022309 67 LVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT---- 142 (299)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~---- 142 (299)
.....++|++.+.||+|+||.||+|.+..+++.||||++.... .......+++..++.++||||+++++++....
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 3455678999999999999999999999999999999886543 22345667788888899999999999986533
Q ss_pred ---eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEecCCCCCCEEecC-CCceE
Q 022309 143 ---QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLH--NKADPPVIYRDLKAGNILLGK-GFHPK 216 (299)
Q Consensus 143 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH--~~~~~~i~H~dikp~Nilv~~-~~~~k 216 (299)
..++||||+.+ +|.+.+.........+++..++.++.|++.||.||| +++ |+||||||+|||++. ++.+|
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEE
T ss_pred cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEE
Confidence 27899999975 665555433245577899999999999999999999 888 999999999999996 89999
Q ss_pred EccccccccCCCCCCcccccccccCccccCcccccCCC-CCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 217 LSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGK-LTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 217 l~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
|+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+..+.
T Consensus 173 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 240 (360)
T 3e3p_A 173 LCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ 240 (360)
T ss_dssp ECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH
Confidence 99999998643322 223356899999999986654 89999999999999999999999988775443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=298.84 Aligned_cols=207 Identities=25% Similarity=0.386 Sum_probs=174.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecC-----Cee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEG-----TQR 144 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-----~~~ 144 (299)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 46799999999999999999999999999999999754322 235678999999999999999999987654 678
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
++|||++. ++|.+++.. ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999997 589998853 56899999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCcc--------cccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 225 FGPTGDKSH--------VSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 225 ~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 231 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ 231 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 643221111 1123468999999998754 6789999999999999999999999998875544
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=294.59 Aligned_cols=208 Identities=30% Similarity=0.402 Sum_probs=168.9
Q ss_pred ccHHHHHHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhh--cCCCcceeeeeEEe
Q 022309 62 FTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSL--MRHPNLVHLIGYCA 139 (299)
Q Consensus 62 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~~~~~ 139 (299)
..........++|++++.||+|+||.||+|.+. ++.||+|++... .......|..++.. ++||||+++++++.
T Consensus 27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 101 (337)
T 3mdy_A 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADI 101 (337)
T ss_dssp SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred CCcccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence 334444556678999999999999999999984 899999998543 23444555555554 49999999999998
Q ss_pred cC----CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCeEecCCCCCCE
Q 022309 140 EG----TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK--------ADPPVIYRDLKAGNI 207 (299)
Q Consensus 140 ~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~--------~~~~i~H~dikp~Ni 207 (299)
.. ...++||||+++++|.+++.. ..+++.+++.++.|++.||.|||++ + |+||||||+||
T Consensus 102 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Ni 173 (337)
T 3mdy_A 102 KGTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNI 173 (337)
T ss_dssp ESCGGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGE
T ss_pred cCCCCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHE
Confidence 77 678999999999999999953 4689999999999999999999998 7 99999999999
Q ss_pred EecCCCceEEccccccccCCCCCCcc--cccccccCccccCcccccCCCCCcc------cceehhHHHHHHHHhC-----
Q 022309 208 LLGKGFHPKLSDFGLAKFGPTGDKSH--VSTRVMGTHGYCAPEYATTGKLTAK------SDIFSFGVVLLELITG----- 274 (299)
Q Consensus 208 lv~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~------~DiwslG~il~elltg----- 274 (299)
|++.++.+||+|||++.......... ......||+.|+|||++.+..++.. +|||||||++|||++|
T Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~ 253 (337)
T 3mdy_A 174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253 (337)
T ss_dssp EECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccc
Confidence 99999999999999997543322211 1123579999999999988766655 9999999999999999
Q ss_pred -----CCCCCCCc
Q 022309 275 -----RPAMDDSQ 282 (299)
Q Consensus 275 -----~~pf~~~~ 282 (299)
..||....
T Consensus 254 ~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 254 IVEEYQLPYHDLV 266 (337)
T ss_dssp BCCCCCCTTTTTS
T ss_pred ccccccccHhhhc
Confidence 77776543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=299.97 Aligned_cols=204 Identities=21% Similarity=0.298 Sum_probs=177.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc-----------------HHHHHHHHHHHhhcCCCccee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG-----------------EKEFLVEVLMLSLMRHPNLVH 133 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~nIv~ 133 (299)
.++|++++.||+|+||.||+|.+ +++.||+|++....... ...+.+|+.+++.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46899999999999999999999 89999999986432111 167899999999999999999
Q ss_pred eeeEEecCCeeEEEEEecCCCCHHHH------hcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCC
Q 022309 134 LIGYCAEGTQRLLVYEYMPLGSLEDH------LLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN-KADPPVIYRDLKAGN 206 (299)
Q Consensus 134 ~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~dikp~N 206 (299)
+++++.+.+..++||||+++++|.++ +.. .....+++..++.++.|++.||.|||+ ++ ++||||||+|
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSN 182 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGG
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHh
Confidence 99999999999999999999999998 432 125779999999999999999999999 98 9999999999
Q ss_pred EEecCCCceEEccccccccCCCCCCcccccccccCccccCcccccCC-CCCc-ccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 207 ILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTG-KLTA-KSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 207 ilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
|+++.++.++|+|||++...... ......|++.|+|||++.+. .++. ++||||||+++|+|++|..||...+..
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred EEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 99999999999999999764322 23345689999999999877 5666 999999999999999999999877653
Q ss_pred h
Q 022309 285 E 285 (299)
Q Consensus 285 ~ 285 (299)
.
T Consensus 259 ~ 259 (348)
T 2pml_X 259 V 259 (348)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=292.29 Aligned_cols=208 Identities=32% Similarity=0.478 Sum_probs=170.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCC---CcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEE-ecCCeeE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAET---GQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYC-AEGTQRL 145 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~-~~~~~~~ 145 (299)
..+|++.+.||+|+||.||+|.+..+ ...+|+|.+...... ..+.+.+|+.+++.++||||+++++++ ..++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 35689999999999999999997543 346899998764332 336788999999999999999999985 4556789
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
+||||+.+++|.+++.. ....+++.+++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++..
T Consensus 104 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 99999999999999963 3466899999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCc--ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 226 GPTGDKS--HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 226 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
....... .......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~ 239 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 239 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH
Confidence 4322211 11223457889999999998899999999999999999999 56777665543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=303.26 Aligned_cols=202 Identities=18% Similarity=0.210 Sum_probs=171.3
Q ss_pred hcCCCCCceecccCceEEEEEEECC--------CCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCccee---------
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAE--------TGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVH--------- 133 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~--------- 133 (299)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+... ..+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3679999999999999999999987 4789999998654 46788999999999999988
Q ss_pred ------eeeEEec-CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 022309 134 ------LIGYCAE-GTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGN 206 (299)
Q Consensus 134 ------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~N 206 (299)
+++++.. +...++||||+ +++|.+++... ....+++.+++.++.||+.||.|||+++ |+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHH
Confidence 5667665 67889999999 99999999642 1367999999999999999999999999 9999999999
Q ss_pred EEecCCC--ceEEccccccccCCCCCCc-----ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCC
Q 022309 207 ILLGKGF--HPKLSDFGLAKFGPTGDKS-----HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMD 279 (299)
Q Consensus 207 ilv~~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 279 (299)
|+++.++ .++|+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 8999999999754322111 11123479999999999999899999999999999999999999998
Q ss_pred CCch
Q 022309 280 DSQG 283 (299)
Q Consensus 280 ~~~~ 283 (299)
....
T Consensus 270 ~~~~ 273 (352)
T 2jii_A 270 NCLP 273 (352)
T ss_dssp GGTT
T ss_pred cCCc
Confidence 7753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=291.26 Aligned_cols=199 Identities=28% Similarity=0.434 Sum_probs=173.7
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEec---------
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAE--------- 140 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--------- 140 (299)
..++|++++.||+|+||.||+|.+..+++.||+|.+.... ..+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4467999999999999999999999899999999987542 457789999999999999999998854
Q ss_pred -------CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC
Q 022309 141 -------GTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF 213 (299)
Q Consensus 141 -------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~ 213 (299)
....++||||+++++|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence 44579999999999999999642 2356899999999999999999999999 99999999999999999
Q ss_pred ceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCC
Q 022309 214 HPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDD 280 (299)
Q Consensus 214 ~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 280 (299)
.++|+|||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 160 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 223 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 223 (284)
T ss_dssp EEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred CEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence 99999999997643322 12234689999999999988899999999999999999999988853
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=292.58 Aligned_cols=198 Identities=36% Similarity=0.531 Sum_probs=165.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|++.+.||+|+||.||+|.+ .++.||+|.+... ...+.+.+|+.+++.++||||+++++++.+ ..++||||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 35689999999999999999998 4788999998754 345678999999999999999999998874 47899999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCeEecCCCCCCEEecCCCc-eEEccccccccC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN---KADPPVIYRDLKAGNILLGKGFH-PKLSDFGLAKFG 226 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~---~~~~~i~H~dikp~Nilv~~~~~-~kl~Dfg~a~~~ 226 (299)
+++++|.+++.... ....+++..++.++.|+++||+|||+ ++ |+||||||+||+++.++. +||+|||++...
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 81 AEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp CTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred CCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 99999999996421 12347889999999999999999999 67 999999999999998886 799999999743
Q ss_pred CCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 157 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 208 (307)
T 2eva_A 157 QT-----HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG 208 (307)
T ss_dssp -------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS
T ss_pred cc-----ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc
Confidence 21 12234589999999999998999999999999999999999999986544
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=290.77 Aligned_cols=206 Identities=25% Similarity=0.397 Sum_probs=172.2
Q ss_pred hcCCCCCceecccCceEEEEEEECC---CCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAE---TGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.++ ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 4679999999999999999998643 345699999976532 3346788999999999999999999998754 5689
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
|||++.+++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++...
T Consensus 90 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 90 IMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 9999999999999964 2356899999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
..... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..
T Consensus 164 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~ 221 (281)
T 3cc6_A 164 EDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK 221 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG
T ss_pred ccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH
Confidence 33221 11223457888999999988899999999999999999998 99999765544
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=297.41 Aligned_cols=210 Identities=27% Similarity=0.383 Sum_probs=159.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcC-CCcceeeeeEEe--------cC
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMR-HPNLVHLIGYCA--------EG 141 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~--------~~ 141 (299)
..+|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.+. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 457999999999999999999999999999999986665455577889999999995 999999999983 34
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccc
Q 022309 142 TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFG 221 (299)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg 221 (299)
..+++||||+. |+|.+++.... ...++++.+++.++.||+.||.|||+++ ++|+||||||+|||++.++.+||+|||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred ceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 45789999996 69999885422 2356999999999999999999999864 459999999999999999999999999
Q ss_pred ccccCCCCCCcc----------cccccccCccccCcccc---cCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 222 LAKFGPTGDKSH----------VSTRVMGTHGYCAPEYA---TTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 222 ~a~~~~~~~~~~----------~~~~~~g~~~y~aPE~~---~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
++.......... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||.....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 997643322111 11134589999999998 566788999999999999999999999976543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=287.89 Aligned_cols=207 Identities=31% Similarity=0.468 Sum_probs=175.7
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
..++|++++.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+ +..++|||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 87 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence 3467999999999999999999975 56789999987653 345678999999999999999999999875 45899999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+.+++|.+++... ....+++.+++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++......
T Consensus 88 ~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 88 YMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp CCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred cCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 99999999999531 1126899999999999999999999999 999999999999999999999999999765332
Q ss_pred CCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
.. .......+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+
T Consensus 163 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 218 (279)
T 1qpc_A 163 EY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218 (279)
T ss_dssp CE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred cc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH
Confidence 21 12223456788999999988889999999999999999999 999998766543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=293.35 Aligned_cols=208 Identities=28% Similarity=0.413 Sum_probs=175.1
Q ss_pred hhcCCCCCceecccCceEEEEEEEC-CCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhc---CCCcceeeeeEEe----
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLA-ETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLM---RHPNLVHLIGYCA---- 139 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~nIv~~~~~~~---- 139 (299)
..++|++++.||+|+||.||+|.+. .+++.||+|++...... ....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3478999999999999999999995 67899999998643221 224566788777766 8999999999987
Q ss_pred -cCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEc
Q 022309 140 -EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLS 218 (299)
Q Consensus 140 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~ 218 (299)
.....++||||+. ++|.+++... ....+++.+++.++.|++.||.|||++| |+||||||+||+++.++.++|+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999997 5999998653 2245899999999999999999999999 9999999999999999999999
Q ss_pred cccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 219 DFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 219 Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
|||++..... ........|++.|+|||++.+..++.++||||||+++|+|++|.+||...+..+.
T Consensus 163 Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 227 (326)
T 1blx_A 163 DFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 227 (326)
T ss_dssp SCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cCcccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 9999975422 1223345689999999999988999999999999999999999999988775443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=296.97 Aligned_cols=201 Identities=33% Similarity=0.462 Sum_probs=171.3
Q ss_pred CCCCceecccCceEEEEEEE----CCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEec--CCeeEE
Q 022309 74 FKDTNFLGQGGFGAVYKGKL----AETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAE--GTQRLL 146 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~l 146 (299)
|++++.||+|+||.||++.. ..+++.||+|++...... ....+.+|+.+++.++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 49999999999999988754 457889999999765332 24668999999999999999999999987 467899
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
||||+++++|.+++.. ..+++.+++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccc
Confidence 9999999999999953 45899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCc-ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 227 PTGDKS-HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 227 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
...... .......+++.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~ 241 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPP 241 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccc
Confidence 443222 12233557888999999998889999999999999999999999997654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=304.56 Aligned_cols=200 Identities=13% Similarity=0.036 Sum_probs=154.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc---HHHHHHHHHHHhhc--CCCcceeee-------eEEe
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG---EKEFLVEVLMLSLM--RHPNLVHLI-------GYCA 139 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l--~h~nIv~~~-------~~~~ 139 (299)
..|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45899999999999999999999999999999998754322 34567785555544 699988755 4443
Q ss_pred cC-----------------CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 022309 140 EG-----------------TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTR------MKIAAGAARGLEYLHNKADPP 196 (299)
Q Consensus 140 ~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~------~~i~~ql~~~l~~lH~~~~~~ 196 (299)
.. ...++||||++ ++|.+++... ...+++... +.++.||+.||+|||+++
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 32 33799999998 8999999642 123344445 677799999999999999
Q ss_pred eEecCCCCCCEEecCCCceEEccccccccCCCCCCcccccccccCccccCcccccC--CCCCcccceehhHHHHHHHHhC
Q 022309 197 VIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATT--GKLTAKSDIFSFGVVLLELITG 274 (299)
Q Consensus 197 i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg 274 (299)
|+||||||+|||++.++.+||+|||++..... ......+++.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 99999999999999999999999999985421 1113457799999999987 6799999999999999999999
Q ss_pred CCCCCCCch
Q 022309 275 RPAMDDSQG 283 (299)
Q Consensus 275 ~~pf~~~~~ 283 (299)
.+||.....
T Consensus 290 ~~Pf~~~~~ 298 (371)
T 3q60_A 290 FLPFGLVTP 298 (371)
T ss_dssp SCSTTBCCT
T ss_pred CCCCCCcCc
Confidence 999987743
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=310.41 Aligned_cols=207 Identities=34% Similarity=0.486 Sum_probs=172.3
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
..++|++.+.||+|+||.||+|.+.. +..||||.++... ...+.+.+|+.+++.++||||+++++++.+ ...++|||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 45678999999999999999999865 4679999997654 345679999999999999999999999876 66899999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+++++|.+++... ....+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 259 ~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 259 YMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 99999999999531 1245889999999999999999999999 999999999999999999999999999764322
Q ss_pred CCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
.. .......+++.|+|||++.+..++.++|||||||++|||++ |..||...+..+
T Consensus 334 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~ 389 (452)
T 1fmk_A 334 EY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 389 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred ce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 11 11223346788999999988899999999999999999999 999998766543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=297.13 Aligned_cols=200 Identities=26% Similarity=0.408 Sum_probs=171.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEecCCe-----
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQ----- 143 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~----- 143 (299)
.++|.+.+.||+|+||.||+|.+..+++.||||++....... ...+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999999999999999997643322 3568899999999999999999999987654
Q ss_pred -eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccc
Q 022309 144 -RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL 222 (299)
Q Consensus 144 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~ 222 (299)
+++||||+. ++|.+++. ..+++.+++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 58877663 34899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 223 AKFGPTGDKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 223 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
+..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+
T Consensus 173 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 231 (353)
T 3coi_A 173 ARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 231 (353)
T ss_dssp TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH
T ss_pred ccCCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 975322 1233568999999999877 678999999999999999999999998876544
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=305.87 Aligned_cols=206 Identities=27% Similarity=0.366 Sum_probs=157.6
Q ss_pred cCCCC-CceecccCceEEEEEEEC--CCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEe--cCCeeEE
Q 022309 72 DNFKD-TNFLGQGGFGAVYKGKLA--ETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA--EGTQRLL 146 (299)
Q Consensus 72 ~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~--~~~~~~l 146 (299)
+.|++ .++||+|+||.||+|.+. .+++.||+|++..... ...+.+|+.+++.++||||+++++++. .+...++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 45766 458999999999999975 5688999999976532 356789999999999999999999994 4678899
Q ss_pred EEEecCCCCHHHHhcccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEe----cCCCceEE
Q 022309 147 VYEYMPLGSLEDHLLGLT-----PEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL----GKGFHPKL 217 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv----~~~~~~kl 217 (299)
||||+. ++|.+++.... .....+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999996 58888775211 12235899999999999999999999999 9999999999999 67789999
Q ss_pred ccccccccCCCCCCc-ccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 218 SDFGLAKFGPTGDKS-HVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 218 ~Dfg~a~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
+|||++......... .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...+.
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 999999764322111 222346789999999999774 589999999999999999999999976554
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=306.39 Aligned_cols=204 Identities=23% Similarity=0.341 Sum_probs=174.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCC-CcceeeeeEEecCCeeEEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRH-PNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~~~~~lv~e 149 (299)
.++|++++.||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.+.| ++|..+..++......+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 4689999999999999999999999999999998765432 2457889999999987 556666677788888999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEe---cCCCceEEccccccccC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL---GKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv---~~~~~~kl~Dfg~a~~~ 226 (299)
|+ +++|.+++.. ....+++.+++.++.||+.||+|||+++ |+||||||+|||| +.++.+||+|||++...
T Consensus 84 ~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 8999999963 2357999999999999999999999999 9999999999999 58899999999999765
Q ss_pred CCCCCcc-----cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 227 PTGDKSH-----VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 227 ~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 4332211 12246799999999999999999999999999999999999999987544
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=295.80 Aligned_cols=205 Identities=34% Similarity=0.483 Sum_probs=175.9
Q ss_pred hcCCCCCceecccCceEEEEEE----ECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCC--ee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGK----LAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT--QR 144 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--~~ 144 (299)
.++|++++.||+|+||.||+|. +..+++.||+|++........+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 4569999999999999999998 45689999999998765555678999999999999999999999986544 68
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
++||||+++++|.+++.. ....+++.+++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 999999999999999964 2356899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCcc-cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCC
Q 022309 225 FGPTGDKSH-VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDS 281 (299)
Q Consensus 225 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 281 (299)
......... ......++..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 251 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 251 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 654332211 122345677899999998888999999999999999999999998643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=301.69 Aligned_cols=207 Identities=31% Similarity=0.466 Sum_probs=163.7
Q ss_pred cCCCCCceecccCceEEEEEEECCC---CcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEe-cCCeeEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAET---GQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCA-EGTQRLL 146 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~-~~~~~~l 146 (299)
..|++.+.||+|+||.||+|.+..+ +..||+|.+..... ...+.+.+|+.+++.++||||+++++++. .++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 3477789999999999999987533 24689999875432 33467899999999999999999999865 4557899
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
||||+++++|.+++.. ....+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 169 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccc
Confidence 9999999999999963 3356889999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCCcc--cccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 227 PTGDKSH--VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 227 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
....... ......+++.|+|||++.+..++.++|||||||++|||++ |.+||...+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~ 303 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 303 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH
Confidence 3222111 1223457788999999999999999999999999999999 78888766543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=296.70 Aligned_cols=205 Identities=22% Similarity=0.334 Sum_probs=175.6
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCC-cEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCc------ceeeeeEEecCC
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETG-QVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPN------LVHLIGYCAEGT 142 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~~~~~~~~~~ 142 (299)
..++|++++.||+|+||.||+|.+..++ +.||+|+++... .....+.+|+.+++.+.|++ ++.+++++....
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 4578999999999999999999998776 689999997542 33456788999999987665 999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEe-------------
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL------------- 209 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv------------- 209 (299)
..++|||++ +++|.+.+.. ....++++.+++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eEEEEEecc-CCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccc
Confidence 999999999 5677777754 22356899999999999999999999999 9999999999999
Q ss_pred ------cCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 210 ------GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 210 ------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 56789999999999763221 2335689999999999999999999999999999999999999998776
Q ss_pred hhh
Q 022309 284 HER 286 (299)
Q Consensus 284 ~~~ 286 (299)
.+.
T Consensus 245 ~~~ 247 (355)
T 2eu9_A 245 REH 247 (355)
T ss_dssp HHH
T ss_pred HHH
Confidence 543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=294.18 Aligned_cols=210 Identities=28% Similarity=0.380 Sum_probs=175.6
Q ss_pred CccHHHHHHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhh--cCCCcceeeeeEE
Q 022309 61 TFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSL--MRHPNLVHLIGYC 138 (299)
Q Consensus 61 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~~~~ 138 (299)
...........++|++.+.||+|+||.||+|.+ +++.||+|++... ....+.+|+.++.. ++||||+++++++
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~ 105 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAAD 105 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence 344445556678899999999999999999998 5899999998643 34567788888877 7999999999999
Q ss_pred ecCC----eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCC
Q 022309 139 AEGT----QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLH--------NKADPPVIYRDLKAGN 206 (299)
Q Consensus 139 ~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH--------~~~~~~i~H~dikp~N 206 (299)
.... ..++||||+++++|.+++.. ..+++.+++.++.|++.||.||| +.+ |+||||||+|
T Consensus 106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~N 177 (342)
T 1b6c_B 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKN 177 (342)
T ss_dssp ECCCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGG
T ss_pred cccCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHH
Confidence 8776 78999999999999999953 46899999999999999999999 888 9999999999
Q ss_pred EEecCCCceEEccccccccCCCCCCcc--cccccccCccccCcccccCCC------CCcccceehhHHHHHHHHhC----
Q 022309 207 ILLGKGFHPKLSDFGLAKFGPTGDKSH--VSTRVMGTHGYCAPEYATTGK------LTAKSDIFSFGVVLLELITG---- 274 (299)
Q Consensus 207 ilv~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~------~~~~~DiwslG~il~elltg---- 274 (299)
|+++.++.++|+|||++.......... ......||+.|+|||++.+.. ++.++||||||+++|+|++|
T Consensus 178 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~ 257 (342)
T 1b6c_B 178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 257 (342)
T ss_dssp EEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred EEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcC
Confidence 999999999999999997543322211 123456999999999987652 34689999999999999999
Q ss_pred ------CCCCCCCch
Q 022309 275 ------RPAMDDSQG 283 (299)
Q Consensus 275 ------~~pf~~~~~ 283 (299)
..||.....
T Consensus 258 ~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 258 GIHEDYQLPYYDLVP 272 (342)
T ss_dssp TBCCCCCCTTTTTSC
T ss_pred CcccccccCccccCc
Confidence 789977644
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=289.13 Aligned_cols=205 Identities=29% Similarity=0.418 Sum_probs=177.1
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC--cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG--FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
...++|++++.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34567999999999999999999999999999999986533 2345678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCC---CceEEcccccc
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKG---FHPKLSDFGLA 223 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~---~~~kl~Dfg~a 223 (299)
|||++.+++|.+.+.. ...+++.+++.++.|++.||.|||+++ ++||||||+||+++.+ +.++|+|||++
T Consensus 99 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999998853 356899999999999999999999999 9999999999999754 47999999999
Q ss_pred ccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 224 KFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
....... ......|++.|+|||++.+ .++.++||||||+++|+|++|.+||...+..
T Consensus 172 ~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 228 (287)
T 2wei_A 172 TCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY 228 (287)
T ss_dssp GTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred eeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH
Confidence 7543222 1223458899999999865 4889999999999999999999999876644
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=297.85 Aligned_cols=207 Identities=26% Similarity=0.319 Sum_probs=175.6
Q ss_pred HHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcC-CC-----cceeeeeEEecC
Q 022309 68 VAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMR-HP-----NLVHLIGYCAEG 141 (299)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----nIv~~~~~~~~~ 141 (299)
....++|++.+.||+|+||+||+|.+..+++.||||++.... .....+..|+.+++.++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 344678999999999999999999999999999999997542 22355677888888774 44 499999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeEecCCCCCCEEec--CCCceEE
Q 022309 142 TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN--KADPPVIYRDLKAGNILLG--KGFHPKL 217 (299)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~--~~~~~i~H~dikp~Nilv~--~~~~~kl 217 (299)
+..++|||++. ++|.+++... ....+++..+..++.|++.||.|||+ .+ |+||||||+|||++ .++.+||
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEE
T ss_pred CceEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEE
Confidence 99999999996 5999998652 22568999999999999999999994 57 99999999999995 4788999
Q ss_pred ccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 218 SDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 218 ~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+.
T Consensus 203 ~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~ 266 (382)
T 2vx3_A 203 VDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ 266 (382)
T ss_dssp CCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999764321 2335789999999999999999999999999999999999999998776544
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=316.23 Aligned_cols=206 Identities=28% Similarity=0.438 Sum_probs=170.1
Q ss_pred CCCCCc-eecccCceEEEEEEEC--CCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 73 NFKDTN-FLGQGGFGAVYKGKLA--ETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 73 ~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++.+.+ .||+|+||.||+|.+. .++..||||+++.... ...+.+.+|+.+++.++||||+++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 344444 7999999999999875 3566799999976533 345789999999999999999999999976 5689999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+.+++|.+++.. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 415 E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 415 EMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp ECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 99999999999953 3466899999999999999999999999 99999999999999999999999999986433
Q ss_pred CCCcc-cccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 229 GDKSH-VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 229 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
..... ......+++.|+|||++.+..++.++|||||||++|||++ |..||...+..+
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~ 547 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Confidence 22111 1122345688999999998899999999999999999998 999998876544
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=288.34 Aligned_cols=200 Identities=32% Similarity=0.470 Sum_probs=166.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecC-CeeEEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEG-TQRLLVYE 149 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-~~~~lv~e 149 (299)
.++|++.+.||+|+||.||+|.+ +++.||+|++.... ..+.+.+|+.+++.++||||+++++++.+. +..++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 46799999999999999999988 48899999997653 446789999999999999999999997554 47899999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+++++|.+++... ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred cCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 99999999999532 1123788999999999999999999999 999999999999999999999999999753221
Q ss_pred CCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
.....+++.|+|||++.+..++.++||||||+++|+|++ |.+||...+..
T Consensus 171 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 221 (278)
T 1byg_A 171 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 221 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG
T ss_pred -----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 122357889999999988899999999999999999998 99999876543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=298.59 Aligned_cols=199 Identities=31% Similarity=0.480 Sum_probs=159.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHH--HhhcCCCcceeeeeEEe-----cCCe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLM--LSLMRHPNLVHLIGYCA-----EGTQ 143 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~nIv~~~~~~~-----~~~~ 143 (299)
.++|++++.||+|+||.||+|.. +++.||+|++... ....+..|..+ +..++||||+++++.+. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 46799999999999999999987 6899999998643 23334444444 45589999999997543 2335
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeEecCCCCCCEEecCCCc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK---------ADPPVIYRDLKAGNILLGKGFH 214 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---------~~~~i~H~dikp~Nilv~~~~~ 214 (299)
+++||||+++++|.+++.. ...++..++.++.||+.||+|||+. + |+||||||+|||++.++.
T Consensus 87 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSC
T ss_pred EEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCc
Confidence 7899999999999999953 3458899999999999999999998 8 999999999999999999
Q ss_pred eEEccccccccCCCCC------CcccccccccCccccCcccccC-------CCCCcccceehhHHHHHHHHhCCCCCCCC
Q 022309 215 PKLSDFGLAKFGPTGD------KSHVSTRVMGTHGYCAPEYATT-------GKLTAKSDIFSFGVVLLELITGRPAMDDS 281 (299)
Q Consensus 215 ~kl~Dfg~a~~~~~~~------~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~elltg~~pf~~~ 281 (299)
+||+|||++....... .........||+.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 9999999997643221 1112223569999999999976 34667899999999999999997766443
Q ss_pred c
Q 022309 282 Q 282 (299)
Q Consensus 282 ~ 282 (299)
.
T Consensus 239 ~ 239 (336)
T 3g2f_A 239 E 239 (336)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=291.19 Aligned_cols=205 Identities=27% Similarity=0.376 Sum_probs=154.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-cHHHHHHHHH-HHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLVEVL-MLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
.++|++++.||+|+||.||+|.+..+++.||+|++...... ....+..|+. +++.++||||+++++++.+++..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 36799999999999999999999999999999999765322 2244555655 777789999999999999999999999
Q ss_pred EecCCCCHHHHhccc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 149 EYMPLGSLEDHLLGL-TPEMKPLDWNTRMKIAAGAARGLEYLHNK-ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 149 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
||+.+ +|.+++... ......+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99975 888777421 11246789999999999999999999998 9 999999999999999999999999999754
Q ss_pred CCCCCcccccccccCccccCcccc----cCCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYA----TTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
.... ......|++.|+|||++ .+..++.++||||||+++|+|++|..||...+
T Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 3221 12234689999999998 45668999999999999999999999997644
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=292.24 Aligned_cols=201 Identities=25% Similarity=0.322 Sum_probs=148.4
Q ss_pred hcCCCCCc-eecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEec----CCeeE
Q 022309 71 TDNFKDTN-FLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAE----GTQRL 145 (299)
Q Consensus 71 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~----~~~~~ 145 (299)
.++|++++ .||+|+||.||+|.+..+++.||+|++... .....+....++.+.||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 46799865 699999999999999999999999998643 1222223344567799999999999865 45689
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC---CCceEEccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK---GFHPKLSDFGL 222 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~---~~~~kl~Dfg~ 222 (299)
+||||++|++|.+++... ....+++.+++.++.||+.||.|||+++ |+||||||+||+++. ++.++|+|||+
T Consensus 103 lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 999999999999999642 2357999999999999999999999999 999999999999976 45599999999
Q ss_pred cccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 223 AKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 223 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
+...... ......||+.|+|||++.+..++.++||||||+++|+|++|.+||......
T Consensus 178 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 235 (336)
T 3fhr_A 178 AKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ 235 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccch
Confidence 9754321 223356899999999998888999999999999999999999999766543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=316.71 Aligned_cols=200 Identities=31% Similarity=0.472 Sum_probs=167.1
Q ss_pred ceecccCceEEEEEEE--CCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCC
Q 022309 78 NFLGQGGFGAVYKGKL--AETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
+.||+|+||.||+|.+ ..+++.||||+++..... ..+.+.+|+.+++.++||||+++++++.. +..++||||+.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999955 456789999999764322 24679999999999999999999999975 457899999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCc-
Q 022309 154 GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKS- 232 (299)
Q Consensus 154 ~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~- 232 (299)
++|.+++. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999995 3356899999999999999999999999 999999999999999999999999999765433221
Q ss_pred ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 233 HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 233 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
.......+++.|+|||++.+..++.++|||||||++|||++ |..||...+..+
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~ 580 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 580 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 12223456788999999999899999999999999999998 999998876644
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=289.18 Aligned_cols=206 Identities=22% Similarity=0.288 Sum_probs=168.5
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcC--CCcceeeeeEEecCCee
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMR--HPNLVHLIGYCAEGTQR 144 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~--h~nIv~~~~~~~~~~~~ 144 (299)
...++|++++.||+|+||.||+|.+. +++.||+|++...... ....+.+|+.+++.+. ||||+++++++.++...
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 44567999999999999999999985 5889999998654332 2367889999999997 59999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
++||| +.+++|.+++.. ...+++.+++.++.|++.||.|||+++ |+||||||+||++++ +.+||+|||++.
T Consensus 104 ~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~ 174 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIAN 174 (313)
T ss_dssp EEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred EEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccc
Confidence 99999 567899999953 357899999999999999999999999 999999999999975 899999999997
Q ss_pred cCCCCCCcccccccccCccccCcccccC-----------CCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 225 FGPTGDKSHVSTRVMGTHGYCAPEYATT-----------GKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
...............|++.|+|||++.+ ..++.++||||||+++|+|++|..||......
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH
Confidence 6543332223334568999999999865 46788999999999999999999999876443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=297.82 Aligned_cols=200 Identities=22% Similarity=0.285 Sum_probs=169.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcC-----------CCcceeeeeEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMR-----------HPNLVHLIGYCA 139 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~~~~~~~ 139 (299)
.++|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+. ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 367999999999999999999999999999999997532 23456788999988876 899999999987
Q ss_pred cCC----eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEec----
Q 022309 140 EGT----QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK-ADPPVIYRDLKAGNILLG---- 210 (299)
Q Consensus 140 ~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~~~~i~H~dikp~Nilv~---- 210 (299)
... ..++|||++ +++|.+++... ....+++..++.++.||+.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence 644 789999999 88999999653 235689999999999999999999998 9 99999999999994
Q ss_pred --CCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 211 --KGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 211 --~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||...+
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 4458999999999764321 223468999999999999999999999999999999999999998665
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=287.39 Aligned_cols=201 Identities=28% Similarity=0.424 Sum_probs=164.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEec----------
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAE---------- 140 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~---------- 140 (299)
.++|++++.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467999999999999999999999999999999986431 234668899999999999999999998854
Q ss_pred ---CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEE
Q 022309 141 ---GTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKL 217 (299)
Q Consensus 141 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl 217 (299)
....++||||+++++|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++.++|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence 3567899999999999999964 2356788999999999999999999999 999999999999999999999
Q ss_pred ccccccccCCCCCC------------cccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCC
Q 022309 218 SDFGLAKFGPTGDK------------SHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDS 281 (299)
Q Consensus 218 ~Dfg~a~~~~~~~~------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~ 281 (299)
+|||++........ ........|++.|+|||++.+. .++.++|||||||++|+|++ ||...
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~ 231 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence 99999975432110 1122335689999999999765 68999999999999999998 55443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=313.37 Aligned_cols=208 Identities=34% Similarity=0.483 Sum_probs=176.2
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
...++|++.+.||+|+||.||+|.+.. +..||||+++... ...+.+.+|+.+++.++||||+++++++.+ ...+|||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 345678899999999999999999865 4679999997654 345679999999999999999999999876 6789999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+.+++|.+++... ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 341 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred ehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 999999999999531 1245889999999999999999999999 99999999999999999999999999975432
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
.. ........++..|+|||++.+..++.++|||||||++|||++ |..||......+
T Consensus 416 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~ 472 (535)
T 2h8h_A 416 NE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 472 (535)
T ss_dssp HH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH
T ss_pred Cc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 11 111122346778999999988899999999999999999999 999998766543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=288.60 Aligned_cols=208 Identities=32% Similarity=0.468 Sum_probs=165.9
Q ss_pred hcCCCCCceecccCceEEEEEEECC-CCc--EEEEEEcCCCCc---ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAE-TGQ--VVAVKQLDDTGF---QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQR 144 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~--~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 144 (299)
.++|++++.||+|+||.||+|.+.. +++ .||+|++..... ...+.+.+|+.+++.++||||+++++++.++. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 3679999999999999999998643 333 689998875432 23467889999999999999999999998765 7
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
++|||++.+++|.+++.. ....+++.+++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence 899999999999999964 2356899999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCcc-cccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 225 FGPTGDKSH-VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 225 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 232 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 232 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH
Confidence 654332221 2223457888999999988889999999999999999999 999998776543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=292.96 Aligned_cols=204 Identities=23% Similarity=0.360 Sum_probs=175.1
Q ss_pred HHhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc------cHHHHHHHHHHHhhcC--CCcceeeeeEEe
Q 022309 68 VAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ------GEKEFLVEVLMLSLMR--HPNLVHLIGYCA 139 (299)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~nIv~~~~~~~ 139 (299)
....++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.+. ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34567899999999999999999999999999999998654322 1245677999999986 599999999999
Q ss_pred cCCeeEEEEEecCC-CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEec-CCCceEE
Q 022309 140 EGTQRLLVYEYMPL-GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLG-KGFHPKL 217 (299)
Q Consensus 140 ~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~-~~~~~kl 217 (299)
..+..++|||++.+ ++|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++ +++.+||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEE
Confidence 99999999999976 899999853 357899999999999999999999999 99999999999999 7899999
Q ss_pred ccccccccCCCCCCcccccccccCccccCcccccCCCC-CcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 218 SDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKL-TAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 218 ~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
+|||++...... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+
T Consensus 192 ~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 253 (320)
T 3a99_A 192 IDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 253 (320)
T ss_dssp CCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred eeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh
Confidence 999999764322 2233568999999999877665 678999999999999999999997543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=290.97 Aligned_cols=202 Identities=24% Similarity=0.400 Sum_probs=166.4
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc------cHHHHHHHHHHHhhc----CCCcceeeeeEE
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ------GEKEFLVEVLMLSLM----RHPNLVHLIGYC 138 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~nIv~~~~~~ 138 (299)
...++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.++..+ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 4457899999999999999999999999999999999765432 223456788888888 899999999999
Q ss_pred ecCCeeEEEEEe-cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEec-CCCceE
Q 022309 139 AEGTQRLLVYEY-MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLG-KGFHPK 216 (299)
Q Consensus 139 ~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~-~~~~~k 216 (299)
...+..++|||+ +.+++|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+||+++ .++.++
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 998999999999 788999999953 356899999999999999999999999 99999999999999 889999
Q ss_pred EccccccccCCCCCCcccccccccCccccCcccccCCCC-CcccceehhHHHHHHHHhCCCCCCCC
Q 022309 217 LSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKL-TAKSDIFSFGVVLLELITGRPAMDDS 281 (299)
Q Consensus 217 l~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~ 281 (299)
|+|||++....... .....|++.|+|||++.+..+ +.++||||||+++|+|++|..||...
T Consensus 181 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 242 (312)
T 2iwi_A 181 LIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD 242 (312)
T ss_dssp ECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred EEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence 99999997643321 233568999999999877665 45899999999999999999999754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=286.06 Aligned_cols=206 Identities=27% Similarity=0.393 Sum_probs=156.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH--HHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE--KEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
.++|++++.||+|+||.||+|.+..+++.||+|++........ ..+..+..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 3679999999999999999999999999999999976543322 23344555778889999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK-ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
||+ ++.+..+... ....+++..++.++.|++.||.|||++ + ++||||||+||+++.++.++|+|||++....
T Consensus 104 e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 5566555532 235789999999999999999999995 8 9999999999999999999999999997543
Q ss_pred CCCCcccccccccCccccCccccc-----CCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYAT-----TGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
... ......|++.|+|||++. +..++.++||||||+++|+|++|..||........
T Consensus 177 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 237 (318)
T 2dyl_A 177 DDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE 237 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH
T ss_pred CCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH
Confidence 221 222346899999999984 45688899999999999999999999987554433
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=313.63 Aligned_cols=209 Identities=26% Similarity=0.411 Sum_probs=173.7
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCC---CcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCee
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAET---GQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQR 144 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 144 (299)
...++|++.+.||+|+||.||+|.+..+ +..||+|.+...... ..+.+.+|+.+++.++||||+++++++.+ +..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cce
Confidence 3457799999999999999999998643 467999998754322 23678899999999999999999999854 568
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~ 224 (299)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 466 ~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp EEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred EEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCe
Confidence 999999999999999963 2356899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 225 FGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
....... .......+++.|+|||++.+..++.++|||||||++|||++ |.+||...+..+
T Consensus 540 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 600 (656)
T 2j0j_A 540 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600 (656)
T ss_dssp SCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred ecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 6433221 12223457789999999988899999999999999999997 999998776543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=290.15 Aligned_cols=206 Identities=24% Similarity=0.346 Sum_probs=169.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
..++|++.+.||+|+||.||+|.+.. .+|+|++..... ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 45779999999999999999999854 399999875432 2235577899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||+++++|.+++.. ....+++.+++.++.|++.||+|||+++ ++||||||+||+++ ++.++|+|||++....
T Consensus 108 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp CBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred eecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 999999999999953 3346899999999999999999999999 99999999999998 6799999999986532
Q ss_pred CCC---CcccccccccCccccCcccccC---------CCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 228 TGD---KSHVSTRVMGTHGYCAPEYATT---------GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 228 ~~~---~~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
... .........|++.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 250 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA 250 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 111 1112223458999999999864 347889999999999999999999998766543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=307.11 Aligned_cols=204 Identities=30% Similarity=0.416 Sum_probs=174.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEec------CCe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAE------GTQ 143 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~------~~~ 143 (299)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 3689999999999999999999999999999999876432 234668899999999999999999998755 667
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCc---eEEccc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFH---PKLSDF 220 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~---~kl~Df 220 (299)
.++||||++|++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++. ++|+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence 899999999999999997532 2346889999999999999999999999 999999999999997664 899999
Q ss_pred cccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCC
Q 022309 221 GLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDS 281 (299)
Q Consensus 221 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 281 (299)
|++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 169 G~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 169 GYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226 (676)
T ss_dssp CCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence 9998643322 223457999999999999999999999999999999999999999765
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=295.24 Aligned_cols=192 Identities=19% Similarity=0.177 Sum_probs=159.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--------ccHHHHHHHHHHHhhcC---------CCccee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--------QGEKEFLVEVLMLSLMR---------HPNLVH 133 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------h~nIv~ 133 (299)
.++|++++.||+|+||+||+|++ +++.||||++..... ...+.+.+|+.+++.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46799999999999999999998 689999999975532 12367888999988886 555555
Q ss_pred eeeE-----------------Eec-------------CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHH
Q 022309 134 LIGY-----------------CAE-------------GTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAA 183 (299)
Q Consensus 134 ~~~~-----------------~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~ 183 (299)
+.+. +.+ ....++||||+++|++.+.+.. ..+++.+++.++.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence 5554 433 6789999999999977776632 5689999999999999
Q ss_pred HHHHHHH-hCCCCCeEecCCCCCCEEecCCC--------------------ceEEccccccccCCCCCCcccccccccCc
Q 022309 184 RGLEYLH-NKADPPVIYRDLKAGNILLGKGF--------------------HPKLSDFGLAKFGPTGDKSHVSTRVMGTH 242 (299)
Q Consensus 184 ~~l~~lH-~~~~~~i~H~dikp~Nilv~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~ 242 (299)
.||+||| +++ |+||||||+|||++.++ .+||+|||+|+.... ....||+
T Consensus 172 ~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~ 241 (336)
T 2vuw_A 172 ASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCD 241 (336)
T ss_dssp HHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCC
T ss_pred HHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEee
Confidence 9999999 899 99999999999999887 899999999985432 1347999
Q ss_pred cccCcccccCCCCCcccceehhHHH-HHHHHhCCCCCCC
Q 022309 243 GYCAPEYATTGKLTAKSDIFSFGVV-LLELITGRPAMDD 280 (299)
Q Consensus 243 ~y~aPE~~~~~~~~~~~DiwslG~i-l~elltg~~pf~~ 280 (299)
.|+|||++.+.. +.++||||||++ .+++++|..||..
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 999999998766 889999998777 7889999999954
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=294.62 Aligned_cols=205 Identities=27% Similarity=0.330 Sum_probs=157.7
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEEEEEe
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
+.|.+.+.||+|+||+||.+. ..+|+.||||++... ..+.+.+|+.+++.+ +||||+++++++.++...++||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 456667889999999998754 457999999988643 234578899999876 899999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCC-------------Cc
Q 022309 151 MPLGSLEDHLLGLTPEMKP---LDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKG-------------FH 214 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~---~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~-------------~~ 214 (299)
+. ++|.+++......... .++..++.++.||+.||+|||+++ |+||||||+|||++.. +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence 96 5999999643221111 133356789999999999999999 9999999999999754 48
Q ss_pred eEEccccccccCCCCCCcc--cccccccCccccCcccccC-------CCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 215 PKLSDFGLAKFGPTGDKSH--VSTRVMGTHGYCAPEYATT-------GKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 215 ~kl~Dfg~a~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
+||+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 9999999998654332211 1234579999999999865 568899999999999999999 99999766443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=310.67 Aligned_cols=195 Identities=26% Similarity=0.395 Sum_probs=167.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECC-CCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCe----
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAE-TGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQ---- 143 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~---- 143 (299)
..++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.+++.++||||+++++++...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 34789999999999999999999975 789999999875432 223568899999999999999999999977655
Q ss_pred -eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccc
Q 022309 144 -RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL 222 (299)
Q Consensus 144 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~ 222 (299)
.|+||||++|++|.+++. ..+++.+++.++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+
T Consensus 158 ~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTT
T ss_pred eeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEeccc
Confidence 699999999999988763 26899999999999999999999999 9999999999999985 899999999
Q ss_pred cccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCC
Q 022309 223 AKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDS 281 (299)
Q Consensus 223 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 281 (299)
+...... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||...
T Consensus 228 a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~ 279 (681)
T 2pzi_A 228 VSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGR 279 (681)
T ss_dssp CEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred chhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccc
Confidence 9864322 335699999999998665 488999999999999999999998653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=274.63 Aligned_cols=176 Identities=16% Similarity=0.142 Sum_probs=155.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH---HHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
.++|++.+.||+|+||.||+|.+..+++.||+|++........ ..+.+|+.++..++||||+++++++.+++..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 4679999999999999999999999999999999986644332 5788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||++|++|.+++.. . ....++..++.|++.||+|||++| |+||||||+|||++.++.++|+++|
T Consensus 110 ~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------
Confidence 999999999999842 2 356678999999999999999999 9999999999999999999998543
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
|++ .++.++|||||||++|+|++|..||...+..
T Consensus 175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~ 208 (286)
T 3uqc_A 175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVR 208 (286)
T ss_dssp ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBC
T ss_pred ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcc
Confidence 333 2688999999999999999999999876654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=292.23 Aligned_cols=202 Identities=27% Similarity=0.318 Sum_probs=159.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
..+|++.+.||+|+||+|+. ....+++.||||++..... ..+.+|+.+++.+ +||||+++++++.+....++|||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 34688999999999999664 3345789999999875432 2356799999998 79999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC-----CCceEEccccccc
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK-----GFHPKLSDFGLAK 224 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~-----~~~~kl~Dfg~a~ 224 (299)
++. ++|.+++... ...+.+.+++.++.||+.||.|||+++ |+||||||+|||++. ...++|+|||++.
T Consensus 99 ~~~-g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 99 LCA-ATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp CCS-EEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred CCC-CCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 996 5999999642 234455567899999999999999999 999999999999953 2357899999998
Q ss_pred cCCCCCCc-ccccccccCccccCcccccC---CCCCcccceehhHHHHHHHHh-CCCCCCCCch
Q 022309 225 FGPTGDKS-HVSTRVMGTHGYCAPEYATT---GKLTAKSDIFSFGVVLLELIT-GRPAMDDSQG 283 (299)
Q Consensus 225 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 283 (299)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.....
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~ 235 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ 235 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH
Confidence 65433211 22334679999999999974 567789999999999999999 8999965543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=269.70 Aligned_cols=179 Identities=26% Similarity=0.361 Sum_probs=153.7
Q ss_pred hcCCCCC-ceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHH-hhcCCCcceeeeeEEec----CCee
Q 022309 71 TDNFKDT-NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLML-SLMRHPNLVHLIGYCAE----GTQR 144 (299)
Q Consensus 71 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~~~~~~~~----~~~~ 144 (299)
.++|.++ +.||+|+||.||+|.+..+++.||+|++... ..+.+|+.++ +..+||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567777 7899999999999999999999999998542 4567788887 56699999999999876 6778
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC---CCceEEcccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK---GFHPKLSDFG 221 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~---~~~~kl~Dfg 221 (299)
++||||+++++|.+++... ....+++.+++.++.|++.||.|||+++ |+||||||+||+++. ++.++|+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 9999999999999999752 2346899999999999999999999999 999999999999998 7899999999
Q ss_pred ccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 222 LAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 222 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
++.... +..++.++|||||||++|+|++|.+||...+.
T Consensus 166 ~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 203 (299)
T 3m2w_A 166 FAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 203 (299)
T ss_dssp TCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---
T ss_pred cccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 986421 23467889999999999999999999976543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=285.96 Aligned_cols=203 Identities=21% Similarity=0.214 Sum_probs=157.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc---HHHHHHHHHHHhhcCC-Cccee--------------
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG---EKEFLVEVLMLSLMRH-PNLVH-------------- 133 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h-~nIv~-------------- 133 (299)
..|...+.||+|+||+||+|.+..+++.||||++....... .+.+.+|+.+++.+.| +|+..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 34777889999999999999999999999999987433222 4678899999999977 32211
Q ss_pred -------eeeEEec-----CCeeEEEEEecCCCCHHHHhccc---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 022309 134 -------LIGYCAE-----GTQRLLVYEYMPLGSLEDHLLGL---TPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVI 198 (299)
Q Consensus 134 -------~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~ 198 (299)
+..++.. ...++++|+.+ +++|.+++... ......+++..++.++.|++.||+|||+++ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 1111111 12356777765 67999888421 223456788899999999999999999999 99
Q ss_pred ecCCCCCCEEecCCCceEEccccccccCCCCCCcccccccccCccccCcccc----------cCCCCCcccceehhHHHH
Q 022309 199 YRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYA----------TTGKLTAKSDIFSFGVVL 268 (299)
Q Consensus 199 H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~DiwslG~il 268 (299)
||||||+|||++.++.+||+|||++..... .....+| +.|+|||++ .+..++.++|||||||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 999999999999999999999999875321 1334567 999999999 555688899999999999
Q ss_pred HHHHhCCCCCCCCchh
Q 022309 269 LELITGRPAMDDSQGH 284 (299)
Q Consensus 269 ~elltg~~pf~~~~~~ 284 (299)
|+|++|..||...+..
T Consensus 308 ~elltg~~Pf~~~~~~ 323 (413)
T 3dzo_A 308 YWIWCADLPNTDDAAL 323 (413)
T ss_dssp HHHHHSSCCCCTTGGG
T ss_pred HHHHHCCCCCCCcchh
Confidence 9999999999876553
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=282.26 Aligned_cols=185 Identities=18% Similarity=0.091 Sum_probs=130.7
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEcCCCCcc----------cHHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEEEE
Q 022309 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ----------GEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 80 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
.+.|++|.+..++..-.|+.|++|++.+.... ..+++.+|+.+|+++ .|+||+++++++.++...||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 45566666666666567889999999654211 124688999999999 7999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||++|++|.++|. ...++++. .|+.||+.||+|||++| |+||||||+|||++.+|.+||+|||+|+....
T Consensus 322 Eyv~G~~L~d~i~----~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLA----AGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHH----TTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHH----hCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999995 34566654 57899999999999999 99999999999999999999999999986432
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCC
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPA 277 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 277 (299)
. .......+||+.|+|||++.+. +..++|+||+|+++++|.+|..+
T Consensus 392 ~--~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 D--CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred C--CccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 2 2233456899999999999764 56789999999988877665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=248.36 Aligned_cols=186 Identities=17% Similarity=0.212 Sum_probs=144.5
Q ss_pred CCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--------HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 75 KDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--------EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 75 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
...+.||+|+||.||+|.. .+..+++|......... .+.+.+|+.+++.++||||+++..++...+..++
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 3456899999999999954 57889999865433221 2347899999999999999966555556677899
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
||||++|++|.+++.. +..++.|++.||+|||+++ |+||||||+|||++. .+||+|||+++..
T Consensus 417 VmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 417 MMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 9999999999999942 4689999999999999999 999999999999999 9999999999875
Q ss_pred CCCCCcc-----cccccccCccccCcccccC--CCCCcccceehhHHHHHHHHhCCCCCC
Q 022309 227 PTGDKSH-----VSTRVMGTHGYCAPEYATT--GKLTAKSDIFSFGVVLLELITGRPAMD 279 (299)
Q Consensus 227 ~~~~~~~-----~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~ 279 (299)
....... ......||+.|+|||++.. ..|+..+|+||..+-..+.+.++.+|.
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 3321111 1234679999999999977 568888999999999988888887774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.5e-28 Score=207.05 Aligned_cols=160 Identities=14% Similarity=0.026 Sum_probs=125.5
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc------------------cHHHHHHHHHHHhhcCCCc
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ------------------GEKEFLVEVLMLSLMRHPN 130 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~h~n 130 (299)
.....|.+.+.||+|+||.||+|.+ .+++.||+|+++..... ....+.+|+.+++.++ |
T Consensus 87 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~ 163 (282)
T 1zar_A 87 RSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G 163 (282)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred hCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence 3445677779999999999999999 78999999999643221 2346889999999998 4
Q ss_pred ceeeeeEEecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEec
Q 022309 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLG 210 (299)
Q Consensus 131 Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~ 210 (299)
+++.+++.. +..++||||++|++|.+ +. . .+...++.|++.||.|||+++ |+||||||+|||++
T Consensus 164 -~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~----~------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~ 227 (282)
T 1zar_A 164 -LAVPKVYAW-EGNAVLMELIDAKELYR-VR----V------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS 227 (282)
T ss_dssp -SSSCCEEEE-ETTEEEEECCCCEEGGG-CC----C------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred -CCcCeEEec-cceEEEEEecCCCcHHH-cc----h------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence 666665544 45699999999999988 41 1 234579999999999999999 99999999999999
Q ss_pred CCCceEEccccccccCCCCCCcccccccccCccccCcccccC----------CCCCcccceeh
Q 022309 211 KGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATT----------GKLTAKSDIFS 263 (299)
Q Consensus 211 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----------~~~~~~~Diws 263 (299)
++.++|+|||+|.. +..+.|||.+.. ..|+..+|+|.
T Consensus 228 -~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp -TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred -CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99999999999973 334688888743 34555666665
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-23 Score=176.76 Aligned_cols=137 Identities=16% Similarity=0.053 Sum_probs=108.0
Q ss_pred CCCCCceecccCceEEEEEEECCCCcE--EEEEEcCCCCccc------------------------HHHHHHHHHHHhhc
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQV--VAVKQLDDTGFQG------------------------EKEFLVEVLMLSLM 126 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~------------------------~~~~~~E~~~l~~l 126 (299)
-|++.+.||+|+||.||+|.+..+|+. ||||+++...... ...+.+|+.++..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999998778888 9999875432110 12578899999999
Q ss_pred CCCcc--eeeeeEEecCCeeEEEEEecCC-C----CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeE
Q 022309 127 RHPNL--VHLIGYCAEGTQRLLVYEYMPL-G----SLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLH-NKADPPVI 198 (299)
Q Consensus 127 ~h~nI--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH-~~~~~~i~ 198 (299)
.|++| +.+++. ...++||||+.+ | +|.+.... .++..+..++.|++.+|.||| +.+ |+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---iv 193 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---LV 193 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 88764 444443 356899999932 3 77776532 234567889999999999999 999 99
Q ss_pred ecCCCCCCEEecCCCceEEcccccccc
Q 022309 199 YRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 199 H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
||||||+|||++. .++|+|||+|..
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred eCCCCHHHEEEcC--cEEEEECccccc
Confidence 9999999999998 999999999975
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.81 E-value=9.7e-21 Score=166.47 Aligned_cols=136 Identities=13% Similarity=0.088 Sum_probs=97.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--------------cHHHH--------HHHHHHHhhcCCC
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--------------GEKEF--------LVEVLMLSLMRHP 129 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------------~~~~~--------~~E~~~l~~l~h~ 129 (299)
.-|++...||+|++|.||+|.+. +|+.||||+++..... ..... .+|...|..+.+.
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 34999999999999999999985 6899999987642110 01112 2344555555333
Q ss_pred cce--eeeeEEecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 022309 130 NLV--HLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNI 207 (299)
Q Consensus 130 nIv--~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Ni 207 (299)
++. ..+++ ...+|||||++|++|..+.. ...+..++.|++.+|.+||+.| ||||||||.||
T Consensus 174 gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~----------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NI 236 (397)
T 4gyi_A 174 GFPVPEPIAQ----SRHTIVMSLVDALPMRQVSS----------VPDPASLYADLIALILRLAKHG---LIHGDFNEFNI 236 (397)
T ss_dssp TCSCCCEEEE----ETTEEEEECCSCEEGGGCCC----------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred CCCCCeeeec----cCceEEEEecCCccHhhhcc----------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHE
Confidence 322 22222 12379999999988865431 1234578899999999999999 99999999999
Q ss_pred EecCCC----------ceEEcccccccc
Q 022309 208 LLGKGF----------HPKLSDFGLAKF 225 (299)
Q Consensus 208 lv~~~~----------~~kl~Dfg~a~~ 225 (299)
|+++++ .+.|+||+-+-.
T Consensus 237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 237 LIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred EEeCCCCcccccccccceEEEEeCCccc
Confidence 998776 389999998753
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=8.1e-15 Score=123.33 Aligned_cols=144 Identities=14% Similarity=0.037 Sum_probs=113.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcC-CCcceeeeeEEecCCeeEEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMR-HPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e 149 (299)
.+.|++...++.|+.+.||++.. .+..+++|............+.+|+.+++.+. +..+.++++++.+.+..|+|||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 35688888899999999999875 36789999986532223346888999999884 6778899999998889999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA------------------------------------ 193 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~------------------------------------ 193 (299)
+++|.+|.+.+. +......++.+++++|..||+..
T Consensus 91 ~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 91 EADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp CCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred ecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 999999987641 11223467889999999999810
Q ss_pred --------------------CCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 194 --------------------DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 194 --------------------~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
...++|+|++|.||+++.++.+.|+||+.+..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13389999999999998765567999998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.40 E-value=1.1e-12 Score=109.73 Aligned_cols=136 Identities=18% Similarity=0.104 Sum_probs=98.9
Q ss_pred CCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCc--ceeeeeEEecCCeeEEEEEec
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPN--LVHLIGYCAEGTQRLLVYEYM 151 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~~~~~~~~~~~~~lv~e~~ 151 (299)
|.+....+.|..+.||++.. .+|..+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++|||++
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp CEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 44333334566699999864 45778999987654 2245778999998885544 566888888878889999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 022309 152 PLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA-------------------------------------- 193 (299)
Q Consensus 152 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~-------------------------------------- 193 (299)
+|.+|. .. . .. ...++.+++..|..||+..
T Consensus 98 ~G~~l~--~~----~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 98 PGQDLL--SS----H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp SSEETT--TS----C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred CCcccC--cC----c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 998884 21 1 11 1256777888888888643
Q ss_pred -----------------CCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 194 -----------------DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 194 -----------------~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
...++|+|++|.||+++.++.+.|+|||.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776667999999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.37 E-value=2.6e-12 Score=113.05 Aligned_cols=143 Identities=12% Similarity=0.183 Sum_probs=106.7
Q ss_pred CCCceecccCceEEEEEEECCCCcEEEEEEcC--CCCc-ccHHHHHHHHHHHhhcC--CCcceeeeeEEecC---CeeEE
Q 022309 75 KDTNFLGQGGFGAVYKGKLAETGQVVAVKQLD--DTGF-QGEKEFLVEVLMLSLMR--HPNLVHLIGYCAEG---TQRLL 146 (299)
Q Consensus 75 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--h~nIv~~~~~~~~~---~~~~l 146 (299)
..++.|+.|.++.||++... +..+++|+.. .... .....+.+|+.+++.+. +..+++++.++.+. +..++
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 34678999999999998763 4678889776 3221 22356888999999886 45678899888766 34789
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA--------------------------------- 193 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--------------------------------- 193 (299)
|||+++|..+.+.. ...++..+...++.+++.+|..||+..
T Consensus 119 vme~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 99999987774321 134678888899999999999999731
Q ss_pred ----------------------CCCeEecCCCCCCEEecCCCc--eEEcccccccc
Q 022309 194 ----------------------DPPVIYRDLKAGNILLGKGFH--PKLSDFGLAKF 225 (299)
Q Consensus 194 ----------------------~~~i~H~dikp~Nilv~~~~~--~kl~Dfg~a~~ 225 (299)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999987653 68999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.30 E-value=1.3e-12 Score=112.20 Aligned_cols=185 Identities=17% Similarity=0.173 Sum_probs=122.6
Q ss_pred CceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcC-CCc--ceeeeeEEecCC---eeEEEEEe
Q 022309 77 TNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMR-HPN--LVHLIGYCAEGT---QRLLVYEY 150 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--Iv~~~~~~~~~~---~~~lv~e~ 150 (299)
++.++.|....||++. ..+++|+.... .....+.+|+.+++.+. +.. +.+++....... ..|+||++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 5678999999999853 45888986432 23467889999998873 333 445555543333 34899999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA------------------------------------- 193 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~------------------------------------- 193 (299)
++|.+|.+... ..++..+...++.|++..+..||+..
T Consensus 98 i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 98 IKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 99988875432 34667778888888998888888621
Q ss_pred ------------------CCCeEecCCCCCCEEecC--CCceEEccccccccCCCCCCcccccccccCccc---cCcccc
Q 022309 194 ------------------DPPVIYRDLKAGNILLGK--GFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGY---CAPEYA 250 (299)
Q Consensus 194 ------------------~~~i~H~dikp~Nilv~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y---~aPE~~ 250 (299)
.+.++|+|++|.||+++. ...+.|+||+.+........ .. ....+ ..|+..
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D---l~---~~~~~~~~~~~~~~ 245 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND---FI---SLMEDDEEYGMEFV 245 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH---HH---TTCCTTTSCCHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH---HH---HHHhhccccCHHHH
Confidence 134799999999999998 55678999999875321100 00 00001 122211
Q ss_pred cC--CCC------------CcccceehhHHHHHHHHhCCCCCCC
Q 022309 251 TT--GKL------------TAKSDIFSFGVVLLELITGRPAMDD 280 (299)
Q Consensus 251 ~~--~~~------------~~~~DiwslG~il~elltg~~pf~~ 280 (299)
.. ..| ....+.|++|.++|.+.+|.++|..
T Consensus 246 ~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 246 SKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp HHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred HHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence 10 001 1125899999999999999988743
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.91 E-value=1.3e-08 Score=87.32 Aligned_cols=137 Identities=18% Similarity=0.149 Sum_probs=96.8
Q ss_pred CceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCC---cceeeeeEEe-cCCeeEEEEEecC
Q 022309 77 TNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHP---NLVHLIGYCA-EGTQRLLVYEYMP 152 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~~~~~~~-~~~~~~lv~e~~~ 152 (299)
++.++.|....||+. +..+++|+.... .....+.+|+.+++.+.+. .+.+++.+.. ..+..++||++++
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~--~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQ--QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSH--HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCc--hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 456888888899987 456888875321 2345788999999998652 3566777664 4556789999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 022309 153 LGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA--------------------------------------- 193 (299)
Q Consensus 153 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--------------------------------------- 193 (299)
|.++.+... ..++..+...++.|+...|..||+..
T Consensus 97 G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 97 GQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp SEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 988876321 22355556666666666666666532
Q ss_pred ------------------CCCeEecCCCCCCEEecC---CCc-eEEccccccccC
Q 022309 194 ------------------DPPVIYRDLKAGNILLGK---GFH-PKLSDFGLAKFG 226 (299)
Q Consensus 194 ------------------~~~i~H~dikp~Nilv~~---~~~-~kl~Dfg~a~~~ 226 (299)
.+.++|+|++|.||+++. ++. +.|+||+.+...
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 223699999999999987 455 479999988753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.86 E-value=2.1e-08 Score=84.29 Aligned_cols=136 Identities=16% Similarity=0.109 Sum_probs=99.0
Q ss_pred eecccCce-EEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcC-CCcceeeeeEEecCCeeEEEEEecCCCCH
Q 022309 79 FLGQGGFG-AVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMR-HPNLVHLIGYCAEGTQRLLVYEYMPLGSL 156 (299)
Q Consensus 79 ~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e~~~~~~L 156 (299)
.+..|..| .||+......+..+++|.-... ....+.+|+.+|+.+. +--+.+++.++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34445554 6898877767778999976432 2356788999888774 33477889999888999999999999888
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 022309 157 EDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA------------------------------------------- 193 (299)
Q Consensus 157 ~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~------------------------------------------- 193 (299)
.+.... .......+..++...|.-||+..
T Consensus 108 ~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 776531 11223456667777777777531
Q ss_pred ------------CCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 194 ------------DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 194 ------------~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
.+.++|+|+.+.||+++.++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999877777999999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.68 E-value=4.1e-08 Score=85.94 Aligned_cols=81 Identities=6% Similarity=-0.038 Sum_probs=55.5
Q ss_pred Ccee-cccCceEEEEEEEC--C----CCcEEEEEEcCCCC---cccHHHHHHHHHHHhhcCC---CcceeeeeEEecC--
Q 022309 77 TNFL-GQGGFGAVYKGKLA--E----TGQVVAVKQLDDTG---FQGEKEFLVEVLMLSLMRH---PNLVHLIGYCAEG-- 141 (299)
Q Consensus 77 ~~~l-g~G~~g~V~~~~~~--~----~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h---~nIv~~~~~~~~~-- 141 (299)
.+.| +.|....+|+.... . ++..+++|...... ......+.+|+.+++.+.. -.+.+++.+..+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88888999987653 0 15678999765432 1112457788888887742 3577788887655
Q ss_pred -CeeEEEEEecCCCCHH
Q 022309 142 -TQRLLVYEYMPLGSLE 157 (299)
Q Consensus 142 -~~~~lv~e~~~~~~L~ 157 (299)
+..++|||+++|.++.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.59 E-value=3.1e-07 Score=81.61 Aligned_cols=76 Identities=14% Similarity=0.079 Sum_probs=49.5
Q ss_pred CceecccCceEEEEEEECCCCcEEEEEEcCCCCc-------ccHHHHHHHHHHHhhcCC--Cc-ceeeeeEEecCCeeEE
Q 022309 77 TNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-------QGEKEFLVEVLMLSLMRH--PN-LVHLIGYCAEGTQRLL 146 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~n-Iv~~~~~~~~~~~~~l 146 (299)
.+.||.|..+.||++....+++.+++|....... .....+..|..+++.+.. +. +.+++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 5679999999999997655678899998653211 122456778888887742 33 4456644 3345689
Q ss_pred EEEecCCC
Q 022309 147 VYEYMPLG 154 (299)
Q Consensus 147 v~e~~~~~ 154 (299)
|||++.|.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.46 E-value=2.5e-06 Score=73.85 Aligned_cols=142 Identities=18% Similarity=0.283 Sum_probs=78.2
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCC--Ccceeeee------EEecCCeeEEEEE
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRH--PNLVHLIG------YCAEGTQRLLVYE 149 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~~~~------~~~~~~~~~lv~e 149 (299)
+.|+.|..+.||++... +..+++|..... ...+..|..+++.+.. -.+++++. +....+..+++|+
T Consensus 38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEET--TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeC--CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 45666778899998763 345899988752 2334445555555431 12344443 1234567899999
Q ss_pred ecCCCCHH-----------HH---hcccCCCC-----C----C-CCHHH-------------------------------
Q 022309 150 YMPLGSLE-----------DH---LLGLTPEM-----K----P-LDWNT------------------------------- 174 (299)
Q Consensus 150 ~~~~~~L~-----------~~---l~~~~~~~-----~----~-~~~~~------------------------------- 174 (299)
|++|.++. .. ++...... . . -.+..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986532 11 11100000 0 0 01110
Q ss_pred HHHHHHHHHHHHHHHHh----------CCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 175 RMKIAAGAARGLEYLHN----------KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 175 ~~~i~~ql~~~l~~lH~----------~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
...+..++..++++|+. .....++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 11111223345666652 0123399999999999998888899999998864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.34 E-value=3.9e-06 Score=71.91 Aligned_cols=75 Identities=19% Similarity=0.126 Sum_probs=59.5
Q ss_pred CceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcC---CCcceeeeeEEecCCeeEEEEEecCC
Q 022309 77 TNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMR---HPNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
.+.|+.|....+|+... ++..+++|..... ....+..|+..|+.+. ...+++++.+....+..++|||+++|
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 46789999999999875 4678889976543 2456888988888873 36688899988888889999999998
Q ss_pred CCH
Q 022309 154 GSL 156 (299)
Q Consensus 154 ~~L 156 (299)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.20 E-value=1.3e-05 Score=67.77 Aligned_cols=78 Identities=21% Similarity=0.234 Sum_probs=55.9
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCC---CcceeeeeEEecCCeeEEEEE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRH---PNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~~~~~~~~~~~~~lv~e 149 (299)
...-++.+|.|..+.||+... .+|+.|++|+...........+..|+..|+.+.. --+++++.+. ..++|||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 344567899999999999886 4688999998765544444567889999988742 2345556543 2378999
Q ss_pred ecCCCC
Q 022309 150 YMPLGS 155 (299)
Q Consensus 150 ~~~~~~ 155 (299)
+++++.
T Consensus 91 ~l~~~~ 96 (288)
T 3f7w_A 91 WVDERP 96 (288)
T ss_dssp CCCCCC
T ss_pred eecccC
Confidence 988654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.20 E-value=1.2e-05 Score=71.96 Aligned_cols=74 Identities=15% Similarity=0.118 Sum_probs=46.2
Q ss_pred CCceecccCceEEEEEEECCCCcEEEEEEcCCCC---------cccHHHHHHHHHHHh-hcCCCcceeeeeEEecCCeeE
Q 022309 76 DTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG---------FQGEKEFLVEVLMLS-LMRHPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 76 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~-~l~h~nIv~~~~~~~~~~~~~ 145 (299)
.++.||.|..+.||++.. ++..++||...... ......+..|+..+. ......+++++.+. ....+
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 356789999999999864 56789999543210 012223344433332 22334667777765 45678
Q ss_pred EEEEec-CC
Q 022309 146 LVYEYM-PL 153 (299)
Q Consensus 146 lv~e~~-~~ 153 (299)
+|||++ +|
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 76
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.97 E-value=3.7e-05 Score=65.42 Aligned_cols=74 Identities=7% Similarity=0.023 Sum_probs=45.8
Q ss_pred CCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcc-eeeeeEEecCCeeEEEEEec-
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNL-VHLIGYCAEGTQRLLVYEYM- 151 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~e~~- 151 (299)
+.-++.|+.|....+|++ ..+++|+..... ....+...|+.+++.+...++ .+++... .+.-++++||+
T Consensus 20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~-~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGT-EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CCSCEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred ccceeEcCCcccccccee------eeEEEECCCCCc-cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 333778999999999998 458889876432 111234567777777643233 4555543 33347899999
Q ss_pred CCCCH
Q 022309 152 PLGSL 156 (299)
Q Consensus 152 ~~~~L 156 (299)
+|.++
T Consensus 91 ~g~~l 95 (301)
T 3dxq_A 91 GAQTM 95 (301)
T ss_dssp TCEEC
T ss_pred CCccC
Confidence 66544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.87 E-value=7.5e-05 Score=64.41 Aligned_cols=143 Identities=15% Similarity=0.062 Sum_probs=72.6
Q ss_pred ceecccCceE-EEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCC--CcceeeeeEEecCCeeEEEEEecCCC
Q 022309 78 NFLGQGGFGA-VYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRH--PNLVHLIGYCAEGTQRLLVYEYMPLG 154 (299)
Q Consensus 78 ~~lg~G~~g~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~~~~lv~e~~~~~ 154 (299)
+.|+.|.... +|+... .++..+++|....... ..+..|+.+++.+.. -.+.+++.+..+.+ +++||++.+.
T Consensus 24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp CC--------CCEEEEC-TTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 4565554444 666643 2366778886544321 234456666666632 23566776644333 6899999776
Q ss_pred CHHHHhccc---------------------CCC-CCCCCHHHHH-------H-H------------HHHHHHHHHHHH--
Q 022309 155 SLEDHLLGL---------------------TPE-MKPLDWNTRM-------K-I------------AAGAARGLEYLH-- 190 (299)
Q Consensus 155 ~L~~~l~~~---------------------~~~-~~~~~~~~~~-------~-i------------~~ql~~~l~~lH-- 190 (299)
++.+.+... ... ...+...... . + ...+...++.+-
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 665443210 000 1112221110 0 0 001111222221
Q ss_pred -hCCCCCeEecCCCCCCEEecCC----CceEEccccccccC
Q 022309 191 -NKADPPVIYRDLKAGNILLGKG----FHPKLSDFGLAKFG 226 (299)
Q Consensus 191 -~~~~~~i~H~dikp~Nilv~~~----~~~kl~Dfg~a~~~ 226 (299)
......++|||+.+.||+++.+ +.+.|+||+.+...
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1112349999999999999874 67899999998753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.86 E-value=0.00029 Score=60.29 Aligned_cols=144 Identities=10% Similarity=0.059 Sum_probs=76.7
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCc--ceeeeeE------EecCCeeEEEEE
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPN--LVHLIGY------CAEGTQRLLVYE 149 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~~~~~------~~~~~~~~lv~e 149 (299)
+.|+.|....+|+.... +..+++|...... ....+..|+.+++.+...+ +.+++.. ....+..+++++
T Consensus 28 ~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTT--KDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEECC---EEEEEEEES--SCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eccCCCcccceEEEEeC--CccEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 45677888899998763 2368899887531 2234556777776663222 3333321 122356789999
Q ss_pred ecCCCCHHH-----------H---hccc----CCCC-CCCC---HHHHHH------------HHHHHHHHHHHHHhC---
Q 022309 150 YMPLGSLED-----------H---LLGL----TPEM-KPLD---WNTRMK------------IAAGAARGLEYLHNK--- 192 (299)
Q Consensus 150 ~~~~~~L~~-----------~---l~~~----~~~~-~~~~---~~~~~~------------i~~ql~~~l~~lH~~--- 192 (299)
+++|..+.. . ++.. .... .... +..... +...+...++.+...
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 998864310 0 1110 0000 0011 111000 001133445555421
Q ss_pred -CCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 193 -ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 193 -~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
....++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 123489999999999999876568999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.75 E-value=6.3e-05 Score=67.40 Aligned_cols=73 Identities=18% Similarity=0.271 Sum_probs=49.6
Q ss_pred CceecccCceEEEEEEECC-------CCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcc-eeeeeEEecCCeeEEEE
Q 022309 77 TNFLGQGGFGAVYKGKLAE-------TGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNL-VHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~ 148 (299)
++.|+.|....+|++.... ++..+++|+..... ....+..|..+++.+...++ +++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4568888889999998643 25789999884321 12455678888888754344 566666542 3899
Q ss_pred EecCCCC
Q 022309 149 EYMPLGS 155 (299)
Q Consensus 149 e~~~~~~ 155 (299)
||++|.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9998643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00017 Score=63.46 Aligned_cols=144 Identities=19% Similarity=0.270 Sum_probs=83.6
Q ss_pred CceecccCceEEEEEEECC-------CCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCC-CcceeeeeEEecCCeeEEEE
Q 022309 77 TNFLGQGGFGAVYKGKLAE-------TGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRH-PNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~~~~~lv~ 148 (299)
++.|..|-...+|++.... +++.|++|+.... ......+.+|..+++.+.. .-..++++.+.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 4567778788899987642 3578999986432 2334567789998888743 223566666543 2899
Q ss_pred EecCCCCHHH--------------Hh---cccC-CCCCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 022309 149 EYMPLGSLED--------------HL---LGLT-PEMKPLD--WNTRMKIAAGAAR-------------------GLEYL 189 (299)
Q Consensus 149 e~~~~~~L~~--------------~l---~~~~-~~~~~~~--~~~~~~i~~ql~~-------------------~l~~l 189 (299)
||++|.+|.. .+ +... ....+.. +.++..+..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9998765421 11 1110 0111121 3455555544422 12232
Q ss_pred ----HhC-CCCCeEecCCCCCCEEecCC----CceEEcccccccc
Q 022309 190 ----HNK-ADPPVIYRDLKAGNILLGKG----FHPKLSDFGLAKF 225 (299)
Q Consensus 190 ----H~~-~~~~i~H~dikp~Nilv~~~----~~~kl~Dfg~a~~ 225 (299)
... ....++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 221 12348999999999999876 7899999998864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00075 Score=60.85 Aligned_cols=75 Identities=11% Similarity=0.019 Sum_probs=48.4
Q ss_pred CceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcc-eeeeeEEecCCeeEEEEEecCCCC
Q 022309 77 TNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNL-VHLIGYCAEGTQRLLVYEYMPLGS 155 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~e~~~~~~ 155 (299)
++.|+.|-...+|++.....+..+++|+..... ....+...|..+++.+...++ .++++.+. + .+|+||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 456788888999999875445789999875432 111223578888888865555 56776663 2 35999998754
Q ss_pred H
Q 022309 156 L 156 (299)
Q Consensus 156 L 156 (299)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00081 Score=57.58 Aligned_cols=75 Identities=12% Similarity=0.014 Sum_probs=47.5
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCC--cceeeeeE-----EecCCeeEEEEEe
Q 022309 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHP--NLVHLIGY-----CAEGTQRLLVYEY 150 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~~~~~-----~~~~~~~~lv~e~ 150 (299)
..++ |....||+... .+|+.+++|...... .....+..|..+++.+... .+++++.. ....+..+++|++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 4566 77788998754 346679999986432 2345667788877776422 24444443 1224556889999
Q ss_pred cCCCC
Q 022309 151 MPLGS 155 (299)
Q Consensus 151 ~~~~~ 155 (299)
++|.+
T Consensus 109 i~G~~ 113 (328)
T 1zyl_A 109 VGGRQ 113 (328)
T ss_dssp CCCEE
T ss_pred cCCCC
Confidence 98754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00021 Score=62.60 Aligned_cols=74 Identities=11% Similarity=0.017 Sum_probs=43.9
Q ss_pred CceecccCceEEEEEEECC--------CCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCc-ceeeeeEEecCCeeEEE
Q 022309 77 TNFLGQGGFGAVYKGKLAE--------TGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPN-LVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~lv 147 (299)
++.|+.|....+|++.... .+..+++|+..... ....+...|..+++.+...+ +.++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 4567778888999987643 12678899875432 11123466888887775333 44666554 2 2689
Q ss_pred EEecCCCC
Q 022309 148 YEYMPLGS 155 (299)
Q Consensus 148 ~e~~~~~~ 155 (299)
|+|++|.+
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.31 E-value=0.0026 Score=54.97 Aligned_cols=31 Identities=23% Similarity=0.308 Sum_probs=27.4
Q ss_pred CCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 195 ~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3499999999999999888899999988764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0012 Score=52.87 Aligned_cols=102 Identities=15% Similarity=0.068 Sum_probs=66.2
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcc
Q 022309 154 GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233 (299)
Q Consensus 154 ~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~ 233 (299)
-+|.++|.. ...+++++++|.++.|.+.+|.-+-...+ -..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc---------
Confidence 489998874 45899999999999999999877622111 11233467899999999987764 1111
Q ss_pred cccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCC
Q 022309 234 VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRP 276 (299)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 276 (299)
.....+.|||... ...+.+.=|||||+++|..+--..
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 0122367888763 344567789999999999886443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.33 E-value=0.017 Score=51.31 Aligned_cols=75 Identities=9% Similarity=0.034 Sum_probs=48.0
Q ss_pred CceecccCceEEEEEEECCC-------CcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCc-ceeeeeEEecCCeeEEEE
Q 022309 77 TNFLGQGGFGAVYKGKLAET-------GQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPN-LVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~lv~ 148 (299)
++.+..|-...+|+...... +..|++++..... ....+..+|..+++.+...+ ..++++.+. -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 45677777889999887521 5789999865432 22233467888887774323 445565432 27899
Q ss_pred EecCCCCH
Q 022309 149 EYMPLGSL 156 (299)
Q Consensus 149 e~~~~~~L 156 (299)
+|++|.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=92.36 E-value=0.45 Score=37.96 Aligned_cols=84 Identities=8% Similarity=0.058 Sum_probs=61.2
Q ss_pred CCCcceeeeeEEecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEecCCCCC
Q 022309 127 RHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLE-YLHNKADPPVIYRDLKAG 205 (299)
Q Consensus 127 ~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~-~lH~~~~~~i~H~dikp~ 205 (299)
.||++ -...-.+++.+.+.++.-+++.-...+ ..++..+.++++.+|+.... +++. -+|=-|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 68888 344446667777777765444333344 34678889999999888766 4442 567789999
Q ss_pred CEEecCCCceEEccccccc
Q 022309 206 NILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 206 Nilv~~~~~~kl~Dfg~a~ 224 (299)
|++++.++.++|.-.|+-.
T Consensus 114 NL~f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKE 132 (219)
T ss_dssp GEEECTTCCEEESCCEETT
T ss_pred eEEEeCCCcEEEEEcCCcc
Confidence 9999999999999887754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.00 E-value=0.51 Score=37.50 Aligned_cols=85 Identities=12% Similarity=0.082 Sum_probs=61.3
Q ss_pred CCCcceeeeeEEecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 022309 127 RHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGN 206 (299)
Q Consensus 127 ~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~N 206 (299)
.||+++.. .+-.+++.+.+.++.-+.+.-...+ ...+....++++.+|+....+++. =+|=-|.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence 68988877 5556666666666654422222223 456788999999999988855543 3677899999
Q ss_pred EEecCCCceEEccccccc
Q 022309 207 ILLGKGFHPKLSDFGLAK 224 (299)
Q Consensus 207 ilv~~~~~~kl~Dfg~a~ 224 (299)
++++.++.+++.--|+-.
T Consensus 110 L~f~~~~~p~i~~RGik~ 127 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQN 127 (215)
T ss_dssp EEECTTSCEEESCCEETT
T ss_pred EEEcCCCCEEEEEccCcc
Confidence 999999999998777754
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=89.78 E-value=0.032 Score=50.23 Aligned_cols=62 Identities=6% Similarity=0.078 Sum_probs=18.1
Q ss_pred CCCceecccCceEEEEEEECCCCcEEEE------EEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEe
Q 022309 75 KDTNFLGQGGFGAVYKGKLAETGQVVAV------KQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCA 139 (299)
Q Consensus 75 ~~~~~lg~G~~g~V~~~~~~~~~~~vav------K~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~ 139 (299)
.+.+.|| ||.||+|........||+ |..+...... ...+.+|+.+.+.++|||+++.+.+-.
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 4556776 999999998655567888 6554322222 245778888888899999999887653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.13 E-value=0.19 Score=44.16 Aligned_cols=29 Identities=31% Similarity=0.442 Sum_probs=24.8
Q ss_pred eEecCCCCCCEEe------cCCCceEEcccccccc
Q 022309 197 VIYRDLKAGNILL------GKGFHPKLSDFGLAKF 225 (299)
Q Consensus 197 i~H~dikp~Nilv------~~~~~~kl~Dfg~a~~ 225 (299)
++|+|+.+.||++ +++..+.++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999998864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 299 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-69 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-68 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-64 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-63 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-62 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-61 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-59 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-59 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-58 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-58 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-55 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-54 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-54 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-53 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-53 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-52 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-51 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-50 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-49 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-49 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-48 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-47 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-46 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-46 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-45 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-44 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-43 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-39 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-38 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-32 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-18 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 8e-69
Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 11/221 (4%)
Query: 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG-EKEFLVEVLMLSLMRH 128
D+F+ + LG G G V+K +G V+A K + + + E+ +L
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 129 PNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEY 188
P +V G + + E+M GSL+ L + + K++ +GL Y
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTY 119
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE 248
L K +++RD+K NIL+ KL DFG++ ++ +GT Y +PE
Sbjct: 120 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPE 173
Query: 249 YATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLV 289
+ +SDI+S G+ L+E+ GR + E L+
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 3e-68
Identities = 69/222 (31%), Positives = 107/222 (48%), Gaps = 15/222 (6%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHP 129
+G G FG VYKGK VAVK L+ T Q + F EV +L RH
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 130 NLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL 189
N++ +GY Q +V ++ SL HL + + + IA A+G++YL
Sbjct: 65 NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYL 120
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEY 249
H K +I+RDLK+ NI L + K+ DFGLA SH ++ G+ + APE
Sbjct: 121 HAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 250 ATT---GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288
+ +SD+++FG+VL EL+TG+ + ++++
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 219
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (511), Expect = 4e-64
Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 8/220 (3%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHP 129
++++ +G G +G K + G+++ K+LD ++ + EV +L ++HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 130 NLVHLIGYCAEGTQRLL--VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLE 187
N+V + T L V EY G L + T E + LD +++ L+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 188 YLHNKAD--PPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYC 245
H ++D V++RDLK N+ L + KL DFGLA+ + + +GT Y
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYM 181
Query: 246 APEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285
+PE KSDI+S G +L EL P E
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 221
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 4e-63
Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 9/223 (4%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLD-DTGFQGEKEFLVEVLMLSLMRHPN 130
+++ LG+G +G V T + VAVK +D + E+ + ++ H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLH 190
+V G+ EG + L EY G L D + + + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 191 NKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYA 250
+ +RD+K N+LL + + K+SDFGLA ++ + ++ GT Y APE
Sbjct: 121 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 251 TTGKL-TAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVDWV 292
+ D++S G+VL ++ G D + DW
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 220
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-62
Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 13/223 (5%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPN 130
D ++ LG G FG VYK + ET + A K +D + ++++VE+ +L+ HPN
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLH 190
+V L+ ++ E+ G+++ +L L +PL + + L YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLH 127
Query: 191 NKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYA 250
+ +I+RDLKAGNIL KL+DFG++ + +GT + APE
Sbjct: 128 DN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVV 182
Query: 251 -----TTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288
K+D++S G+ L+E+ P + +L
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL 225
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 2e-62
Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 14/217 (6%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMRH 128
++F+ LG+G FG VY + ++ ++A+K L E + EV + S +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 129 PNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEY 188
PN++ L GY + T+ L+ EY PLG++ L ++ D A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSY 121
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE 248
H+K VI+RD+K N+LLG K++DFG + P S T + GT Y PE
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPE 174
Query: 249 YATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285
K D++S GV+ E + G+P + + E
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 211
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 7e-62
Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 9/217 (4%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNL 131
+ K LG G FG V+ G VAVK L G FL E ++ ++H L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRL 70
Query: 132 VHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN 191
V L + ++ EYM GSL D L TP L N + +AA A G+ ++
Sbjct: 71 VRLYAVVTQE-PIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 192 KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYAT 251
+ I+RDL+A NIL+ K++DFGLA+ ++ + APE
Sbjct: 128 R---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAIN 183
Query: 252 TGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288
G T KSD++SFG++L E++T + ++
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 6e-61
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 10/215 (4%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNL 131
+ LG G FG V GK VA+K + + G E EF+ E ++ + H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKL 61
Query: 132 VHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN 191
V L G C + ++ EYM G L ++ L +++ +EYL +
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNY---LREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 192 KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYAT 251
K ++RDL A N L+ K+SDFGL+++ D+ S + PE
Sbjct: 119 K---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLM 174
Query: 252 TGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285
K ++KSDI++FGV++ E+ + G+ + E
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (489), Expect = 2e-60
Identities = 66/223 (29%), Positives = 100/223 (44%), Gaps = 19/223 (8%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMR 127
F D +G G FGAVY + +VVA+K++ +G Q ++ + EV L +R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 128 HPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLE 187
HPN + G LV EY + + + KPL + GA +GL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLA 129
Query: 188 YLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAP 247
YLH+ +I+RD+KAGNILL + KL DFG A + +GT + AP
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAP 180
Query: 248 EYATT---GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
E G+ K D++S G+ +EL +P + + +
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 192 bits (488), Expect = 3e-60
Identities = 66/242 (27%), Positives = 105/242 (43%), Gaps = 23/242 (9%)
Query: 61 TFTYRQLVAATDNF---------KDTNFLGQGGFGAVYKGKLAETGQ---VVAVKQLD-D 107
FT+ A F K +G G FG V G L G+ VA+K L
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 108 TGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEM 167
+ ++FL E ++ HPN++HL G + T +++ E+M GSL+ L
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF---LRQND 122
Query: 168 KPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227
+ + G A G++YL + ++RDL A NIL+ K+SDFGL++F
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 228 TGDKSHVSTRV---MGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQG 283
T + APE K T+ SD++S+G+V+ E+++ G D
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239
Query: 284 HE 285
+
Sbjct: 240 QD 241
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 7e-60
Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 17/216 (7%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGY 137
+G+G F VYKG ET VA +L D + F E ML ++HPN+V
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 138 CAEGTQR----LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA 193
+ +LV E M G+L+ +L K + +GL++LH +
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTR- 131
Query: 194 DPPVIYRDLKAGNILL-GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATT 252
PP+I+RDLK NI + G K+ D GLA ++ + V+GT + APE
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEMY-E 186
Query: 253 GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288
K D+++FG+ +LE+ T + Q ++
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 222
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (482), Expect = 2e-59
Identities = 62/243 (25%), Positives = 107/243 (44%), Gaps = 29/243 (11%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKL-----AETGQVVAVKQLDDTGFQG-EKEFLVEVLMLSL 125
+N + +G+G FG V++ + E +VAVK L + + +F E +++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 126 MRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEM------------------ 167
+PN+V L+G CA G L++EYM G L + L ++P
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 168 --KPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225
PL ++ IA A G+ YL ++RDL N L+G+ K++DFGL++
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 226 GPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285
+ D + PE + T +SD++++GVVL E+ + HE
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249
Query: 286 RML 288
++
Sbjct: 250 EVI 252
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-59
Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 9/217 (4%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNL 131
+G G FG V+ G VA+K + + G E++F+ E ++ + HP L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKL 62
Query: 132 VHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN 191
V L G C E LV+E+M G L D+L + T + + G+ YL
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLE- 118
Query: 192 KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYAT 251
+ VI+RDL A N L+G+ K+SDFG+ +F D+ ST + +PE +
Sbjct: 119 --EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFS 175
Query: 252 TGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288
+ ++KSD++SFGV++ E+ + +++ + ++
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 212
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 5e-59
Identities = 64/242 (26%), Positives = 100/242 (41%), Gaps = 24/242 (9%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKL-----AETGQVVAVKQLDDTGFQGEKE-FLVEVLMLS- 124
+ LG G FG V + ++ VAVK L + E+E + E+ +LS
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 125 LMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHL--------------LGLTPEMKPL 170
L H N+V+L+G C G L++ EY G L + L + + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 171 DWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230
D + + A+G+ +L +K I+RDL A NILL G K+ DFGLA+
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVD 290
V + APE T +SD++S+G+ L EL + + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 291 WV 292
+
Sbjct: 260 MI 261
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 188 bits (477), Expect = 8e-59
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 7/217 (3%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNL 131
+ + LG G +G VY+G + VAVK L + + E EFL E ++ ++HPNL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 75
Query: 132 VHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN 191
V L+G C ++ E+M G+L D+L + + + +A + +EYL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK 133
Query: 192 KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYAT 251
K I+RDL A N L+G+ K++DFGL++ GD + APE
Sbjct: 134 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA 189
Query: 252 TGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288
K + KSD+++FGV+L E+ T + ++
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 226
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 1e-58
Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 10/217 (4%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPN 130
+ +GQG G VY TGQ VA++Q++ ++ + E+L++ ++PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLH 190
+V+ + G + +V EY+ GSL D + +D + + LE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLH 133
Query: 191 NKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYA 250
+ VI+RD+K+ NILLG KL+DFG + + ++GT + APE
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGTPYWMAPEVV 188
Query: 251 TTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
T K DI+S G++ +E+I G P + +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 1e-58
Identities = 61/227 (26%), Positives = 107/227 (47%), Gaps = 13/227 (5%)
Query: 65 RQLVAATDNFKDTNF-LGQGGFGAVYKGKLAET--GQVVAVKQLDDTGFQGE-KEFLVEV 120
++L DN + LG G FG+V +G VA+K L + + +E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 121 LMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAA 180
++ + +P +V LIG C + +LV E G L L+G + + + + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLH 116
Query: 181 GAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF-GPTGDKSHVSTRVM 239
+ G++YL K ++RDL A N+LL + K+SDFGL+K G +
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 240 GTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285
+ APE K +++SD++S+GV + E ++ G+ +G E
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 220
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 3e-58
Identities = 60/230 (26%), Positives = 97/230 (42%), Gaps = 25/230 (10%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCA 139
+G+G FG V++GK G+ VAVK + E+ ++RH N++ I
Sbjct: 11 IGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 140 EG----TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA-- 193
+ TQ LV +Y GSL D+L + +K+A A GL +LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 194 ---DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK--SHVSTRVMGTHGYCAPE 248
P + +RDLK+ NIL+ K ++D GLA + +GT Y APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 249 YATT------GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVDWV 292
+ ++DI++ G+V E+ + ++ D V
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 4e-58
Identities = 63/248 (25%), Positives = 102/248 (41%), Gaps = 29/248 (11%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQ-----VVAVKQLDDTGFQGEKE-FLVEV-LMLS 124
+N + LG G FG V + VAVK L + E+E + E+ +M
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 125 LMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHL-------------------LGLTP 165
L H N+V+L+G C L++EY G L ++L L
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 166 EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225
++ L + + A A+G+E+L K ++RDL A N+L+ G K+ DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 226 GPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285
+ V + APE G T KSD++S+G++L E+ + +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 286 RMLVDWVT 293
+
Sbjct: 274 ANFYKLIQ 281
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 4e-58
Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 15/218 (6%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNL 131
K +G+G FG V G G VAVK + + + FL E +++ +RH NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNL 62
Query: 132 VHLIGYCAEGTQRL-LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLH 190
V L+G E L +V EYM GSL D+L + L + +K + +EYL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 191 NKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYA 250
++RDL A N+L+ + K+SDFGL K + S + APE
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEAL 172
Query: 251 TTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288
K + KSD++SFG++L E+ + + ++
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 210
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 6e-58
Identities = 56/219 (25%), Positives = 89/219 (40%), Gaps = 10/219 (4%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMRH 128
++FK LG+G F V + T + A+K L+ E E ++S + H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 129 PNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEY 188
P V L + + Y G L ++ ++ D A LEY
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 123
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE 248
LH +I+RDLK NILL + H +++DFG AK K + +GT Y +PE
Sbjct: 124 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 249 YATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
T SD+++ G ++ +L+ G P +
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 219
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 2e-56
Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 14/212 (6%)
Query: 80 LGQGGFGAVYKGKLA--ETGQVVAVKQLDDTGFQGE--KEFLVEVLMLSLMRHPNLVHLI 135
LG G FG V KG + + VAVK L + E L E ++ + +P +V +I
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 136 GYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADP 195
G C E +LV E LG L +L + + + +++ + G++YL
Sbjct: 75 GIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES--- 126
Query: 196 PVIYRDLKAGNILLGKGFHPKLSDFGLAK-FGPTGDKSHVSTRVMGTHGYCAPEYATTGK 254
++RDL A N+LL + K+SDFGL+K + T + APE K
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 255 LTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285
++KSD++SFGV++ E + G+ +G E
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 6e-56
Identities = 66/226 (29%), Positives = 111/226 (49%), Gaps = 14/226 (6%)
Query: 66 QLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQV----VAVKQL-DDTGFQGEKEFLVEV 120
+++ T+ FK LG G FG VYKG G+ VA+K+L + T + KE L E
Sbjct: 4 RILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62
Query: 121 LMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAA 180
+++ + +P++ L+G C T +L + + MP G L D++ + +
Sbjct: 63 YVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYV---REHKDNIGSQYLLNWCV 118
Query: 181 GAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMG 240
A+G+ YL ++ +++RDL A N+L+ H K++DFGLAK +K + +
Sbjct: 119 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175
Query: 241 THGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285
+ A E T +SD++S+GV + EL+T G D E
Sbjct: 176 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 2e-55
Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 22/233 (9%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETG--QVVAVKQLDDTGF-QGEKEFLVEV-LMLSLMR 127
++ K + +G+G FG V K ++ + G A+K++ + ++F E+ ++ L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 128 HPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLG------------LTPEMKPLDWNTR 175
HPN+++L+G C L EY P G+L D L L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 176 MKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVS 235
+ AA ARG++YL K I+RDL A NIL+G+ + K++DFGL++ K
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---K 183
Query: 236 TRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288
T + A E T SD++S+GV+L E+++ +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-55
Identities = 71/217 (32%), Positives = 105/217 (48%), Gaps = 9/217 (4%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNL 131
++ + LGQG FG V+ G T +V A+K L G + FL E ++ +RH L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKP-GTMSPEAFLQEAQVMKKLRHEKL 74
Query: 132 VHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN 191
V L +E +V EYM GSL D L G K L + +AA A G+ Y+
Sbjct: 75 VQLYAVVSEE-PIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 192 KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYAT 251
++RDL+A NIL+G+ K++DFGLA+ ++ + APE A
Sbjct: 132 M---NYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAAL 187
Query: 252 TGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288
G+ T KSD++SFG++L EL T + +L
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 224
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 1e-54
Identities = 67/210 (31%), Positives = 101/210 (48%), Gaps = 15/210 (7%)
Query: 73 NFKDTNFLGQGGFGAVYKGKLAE---TGQVVAVKQLDDTGFQGE-KEFLVEVLMLSLMRH 128
+F + +G+G FG VY G L + AVK L+ GE +FL E +++ H
Sbjct: 30 HFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 129 PNLVHLIGYCAEG-TQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLE 187
PN++ L+G C L+V YM G L + + E + A+G++
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMK 144
Query: 188 YLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF--GPTGDKSHVSTRVMGTHGYC 245
+L +K ++RDL A N +L + F K++DFGLA+ D H T +
Sbjct: 145 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 246 APEYATTGKLTAKSDIFSFGVVLLELITGR 275
A E T K T KSD++SFGV+L EL+T
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRG 231
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (450), Expect = 4e-54
Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 11/218 (5%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNL 131
D++ LG G FG V++ TG A K + ++ E+ +S++RHP L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 132 VHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN 191
V+L + + +++YE+M G L + + E + + ++ +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 192 KADPPVIYRDLKAGNILLG--KGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEY 249
++ DLK NI+ + KL DFGL V GT + APE
Sbjct: 143 N---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEV 196
Query: 250 ATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
A + +D++S GV+ L++G E +
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL 234
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 176 bits (447), Expect = 1e-53
Identities = 47/218 (21%), Positives = 90/218 (41%), Gaps = 11/218 (5%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNL 131
D + LG G FG V++ TG+V K ++ + E+ +++ + HP L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 132 VHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN 191
++L + + +L+ E++ G L D + E + + A GL+++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 192 KADPPVIYRDLKAGNILL--GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEY 249
+++ D+K NI+ K K+ DFGLA + T + APE
Sbjct: 146 H---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEFAAPEI 199
Query: 250 ATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
+ +D+++ GV+ L++G E +
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL 237
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-53
Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 12/223 (5%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQ----VVAVKQLDDTGFQGEK-EFLVEVLMLSLM 126
+G G FG VYKG L + VA+K L + ++ +FL E ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 127 RHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGL 186
H N++ L G ++ +++ EYM G+L+ L + + + G A G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGM 123
Query: 187 EYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK-FGPTGDKSHVSTRVMGTHGYC 245
+YL N ++RDL A NIL+ K+SDFGL++ + ++ ++ +
Sbjct: 124 KYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 246 APEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288
APE + K T+ SD++SFG+V+ E++T + ++
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM 223
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 175 bits (445), Expect = 4e-53
Identities = 73/235 (31%), Positives = 109/235 (46%), Gaps = 18/235 (7%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---QGEKEFLVEVLMLSLMR- 127
++F +G+GGFG VY + A+TG++ A+K LD QGE L E +MLSL+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 128 --HPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARG 185
P +V + + + + M G L HL + AA G
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILG 119
Query: 186 LEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYC 245
LE++HN+ V+YRDLK NILL + H ++SD GLA +GTHGY
Sbjct: 120 LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYM 172
Query: 246 APEYATTGK-LTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVDWVTLFFCMH 299
APE G + +D FS G +L +L+ G + ++ +D +TL +
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 227
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 171 bits (435), Expect = 1e-52
Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 15/226 (6%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMR 127
+D ++ LG GG V+ + + VAVK L + F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 128 HPNLVHLIGYCAE----GTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAA 183
HP +V + G +V EY+ +L D + P+ +++ A A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADAC 121
Query: 184 RGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK-FGPTGDKSHVSTRVMGTH 242
+ L + H +I+RD+K NI++ K+ DFG+A+ +G+ + V+GT
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 243 GYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288
Y +PE A + A+SD++S G VL E++TG P
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY 224
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 1e-52
Identities = 67/224 (29%), Positives = 94/224 (41%), Gaps = 15/224 (6%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAET---GQVVAVKQLDDTGF---QGEKEFLVEVLMLSL 125
+ + LG G FG V +G+ VAVK L + +F+ EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 126 MRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARG 185
+ H NL+ L G ++ V E PLGSL D L T + A A G
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEG 123
Query: 186 LEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHV-STRVMGTHGY 244
+ YL +K I+RDL A N+LL K+ DFGL + P D +V +
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 245 CAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHERM 287
CAPE T + SD + FGV L E+ T G+ G + +
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL 224
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 3e-52
Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 13/219 (5%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLA---ETGQVVAVKQLDDTGFQGEKE-FLVEVLMLSLMR 127
+ + +G+G FG V++G VA+K + +E FL E L +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 128 HPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLE 187
HP++V LIG E ++ E LG L L LD + + A + L
Sbjct: 67 HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALA 122
Query: 188 YLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAP 247
YL +K ++RD+ A N+L+ KL DFGL+++ + +++ + AP
Sbjct: 123 YLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAP 178
Query: 248 EYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285
E + T+ SD++ FGV + E++ G + ++
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 217
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 5e-52
Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 15/229 (6%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKL-----AETGQVVAVKQLDDTGFQGEK-EFLVEVLMLSL 125
+ + LGQG FG VY+G E VA+K +++ E+ EFL E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 126 MRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHL------LGLTPEMKPLDWNTRMKIA 179
++V L+G ++G L++ E M G L+ +L + P + P + +++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 180 AGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVM 239
A G+ YL+ ++RDL A N ++ + F K+ DFG+ + D + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 240 GTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288
+ +PE G T SD++SFGVVL E+ T +E++L
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 245
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (425), Expect = 7e-51
Identities = 53/225 (23%), Positives = 88/225 (39%), Gaps = 8/225 (3%)
Query: 64 YRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG-EKEFLVEVLM 122
++Q D + + LG G F V + T ++VA+K + +G E E+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 123 LSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGA 182
L ++HPN+V L G L+ + + G L D ++ E ++
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQV 116
Query: 183 ARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTH 242
++YLH+ + L + +SDFGL+K D V + GT
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTP 173
Query: 243 GYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
GY APE + D +S GV+ L+ G P D +
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF 218
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 1e-50
Identities = 69/220 (31%), Positives = 97/220 (44%), Gaps = 13/220 (5%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE---FLVEVLMLSL-MR 127
++F LG+G FG V+ + +T Q A+K L + + +VE +LSL
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 128 HPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLE 187
HP L H+ V EY+ G L H+ D + AA GL+
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQ 117
Query: 188 YLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAP 247
+LH+K ++YRDLK NILL K H K++DFG+ K GD GT Y AP
Sbjct: 118 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAP 172
Query: 248 EYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
E K D +SFGV+L E++ G+ E
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 212
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 8e-50
Identities = 38/218 (17%), Positives = 90/218 (41%), Gaps = 12/218 (5%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNL 131
+ + LG+G FG V++ + + K + G + E+ +L++ RH N+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNI 63
Query: 132 VHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN 191
+HL + ++++E++ + + + L+ + L++LH+
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFER---INTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 192 KADPPVIYRDLKAGNILLG--KGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEY 249
+ + D++ NI+ + K+ +FG A+ GD + + Y APE
Sbjct: 121 H---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEV 174
Query: 250 ATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
++ +D++S G ++ L++G + +
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-49
Identities = 62/241 (25%), Positives = 102/241 (42%), Gaps = 23/241 (9%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLA-----ETGQVVAVKQLDDTGFQGE-KEFLVEVLMLSL 125
D K LG+G FG V + T + VAVK L + E + + E+ +L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 126 MRH-PNLVHLIGYCAE-GTQRLLVYEYMPLGSLEDHLLGLTPEMKP------------LD 171
+ H N+V+L+G C + G +++ E+ G+L +L E P L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 172 WNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231
+ + A+G+E+L ++ I+RDL A NILL + K+ DFGLA+
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 232 SHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVDW 291
+ APE T +SD++SFGV+L E+ + + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249
Query: 292 V 292
+
Sbjct: 250 L 250
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 163 bits (414), Expect = 1e-49
Identities = 62/232 (26%), Positives = 95/232 (40%), Gaps = 26/232 (11%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF---------QGEKEFLVEV-L 121
+N++ LG+G V + T + AVK +D TG + + L EV +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 122 MLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAG 181
+ + HPN++ L T LV++ M G L D+L E L KI
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRA 118
Query: 182 AARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGT 241
+ LH +++RDLK NILL + KL+DFG + G+K V GT
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGT 172
Query: 242 HGYCAPEYATTG------KLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
Y APE + D++S GV++ L+ G P + +
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 224
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 8e-49
Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 24/238 (10%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAET-------GQVVAVKQLD-DTGFQGEKEFLVEV-LM 122
D LG+G FG V + VAVK L D + + + E+ +M
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 123 LSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEM------------KPL 170
+ +H N+++L+G C + ++ EY G+L ++L P + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 171 DWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230
+ A ARG+EYL I+RDL A N+L+ + K++DFGLA+ D
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288
+T + APE T +SD++SFGV+L E+ T + E +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 162 bits (411), Expect = 1e-48
Identities = 66/219 (30%), Positives = 99/219 (45%), Gaps = 15/219 (6%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE---FLVEVLMLSLMRH 128
+F+ LG G FG V+ + G+ A+K L K+ E LMLS++ H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 129 PNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEY 188
P ++ + G + Q ++ +Y+ G L + + AA LEY
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSL----LRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE 248
LH +IYRDLK NILL K H K++DFG AK+ P V+ + GT Y APE
Sbjct: 120 LH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPE 171
Query: 249 YATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
+T D +SFG+++ E++ G DS +
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 210
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 4e-47
Identities = 57/225 (25%), Positives = 98/225 (43%), Gaps = 7/225 (3%)
Query: 66 QLVAATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE-KEFLVEVLMLS 124
Q+ + + +++G+G +G V VA+K++ Q + L E+ +L
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 125 LMRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAAR 184
RH N++ + T + Y+ + L L + + L + R
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILR 120
Query: 185 GLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF-GPTGDKSHVSTRVMGTHG 243
GL+Y+H+ V++RDLK N+LL K+ DFGLA+ P D + T + T
Sbjct: 121 GLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 244 YCAPEYATTGKL-TAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
Y APE K T DI+S G +L E+++ RP +++
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 222
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 1e-46
Identities = 54/223 (24%), Positives = 98/223 (43%), Gaps = 17/223 (7%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNL 131
++ DT +G G FG VY+ KL ++G++VA+K++ Q ++ E+ ++ + H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNI 75
Query: 132 VHLIGYCAEGTQR------LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARG 185
V L + ++ LV +Y+P + + L R
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQLFRS 134
Query: 186 LEYLHNKADPPVIYRDLKAGNILL-GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGY 244
L Y+H+ + +RD+K N+LL KL DFG AK G+ + + + +
Sbjct: 135 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYYR 189
Query: 245 CAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
T+ D++S G VL EL+ G+P G +++
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-46
Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 15/216 (6%)
Query: 78 NFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE-----FLVEVLMLSLMRHPNLV 132
+FLG+G F VYK + T Q+VA+K++ K+ L E+ +L + HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 133 HLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK 192
L+ + LV+++M D + + L + +GLEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 193 ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATT 252
+++RDLK N+LL + KL+DFGLAK G + T + T Y APE
Sbjct: 120 ---WILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPELLFG 174
Query: 253 GKL-TAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
++ D+++ G +L EL+ P + +++
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL 210
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 4e-46
Identities = 56/226 (24%), Positives = 90/226 (39%), Gaps = 20/226 (8%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE------KEFLVEVLMLSL 125
D + LG G F V K + TG A K + + ++ EV +L
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 126 MRHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARG 185
++HPN++ L T +L+ E + G L D E + L + G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDF----LAEKESLTEEEATEFLKQILNG 125
Query: 186 LEYLHNKADPPVIYRDLKAGNILL----GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGT 241
+ YLH+ + + DLK NI+L K+ DFGLA G++ + GT
Sbjct: 126 VYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGT 179
Query: 242 HGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
+ APE L ++D++S GV+ L++G E +
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 225
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-45
Identities = 51/216 (23%), Positives = 81/216 (37%), Gaps = 21/216 (9%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEV-LMLSLMRHPNLVHLIGYC 138
LG G G V + T + A+K L D + EV L + P++V ++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVY 74
Query: 139 ----AEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKAD 194
A L+V E + G L + + +I ++YLH+
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN- 131
Query: 195 PPVIYRDLKAGNILL---GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYAT 251
+ +RD+K N+L KL+DFG AK + + T Y APE
Sbjct: 132 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVLG 186
Query: 252 TGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
K D++S GV++ L+ G P + G
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS 222
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 3e-45
Identities = 49/218 (22%), Positives = 92/218 (42%), Gaps = 9/218 (4%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHP 129
+NF+ +G+G +G VYK + TG+VVA+K++ + E+ +L + HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 130 NLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL 189
N+V L+ + LV+E++ + + + +GL +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEY 249
H+ V++RDLK N+L+ KL+DFGLA+ + + V+
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEIL 174
Query: 250 ATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
+ DI+S G + E++T R +++
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (380), Expect = 3e-44
Identities = 48/225 (21%), Positives = 85/225 (37%), Gaps = 18/225 (8%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNL 131
+ ++ +G G FG +Y G G+ VA+K + +E + +M+
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVG 64
Query: 132 VHLIGYC-AEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLH 190
+ I +C AEG ++V E + + + T + +A +EY+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIH 120
Query: 191 NKADPPVIYRDLKAGNIL---LGKGFHPKLSDFGLAKF-----GPTGDKSHVSTRVMGTH 242
+K I+RD+K N L KG + DFGLAK + + GT
Sbjct: 121 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 243 GYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
Y + + + + D+ S G VL+ G + +
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR 222
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-43
Identities = 62/217 (28%), Positives = 86/217 (39%), Gaps = 12/217 (5%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKE---FLVEVLMLSLMRH 128
++F LG+G FG V + TG+ A+K L + E + E +L RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 129 PNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEY 188
P L L + V EY G L HL + A LEY
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEY 120
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE 248
LH V+YRD+K N++L K H K++DFGL K G + + GT Y APE
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPE 175
Query: 249 YATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285
D + GVV+ E++ GR +
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 2e-43
Identities = 48/213 (22%), Positives = 80/213 (37%), Gaps = 20/213 (9%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVKQL------DDTGFQGEKEFLVEVLMLSLMR--HPNL 131
LG GGFG+VY G VA+K + D +EV++L + +
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 132 VHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN 191
+ L+ + +L+ E + E L + + HN
Sbjct: 72 IRLLDWFERPDSFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHN 128
Query: 192 KADPPVIYRDLKAGNILL-GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYA 250
V++RD+K NIL+ KL DFG K V T GT Y PE+
Sbjct: 129 C---GVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTRVYSPPEWI 181
Query: 251 TTGKLTAKS-DIFSFGVVLLELITGRPAMDDSQ 282
+ +S ++S G++L +++ G + +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-43
Identities = 55/226 (24%), Positives = 95/226 (42%), Gaps = 14/226 (6%)
Query: 70 ATDNFKDTNFLGQGGFGAVYKGK-LAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLM 126
A ++ +G+G +G V+K + L G+ VA+K++ + + EV +L +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 127 ---RHPNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMK--PLDWNTRMKIAAG 181
HPN+V L C + ++ L ++ + T +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 182 AARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGT 241
RGL++LH+ V++RDLK NIL+ KL+DFGLA+ T V+ T
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
Query: 242 HGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
Y APE D++S G + E+ +P S +++
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 224
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 148 bits (374), Expect = 2e-43
Identities = 40/227 (17%), Positives = 79/227 (34%), Gaps = 20/227 (8%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRH-PN 130
++K +G+G FG +++G Q VA+K + E L+
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTG 62
Query: 131 LVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLH 190
+ ++ + EG +LV + + + L + T A ++ +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 191 NKADPPVIYRDLKAGNILLGKGFHP-----KLSDFGLAKFGPTGDKS-----HVSTRVMG 240
K ++YRD+K N L+G+ + DFG+ KF + G
Sbjct: 119 EK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 241 THGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
T Y + + + + D+ + G V + + G +
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK 222
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (365), Expect = 1e-41
Identities = 64/251 (25%), Positives = 102/251 (40%), Gaps = 15/251 (5%)
Query: 38 ETPARRNTLDDTLSAHENKNKENTFTYRQLVAATDNFKDTNFLGQGGFGAVYKGKLAETG 97
+ + + ++ + L+ + + T Q A D F LG G FG V K E+G
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66
Query: 98 QVVAVKQLDDTGFQGEKE---FLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPLG 154
A+K LD K+ L E +L + P LV L + + +V EY+ G
Sbjct: 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 155 SLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFH 214
+ HL + AA EYLH+ +IYRDLK N+L+ + +
Sbjct: 127 EMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGY 179
Query: 215 PKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITG 274
+++DFG AK + + GT APE + D ++ GV++ E+ G
Sbjct: 180 IQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 275 RPAMDDSQGHE 285
P Q +
Sbjct: 235 YPPFFADQPIQ 245
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-41
Identities = 54/223 (24%), Positives = 96/223 (43%), Gaps = 20/223 (8%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHP 129
++ +GQG FG V+K + +TGQ VA+K++ + L E+ +L L++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 130 NLVHLIGYCAEGTQR--------LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAG 181
N+V+LI C LV+++ + + ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQM 125
Query: 182 AARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVS--TRVM 239
GL Y+H +++RD+KA N+L+ + KL+DFGLA+ S + T +
Sbjct: 126 LLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 240 GTHGYCAPEYATTGKL-TAKSDIFSFGVVLLELITGRPAMDDS 281
T Y PE + D++ G ++ E+ T P M +
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 225
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 142 bits (359), Expect = 2e-41
Identities = 45/218 (20%), Positives = 91/218 (41%), Gaps = 11/218 (5%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHP 129
+ + +G+G +G VYK + G+ A+K++ + E+ +L ++H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 130 NLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL 189
N+V L + +LV+E++ + + L+ T G+ Y
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYC 116
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEY 249
H D V++RDLK N+L+ + K++DFGLA+ + + ++
Sbjct: 117 H---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVL 172
Query: 250 ATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
+ K + DI+S G + E++ G P +++
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL 210
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-40
Identities = 51/207 (24%), Positives = 87/207 (42%), Gaps = 9/207 (4%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHP 129
++D +G G +GAV TG VA+K+L K E+ +L MRH
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 130 NLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL 189
N++ L+ ++ + LG + + L + + +GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEY 249
H +I+RDLK GN+ + + K+ DFGLA+ S ++ V+
Sbjct: 138 HAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYRAPEVI 190
Query: 250 ATTGKLTAKSDIFSFGVVLLELITGRP 276
+ T DI+S G ++ E+ITG+
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKT 217
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 1e-39
Identities = 49/219 (22%), Positives = 90/219 (41%), Gaps = 10/219 (4%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQL--DDTGFQGEKEFLVEVLMLSLMRHP 129
++ +G+G +G V+K K ET ++VA+K++ DD L E+ +L ++H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 130 NLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYL 189
N+V L + LV+E+ + LD +GL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYF----DSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 190 HNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEY 249
H++ V++RDLK N+L+ + KL++FGLA+ + + S V+
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVL 173
Query: 250 ATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288
+ D++S G + EL + + L
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 136 bits (343), Expect = 2e-38
Identities = 45/243 (18%), Positives = 92/243 (37%), Gaps = 24/243 (9%)
Query: 55 NKNKENTFTYRQLVAAT---DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ 111
+ Y V D+++ LG+G + V++ + V VK L
Sbjct: 15 THRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---V 71
Query: 112 GEKEFLVEV-LMLSLMRHPNLVHLIGYCAEGTQRL--LVYEYMPLGSLEDHLLGLTPEMK 168
+K+ E+ ++ +L PN++ L + R LV+E++ + +
Sbjct: 72 KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL-------YQ 124
Query: 169 PLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLG-KGFHPKLSDFGLAKFGP 227
L + L+Y H+ +++RD+K N+++ + +L D+GLA+F
Sbjct: 125 TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181
Query: 228 TGDKSHVSTRVMGTHGYCAPE-YATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286
G + + + + PE D++S G +L +I + +
Sbjct: 182 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 238
Query: 287 MLV 289
LV
Sbjct: 239 QLV 241
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 5e-35
Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 18/215 (8%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLA---ETGQVVAVKQLDDTGF----QGEKEFLVEVLMLS 124
+NF+ LG G +G V+ + +TG++ A+K L + + E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 125 LMRH-PNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAA 183
+R P LV L T+ L+ +Y+ G L HL + + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL----SQRERFTEHEVQIYVGEIV 139
Query: 184 RGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG 243
LE+LH +IYRD+K NILL H L+DFGL+K D++ + GT
Sbjct: 140 LALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIE 195
Query: 244 YCAPEYATTGK--LTAKSDIFSFGVVLLELITGRP 276
Y AP+ G D +S GV++ EL+TG
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 4e-34
Identities = 49/224 (21%), Positives = 86/224 (38%), Gaps = 21/224 (9%)
Query: 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHP 129
+++ +G G G V A + VA+K+L K E++++ + H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 130 NLVHLIGYCA------EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAA 183
N++ L+ E LV E M + LD +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------QMELDHERMSYLLYQML 129
Query: 184 RGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHG 243
G+++LH+ +I+RDLK NI++ K+ DFGLA+ S + T + T
Sbjct: 130 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRY 183
Query: 244 YCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
Y APE DI+S G ++ E++ + ++
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 227
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 7e-34
Identities = 48/208 (23%), Positives = 86/208 (41%), Gaps = 9/208 (4%)
Query: 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE--KEFLVEVLMLSLMRH 128
+ +++ + +G G +G+V +TG VAVK+L K E+ +L M+H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 129 PNLVHLIGYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEY 188
N++ L+ + + L L + + L + + RGL+Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 189 LHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPE 248
+H+ +I+RDLK N+ + + K+ DFGLA+ ++ V
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYVATRWYRAPEI 189
Query: 249 YATTGKLTAKSDIFSFGVVLLELITGRP 276
DI+S G ++ EL+TGR
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRT 217
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 120 bits (302), Expect = 2e-32
Identities = 46/234 (19%), Positives = 81/234 (34%), Gaps = 21/234 (8%)
Query: 72 DNFKDTNF-----LGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLM 126
+ +KD + LG G F V+ K VA+K + + E+ +L +
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRV 66
Query: 127 RHPNLVHLIGYCAEGTQRLLVYEY------------MPLGSLEDHLLGLTPEMKPLDWNT 174
+ A +LL + + L E + +
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126
Query: 175 RMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK-GFHPKLSDFGLAKFGPTGDKSH 233
+I+ GL+Y+H + +I+ D+K N+L+ L +A G
Sbjct: 127 VKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 184
Query: 234 VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287
T + T Y +PE +DI+S ++ ELITG + +GH
Sbjct: 185 HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 78.7 bits (193), Expect = 3e-18
Identities = 21/159 (13%), Positives = 49/159 (30%), Gaps = 30/159 (18%)
Query: 80 LGQGGFGAVYKGKLAETGQVVAVK----------QLDDTGFQGEKEFLVEVLMLSLMRHP 129
+G+G AV+ E VK ++ + G+ F V + +
Sbjct: 8 MGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 130 NLVHLIGYCA----EGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARG 185
L L G ++ E + E+ + ++
Sbjct: 67 ALQKLQGLAVPKVYAWEGNAVLMELIDAK-----------ELYRVRVENPDEVLDMILEE 115
Query: 186 LEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAK 224
+ +++ +++ DL N+L+ + + DF +
Sbjct: 116 VAKFYHR---GIVHGDLSQYNVLVSE-EGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 299 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.97 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.35 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.31 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.27 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.23 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.11 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-56 Score=378.77 Aligned_cols=214 Identities=26% Similarity=0.395 Sum_probs=185.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
.++|++++.||+|+||+||+|++..+++.||||++...... ..+.+.+|+.+++.++||||+++++++.+++..+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 46799999999999999999999999999999999754332 23568999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|++||+|.+++. ....+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ccCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 999999999984 4467999999999999999999999999 999999999999999999999999999865443
Q ss_pred CCcccccccccCccccCcccccCCCC-CcccceehhHHHHHHHHhCCCCCCCCchhhhhhHHH
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKL-TAKSDIFSFGVVLLELITGRPAMDDSQGHERMLVDW 291 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~ 291 (299)
.........+||+.|+|||++.+..+ +.++|||||||++|||++|.+||...+.....+..+
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~ 219 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 219 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 33334455789999999999988776 578999999999999999999998776655544443
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-55 Score=375.13 Aligned_cols=205 Identities=29% Similarity=0.449 Sum_probs=185.5
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEec
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYM 151 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 151 (299)
++|++++.||+|+||+||+|.+..+|+.||||++........+.+.+|+.+++.++||||+++++++.+++.+++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999999999999999997665556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCC
Q 022309 152 PLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231 (299)
Q Consensus 152 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~ 231 (299)
+||+|.+++.. ..+++.+++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|.......
T Consensus 100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~- 170 (293)
T d1yhwa1 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (293)
T ss_dssp TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred CCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence 99999998843 46899999999999999999999999 9999999999999999999999999998653322
Q ss_pred cccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 232 SHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
......+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+.
T Consensus 171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 224 (293)
T d1yhwa1 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224 (293)
T ss_dssp -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH
Confidence 223446799999999999999999999999999999999999999987765544
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-55 Score=368.00 Aligned_cols=203 Identities=32% Similarity=0.528 Sum_probs=182.0
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC---cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG---FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++++.||+|+||+||+|++..+++.||+|++.+.. ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 56999999999999999999999999999999986432 223467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||++||+|.+++. ...++++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|.....
T Consensus 86 Ey~~~g~L~~~l~----~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999995 3357999999999999999999999999 99999999999999999999999999975432
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
. ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+
T Consensus 159 ~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 211 (263)
T d2j4za1 159 S----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 211 (263)
T ss_dssp C----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred C----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH
Confidence 2 2234579999999999999999999999999999999999999998776544
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-55 Score=374.63 Aligned_cols=207 Identities=27% Similarity=0.390 Sum_probs=180.8
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC---cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG---FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++++.||+|+||+||+|++..+++.||||++.+.. ....+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999999999999999999999999986432 123356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||++||+|.+++. ....+++.+++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999885 3467999999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
..........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||...+..+
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~ 217 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 217 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH
Confidence 444444455679999999999999999999999999999999999999998876543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=369.81 Aligned_cols=207 Identities=28% Similarity=0.432 Sum_probs=183.1
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEec
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYM 151 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 151 (299)
+.|++++.||+|+||+||+|++..+++.||+|++........+.+.+|+.+++.++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56999999999999999999999999999999998766566678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCC
Q 022309 152 PLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231 (299)
Q Consensus 152 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~ 231 (299)
+||+|.+++.. ...++++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|..... .
T Consensus 92 ~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~ 163 (288)
T d2jfla1 92 AGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--T 163 (288)
T ss_dssp TTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH--H
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC--C
Confidence 99999998753 2357999999999999999999999999 99999999999999999999999999964311 1
Q ss_pred cccccccccCccccCccccc-----CCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 232 SHVSTRVMGTHGYCAPEYAT-----TGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
........||+.|+|||++. +..|+.++|||||||++|||+||.+||...+..+.
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~ 223 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV 223 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH
Confidence 11233467999999999984 45688999999999999999999999988776544
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-55 Score=368.11 Aligned_cols=212 Identities=27% Similarity=0.398 Sum_probs=172.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEec--CCeeEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAE--GTQRLLV 147 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~lv 147 (299)
++|++++.||+|+||+||+|++..+|+.||+|++....... .+.+.+|+.+++.++||||+++++++.+ +..+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999999999999999997654332 3568899999999999999999999864 4568999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA--DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
|||++||+|.+++.........+++.+++.++.||+.||+|||+++ ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998654344567999999999999999999999854 23499999999999999999999999999986
Q ss_pred CCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 226 GPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.... ........||+.|+|||++.+..|+.++|||||||++|||+||.+||...+..+
T Consensus 164 ~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~ 221 (269)
T d2java1 164 LNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 221 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH
Confidence 4322 222334679999999999999999999999999999999999999998776543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-54 Score=374.83 Aligned_cols=204 Identities=26% Similarity=0.369 Sum_probs=180.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc-ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF-QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
.++|++++.||+|+||+||+|++..+++.||+|+++.... .....+.+|+.+++.++|||||+++++|.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 5789999999999999999999999999999999975432 234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN-KADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
|++||+|.+++.. ...+++.++..++.|++.||.|||+ ++ |+||||||+|||++.++.+||+|||+|.....
T Consensus 85 y~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999953 3568999999999999999999997 48 99999999999999999999999999975321
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+..+
T Consensus 158 ----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~ 210 (322)
T d1s9ja_ 158 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210 (322)
T ss_dssp ----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTH
T ss_pred ----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 22334689999999999999999999999999999999999999998766543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=370.51 Aligned_cols=205 Identities=30% Similarity=0.398 Sum_probs=184.0
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC---cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG---FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++++.||+|+||+||+|++..+++.||+|++++.. ....+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 56999999999999999999999999999999997542 223466889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||++||+|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 9999999999985 3467899999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
. .......+||+.|+|||++.+..|+.++|||||||++|||++|.+||...+..+
T Consensus 158 ~--~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~ 212 (337)
T d1o6la_ 158 D--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212 (337)
T ss_dssp T--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred C--CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH
Confidence 2 223345689999999999999999999999999999999999999999887654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.2e-53 Score=370.10 Aligned_cols=206 Identities=25% Similarity=0.379 Sum_probs=184.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|++++.||+|+||.||+|++..+|+.||||++........+.+.+|+.+++.++|||||++++++.+++.++|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999999999999999999876656667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC--CCceEEccccccccCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK--GFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~--~~~~kl~Dfg~a~~~~~ 228 (299)
++||+|.+++.. ...++++.++..++.||+.||+|||++| |+||||||+|||++. ++.+||+|||+|.....
T Consensus 105 ~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999999853 3457999999999999999999999999 999999999999964 57899999999986432
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
. .......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+
T Consensus 179 ~---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 232 (350)
T d1koaa2 179 K---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 232 (350)
T ss_dssp T---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred c---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH
Confidence 2 22334679999999999999999999999999999999999999998776544
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-53 Score=366.81 Aligned_cols=205 Identities=27% Similarity=0.428 Sum_probs=167.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
.+.|++++.||+|+||+||+|++..+++.||||++.+.... ....+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 46799999999999999999999999999999999765433 23567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEec---CCCceEEccccccccC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLG---KGFHPKLSDFGLAKFG 226 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~---~~~~~kl~Dfg~a~~~ 226 (299)
|++||+|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+||++. +++.+||+|||+|+..
T Consensus 88 ~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999995 3467999999999999999999999999 99999999999995 5789999999999854
Q ss_pred CCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
... ......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+
T Consensus 161 ~~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~ 216 (307)
T d1a06a_ 161 DPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK 216 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cCC---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH
Confidence 322 22334679999999999999999999999999999999999999998776543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.4e-53 Score=369.67 Aligned_cols=207 Identities=23% Similarity=0.337 Sum_probs=185.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|++++.||+|+||+||+|.+..+|+.||||++..........+.+|+.+++.++||||+++++++.+++.+||||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999999999999999999876655567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEec--CCCceEEccccccccCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLG--KGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~--~~~~~kl~Dfg~a~~~~~ 228 (299)
++||+|.+.+.. ...++++.+++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||+|.....
T Consensus 108 ~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC
Confidence 999999988752 3457999999999999999999999999 99999999999997 568999999999986543
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
. .......||+.|+|||++.+..++.++|||||||++|+|+||.+||.+.+..+.
T Consensus 182 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~ 236 (352)
T d1koba_ 182 D---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET 236 (352)
T ss_dssp T---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred C---CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 2 223345799999999999999999999999999999999999999988765543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.9e-53 Score=365.67 Aligned_cols=202 Identities=33% Similarity=0.499 Sum_probs=181.7
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC---cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG---FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++++.||+|+||+||+|++..+|+.||||++++.. ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56999999999999999999999999999999986432 223467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+.|++|..++. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999999885 4467889999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||...+..+
T Consensus 157 -----~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 208 (316)
T d1fota_ 157 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 208 (316)
T ss_dssp -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred -----ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH
Confidence 2234679999999999999999999999999999999999999998876544
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.2e-53 Score=363.17 Aligned_cols=202 Identities=33% Similarity=0.498 Sum_probs=178.4
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH---HHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
+.|+.++.||+|+||+||+|++..+++.||||++........ +.+.+|+.+++.++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 359999999999999999999999999999999976543332 46889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+.+|+|..++. ...++++.+++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|.....
T Consensus 95 E~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999877664 3467999999999999999999999999 99999999999999999999999999985322
Q ss_pred CCCcccccccccCccccCcccccC---CCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATT---GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.
T Consensus 168 ------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~ 222 (309)
T d1u5ra_ 168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222 (309)
T ss_dssp ------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred ------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 234579999999999864 4589999999999999999999999987765543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=357.20 Aligned_cols=206 Identities=27% Similarity=0.371 Sum_probs=182.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc------cHHHHHHHHHHHhhcCCCcceeeeeEEecCCee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ------GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQR 144 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 144 (299)
.++|++++.||+|+||+||+|++..+|+.||||++.+.... ..+.+.+|+.+++.++|||||++++++.+++.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46799999999999999999999999999999998654322 246789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC----ceEEccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF----HPKLSDF 220 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~----~~kl~Df 220 (299)
+|||||++||+|.+++.. ...+++.+++.++.|++.||+|||+++ |+||||||+||+++.++ .+||+||
T Consensus 89 ~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence 999999999999999953 357999999999999999999999999 99999999999998776 5999999
Q ss_pred cccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 221 GLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 221 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
|+|....... ......||+.|+|||++.+..++.++|||||||++|||++|.+||...+..+.
T Consensus 162 G~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~ 224 (293)
T d1jksa_ 162 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 224 (293)
T ss_dssp TTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred hhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH
Confidence 9998653322 23345789999999999999999999999999999999999999988765543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-52 Score=353.71 Aligned_cols=207 Identities=33% Similarity=0.491 Sum_probs=172.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
.++|++.+.||+|+||+||+|+.. ..||||+++.... ...+.+.+|+.+++.++|||||++++++.+ +..++||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 467999999999999999999853 3599999975432 234678999999999999999999998765 5679999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+++|+|.+++.. ...++++.++..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 83 Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 83 QWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp ECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred ecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 99999999999963 3356999999999999999999999999 99999999999999999999999999986544
Q ss_pred CCCcccccccccCccccCcccccCC---CCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTG---KLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
...........||+.|+|||++.+. .|+.++|||||||++|||+||+.||.+.+..+.+
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~ 218 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH
Confidence 4333444556799999999998643 4788999999999999999999999887665544
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-52 Score=351.92 Aligned_cols=203 Identities=31% Similarity=0.463 Sum_probs=173.7
Q ss_pred CCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEec----CCeeEEEE
Q 022309 75 KDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAE----GTQRLLVY 148 (299)
Q Consensus 75 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~----~~~~~lv~ 148 (299)
++.++||+|+||+||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++.+ +..+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 5667899999999999999999999999998654322 23568899999999999999999999864 35679999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEec-CCCceEEccccccccCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLG-KGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~-~~~~~kl~Dfg~a~~~~ 227 (299)
||+++|+|.+++.. ...+++.+++.++.||+.||+|||+++ ++|+||||||+|||++ .++.+||+|||+|+...
T Consensus 92 E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999953 367899999999999999999999864 5599999999999996 57899999999998532
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
. ......+||+.|+|||++.+ .++.++|||||||++|||++|.+||...+..+.+
T Consensus 167 ~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~ 221 (270)
T d1t4ha_ 167 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI 221 (270)
T ss_dssp T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH
T ss_pred C----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH
Confidence 2 22335679999999999865 5999999999999999999999999876655443
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-52 Score=365.87 Aligned_cols=202 Identities=29% Similarity=0.374 Sum_probs=181.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC---cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG---FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 148 (299)
++|++++.||+|+||.||+|++..+|+.||||++.+.. ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999999999999999986432 223356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPT 228 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~ 228 (299)
||+.||+|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999953 357999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
......||+.|+|||++.+..++.++|||||||++|+|+||.+||...+..+
T Consensus 194 -----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 245 (350)
T d1rdqe_ 194 -----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245 (350)
T ss_dssp -----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH
Confidence 2234679999999999999999999999999999999999999998776543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-52 Score=357.31 Aligned_cols=209 Identities=29% Similarity=0.437 Sum_probs=181.7
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
..++|++.+.||+|+||+||+|.+..+++.||||+++... ...+.+.+|+.+++.++|||||++++++.+++..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 3467999999999999999999999999999999997654 445679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+++|+|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 94 ~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 94 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp CCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred cccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 99999999998642 3467899999999999999999999999 999999999999999999999999999865432
Q ss_pred CCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
. ........|++.|+|||++.+..|+.++|||||||++|||++|..||.......
T Consensus 169 ~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~ 223 (287)
T d1opja_ 169 T-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 223 (287)
T ss_dssp S-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred C-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH
Confidence 2 222333468899999999999999999999999999999999766654444333
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-51 Score=353.23 Aligned_cols=205 Identities=18% Similarity=0.289 Sum_probs=181.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|++++.||+|+||+||+|.+..+++.||+|+++... .+...+.+|+.+++.++||||+++++++.+++.+||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 467999999999999999999999999999999997653 3345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCC--CceEEccccccccCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKG--FHPKLSDFGLAKFGPT 228 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~--~~~kl~Dfg~a~~~~~ 228 (299)
++|++|.+++.. ...++++.+++.++.||+.||+|||+++ |+||||||+|||++.+ +.++|+|||++.....
T Consensus 83 ~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999999953 3347999999999999999999999999 9999999999999854 5899999999986433
Q ss_pred CCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 229 GDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
. .......+++.|+|||.+.+..|+.++|||||||++|+|++|.+||...+..+
T Consensus 157 ~---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~ 210 (321)
T d1tkia_ 157 G---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210 (321)
T ss_dssp T---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred C---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH
Confidence 2 22334578999999999999999999999999999999999999998877543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.5e-51 Score=348.76 Aligned_cols=209 Identities=27% Similarity=0.396 Sum_probs=175.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccH---HHHHHHHHHHhhcCCCcceeeeeEEecCC----e
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGE---KEFLVEVLMLSLMRHPNLVHLIGYCAEGT----Q 143 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~~~~~~~~----~ 143 (299)
.++|++.+.||+|+||+||+|.+..+++.||||++++....+. +.+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4779999999999999999999999999999999986554433 46889999999999999999999986543 4
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA 223 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a 223 (299)
+|+||||++|++|.+++. ...++++.+++.++.||+.||+|||+++ |+||||||+|||++.++..+|+|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence 789999999999999885 3367999999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCC-cccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 224 KFGPTGDK-SHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 224 ~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
........ .......+||+.|+|||++.+..++.++|||||||++|+|+||.+||...+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~ 222 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 222 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH
Confidence 75433222 2233446799999999999999999999999999999999999999988775543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-51 Score=354.29 Aligned_cols=205 Identities=33% Similarity=0.499 Sum_probs=179.4
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCC---cccHHHHHHHHHHHh-hcCCCcceeeeeEEecCCeeEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTG---FQGEKEFLVEVLMLS-LMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
++|++++.||+|+||+||+|++..+++.||||++++.. ....+.+..|..++. .++||||+++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999999999999999996532 122345666666654 68999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||++||+|.+++. ....+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 82 mEy~~~g~L~~~i~----~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999999995 3356899999999999999999999999 9999999999999999999999999998543
Q ss_pred CCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.. ........||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+
T Consensus 155 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~ 210 (320)
T d1xjda_ 155 LG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 210 (320)
T ss_dssp CT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cc--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH
Confidence 22 222334679999999999999999999999999999999999999998877554
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-51 Score=351.55 Aligned_cols=209 Identities=29% Similarity=0.468 Sum_probs=168.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCc---EEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQ---VVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
.++|++.+.||+|+||+||+|.+..+++ .||||.+...... ..+.+.+|+.+++.++|||||++++++.+++..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 3568889999999999999999976654 5899988765433 33679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
||||+++|+|.+++.. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 105 v~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEc
Confidence 9999999999998863 3457899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCccc---ccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 227 PTGDKSHV---STRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 227 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
........ .....||+.|+|||.+.+..++.++|||||||++|||+| |.+||.+.+..+
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~ 241 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH
Confidence 43222211 112457899999999999999999999999999999998 899998876543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-51 Score=355.63 Aligned_cols=213 Identities=28% Similarity=0.432 Sum_probs=179.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCc-----EEEEEEcCCCCc-ccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQ-----VVAVKQLDDTGF-QGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQ 143 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 143 (299)
.++|++.+.||+|+||+||+|++..+++ .||+|.+..... .....+.+|+.++..+ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4679999999999999999999865543 699998865432 3346788999999988 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTP-------------------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKA 204 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~-------------------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp 204 (299)
.++||||+++|+|.+++..... ....+++.+++.++.|++.||+|||+++ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999964321 1245899999999999999999999999 99999999
Q ss_pred CCEEecCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCch
Q 022309 205 GNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQG 283 (299)
Q Consensus 205 ~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 283 (299)
+|||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+.
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999986544433334445678999999999999999999999999999999998 8999987765
Q ss_pred hhh
Q 022309 284 HER 286 (299)
Q Consensus 284 ~~~ 286 (299)
.+.
T Consensus 273 ~~~ 275 (325)
T d1rjba_ 273 DAN 275 (325)
T ss_dssp SHH
T ss_pred HHH
Confidence 543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-51 Score=343.66 Aligned_cols=204 Identities=29% Similarity=0.468 Sum_probs=168.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|++++.||+|+||+||+|.+. +++.||||+++... ...+++.+|+.+++.++||||+++++++.+++..++||||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 357899999999999999999986 56789999997654 4457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+++|+|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 82 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp CTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred cCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC
Confidence 999999999863 4466889999999999999999999999 9999999999999999999999999997653322
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhC-CCCCCCCch
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITG-RPAMDDSQG 283 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~ 283 (299)
. .......||+.|+|||++.+..++.++|||||||++|||+|| .+||...+.
T Consensus 156 ~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~ 208 (263)
T d1sm2a_ 156 Y-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 208 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH
T ss_pred c-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH
Confidence 2 222335689999999999999999999999999999999995 666655443
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.4e-51 Score=358.67 Aligned_cols=203 Identities=32% Similarity=0.453 Sum_probs=175.0
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc---cHHHHHH---HHHHHhhcCCCcceeeeeEEecCCeeE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ---GEKEFLV---EVLMLSLMRHPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~---E~~~l~~l~h~nIv~~~~~~~~~~~~~ 145 (299)
++|++++.||+|+||.||+|++..+|+.||||++.+.... ....+.+ |+.+++.++|||||++++++.+++.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5799999999999999999999999999999998643221 1223334 466777778999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
+||||++||+|.+++. ....+++.+++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|..
T Consensus 84 ivmE~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHH----hcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999995 3467899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 226 GPTGDKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.... ......||+.|+|||++.+ ..|+.++|||||||++|||+||.+||...+..+
T Consensus 157 ~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 213 (364)
T d1omwa3 157 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 213 (364)
T ss_dssp CSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC
T ss_pred cCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH
Confidence 4322 2234579999999999864 568999999999999999999999998765543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=344.24 Aligned_cols=207 Identities=29% Similarity=0.455 Sum_probs=175.4
Q ss_pred cCCCCCce-ecccCceEEEEEEECC--CCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEE
Q 022309 72 DNFKDTNF-LGQGGFGAVYKGKLAE--TGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 72 ~~y~~~~~-lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 147 (299)
++|.+.+. ||+|+||+||+|.+.. ++..||||+++..... ..+.+.+|+.+++.++|||||++++++.++ ..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEE
Confidence 45777774 9999999999998754 4457999999765433 346789999999999999999999999764 57899
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCC
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGP 227 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~ 227 (299)
|||+++|+|.+++.. ....+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 87 mE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 999999999998752 3467999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCc-ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 228 TGDKS-HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 228 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
..... .......||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~ 220 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 220 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH
Confidence 33222 22234568999999999998999999999999999999998 999998776543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.1e-50 Score=340.45 Aligned_cols=205 Identities=30% Similarity=0.382 Sum_probs=180.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc---------HHHHHHHHHHHhhcC-CCcceeeeeEEec
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG---------EKEFLVEVLMLSLMR-HPNLVHLIGYCAE 140 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~-h~nIv~~~~~~~~ 140 (299)
.++|++.+.||+|+||+||+|++..+++.||||++++..... .+.+.+|+.+++.++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 468999999999999999999999999999999987643221 135788999999997 9999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccc
Q 022309 141 GTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDF 220 (299)
Q Consensus 141 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Df 220 (299)
++..||||||++||+|.+++. ...++++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred CcceEEEEEcCCCchHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccc
Confidence 999999999999999999995 3467999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccCccccCcccccC------CCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 221 GLAKFGPTGDKSHVSTRVMGTHGYCAPEYATT------GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 221 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
|++....... ......||+.|+|||.+.+ ..++.++||||+||++|+|++|.+||...+..+
T Consensus 155 G~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~ 222 (277)
T d1phka_ 155 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 222 (277)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred hheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH
Confidence 9998654322 2234579999999998853 347889999999999999999999999887544
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-50 Score=336.92 Aligned_cols=206 Identities=28% Similarity=0.425 Sum_probs=182.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|++++.||+|+||+||+|+++ +++.||||++++.. ...+++.+|+.+++.++||||+++++++.+++..++||||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 367999999999999999999985 67899999998654 3457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+++|+|.+++.. ....+++..++.++.|+++||+|||+++ |+||||||+||++++++.+||+|||+++......
T Consensus 81 ~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 81 MANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred cCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 999999999753 3467889999999999999999999999 9999999999999999999999999997643322
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
. .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...+..+
T Consensus 155 ~-~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~ 209 (258)
T d1k2pa_ 155 Y-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209 (258)
T ss_dssp C-CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH
T ss_pred c-eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH
Confidence 2 22333568999999999999999999999999999999998 899998887554
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=341.83 Aligned_cols=203 Identities=31% Similarity=0.450 Sum_probs=173.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|++++.||+|+||+||+|.+. ++..||||+++... ...+.+.+|+.+++.++|||||++++++.+ +..++||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 467999999999999999999985 57889999997653 445679999999999999999999998865 567899999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+++|+|.+++... ...++++.+++.++.||++||.|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 89 ~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 89 MENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 9999999987532 2235899999999999999999999999 9999999999999999999999999998654322
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCC-CCCCCCc
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGR-PAMDDSQ 282 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~ 282 (299)
........||+.|+|||++.+..++.++|||||||++|||+||. +||...+
T Consensus 164 -~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~ 215 (272)
T d1qpca_ 164 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215 (272)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred -cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC
Confidence 22233456899999999999889999999999999999999965 4555444
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=346.11 Aligned_cols=203 Identities=28% Similarity=0.385 Sum_probs=172.4
Q ss_pred CCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc-----HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 76 DTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG-----EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 76 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.+++||+|+||+||+|++..+|+.||||+++...... ...+.+|+.+++.++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4678999999999999999999999999997543222 24688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+.++++..+. .....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|.......
T Consensus 82 ~~~~~~~~~~----~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHT----TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhh----hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 9987776655 34567899999999999999999999999 9999999999999999999999999997643322
Q ss_pred CcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
......+||+.|+|||++.+. .|+.++|||||||++|||++|.+||...+..+.+
T Consensus 155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l 210 (299)
T d1ua2a_ 155 --RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL 210 (299)
T ss_dssp --CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred --ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHH
Confidence 223345799999999998654 5799999999999999999999999887765543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=351.23 Aligned_cols=200 Identities=27% Similarity=0.336 Sum_probs=172.6
Q ss_pred hcCCCCCc-eecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhh-cCCCcceeeeeEEec----CCee
Q 022309 71 TDNFKDTN-FLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSL-MRHPNLVHLIGYCAE----GTQR 144 (299)
Q Consensus 71 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~~~~~~~~----~~~~ 144 (299)
.++|+++. .||+|+||+||+|++..+++.||||+++.. ..+.+|+.++.+ ++||||++++++|.+ +..+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 36798875 599999999999999999999999998643 567789988654 589999999999865 4678
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC---CCceEEcccc
Q 022309 145 LLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK---GFHPKLSDFG 221 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~---~~~~kl~Dfg 221 (299)
|+|||||+||+|.+++... ...++++.+++.++.||+.||+|||+++ |+||||||+|||++. .+.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccc
Confidence 9999999999999999642 2357999999999999999999999999 999999999999985 5679999999
Q ss_pred ccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 222 LAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 222 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
+|+...... ......||+.|+|||++.+..|+.++|||||||++|+|+||.+||.+.+.
T Consensus 160 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~ 218 (335)
T d2ozaa1 160 FAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 218 (335)
T ss_dssp TCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTC
T ss_pred eeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCH
Confidence 998644322 22345799999999999999999999999999999999999999976543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=341.70 Aligned_cols=200 Identities=31% Similarity=0.471 Sum_probs=168.1
Q ss_pred ceecccCceEEEEEEEC--CCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEecCC
Q 022309 78 NFLGQGGFGAVYKGKLA--ETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEYMPL 153 (299)
Q Consensus 78 ~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 153 (299)
++||+|+||+||+|.+. .+++.||||+++...... .+.+.+|+.++++++|||||++++++.++ ..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 46999999999999864 456789999997543322 36789999999999999999999999654 56899999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCCcc
Q 022309 154 GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDKSH 233 (299)
Q Consensus 154 ~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~ 233 (299)
|+|.+++. ...++++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.........
T Consensus 92 g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999985 3467999999999999999999999999 9999999999999999999999999998654332222
Q ss_pred -cccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 234 -VSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 234 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
......||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~ 218 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH
Confidence 2234568999999999999999999999999999999998 899998876543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=341.65 Aligned_cols=207 Identities=27% Similarity=0.401 Sum_probs=175.7
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
++|++++.||+|+||+||+|++..+++.||||+++..... ..+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5799999999999999999999999999999999754332 23678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+.+ .+.+.+.. .....+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~-~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence 9975 44444432 24467999999999999999999999999 999999999999999999999999999764332
Q ss_pred CCcccccccccCccccCcccccCCC-CCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGK-LTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
. .......||+.|+|||++.... ++.++|||||||++|+|++|.+||...+..+.
T Consensus 156 ~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~ 211 (298)
T d1gz8a_ 156 V--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 211 (298)
T ss_dssp S--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred c--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH
Confidence 2 2233457999999999876665 57899999999999999999999988765554
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=337.29 Aligned_cols=208 Identities=28% Similarity=0.396 Sum_probs=168.1
Q ss_pred cCCCCCceecccCceEEEEEEECCCC----cEEEEEEcCCCCccc-HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETG----QVVAVKQLDDTGFQG-EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
+.|++.++||+|+||+||+|.+..++ ..||||++....... ...+.+|+.+++.++|||||++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 56888999999999999999986554 469999997544333 3568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
||||+.++++.+.+.. ....+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 87 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999998753 3467999999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCc-ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 227 PTGDKS-HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 227 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~ 220 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH 220 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH
Confidence 333222 22233568999999999999999999999999999999999655544433333
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=343.15 Aligned_cols=207 Identities=30% Similarity=0.489 Sum_probs=172.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCc----EEEEEEcCCCC-cccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQ----VVAVKQLDDTG-FQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
++|++++.||+|+||+||+|.+..+|+ .||+|.++... ....+.+.+|+.+++.++|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 469999999999999999999987776 58888886533 23457799999999999999999999999875 4678
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
+++++.+++|.+.+.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceec
Confidence 8899999999998864 4467899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
.............||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~ 221 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH
Confidence 54444444444568999999999999999999999999999999999 799998776543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=337.72 Aligned_cols=201 Identities=23% Similarity=0.372 Sum_probs=172.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc------HHHHHHHHHHHhhcC--CCcceeeeeEEecCC
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG------EKEFLVEVLMLSLMR--HPNLVHLIGYCAEGT 142 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~E~~~l~~l~--h~nIv~~~~~~~~~~ 142 (299)
.++|++.+.||+|+||+||+|++..+++.||||++.+..... ...+.+|+.+++.++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 468999999999999999999999999999999987543221 234678999999886 899999999999999
Q ss_pred eeEEEEEecCC-CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC-CCceEEccc
Q 022309 143 QRLLVYEYMPL-GSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK-GFHPKLSDF 220 (299)
Q Consensus 143 ~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~-~~~~kl~Df 220 (299)
..++|||++.+ +++.+++. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcc
Confidence 99999999976 57778774 3367999999999999999999999999 999999999999985 479999999
Q ss_pred cccccCCCCCCcccccccccCccccCcccccCCCC-CcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 221 GLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKL-TAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 221 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
|+|...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|.+||...+
T Consensus 156 G~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 214 (273)
T d1xwsa_ 156 GSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214 (273)
T ss_dssp TTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred ccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch
Confidence 999764322 2334679999999999977665 677999999999999999999997643
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-49 Score=334.68 Aligned_cols=209 Identities=33% Similarity=0.462 Sum_probs=171.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEEe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYEY 150 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 150 (299)
.++|++.+.||+|+||+||+|++..+ +.||||+++... ...+.+.+|+.+++.++|||||++++++.+ +..++||||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 36799999999999999999998754 579999997554 445789999999999999999999999865 457899999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCC
Q 022309 151 MPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGD 230 (299)
Q Consensus 151 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 230 (299)
+++|+|..++... ....+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+......
T Consensus 93 ~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 93 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred cCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 9999999988542 2346899999999999999999999999 9999999999999999999999999997643322
Q ss_pred CcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhhhh
Q 022309 231 KSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERML 288 (299)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 288 (299)
. .......||+.|+|||.+.+..++.++|||||||++|||++|..||........++
T Consensus 168 ~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~ 224 (285)
T d1fmka3 168 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 224 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred c-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHH
Confidence 2 22333568999999999999999999999999999999999765555444444443
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-49 Score=333.29 Aligned_cols=207 Identities=26% Similarity=0.422 Sum_probs=167.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCC---cEEEEEEcCCCCccc-HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETG---QVVAVKQLDDTGFQG-EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 146 (299)
.++|++.+.||+|+||.||+|.+..++ ..||||.++...... .+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence 467999999999999999999986543 568999987544333 3568999999999999999999999964 67899
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccC
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFG 226 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~ 226 (299)
||||+++|+|.+++.. ....+++.+++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+|+..
T Consensus 85 v~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence 9999999999998753 3467899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 227 PTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
.... ........||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+
T Consensus 159 ~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~ 217 (273)
T d1mp8a_ 159 EDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 217 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred cCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH
Confidence 3322 222334568999999999999999999999999999999998 899998877654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=336.36 Aligned_cols=207 Identities=27% Similarity=0.377 Sum_probs=173.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCC-CcEEEEEEcCCCCcc--cHHHHHHHHHHHhhc---CCCcceeeeeEEec----
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAET-GQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLM---RHPNLVHLIGYCAE---- 140 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~---- 140 (299)
.++|++++.||+|+||+||+|++..+ ++.||||+++..... ....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999999655 677999998643222 224566788877765 79999999999853
Q ss_pred -CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcc
Q 022309 141 -GTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSD 219 (299)
Q Consensus 141 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~D 219 (299)
....+++||++.++.+..... .....+++..++.++.|++.||+|||+++ |+||||||+|||++..+.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 346789999998876654443 24467899999999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 220 FGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 220 fg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
||++.... .........||+.|+|||++.+..|+.++|||||||++|||++|.+||...+..+.
T Consensus 160 fg~~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 223 (305)
T d1blxa_ 160 FGLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 223 (305)
T ss_dssp CCSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred hhhhhhhc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH
Confidence 99987532 22334456799999999999999999999999999999999999999988776554
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.4e-49 Score=338.12 Aligned_cols=213 Identities=29% Similarity=0.493 Sum_probs=180.2
Q ss_pred hhcCCCCCceecccCceEEEEEEEC-----CCCcEEEEEEcCCCCccc-HHHHHHHHHHHhhcCCCcceeeeeEEecCCe
Q 022309 70 ATDNFKDTNFLGQGGFGAVYKGKLA-----ETGQVVAVKQLDDTGFQG-EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQ 143 (299)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 143 (299)
..++|++++.||+|+||+||+|+.. .+++.||||+++...... .+.+.+|+.+++.++||||+++++++.....
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 4578999999999999999999874 356789999997654333 3679999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 022309 144 RLLVYEYMPLGSLEDHLLGLT--------------------PEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLK 203 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dik 203 (299)
.+++|||+.+|+|.+++.... .....+++.+++.++.|++.||+|||+++ |+|||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence 999999999999999985321 12235889999999999999999999999 9999999
Q ss_pred CCCEEecCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCC-CCCCCCc
Q 022309 204 AGNILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGR-PAMDDSQ 282 (299)
Q Consensus 204 p~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~ 282 (299)
|+|||++.++.+||+|||+|+...............|++.|+|||.+.+..|+.++|||||||++|||++|. +||...+
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999997544333333344567899999999999999999999999999999999995 6787776
Q ss_pred hhh
Q 022309 283 GHE 285 (299)
Q Consensus 283 ~~~ 285 (299)
..+
T Consensus 248 ~~e 250 (301)
T d1lufa_ 248 HEE 250 (301)
T ss_dssp HHH
T ss_pred HHH
Confidence 554
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=335.52 Aligned_cols=218 Identities=27% Similarity=0.355 Sum_probs=170.5
Q ss_pred HHHhhcCCCCCceecccCceEEEEEEECC-----CCcEEEEEEcCCCCccc-HHHHHHHHHHHhhc-CCCcceeeeeEEe
Q 022309 67 LVAATDNFKDTNFLGQGGFGAVYKGKLAE-----TGQVVAVKQLDDTGFQG-EKEFLVEVLMLSLM-RHPNLVHLIGYCA 139 (299)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 139 (299)
.....++|++++.||+|+||.||+|.+.. +++.||||+++...... ...+.+|..++..+ +|+||+.+++++.
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 33445789999999999999999999743 45789999997544332 35677777777766 6899999999886
Q ss_pred cC-CeeEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 022309 140 EG-TQRLLVYEYMPLGSLEDHLLGLTP------------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGN 206 (299)
Q Consensus 140 ~~-~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~N 206 (299)
.+ ...++||||+++|+|.+++..... ....+++.+++.++.|++.||.|||+++ |+||||||+|
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~N 164 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARN 164 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccc
Confidence 54 468999999999999999864211 1345889999999999999999999999 9999999999
Q ss_pred EEecCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhC-CCCCCCCchhh
Q 022309 207 ILLGKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITG-RPAMDDSQGHE 285 (299)
Q Consensus 207 ilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~ 285 (299)
||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+|| .+||...+..+
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999865444444444556799999999999999999999999999999999997 57887766554
Q ss_pred hh
Q 022309 286 RM 287 (299)
Q Consensus 286 ~~ 287 (299)
.+
T Consensus 245 ~~ 246 (299)
T d1ywna1 245 EF 246 (299)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.1e-48 Score=331.17 Aligned_cols=205 Identities=24% Similarity=0.347 Sum_probs=174.4
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
++|++++.||+|+||+||+|++. +++.||||+++...... .+.+.+|+.+++.++||||+++++++.+++..+++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 58999999999999999999986 78999999997654322 3678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
++.++.+..+. .....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|......
T Consensus 81 ~~~~~~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 81 HLDQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CCSEEHHHHHH----TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred eehhhhHHHHH----hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 99876666665 34578999999999999999999999999 999999999999999999999999999764322
Q ss_pred CCcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
. .......|++.|+|||.+.+. .++.++|||||||++|||++|++||.+.+..+.
T Consensus 154 ~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~ 209 (286)
T d1ob3a_ 154 V--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ 209 (286)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred c--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH
Confidence 2 222334689999999998664 568999999999999999999999988776554
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-48 Score=330.15 Aligned_cols=212 Identities=30% Similarity=0.416 Sum_probs=176.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCC-------cEEEEEEcCCCCccc-HHHHHHHHHHHhhc-CCCcceeeeeEEecC
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETG-------QVVAVKQLDDTGFQG-EKEFLVEVLMLSLM-RHPNLVHLIGYCAEG 141 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~-~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 141 (299)
.++|++++.||+|+||.||+|+...++ ..||||+++...... ...+.+|...+..+ +|||||++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 467999999999999999999876544 479999997655433 36788888888877 899999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEe
Q 022309 142 TQRLLVYEYMPLGSLEDHLLGLTP------------EMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL 209 (299)
Q Consensus 142 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv 209 (299)
+..++||||+++|+|.+++..... ....+++.+++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999964321 2356899999999999999999999999 9999999999999
Q ss_pred cCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhh
Q 022309 210 GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHE 285 (299)
Q Consensus 210 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 285 (299)
+.++.+||+|||++................|++.|+|||.+.+..|+.++|||||||++|||++ |.+||...+..+
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~ 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence 9999999999999986544444444455678999999999999999999999999999999998 789998776543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=335.37 Aligned_cols=208 Identities=25% Similarity=0.361 Sum_probs=172.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEecCC----eeE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT----QRL 145 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~----~~~ 145 (299)
.++|++++.||+|+||+||+|.+..+|+.||||++.+.... ..+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 46799999999999999999999999999999999765432 2356889999999999999999999986653 234
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
++++++.+++|.+++.. ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|..
T Consensus 87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 55566779999999953 46899999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCCc-ccccccccCccccCccccc-CCCCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 226 GPTGDKS-HVSTRVMGTHGYCAPEYAT-TGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 226 ~~~~~~~-~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
....... ......+||+.|+|||++. +..++.++||||+||++|+|++|.+||...+..+.
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~ 221 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 221 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH
Confidence 4332221 2234467999999999984 45678999999999999999999999988775443
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=329.08 Aligned_cols=208 Identities=33% Similarity=0.462 Sum_probs=166.6
Q ss_pred cCCCCCceecccCceEEEEEEECC-CC--cEEEEEEcCCCCcc---cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAE-TG--QVVAVKQLDDTGFQ---GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRL 145 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~-~~--~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 145 (299)
++|++++.||+|+||.||+|+... ++ ..||||++.+.... ..+.+.+|+.+++.++||||+++++++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 569999999999999999998643 33 36899998754322 23578999999999999999999999976 4678
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 146 LVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 146 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
+||||++++++.+.+.. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 99999999999998763 3356999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCccc-ccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhhh
Q 022309 226 GPTGDKSHV-STRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHER 286 (299)
Q Consensus 226 ~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~ 286 (299)
......... .....|+..|+|||++.+..++.++|||||||++|||+| |.+||...+..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~ 223 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 223 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH
Confidence 544333222 233457889999999999999999999999999999998 8999987766553
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=329.45 Aligned_cols=209 Identities=26% Similarity=0.370 Sum_probs=172.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCc--ccHHHHHHHHHHHhhcCCCcceeeeeEEec--------
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGF--QGEKEFLVEVLMLSLMRHPNLVHLIGYCAE-------- 140 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-------- 140 (299)
.++|++++.||+|+||+||+|++..+|+.||||++..... .....+.+|+.+++.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 4789999999999999999999999999999999865432 233678899999999999999999998754
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccc
Q 022309 141 GTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDF 220 (299)
Q Consensus 141 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Df 220 (299)
....++|||++.++.+.... .....+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeec
Confidence 34578999999876665544 34567899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCc--ccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 221 GLAKFGPTGDKS--HVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 221 g~a~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
|++......... ......+||+.|+|||++.+. .++.++|||||||++|||++|.+||...+..+.
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~ 230 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ 230 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH
Confidence 999754432221 122335799999999998765 689999999999999999999999987665443
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=325.20 Aligned_cols=200 Identities=32% Similarity=0.471 Sum_probs=166.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEec-CCeeEEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAE-GTQRLLVYE 149 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~~~~lv~e 149 (299)
.++|++++.||+|+||.||+|.+ +|..||||+++... ..+.+.+|+.+++.++||||+++++++.+ .+.+++|||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 35688999999999999999998 57889999997653 44678999999999999999999999855 456899999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
|+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 y~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~- 155 (262)
T d1byga_ 82 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 155 (262)
T ss_dssp CCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC-
Confidence 99999999998532 2235899999999999999999999999 99999999999999999999999999985322
Q ss_pred CCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGH 284 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 284 (299)
......+++.|+|||++.+..++.++|||||||++|||+| |.+||...+..
T Consensus 156 ----~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~ 207 (262)
T d1byga_ 156 ----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 207 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG
T ss_pred ----CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH
Confidence 1223457889999999998999999999999999999998 78888776544
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=333.40 Aligned_cols=202 Identities=29% Similarity=0.404 Sum_probs=169.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEecCC------
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAEGT------ 142 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~------ 142 (299)
.++|++++.||+|+||+||+|.+..+|+.||||++++..... .+.+.+|+.+++.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999999999999999997654332 356889999999999999999999997654
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccc
Q 022309 143 QRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGL 222 (299)
Q Consensus 143 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~ 222 (299)
.+++||||+ +.+|..++. ..++++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 469999999 667887774 257999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 223 AKFGPTGDKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 223 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
|..... ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...+..+.
T Consensus 168 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~ 227 (346)
T d1cm8a_ 168 ARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 227 (346)
T ss_dssp CEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred eeccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH
Confidence 986432 22345799999999998764 578999999999999999999999988765443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.4e-47 Score=323.83 Aligned_cols=204 Identities=22% Similarity=0.307 Sum_probs=175.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCC-CcceeeeeEEecCCeeEEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRH-PNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~~~~~lv~e 149 (299)
.++|++++.||+|+||+||+|++..+++.||||++.... ....+.+|+..++.+.| +||+.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999999999999999886542 23457788899988865 899999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC-----CCceEEccccccc
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK-----GFHPKLSDFGLAK 224 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~-----~~~~kl~Dfg~a~ 224 (299)
++ +++|.+++.. ....+++.++..++.|++.||+|||++| |+||||||+|||++. .+.++|+|||+|+
T Consensus 82 ~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeE
Confidence 98 6899998864 3357899999999999999999999999 999999999999974 5789999999998
Q ss_pred cCCCCCCc-----ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 225 FGPTGDKS-----HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 225 ~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
........ .......||+.|+|||++.+..++.++|||||||++|||++|..||...+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~ 218 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence 65332211 123346799999999999999999999999999999999999999976544
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-47 Score=326.75 Aligned_cols=213 Identities=29% Similarity=0.429 Sum_probs=181.7
Q ss_pred hcCCCCCceecccCceEEEEEEE-----CCCCcEEEEEEcCCCCcc-cHHHHHHHHHHHhhc-CCCcceeeeeEEecCCe
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKL-----AETGQVVAVKQLDDTGFQ-GEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQ 143 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 143 (299)
.++|++.+.||+|+||.||+|++ ..+++.||||+++..... ....+.+|+.+++.+ +|||||++++++.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 46799999999999999999986 346678999999765433 335688999999998 69999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccC--------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEe
Q 022309 144 RLLVYEYMPLGSLEDHLLGLT--------------PEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILL 209 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv 209 (299)
.++||||+++|+|.+++.... .....+++..+..++.||+.||+|||+++ ++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999986432 12346899999999999999999999999 9999999999999
Q ss_pred cCCCceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHh-CCCCCCCCchhhh
Q 022309 210 GKGFHPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELIT-GRPAMDDSQGHER 286 (299)
Q Consensus 210 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~ 286 (299)
+.++.++|+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+.
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999987655444444555789999999999999999999999999999999999 5666766655443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-47 Score=326.11 Aligned_cols=208 Identities=30% Similarity=0.472 Sum_probs=173.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcE--EEEEEcCCCCc-ccHHHHHHHHHHHhhc-CCCcceeeeeEEecCCeeEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQV--VAVKQLDDTGF-QGEKEFLVEVLMLSLM-RHPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv 147 (299)
++|++.+.||+|+||+||+|.+..++.. ||||.++.... ...+.+.+|+.++..+ +||||+++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 6799999999999999999999888764 67787754322 2346799999999998 799999999999999999999
Q ss_pred EEecCCCCHHHHhccc------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCce
Q 022309 148 YEYMPLGSLEDHLLGL------------TPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHP 215 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~ 215 (299)
|||+++|+|.+++... ......+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998642 123467899999999999999999999999 9999999999999999999
Q ss_pred EEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCC-CCCCCCchhh
Q 022309 216 KLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGR-PAMDDSQGHE 285 (299)
Q Consensus 216 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~ 285 (299)
||+|||+|+..... .......||+.|+|||.+.+..++.++|||||||++|||++|. +||...+..+
T Consensus 167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~ 234 (309)
T d1fvra_ 167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 234 (309)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999753221 1122346899999999999999999999999999999999975 5777665444
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-47 Score=330.91 Aligned_cols=204 Identities=28% Similarity=0.392 Sum_probs=169.4
Q ss_pred CCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEec------CCeeEE
Q 022309 73 NFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAE------GTQRLL 146 (299)
Q Consensus 73 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~------~~~~~l 146 (299)
+|+.+++||+|+||+||+|++..+++.||||++..... ...+|+.+++.++||||++++++|.. ..+.+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 48889999999999999999999999999999975432 23469999999999999999999843 235789
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC-ceEEcccccccc
Q 022309 147 VYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF-HPKLSDFGLAKF 225 (299)
Q Consensus 147 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~-~~kl~Dfg~a~~ 225 (299)
||||+.++ +.+.+.........+++.+++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||++..
T Consensus 97 v~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999765 44444322234567999999999999999999999999 99999999999999765 899999999976
Q ss_pred CCCCCCcccccccccCccccCcccccC-CCCCcccceehhHHHHHHHHhCCCCCCCCchhhhh
Q 022309 226 GPTGDKSHVSTRVMGTHGYCAPEYATT-GKLTAKSDIFSFGVVLLELITGRPAMDDSQGHERM 287 (299)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 287 (299)
..... ......|++.|+|||.+.+ ..++.++|||||||++|||++|.+||...+..+.+
T Consensus 173 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l 232 (350)
T d1q5ka_ 173 LVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232 (350)
T ss_dssp CCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH
T ss_pred ccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHH
Confidence 53322 2334579999999998765 46899999999999999999999999887765543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.8e-46 Score=324.19 Aligned_cols=198 Identities=21% Similarity=0.327 Sum_probs=172.0
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcC-CCcceeeeeEEec--CCeeEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMR-HPNLVHLIGYCAE--GTQRLLVY 148 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~--~~~~~lv~ 148 (299)
++|+++++||+|+||+||+|++..+++.||||+++.. ..+.+.+|+.+++.+. ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 6799999999999999999999999999999999754 3467889999999985 9999999999974 35689999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCC-ceEEccccccccCC
Q 022309 149 EYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGF-HPKLSDFGLAKFGP 227 (299)
Q Consensus 149 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~-~~kl~Dfg~a~~~~ 227 (299)
||+.+++|..+. +.+++.++..++.||+.||+|||++| |+||||||+|||++.++ .++|+|||+|....
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence 999999987654 56899999999999999999999999 99999999999998654 69999999998654
Q ss_pred CCCCcccccccccCccccCcccccCC-CCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 228 TGDKSHVSTRVMGTHGYCAPEYATTG-KLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
... ......+|+.|+|||.+.+. .++.++||||+||++|+|++|..||.......
T Consensus 182 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~ 237 (328)
T d3bqca1 182 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 237 (328)
T ss_dssp TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred CCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhH
Confidence 322 23345689999999998765 47999999999999999999999998766544
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=318.82 Aligned_cols=206 Identities=23% Similarity=0.308 Sum_probs=178.0
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecCCeeEEEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 149 (299)
++|++++.||+|+||+||+|++..+++.||||+++..... ....+.+|+.+++.++||||+++++++.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999999999999999998654332 24678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTG 229 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~ 229 (299)
++.+++|..++. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.|......
T Consensus 82 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999988888774 4467899999999999999999999999 999999999999999999999999999865433
Q ss_pred CCcccccccccCccccCcccccCCC-CCcccceehhHHHHHHHHhCCCCCCCCchhhh
Q 022309 230 DKSHVSTRVMGTHGYCAPEYATTGK-LTAKSDIFSFGVVLLELITGRPAMDDSQGHER 286 (299)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 286 (299)
.. ......+++.|+|||++.+.. ++.++|||||||++|||++|..||.......+
T Consensus 155 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 210 (292)
T d1unla_ 155 VR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210 (292)
T ss_dssp CS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH
T ss_pred Cc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH
Confidence 22 222345778899999987665 68999999999999999999988655544333
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-47 Score=325.48 Aligned_cols=213 Identities=28% Similarity=0.443 Sum_probs=180.8
Q ss_pred hcCCCCCceecccCceEEEEEEECC-----CCcEEEEEEcCCCCccc-HHHHHHHHHHHhhcCCCcceeeeeEEecCCee
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAE-----TGQVVAVKQLDDTGFQG-EKEFLVEVLMLSLMRHPNLVHLIGYCAEGTQR 144 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 144 (299)
.++|++.+.||+|+||+||+|.+.. ++..||||+++...... ...+.+|+.+++.++||||+++++++..+...
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 4679999999999999999998742 35789999997654333 35688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccc------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEc
Q 022309 145 LLVYEYMPLGSLEDHLLGL------TPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLS 218 (299)
Q Consensus 145 ~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~ 218 (299)
++||||+.+|+|.+++... ......+++..+..++.|+++||.|||+++ |+||||||+|||++.++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 9999999999999987531 123345788999999999999999999999 9999999999999999999999
Q ss_pred cccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhC-CCCCCCCchhhh
Q 022309 219 DFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITG-RPAMDDSQGHER 286 (299)
Q Consensus 219 Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~ 286 (299)
|||+|+...............|++.|+|||.+.+..++.++||||||+++|||+|| .+||...+..+.
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~ 244 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 244 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999765433333334445789999999999999999999999999999999998 577877665443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-47 Score=327.42 Aligned_cols=206 Identities=29% Similarity=0.403 Sum_probs=175.6
Q ss_pred cCCCCCceecccCceEEEEEEE---CCCCcEEEEEEcCCCCc----ccHHHHHHHHHHHhhcCC-CcceeeeeEEecCCe
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKL---AETGQVVAVKQLDDTGF----QGEKEFLVEVLMLSLMRH-PNLVHLIGYCAEGTQ 143 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~~~ 143 (299)
++|++++.||+|+||+||+|++ ..+|+.||||++++... ...+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6699999999999999999987 44789999999875432 223567889999999977 899999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA 223 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a 223 (299)
.+++|||+.+++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.++|+|||+|
T Consensus 104 ~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999953 356788999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCcccccccccCccccCcccccCC--CCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 224 KFGPTGDKSHVSTRVMGTHGYCAPEYATTG--KLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
+...... ........|++.|+|||.+.+. .++.++|||||||++|+|++|..||...+..+
T Consensus 177 ~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~ 239 (322)
T d1vzoa_ 177 KEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239 (322)
T ss_dssp EECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC
T ss_pred hhhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 7643322 2223345799999999998665 46789999999999999999999997765443
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=317.86 Aligned_cols=201 Identities=31% Similarity=0.469 Sum_probs=167.6
Q ss_pred CceecccCceEEEEEEECCCC---cEEEEEEcCCCCcc-cHHHHHHHHHHHhhcCCCcceeeeeEEec-CCeeEEEEEec
Q 022309 77 TNFLGQGGFGAVYKGKLAETG---QVVAVKQLDDTGFQ-GEKEFLVEVLMLSLMRHPNLVHLIGYCAE-GTQRLLVYEYM 151 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~~~~lv~e~~ 151 (299)
.++||+|+||+||+|.+..++ ..||||.++..... ..+.+.+|+.++++++||||+++++++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 468999999999999986543 36899999754322 33679999999999999999999999765 56889999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEccccccccCCCCCC
Q 022309 152 PLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKFGPTGDK 231 (299)
Q Consensus 152 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~~~~~~~ 231 (299)
++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999998863 4456788899999999999999999999 99999999999999999999999999986543322
Q ss_pred c--ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 232 S--HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 232 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
. .......||+.|+|||.+.+..++.++||||||+++|||+||..||.....
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~ 239 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 239 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC
Confidence 2 122335689999999999999999999999999999999998777765443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-46 Score=325.53 Aligned_cols=202 Identities=26% Similarity=0.372 Sum_probs=170.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc--cHHHHHHHHHHHhhcCCCcceeeeeEEecC-----Ce
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ--GEKEFLVEVLMLSLMRHPNLVHLIGYCAEG-----TQ 143 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-----~~ 143 (299)
.++|++++.||+|+||+||+|++..+|+.||||++++.... ..+.+.+|+.+++.++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46899999999999999999999999999999999765432 235688999999999999999999998533 34
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA 223 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a 223 (299)
.+++++++.|++|.+++. ..++++.+++.++.||+.||+|||++| |+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 467778888999999984 257999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCcccccccccCccccCcccccCCC-CCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 224 KFGPTGDKSHVSTRVMGTHGYCAPEYATTGK-LTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
.... .......|++.|+|||.+.+.. ++.++|||||||++|+|++|.+||...+...
T Consensus 169 ~~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~ 226 (348)
T d2gfsa1 169 RHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 226 (348)
T ss_dssp -CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH
Confidence 7532 2233457899999999876654 6889999999999999999999998776543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.3e-46 Score=318.02 Aligned_cols=205 Identities=24% Similarity=0.304 Sum_probs=170.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcc-eeeeeEEecCCeeEEEEE
Q 022309 71 TDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNL-VHLIGYCAEGTQRLLVYE 149 (299)
Q Consensus 71 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~e 149 (299)
.++|++++.||+|+||+||+|++..+++.||||++.... ....+..|+.+++.++|+|+ +.+.+++.+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 357999999999999999999999999999999886543 23457889999999987665 555666688888999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecC---CCceEEccccccccC
Q 022309 150 YMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGK---GFHPKLSDFGLAKFG 226 (299)
Q Consensus 150 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~---~~~~kl~Dfg~a~~~ 226 (299)
++ +++|.+.+.. ....+++.++..++.|++.||+|||+++ |+||||||+|||++. +..++|+|||+|+..
T Consensus 84 ~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred Ec-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 98 5677776643 3467999999999999999999999999 999999999999864 457999999999865
Q ss_pred CCCCCc-----ccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchh
Q 022309 227 PTGDKS-----HVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGH 284 (299)
Q Consensus 227 ~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 284 (299)
...... .......||+.|+|||++.+..++.++|||||||++|||++|.+||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~ 219 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchH
Confidence 433221 1223467999999999999999999999999999999999999999776543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-46 Score=325.31 Aligned_cols=201 Identities=24% Similarity=0.305 Sum_probs=164.8
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCccc--HHHHHHHHHHHhhcCCCcceeeeeEEec------CCe
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQG--EKEFLVEVLMLSLMRHPNLVHLIGYCAE------GTQ 143 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~~~~~~------~~~ 143 (299)
++|+++++||+|+||+||+|++..+|+.||||++....... ...+.+|+.+++.++||||++++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999999999999999997654332 2468899999999999999999999953 367
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCceEEcccccc
Q 022309 144 RLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHPKLSDFGLA 223 (299)
Q Consensus 144 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a 223 (299)
.|+||||+.++ +.+.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.++++|||++
T Consensus 97 ~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 89999999765 444442 45899999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCchhh
Q 022309 224 KFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQGHE 285 (299)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 285 (299)
...... .......+|+.|+|||++.+..+++++||||+||++|+|++|.+||...+...
T Consensus 167 ~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~ 225 (355)
T d2b1pa1 167 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred hccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH
Confidence 754322 22334578999999999999999999999999999999999999998776443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=321.73 Aligned_cols=203 Identities=28% Similarity=0.374 Sum_probs=162.2
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcceeeeeEEecCC----eeEEE
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNLVHLIGYCAEGT----QRLLV 147 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~----~~~lv 147 (299)
.+|.+.+.||+|+||.||+|+. +|+.||||+++... ........|+..+..++||||+++++++.+++ .+++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 3577788999999999999987 68999999986442 11122344555666789999999999997643 57899
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEecCCCCCCEEecCCCceEEccccc
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK-----ADPPVIYRDLKAGNILLGKGFHPKLSDFGL 222 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-----~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~ 222 (299)
|||+++|+|.+++.. .++++.+++.++.|++.||+|||+. .+.+|+||||||+||||+.++.+||+|||+
T Consensus 80 ~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 999999999999953 4688999999999999999999973 112399999999999999999999999999
Q ss_pred cccCCCCCCcc--cccccccCccccCcccccCCC------CCcccceehhHHHHHHHHhCCCCCCCCc
Q 022309 223 AKFGPTGDKSH--VSTRVMGTHGYCAPEYATTGK------LTAKSDIFSFGVVLLELITGRPAMDDSQ 282 (299)
Q Consensus 223 a~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~------~~~~~DiwslG~il~elltg~~pf~~~~ 282 (299)
+.......... ......||+.|+|||++.+.. ++.++|||||||++|||+||.+||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~ 222 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccc
Confidence 97653332221 223467999999999987643 5678999999999999999998875433
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-39 Score=285.65 Aligned_cols=202 Identities=22% Similarity=0.260 Sum_probs=160.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcC-----------CCcceeeeeEEec
Q 022309 72 DNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMR-----------HPNLVHLIGYCAE 140 (299)
Q Consensus 72 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~~~~~~~~ 140 (299)
++|+++++||+|+||+||+|++..+|+.||||++++... ..+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 469999999999999999999999999999999976532 2356778888887765 5789999988754
Q ss_pred --CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEecCCC----
Q 022309 141 --GTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHN-KADPPVIYRDLKAGNILLGKGF---- 213 (299)
Q Consensus 141 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~dikp~Nilv~~~~---- 213 (299)
....+++++++..+........ ......+++..+..++.|++.||+|||+ .| |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred ccccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccc
Confidence 3455666766654433222221 1345678999999999999999999998 88 99999999999998654
Q ss_pred --ceEEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHHHHHHHhCCCCCCCCch
Q 022309 214 --HPKLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVVLLELITGRPAMDDSQG 283 (299)
Q Consensus 214 --~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 283 (299)
.++|+|||.+..... ......||+.|+|||++.+..++.++||||+||++++|++|..||...+.
T Consensus 168 ~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~ 234 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 234 (362)
T ss_dssp EEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred cceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence 389999999975322 22345799999999999999999999999999999999999999975543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=1e-27 Score=191.40 Aligned_cols=169 Identities=12% Similarity=0.035 Sum_probs=118.4
Q ss_pred CCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcc-----c-------------HHHHHHHHHHHhhcCCCcceeee
Q 022309 74 FKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQ-----G-------------EKEFLVEVLMLSLMRHPNLVHLI 135 (299)
Q Consensus 74 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~-------------~~~~~~E~~~l~~l~h~nIv~~~ 135 (299)
+.+.+.||+|+||+||+|.+. +|+.||||+++..... . .....+|...+..+.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 346789999999999999985 6899999987542211 0 12345678888899999999988
Q ss_pred eEEecCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEecCCCce
Q 022309 136 GYCAEGTQRLLVYEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKADPPVIYRDLKAGNILLGKGFHP 215 (299)
Q Consensus 136 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~dikp~Nilv~~~~~~ 215 (299)
++.. .+++||++++..+.+ ++...+..++.|++.+|.|||+++ |+||||||+|||++++ .+
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EE
T ss_pred EecC----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CE
Confidence 7642 379999998765432 233456789999999999999999 9999999999999976 48
Q ss_pred EEccccccccCCCCCCcccccccccCccccCcccccCCCCCcccceehhHHH
Q 022309 216 KLSDFGLAKFGPTGDKSHVSTRVMGTHGYCAPEYATTGKLTAKSDIFSFGVV 267 (299)
Q Consensus 216 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~i 267 (299)
+|+|||+|.....+.........+.. -.+. ....|+.++|+||+.--
T Consensus 142 ~liDFG~a~~~~~~~~~~~l~rd~~~----~~~~-f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 142 WIIDFPQSVEVGEEGWREILERDVRN----IITY-FSRTYRTEKDINSAIDR 188 (191)
T ss_dssp EECCCTTCEETTSTTHHHHHHHHHHH----HHHH-HHHHHCCCCCHHHHHHH
T ss_pred EEEECCCcccCCCCCcHHHHHHHHHH----HHHH-HcCCCCCcccHHHHHHH
Confidence 99999999753221111000000000 0011 13567889999996543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.97 E-value=2.2e-09 Score=87.85 Aligned_cols=146 Identities=13% Similarity=0.035 Sum_probs=100.9
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcC-CCcceeeeeEEecCCeeEEE
Q 022309 69 AATDNFKDTNFLGQGGFGAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMR-HPNLVHLIGYCAEGTQRLLV 147 (299)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv 147 (299)
.....|++++..+.++.+.||+... ++..+++|............+.+|..+++.+. +--+.+++.+..+++..++|
T Consensus 11 ~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 11 KLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 3345677666655555678998753 56678889876554344456778888887764 44467888888888889999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 022309 148 YEYMPLGSLEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNKA---------------------------------- 193 (299)
Q Consensus 148 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---------------------------------- 193 (299)
|++++|.++.+.... . .....++.++...+..||+..
T Consensus 89 ~~~l~G~~~~~~~~~-----~----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 89 MSEADGVLCSEEYED-----E----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EECCSSEEHHHHTTT-----C----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEecccccccccccc-----c----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 999999888665421 0 112234555555566666421
Q ss_pred ----------------------CCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 194 ----------------------DPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 194 ----------------------~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
.+.++|+|+.|.||++++++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12279999999999999876667999999874
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.35 E-value=9.6e-07 Score=76.19 Aligned_cols=77 Identities=16% Similarity=0.071 Sum_probs=48.6
Q ss_pred CceecccCceEEEEEEECCCCcEEEEEEcCCC----C---cccHHHHHHHHHHHhhcC-C--CcceeeeeEEecCCeeEE
Q 022309 77 TNFLGQGGFGAVYKGKLAETGQVVAVKQLDDT----G---FQGEKEFLVEVLMLSLMR-H--PNLVHLIGYCAEGTQRLL 146 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~-h--~nIv~~~~~~~~~~~~~l 146 (299)
.+.||.|....||++.+..+++.+++|..... . .........|+.+++.+. + ..+++++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 45789999999999988777889999975421 0 111234556887777663 2 345566654 3345689
Q ss_pred EEEecCCCC
Q 022309 147 VYEYMPLGS 155 (299)
Q Consensus 147 v~e~~~~~~ 155 (299)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.31 E-value=1.6e-06 Score=69.90 Aligned_cols=131 Identities=20% Similarity=0.118 Sum_probs=83.7
Q ss_pred eecccCc-eEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCC--CcceeeeeEEecCCeeEEEEEecCCCC
Q 022309 79 FLGQGGF-GAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRH--PNLVHLIGYCAEGTQRLLVYEYMPLGS 155 (299)
Q Consensus 79 ~lg~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~~~~lv~e~~~~~~ 155 (299)
.+..|.. +.||+... .++..+++|...... ...+..|+..++.+.. -.+.+++.+..+++..++||++++|.+
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 3444443 67898765 356678889765442 2346678887776643 336778888888888999999998865
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 022309 156 LEDHLLGLTPEMKPLDWNTRMKIAAGAARGLEYLHNK------------------------------------------- 192 (299)
Q Consensus 156 L~~~l~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~------------------------------------------- 192 (299)
+.+.. .... .++.++...|.-||+.
T Consensus 93 ~~~~~---------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
T d1nd4a_ 93 LLSSH---------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 160 (255)
T ss_dssp TTTSC---------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred ccccc---------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHH
Confidence 53211 1111 1122333333333321
Q ss_pred ------------CCCCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 193 ------------ADPPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 193 ------------~~~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
..+.++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 161 ~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 161 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 112379999999999999876677999999864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.27 E-value=0.00053 Score=58.51 Aligned_cols=74 Identities=19% Similarity=0.296 Sum_probs=50.5
Q ss_pred CceecccCceEEEEEEECC-------CCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcc-eeeeeEEecCCeeEEEE
Q 022309 77 TNFLGQGGFGAVYKGKLAE-------TGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNL-VHLIGYCAEGTQRLLVY 148 (299)
Q Consensus 77 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~ 148 (299)
++.|+.|--=.+|++.... ..+.|.+++.-.. ....+..+|..+++.+.-.++ .++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 4568778888999988643 3456778876532 334566788888888753344 467777653 6899
Q ss_pred EecCCCCH
Q 022309 149 EYMPLGSL 156 (299)
Q Consensus 149 e~~~~~~L 156 (299)
||++|.++
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.23 E-value=0.00077 Score=55.84 Aligned_cols=136 Identities=15% Similarity=0.090 Sum_probs=75.5
Q ss_pred eEEEEEEECCCCcEEEEEEcCCCCcccHHHHHHHHHHHhhcCCCcc--eeee-----eEEecCCeeEEEEEecCCCCHH-
Q 022309 86 GAVYKGKLAETGQVVAVKQLDDTGFQGEKEFLVEVLMLSLMRHPNL--VHLI-----GYCAEGTQRLLVYEYMPLGSLE- 157 (299)
Q Consensus 86 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI--v~~~-----~~~~~~~~~~lv~e~~~~~~L~- 157 (299)
-.||++.. .+|..|++|+.+... ...+.+..|...+..|...+| +..+ ..+..+...+.+++++.|..+.
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 47999876 468889999887543 334667788888877743222 1111 1234556778899998763221
Q ss_pred ----H------Hh-------cccC-CCCCCCCH-------------------H---HHHHHHHHHHHHHHHHH-hCCCCC
Q 022309 158 ----D------HL-------LGLT-PEMKPLDW-------------------N---TRMKIAAGAARGLEYLH-NKADPP 196 (299)
Q Consensus 158 ----~------~l-------~~~~-~~~~~~~~-------------------~---~~~~i~~ql~~~l~~lH-~~~~~~ 196 (299)
. .+ .... .....++. . .....+.++...+.-+- ......
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 0 00 0000 00111111 1 11222233333332221 112345
Q ss_pred eEecCCCCCCEEecCCCceEEcccccccc
Q 022309 197 VIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 197 i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
++|+|+.+.|||++.+ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999753 45899999875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.11 E-value=0.003 Score=51.70 Aligned_cols=31 Identities=29% Similarity=0.174 Sum_probs=27.1
Q ss_pred CCeEecCCCCCCEEecCCCceEEcccccccc
Q 022309 195 PPVIYRDLKAGNILLGKGFHPKLSDFGLAKF 225 (299)
Q Consensus 195 ~~i~H~dikp~Nilv~~~~~~kl~Dfg~a~~ 225 (299)
.+++|+|+.++||+++.+...-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 3489999999999999887778999999863
|